CDMCnumber Block Column Rown OligoID SampleID ORF Flag? sequence length FBan_Number FBgn_Number Gene_Symbol Chromosome_arm Chromosome_arm GO_Biological_process GO_Molecular_function GO_Cellular_component Gene_Symbol Full_name Synonyms CDMC20001 1 1 1 DAC01-A12 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC20001 1 2 1 DAC01-A12 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC20002 1 3 1 DAC01-A24 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC20002 1 4 1 DAC01-A24 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC20003 1 5 1 DAC01-E12 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC20003 1 6 1 DAC01-E12 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC20004 1 7 1 DAC01-E24 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC20004 1 8 1 DAC01-E24 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC20005 1 9 1 DAC01-I12 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC20005 1 10 1 DAC01-I12 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC20006 1 11 1 DAC01-I24 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC20006 1 12 1 DAC01-I24 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC20007 1 13 1 DAC01-M12 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC20007 1 14 1 DAC01-M12 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC20008 1 15 1 DAC01-M24 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC20008 1 16 1 DAC01-M24 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC20009 1 17 1 DAC02-A12 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC20009 1 18 1 DAC02-A12 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC20010 1 19 1 DAC02-A24 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC20010 1 20 1 DAC02-A24 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC20011 1 21 1 DAC02-E12 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC20011 1 22 1 DAC02-E12 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC20012 1 23 1 DAC02-E24 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC20012 1 24 1 DAC02-E24 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC20013 1 25 1 DAC02-I12 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC20013 1 26 1 DAC02-I12 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC20014 1 1 2 DAC02-I24 N/A CG9075 (01674-01910) CDMC20014 1 2 2 DAC02-I24 N/A CG9075 (01674-01910) CDMC20015 1 3 2 DAC02-M12 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC20015 1 4 2 DAC02-M12 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC20016 1 5 2 DAC02-M24 AutoBlank AutoBlank CDMC20016 1 6 2 DAC02-M24 AutoBlank AutoBlank CDMC20017 1 7 2 DAC03-A12 23-CG32207-RA_1 CG32207 CGACTGATGCATTTCTCAATCACAGCCATTTCTAAATCAATCGTCAAATCTAAACTAACTGCAAATTTT 69 FBan0032207 FBgn0052207 CG32207 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32207 CG32207 BcDNA:LD41276 CDMC20017 1 8 2 DAC03-A12 23-CG32207-RA_1 CG32207 CGACTGATGCATTTCTCAATCACAGCCATTTCTAAATCAATCGTCAAATCTAAACTAACTGCAAATTTT 69 FBan0032207 FBgn0052207 CG32207 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32207 CG32207 BcDNA:LD41276 CDMC20018 1 9 2 DAC03-A24 11-CG3221-RA_2 CG3221 GCCACGCAGTGTCTTATTGACCAGTTGGATCTTGGCAAGATTCACTGCCTCAGTTTAACGGACATGGCG 69 FBan0003221 FBgn0034569 CG3221 2 2R CG3221 CG3221 CDMC20018 1 10 2 DAC03-A24 11-CG3221-RA_2 CG3221 GCCACGCAGTGTCTTATTGACCAGTTGGATCTTGGCAAGATTCACTGCCTCAGTTTAACGGACATGGCG 69 FBan0003221 FBgn0034569 CG3221 2 2R CG3221 CG3221 CDMC20019 1 11 2 DAC03-E12 16-CG32248-RA_1 CG32248 TCAGCACTTCCGTTTGGATCCGCAGATTCTCCGACTTGTATAAAAGTACAGGAGTCGCCGGTCTAAGAT 69 FBan0032248 FBgn0052248 CG32248 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32248 CG32248 CDMC20019 1 12 2 DAC03-E12 16-CG32248-RA_1 CG32248 TCAGCACTTCCGTTTGGATCCGCAGATTCTCCGACTTGTATAAAAGTACAGGAGTCGCCGGTCTAAGAT 69 FBan0032248 FBgn0052248 CG32248 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32248 CG32248 CDMC20020 1 13 2 DAC03-E24 6-CG32254-RA_1 CG32254 GCATGCAACCAACTACCACCTAGCCTGGCTTCTTTCTCAAAAGCCCCCACCAAATGCTAAGGCGTATTT 69 FBan0032254 FBgn0052254 CG32254 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32254 CG32254 BcDNA:RH01388 CDMC20020 1 14 2 DAC03-E24 6-CG32254-RA_1 CG32254 GCATGCAACCAACTACCACCTAGCCTGGCTTCTTTCTCAAAAGCCCCCACCAAATGCTAAGGCGTATTT 69 FBan0032254 FBgn0052254 CG32254 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32254 CG32254 BcDNA:RH01388 CDMC20021 1 15 2 DAC03-I12 3-CG32296-RA_2 CG32296 GACAGCTCCTCTGTGCAAACGCAAGACGGCAAGCATTAAGTCCGAACAAGTCAGCGATGTTCTGGACAT 69 FBan0032296 FBgn0052296 Mrtf 3 3L "actin cytoskeleton organization and biogenesis; GO:0030036; border follicle cell migration (sensu Insecta); GO:0007298; mesodermal cell migration; GO:0008078; positive regulation of transcription, DNA-dependent; GO:0045893; tracheal system development (sensu Insecta); GO:0007424; wing morphogenesis; GO:0007476" DNA binding; GO:0003677; transcriptional activator activity; GO:0016563; ; GO:0016563; ; GO:0003677 Mrtf Myocardin-related transcription factor "CG12188, CG32296, CG14951, CG12188, CG12188, CG12188, CG32296, mal-d, DMRTF" CDMC20021 1 16 2 DAC03-I12 3-CG32296-RA_2 CG32296 GACAGCTCCTCTGTGCAAACGCAAGACGGCAAGCATTAAGTCCGAACAAGTCAGCGATGTTCTGGACAT 69 FBan0032296 FBgn0052296 Mrtf 3 3L "actin cytoskeleton organization and biogenesis; GO:0030036; border follicle cell migration (sensu Insecta); GO:0007298; mesodermal cell migration; GO:0008078; positive regulation of transcription, DNA-dependent; GO:0045893; tracheal system development (sensu Insecta); GO:0007424; wing morphogenesis; GO:0007476" DNA binding; GO:0003677; transcriptional activator activity; GO:0016563; ; GO:0016563; ; GO:0003677 Mrtf Myocardin-related transcription factor "CG12188, CG32296, CG14951, CG12188, CG12188, CG12188, CG32296, mal-d, DMRTF" CDMC20022 1 17 2 DAC03-I24 23-CG32306-RA_1 CG32306 AGCTAACTAGTTGTCTCATAGTAATCCCAATAATGAAAACAAACTGAACGAAACGAAAATTCCACAGAT 69 FBan0032306 FBgn0052306 CG32306 3 3L CG32306 CG32306 "CG13797, CG16763, CG13798, CG12790, CG13799, CG13797, CG16763, CG13797, CG13798" CDMC20022 1 18 2 DAC03-I24 23-CG32306-RA_1 CG32306 AGCTAACTAGTTGTCTCATAGTAATCCCAATAATGAAAACAAACTGAACGAAACGAAAATTCCACAGAT 69 FBan0032306 FBgn0052306 CG32306 3 3L CG32306 CG32306 "CG13797, CG16763, CG13798, CG12790, CG13799, CG13797, CG16763, CG13797, CG13798" CDMC20023 1 19 2 DAC03-M12 16-CG32350-RA_1 CG32350 TCTTGCAACCCTATCAAAAATGTATTTCGCATGTACCCCGTCCAATCAGGTCCCAGTTGAAGAAGAGCA 69 FBan0032350 FBgn0052350 CG32350 3 3L protein transport; GO:0015031; protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG32350 CG32350 BcDNA:LD20292 CDMC20023 1 20 2 DAC03-M12 16-CG32350-RA_1 CG32350 TCTTGCAACCCTATCAAAAATGTATTTCGCATGTACCCCGTCCAATCAGGTCCCAGTTGAAGAAGAGCA 69 FBan0032350 FBgn0052350 CG32350 3 3L protein transport; GO:0015031; protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG32350 CG32350 BcDNA:LD20292 CDMC20024 1 21 2 DAC03-M24 15-CG32364-RA_7 CG32364 TTCGGGAAATTCTCGCGGCTACGCCTACTTGCAATATATCAATGTGGACCTCAAGGAATCGGCAATGCA 69 FBan0032364 FBgn0052364 CG32364 3 3L biological process unknown; GO:0000004 mRNA binding; GO:0003729; ; GO:0003729 cellular component unknown; GO:0008372 CG32364 CG32364 anon-WO0118547.705 CDMC20024 1 22 2 DAC03-M24 15-CG32364-RA_7 CG32364 TTCGGGAAATTCTCGCGGCTACGCCTACTTGCAATATATCAATGTGGACCTCAAGGAATCGGCAATGCA 69 FBan0032364 FBgn0052364 CG32364 3 3L biological process unknown; GO:0000004 mRNA binding; GO:0003729; ; GO:0003729 cellular component unknown; GO:0008372 CG32364 CG32364 anon-WO0118547.705 CDMC20025 1 23 2 DAC04-A12 16-CG2928-RA_1 CG2928 AGGCCTAGACCTAAGTCCTTGTGTGAATGTGATAGAGCAGATGAGGAGATCCTGCATCATAGAGTGCGA 69 FBan0002928 FBgn0015801 Reg-5 2 2R circadian rhythm; GO:0007623 Reg-5 Rhythmically expressed gene 5 "CG2928, Dreg, Dreg-5, Drosophila Rhythmically expressed gene 5, DREG-5, reg-5, dreg-5, Dreg5, Rhythmically expressed gene 5" CDMC20025 1 24 2 DAC04-A12 16-CG2928-RA_1 CG2928 AGGCCTAGACCTAAGTCCTTGTGTGAATGTGATAGAGCAGATGAGGAGATCCTGCATCATAGAGTGCGA 69 FBan0002928 FBgn0015801 Reg-5 2 2R circadian rhythm; GO:0007623 Reg-5 Rhythmically expressed gene 5 "CG2928, Dreg, Dreg-5, Drosophila Rhythmically expressed gene 5, DREG-5, reg-5, dreg-5, Dreg5, Rhythmically expressed gene 5" CDMC20026 1 25 2 DAC04-A24 3-CG2943-RA_3 CG2943 GGCGATCGATCGGTGCTGTACAAGTACATCAACCCTAATCTAGTGGCTTTCGTCACACAGGCACCGGAT 69 FBan0002943 FBgn0037530 CG2943 3 3R CG2943 CG2943 NEST:bs09f06 CDMC20026 1 26 2 DAC04-A24 3-CG2943-RA_3 CG2943 GGCGATCGATCGGTGCTGTACAAGTACATCAACCCTAATCTAGTGGCTTTCGTCACACAGGCACCGGAT 69 FBan0002943 FBgn0037530 CG2943 3 3R CG2943 CG2943 NEST:bs09f06 CDMC20027 1 1 3 DAC04-E12 14-CG2983-RA_2 CG2983 CCGGGAGTCGTGGCTAAAAACGAAGATGGCCTTGAAGTACCTTCATGATCATCACCTAAACGATGCCGA 69 FBan0002983 FBgn0031472 CG2983 2 2L protein amino acid glycosylation; GO:0006486; protein metabolism; GO:0019538; protein modification; GO:0006464 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-" CG2983 CG2983 CDMC20027 1 2 3 DAC04-E12 14-CG2983-RA_2 CG2983 CCGGGAGTCGTGGCTAAAAACGAAGATGGCCTTGAAGTACCTTCATGATCATCACCTAAACGATGCCGA 69 FBan0002983 FBgn0031472 CG2983 2 2L protein amino acid glycosylation; GO:0006486; protein metabolism; GO:0019538; protein modification; GO:0006464 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-" CG2983 CG2983 CDMC20028 1 3 3 DAC04-E24 2-CG2991-RA_2 CG2991 AGGGCTTCACCATTCAGCATTGGTCCAAGACGGTTATATTGATCACCTTGATGTGCGTAACCGGTGCCA 69 FBan0002991 FBgn0031474 CG2991 2 2L protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG2991 CG2991 "CT10107, CT42388" CDMC20028 1 4 3 DAC04-E24 2-CG2991-RA_2 CG2991 AGGGCTTCACCATTCAGCATTGGTCCAAGACGGTTATATTGATCACCTTGATGTGCGTAACCGGTGCCA 69 FBan0002991 FBgn0031474 CG2991 2 2L protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG2991 CG2991 "CT10107, CT42388" CDMC20029 1 5 3 DAC04-I12 3-CG30019-RA_4 CG30019 TGCTGGCACCTAATCTTAGTGGGTTCAGTGCGAGTCTGGGAGGTGCGTCAAGAGGTGTTGTCAAACATT 69 FBgn0050019 CDMC20029 1 6 3 DAC04-I12 3-CG30019-RA_4 CG30019 TGCTGGCACCTAATCTTAGTGGGTTCAGTGCGAGTCTGGGAGGTGCGTCAAGAGGTGTTGTCAAACATT 69 FBgn0050019 CDMC20030 1 7 3 DAC04-I24 1-CG30029-RA_1 CG30029 GCTCGTGGTTAAGGTCATGGCAACTACGGACATGGCAACTACGGACATGGCAACTACGGACATGGTCAT 69 FBan0030029 FBgn0050029 CG30029 2 2R CG30029 CG30029 "CG18337, CG18337, BcDNA:LP05669" CDMC20030 1 8 3 DAC04-I24 1-CG30029-RA_1 CG30029 GCTCGTGGTTAAGGTCATGGCAACTACGGACATGGCAACTACGGACATGGCAACTACGGACATGGTCAT 69 FBan0030029 FBgn0050029 CG30029 2 2R CG30029 CG30029 "CG18337, CG18337, BcDNA:LP05669" CDMC20031 1 9 3 DAC04-M12 22-CG30058-RA_1 CG30058 AGGCTCAGCGGACATATAGATCACTCAGACGACAACATTACCCATACGAAAATGATCCCGAGACACCAA 69 FBan0030058 FBgn0050058 CG30058 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30058 CG30058 CDMC20031 1 10 3 DAC04-M12 22-CG30058-RA_1 CG30058 AGGCTCAGCGGACATATAGATCACTCAGACGACAACATTACCCATACGAAAATGATCCCGAGACACCAA 69 FBan0030058 FBgn0050058 CG30058 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30058 CG30058 CDMC20032 1 11 3 DAC04-M24 18-CG30071-RA_1 CG30071 TGCTCCCTCGATCTCCTTCACCTCGATTTGTTACCGTTTGAATTTATTGCTGCCCACTACACTTTTGGT 69 FBan0030071 FBgn0050071 CG30071 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30071 CG30071 CDMC20032 1 12 3 DAC04-M24 18-CG30071-RA_1 CG30071 TGCTCCCTCGATCTCCTTCACCTCGATTTGTTACCGTTTGAATTTATTGCTGCCCACTACACTTTTGGT 69 FBan0030071 FBgn0050071 CG30071 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30071 CG30071 CDMC20033 1 13 3 DAC05-A12 3-CG17820-RA_2 CG17820 GCACTCTGTCAACTGGCCCTGTGATGTGGGTCACTTCCCAGAGGCATTCATTCTAATGCACAAGGTGG 68 FBan0017820 FBgn0038914 fit 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 fit female-specific independent of transformer "CG17820, CG17820, CG17820, CG17820, female-specific independent of transformer" CDMC20033 1 14 3 DAC05-A12 3-CG17820-RA_2 CG17820 GCACTCTGTCAACTGGCCCTGTGATGTGGGTCACTTCCCAGAGGCATTCATTCTAATGCACAAGGTGG 68 FBan0017820 FBgn0038914 fit 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 fit female-specific independent of transformer "CG17820, CG17820, CG17820, CG17820, female-specific independent of transformer" CDMC20034 1 15 3 DAC05-A24 3-CG18112-RA_1 CG18112 ACTGCGAGAATGCGCTGAAAAGCCTCCAGAGCAAGCGATGGACTACGGACAACATCAAGCTCAAGTTG 68 FBan0018112 FBgn0039702 Vps16B 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Vps16B Vps16B "CG18112, CG18112" CDMC20034 1 16 3 DAC05-A24 3-CG18112-RA_1 CG18112 ACTGCGAGAATGCGCTGAAAAGCCTCCAGAGCAAGCGATGGACTACGGACAACATCAAGCTCAAGTTG 68 FBan0018112 FBgn0039702 Vps16B 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Vps16B Vps16B "CG18112, CG18112" CDMC20035 1 17 3 DAC05-E12 3-CG2102-RA_5 CG2102 ACGCGCTTTAAGCAGGTTTAGGTGGGTTTTTTTGTGGGTTCAGGCAGATCCAGGACAAGGCATCCTTC 68 FBan0002102 FBgn0004878 cas 3 3R "central nervous system development; GO:0007417; ganglion mother cell fate determination; GO:0007402; mushroom body development; GO:0016319; negative regulation of transcription, DNA-dependent; GO:0045892; post-embryonic development; GO:0009791; regulation of development, heterochronic; GO:0040034; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; ventral cord development; GO:0007419" DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700 nucleus; GO:0005634 cas castor "CG2102, l(3)neo33, ming, Cas, Castor, l(3)j1C2, castor" CDMC20035 1 18 3 DAC05-E12 3-CG2102-RA_5 CG2102 ACGCGCTTTAAGCAGGTTTAGGTGGGTTTTTTTGTGGGTTCAGGCAGATCCAGGACAAGGCATCCTTC 68 FBan0002102 FBgn0004878 cas 3 3R "central nervous system development; GO:0007417; ganglion mother cell fate determination; GO:0007402; mushroom body development; GO:0016319; negative regulation of transcription, DNA-dependent; GO:0045892; post-embryonic development; GO:0009791; regulation of development, heterochronic; GO:0040034; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; ventral cord development; GO:0007419" DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003702; ; GO:0003700 nucleus; GO:0005634 cas castor "CG2102, l(3)neo33, ming, Cas, Castor, l(3)j1C2, castor" CDMC20036 1 19 3 DAC05-E24 15-CG2225-RC_1 CG2225 CCTGGAGTATCGACTCGCAATACCGCAAGAAATCGCCAAAGCTATTTGGTCATTATAGCAGCGGTGGC 68 FBan0002225 FBgn0032957 CG2225 2 2L CG2225 CG2225 CDMC20036 1 20 3 DAC05-E24 15-CG2225-RC_1 CG2225 CCTGGAGTATCGACTCGCAATACCGCAAGAAATCGCCAAAGCTATTTGGTCATTATAGCAGCGGTGGC 68 FBan0002225 FBgn0032957 CG2225 2 2L CG2225 CG2225 CDMC20037 1 21 3 DAC05-I12 3-CG30165-RA_1 CG30165 TGCCGCAACATGGTGGATTTCATCAACGGCCTCACCTTCTTCATCTTCCTTACACTGCTTCTCTGGGC 68 FBan0030165 FBgn0050165 CG30165 2 2R CG30165 CG30165 CG4556 CDMC20037 1 22 3 DAC05-I12 3-CG30165-RA_1 CG30165 TGCCGCAACATGGTGGATTTCATCAACGGCCTCACCTTCTTCATCTTCCTTACACTGCTTCTCTGGGC 68 FBan0030165 FBgn0050165 CG30165 2 2R CG30165 CG30165 CG4556 CDMC20038 1 23 3 DAC05-I24 2-CG30386-RA_2 CG30386 CCTGGCTATGTTGGTGTTGTAACCTTGTTGCTCTACCGCTTGTTGGATCCTAACCCCCGAGATTGGCC 68 FBan0030386 FBgn0050386 CG30386 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30386 CG30386 CDMC20038 1 24 3 DAC05-I24 2-CG30386-RA_2 CG30386 CCTGGCTATGTTGGTGTTGTAACCTTGTTGCTCTACCGCTTGTTGGATCCTAACCCCCGAGATTGGCC 68 FBan0030386 FBgn0050386 CG30386 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30386 CG30386 CDMC20039 1 25 3 DAC05-M12 3-CG31266-RA_2 CG31266 TGGACTGGTGGGATCTGTATGCTCCGTACTACACTGTGAGCCAGATCCATGTGCACTGCAACTTCGAC 68 FBan0031266 FBgn0051266 CG31266 3 3R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG31266 CG31266 "CG5240, SPH146" CDMC20039 1 26 3 DAC05-M12 3-CG31266-RA_2 CG31266 TGGACTGGTGGGATCTGTATGCTCCGTACTACACTGTGAGCCAGATCCATGTGCACTGCAACTTCGAC 68 FBan0031266 FBgn0051266 CG31266 3 3R proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG31266 CG31266 "CG5240, SPH146" CDMC20040 1 1 4 DAC05-M24 2-CG31363-RB_1 CG31363 GCTGTCAAACTCGGCGAGACTCTGGAAATAATCCCGAACAGCCATACTCGCTGAACAAGATGGCAGGC 68 FBan0031363 FBgn0051363 Jupiter 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 colocalizes_with microtubule cytoskeleton; GO:0015630 Jupiter Jupiter "CG31363, CG17238, CG18763, CG18762, CG17238, CG18763, CG17238, clone 1.76, anon-WO0140519.173, BcDNA:GH06373, BcDNA:LD21358, BcDNA:LD43690, BcDNA:RH53211, anon-EST:Liang-1.76, BEST:LP05168" CDMC20040 1 2 4 DAC05-M24 2-CG31363-RB_1 CG31363 GCTGTCAAACTCGGCGAGACTCTGGAAATAATCCCGAACAGCCATACTCGCTGAACAAGATGGCAGGC 68 FBan0031363 FBgn0051363 Jupiter 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 colocalizes_with microtubule cytoskeleton; GO:0015630 Jupiter Jupiter "CG31363, CG17238, CG18763, CG18762, CG17238, CG18763, CG17238, clone 1.76, anon-WO0140519.173, BcDNA:GH06373, BcDNA:LD21358, BcDNA:LD43690, BcDNA:RH53211, anon-EST:Liang-1.76, BEST:LP05168" CDMC20041 1 3 4 DAC06-A12 23-CG5227-RC_10 CG5227 CCTGTGATAAAACGATTTCCTTGTGCCCTAATAAGTTTTTCCAATGATTTCCAAGTGTGTTCAGCGCGT 69 FBan0005227 FBgn0021764 sdk X X cell adhesion; GO:0007155; cone cell differentiation (sensu Endopterygota); GO:0042674; negative regulation of photoreceptor differentiation (sensu Endopterygota); GO:0045674; pigment cell differentiation; GO:0050931 integral to plasma membrane; GO:0005887 sdk sidekick "CG5227, CG5227, CG5227, CT16627, EG:BACR19J1.1, BcDNA:RE63453, BcDNA:LD22322, sidekick" CDMC20041 1 4 4 DAC06-A12 23-CG5227-RC_10 CG5227 CCTGTGATAAAACGATTTCCTTGTGCCCTAATAAGTTTTTCCAATGATTTCCAAGTGTGTTCAGCGCGT 69 FBan0005227 FBgn0021764 sdk X X cell adhesion; GO:0007155; cone cell differentiation (sensu Endopterygota); GO:0042674; negative regulation of photoreceptor differentiation (sensu Endopterygota); GO:0045674; pigment cell differentiation; GO:0050931 integral to plasma membrane; GO:0005887 sdk sidekick "CG5227, CG5227, CG5227, CT16627, EG:BACR19J1.1, BcDNA:RE63453, BcDNA:LD22322, sidekick" CDMC20042 1 5 4 DAC06-A24 3-CG5245-RA_2 CG5245 GCCATGAGGTCACTTTATCGAGTCCACGTGCGTTTGCATACAAGAGAGCGACAGTACAAGTGCGCCGAA 69 FBan0005245 FBgn0038047 CG5245 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG5245 CG5245 anon-WO0118547.611 CDMC20042 1 6 4 DAC06-A24 3-CG5245-RA_2 CG5245 GCCATGAGGTCACTTTATCGAGTCCACGTGCGTTTGCATACAAGAGAGCGACAGTACAAGTGCGCCGAA 69 FBan0005245 FBgn0038047 CG5245 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG5245 CG5245 anon-WO0118547.611 CDMC20043 1 7 4 DAC06-E12 1-CG5279-RA_1 CG5279 CGTGTGGTCCTACGTGATACCGATGACCATGATCCTGGTGTCCTACTACAAGCTCTTCACCCACGTCCG 69 FBan0005279 FBgn0014019 Rh5 2 2L "G-protein coupled receptor protein signaling pathway; GO:0007186; UV-A, blue light phototransduction; GO:0009588; absorption of visible light; GO:0016038; phototransduction; GO:0007602; sensory perception; GO:0007600; visual perception; GO:0007601" G-protein coupled photoreceptor activity; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020 integral to membrane; GO:0016021; rhabdomere; GO:0016028 Rh5 Rhodopsin 5 "CG5279, rh5, Dm Rh5, rhodopsin, Rh, DMELRH5, RH5, Rhodopsin, Rhodopsin5, Rhodopsin 5" CDMC20043 1 8 4 DAC06-E12 1-CG5279-RA_1 CG5279 CGTGTGGTCCTACGTGATACCGATGACCATGATCCTGGTGTCCTACTACAAGCTCTTCACCCACGTCCG 69 FBan0005279 FBgn0014019 Rh5 2 2L "G-protein coupled receptor protein signaling pathway; GO:0007186; UV-A, blue light phototransduction; GO:0009588; absorption of visible light; GO:0016038; phototransduction; GO:0007602; sensory perception; GO:0007600; visual perception; GO:0007601" G-protein coupled photoreceptor activity; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020 integral to membrane; GO:0016021; rhabdomere; GO:0016028 Rh5 Rhodopsin 5 "CG5279, rh5, Dm Rh5, rhodopsin, Rh, DMELRH5, RH5, Rhodopsin, Rhodopsin5, Rhodopsin 5" CDMC20044 1 9 4 DAC06-E24 15-CG5302-RA_8 CG5302 TGCTGAGATCACTTCCCATCCCTGGATGGCCTATCTGTACAACGAGTTTCATTATTTCTGCGCTGGCAC 69 FBan0005302 FBgn0038351 CG5302 3 3R metabolism; GO:0008152; proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0016491 ; EC:1.-.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG5302 CG5302 SPH73 CDMC20044 1 10 4 DAC06-E24 15-CG5302-RA_8 CG5302 TGCTGAGATCACTTCCCATCCCTGGATGGCCTATCTGTACAACGAGTTTCATTATTTCTGCGCTGGCAC 69 FBan0005302 FBgn0038351 CG5302 3 3R metabolism; GO:0008152; proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0016491 ; EC:1.-.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG5302 CG5302 SPH73 CDMC20045 1 11 4 DAC06-I12 23-CG5338-RB_5 CG5338 CACAGTAAAGGAAATCGATCAGCACGTTCTGACCAAAAACATGGCTGCTTTTCTCAAAAAATCCGGAAA 69 FBan0005338 FBgn0039129 RpS19b 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS19b Ribosomal protein S19b "CG5338, BcDNA:SD22440, Ribosomal protein S19b" CDMC20045 1 12 4 DAC06-I12 23-CG5338-RB_5 CG5338 CACAGTAAAGGAAATCGATCAGCACGTTCTGACCAAAAACATGGCTGCTTTTCTCAAAAAATCCGGAAA 69 FBan0005338 FBgn0039129 RpS19b 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS19b Ribosomal protein S19b "CG5338, BcDNA:SD22440, Ribosomal protein S19b" CDMC20046 1 13 4 DAC06-I24 1-CG5354-RA_2 CG5354 ACCTCCGGATATTACTTGCGTTGCATTTGGTGTCGTTCGGAACGTTTCAGGGATTCCATACGCCTGCAG 69 FBan0005354 FBgn0005683 pie 2 2L "electron transport; GO:0006118; eye development (sensu Endopterygota); GO:0007456; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 pie pineapple eye "CG5354, l(2)54, mat(2)earlyQM47, l(2)31Ek, mat(2)QM47, mat(2)ea-E: maternal effect early arrest E, rumpled, lethal(2)54, maternal effect early arrest E" CDMC20046 1 14 4 DAC06-I24 1-CG5354-RA_2 CG5354 ACCTCCGGATATTACTTGCGTTGCATTTGGTGTCGTTCGGAACGTTTCAGGGATTCCATACGCCTGCAG 69 FBan0005354 FBgn0005683 pie 2 2L "electron transport; GO:0006118; eye development (sensu Endopterygota); GO:0007456; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 pie pineapple eye "CG5354, l(2)54, mat(2)earlyQM47, l(2)31Ek, mat(2)QM47, mat(2)ea-E: maternal effect early arrest E, rumpled, lethal(2)54, maternal effect early arrest E" CDMC20047 1 15 4 DAC06-M12 1-CG5392-RA_1 CG5392 TCCTCAGGGTCAAGTTGCCTATTGGTCCGCCTGTCAATCCAGTCGCTTTAATACCTCACCTTCACCAGT 69 FBan0005392 FBgn0036463 CG5392 3 3L serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG5392 CG5392 CDMC20047 1 16 4 DAC06-M12 1-CG5392-RA_1 CG5392 TCCTCAGGGTCAAGTTGCCTATTGGTCCGCCTGTCAATCCAGTCGCTTTAATACCTCACCTTCACCAGT 69 FBan0005392 FBgn0036463 CG5392 3 3L serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG5392 CG5392 CDMC20048 1 17 4 DAC06-M24 3-CG5400-RA_3 CG5400 GCGGTGTGTGCTTTTATGGCCTGTGACTCAGGTGTGGATTTGGGTCAATGTGATGCTCAACACGATGCT 69 FBan0005400 FBgn0000564 Eh 3 3R adult behavior; GO:0030534; ecdysis (sensu Insecta); GO:0018990; eclosion; GO:0007562; neuropeptide signaling pathway; GO:0007218; regulation of eclosion; GO:0007563 neuropeptide hormone activity; GO:0005184; ; GO:0005184; eclosion hormone activity; GO:0008031; ; GO:0008031; ; GO:0005184; ; GO:0008031; ; GO:0008031; ecdysis-triggering hormone activity; GO:0008255; ; GO:0008255 Eh Eclosion hormone "CG5400, EH, DMEHAB, EHAB, eh, Drm-EH" CDMC20048 1 18 4 DAC06-M24 3-CG5400-RA_3 CG5400 GCGGTGTGTGCTTTTATGGCCTGTGACTCAGGTGTGGATTTGGGTCAATGTGATGCTCAACACGATGCT 69 FBan0005400 FBgn0000564 Eh 3 3R adult behavior; GO:0030534; ecdysis (sensu Insecta); GO:0018990; eclosion; GO:0007562; neuropeptide signaling pathway; GO:0007218; regulation of eclosion; GO:0007563 neuropeptide hormone activity; GO:0005184; ; GO:0005184; eclosion hormone activity; GO:0008031; ; GO:0008031; ; GO:0005184; ; GO:0008031; ; GO:0008031; ecdysis-triggering hormone activity; GO:0008255; ; GO:0008255 Eh Eclosion hormone "CG5400, EH, DMEHAB, EHAB, eh, Drm-EH" CDMC20049 1 19 4 DAC07-A12 17-CG9757-RA_1 CG9757 ACTTTGCCGGTGATTAGTAGCAGAAGTTTCCTCGAAAATGCGCACATTTGTTTGCCTTGCCCTGG 65 FBan0009757 FBgn0003060 CG9757 3 3R CG9757 CG9757 "GCR-20, GCR 20, GCR20, Pen50DE, anon-Pen50DE, pen50DE" CDMC20049 1 20 4 DAC07-A12 17-CG9757-RA_1 CG9757 ACTTTGCCGGTGATTAGTAGCAGAAGTTTCCTCGAAAATGCGCACATTTGTTTGCCTTGCCCTGG 65 FBan0009757 FBgn0003060 CG9757 3 3R CG9757 CG9757 "GCR-20, GCR 20, GCR20, Pen50DE, anon-Pen50DE, pen50DE" CDMC20050 1 21 4 DAC07-A24 8-CG9783-RA_1 CG9783 CCGTCCAGGACTTTGAACGGGATCTATGCCCACAACAGCAATAGTACCAGTTCCCATGGTGCAGC 65 FBan0009783 FBgn0037256 CG9783 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cell homeostasis; GO:0019725; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468; visual perception; GO:0007601 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; receptor activity; GO:0004872; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2; ; GO:0004872 CG9783 CG9783 GYC CDMC20050 1 22 4 DAC07-A24 8-CG9783-RA_1 CG9783 CCGTCCAGGACTTTGAACGGGATCTATGCCCACAACAGCAATAGTACCAGTTCCCATGGTGCAGC 65 FBan0009783 FBgn0037256 CG9783 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cell homeostasis; GO:0019725; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468; visual perception; GO:0007601 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; receptor activity; GO:0004872; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2; ; GO:0004872 CG9783 CG9783 GYC CDMC20051 1 23 4 DAC07-E12 15-CG9904-RA_4 CG9904 ATGAGGGACTACGACTCGATGCTGAGGGGTCACTCCTGTCGGTCTGCCATGATGCGCTATCGTTC 65 FBan0009904 FBgn0040336 CG9904 X X CG9904 CG9904 EG:BACR7C10.1 CDMC20051 1 24 4 DAC07-E12 15-CG9904-RA_4 CG9904 ATGAGGGACTACGACTCGATGCTGAGGGGTCACTCCTGTCGGTCTGCCATGATGCGCTATCGTTC 65 FBan0009904 FBgn0040336 CG9904 X X CG9904 CG9904 EG:BACR7C10.1 CDMC20052 1 25 4 DAC07-E24 17-CG9964-RA_8 CG9964 TTCGTGCGAAAGCTTTTCTCCATGCGATTCTTCACCAAAGCAACGGATGAGTTCTTCCTGCGACT 65 FBan0009964 FBgn0031432 Cyp309a1 2 2L DNA methylation; GO:0006306; electron transport; GO:0006118; steroid metabolism; GO:0008202 DNA binding; GO:0003677; electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; ; GO:0003677; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp309a1 Cyp309a1 "CG9964, 309a1" CDMC20052 1 26 4 DAC07-E24 17-CG9964-RA_8 CG9964 TTCGTGCGAAAGCTTTTCTCCATGCGATTCTTCACCAAAGCAACGGATGAGTTCTTCCTGCGACT 65 FBan0009964 FBgn0031432 Cyp309a1 2 2L DNA methylation; GO:0006306; electron transport; GO:0006118; steroid metabolism; GO:0008202 DNA binding; GO:0003677; electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; ; GO:0003677; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp309a1 Cyp309a1 "CG9964, 309a1" CDMC20053 1 1 5 DAC07-I12 2-CR31356-RA_1 CR31356 TTAGCTCAGTGGCAGAGCACTGGTCTTGTAAACCAGGGGCCGTGAGTTCAATTCTCACAAGAGGC 65 FBan0031356 FBgn0051356 CR31356 3 3R protein biosynthesis; GO:0006412 triplet codon-amino acid adaptor activity; GO:0030533; ; GO:0030533 cytosol; GO:0005829 CR31356 CR31356 "tRNA[Thr][[3]], AE002708.trna4-ThrTGT, tRNA:T:TGT:AE002708-a, tRNA:T3:87BC, tRNA:thr3:87BC, transfer RNA:thr3:87BC" CDMC20053 1 2 5 DAC07-I12 2-CR31356-RA_1 CR31356 TTAGCTCAGTGGCAGAGCACTGGTCTTGTAAACCAGGGGCCGTGAGTTCAATTCTCACAAGAGGC 65 FBan0031356 FBgn0051356 CR31356 3 3R protein biosynthesis; GO:0006412 triplet codon-amino acid adaptor activity; GO:0030533; ; GO:0030533 cytosol; GO:0005829 CR31356 CR31356 "tRNA[Thr][[3]], AE002708.trna4-ThrTGT, tRNA:T:TGT:AE002708-a, tRNA:T3:87BC, tRNA:thr3:87BC, transfer RNA:thr3:87BC" CDMC20054 1 3 5 DAC07-I24 2-CR31541-RA_1 CR31541 CTCGGAGCGTCGTCTGGGAATGATCTGGGAAAACTAGGCACCCACAATTGGTTTACCGATGCCAC 65 FBan0031541 FBgn0037309 CR31541 3 3R CR31541 CR31541 CG2676 CDMC20054 1 4 5 DAC07-I24 2-CR31541-RA_1 CR31541 CTCGGAGCGTCGTCTGGGAATGATCTGGGAAAACTAGGCACCCACAATTGGTTTACCGATGCCAC 65 FBan0031541 FBgn0037309 CR31541 3 3R CR31541 CR31541 CG2676 CDMC20055 1 5 5 DAC07-M12 23-CR32894-RA_1 CR32894 AGCTCGCTTTGATTTCTATGAAGAAAACTGTTCCATATCCAACGCAAAAAATTATCTTGCTGACT 65 FBan0032894 FBgn0063383 snoRNA:U29:54Ec 2 2R snoRNA:U29:54Ec snoRNA:U29:54Ec "U29snoRNA, CR32894" CDMC20055 1 6 5 DAC07-M12 23-CR32894-RA_1 CR32894 AGCTCGCTTTGATTTCTATGAAGAAAACTGTTCCATATCCAACGCAAAAAATTATCTTGCTGACT 65 FBan0032894 FBgn0063383 snoRNA:U29:54Ec 2 2R snoRNA:U29:54Ec snoRNA:U29:54Ec "U29snoRNA, CR32894" CDMC20056 1 7 5 DAC07-M24 23-CR32905-RA_1 CR32905 TGATGATTTTTCAGTTCTGCTACTGAAGACAGTTGACGAAAGCAAAAATACCAAAATCACTGAAA 65 FBan0032905 FBgn0015543 snoRNA:Z1 2 2R RNA modification guide activity; GO:0030555; ; GO:0030555 nucleolus; GO:0005730 snoRNA:Z1 snoRNA:Z1 "snoRNA Z1, Z1, snoR797, Dm-797, CR32905" CDMC20056 1 8 5 DAC07-M24 23-CR32905-RA_1 CR32905 TGATGATTTTTCAGTTCTGCTACTGAAGACAGTTGACGAAAGCAAAAATACCAAAATCACTGAAA 65 FBan0032905 FBgn0015543 snoRNA:Z1 2 2R RNA modification guide activity; GO:0030555; ; GO:0030555 nucleolus; GO:0005730 snoRNA:Z1 snoRNA:Z1 "snoRNA Z1, Z1, snoR797, Dm-797, CR32905" CDMC20057 1 9 5 DAC08-A12 23-CG5603-RC_3 CG5603 TGGATACAATATACCTGAAATTACGTGTGTTCCAGAATTAACACAGTGGCTCTCGGAAGAAGGCGCACG 69 FBan0005603 FBgn0032210 CYLD 2 2L microtubule binding; GO:0008017; ; GO:0008017; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; transcription factor activity; GO:0003700; ; GO:0004221 ; EC:3.1.2.15; ; GO:0003700 nucleus; GO:0005634 CYLD CYLD "CG5603, CG5603, CG5603" CDMC20057 1 10 5 DAC08-A12 23-CG5603-RC_3 CG5603 TGGATACAATATACCTGAAATTACGTGTGTTCCAGAATTAACACAGTGGCTCTCGGAAGAAGGCGCACG 69 FBan0005603 FBgn0032210 CYLD 2 2L microtubule binding; GO:0008017; ; GO:0008017; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; transcription factor activity; GO:0003700; ; GO:0004221 ; EC:3.1.2.15; ; GO:0003700 nucleus; GO:0005634 CYLD CYLD "CG5603, CG5603, CG5603" CDMC20058 1 11 5 DAC08-A24 2-CG5612-RA_2 CG5612 GCTGCCCGGAGTGACGTTCACCTACGAGATTTTGGAGCCAATCACTTGCGTGGAAATTCTATCGGAGGA 69 FBan0005612 FBgn0039529 CG5612 3 3R CG5612 CG5612 CDMC20058 1 12 5 DAC08-A24 2-CG5612-RA_2 CG5612 GCTGCCCGGAGTGACGTTCACCTACGAGATTTTGGAGCCAATCACTTGCGTGGAAATTCTATCGGAGGA 69 FBan0005612 FBgn0039529 CG5612 3 3R CG5612 CG5612 CDMC20059 1 13 5 DAC08-E12 23-CG5650-RA_6 CG5650 CAGCGCTTTTATAGGTTTTGTCCAAAATTTAAACACTAGGTTAATCAACTGACCGTTCGAGCAGAGCAC 69 FBan0005650 FBgn0004103 Pp1-87B 3 3R adult locomotory behavior; GO:0008344; chromosome condensation; GO:0030261; learning and/or memory; GO:0007611; locomotion; GO:0040011; mitosis; GO:0007067; mitotic sister chromatid segregation; GO:0000070; nervous system development; GO:0007399; olfactory learning; GO:0008355; oogenesis (sensu Insecta); GO:0009993; protein amino acid dephosphorylation; GO:0006470; visual learning; GO:0008542 protein serine/threonine phosphatase activity; GO:0004722; protein phosphatase type 1 activity; GO:0000163; ; GO:0000163; ; GO:0004722; ; GO:0000163; myosin phosphatase activity; GO:0017018; ; GO:0017018 cytoplasm; GO:0005737; protein phosphatase type 1 complex; GO:0000164 Pp1-87B Protein phosphatase 1 at 87B "CG5650, CG5650, CG5650, l(3)ck19, Su-var(3)6, Su(var)3-6: Suppressor of variegation, PP-1alpha, ck19, PP1 87B, PP1alpha87B, PP1alpha[[2]], Protein phosphatase 1, PP1A87B, l(3)j6E7, PP187B, Su(var)(3)6, su-var(3)6, Suvar(3)6, Pp1, PP1, PP1-87B, Su(Var)3-6, Pp1-87Bb, PP1c, Pp-1alpha, l(3)87Bg, Suppressor of variegation, Su(var)3-6" CDMC20059 1 14 5 DAC08-E12 23-CG5650-RA_6 CG5650 CAGCGCTTTTATAGGTTTTGTCCAAAATTTAAACACTAGGTTAATCAACTGACCGTTCGAGCAGAGCAC 69 FBan0005650 FBgn0004103 Pp1-87B 3 3R adult locomotory behavior; GO:0008344; chromosome condensation; GO:0030261; learning and/or memory; GO:0007611; locomotion; GO:0040011; mitosis; GO:0007067; mitotic sister chromatid segregation; GO:0000070; nervous system development; GO:0007399; olfactory learning; GO:0008355; oogenesis (sensu Insecta); GO:0009993; protein amino acid dephosphorylation; GO:0006470; visual learning; GO:0008542 protein serine/threonine phosphatase activity; GO:0004722; protein phosphatase type 1 activity; GO:0000163; ; GO:0000163; ; GO:0004722; ; GO:0000163; myosin phosphatase activity; GO:0017018; ; GO:0017018 cytoplasm; GO:0005737; protein phosphatase type 1 complex; GO:0000164 Pp1-87B Protein phosphatase 1 at 87B "CG5650, CG5650, CG5650, l(3)ck19, Su-var(3)6, Su(var)3-6: Suppressor of variegation, PP-1alpha, ck19, PP1 87B, PP1alpha87B, PP1alpha[[2]], Protein phosphatase 1, PP1A87B, l(3)j6E7, PP187B, Su(var)(3)6, su-var(3)6, Suvar(3)6, Pp1, PP1, PP1-87B, Su(Var)3-6, Pp1-87Bb, PP1c, Pp-1alpha, l(3)87Bg, Suppressor of variegation, Su(var)3-6" CDMC20060 1 15 5 DAC08-E24 23-CG5661-RA_11 CG5661 ATCCAAAAGTGCCATCTAATGACTATGGAAATGTTACAACGAGAGAGACAAGTTTTATTTTTGCGCCAA 69 FBan0005661 FBgn0028679 Sema-5c 3 3L aromatic compound metabolism; GO:0006725; axon guidance; GO:0007411; cell surface receptor linked signal transduction; GO:0007166; cell-cell adhesion; GO:0016337; ectoderm development; GO:0007398; embryonic development (sensu Insecta); GO:0001700 ferric iron binding; GO:0008199; receptor binding; GO:0005102; receptor activity; GO:0004872; catalytic activity; GO:0003824; ; GO:0005102; ; GO:0004872; ; GO:0003824; ; GO:0008199 plasma membrane; GO:0005886 Sema-5c Sema-5c "CG5661, CG5661, CG5661, CK02567, sema 5c, semaphorin 5C, CT17880, sema-5c, Sema 5c, semaphorin, semiphorin, BEST:CK02567" CDMC20060 1 16 5 DAC08-E24 23-CG5661-RA_11 CG5661 ATCCAAAAGTGCCATCTAATGACTATGGAAATGTTACAACGAGAGAGACAAGTTTTATTTTTGCGCCAA 69 FBan0005661 FBgn0028679 Sema-5c 3 3L aromatic compound metabolism; GO:0006725; axon guidance; GO:0007411; cell surface receptor linked signal transduction; GO:0007166; cell-cell adhesion; GO:0016337; ectoderm development; GO:0007398; embryonic development (sensu Insecta); GO:0001700 ferric iron binding; GO:0008199; receptor binding; GO:0005102; receptor activity; GO:0004872; catalytic activity; GO:0003824; ; GO:0005102; ; GO:0004872; ; GO:0003824; ; GO:0008199 plasma membrane; GO:0005886 Sema-5c Sema-5c "CG5661, CG5661, CG5661, CK02567, sema 5c, semaphorin 5C, CT17880, sema-5c, Sema 5c, semaphorin, semiphorin, BEST:CK02567" CDMC20061 1 17 5 DAC08-I12 12-CG5691-RA_4 CG5691 CGCCCTGCAATGGACCCTGAACTTCGAGCTCCTAAAGACCAGTCAGTTGTTTTACAACGAGTTTGCCAA 69 FBan0005691 FBgn0035297 CG5691 3 3L lysosome organization and biogenesis; GO:0007040 CG5691 CG5691 CDMC20061 1 18 5 DAC08-I12 12-CG5691-RA_4 CG5691 CGCCCTGCAATGGACCCTGAACTTCGAGCTCCTAAAGACCAGTCAGTTGTTTTACAACGAGTTTGCCAA 69 FBan0005691 FBgn0035297 CG5691 3 3L lysosome organization and biogenesis; GO:0007040 CG5691 CG5691 CDMC20062 1 19 5 DAC08-I24 14-CG5706-RA_1 CG5706 GCCCATCATCAACGGTGATCATTCCAAGATTACGCTGAAGACCAAGAACGTATTCATCGAGTGCACGGC 69 FBan0005706 FBgn0039175 CG5706 3 3R phenylalanyl-tRNA aminoacylation; GO:0006432 ATP binding; GO:0005524; ; GO:0005524; phenylalanine-tRNA ligase activity; GO:0004826 ; EC:6.1.1.20; ; GO:0004826 ; EC:6.1.1.20 cytoplasm; GO:0005737; phenylalanine-tRNA ligase complex; GO:0009328 CG5706 CG5706 CDMC20062 1 20 5 DAC08-I24 14-CG5706-RA_1 CG5706 GCCCATCATCAACGGTGATCATTCCAAGATTACGCTGAAGACCAAGAACGTATTCATCGAGTGCACGGC 69 FBan0005706 FBgn0039175 CG5706 3 3R phenylalanyl-tRNA aminoacylation; GO:0006432 ATP binding; GO:0005524; ; GO:0005524; phenylalanine-tRNA ligase activity; GO:0004826 ; EC:6.1.1.20; ; GO:0004826 ; EC:6.1.1.20 cytoplasm; GO:0005737; phenylalanine-tRNA ligase complex; GO:0009328 CG5706 CG5706 CDMC20063 1 21 5 DAC08-M12 6-CG5730-RD_3 CG5730 GTCGGAGATCGATCTGGGTGACATCAAGGAGGCATTCCAGAACAAGTACGGCAAGAGCTTGGAGTCCTG 69 FBan0005730 FBgn0000083 AnnIX 3 3R lipid metabolism; GO:0006629; negative regulation of coagulation; GO:0050819 actin binding; GO:0003779; calcium-dependent phospholipid binding; GO:0005544; ; GO:0003779; calcium ion binding; GO:0005509; phospholipid binding; GO:0005543; ; GO:0005509; ; GO:0005543; ; GO:0005509; ; GO:0005544 AnnIX Annexin IX "CG5730, CG5730, CG5730, Ann, AnxB9" CDMC20063 1 22 5 DAC08-M12 6-CG5730-RD_3 CG5730 GTCGGAGATCGATCTGGGTGACATCAAGGAGGCATTCCAGAACAAGTACGGCAAGAGCTTGGAGTCCTG 69 FBan0005730 FBgn0000083 AnnIX 3 3R lipid metabolism; GO:0006629; negative regulation of coagulation; GO:0050819 actin binding; GO:0003779; calcium-dependent phospholipid binding; GO:0005544; ; GO:0003779; calcium ion binding; GO:0005509; phospholipid binding; GO:0005543; ; GO:0005509; ; GO:0005543; ; GO:0005509; ; GO:0005544 AnnIX Annexin IX "CG5730, CG5730, CG5730, Ann, AnxB9" CDMC20064 1 23 5 DAC08-M24 18-CG5746-RA_2 CG5746 GCGCGTGCTTCGATAGGCCAAAAAACCAAATAAGAAGGGACTAGGGCAGAGTAACATGGAAGGGAATAT 69 FBan0005746 FBgn0039186 CG5746 3 3R CG5746 CG5746 CDMC20064 1 24 5 DAC08-M24 18-CG5746-RA_2 CG5746 GCGCGTGCTTCGATAGGCCAAAAAACCAAATAAGAAGGGACTAGGGCAGAGTAACATGGAAGGGAATAT 69 FBan0005746 FBgn0039186 CG5746 3 3R CG5746 CG5746 CDMC20065 1 25 5 DAC09-A13 3-CG31231-RA_4 CG31231 AGTGCAAGGATGTTGCGGTCATGCAGTCGAACTACAAGAAGTCCATGATAGAGGAGACGTGCGTGCG 67 FBan0031231 FBgn0051231 CG31231 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31231 CG31231 "anon-WO0140519.92, BcDNA:AT20662, BcDNA:GH08511" CDMC20065 1 26 5 DAC09-A13 3-CG31231-RA_4 CG31231 AGTGCAAGGATGTTGCGGTCATGCAGTCGAACTACAAGAAGTCCATGATAGAGGAGACGTGCGTGCG 67 FBan0031231 FBgn0051231 CG31231 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31231 CG31231 "anon-WO0140519.92, BcDNA:AT20662, BcDNA:GH08511" CDMC20066 1 1 6 DAC09-B01 3-CG31465-RA_3 CG31465 GGCTCAAAGGATTGTGGGAACCGGTCAAAATGCAGCCGATGGTGGATTGAGATATGCACCCAATCGC 67 FBan0031465 FBgn0051465 CG31465 3 3R CG31465 CG31465 CG6670 CDMC20066 1 2 6 DAC09-B01 3-CG31465-RA_3 CG31465 GGCTCAAAGGATTGTGGGAACCGGTCAAAATGCAGCCGATGGTGGATTGAGATATGCACCCAATCGC 67 FBan0031465 FBgn0051465 CG31465 3 3R CG31465 CG31465 CG6670 CDMC20067 1 3 6 DAC09-E13 6-CG32040-RA_4 CG32040 GGAAGAACCTCCGGTGGAGAACACAACCCGAAAACCTCCTCCGATAACCTTCGATTCCGGGCAAATG 67 FBan0032040 FBgn0052040 CG32040 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32040 CG32040 CDMC20067 1 4 6 DAC09-E13 6-CG32040-RA_4 CG32040 GGAAGAACCTCCGGTGGAGAACACAACCCGAAAACCTCCTCCGATAACCTTCGATTCCGGGCAAATG 67 FBan0032040 FBgn0052040 CG32040 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32040 CG32040 CDMC20068 1 5 6 DAC09-F01 2-CG32100-RA_1 CG32100 GGGCGAGAAACCTCTGCCAAATCAAAGAGCAGCGTACAAGAACCACCGAAATGCAAGGGTCGCAAAC 67 FBan0032100 FBgn0052100 CG32100 3 3L CG32100 CG32100 "CG10429, CG18638" CDMC20068 1 6 6 DAC09-F01 2-CG32100-RA_1 CG32100 GGGCGAGAAACCTCTGCCAAATCAAAGAGCAGCGTACAAGAACCACCGAAATGCAAGGGTCGCAAAC 67 FBan0032100 FBgn0052100 CG32100 3 3L CG32100 CG32100 "CG10429, CG18638" CDMC20069 1 7 6 DAC09-I13 3-CG3253-RA_1 CG3253 TGCTGGCTATCAGTTCTACGTCCTTTCCCCTGTGTTTACCGGTCATTGGGGATTGCAGAGGAAGCAG 67 FBan0003253 FBgn0041706 CG3253 2 2R "N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity; GO:0008532 ; EC:2.4.1.149; ; GO:0008532 ; EC:2.4.1.149" CG3253 CG3253 "L-gene, BEST:GH04269" CDMC20069 1 8 6 DAC09-I13 3-CG3253-RA_1 CG3253 TGCTGGCTATCAGTTCTACGTCCTTTCCCCTGTGTTTACCGGTCATTGGGGATTGCAGAGGAAGCAG 67 FBan0003253 FBgn0041706 CG3253 2 2R "N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity; GO:0008532 ; EC:2.4.1.149; ; GO:0008532 ; EC:2.4.1.149" CG3253 CG3253 "L-gene, BEST:GH04269" CDMC20070 1 9 6 DAC09-J01 22-CG32691-RA_1 CG32691 CGCGTACACGCTTCAAAAATTCAACGGTCCGCCTATGAAAACGAACCTGCAAGAGGAAAAGCCACAG 67 FBan0032691 FBgn0052691 CG32691 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32691 CG32691 CDMC20070 1 10 6 DAC09-J01 22-CG32691-RA_1 CG32691 CGCGTACACGCTTCAAAAATTCAACGGTCCGCCTATGAAAACGAACCTGCAAGAGGAAAAGCCACAG 67 FBan0032691 FBgn0052691 CG32691 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32691 CG32691 CDMC20071 1 11 6 DAC09-M13 2-CG3333-RA_1 CG3333 GCTGTACGAAAACCACAAGGACGAGTCTATGCTGCGACGTGTGATCAAGCCGCTAGAAGGTCTGCTG 67 FBan0003333 FBgn0023184 Nop60B 2 2R chromosome segregation; GO:0007059; germ cell development; GO:0007281; mitosis; GO:0007067; pseudouridine synthesis; GO:0001522; rRNA metabolism; GO:0016072; rRNA processing; GO:0006364; ribosome biogenesis; GO:0007046 mRNA binding; GO:0003729; pseudouridylate synthase activity; GO:0004730 ; EC:4.2.1.70; centromeric DNA binding; GO:0019237; ; GO:0003729; ; GO:0019237; ; GO:0004730 ; EC:4.2.1.70 nucleolus; GO:0005730; nucleus; GO:0005634 Nop60B Nucleolar protein at 60B "CG3333, mfl: minifly, minifly, nop60B, FBgn0023184, l(2)k05318, mfl" CDMC20071 1 12 6 DAC09-M13 2-CG3333-RA_1 CG3333 GCTGTACGAAAACCACAAGGACGAGTCTATGCTGCGACGTGTGATCAAGCCGCTAGAAGGTCTGCTG 67 FBan0003333 FBgn0023184 Nop60B 2 2R chromosome segregation; GO:0007059; germ cell development; GO:0007281; mitosis; GO:0007067; pseudouridine synthesis; GO:0001522; rRNA metabolism; GO:0016072; rRNA processing; GO:0006364; ribosome biogenesis; GO:0007046 mRNA binding; GO:0003729; pseudouridylate synthase activity; GO:0004730 ; EC:4.2.1.70; centromeric DNA binding; GO:0019237; ; GO:0003729; ; GO:0019237; ; GO:0004730 ; EC:4.2.1.70 nucleolus; GO:0005730; nucleus; GO:0005634 Nop60B Nucleolar protein at 60B "CG3333, mfl: minifly, minifly, nop60B, FBgn0023184, l(2)k05318, mfl" CDMC20072 1 13 6 DAC09-N01 2-CG3395-RB_1 CG3395 GGCGCCAATGCTTGTACCGACTCTCAACGTCTGTAGATTGCGCATGTGACTCCGTTCACACCAATCG 67 FBan0003395 FBgn0010408 RpS9 3 3L protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003729; ; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS9 Ribosomal protein S9 "CG3395, RpL11" CDMC20072 1 14 6 DAC09-N01 2-CG3395-RB_1 CG3395 GGCGCCAATGCTTGTACCGACTCTCAACGTCTGTAGATTGCGCATGTGACTCCGTTCACACCAATCG 67 FBan0003395 FBgn0010408 RpS9 3 3L protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003729; ; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS9 Ribosomal protein S9 "CG3395, RpL11" CDMC20073 1 15 6 DAC10-A12 23-CG18317-RA_1 CG18317 CGAGCGCAAATTCTTAGTTAACTAGCTTCTAAGTCAGATATGAAACGAACTCGATAGACTTAAGACGTT 69 FBan0018317 FBgn0031359 CG18317 2 2L mitochondrial transport; GO:0006839; transport; GO:0006810 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG18317 CG18317 CDMC20073 1 16 6 DAC10-A12 23-CG18317-RA_1 CG18317 CGAGCGCAAATTCTTAGTTAACTAGCTTCTAAGTCAGATATGAAACGAACTCGATAGACTTAAGACGTT 69 FBan0018317 FBgn0031359 CG18317 2 2L mitochondrial transport; GO:0006839; transport; GO:0006810 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG18317 CG18317 CDMC20074 1 17 6 DAC10-A24 3-CG18331-RA_2 CG18331 TCTCCGGACATTCGCATTCGATTGGGCCGAGAACAGTCAGGAAACGATGCTCAGTCCCAAAACTCGAAT 69 FBan0018331 FBgn0036181 CG18331 3 3L CG18331 CG18331 CDMC20074 1 18 6 DAC10-A24 3-CG18331-RA_2 CG18331 TCTCCGGACATTCGCATTCGATTGGGCCGAGAACAGTCAGGAAACGATGCTCAGTCCCAAAACTCGAAT 69 FBan0018331 FBgn0036181 CG18331 3 3L CG18331 CG18331 CDMC20075 1 19 6 DAC10-E12 3-CG18398-RA_6 CG18398 TGCCCGGTCTACTCACATCAAGCTCTCATCATTCCCTCACCTGCAAAGTTTTCCTCTCTCTTCTGGGCT 69 FBan0018398 FBgn0032728 CG18398 2 2L CG18398 CG18398 CDMC20075 1 20 6 DAC10-E12 3-CG18398-RA_6 CG18398 TGCCCGGTCTACTCACATCAAGCTCTCATCATTCCCTCACCTGCAAAGTTTTCCTCTCTCTTCTGGGCT 69 FBan0018398 FBgn0032728 CG18398 2 2L CG18398 CG18398 CDMC20076 1 21 6 DAC10-E24 12-CG18417-RA_5 CG18417 AGGTCTCTAGTGAAGCGCGTTCTGTAGCCTTTTCAGAAGCTCTGTCCGAACTGGTCAAGAATGCGTCAT 69 FBan0018417 FBgn0035780 CG18417 3 3L protein metabolism; GO:0019538; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; metallopeptidase activity; GO:0008237; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008237; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 CG18417 CG18417 CDMC20076 1 22 6 DAC10-E24 12-CG18417-RA_5 CG18417 AGGTCTCTAGTGAAGCGCGTTCTGTAGCCTTTTCAGAAGCTCTGTCCGAACTGGTCAAGAATGCGTCAT 69 FBan0018417 FBgn0035780 CG18417 3 3L protein metabolism; GO:0019538; proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; metallopeptidase activity; GO:0008237; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008237; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 CG18417 CG18417 CDMC20077 1 23 6 DAC10-I12 22-CG18482-RA_1 CG18482 TGCTGTTTTCGTCTGGTTAAACAGGTACTACGGACTTCCAACTACACTTGTTAACATGCCTCCAGAGCA 69 FBan0018482 FBgn0028891 CG18482 2 2L CG18482 CG18482 "BG:DS03023.4, DS03023.4" CDMC20077 1 24 6 DAC10-I12 22-CG18482-RA_1 CG18482 TGCTGTTTTCGTCTGGTTAAACAGGTACTACGGACTTCCAACTACACTTGTTAACATGCCTCCAGAGCA 69 FBan0018482 FBgn0028891 CG18482 2 2L CG18482 CG18482 "BG:DS03023.4, DS03023.4" CDMC20078 1 25 6 DAC10-I24 16-CG18496-RA_1 CG18496 CAACATATCCAGCTGCTCCACGCTAGACATTGTCAACAAAGTGAGTAATGATGCCCGCACTGAGAGAAA 69 FBan0018496 FBgn0038329 CG18496 3 3R CG18496 CG18496 CDMC20078 1 26 6 DAC10-I24 16-CG18496-RA_1 CG18496 CAACATATCCAGCTGCTCCACGCTAGACATTGTCAACAAAGTGAGTAATGATGCCCGCACTGAGAGAAA 69 FBan0018496 FBgn0038329 CG18496 3 3R CG18496 CG18496 CDMC20079 1 1 7 DAC10-M12 2-CG1854-RA_2 CG1854 CGGCTTAGCTCTACCAGGAGTGAGCATGACCAGTTCACCCGTCTACGAGGTTATCTACTTGGCCCAACT 69 FBan0001854 FBgn0026389 Or43a 2 2R sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549; ; GO:0004984 integral to membrane; GO:0016021 Or43a Odorant receptor 43a "CG1854, CG1854, DOR43B.1, Olfactory receptor 43B.1, dor87, AN14, Dor87, 43B.1, DOR87, Or, 43a, Or43A, or43a, 43B1, Or43B.1, Or87: Odorant receptor 87, Odorant receptor 87" CDMC20079 1 2 7 DAC10-M12 2-CG1854-RA_2 CG1854 CGGCTTAGCTCTACCAGGAGTGAGCATGACCAGTTCACCCGTCTACGAGGTTATCTACTTGGCCCAACT 69 FBan0001854 FBgn0026389 Or43a 2 2R sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549; ; GO:0004984 integral to membrane; GO:0016021 Or43a Odorant receptor 43a "CG1854, CG1854, DOR43B.1, Olfactory receptor 43B.1, dor87, AN14, Dor87, 43B.1, DOR87, Or, 43a, Or43A, or43a, 43B1, Or43B.1, Or87: Odorant receptor 87, Odorant receptor 87" CDMC20080 1 3 7 DAC10-M24 8-CG18577-RA_1 CG18577 ACGGCTGATGACAGAGCGTTTAAACGAACCCATCAACATCTCCATTCGCATGGGACCTGCCTATGACTA 69 FBan0018577 FBgn0037870 CG18577 3 3R CG18577 CG18577 CDMC20080 1 4 7 DAC10-M24 8-CG18577-RA_1 CG18577 ACGGCTGATGACAGAGCGTTTAAACGAACCCATCAACATCTCCATTCGCATGGGACCTGCCTATGACTA 69 FBan0018577 FBgn0037870 CG18577 3 3R CG18577 CG18577 CDMC20081 1 5 7 DAC11-A12 6-CG1017-RA_1 CG1017 TGCAGAAGTACTATCATCGTGGTGCCTTCTACCTGGATGAGGAGAACGACGTCCTCAAGCGCGACTT 67 FBan0001017 FBgn0035294 CG1017 3 3L cytoskeleton organization and biogenesis; GO:0007010 structural molecule activity; GO:0005198; ; GO:0005198 microfibril; GO:0001527 CG1017 CG1017 CDMC20081 1 6 7 DAC11-A12 6-CG1017-RA_1 CG1017 TGCAGAAGTACTATCATCGTGGTGCCTTCTACCTGGATGAGGAGAACGACGTCCTCAAGCGCGACTT 67 FBan0001017 FBgn0035294 CG1017 3 3L cytoskeleton organization and biogenesis; GO:0007010 structural molecule activity; GO:0005198; ; GO:0005198 microfibril; GO:0001527 CG1017 CG1017 CDMC20082 1 7 7 DAC11-A24 1-CG10340-RA_1 CG10340 ACGCTCCGGAGTGTCTCACAGTGGTTCACTATACCGAGGTCCAAGACAAGGGTGTAGTTCTCATGCG 67 FBan0010340 FBgn0022344 CG10340 3 3R protein complex assembly; GO:0006461; protein metabolism; GO:0019538 CG10340 CG10340 "anon2A5, anon-EST:fe2A5: anon-fast-evolving-2A5, anon-fast-evolving-2A5" CDMC20082 1 8 7 DAC11-A24 1-CG10340-RA_1 CG10340 ACGCTCCGGAGTGTCTCACAGTGGTTCACTATACCGAGGTCCAAGACAAGGGTGTAGTTCTCATGCG 67 FBan0010340 FBgn0022344 CG10340 3 3R protein complex assembly; GO:0006461; protein metabolism; GO:0019538 CG10340 CG10340 "anon2A5, anon-EST:fe2A5: anon-fast-evolving-2A5, anon-fast-evolving-2A5" CDMC20083 1 9 7 DAC11-E12 1-CG10754-RA_1 CG10754 TGGAACCGTGACACCAAGCAGTTCTTCCTTCAGTTCGCCTTCAAGTTCGAACCTAAGATCCTGCCGC 67 FBan0010754 FBgn0036314 CG10754 3 3L "nuclear mRNA splicing, via spliceosome; GO:0000398" "zinc ion binding; GO:0008270; ; GO:0008270; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" snRNP U2; GO:0005686; spliceosome complex; GO:0005681 CG10754 CG10754 CDMC20083 1 10 7 DAC11-E12 1-CG10754-RA_1 CG10754 TGGAACCGTGACACCAAGCAGTTCTTCCTTCAGTTCGCCTTCAAGTTCGAACCTAAGATCCTGCCGC 67 FBan0010754 FBgn0036314 CG10754 3 3L "nuclear mRNA splicing, via spliceosome; GO:0000398" "zinc ion binding; GO:0008270; ; GO:0008270; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" snRNP U2; GO:0005686; spliceosome complex; GO:0005681 CG10754 CG10754 CDMC20084 1 11 7 DAC11-E24 3-CG10880-RA_5 CG10880 TGGATTTGGCCTCTCTCACCGACGAAGATTTGGAACTCTTCGGGTTCAAGTGTCGAAAGCAACGGCA 67 FBan0010880 FBgn0031398 CG10880 2 2L CG10880 CG10880 CDMC20084 1 12 7 DAC11-E24 3-CG10880-RA_5 CG10880 TGGATTTGGCCTCTCTCACCGACGAAGATTTGGAACTCTTCGGGTTCAAGTGTCGAAAGCAACGGCA 67 FBan0010880 FBgn0031398 CG10880 2 2L CG10880 CG10880 CDMC20085 1 13 7 DAC11-I12 13-CG11227-RC_1 CG11227 GGGCATTCTGAAAAACCTTGCCAACGGTTATTTGAAGTTGGTCCACGAAATCGAGACCCACCTCTGC 67 FBan0011227 FBgn0031139 CG11227 X X CG11227 CG11227 CDMC20085 1 14 7 DAC11-I12 13-CG11227-RC_1 CG11227 GGGCATTCTGAAAAACCTTGCCAACGGTTATTTGAAGTTGGTCCACGAAATCGAGACCCACCTCTGC 67 FBan0011227 FBgn0031139 CG11227 X X CG11227 CG11227 CDMC20086 1 15 7 DAC11-I24 19-CG11293-RA_2 CG11293 CGTGAAGTGTTCACTGTACTTTGGGAGCGGAGGATAAGTCAAGACGTCAACAGAGGAAGCTGTACGA 67 FBan0011293 FBgn0034889 CG11293 2 2R CG11293 CG11293 CDMC20086 1 16 7 DAC11-I24 19-CG11293-RA_2 CG11293 CGTGAAGTGTTCACTGTACTTTGGGAGCGGAGGATAAGTCAAGACGTCAACAGAGGAAGCTGTACGA 67 FBan0011293 FBgn0034889 CG11293 2 2R CG11293 CG11293 CDMC20087 1 17 7 DAC11-M12 2-CG11980-RB_1 CG11980 GGATACTGCAGGTCGTGAGTTTGTGGACAACGTTGTGGAGGTATCATGTTCCTGGATTCCAGCCCGG 67 FBan0011980 FBgn0037652 CG11980 3 3R CG11980 CG11980 anon-WO0118547.327 CDMC20087 1 18 7 DAC11-M12 2-CG11980-RB_1 CG11980 GGATACTGCAGGTCGTGAGTTTGTGGACAACGTTGTGGAGGTATCATGTTCCTGGATTCCAGCCCGG 67 FBan0011980 FBgn0037652 CG11980 3 3R CG11980 CG11980 anon-WO0118547.327 CDMC20088 1 19 7 DAC11-M24 1-CG12081-RA_1 CG12081 TTGGAGCTCGAATAACACTTTCGGGAGAGATGACGAATGGAGGACCTGAGCGAACGAGGGAGAAGCC 67 FBan0012081 FBgn0030053 CG12081 X X "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" CG12081 CG12081 CDMC20088 1 20 7 DAC11-M24 1-CG12081-RA_1 CG12081 TTGGAGCTCGAATAACACTTTCGGGAGAGATGACGAATGGAGGACCTGAGCGAACGAGGGAGAAGCC 67 FBan0012081 FBgn0030053 CG12081 X X "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" CG12081 CG12081 CDMC20089 1 21 7 DAC12-A12 6-CG10125-RA_4 CG10125 CGGTCGGCTGAAGCATTTGTGCGATGATTTCCACAAGATGGCCGTTTGCAAGGACAAGAGCAGGAC 66 FBan0010125 FBgn0024177 zpg 3 3L germ cell development; GO:0007281; signal transduction; GO:0007165 innexin channel activity; GO:0015286; ; GO:0015286 gap junction; GO:0005921; integral to membrane; GO:0016021 zpg zero population growth "CG10125, CG10125, Dm-inx4, inx4, zero population growth" CDMC20089 1 22 7 DAC12-A12 6-CG10125-RA_4 CG10125 CGGTCGGCTGAAGCATTTGTGCGATGATTTCCACAAGATGGCCGTTTGCAAGGACAAGAGCAGGAC 66 FBan0010125 FBgn0024177 zpg 3 3L germ cell development; GO:0007281; signal transduction; GO:0007165 innexin channel activity; GO:0015286; ; GO:0015286 gap junction; GO:0005921; integral to membrane; GO:0016021 zpg zero population growth "CG10125, CG10125, Dm-inx4, inx4, zero population growth" CDMC20090 1 23 7 DAC12-A24 2-CG10211-RA_1 CG10211 GCTGCCTTCCGTATCGGTCACTCTCTGCTACGTCCCCATATTCCTCGTCTAAGTGTCCAGCACCAG 66 FBan0010211 FBgn0032685 CG10211 2 2L defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800; transport; GO:0006810 DNA binding; GO:0003677; peroxidase activity; GO:0004601 ; EC:1.11.1.7; transporter activity; GO:0005215; ; GO:0005215; ; GO:0004601 ; EC:1.11.1.7; ; GO:0003677 membrane; GO:0016020; nucleus; GO:0005634 CG10211 CG10211 CDMC20090 1 24 7 DAC12-A24 2-CG10211-RA_1 CG10211 GCTGCCTTCCGTATCGGTCACTCTCTGCTACGTCCCCATATTCCTCGTCTAAGTGTCCAGCACCAG 66 FBan0010211 FBgn0032685 CG10211 2 2L defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800; transport; GO:0006810 DNA binding; GO:0003677; peroxidase activity; GO:0004601 ; EC:1.11.1.7; transporter activity; GO:0005215; ; GO:0005215; ; GO:0004601 ; EC:1.11.1.7; ; GO:0003677 membrane; GO:0016020; nucleus; GO:0005634 CG10211 CG10211 CDMC20091 1 25 7 DAC12-E12 14-CG10638-RA_1 CG10638 ACTGAGCGATGTCGACTATCTGGATACGTACAAAGCCATGGAAAAGCTGGTAAAACTGGGCCTGGT 66 FBan0010638 FBgn0036290 CG10638 3 3L aldehyde metabolism; GO:0006081 aldehyde reductase activity; GO:0004032 ; EC:1.1.1.21; ; GO:0004032 ; EC:1.1.1.21 CG10638 CG10638 "CG32101, anon-WO0172774.89" CDMC20091 1 26 7 DAC12-E12 14-CG10638-RA_1 CG10638 ACTGAGCGATGTCGACTATCTGGATACGTACAAAGCCATGGAAAAGCTGGTAAAACTGGGCCTGGT 66 FBan0010638 FBgn0036290 CG10638 3 3L aldehyde metabolism; GO:0006081 aldehyde reductase activity; GO:0004032 ; EC:1.1.1.21; ; GO:0004032 ; EC:1.1.1.21 CG10638 CG10638 "CG32101, anon-WO0172774.89" CDMC20092 1 1 8 DAC12-E24 2-CG10776-RA_2 CG10776 TCAACGGGACCACCAACAATAACTCCATCCAGAGTCATGGTAGCGAATTGCAGACCCTCACCCGTC 66 FBan0010776 FBgn0024179 wit 3 3L dendrite morphogenesis; GO:0016358; neuromuscular junction development; GO:0007528; neuromuscular synaptic transmission; GO:0007274; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178 "ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; transforming growth factor beta receptor activity, type II; GO:0005026; ; GO:0005026; ; GO:0005026; ; GO:0005026" plasma membrane; GO:0005886 wit wishful thinking "CG10776, CG10776, CG10776, l(3)64Aa, l(3)SH12, STK-D, SE20, 1262/15, ALK3/BMPRII, Stk-D, l(3)S126215, Serine/threonine kinase-D, wishful thinking" CDMC20092 1 2 8 DAC12-E24 2-CG10776-RA_2 CG10776 TCAACGGGACCACCAACAATAACTCCATCCAGAGTCATGGTAGCGAATTGCAGACCCTCACCCGTC 66 FBan0010776 FBgn0024179 wit 3 3L dendrite morphogenesis; GO:0016358; neuromuscular junction development; GO:0007528; neuromuscular synaptic transmission; GO:0007274; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178 "ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; transforming growth factor beta receptor activity, type II; GO:0005026; ; GO:0005026; ; GO:0005026; ; GO:0005026" plasma membrane; GO:0005886 wit wishful thinking "CG10776, CG10776, CG10776, l(3)64Aa, l(3)SH12, STK-D, SE20, 1262/15, ALK3/BMPRII, Stk-D, l(3)S126215, Serine/threonine kinase-D, wishful thinking" CDMC20093 1 3 8 DAC12-I12 3-CG11132-RA_4 CG11132 CGCTTCATTGTGATGGCAGATCGTTGGAACCGTCAGCAGCATGGAACCAAAACTGTGGAGGAGCTC 66 FBan0011132 FBgn0034537 DMAP1 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 colocalizes_with TIP60 histone acetyltransferase complex; GO:0035267 DMAP1 DMAP1 "CG11132, CG11132, CG11132, dDMAP1" CDMC20093 1 4 8 DAC12-I12 3-CG11132-RA_4 CG11132 CGCTTCATTGTGATGGCAGATCGTTGGAACCGTCAGCAGCATGGAACCAAAACTGTGGAGGAGCTC 66 FBan0011132 FBgn0034537 DMAP1 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 colocalizes_with TIP60 histone acetyltransferase complex; GO:0035267 DMAP1 DMAP1 "CG11132, CG11132, CG11132, dDMAP1" CDMC20094 1 5 8 DAC12-I24 9-CG11178-RA_1 CG11178 TGAGCACCGAGGATCTGCGCTACATGGACTACATCATGAAGCATGTGCAATCGCCAAAGGAGGATG 66 FBan0011178 FBgn0030499 CG11178 X X CG11178 CG11178 CDMC20094 1 6 8 DAC12-I24 9-CG11178-RA_1 CG11178 TGAGCACCGAGGATCTGCGCTACATGGACTACATCATGAAGCATGTGCAATCGCCAAAGGAGGATG 66 FBan0011178 FBgn0030499 CG11178 X X CG11178 CG11178 CDMC20095 1 7 8 DAC12-M12 1-CG11928-RA_1 CG11928 CGACTTCAACGAGGAGGAATTATGCAGCATCACCAAGGATTCGCAGGACATTGCCGTGCTTCTGGC 66 FBan0011928 FBgn0031625 CG11928 2 2L CG11928 CG11928 CDMC20095 1 8 8 DAC12-M12 1-CG11928-RA_1 CG11928 CGACTTCAACGAGGAGGAATTATGCAGCATCACCAAGGATTCGCAGGACATTGCCGTGCTTCTGGC 66 FBan0011928 FBgn0031625 CG11928 2 2L CG11928 CG11928 CDMC20096 1 9 8 DAC12-M24 1-CG12045-RA_1 CG12045 TACGGAGATGATGGTTCCTACGATCCCCGCTACAACGATCCCTCTTTCGGACAGAACCAGCAGAGC 66 FBan0012045 FBgn0039805 CG12045 3 3R structural constituent of cuticle; GO:0042302; ; GO:0042302 CG12045 CG12045 CDMC20096 1 10 8 DAC12-M24 1-CG12045-RA_1 CG12045 TACGGAGATGATGGTTCCTACGATCCCCGCTACAACGATCCCTCTTTCGGACAGAACCAGCAGAGC 66 FBan0012045 FBgn0039805 CG12045 3 3R structural constituent of cuticle; GO:0042302; ; GO:0042302 CG12045 CG12045 CDMC20097 1 11 8 DAC13-A12 1-CG14529-RA_1 CG14529 CCATGCTGTCCAACATGAGCGATGCTTACGGACCGATTCTTAACGTGACTCGCTTTGTGACCTCCTGGT 69 FBan0014529 FBgn0039609 CG14529 3 3R proteolysis; GO:0006508 zinc ion binding; GO:0008270; metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG14529 CG14529 CDMC20097 1 12 8 DAC13-A12 1-CG14529-RA_1 CG14529 CCATGCTGTCCAACATGAGCGATGCTTACGGACCGATTCTTAACGTGACTCGCTTTGTGACCTCCTGGT 69 FBan0014529 FBgn0039609 CG14529 3 3R proteolysis; GO:0006508 zinc ion binding; GO:0008270; metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG14529 CG14529 CDMC20098 1 13 8 DAC13-A24 3-CG14543-RA_2 CG14543 CAGTTTCCGCAAATAGAGGCTGAATTGAGTAAACTTCCTGCTGGCAAGGAGTGGCTGCGTCCGGATGTT 69 FBan0014543 FBgn0039404 CG14543 3 3R CG14543 CG14543 CDMC20098 1 14 8 DAC13-A24 3-CG14543-RA_2 CG14543 CAGTTTCCGCAAATAGAGGCTGAATTGAGTAAACTTCCTGCTGGCAAGGAGTGGCTGCGTCCGGATGTT 69 FBan0014543 FBgn0039404 CG14543 3 3R CG14543 CG14543 CDMC20099 1 15 8 DAC13-E12 14-CG14581-RA_1 CG14581 CGCAGCCTGCCTTCAATCGAAACCGATATTCAAACGATCGCACGGCTTAATCAACTGAAGTTGGAGGAA 69 FBan0014581 FBgn0040645 CG14581 X X CG14581 CG14581 CDMC20099 1 16 8 DAC13-E12 14-CG14581-RA_1 CG14581 CGCAGCCTGCCTTCAATCGAAACCGATATTCAAACGATCGCACGGCTTAATCAACTGAAGTTGGAGGAA 69 FBan0014581 FBgn0040645 CG14581 X X CG14581 CG14581 CDMC20100 1 17 8 DAC13-E24 8-CG14591-RB_1 CG14591 GGGCTTCAAACTCTCCGGACAGTCAATGATTTTCGCCTTGAATCCATGTCATGTCCAGTCATGCCTGCA 69 FBan0014591 FBgn0033054 CG14591 2 2R CG14591 CG14591 CDMC20100 1 18 8 DAC13-E24 8-CG14591-RB_1 CG14591 GGGCTTCAAACTCTCCGGACAGTCAATGATTTTCGCCTTGAATCCATGTCATGTCCAGTCATGCCTGCA 69 FBan0014591 FBgn0033054 CG14591 2 2R CG14591 CG14591 CDMC20101 1 19 8 DAC13-I12 3-CG14637-RA_2 CG14637 CCCCTGGTCGTCTAATGGATATGCTGGACAAGAAGATCCTTACGCTGGACATGTGCCGGTACTTGTGCA 69 FBan0014637 FBgn0015331 abs 3 3R "apoptosis; GO:0006915; establishment of cell polarity; GO:0030010; morphogenesis; GO:0009653; nervous system development; GO:0007399; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; ATP-dependent helicase activity; GO:0008026; ; GO:0004386; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004; ; GO:0008026 nucleus; GO:0005634 abs abstrakt "CG14637, abstract, DmRH23, ABS, anon-WO0118547.315, l(3)00620, l(3)04505, l(3)06862, l(3)06863" CDMC20101 1 20 8 DAC13-I12 3-CG14637-RA_2 CG14637 CCCCTGGTCGTCTAATGGATATGCTGGACAAGAAGATCCTTACGCTGGACATGTGCCGGTACTTGTGCA 69 FBan0014637 FBgn0015331 abs 3 3R "apoptosis; GO:0006915; establishment of cell polarity; GO:0030010; morphogenesis; GO:0009653; nervous system development; GO:0007399; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; ; GO:0003676; ATP-dependent helicase activity; GO:0008026; ; GO:0004386; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004; ; GO:0008026 nucleus; GO:0005634 abs abstrakt "CG14637, abstract, DmRH23, ABS, anon-WO0118547.315, l(3)00620, l(3)04505, l(3)06862, l(3)06863" CDMC20102 1 21 8 DAC13-I24 1-CG1464-RA_1 CG1464 CCTGTTTCTACTCACCGTGGGTCTAGGAACAGACTGGCGATTTGAGCAGAGAAGCACTGCGAAAGGACT 69 FBan0001464 FBgn0005558 ey 4 4 "DNA methylation; GO:0006306; adult walking behavior; GO:0007628; brain development; GO:0007420; cell proliferation; GO:0008283; compound eye morphogenesis (sensu Endopterygota); GO:0001745; ectoderm development; GO:0007398; endoderm development; GO:0007492; eye development (sensu Endopterygota); GO:0007456; eye-antennal disc morphogenesis; GO:0007455; glial cell migration; GO:0008347; mesoderm development; GO:0007498; muscle development; GO:0007517; mushroom body development; GO:0016319; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634; transcription factor complex; GO:0005667 ey eyeless "CG1464, CG1464, l(4)33, pax6, EYEL, eye, DPax-6, Pax6, Ey, Ey/Pax6, Pax-6, l(4)102CDh, l(4)102CDr, tumor-head-63, eyeless" CDMC20102 1 22 8 DAC13-I24 1-CG1464-RA_1 CG1464 CCTGTTTCTACTCACCGTGGGTCTAGGAACAGACTGGCGATTTGAGCAGAGAAGCACTGCGAAAGGACT 69 FBan0001464 FBgn0005558 ey 4 4 "DNA methylation; GO:0006306; adult walking behavior; GO:0007628; brain development; GO:0007420; cell proliferation; GO:0008283; compound eye morphogenesis (sensu Endopterygota); GO:0001745; ectoderm development; GO:0007398; endoderm development; GO:0007492; eye development (sensu Endopterygota); GO:0007456; eye-antennal disc morphogenesis; GO:0007455; glial cell migration; GO:0008347; mesoderm development; GO:0007498; muscle development; GO:0007517; mushroom body development; GO:0016319; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634; transcription factor complex; GO:0005667 ey eyeless "CG1464, CG1464, l(4)33, pax6, EYEL, eye, DPax-6, Pax6, Ey, Ey/Pax6, Pax-6, l(4)102CDh, l(4)102CDr, tumor-head-63, eyeless" CDMC20103 1 23 8 DAC13-M12 2-CG14685-RB_1 CG14685 CCCATCCCAAAGATGTGGCCTACTCCTTCTGATGCCGACTCGGGGATATCTTCGATGGGCTCATCATTG 69 FBan0014685 FBgn0037831 CG14685 3 3R CG14685 CG14685 CDMC20103 1 24 8 DAC13-M12 2-CG14685-RB_1 CG14685 CCCATCCCAAAGATGTGGCCTACTCCTTCTGATGCCGACTCGGGGATATCTTCGATGGGCTCATCATTG 69 FBan0014685 FBgn0037831 CG14685 3 3R CG14685 CG14685 CDMC20104 1 25 8 DAC13-M24 23-CG14691-RB_1 CG14691 GATGGTTTTACTGCTGATCATGACCTTTGGGAGACTTGGATCTGTAAGTGGCAATATGTTACTGCCGGT 69 FBan0014691 FBgn0037829 CG14691 3 3R neurotransmitter secretion; GO:0007269; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021; synaptic vesicle; GO:0008021 CG14691 CG14691 CDMC20104 1 26 8 DAC13-M24 23-CG14691-RB_1 CG14691 GATGGTTTTACTGCTGATCATGACCTTTGGGAGACTTGGATCTGTAAGTGGCAATATGTTACTGCCGGT 69 FBan0014691 FBgn0037829 CG14691 3 3R neurotransmitter secretion; GO:0007269; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021; synaptic vesicle; GO:0008021 CG14691 CG14691 CDMC20105 1 1 9 DAC14-A12 3-CG17248-RC_2 CG17248 CATGGGCGTGATTGGCCTGGTTGTCGTGGGCATTATTGCAAATAAACTTGGACTCATAGGCGGGG 65 FBan0017248 FBgn0013342 n-syb 3 3L exocytosis; GO:0006887; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle docking during exocytosis; GO:0016081; vesicle-mediated transport; GO:0016192 v-SNARE activity; GO:0005485; ; GO:0005485; ; GO:0005485 plasma membrane; GO:0005886; synaptic vesicle; GO:0008021 n-syb n-synaptobrevin "CG17248, CG17248, CG17248, n-Syb, Dn-syb, SYB, nsyb, nSYB, syb, Nsyb, synaptobrevin, N-synaptobrevin, Syb62A: Synaptobrevin-62A, Synaptobrevin-62A" CDMC20105 1 2 9 DAC14-A12 3-CG17248-RC_2 CG17248 CATGGGCGTGATTGGCCTGGTTGTCGTGGGCATTATTGCAAATAAACTTGGACTCATAGGCGGGG 65 FBan0017248 FBgn0013342 n-syb 3 3L exocytosis; GO:0006887; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle docking during exocytosis; GO:0016081; vesicle-mediated transport; GO:0016192 v-SNARE activity; GO:0005485; ; GO:0005485; ; GO:0005485 plasma membrane; GO:0005886; synaptic vesicle; GO:0008021 n-syb n-synaptobrevin "CG17248, CG17248, CG17248, n-Syb, Dn-syb, SYB, nsyb, nSYB, syb, Nsyb, synaptobrevin, N-synaptobrevin, Syb62A: Synaptobrevin-62A, Synaptobrevin-62A" CDMC20106 1 3 9 DAC14-A24 2-CG17268-RA_1 CG17268 GATGGCTCTGCACGTCTCTTTCATACCGAACCATCCGGGATATTCCACGAGTACAAGGCGACCGC 65 FBan0017268 FBgn0017557 Pros28.1A 3 3R proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 Pros28.1A Pros28.1A "CG17268, alpha4t1_dm, testes-specific proteasome subunit, 20S proteasome, dalpha7, a4-t1, 20s proteasome, alpha4t1" CDMC20106 1 4 9 DAC14-A24 2-CG17268-RA_1 CG17268 GATGGCTCTGCACGTCTCTTTCATACCGAACCATCCGGGATATTCCACGAGTACAAGGCGACCGC 65 FBan0017268 FBgn0017557 Pros28.1A 3 3R proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175 proteasome core complex (sensu Eukaryota); GO:0005839 Pros28.1A Pros28.1A "CG17268, alpha4t1_dm, testes-specific proteasome subunit, 20S proteasome, dalpha7, a4-t1, 20s proteasome, alpha4t1" CDMC20107 1 5 9 DAC14-E12 3-CG17429-RA_1 CG17429 GTGCACCTAAGCGAGAATCAAGGACCAAGCCAAGAGTGTTGCACGTGAATTGTGCTCGCGAGGAG 65 FBgn0039954 CG17429 CG17429 CG17429 CG40065 CDMC20107 1 6 9 DAC14-E12 3-CG17429-RA_1 CG17429 GTGCACCTAAGCGAGAATCAAGGACCAAGCCAAGAGTGTTGCACGTGAATTGTGCTCGCGAGGAG 65 FBgn0039954 CG17429 CG17429 CG17429 CG40065 CDMC20108 1 7 9 DAC14-E24 3-CG17525-RA_1 CG17525 GACCAATTGATGCACTTCGAGTCGGGTGTCATCTTCGAGTCTGCCCTAAGGAGACTCACCCGTCC 65 FBgn0034338 CDMC20108 1 8 9 DAC14-E24 3-CG17525-RA_1 CG17525 GACCAATTGATGCACTTCGAGTCGGGTGTCATCTTCGAGTCTGCCCTAAGGAGACTCACCCGTCC 65 FBgn0034338 CDMC20109 1 9 9 DAC14-I12 2-CG17652-RA_3 CG17652 TCTGCTGCAGGAGAGTCTTCGCAAGATTCCCGGACGTTGTCTGCTCTATCTGCACAAAGCCACTC 65 FBan0017652 FBgn0031361 CG17652 2 2L CG17652 CG17652 CDMC20109 1 10 9 DAC14-I12 2-CG17652-RA_3 CG17652 TCTGCTGCAGGAGAGTCTTCGCAAGATTCCCGGACGTTGTCTGCTCTATCTGCACAAAGCCACTC 65 FBan0017652 FBgn0031361 CG17652 2 2L CG17652 CG17652 CDMC20110 1 11 9 DAC14-I24 2-CG17689-RA_1 CG17689 GAAAACCATCGTTCACTCTCCCGCCACATCTTCGATACACTCGCCCATGTCTAGTCCGCATCCGC 65 FBan0017689 FBgn0036374 CG17689 3 3L CG17689 CG17689 CDMC20110 1 12 9 DAC14-I24 2-CG17689-RA_1 CG17689 GAAAACCATCGTTCACTCTCCCGCCACATCTTCGATACACTCGCCCATGTCTAGTCCGCATCCGC 65 FBan0017689 FBgn0036374 CG17689 3 3L CG17689 CG17689 CDMC20111 1 13 9 DAC14-M12 24-CG17826-RA_1 CG17826 ATTGGCCCGATAATGTTAAGTGCTAAGTGGTTTCAATAAACAATATTTAAAGCAGAGTATTAAAC 65 FBan0017826 FBgn0036227 CG17826 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG17826 CG17826 CDMC20111 1 14 9 DAC14-M12 24-CG17826-RA_1 CG17826 ATTGGCCCGATAATGTTAAGTGCTAAGTGGTTTCAATAAACAATATTTAAAGCAGAGTATTAAAC 65 FBan0017826 FBgn0036227 CG17826 3 3L chitin metabolism; GO:0006030 chitin binding; GO:0008061; ; GO:0008061 extracellular region; GO:0005576 CG17826 CG17826 CDMC20112 1 15 9 DAC14-M24 2-CG1785-RA_1 CG1785 ATTTTCGCGACGAGATTCCTGGACTCAAGGACGAGAAGGGTTGGATCAGTCGCGAACTGGCACTG 65 FBan0001785 FBgn0030061 CG1785 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG1785 CG1785 CDMC20112 1 16 9 DAC14-M24 2-CG1785-RA_1 CG1785 ATTTTCGCGACGAGATTCCTGGACTCAAGGACGAGAAGGGTTGGATCAGTCGCGAACTGGCACTG 65 FBan0001785 FBgn0030061 CG1785 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG1785 CG1785 CDMC20113 1 17 9 DAC15-A12 3-CG12538-RA_1 CG12538 CCCGCCGTCGTTTCTCAGACGTTGTTGTACAGAATTTGCATGTCCTGCCAGTCCGACGCTCTCAAAAC 68 FBan0012538 FBgn0038157 CG12538 3 3R CG12538 CG12538 CDMC20113 1 18 9 DAC15-A12 3-CG12538-RA_1 CG12538 CCCGCCGTCGTTTCTCAGACGTTGTTGTACAGAATTTGCATGTCCTGCCAGTCCGACGCTCTCAAAAC 68 FBan0012538 FBgn0038157 CG12538 3 3R CG12538 CG12538 CDMC20114 1 19 9 DAC15-A24 3-CG12736-RA_1 CG12736 GGCTTCAATCAGAACCTGAAGACAAGCATCAGCGACATCCAGATATTCCGGAAGAGCGTGCCTCAGGC 68 FBan0012736 FBgn0033184 CG12736 2 2R protein biosynthesis; GO:0006412; regulation of translation; GO:0006445; translational elongation; GO:0006414 GTP binding; GO:0005525; GTPase activity; GO:0003924; translation elongation factor activity; GO:0003746; ; GO:0003746; ; GO:0003924; ; GO:0003746; ; GO:0005525 mitochondrion; GO:0005739 CG12736 CG12736 CDMC20114 1 20 9 DAC15-A24 3-CG12736-RA_1 CG12736 GGCTTCAATCAGAACCTGAAGACAAGCATCAGCGACATCCAGATATTCCGGAAGAGCGTGCCTCAGGC 68 FBan0012736 FBgn0033184 CG12736 2 2R protein biosynthesis; GO:0006412; regulation of translation; GO:0006445; translational elongation; GO:0006414 GTP binding; GO:0005525; GTPase activity; GO:0003924; translation elongation factor activity; GO:0003746; ; GO:0003746; ; GO:0003924; ; GO:0003746; ; GO:0005525 mitochondrion; GO:0005739 CG12736 CG12736 CDMC20115 1 21 9 DAC15-E12 12-CG13353-RA_8 CG13353 ACGTTGGGGAGCTGATAACGCATTCGGATGACACCATTTTCATCAAGCAAGTGTCCCACAAATGGTGG 68 FBan0013353 FBgn0033896 CG13353 2 2R CG13353 CG13353 CDMC20115 1 22 9 DAC15-E12 12-CG13353-RA_8 CG13353 ACGTTGGGGAGCTGATAACGCATTCGGATGACACCATTTTCATCAAGCAAGTGTCCCACAAATGGTGG 68 FBan0013353 FBgn0033896 CG13353 2 2R CG13353 CG13353 CDMC20116 1 23 9 DAC15-E24 2-CG13434-RA_1 CG13434 GCAATGCCAATCGCGAGCGACTCCAACATGTCCATGACAAGCGCCTGAAATTGACTGTCCAAATGGAG 68 FBan0013434 FBgn0034523 CG13434 2 2R CG13434 CG13434 CDMC20116 1 24 9 DAC15-E24 2-CG13434-RA_1 CG13434 GCAATGCCAATCGCGAGCGACTCCAACATGTCCATGACAAGCGCCTGAAATTGACTGTCCAAATGGAG 68 FBan0013434 FBgn0034523 CG13434 2 2R CG13434 CG13434 CDMC20117 1 25 9 DAC15-I12 4-CG13813-RA_1 CG13813 CGCCGTTACCCGAGTCCTTTTGGAGCTGTATCAACGCCATGGTATACCTATGGTCTCGCAACCAATGG 68 FBan0013813 FBgn0036956 CG13813 3 3L CG13813 CG13813 CDMC20117 1 26 9 DAC15-I12 4-CG13813-RA_1 CG13813 CGCCGTTACCCGAGTCCTTTTGGAGCTGTATCAACGCCATGGTATACCTATGGTCTCGCAACCAATGG 68 FBan0013813 FBgn0036956 CG13813 3 3L CG13813 CG13813 CDMC20118 1 1 10 DAC15-I24 16-CG13876-RA_3 CG13876 TCCGGAGACCAGACTTCCAGCTCACTTCATATTCAGAGCGAAGAGGATTATCCCATTCACACGATTGC 68 FBan0013876 FBgn0035109 CG13876 3 3L CG13876 CG13876 CDMC20118 1 2 10 DAC15-I24 16-CG13876-RA_3 CG13876 TCCGGAGACCAGACTTCCAGCTCACTTCATATTCAGAGCGAAGAGGATTATCCCATTCACACGATTGC 68 FBan0013876 FBgn0035109 CG13876 3 3L CG13876 CG13876 CDMC20119 1 3 10 DAC15-M12 23-CG14292-RA_1 CG14292 ACCCAACGACTGAGAACCAAGTGAACTCAGATAAATTAAAAGAAATGAAATTCGCAATTGTTCTACTG 68 FBan0014292 FBgn0038658 CG14292 3 3R CG14292 CG14292 CDMC20119 1 4 10 DAC15-M12 23-CG14292-RA_1 CG14292 ACCCAACGACTGAGAACCAAGTGAACTCAGATAAATTAAAAGAAATGAAATTCGCAATTGTTCTACTG 68 FBan0014292 FBgn0038658 CG14292 3 3R CG14292 CG14292 CDMC20120 1 5 10 DAC15-M24 2-CG14376-RA_1 CG14376 TGGCTGGCTCAACGCGTATCAGGCTTCCAATTGCGGAATCTCAATGGATATTTCCCCACCTGCTTGAG 68 FBan0014376 FBgn0038153 CG14376 3 3R transport; GO:0006810 transporter activity; GO:0005215; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0005215; ; GO:0004867 CG14376 CG14376 CDMC20120 1 6 10 DAC15-M24 2-CG14376-RA_1 CG14376 TGGCTGGCTCAACGCGTATCAGGCTTCCAATTGCGGAATCTCAATGGATATTTCCCCACCTGCTTGAG 68 FBan0014376 FBgn0038153 CG14376 3 3R transport; GO:0006810 transporter activity; GO:0005215; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0005215; ; GO:0004867 CG14376 CG14376 CDMC20121 1 7 10 DAC16-A12 2-CG31049-RA_1 CG31049 AGGAGGAAGAACAGCAAGTACGCACGCTCAATGCACGAGTATCTGTACAGCGATGACCCTGGACA 65 FBgn0051049 CDMC20121 1 8 10 DAC16-A12 2-CG31049-RA_1 CG31049 AGGAGGAAGAACAGCAAGTACGCACGCTCAATGCACGAGTATCTGTACAGCGATGACCCTGGACA 65 FBgn0051049 CDMC20122 1 9 10 DAC16-A24 3-CG31078-RA_1 CG31078 ATGATGACCATTTTGGCTTGGGAGGTTCTATTGGGAAAGTCGATGGCTTGCACGCTCCGGCAATG 65 FBan0031078 FBgn0051078 CG31078 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31078 CG31078 CDMC20122 1 10 10 DAC16-A24 3-CG31078-RA_1 CG31078 ATGATGACCATTTTGGCTTGGGAGGTTCTATTGGGAAAGTCGATGGCTTGCACGCTCCGGCAATG 65 FBan0031078 FBgn0051078 CG31078 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31078 CG31078 CDMC20123 1 11 10 DAC16-E12 24-CG3119-RB_1 CG3119 TAGAGTTTATCTGACGGATTGATTATTCCTAATGCATCATAAATGTTTAATGATTTGTGATTGAT 65 FBan0003119 FBgn0031466 CG3119 2 2L CG3119 CG3119 CDMC20123 1 12 10 DAC16-E12 24-CG3119-RB_1 CG3119 TAGAGTTTATCTGACGGATTGATTATTCCTAATGCATCATAAATGTTTAATGATTTGTGATTGAT 65 FBan0003119 FBgn0031466 CG3119 2 2L CG3119 CG3119 CDMC20124 1 13 10 DAC16-E24 3-CG31229-RA_1 CG31229 TTTGTTTAGCGCCTCCGTTAATCCCAACATGGCCGATCCGTTCGCGAATGAGAAGAAGCAGACGG 65 FBan0031229 FBgn0051229 CG31229 3 3R protein targeting to mitochondrion; GO:0006626 protein translocase activity; GO:0015450; ; GO:0015450 mitochondrial inner membrane presequence translocase complex; GO:0005744 CG31229 CG31229 CDMC20124 1 14 10 DAC16-E24 3-CG31229-RA_1 CG31229 TTTGTTTAGCGCCTCCGTTAATCCCAACATGGCCGATCCGTTCGCGAATGAGAAGAAGCAGACGG 65 FBan0031229 FBgn0051229 CG31229 3 3R protein targeting to mitochondrion; GO:0006626 protein translocase activity; GO:0015450; ; GO:0015450 mitochondrial inner membrane presequence translocase complex; GO:0005744 CG31229 CG31229 CDMC20125 1 15 10 DAC16-I12 23-CG31315-RA_1 CG31315 GCCCCATTTTGCAACTCAATTCCAACATACATTTGCATGTCAGGACACCTAATCACAAACGGATA 65 FBan0031315 FBgn0051315 CG31315 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31315 CG31315 CDMC20125 1 16 10 DAC16-I12 23-CG31315-RA_1 CG31315 GCCCCATTTTGCAACTCAATTCCAACATACATTTGCATGTCAGGACACCTAATCACAAACGGATA 65 FBan0031315 FBgn0051315 CG31315 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31315 CG31315 CDMC20126 1 17 10 DAC16-I24 1-CG31349-RA_1 CG31349 GAGTTCCCCAATCGGTGACAGCTGTACCTCCATCGAAACCCAGTACACATCACAAGCCAGCTTGC 65 FBan0031349 FBgn0003177 pyd 3 3R JNK cascade; GO:0007254; dorsal closure; GO:0007391; electron transport; GO:0006118; establishment and/or maintenance of cell polarity; GO:0007163; regulation of JNK cascade; GO:0046328 guanylate kinase activity; GO:0004385 ; EC:2.7.4.8; ; GO:0004385 ; EC:2.7.4.8; ; GO:0004385 ; EC:2.7.4.8; structural molecule activity; GO:0005198; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0005198; protein binding; GO:0005515; ; GO:0016491 ; EC:1.-.-.-; ; GO:0004385 ; EC:2.7.4.8; ; GO:0005515 adherens junction; GO:0005912 pyd polychaetoid "CG9763, CG31349, CG11782, CG11962, CG12409, CG9729, CG9763, tam, tamou, DZO-1, ZO-1, dzo-1, Pyd, Pyd/ZO-1, Tamou, ZO1, CT36877, pyd(Z01), Pch, xvt: extra verticals, extra verticals" CDMC20126 1 18 10 DAC16-I24 1-CG31349-RA_1 CG31349 GAGTTCCCCAATCGGTGACAGCTGTACCTCCATCGAAACCCAGTACACATCACAAGCCAGCTTGC 65 FBan0031349 FBgn0003177 pyd 3 3R JNK cascade; GO:0007254; dorsal closure; GO:0007391; electron transport; GO:0006118; establishment and/or maintenance of cell polarity; GO:0007163; regulation of JNK cascade; GO:0046328 guanylate kinase activity; GO:0004385 ; EC:2.7.4.8; ; GO:0004385 ; EC:2.7.4.8; ; GO:0004385 ; EC:2.7.4.8; structural molecule activity; GO:0005198; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0005198; protein binding; GO:0005515; ; GO:0016491 ; EC:1.-.-.-; ; GO:0004385 ; EC:2.7.4.8; ; GO:0005515 adherens junction; GO:0005912 pyd polychaetoid "CG9763, CG31349, CG11782, CG11962, CG12409, CG9729, CG9763, tam, tamou, DZO-1, ZO-1, dzo-1, Pyd, Pyd/ZO-1, Tamou, ZO1, CT36877, pyd(Z01), Pch, xvt: extra verticals, extra verticals" CDMC20127 1 19 10 DAC16-M12 2-CG31468-RA_1 CG31468 TGCCTACAATCTGCCCAGCACCTTTGGGTTTAAGAACTGCGACAAGAGGATGCAGCGAAGTCCAC 65 FBan0031468 FBgn0047351 CG31468 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31468 CG31468 "BcDNA:AT08725, NEST:bs12h04, NEST:bs34b06, NEST:bs21c04, NEST:bs18e02" CDMC20127 1 20 10 DAC16-M12 2-CG31468-RA_1 CG31468 TGCCTACAATCTGCCCAGCACCTTTGGGTTTAAGAACTGCGACAAGAGGATGCAGCGAAGTCCAC 65 FBan0031468 FBgn0047351 CG31468 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31468 CG31468 "BcDNA:AT08725, NEST:bs12h04, NEST:bs34b06, NEST:bs21c04, NEST:bs18e02" CDMC20128 1 21 10 DAC16-M24 23-CG31516-RA_1 CG31516 CGCGTGGAGATTTGTCGAATGCAAAATACACAACCTTATCAGTGTACTAATTACCACCGCCCTAC 65 FBan0031516 FBgn0051516 CG31516 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31516 CG31516 BcDNA:RE68446 CDMC20128 1 22 10 DAC16-M24 23-CG31516-RA_1 CG31516 CGCGTGGAGATTTGTCGAATGCAAAATACACAACCTTATCAGTGTACTAATTACCACCGCCCTAC 65 FBan0031516 FBgn0051516 CG31516 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31516 CG31516 BcDNA:RE68446 CDMC20129 1 23 10 DAC17-A12 26-CG32668-RA_2 CG32668 CTCTAATGCCTCCCGCTCTATCGGCCATATCGACTTCGCTGTGTCCCAGGAAATTGACGGGTCAG 65 FBan0032668 FBgn0052668 CG32668 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32668 CG32668 CDMC20129 1 24 10 DAC17-A12 26-CG32668-RA_2 CG32668 CTCTAATGCCTCCCGCTCTATCGGCCATATCGACTTCGCTGTGTCCCAGGAAATTGACGGGTCAG 65 FBan0032668 FBgn0052668 CG32668 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32668 CG32668 CDMC20130 1 25 10 DAC17-A24 2-CG32693-RA_1 CG32693 GCTGTGGCTGGAACACTTTCTAACTGGCTACTTTCAGCTATGCGGACTGGTCTGTGGCTGGAGTG 65 FBan0032693 FBgn0052693 Gr9a X X sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr9a Gr9a "CG32693, CG32693" CDMC20130 1 26 10 DAC17-A24 2-CG32693-RA_1 CG32693 GCTGTGGCTGGAACACTTTCTAACTGGCTACTTTCAGCTATGCGGACTGGTCTGTGGCTGGAGTG 65 FBan0032693 FBgn0052693 Gr9a X X sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr9a Gr9a "CG32693, CG32693" CDMC20131 1 1 11 DAC17-E12 21-CG32821-RA_1 CG32821 ACTGTCCAATGCACACCCAAACAGCCTGGCCAGGACGCTAGGAACCGCAGCTGCAGCCAATGCTG 65 FBan0032821 FBgn0052821 CG32821 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32821 CG32821 CDMC20131 1 2 11 DAC17-E12 21-CG32821-RA_1 CG32821 ACTGTCCAATGCACACCCAAACAGCCTGGCCAGGACGCTAGGAACCGCAGCTGCAGCCAATGCTG 65 FBan0032821 FBgn0052821 CG32821 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32821 CG32821 CDMC20132 1 3 11 DAC17-E24 18-CG32836-RA_10 CG32836 CACAAGGAAGGCAGTCAAATGGAGGAGGCTCTAGCAGGCGCTCATACCACGGATCAAGCGGCACC 65 FBan0032836 FBgn0052836 CG32836 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32836 CG32836 CDMC20132 1 4 11 DAC17-E24 18-CG32836-RA_10 CG32836 CACAAGGAAGGCAGTCAAATGGAGGAGGCTCTAGCAGGCGCTCATACCACGGATCAAGCGGCACC 65 FBan0032836 FBgn0052836 CG32836 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32836 CG32836 CDMC20133 1 5 11 DAC17-I12 24-CG33075-RA_2 CG33075 GCCCCATTCGAAATTGTTAAATTGTAGTGAAATAAAATTCTTGTTTTTCTTGGTTCGAAAACAAA 65 FBgn0053075 CDMC20133 1 6 11 DAC17-I12 24-CG33075-RA_2 CG33075 GCCCCATTCGAAATTGTTAAATTGTAGTGAAATAAAATTCTTGTTTTTCTTGGTTCGAAAACAAA 65 FBgn0053075 CDMC20134 1 7 11 DAC17-I24 1-CG33114-RA_1 CG33114 CAGCAACCCGAGTTAACGCCGGATCTGATTAGCACCGTGGATACTTTGGACACCTACTGCTCCGG 65 FBan0033114 FBgn0010197 Gyc32E 2 2L cGMP biosynthesis; GO:0006182; nitric oxide mediated signal transduction; GO:0007263; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; receptor activity; GO:0004872; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004872; ; GO:0004383 ; EC:4.6.1.2; ; GO:0004872 plasma membrane; GO:0005886 Gyc32E Guanyl cyclase at 32E "CG6275, CG33114, CG6275, GC, DMRGC, GYC 32E, Cyg1, Gyc-r: Guanylate cyclase receptor-type, Guanylate cyclase receptor-type" CDMC20134 1 8 11 DAC17-I24 1-CG33114-RA_1 CG33114 CAGCAACCCGAGTTAACGCCGGATCTGATTAGCACCGTGGATACTTTGGACACCTACTGCTCCGG 65 FBan0033114 FBgn0010197 Gyc32E 2 2L cGMP biosynthesis; GO:0006182; nitric oxide mediated signal transduction; GO:0007263; protein amino acid phosphorylation; GO:0006468; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; receptor activity; GO:0004872; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004872; ; GO:0004383 ; EC:4.6.1.2; ; GO:0004872 plasma membrane; GO:0005886 Gyc32E Guanyl cyclase at 32E "CG6275, CG33114, CG6275, GC, DMRGC, GYC 32E, Cyg1, Gyc-r: Guanylate cyclase receptor-type, Guanylate cyclase receptor-type" CDMC20135 1 9 11 DAC17-M12 3-CG33207-RB_1 CG33207 CTATAGGCATCCGTACGGGGACTCCAGTTTTGGATCCGATTCGGGATACAGCCACCATACGCCTG 65 FBan0033207 FBgn0053207 pxb 3 3R learning and/or memory; GO:0007611; olfactory learning; GO:0008355; smoothened signaling pathway; GO:0007224 pxb pxb "CG14873, CG33207, CG14874, CG14873, CG14873, CG33207, baikal, BcDNA:RE16319" CDMC20135 1 10 11 DAC17-M12 3-CG33207-RB_1 CG33207 CTATAGGCATCCGTACGGGGACTCCAGTTTTGGATCCGATTCGGGATACAGCCACCATACGCCTG 65 FBan0033207 FBgn0053207 pxb 3 3R learning and/or memory; GO:0007611; olfactory learning; GO:0008355; smoothened signaling pathway; GO:0007224 pxb pxb "CG14873, CG33207, CG14874, CG14873, CG14873, CG33207, baikal, BcDNA:RE16319" CDMC20136 1 11 11 DAC17-M24 23-CG33252-RA_1 CG33252 GCATTACATGGTTCCCTTCGTTGTGCTTTCGTTGATCATCTTGATCATCTATGTGTTCGTCGTGG 65 FBan0033252 FBgn0053252 CG33252 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33252 CG33252 CDMC20136 1 12 11 DAC17-M24 23-CG33252-RA_1 CG33252 GCATTACATGGTTCCCTTCGTTGTGCTTTCGTTGATCATCTTGATCATCTATGTGTTCGTCGTGG 65 FBan0033252 FBgn0053252 CG33252 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33252 CG33252 CDMC20137 1 13 11 DAC18-A12 3-CG5864-RA_1 CG5864 CATGGCCTATCCGGATAAGGTGAAAAAGAAGATCACCCGGGAACTGGTCACTACGATACTGGCCCGCA 68 FBan0005864 FBgn0039132 AP-1sigma 3 3R intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; pinocytosis; GO:0006907; receptor mediated endocytosis; GO:0006898; synaptic vesicle coating; GO:0016183; vesicle coating; GO:0006901 clathrin vesicle coat; GO:0030125; coated vesicle; GO:0030135; synaptic vesicle; GO:0008021 AP-1sigma AP-1sigma "CG5864, CG5864, sigma1, AP-1[sigma], cg5864, AP-1sigma" CDMC20137 1 14 11 DAC18-A12 3-CG5864-RA_1 CG5864 CATGGCCTATCCGGATAAGGTGAAAAAGAAGATCACCCGGGAACTGGTCACTACGATACTGGCCCGCA 68 FBan0005864 FBgn0039132 AP-1sigma 3 3R intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; pinocytosis; GO:0006907; receptor mediated endocytosis; GO:0006898; synaptic vesicle coating; GO:0016183; vesicle coating; GO:0006901 clathrin vesicle coat; GO:0030125; coated vesicle; GO:0030135; synaptic vesicle; GO:0008021 AP-1sigma AP-1sigma "CG5864, CG5864, sigma1, AP-1[sigma], cg5864, AP-1sigma" CDMC20138 1 15 11 DAC18-A24 3-CG5946-RB_2 CG5946 CCCTCGGGTAGGCTACAATATCTCGGCAATGGCACCTTCTCCATCAAAAAGTTGCGCAAGGATCCTCC 68 FBan0005946 FBgn0036211 CG5946 3 3L cholesterol metabolism; GO:0008203; electron transport; GO:0006118; fatty acid desaturation; GO:0006636 cytochrome-b5 reductase activity; GO:0004128 ; EC:1.6.2.2; ; GO:0004128 ; EC:1.6.2.2 CG5946 CG5946 CDMC20138 1 16 11 DAC18-A24 3-CG5946-RB_2 CG5946 CCCTCGGGTAGGCTACAATATCTCGGCAATGGCACCTTCTCCATCAAAAAGTTGCGCAAGGATCCTCC 68 FBan0005946 FBgn0036211 CG5946 3 3L cholesterol metabolism; GO:0008203; electron transport; GO:0006118; fatty acid desaturation; GO:0006636 cytochrome-b5 reductase activity; GO:0004128 ; EC:1.6.2.2; ; GO:0004128 ; EC:1.6.2.2 CG5946 CG5946 CDMC20139 1 17 11 DAC18-E12 23-CG6283-RA_1 CG6283 GCACCCTTCGGCAAGATTGAGTAGAACCATGTTCTCTGAATAAAATACATTACTGAATACTCAAAAAA 68 FBan0006283 FBgn0039474 CG6283 3 3R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; phospholipase A1 activity; GO:0008970 ; EC:3.1.1.32; ; GO:0004806 ; EC:3.1.1.3; ; GO:0008970 ; EC:3.1.1.32 CG6283 CG6283 CDMC20139 1 18 11 DAC18-E12 23-CG6283-RA_1 CG6283 GCACCCTTCGGCAAGATTGAGTAGAACCATGTTCTCTGAATAAAATACATTACTGAATACTCAAAAAA 68 FBan0006283 FBgn0039474 CG6283 3 3R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; phospholipase A1 activity; GO:0008970 ; EC:3.1.1.32; ; GO:0004806 ; EC:3.1.1.3; ; GO:0008970 ; EC:3.1.1.32 CG6283 CG6283 CDMC20140 1 19 11 DAC18-E24 1-CG6420-RA_1 CG6420 CCGTCGCAGACTACATCGGGATACAACAGCAAGACTTCCAACAGCTCGAACAAGTCCTCCAACTCGGG 68 FBan0006420 FBgn0039451 CG6420 3 3R CG6420 CG6420 CDMC20140 1 20 11 DAC18-E24 1-CG6420-RA_1 CG6420 CCGTCGCAGACTACATCGGGATACAACAGCAAGACTTCCAACAGCTCGAACAAGTCCTCCAACTCGGG 68 FBan0006420 FBgn0039451 CG6420 3 3R CG6420 CG6420 CDMC20141 1 21 11 DAC18-I12 3-CG6811-RA_4 CG6811 TTCTAGACTGGCCCAAGGAAGAGCGTTCGAGGAACGTGACGCAACTGATACGCGAAAAACTGCCAGAG 68 FBan0006811 FBgn0036257 RhoGAP68F 3 3L cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010; intracellular signaling cascade; GO:0007242 receptor binding; GO:0005102; guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005102; ; GO:0005085; Rho GTPase activator activity; GO:0005100; ; GO:0005100 RhoGAP68F RhoGAP68F "CG6811, CG6811, CG6811, CG 6811" CDMC20141 1 22 11 DAC18-I12 3-CG6811-RA_4 CG6811 TTCTAGACTGGCCCAAGGAAGAGCGTTCGAGGAACGTGACGCAACTGATACGCGAAAAACTGCCAGAG 68 FBan0006811 FBgn0036257 RhoGAP68F 3 3L cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010; intracellular signaling cascade; GO:0007242 receptor binding; GO:0005102; guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005102; ; GO:0005085; Rho GTPase activator activity; GO:0005100; ; GO:0005100 RhoGAP68F RhoGAP68F "CG6811, CG6811, CG6811, CG 6811" CDMC20142 1 23 11 DAC18-I24 3-CG6976-RD_2 CG6976 TCCTGGCACCATTGATGTGGAGTCCTCCAAGCAAATGGTGGATGACGTGTTCCGCTTCCTAAACGATG 68 FBan0006976 FBgn0040299 Myo28B1 2 2L intracellular protein transport; GO:0006886; sensory perception of sound; GO:0007605; vesicle-mediated transport; GO:0016192; visual perception; GO:0007601 "actin binding; GO:0003779; ; GO:0003779; ATP binding; GO:0005524; cytoskeletal protein binding; GO:0008092; ; GO:0005524; motor activity; GO:0003774; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; ; GO:0003774" myosin; GO:0016459 Myo28B1 Myo28B1 "CG6976, CG6976 (28B), CG6976, CG6976, myosin VII 28B1-B4, DmVIIB, VIIb 28B, 28B, Myo28B, Myosin VIIB, myosin VII (28B), myosin VII" CDMC20142 1 24 11 DAC18-I24 3-CG6976-RD_2 CG6976 TCCTGGCACCATTGATGTGGAGTCCTCCAAGCAAATGGTGGATGACGTGTTCCGCTTCCTAAACGATG 68 FBan0006976 FBgn0040299 Myo28B1 2 2L intracellular protein transport; GO:0006886; sensory perception of sound; GO:0007605; vesicle-mediated transport; GO:0016192; visual perception; GO:0007601 "actin binding; GO:0003779; ; GO:0003779; ATP binding; GO:0005524; cytoskeletal protein binding; GO:0008092; ; GO:0005524; motor activity; GO:0003774; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; ; GO:0003774" myosin; GO:0016459 Myo28B1 Myo28B1 "CG6976, CG6976 (28B), CG6976, CG6976, myosin VII 28B1-B4, DmVIIB, VIIb 28B, 28B, Myo28B, Myosin VIIB, myosin VII (28B), myosin VII" CDMC20143 1 25 11 DAC18-M12 2-CG7399-RA_1 CG7399 CCCGACCCTTTGGTGTTCGCTACAATGCCTATACTCAGAGTGTTGAGGTTCTCGACTCGAAGCCCCAG 68 FBan0007399 FBgn0001208 Hn 3 3L L-phenylalanine catabolism; GO:0006559; eye pigment biosynthesis; GO:0006726; signal transduction; GO:0007165 phenylalanine 4-monooxygenase activity; GO:0004505 ; EC:1.14.16.1; ; GO:0004505 ; EC:1.14.16.1; tryptophan 5-monooxygenase activity; GO:0004510 ; EC:1.14.16.4; iron ion binding; GO:0005506; ; GO:0004505 ; EC:1.14.16.1; ; GO:0004510 ; EC:1.14.16.4; amino acid binding; GO:0016597; ; GO:0016597; ; GO:0005506; ; GO:0004505 ; EC:1.14.16.1; ; GO:0004505 ; EC:1.14.16.1 Hn Henna "CG7399, pah, phenylalanine hydroxylase, Pah: Phenylalanine-hydroxylase, DTPH, PAH, Tph, phenylalanine hydroxylase., TPH, bu, Phenylalanine-hydroxylase, Tryptophan hydrolase, brunette, Pah, Henna" CDMC20143 1 26 11 DAC18-M12 2-CG7399-RA_1 CG7399 CCCGACCCTTTGGTGTTCGCTACAATGCCTATACTCAGAGTGTTGAGGTTCTCGACTCGAAGCCCCAG 68 FBan0007399 FBgn0001208 Hn 3 3L L-phenylalanine catabolism; GO:0006559; eye pigment biosynthesis; GO:0006726; signal transduction; GO:0007165 phenylalanine 4-monooxygenase activity; GO:0004505 ; EC:1.14.16.1; ; GO:0004505 ; EC:1.14.16.1; tryptophan 5-monooxygenase activity; GO:0004510 ; EC:1.14.16.4; iron ion binding; GO:0005506; ; GO:0004505 ; EC:1.14.16.1; ; GO:0004510 ; EC:1.14.16.4; amino acid binding; GO:0016597; ; GO:0016597; ; GO:0005506; ; GO:0004505 ; EC:1.14.16.1; ; GO:0004505 ; EC:1.14.16.1 Hn Henna "CG7399, pah, phenylalanine hydroxylase, Pah: Phenylalanine-hydroxylase, DTPH, PAH, Tph, phenylalanine hydroxylase., TPH, bu, Phenylalanine-hydroxylase, Tryptophan hydrolase, brunette, Pah, Henna" CDMC20144 1 1 12 DAC18-M24 3-CG7452-RA_1 CG7452 GCAGGTGGAACCGGATAGCGAGTCAACTGAGAGACTGGAGCTAAAAGAGAAGCCAGAATGACCCGCAG 68 FBan0007452 FBgn0035540 Syx17 3 3L intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle docking during exocytosis; GO:0016081; vesicle-mediated transport; GO:0016192 t-SNARE activity; GO:0005486; ; GO:0005486; ; GO:0005486 plasma membrane; GO:0005886 Syx17 Syntaxin 17 "CG7452, Dm Syx17, DmSyx17, syntaxin, Syntaxin 17" CDMC20144 1 2 12 DAC18-M24 3-CG7452-RA_1 CG7452 GCAGGTGGAACCGGATAGCGAGTCAACTGAGAGACTGGAGCTAAAAGAGAAGCCAGAATGACCCGCAG 68 FBan0007452 FBgn0035540 Syx17 3 3L intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; synaptic vesicle docking during exocytosis; GO:0016081; vesicle-mediated transport; GO:0016192 t-SNARE activity; GO:0005486; ; GO:0005486; ; GO:0005486 plasma membrane; GO:0005886 Syx17 Syntaxin 17 "CG7452, Dm Syx17, DmSyx17, syntaxin, Syntaxin 17" CDMC20145 1 3 12 DAC19-A12 2-CG17778-RA_1 CG17778 CCTCCCTGGCGAATAGGTGCGGTAAATGTGTCAATGGGGACGCAAATGTAGGGACTAAATTGGCACCAA 69 FBan0017778 FBgn0023534 CG17778 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG17778 CG17778 "EG:171D11.5, BcDNA:RH02374" CDMC20145 1 4 12 DAC19-A12 2-CG17778-RA_1 CG17778 CCTCCCTGGCGAATAGGTGCGGTAAATGTGTCAATGGGGACGCAAATGTAGGGACTAAATTGGCACCAA 69 FBan0017778 FBgn0023534 CG17778 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG17778 CG17778 "EG:171D11.5, BcDNA:RH02374" CDMC20146 1 5 12 DAC19-A24 3-CG17797-RA_1 CG17797 TGGCGGCACATTCGTCTCCACCCTAACCGGACGAGAACCCTTCTTTGTCAAATGGAAGAGTAATCAGGA 69 FBan0017797 FBgn0015583 Acp29AB 2 2L physiological process; GO:0007582; post-mating behavior; GO:0045297; sperm competition; GO:0046692; sperm displacement; GO:0007321; spermatogenesis; GO:0007283 galactose binding; GO:0005534; sugar binding; GO:0005529; hormone activity; GO:0005179; ; GO:0005179; ; GO:0005534; ; GO:0005529 extracellular region; GO:0005576 Acp29AB Accessory gland-specific peptide 29AB "CG17797, Acp29B, Accessory gland protein 29AB, AC 004423B, AC004423b, accessory gland protein, Acp29AB-II" CDMC20146 1 6 12 DAC19-A24 3-CG17797-RA_1 CG17797 TGGCGGCACATTCGTCTCCACCCTAACCGGACGAGAACCCTTCTTTGTCAAATGGAAGAGTAATCAGGA 69 FBan0017797 FBgn0015583 Acp29AB 2 2L physiological process; GO:0007582; post-mating behavior; GO:0045297; sperm competition; GO:0046692; sperm displacement; GO:0007321; spermatogenesis; GO:0007283 galactose binding; GO:0005534; sugar binding; GO:0005529; hormone activity; GO:0005179; ; GO:0005179; ; GO:0005534; ; GO:0005529 extracellular region; GO:0005576 Acp29AB Accessory gland-specific peptide 29AB "CG17797, Acp29B, Accessory gland protein 29AB, AC 004423B, AC004423b, accessory gland protein, Acp29AB-II" CDMC20147 1 7 12 DAC19-E12 8-CG1783-RA_2 CG1783 ACGGTGAAAGTGCTGAGGAAATACCCATGGTATGGAAGGTTAAAAGGCGACCAGATGGAACGCGGTACA 69 FBgn0039919 CDMC20147 1 8 12 DAC19-E12 8-CG1783-RA_2 CG1783 ACGGTGAAAGTGCTGAGGAAATACCCATGGTATGGAAGGTTAAAAGGCGACCAGATGGAACGCGGTACA 69 FBgn0039919 CDMC20148 1 9 12 DAC19-E24 14-CG17868-RB_2 CG17868 TGCGATTTGGTTTGGTGCTAAGACAGTTGAGCTGCTTTCTTTAGGACAGATTGGTTCCGACTTGGCCTT 69 FBan0017868 FBgn0028946 Or35a 2 2L sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or35a Odorant receptor 35a "CG17868, CG17868, CG17868, BG:BACR44L22.5, BACR44L22.5, 36E.1, DOR91, 35a" CDMC20148 1 10 12 DAC19-E24 14-CG17868-RB_2 CG17868 TGCGATTTGGTTTGGTGCTAAGACAGTTGAGCTGCTTTCTTTAGGACAGATTGGTTCCGACTTGGCCTT 69 FBan0017868 FBgn0028946 Or35a 2 2L sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or35a Odorant receptor 35a "CG17868, CG17868, CG17868, BG:BACR44L22.5, BACR44L22.5, 36E.1, DOR91, 35a" CDMC20149 1 11 12 DAC19-I12 14-CG17921-RA_2 CG17921 GCCAGCCCAGTACATTTTGTTCAGTTTCAGTCTCAGTTCAGTTCGTGCAAGGCAATTTTCACAGGCAGC 69 FBan0017921 FBgn0010228 HmgZ 2 2R chromatin assembly or disassembly; GO:0006333; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0003682; ; GO:0030528 nucleus; GO:0005634 HmgZ HMG protein Z "CG17921, dHMG-Z, HMG-Z, clone 1.58, hmg-Z, BcDNA:RE28596, anon-EST:Liang-1.58" CDMC20149 1 12 12 DAC19-I12 14-CG17921-RA_2 CG17921 GCCAGCCCAGTACATTTTGTTCAGTTTCAGTCTCAGTTCAGTTCGTGCAAGGCAATTTTCACAGGCAGC 69 FBan0017921 FBgn0010228 HmgZ 2 2R chromatin assembly or disassembly; GO:0006333; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0003682; ; GO:0030528 nucleus; GO:0005634 HmgZ HMG protein Z "CG17921, dHMG-Z, HMG-Z, clone 1.58, hmg-Z, BcDNA:RE28596, anon-EST:Liang-1.58" CDMC20150 1 13 12 DAC19-I24 2-CG1792-RA_1 CG1792 CGCGGAATTGATCGAATCCTTCGCAGTTGGTGTGGAGAAGGAGATTCAGTACGCTGAAGAGGTCACCGA 69 FBan0001792 FBgn0039860 CG1792 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG1792 CG1792 CDMC20150 1 14 12 DAC19-I24 2-CG1792-RA_1 CG1792 CGCGGAATTGATCGAATCCTTCGCAGTTGGTGTGGAGAAGGAGATTCAGTACGCTGAAGAGGTCACCGA 69 FBan0001792 FBgn0039860 CG1792 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG1792 CG1792 CDMC20151 1 15 12 DAC19-M12 12-CG17970-RA_2 CG17970 ACCGCACTGGGAGTAAAACTTGATGACTTGTCGGAGGGTATTCGATATCGCCAGTCGATTCACGCCATT 69 FBan0017970 FBgn0031694 Cyp4ac2 2 2L electron transport; GO:0006118; hormone metabolism; GO:0042445; insecticide catabolism; GO:0046701; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4ac2 Cyp4ac2 "CG17970, 4ac2" CDMC20151 1 16 12 DAC19-M12 12-CG17970-RA_2 CG17970 ACCGCACTGGGAGTAAAACTTGATGACTTGTCGGAGGGTATTCGATATCGCCAGTCGATTCACGCCATT 69 FBan0017970 FBgn0031694 Cyp4ac2 2 2L electron transport; GO:0006118; hormone metabolism; GO:0042445; insecticide catabolism; GO:0046701; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4ac2 Cyp4ac2 "CG17970, 4ac2" CDMC20152 1 17 12 DAC19-M24 2-CG17991-RA_2 CG17991 TCAATGATGTGCCTAGGACGGAAATATGACCACCAGACCGAACCATACCCTTCTGCGCCAATGACCGAA 69 FBan0017991 FBgn0039498 CG17991 3 3R CG17991 CG17991 CDMC20152 1 18 12 DAC19-M24 2-CG17991-RA_2 CG17991 TCAATGATGTGCCTAGGACGGAAATATGACCACCAGACCGAACCATACCCTTCTGCGCCAATGACCGAA 69 FBan0017991 FBgn0039498 CG17991 3 3R CG17991 CG17991 CDMC20153 1 19 12 DAC20-A12 2-CG10602-RA_2 CG10602 AAGACTGCCACTGAGTTGTGTGGTCCGTATGTCTGGAAGCAGTACGATCTTCTGGTGATGCCCCC 65 FBan0010602 FBgn0032721 CG10602 2 2L cell surface receptor linked signal transduction; GO:0007166; defense response; GO:0006952; proteolysis; GO:0006508 metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; ; GO:0008237; leukotriene-A4 hydrolase activity; GO:0004463 ; EC:3.3.2.6; ; GO:0004463 ; EC:3.3.2.6; ; GO:0008270; ; GO:0004179 ; EC:3.4.11.2 CG10602 CG10602 pepCG10602 CDMC20153 1 20 12 DAC20-A12 2-CG10602-RA_2 CG10602 AAGACTGCCACTGAGTTGTGTGGTCCGTATGTCTGGAAGCAGTACGATCTTCTGGTGATGCCCCC 65 FBan0010602 FBgn0032721 CG10602 2 2L cell surface receptor linked signal transduction; GO:0007166; defense response; GO:0006952; proteolysis; GO:0006508 metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; ; GO:0008237; leukotriene-A4 hydrolase activity; GO:0004463 ; EC:3.3.2.6; ; GO:0004463 ; EC:3.3.2.6; ; GO:0008270; ; GO:0004179 ; EC:3.4.11.2 CG10602 CG10602 pepCG10602 CDMC20154 1 21 12 DAC20-A24 23-CG10659-RA_1 CG10659 TTTCGGCATCTCGAAACTGCTCTACTCCCACATTACCAGTGTCGAATCTTCGATGAGGGGCAAAG 65 FBan0010659 FBgn0032839 CG10659 2 2L CG10659 CG10659 CDMC20154 1 22 12 DAC20-A24 23-CG10659-RA_1 CG10659 TTTCGGCATCTCGAAACTGCTCTACTCCCACATTACCAGTGTCGAATCTTCGATGAGGGGCAAAG 65 FBan0010659 FBgn0032839 CG10659 2 2L CG10659 CG10659 CDMC20155 1 23 12 DAC20-E12 23-CG10742-RA_1 CG10742 TACAACCGCACCTGAACATACATACTCTCGGAATCAGTACTCATTTTTTTGTGCACCACTCACGT 65 FBan0010742 FBgn0040334 Tsp3A X X cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 receptor binding; GO:0005102; ; GO:0005102 integral to membrane; GO:0016021 Tsp3A Tetraspanin 3A "CG10742, CG10742, CG10742, CG10742, CG10742, CG10742, Dm.Tsp3A, EG:BACR7C10.6, BACR7C10.6, Tetraspanin 3A" CDMC20155 1 24 12 DAC20-E12 23-CG10742-RA_1 CG10742 TACAACCGCACCTGAACATACATACTCTCGGAATCAGTACTCATTTTTTTGTGCACCACTCACGT 65 FBan0010742 FBgn0040334 Tsp3A X X cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 receptor binding; GO:0005102; ; GO:0005102 integral to membrane; GO:0016021 Tsp3A Tetraspanin 3A "CG10742, CG10742, CG10742, CG10742, CG10742, CG10742, Dm.Tsp3A, EG:BACR7C10.6, BACR7C10.6, Tetraspanin 3A" CDMC20156 1 25 12 DAC20-E24 9-CG10795-RA_4 CG10795 AAACCGGAATCGAAAACGACAACAGATAGTACCCGCGAGAAAGAGCTCCCGCCAACAGAACACCA 65 FBan0010795 FBgn0034626 CG10795 2 2R CG10795 CG10795 LD27358 CDMC20156 1 26 12 DAC20-E24 9-CG10795-RA_4 CG10795 AAACCGGAATCGAAAACGACAACAGATAGTACCCGCGAGAAAGAGCTCCCGCCAACAGAACACCA 65 FBan0010795 FBgn0034626 CG10795 2 2R CG10795 CG10795 LD27358 CDMC20157 1 1 13 DAC20-I12 5-CG10911-RA_1 CG10911 CAAGACCCAGAGGGCCTATGGAGAGAGCTACGGTCAGCTGTACGCGGATTTGGGTGATTGCATTG 65 FBan0010911 FBgn0034295 CG10911 2 2R CG10911 CG10911 anon-WO0140519.211 CDMC20157 1 2 13 DAC20-I12 5-CG10911-RA_1 CG10911 CAAGACCCAGAGGGCCTATGGAGAGAGCTACGGTCAGCTGTACGCGGATTTGGGTGATTGCATTG 65 FBan0010911 FBgn0034295 CG10911 2 2R CG10911 CG10911 anon-WO0140519.211 CDMC20158 1 3 13 DAC20-I24 1-CG10936-RA_1 CG10936 AGCGCTTCACCAACTCAATGCACGGTAGCAACAGTTCCAACATCTACGACAGTTGGCGATCCACC 65 FBan0010936 FBgn0034253 CG10936 2 2R CG10936 CG10936 CDMC20158 1 4 13 DAC20-I24 1-CG10936-RA_1 CG10936 AGCGCTTCACCAACTCAATGCACGGTAGCAACAGTTCCAACATCTACGACAGTTGGCGATCCACC 65 FBan0010936 FBgn0034253 CG10936 2 2R CG10936 CG10936 CDMC20159 1 5 13 DAC20-M12 23-CG11079-RC_3 CG11079 CGTCCGTTTGCACAGTGTAATTACGGAAAACTAACTTTTGGCTTACATACAAAGTGGGAAGTAAA 65 FBan0011079 FBgn0034851 CG11079 2 2R metabolism; GO:0008152; negative regulation of nucleoside metabolism; GO:0045978 enzyme inhibitor activity; GO:0004857; ; GO:0004857; 5-formyltetrahydrofolate cyclo-ligase activity; GO:0030272 ; EC:6.3.3.2; ; GO:0030272 ; EC:6.3.3.2 mitochondrion; GO:0005739 CG11079 CG11079 anon-WO0118547.139 CDMC20159 1 6 13 DAC20-M12 23-CG11079-RC_3 CG11079 CGTCCGTTTGCACAGTGTAATTACGGAAAACTAACTTTTGGCTTACATACAAAGTGGGAAGTAAA 65 FBan0011079 FBgn0034851 CG11079 2 2R metabolism; GO:0008152; negative regulation of nucleoside metabolism; GO:0045978 enzyme inhibitor activity; GO:0004857; ; GO:0004857; 5-formyltetrahydrofolate cyclo-ligase activity; GO:0030272 ; EC:6.3.3.2; ; GO:0030272 ; EC:6.3.3.2 mitochondrion; GO:0005739 CG11079 CG11079 anon-WO0118547.139 CDMC20160 1 7 13 DAC20-M24 6-CG11103-RA_1 CG11103 GCAGCAGGAAAAGAAATACGGATGCCTGAAGTTCGGTGGTTCCACGTACGAAGAGGTGGAGCACG 65 FBan0011103 FBgn0030522 CG11103 X X CG11103 CG11103 BcDNA:LP03404 CDMC20160 1 8 13 DAC20-M24 6-CG11103-RA_1 CG11103 GCAGCAGGAAAAGAAATACGGATGCCTGAAGTTCGGTGGTTCCACGTACGAAGAGGTGGAGCACG 65 FBan0011103 FBgn0030522 CG11103 X X CG11103 CG11103 BcDNA:LP03404 CDMC20161 1 9 13 DAC21-A12 2-CG11183-RA_1 CG11183 ATTCAGCTCCTGAGCGACCTGAAGATCGGTAAAAGCTACGCTACGGCTCAATCTCCGACAGTCGC 65 FBan0011183 FBgn0034921 CG11183 2 2R "cell surface receptor linked signal transduction; GO:0007166; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165; tRNA aminoacylation for protein translation; GO:0006418; transcription from RNA polymerase II promoter; GO:0006366; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178" ATP binding; GO:0005524; ; GO:0005524; transcription regulator activity; GO:0030528; transcription cofactor activity; GO:0003712; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; ; GO:0030528; ; GO:0003712; ; GO:0004812 ; EC:6.1.1.- CG11183 CG11183 anon-WO0118547.163 CDMC20161 1 10 13 DAC21-A12 2-CG11183-RA_1 CG11183 ATTCAGCTCCTGAGCGACCTGAAGATCGGTAAAAGCTACGCTACGGCTCAATCTCCGACAGTCGC 65 FBan0011183 FBgn0034921 CG11183 2 2R "cell surface receptor linked signal transduction; GO:0007166; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165; tRNA aminoacylation for protein translation; GO:0006418; transcription from RNA polymerase II promoter; GO:0006366; transmembrane receptor protein serine/threonine kinase signaling pathway; GO:0007178" ATP binding; GO:0005524; ; GO:0005524; transcription regulator activity; GO:0030528; transcription cofactor activity; GO:0003712; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; ; GO:0030528; ; GO:0003712; ; GO:0004812 ; EC:6.1.1.- CG11183 CG11183 anon-WO0118547.163 CDMC20162 1 11 13 DAC21-A24 1-CG11213-RA_1 CG11213 TGAGCCCGTGTTCGTCAATGTGGTCAAGCCCCCAGCAGAGAAGTACTTTGTCAACGAGAACAAGC 65 FBan0011213 FBgn0000360 Cp38 X X insect chorion formation; GO:0007306 structural constituent of chorion (sensu Insecta); GO:0005213; ; GO:0005213 chorion; GO:0042600 Cp38 Chorion protein 38 "CG11213, E3, s38-1, s38, S38: Shell-38, Dms38, CP38, ACE1, Shell-38, S38" CDMC20162 1 12 13 DAC21-A24 1-CG11213-RA_1 CG11213 TGAGCCCGTGTTCGTCAATGTGGTCAAGCCCCCAGCAGAGAAGTACTTTGTCAACGAGAACAAGC 65 FBan0011213 FBgn0000360 Cp38 X X insect chorion formation; GO:0007306 structural constituent of chorion (sensu Insecta); GO:0005213; ; GO:0005213 chorion; GO:0042600 Cp38 Chorion protein 38 "CG11213, E3, s38-1, s38, S38: Shell-38, Dms38, CP38, ACE1, Shell-38, S38" CDMC20163 1 13 13 DAC21-E12 2-CG11337-RB_3 CG11337 CAAAGTTCGAGAACGACGACACTAAGCACCTGCAGGACTACCGCATTCTCACCGACATCCTGGGC 65 FBan0011337 FBgn0039846 CG11337 3 3R RNA catabolism; GO:0006401; RNA processing; GO:0006396 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; polyribonucleotide nucleotidyltransferase activity; GO:0004654 ; EC:2.7.7.8; ; GO:0003676; ; GO:0003729; 3'-5'-exoribonuclease activity; GO:0000175 ; EC:3.1.13.-; ; GO:0004654 ; EC:2.7.7.8; ; GO:0000175 ; EC:3.1.13.- CG11337 CG11337 CDMC20163 1 14 13 DAC21-E12 2-CG11337-RB_3 CG11337 CAAAGTTCGAGAACGACGACACTAAGCACCTGCAGGACTACCGCATTCTCACCGACATCCTGGGC 65 FBan0011337 FBgn0039846 CG11337 3 3R RNA catabolism; GO:0006401; RNA processing; GO:0006396 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; polyribonucleotide nucleotidyltransferase activity; GO:0004654 ; EC:2.7.7.8; ; GO:0003676; ; GO:0003729; 3'-5'-exoribonuclease activity; GO:0000175 ; EC:3.1.13.-; ; GO:0004654 ; EC:2.7.7.8; ; GO:0000175 ; EC:3.1.13.- CG11337 CG11337 CDMC20164 1 15 13 DAC21-E24 14-CG11401-RA_1 CG11401 CCAGCGTGCCTCATATATTTGCAGTTGGGGACATCATATATGGTCGACCAGAGCTAACGCCGGTG 65 FBan0011401 FBgn0037170 Trxr-2 3 3L sulfur metabolism; GO:0006790; thioredoxin pathway; GO:0006125 "antioxidant activity; GO:0016209; thioredoxin-disulfide reductase activity; GO:0004791 ; EC:1.8.1.9; metal ion binding; GO:0046872; ; GO:0016209; ; GO:0004791 ; EC:1.8.1.9; ; GO:0016209; ; GO:0004791 ; EC:1.8.1.9; ; GO:0046872; disulfide oxidoreductase activity; GO:0015036; oxidoreductase activity, acting on NADH or NADPH, disulfide as acceptor; GO:0016654 ; EC:1.6.4.-; ; GO:0015036; ; GO:0016654 ; EC:1.6.4.-" cytoplasm; GO:0005737; mitochondrion; GO:0005739 Trxr-2 thioredoxin reductase 2 "CG11401, DmTrxR-2, Trxr2, trxr-2, thioredoxin-reductase-2, thioredoxin reductase 2" CDMC20164 1 16 13 DAC21-E24 14-CG11401-RA_1 CG11401 CCAGCGTGCCTCATATATTTGCAGTTGGGGACATCATATATGGTCGACCAGAGCTAACGCCGGTG 65 FBan0011401 FBgn0037170 Trxr-2 3 3L sulfur metabolism; GO:0006790; thioredoxin pathway; GO:0006125 "antioxidant activity; GO:0016209; thioredoxin-disulfide reductase activity; GO:0004791 ; EC:1.8.1.9; metal ion binding; GO:0046872; ; GO:0016209; ; GO:0004791 ; EC:1.8.1.9; ; GO:0016209; ; GO:0004791 ; EC:1.8.1.9; ; GO:0046872; disulfide oxidoreductase activity; GO:0015036; oxidoreductase activity, acting on NADH or NADPH, disulfide as acceptor; GO:0016654 ; EC:1.6.4.-; ; GO:0015036; ; GO:0016654 ; EC:1.6.4.-" cytoplasm; GO:0005737; mitochondrion; GO:0005739 Trxr-2 thioredoxin reductase 2 "CG11401, DmTrxR-2, Trxr2, trxr-2, thioredoxin-reductase-2, thioredoxin reductase 2" CDMC20165 1 17 13 DAC21-I12 9-CG11527-RA_1 CG11527 CAGCAGCAAATTGAGGAGCTGGGATGGAACGAAAAGCTAGAGGACCTTGGACAGCAGACGCAAGT 65 FBan0011527 FBgn0011722 Tig 2 2L axon guidance; GO:0007411 binding; GO:0005488; ; GO:0005488 extracellular matrix (sensu Metazoa); GO:0005578 Tig Tiggrin "CG11527, tig, tiggrin, TIG, CT36389" CDMC20165 1 18 13 DAC21-I12 9-CG11527-RA_1 CG11527 CAGCAGCAAATTGAGGAGCTGGGATGGAACGAAAAGCTAGAGGACCTTGGACAGCAGACGCAAGT 65 FBan0011527 FBgn0011722 Tig 2 2L axon guidance; GO:0007411 binding; GO:0005488; ; GO:0005488 extracellular matrix (sensu Metazoa); GO:0005578 Tig Tiggrin "CG11527, tig, tiggrin, TIG, CT36389" CDMC20166 1 19 13 DAC21-I24 3-CG11560-RA_2 CG11560 TGGTCTTGGGTCGTCTGGAGCGACTGAGCATTTCCACGGTCACATCCTTGACCACAAACCTGTAG 65 FBan0011560 FBgn0036249 CG11560 3 3L CG11560 CG11560 CDMC20166 1 20 13 DAC21-I24 3-CG11560-RA_2 CG11560 TGGTCTTGGGTCGTCTGGAGCGACTGAGCATTTCCACGGTCACATCCTTGACCACAAACCTGTAG 65 FBan0011560 FBgn0036249 CG11560 3 3L CG11560 CG11560 CDMC20167 1 21 13 DAC21-M12 1-CG11659-RA_2 CG11659 AACTGCCCAGATTTCGAGACGTGCGATCTGTCGAGCCTACGGTGCTACATGTTTGGAGGATCTCG 65 FBan0011659 FBgn0038731 CG11659 3 3R metabolism; GO:0008152 actin binding; GO:0003779; long-chain fatty acid transporter activity; GO:0005324; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0003779; ; GO:0016874 ; EC:6.-.-.-; ; GO:0005324 CG11659 CG11659 CDMC20167 1 22 13 DAC21-M12 1-CG11659-RA_2 CG11659 AACTGCCCAGATTTCGAGACGTGCGATCTGTCGAGCCTACGGTGCTACATGTTTGGAGGATCTCG 65 FBan0011659 FBgn0038731 CG11659 3 3R metabolism; GO:0008152 actin binding; GO:0003779; long-chain fatty acid transporter activity; GO:0005324; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0003779; ; GO:0016874 ; EC:6.-.-.-; ; GO:0005324 CG11659 CG11659 CDMC20168 1 23 13 DAC21-M24 18-CG1168-RA_1 CG1168 ATGTCTTGATGACGGATCTGCTGAATCGCATGGACAAAGACATGCAGGTGGGCTATTACGACGTG 65 FBan0001168 FBgn0041707 7B2 3 3R neuropeptide signaling pathway; GO:0007218; peptide hormone processing; GO:0016486; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 proprotein convertase 2 activator activity; GO:0016484; neuropeptide hormone activity; GO:0005184; ; GO:0005184; ; GO:0016484 secretory granule; GO:0030141 7B2 7B2 "CG1168, CG1168, d7B2, FBgn0040073" CDMC20168 1 24 13 DAC21-M24 18-CG1168-RA_1 CG1168 ATGTCTTGATGACGGATCTGCTGAATCGCATGGACAAAGACATGCAGGTGGGCTATTACGACGTG 65 FBan0001168 FBgn0041707 7B2 3 3R neuropeptide signaling pathway; GO:0007218; peptide hormone processing; GO:0016486; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 proprotein convertase 2 activator activity; GO:0016484; neuropeptide hormone activity; GO:0005184; ; GO:0005184; ; GO:0016484 secretory granule; GO:0030141 7B2 7B2 "CG1168, CG1168, d7B2, FBgn0040073" CDMC20169 1 25 13 DAC22-A12 24-CG31619-RB_1 CG31619 ATTACGCTCATATCCATAACTTTAAGTCGAAACATATTGCTAATAAATAACGCCGCACTTAATAA 65 FBan0031619 FBgn0051619 CG31619 2 2L cell-cell adhesion; GO:0016337; defense response; GO:0006952; proteolysis; GO:0006508; signal transduction; GO:0007165 procollagen N-endopeptidase activity; GO:0017074 ; EC:3.4.24.14; ; GO:0017074 ; EC:3.4.24.14 CG31619 CG31619 "CG2131, CG13236, CG2122, CG2131, CT6940" CDMC20169 1 26 13 DAC22-A12 24-CG31619-RB_1 CG31619 ATTACGCTCATATCCATAACTTTAAGTCGAAACATATTGCTAATAAATAACGCCGCACTTAATAA 65 FBan0031619 FBgn0051619 CG31619 2 2L cell-cell adhesion; GO:0016337; defense response; GO:0006952; proteolysis; GO:0006508; signal transduction; GO:0007165 procollagen N-endopeptidase activity; GO:0017074 ; EC:3.4.24.14; ; GO:0017074 ; EC:3.4.24.14 CG31619 CG31619 "CG2131, CG13236, CG2122, CG2131, CT6940" CDMC20170 1 1 14 DAC22-A24 3-CG31657-RA_5 CG31657 AACTGGAACCGCATTTTGCTCATGACATTCCCGTGATACCCATGGATGACCTGACGGGGAATCCG 65 FBgn0051657 CDMC20170 1 2 14 DAC22-A24 3-CG31657-RA_5 CG31657 AACTGGAACCGCATTTTGCTCATGACATTCCCGTGATACCCATGGATGACCTGACGGGGAATCCG 65 FBgn0051657 CDMC20171 1 3 14 DAC22-E12 23-CG31737-RA_6 CG31737 TTCAATCAGTCGAAAGTGTGGTTACCATTTCCGATGTGAATGAAAGGCATACCACCAATCATTAC 65 FBan0031737 FBgn0051737 CG31737 2 2L CG31737 CG31737 "CG18115, BG:DS02740.19, DS02740.19" CDMC20171 1 4 14 DAC22-E12 23-CG31737-RA_6 CG31737 TTCAATCAGTCGAAAGTGTGGTTACCATTTCCGATGTGAATGAAAGGCATACCACCAATCATTAC 65 FBan0031737 FBgn0051737 CG31737 2 2L CG31737 CG31737 "CG18115, BG:DS02740.19, DS02740.19" CDMC20172 1 5 14 DAC22-E24 1-CG31773-RA_1 CG31773 ACGTGTGCCATCGTGGAGAGTATTCTTCGGTGTCATGGGGTGAAAACTGGTGTTCTCTCCTCGCC 65 FBan0031773 FBgn0051773 CG31773 2 2L folic acid and derivative biosynthesis; GO:0009396 ATP binding; GO:0005524; ; GO:0005524; tetrahydrofolylpolyglutamate synthase activity; GO:0004326 ; EC:6.3.2.17; ; GO:0004326 ; EC:6.3.2.17 CG31773 CG31773 "CG3390, CG3390" CDMC20172 1 6 14 DAC22-E24 1-CG31773-RA_1 CG31773 ACGTGTGCCATCGTGGAGAGTATTCTTCGGTGTCATGGGGTGAAAACTGGTGTTCTCTCCTCGCC 65 FBan0031773 FBgn0051773 CG31773 2 2L folic acid and derivative biosynthesis; GO:0009396 ATP binding; GO:0005524; ; GO:0005524; tetrahydrofolylpolyglutamate synthase activity; GO:0004326 ; EC:6.3.2.17; ; GO:0004326 ; EC:6.3.2.17 CG31773 CG31773 "CG3390, CG3390" CDMC20173 1 7 14 DAC22-I12 5-CG31913-RA_2 CG31913 CCTGGAGCTCGAAACGAGACAGAACCCGAACACACGCTACCTGCTTAAGAAGCCCCCGAACTACT 65 FBan0031913 FBgn0051913 CG31913 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31913 CG31913 "NEST:bs09g05, NEST:bs14h07, NEST:bs35c08, NEST:bs28e01, NEST:bs23g06" CDMC20173 1 8 14 DAC22-I12 5-CG31913-RA_2 CG31913 CCTGGAGCTCGAAACGAGACAGAACCCGAACACACGCTACCTGCTTAAGAAGCCCCCGAACTACT 65 FBan0031913 FBgn0051913 CG31913 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31913 CG31913 "NEST:bs09g05, NEST:bs14h07, NEST:bs35c08, NEST:bs28e01, NEST:bs23g06" CDMC20174 1 9 14 DAC22-I24 3-CG3193-RA_2 CG3193 TCGACTTCGAGGTAGCCCTAGGCGAAACAGAGCTAGCCAGACAGCTTTACGAGCGACTCCTTGAG 65 FBan0003193 FBgn0000377 crn X X "Malpighian tubule morphogenesis; GO:0007443; central nervous system development; GO:0007417; neuroblast proliferation; GO:0007405; neuron lineage restriction; GO:0042055; nuclear mRNA splicing, via spliceosome; GO:0000398; peripheral nervous system development; GO:0007422; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; transport; GO:0006810" transporter activity; GO:0005215; ; GO:0005215 nuclear speck; GO:0016607; nucleus; GO:0005634; spliceosome complex; GO:0005681 crn crooked neck "CG3193, CG18842, CG3193, CG3193, N5, l(1)2, l30, N10, l(1)CRN, RC63, yok: yolky, yolky, EG:30B8.1, 62D9.a, CDC16, l(1)2Fa, l(1)N7, l(1)crn, yok" CDMC20174 1 10 14 DAC22-I24 3-CG3193-RA_2 CG3193 TCGACTTCGAGGTAGCCCTAGGCGAAACAGAGCTAGCCAGACAGCTTTACGAGCGACTCCTTGAG 65 FBan0003193 FBgn0000377 crn X X "Malpighian tubule morphogenesis; GO:0007443; central nervous system development; GO:0007417; neuroblast proliferation; GO:0007405; neuron lineage restriction; GO:0042055; nuclear mRNA splicing, via spliceosome; GO:0000398; peripheral nervous system development; GO:0007422; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; transport; GO:0006810" transporter activity; GO:0005215; ; GO:0005215 nuclear speck; GO:0016607; nucleus; GO:0005634; spliceosome complex; GO:0005681 crn crooked neck "CG3193, CG18842, CG3193, CG3193, N5, l(1)2, l30, N10, l(1)CRN, RC63, yok: yolky, yolky, EG:30B8.1, 62D9.a, CDC16, l(1)2Fa, l(1)N7, l(1)crn, yok" CDMC20175 1 11 14 DAC22-M12 9-CG32082-RA_1 CG32082 GTTTGGCCGGAAACAAGAGCTACGGACCATGGTACGACTTCTGGGATCAGGAACAGCATGGCCAG 65 FBan0032082 FBgn0052082 CG32082 3 3L signal transduction; GO:0007165 signal transducer activity; GO:0004871; ; GO:0004871 CG32082 CG32082 "CG7624, anon-WO0118547.199" CDMC20175 1 12 14 DAC22-M12 9-CG32082-RA_1 CG32082 GTTTGGCCGGAAACAAGAGCTACGGACCATGGTACGACTTCTGGGATCAGGAACAGCATGGCCAG 65 FBan0032082 FBgn0052082 CG32082 3 3L signal transduction; GO:0007165 signal transducer activity; GO:0004871; ; GO:0004871 CG32082 CG32082 "CG7624, anon-WO0118547.199" CDMC20176 1 13 14 DAC22-M24 23-CG32118-RA_3 CG32118 TGATACAACTCGAGTGCAAAGAAAACAAAACACGAAACCCTAGTAGTCTTCTTGGTCTTGTGCCC 65 FBan0032118 FBgn0052118 CG32118 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32118 CG32118 CDMC20176 1 14 14 DAC22-M24 23-CG32118-RA_3 CG32118 TGATACAACTCGAGTGCAAAGAAAACAAAACACGAAACCCTAGTAGTCTTCTTGGTCTTGTGCCC 65 FBan0032118 FBgn0052118 CG32118 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32118 CG32118 CDMC20177 1 15 14 DAC23-A12 8-CG10737-RC_1 CG10737 CCACCGGAACCCTCAATGGTGATTCTTCCCGTTCATTATCTGTCGATCGTGCCACTCTGTCCAAAAGCA 69 FBan0010737 FBgn0034420 CG10737 2 2R intracellular signaling cascade; GO:0007242 diacylglycerol binding; GO:0019992; ; GO:0019992 CG10737 CG10737 "Gene 1, 10737" CDMC20177 1 16 14 DAC23-A12 8-CG10737-RC_1 CG10737 CCACCGGAACCCTCAATGGTGATTCTTCCCGTTCATTATCTGTCGATCGTGCCACTCTGTCCAAAAGCA 69 FBan0010737 FBgn0034420 CG10737 2 2R intracellular signaling cascade; GO:0007242 diacylglycerol binding; GO:0019992; ; GO:0019992 CG10737 CG10737 "Gene 1, 10737" CDMC20178 1 17 14 DAC23-A24 24-CG10750-RA_1 CG10750 GCTGGACGTATGTGCTAGTCGGAAAATATAATATTTTTCATGGAGCATAAATAAATAAATAAATGATTT 69 FBan0010750 FBgn0032769 CG10750 2 2L CG10750 CG10750 CDMC20178 1 18 14 DAC23-A24 24-CG10750-RA_1 CG10750 GCTGGACGTATGTGCTAGTCGGAAAATATAATATTTTTCATGGAGCATAAATAAATAAATAAATGATTT 69 FBan0010750 FBgn0032769 CG10750 2 2L CG10750 CG10750 CDMC20179 1 19 14 DAC23-E12 16-CG10793-RA_2 CG10793 TGGCCAGGATAATGCTTGTGAAATCGAACATGTCCATTTGGGTGGTGATGATGTTCTCTTCTCCTCCTT 69 FBan0010793 FBgn0029656 CG10793 X X response to oxidative stress; GO:0006979 ATP binding; GO:0005524; ATPase activity; GO:0016887; ; GO:0005524; peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0016887; ; GO:0004601 ; EC:1.11.1.7 CG10793 CG10793 CDMC20179 1 20 14 DAC23-E12 16-CG10793-RA_2 CG10793 TGGCCAGGATAATGCTTGTGAAATCGAACATGTCCATTTGGGTGGTGATGATGTTCTCTTCTCCTCCTT 69 FBan0010793 FBgn0029656 CG10793 X X response to oxidative stress; GO:0006979 ATP binding; GO:0005524; ATPase activity; GO:0016887; ; GO:0005524; peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0016887; ; GO:0004601 ; EC:1.11.1.7 CG10793 CG10793 CDMC20180 1 21 14 DAC23-E24 15-CG10803-RA_2 CG10803 TGTCCGCAATAAGTTCTACTAGACGGTGAGCTGCATTGCGAATATCGGACGACCCATTTCATCGCACAA 69 FBan0010803 FBgn0029666 CG10803 X X mRNA binding; GO:0003729; ; GO:0003729 ribonucleoprotein complex; GO:0030529 CG10803 CG10803 CDMC20180 1 22 14 DAC23-E24 15-CG10803-RA_2 CG10803 TGTCCGCAATAAGTTCTACTAGACGGTGAGCTGCATTGCGAATATCGGACGACCCATTTCATCGCACAA 69 FBan0010803 FBgn0029666 CG10803 X X mRNA binding; GO:0003729; ; GO:0003729 ribonucleoprotein complex; GO:0030529 CG10803 CG10803 CDMC20181 1 23 14 DAC23-I12 17-CG10834-RA_1 CG10834 GGCATAATTATTTTGGACCCGTTCGCTATACCAATCAAGACCACCATGGAGTACACCTTGACCGTGCAT 69 FBan0010834 FBgn0032972 CG10834 2 2L cell motility; GO:0006928; microtubule-based movement; GO:0007018 "structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623" dynein complex; GO:0030286 CG10834 CG10834 CDMC20181 1 24 14 DAC23-I12 17-CG10834-RA_1 CG10834 GGCATAATTATTTTGGACCCGTTCGCTATACCAATCAAGACCACCATGGAGTACACCTTGACCGTGCAT 69 FBan0010834 FBgn0032972 CG10834 2 2L cell motility; GO:0006928; microtubule-based movement; GO:0007018 "structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623" dynein complex; GO:0030286 CG10834 CG10834 CDMC20182 1 25 14 DAC23-I24 13-CG10843-RA_1 CG10843 ACTGCGGACCAAGAACCAGATTCACGTGAAGCTCGTGAGAAGAAAATGAGGCAGCTTTAACGGAATGGA 69 FBan0010843 FBgn0033397 Cyp4p3 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4p3 Cyp4p3 "CG10843, 4p3" CDMC20182 1 26 14 DAC23-I24 13-CG10843-RA_1 CG10843 ACTGCGGACCAAGAACCAGATTCACGTGAAGCTCGTGAGAAGAAAATGAGGCAGCTTTAACGGAATGGA 69 FBan0010843 FBgn0033397 Cyp4p3 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4p3 Cyp4p3 "CG10843, 4p3" CDMC20183 1 1 15 DAC23-M12 17-CG1088-RA_2 CG1088 CATGCACCAACGACGATGAAGTTTTGCCAAGTAGCTAAGTTTGTTGACCTGACCATCAAGTGCAGCTTT 69 FBan0001088 FBgn0015324 Vha26 3 3R ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V1 domain; GO:0000221; proton-transporting two-sector ATPase complex; GO:0016469 Vha26 Vacuolar H[+]-ATPase 26kD E subunit "CG1088, CG1088, vha26, E subunit, BcDNA.GH03683, V-ATPase, BcDNA:GH03683, VhaE, anon-83Bb" CDMC20183 1 2 15 DAC23-M12 17-CG1088-RA_2 CG1088 CATGCACCAACGACGATGAAGTTTTGCCAAGTAGCTAAGTTTGTTGACCTGACCATCAAGTGCAGCTTT 69 FBan0001088 FBgn0015324 Vha26 3 3R ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V1 domain; GO:0000221; proton-transporting two-sector ATPase complex; GO:0016469 Vha26 Vacuolar H[+]-ATPase 26kD E subunit "CG1088, CG1088, vha26, E subunit, BcDNA.GH03683, V-ATPase, BcDNA:GH03683, VhaE, anon-83Bb" CDMC20184 1 3 15 DAC23-M24 1-CG10904-RA_1 CG10904 TCGAGGAGTCTGGAGGAGATCGAGATTCGGAGAAGGCTTGTCGATGGGAGCACTTCAAGACGTTGATGT 69 FBan0010904 FBgn0034945 CG10904 2 2R CG10904 CG10904 CDMC20184 1 4 15 DAC23-M24 1-CG10904-RA_1 CG10904 TCGAGGAGTCTGGAGGAGATCGAGATTCGGAGAAGGCTTGTCGATGGGAGCACTTCAAGACGTTGATGT 69 FBan0010904 FBgn0034945 CG10904 2 2R CG10904 CG10904 CDMC20185 1 5 15 DAC24-A12 1-CG14926-RA_1 CG14926 GGCTGCACTCAAGTCAAGCGAACACCCAAAACTATTTGCATGGATCCAGTGGAATGGGATCGCACCAGA 69 FBan0014926 FBgn0032360 CG14926 2 2L CG14926 CG14926 bs34f02.y1 CDMC20185 1 6 15 DAC24-A12 1-CG14926-RA_1 CG14926 GGCTGCACTCAAGTCAAGCGAACACCCAAAACTATTTGCATGGATCCAGTGGAATGGGATCGCACCAGA 69 FBan0014926 FBgn0032360 CG14926 2 2L CG14926 CG14926 bs34f02.y1 CDMC20186 1 7 15 DAC24-A24 6-CG14934-RA_3 CG14934 GCCCCCAGTTTCCCTTCAACTTTGACTTCATCACCGAACTGAATGCCAATTCGACAGCTGCGGACTTTG 69 FBan0014934 FBgn0032381 CG14934 2 2L carbohydrate metabolism; GO:0005975 alpha-glucosidase activity; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20; transporter activity; GO:0005215; ; GO:0005215; ; GO:0004558 ; EC:3.2.1.20; alpha-amylase activity; GO:0004556 ; EC:3.2.1.1; ; GO:0004558 ; EC:3.2.1.20; ; GO:0004556 ; EC:3.2.1.1 CG14934 CG14934 CDMC20186 1 8 15 DAC24-A24 6-CG14934-RA_3 CG14934 GCCCCCAGTTTCCCTTCAACTTTGACTTCATCACCGAACTGAATGCCAATTCGACAGCTGCGGACTTTG 69 FBan0014934 FBgn0032381 CG14934 2 2L carbohydrate metabolism; GO:0005975 alpha-glucosidase activity; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20; transporter activity; GO:0005215; ; GO:0005215; ; GO:0004558 ; EC:3.2.1.20; alpha-amylase activity; GO:0004556 ; EC:3.2.1.1; ; GO:0004558 ; EC:3.2.1.20; ; GO:0004556 ; EC:3.2.1.1 CG14934 CG14934 CDMC20187 1 9 15 DAC24-E12 10-CG14963-RA_1 CG14963 GCCCAGTTCTGGTCGAGATTACAGGGGTTGCGAGTCATGTATGAACGTTGGCTGACTACAGTGGAAACT 69 FBan0014963 FBgn0035409 CG14963 3 3L CG14963 CG14963 CDMC20187 1 10 15 DAC24-E12 10-CG14963-RA_1 CG14963 GCCCAGTTCTGGTCGAGATTACAGGGGTTGCGAGTCATGTATGAACGTTGGCTGACTACAGTGGAAACT 69 FBan0014963 FBgn0035409 CG14963 3 3L CG14963 CG14963 CDMC20188 1 11 15 DAC24-E24 2-CG14973-RA_2 CG14973 GCGGCAAATCCTGGTGTGAACTCCCCCAAACACTCGGCTAATTCTAGTTCCATAAGCGATGCCATCGAC 69 FBan0014973 FBgn0035451 CG14973 3 3L CG14973 CG14973 CDMC20188 1 12 15 DAC24-E24 2-CG14973-RA_2 CG14973 GCGGCAAATCCTGGTGTGAACTCCCCCAAACACTCGGCTAATTCTAGTTCCATAAGCGATGCCATCGAC 69 FBan0014973 FBgn0035451 CG14973 3 3L CG14973 CG14973 CDMC20189 1 13 15 DAC24-I12 1-CG15000-RA_1 CG15000 CGCGCTACAATCTGTTCGCCATGTACCAAAAGTTTGCCAAGCCGCCATTTGATCTGTCGGAAATTGCCA 69 FBgn0035502 CDMC20189 1 14 15 DAC24-I12 1-CG15000-RA_1 CG15000 CGCGCTACAATCTGTTCGCCATGTACCAAAAGTTTGCCAAGCCGCCATTTGATCTGTCGGAAATTGCCA 69 FBgn0035502 CDMC20190 1 15 15 DAC24-I24 12-CG15010-RC_8 CG15010 ACGGAACGGAGGAAACAAAGCTAATGGTCCTCGACTTTGATGTTGAGGGTGCATGTGTGAAGTGCTCAT 69 FBan0015010 FBgn0041171 ago 3 3L DNA endoreduplication; GO:0042023; cyclin catabolism; GO:0008054; negative regulation of growth; GO:0045926; regulation of exit from mitosis; GO:0007096; regulation of mitosis; GO:0007088; regulation of proteolysis; GO:0030162 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19; cyclin binding; GO:0030332; ; GO:0030332 SCF ubiquitin ligase complex; GO:0019005 ago archipelago "CG15010, CG15010, CG15010, CG15010, DmFbw7, cdc4, SCF[Ago], anon-WO0118547.345, archipelago" CDMC20190 1 16 15 DAC24-I24 12-CG15010-RC_8 CG15010 ACGGAACGGAGGAAACAAAGCTAATGGTCCTCGACTTTGATGTTGAGGGTGCATGTGTGAAGTGCTCAT 69 FBan0015010 FBgn0041171 ago 3 3L DNA endoreduplication; GO:0042023; cyclin catabolism; GO:0008054; negative regulation of growth; GO:0045926; regulation of exit from mitosis; GO:0007096; regulation of mitosis; GO:0007088; regulation of proteolysis; GO:0030162 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19; cyclin binding; GO:0030332; ; GO:0030332 SCF ubiquitin ligase complex; GO:0019005 ago archipelago "CG15010, CG15010, CG15010, CG15010, DmFbw7, cdc4, SCF[Ago], anon-WO0118547.345, archipelago" CDMC20191 1 17 15 DAC24-M12 14-CG15043-RA_1 CG15043 TGCCGTGACTGGAGACCCTTAGTCCACACACTTCGTTTACCTCGAATTTCAATTCAACGCCCAAGATGT 69 FBan0015043 FBgn0030929 CG15043 X X CG15043 CG15043 BcDNA:RE41194 CDMC20191 1 18 15 DAC24-M12 14-CG15043-RA_1 CG15043 TGCCGTGACTGGAGACCCTTAGTCCACACACTTCGTTTACCTCGAATTTCAATTCAACGCCCAAGATGT 69 FBan0015043 FBgn0030929 CG15043 X X CG15043 CG15043 BcDNA:RE41194 CDMC20192 1 19 15 DAC24-M24 24-CG15064-RA_1 CG15064 CGCCTCTGCAAACCGACTTTATTTTTTTTCCTGTTAATAAATAGTTAAGTAATAAAGATTTTTTTTGAA 69 FBan0015064 FBgn0030900 Him X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Him Him "CG15064, CG15064, CG15064" CDMC20192 1 20 15 DAC24-M24 24-CG15064-RA_1 CG15064 CGCCTCTGCAAACCGACTTTATTTTTTTTCCTGTTAATAAATAGTTAAGTAATAAAGATTTTTTTTGAA 69 FBan0015064 FBgn0030900 Him X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Him Him "CG15064, CG15064, CG15064" CDMC20193 1 21 15 DAC25-A12 18-CG14307-RA_6 CG14307 ACGCTCGAGCGGACGGATAGTCGCGATGATCTATTGCAGCTGGATTATAGCAACAAGGATAACAACAAT 69 FBan0014307 FBgn0004652 fru 3 3R "central nervous system development; GO:0007417; chromatin assembly or disassembly; GO:0006333; copulation; GO:0007620; development; GO:0007275; male courtship behavior (sensu Insecta); GO:0016542; male courtship behavior (sensu Insecta), orientation; GO:0016543; male courtship behavior (sensu Insecta), song production; GO:0045433; male courtship behavior (sensu Insecta), wing vibration; GO:0016545; male courtship behavior; GO:0008049; male sex differentiation; GO:0046661; mating; GO:0007618; mating behavior, sex discrimination; GO:0048047; muscle development; GO:0007517; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003702; ; GO:0003700; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 nucleus; GO:0005634 fru fruitless "CG7688, CG7689, CG7690, CG14307, CG7688, CG7689, CG7690, CG7689, CG7690, CG7689, CG14307, CG7689, CG14307, CG14307, BTB-VI, sat, satori, fru-satori, cg7688, cg7689, CT22773, BtbVI, fty: fruity, ms(3)06411, BTB-protein-VI, fruity, fruitless" CDMC20193 1 22 15 DAC25-A12 18-CG14307-RA_6 CG14307 ACGCTCGAGCGGACGGATAGTCGCGATGATCTATTGCAGCTGGATTATAGCAACAAGGATAACAACAAT 69 FBan0014307 FBgn0004652 fru 3 3R "central nervous system development; GO:0007417; chromatin assembly or disassembly; GO:0006333; copulation; GO:0007620; development; GO:0007275; male courtship behavior (sensu Insecta); GO:0016542; male courtship behavior (sensu Insecta), orientation; GO:0016543; male courtship behavior (sensu Insecta), song production; GO:0045433; male courtship behavior (sensu Insecta), wing vibration; GO:0016545; male courtship behavior; GO:0008049; male sex differentiation; GO:0046661; mating; GO:0007618; mating behavior, sex discrimination; GO:0048047; muscle development; GO:0007517; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" RNA polymerase II transcription factor activity; GO:0003702; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003702; ; GO:0003700; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 nucleus; GO:0005634 fru fruitless "CG7688, CG7689, CG7690, CG14307, CG7688, CG7689, CG7690, CG7689, CG7690, CG7689, CG14307, CG7689, CG14307, CG14307, BTB-VI, sat, satori, fru-satori, cg7688, cg7689, CT22773, BtbVI, fty: fruity, ms(3)06411, BTB-protein-VI, fruity, fruitless" CDMC20194 1 23 15 DAC25-A24 11-CG14316-RA_1 CG14316 GCCCGTTGGCATAACCTTTGCTCGATTCACCAACTGTCCAGATCTCACTGATGAACAGCTCTTGGACTT 69 FBan0014316 FBgn0038567 CG14316 3 3R CG14316 CG14316 CDMC20194 1 24 15 DAC25-A24 11-CG14316-RA_1 CG14316 GCCCGTTGGCATAACCTTTGCTCGATTCACCAACTGTCCAGATCTCACTGATGAACAGCTCTTGGACTT 69 FBan0014316 FBgn0038567 CG14316 3 3R CG14316 CG14316 CDMC20195 1 25 15 DAC25-E12 22-CG14357-RA_4 CG14357 CAATTGCTGAATACGGATAACGTGACCAATTACGGATTGATGAGGACAGGCAGATGCAAGGGAAATGCC 69 FBan0014357 FBgn0038204 CG14357 3 3R CG14357 CG14357 CDMC20195 1 26 15 DAC25-E12 22-CG14357-RA_4 CG14357 CAATTGCTGAATACGGATAACGTGACCAATTACGGATTGATGAGGACAGGCAGATGCAAGGGAAATGCC 69 FBan0014357 FBgn0038204 CG14357 3 3R CG14357 CG14357 CDMC20196 1 1 16 DAC25-E24 23-CG14375-RA_2 CG14375 AGAAATATCCACAACGTACATTAAAAACCGGAAATAAGCCTCAAAAACAAGAGCAACAACATCAAGAGA 69 FBan0014375 FBgn0038147 CG14375 3 3R CG14375 CG14375 BcDNA:RE10132 CDMC20196 1 2 16 DAC25-E24 23-CG14375-RA_2 CG14375 AGAAATATCCACAACGTACATTAAAAACCGGAAATAAGCCTCAAAAACAAGAGCAACAACATCAAGAGA 69 FBan0014375 FBgn0038147 CG14375 3 3R CG14375 CG14375 BcDNA:RE10132 CDMC20197 1 3 16 DAC25-I12 15-CG14423-RA_1 CG14423 TCACCGCCGTCTAAGGATCTAGGATTCAAGGTCAGGATCCAACGATCCGACACATTCCGGCAAGATAAT 69 FBan0014423 FBgn0029646 CG14423 X X CG14423 CG14423 CDMC20197 1 4 16 DAC25-I12 15-CG14423-RA_1 CG14423 TCACCGCCGTCTAAGGATCTAGGATTCAAGGTCAGGATCCAACGATCCGACACATTCCGGCAAGATAAT 69 FBan0014423 FBgn0029646 CG14423 X X CG14423 CG14423 CDMC20198 1 5 16 DAC25-I24 6-CG14434-RA_1 CG14434 ACCTGGACGAGGTAAAGGATCTGGGATACTTCATGGAACTGGAGGTGTGCCTGACAGAGGATCAAACCC 69 FBan0014434 FBgn0029915 CG14434 X X CG14434 CG14434 CDMC20198 1 6 16 DAC25-I24 6-CG14434-RA_1 CG14434 ACCTGGACGAGGTAAAGGATCTGGGATACTTCATGGAACTGGAGGTGTGCCTGACAGAGGATCAAACCC 69 FBan0014434 FBgn0029915 CG14434 X X CG14434 CG14434 CDMC20199 1 7 16 DAC25-M12 3-CG14481-RA_3 CG14481 GGAATCCGTGAGCCAGAATGAAGCCGGACATCTGCAGGTTAAAGGTGTGATTAACCAGCCCTTCGAGGA 69 FBan0014481 FBgn0034260 CG14481 2 2R CG14481 CG14481 CDMC20199 1 8 16 DAC25-M12 3-CG14481-RA_3 CG14481 GGAATCCGTGAGCCAGAATGAAGCCGGACATCTGCAGGTTAAAGGTGTGATTAACCAGCCCTTCGAGGA 69 FBan0014481 FBgn0034260 CG14481 2 2R CG14481 CG14481 CDMC20200 1 9 16 DAC25-M24 1-CG14499-RA_1 CG14499 CCACTGCAAATCTTCAAGACGCAGCTTTGTCTTAACACCACTGCTTTCTTCGAGGCCAAGGTACCCGCT 69 FBan0014499 FBgn0034317 CR14499 2 2R CR14499 CR14499 "CG14499, CG14499, CG14499" CDMC20200 1 10 16 DAC25-M24 1-CG14499-RA_1 CG14499 CCACTGCAAATCTTCAAGACGCAGCTTTGTCTTAACACCACTGCTTTCTTCGAGGCCAAGGTACCCGCT 69 FBan0014499 FBgn0034317 CR14499 2 2R CR14499 CR14499 "CG14499, CG14499, CG14499" CDMC20201 1 11 16 DAC26-A12 11-CG4714-RA_4 CG4714 AGGCGGTAGTCCGTGAACTACTGTACGACCTTTTCGAGGAGACGGCTAGTTTATCGGACATCCACAACA 69 FBan0004714 FBgn0033819 CG4714 2 2R CG4714 CG4714 anon-WO0140519.159 CDMC20201 1 12 16 DAC26-A12 11-CG4714-RA_4 CG4714 AGGCGGTAGTCCGTGAACTACTGTACGACCTTTTCGAGGAGACGGCTAGTTTATCGGACATCCACAACA 69 FBan0004714 FBgn0033819 CG4714 2 2R CG4714 CG4714 anon-WO0140519.159 CDMC20202 1 13 16 DAC26-A24 15-CG4725-RA_1 CG4725 GCGGCCAGAACCAGACTGTCACAATATCGAGTGTCTCTGCCGGATTACCAAAGTTTGGATCTAACCGAT 69 FBan0004725 FBgn0039022 CG4725 3 3R proteolysis; GO:0006508; signal transduction; GO:0007165 endothelin-converting enzyme activity; GO:0016511; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0016511; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG4725 CG4725 CDMC20202 1 14 16 DAC26-A24 15-CG4725-RA_1 CG4725 GCGGCCAGAACCAGACTGTCACAATATCGAGTGTCTCTGCCGGATTACCAAAGTTTGGATCTAACCGAT 69 FBan0004725 FBgn0039022 CG4725 3 3R proteolysis; GO:0006508; signal transduction; GO:0007165 endothelin-converting enzyme activity; GO:0016511; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0016511; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG4725 CG4725 CDMC20203 1 15 16 DAC26-E12 23-CG4753-RA_2 CG4753 TTATAAACTCTGCAACAGTTTTGGAATATACGACCTATGGACTAATAACTCAACTGCACTGACCATAGA 69 FBan0004753 FBgn0036622 CG4753 3 3L metabolism; GO:0008152 1-acylglycerol-3-phosphate O-acyltransferase activity; GO:0003841 ; EC:2.3.1.51; ; GO:0003841 ; EC:2.3.1.51 CG4753 CG4753 CDMC20203 1 16 16 DAC26-E12 23-CG4753-RA_2 CG4753 TTATAAACTCTGCAACAGTTTTGGAATATACGACCTATGGACTAATAACTCAACTGCACTGACCATAGA 69 FBan0004753 FBgn0036622 CG4753 3 3L metabolism; GO:0008152 1-acylglycerol-3-phosphate O-acyltransferase activity; GO:0003841 ; EC:2.3.1.51; ; GO:0003841 ; EC:2.3.1.51 CG4753 CG4753 CDMC20204 1 17 16 DAC26-E24 14-CG4759-RA_1 CG4759 ACTGACCGAAGTGGATCCTGTGCCTTCTTATTAAGTGTGCAAGTGGGACAAACGTGCCTATGGTGATGA 69 FBan0004759 FBgn0039359 RpL27 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL27 Ribosomal protein L27 "CG4759, Ribosomal protein L27" CDMC20204 1 18 16 DAC26-E24 14-CG4759-RA_1 CG4759 ACTGACCGAAGTGGATCCTGTGCCTTCTTATTAAGTGTGCAAGTGGGACAAACGTGCCTATGGTGATGA 69 FBan0004759 FBgn0039359 RpL27 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL27 Ribosomal protein L27 "CG4759, Ribosomal protein L27" CDMC20205 1 19 16 DAC26-I12 3-CG4787-RA_1 CG4787 GCCCTCTCTGGCTTCCTCAACGAGGAGATTCTGCAGAAGACCTTTTCGCCGTATGGCACAATACAGGAG 69 FBan0004787 FBgn0039572 CG4787 3 3R apoptosis; GO:0006915 mRNA binding; GO:0003729; ; GO:0003729 CG4787 CG4787 cg4787 CDMC20205 1 20 16 DAC26-I12 3-CG4787-RA_1 CG4787 GCCCTCTCTGGCTTCCTCAACGAGGAGATTCTGCAGAAGACCTTTTCGCCGTATGGCACAATACAGGAG 69 FBan0004787 FBgn0039572 CG4787 3 3R apoptosis; GO:0006915 mRNA binding; GO:0003729; ; GO:0003729 CG4787 CG4787 cg4787 CDMC20206 1 21 16 DAC26-I24 22-CG4797-RA_1 CG4797 CCCAATGGGCCACTCCGACAGGGAATCTTCAAATGTTAGGTTACCAATTCAAATTGTGATCGCTATGCT 69 FBan0004797 FBgn0034909 CG4797 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 glucose transporter activity; GO:0005355; ; GO:0005355 integral to membrane; GO:0016021; membrane; GO:0016020 CG4797 CG4797 CDMC20206 1 22 16 DAC26-I24 22-CG4797-RA_1 CG4797 CCCAATGGGCCACTCCGACAGGGAATCTTCAAATGTTAGGTTACCAATTCAAATTGTGATCGCTATGCT 69 FBan0004797 FBgn0034909 CG4797 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 glucose transporter activity; GO:0005355; ; GO:0005355 integral to membrane; GO:0016021; membrane; GO:0016020 CG4797 CG4797 CDMC20207 1 23 16 DAC26-M12 3-CG4836-RC_5 CG4836 GCTTCCAAGCAGTCGAGTTCGATAGCAACGCACTGTTCGGAGAGGTCCTTGAAGCCATCTACAGCAAGT 69 FBan0004836 FBgn0038762 CG4836 3 3R carbohydrate metabolism; GO:0005975 "L-iditol 2-dehydrogenase activity; GO:0003939 ; EC:1.1.1.14; zinc ion binding; GO:0008270; ; GO:0003939 ; EC:1.1.1.14; ; GO:0008270; alcohol dehydrogenase activity, zinc-dependent; GO:0004024; ; GO:0004024" CG4836 CG4836 "bs15h04.y1, bs36e10.y1, DM_7300579, anon-WO0140519.105, anon-WO0140519.33" CDMC20207 1 24 16 DAC26-M12 3-CG4836-RC_5 CG4836 GCTTCCAAGCAGTCGAGTTCGATAGCAACGCACTGTTCGGAGAGGTCCTTGAAGCCATCTACAGCAAGT 69 FBan0004836 FBgn0038762 CG4836 3 3R carbohydrate metabolism; GO:0005975 "L-iditol 2-dehydrogenase activity; GO:0003939 ; EC:1.1.1.14; zinc ion binding; GO:0008270; ; GO:0003939 ; EC:1.1.1.14; ; GO:0008270; alcohol dehydrogenase activity, zinc-dependent; GO:0004024; ; GO:0004024" CG4836 CG4836 "bs15h04.y1, bs36e10.y1, DM_7300579, anon-WO0140519.105, anon-WO0140519.33" CDMC20208 1 25 16 DAC26-M24 3-CG4847-RC_1 CG4847 AGCCGAACCACTCCATTCTGGTCGTCGGTTACGGATCGGAGAAAGGACAGGATTACTGGATCGTCAAGA 69 FBan0004847 FBgn0034229 CG4847 2 2R proteolysis; GO:0006508 cathepsin K activity; GO:0004216 ; EC:3.4.22.38; cysteine-type peptidase activity; GO:0008234 ; EC:3.4.-.-; ; GO:0004216 ; EC:3.4.22.38; ; GO:0008234 ; EC:3.4.-.- CG4847 CG4847 BEST:GH19547 CDMC20208 1 26 16 DAC26-M24 3-CG4847-RC_1 CG4847 AGCCGAACCACTCCATTCTGGTCGTCGGTTACGGATCGGAGAAAGGACAGGATTACTGGATCGTCAAGA 69 FBan0004847 FBgn0034229 CG4847 2 2R proteolysis; GO:0006508 cathepsin K activity; GO:0004216 ; EC:3.4.22.38; cysteine-type peptidase activity; GO:0008234 ; EC:3.4.-.-; ; GO:0004216 ; EC:3.4.22.38; ; GO:0008234 ; EC:3.4.-.- CG4847 CG4847 BEST:GH19547 CDMC20209 1 1 17 DAC27-A12 18-CG3461-RA_2 CG3461 GCTGCAAGGGCGGATATTAGTAAGCTAACTCTCACCGAAGTTTTGCGCAAGGATATGAAGGTCTTGCAA 69 FBan0003461 FBgn0003116 pn X X eye pigmentation (sensu Endopterygota); GO:0048072 pyrophosphatase activity; GO:0016462 ; EC:3.6.1.-; ; GO:0016462 ; EC:3.6.1.- cytoplasm; GO:0005737 pn prune "CG3461, CG3461, N4, TcD37, transcription unit II, EG:152A3.5, N3, se-like-62, prune" CDMC20209 1 2 17 DAC27-A12 18-CG3461-RA_2 CG3461 GCTGCAAGGGCGGATATTAGTAAGCTAACTCTCACCGAAGTTTTGCGCAAGGATATGAAGGTCTTGCAA 69 FBan0003461 FBgn0003116 pn X X eye pigmentation (sensu Endopterygota); GO:0048072 pyrophosphatase activity; GO:0016462 ; EC:3.6.1.-; ; GO:0016462 ; EC:3.6.1.- cytoplasm; GO:0005737 pn prune "CG3461, CG3461, N4, TcD37, transcription unit II, EG:152A3.5, N3, se-like-62, prune" CDMC20210 1 3 17 DAC27-A24 3-CG3485-RA_3 CG3485 GCCCCCCGAAATGAAAGTGTTGCACCTGATCATCAGCAAGGTGAGACTGACACCGAAATTGGCTTTGGA 69 FBan0003485 FBgn0031511 CG3485 2 2L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG3485 CG3485 CDMC20210 1 4 17 DAC27-A24 3-CG3485-RA_3 CG3485 GCCCCCCGAAATGAAAGTGTTGCACCTGATCATCAGCAAGGTGAGACTGACACCGAAATTGGCTTTGGA 69 FBan0003485 FBgn0031511 CG3485 2 2L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG3485 CG3485 CDMC20211 1 5 17 DAC27-E12 11-CG3525-RC_1 CG3525 TCGTGCCAGCCTTAGTGTATGTACAGTGCTCACTCGAAACAGTGGACTATTGAGAACCAAGGGTGTGCA 69 FBan0003525 FBgn0000536 eas X X associative learning; GO:0008306; brain development; GO:0007420; habituation; GO:0046959; long-term memory; GO:0007616; mechanosensory behavior; GO:0007638; mushroom body development; GO:0016319; neuroblast division; GO:0045034; phosphatidylethanolamine biosynthesis; GO:0006646; phosphorylation; GO:0016310; response to mechanical stimulus; GO:0009612 choline kinase activity; GO:0004103 ; EC:2.7.1.32; ethanolamine kinase activity; GO:0004305 ; EC:2.7.1.82; ; GO:0004305 ; EC:2.7.1.82; ; GO:0004103 ; EC:2.7.1.32; ; GO:0004103 ; EC:2.7.1.32; ; GO:0004305 ; EC:2.7.1.82 eas easily shocked "CG3525, CG3525, CG3525, CG3525, EtnK, Ethanolamine kinase, ala, alpha lobes absent, alpha-lobe absent, EP770, PC80, RH11, easily shocked" CDMC20211 1 6 17 DAC27-E12 11-CG3525-RC_1 CG3525 TCGTGCCAGCCTTAGTGTATGTACAGTGCTCACTCGAAACAGTGGACTATTGAGAACCAAGGGTGTGCA 69 FBan0003525 FBgn0000536 eas X X associative learning; GO:0008306; brain development; GO:0007420; habituation; GO:0046959; long-term memory; GO:0007616; mechanosensory behavior; GO:0007638; mushroom body development; GO:0016319; neuroblast division; GO:0045034; phosphatidylethanolamine biosynthesis; GO:0006646; phosphorylation; GO:0016310; response to mechanical stimulus; GO:0009612 choline kinase activity; GO:0004103 ; EC:2.7.1.32; ethanolamine kinase activity; GO:0004305 ; EC:2.7.1.82; ; GO:0004305 ; EC:2.7.1.82; ; GO:0004103 ; EC:2.7.1.32; ; GO:0004103 ; EC:2.7.1.32; ; GO:0004305 ; EC:2.7.1.82 eas easily shocked "CG3525, CG3525, CG3525, CG3525, EtnK, Ethanolamine kinase, ala, alpha lobes absent, alpha-lobe absent, EP770, PC80, RH11, easily shocked" CDMC20212 1 7 17 DAC27-E24 2-CG3534-RA_1 CG3534 TGGCTGAAGACCTTGGCTACAAATTCGGACCCGAGACACAAATCCTTGTCACAGGAGGCGCATCTGTTA 69 FBan0003534 FBgn0038463 CG3534 3 3R carbohydrate metabolism; GO:0005975 xylulokinase activity; GO:0004856 ; EC:2.7.1.17; ; GO:0004856 ; EC:2.7.1.17 CG3534 CG3534 CDMC20212 1 8 17 DAC27-E24 2-CG3534-RA_1 CG3534 TGGCTGAAGACCTTGGCTACAAATTCGGACCCGAGACACAAATCCTTGTCACAGGAGGCGCATCTGTTA 69 FBan0003534 FBgn0038463 CG3534 3 3R carbohydrate metabolism; GO:0005975 xylulokinase activity; GO:0004856 ; EC:2.7.1.17; ; GO:0004856 ; EC:2.7.1.17 CG3534 CG3534 CDMC20213 1 9 17 DAC27-I12 3-CG3582-RA_4 CG3582 GCTCTCGCATCCACAACAAACCCACTTTCTCGCAGACGGTGCTTCTCCAAAATCTATACGTGAACCCCC 69 FBan0003582 FBgn0017457 U2af38 2 2L "nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" poly-pyrimidine tract binding; GO:0008187; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008187; ; GO:0008187 nucleus; GO:0005634; snRNP U2; GO:0005686; spliceosome complex; GO:0005681 U2af38 U2 small nuclear riboprotein auxiliary factor 38 "CG3582, CG3582, dU2AF[38], U2AF, dU2AF38, DU2AF38, U2AF38, l(2)06751" CDMC20213 1 10 17 DAC27-I12 3-CG3582-RA_4 CG3582 GCTCTCGCATCCACAACAAACCCACTTTCTCGCAGACGGTGCTTCTCCAAAATCTATACGTGAACCCCC 69 FBan0003582 FBgn0017457 U2af38 2 2L "nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" poly-pyrimidine tract binding; GO:0008187; mRNA binding; GO:0003729; ; GO:0003729; ; GO:0008187; ; GO:0008187 nucleus; GO:0005634; snRNP U2; GO:0005686; spliceosome complex; GO:0005681 U2af38 U2 small nuclear riboprotein auxiliary factor 38 "CG3582, CG3582, dU2AF[38], U2AF, dU2AF38, DU2AF38, U2AF38, l(2)06751" CDMC20214 1 11 17 DAC27-I24 23-CG3590-RA_5 CG3590 CAATGTCTCGCTGTTGCTAAATGGATTATCACATTTAATTGACTGCATTCAGATCAGATCAGATTGCAA 69 FBan0003590 FBgn0038467 CG3590 3 3R purine base metabolism; GO:0006144; purine ribonucleotide biosynthesis; GO:0009152 adenylosuccinate lyase activity; GO:0004018 ; EC:4.3.2.2; ; GO:0004018 ; EC:4.3.2.2 CG3590 CG3590 CDMC20214 1 12 17 DAC27-I24 23-CG3590-RA_5 CG3590 CAATGTCTCGCTGTTGCTAAATGGATTATCACATTTAATTGACTGCATTCAGATCAGATCAGATTGCAA 69 FBan0003590 FBgn0038467 CG3590 3 3R purine base metabolism; GO:0006144; purine ribonucleotide biosynthesis; GO:0009152 adenylosuccinate lyase activity; GO:0004018 ; EC:4.3.2.2; ; GO:0004018 ; EC:4.3.2.2 CG3590 CG3590 CDMC20215 1 13 17 DAC27-M12 15-CG3631-RA_1 CG3631 ACATCGAGGGCGACAAAATGTTCAAAACTCTGTAGTTTCAGCTCAAGATTGGGGCTAATGGCCAGCACT 69 FBan0003631 FBgn0038268 CG3631 3 3R CG3631 CG3631 CDMC20215 1 14 17 DAC27-M12 15-CG3631-RA_1 CG3631 ACATCGAGGGCGACAAAATGTTCAAAACTCTGTAGTTTCAGCTCAAGATTGGGGCTAATGGCCAGCACT 69 FBan0003631 FBgn0038268 CG3631 3 3R CG3631 CG3631 CDMC20216 1 15 17 DAC27-M24 12-CG3644-RB_1 CG3644 TCCGACTTTTCGATGTAACCCCGCCCTCAAGGAATCCTCAATTGAAAACGAAAACAAGCTGAGGCCACA 69 FBan0003644 FBgn0000181 bic 2 2R regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription initiation from RNA polymerase II promoter; GO:0006367 transcription factor activity; GO:0003700; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003700; ; GO:0016251 nascent polypeptide-associated complex; GO:0005854 bic bicaudal "CG3644, CG3644, l(2)49Da, l(2)vr22, l(2)k10712, E(Bic), vr22, 107/12, Btf, BcDNA.GM05329, 5A, Bic, BcDNA:GM05329, E(2)Bic, Enhancer of Bicaudal" CDMC20216 1 16 17 DAC27-M24 12-CG3644-RB_1 CG3644 TCCGACTTTTCGATGTAACCCCGCCCTCAAGGAATCCTCAATTGAAAACGAAAACAAGCTGAGGCCACA 69 FBan0003644 FBgn0000181 bic 2 2R regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription initiation from RNA polymerase II promoter; GO:0006367 transcription factor activity; GO:0003700; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003700; ; GO:0016251 nascent polypeptide-associated complex; GO:0005854 bic bicaudal "CG3644, CG3644, l(2)49Da, l(2)vr22, l(2)k10712, E(Bic), vr22, 107/12, Btf, BcDNA.GM05329, 5A, Bic, BcDNA:GM05329, E(2)Bic, Enhancer of Bicaudal" CDMC20217 1 17 17 DAC28-A12 9-CG14731-RA_1 CG14731 TGGCCATTTTGATGCCACGGTCCTTTCCAAAAATGAAACCTCGCTGCAAGGACCTATCACAAGGACTGA 69 FBan0014731 FBgn0037964 CG14731 3 3R CG14731 CG14731 CDMC20217 1 18 17 DAC28-A12 9-CG14731-RA_1 CG14731 TGGCCATTTTGATGCCACGGTCCTTTCCAAAAATGAAACCTCGCTGCAAGGACCTATCACAAGGACTGA 69 FBan0014731 FBgn0037964 CG14731 3 3R CG14731 CG14731 CDMC20218 1 19 17 DAC28-A24 3-CG14749-RA_4 CG14749 TCCGCTGGCCCGAGACTATTGCATGCTACTTATGGCCAAGAAGTTTGTCAGTCAAACGGAGACTGCCAT 69 FBan0014749 FBgn0033316 CG14749 2 2R poly(A)+ mRNA export from nucleus; GO:0016973 CG14749 CG14749 CDMC20218 1 20 17 DAC28-A24 3-CG14749-RA_4 CG14749 TCCGCTGGCCCGAGACTATTGCATGCTACTTATGGCCAAGAAGTTTGTCAGTCAAACGGAGACTGCCAT 69 FBan0014749 FBgn0033316 CG14749 2 2R poly(A)+ mRNA export from nucleus; GO:0016973 CG14749 CG14749 CDMC20219 1 21 17 DAC28-E12 8-CG14801-RB_1 CG14801 GCCCGTGTGCGACATAATAGACTACAACACCCAGTATTCGGGCATTACGGAAACGGATCTGTGTTCCGG 69 FBan0014801 FBgn0024988 CG14801 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; exonuclease activity; GO:0004527; ; GO:0003676; exoribonuclease activity; GO:0004532; ; GO:0004527; ; GO:0004532 intracellular; GO:0005622 CG14801 CG14801 "CG17968, CG14800, CG17968, CG14800, CG17968, CG14800, EG:137E7.1, EG:131F2.2" CDMC20219 1 22 17 DAC28-E12 8-CG14801-RB_1 CG14801 GCCCGTGTGCGACATAATAGACTACAACACCCAGTATTCGGGCATTACGGAAACGGATCTGTGTTCCGG 69 FBan0014801 FBgn0024988 CG14801 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; exonuclease activity; GO:0004527; ; GO:0003676; exoribonuclease activity; GO:0004532; ; GO:0004527; ; GO:0004532 intracellular; GO:0005622 CG14801 CG14801 "CG17968, CG14800, CG17968, CG14800, CG17968, CG14800, EG:137E7.1, EG:131F2.2" CDMC20220 1 23 17 DAC28-E24 23-CG14812-RA_15 CG14812 GCCTGTTACATTTGTCGCTCATTCTAACCGATAGCCATTACCATAAGCATTGTTTTGTACGACTCGCAT 69 FBan0014812 FBgn0026090 CG14812 X X CG14812 CG14812 "EG:131F2.3, BcDNA:RE59545" CDMC20220 1 24 17 DAC28-E24 23-CG14812-RA_15 CG14812 GCCTGTTACATTTGTCGCTCATTCTAACCGATAGCCATTACCATAAGCATTGTTTTGTACGACTCGCAT 69 FBan0014812 FBgn0026090 CG14812 X X CG14812 CG14812 "EG:131F2.3, BcDNA:RE59545" CDMC20221 1 25 17 DAC28-I12 3-CG14843-RA_1 CG14843 GCCCACGAGACACAATTAACGCTATCGCACCCGGCTAATCCACATTTGGTCACCGATACGGACAACCTA 69 FBan0014843 FBgn0038230 CG14843 3 3R CG14843 CG14843 CDMC20221 1 26 17 DAC28-I12 3-CG14843-RA_1 CG14843 GCCCACGAGACACAATTAACGCTATCGCACCCGGCTAATCCACATTTGGTCACCGATACGGACAACCTA 69 FBan0014843 FBgn0038230 CG14843 3 3R CG14843 CG14843 CDMC20222 1 1 18 DAC28-I24 1-CG14864-RA_2 CG14864 CGCCTCCAGAGATTTGCGTTCAAGAGTCCGATCTGACCGAAAATGATGAGCGAGCTGTGTTCCCGGAAA 69 FBan0014864 FBgn0038311 CG14864 3 3R CG14864 CG14864 BcDNA:AT13896 CDMC20222 1 2 18 DAC28-I24 1-CG14864-RA_2 CG14864 CGCCTCCAGAGATTTGCGTTCAAGAGTCCGATCTGACCGAAAATGATGAGCGAGCTGTGTTCCCGGAAA 69 FBan0014864 FBgn0038311 CG14864 3 3R CG14864 CG14864 BcDNA:AT13896 CDMC20223 1 3 18 DAC28-M12 24-CG1488-RA_1 CG1488 AGCGAAACCATTTTAATATTAAGCCATACCAAAATTATAAATATTTCATTTTGACGTCCTTACTTTGCG 69 FBan0001488 FBgn0030367 Cyp311a1 X X electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp311a1 Cyp311a1 "CG1488, 311a1" CDMC20223 1 4 18 DAC28-M12 24-CG1488-RA_1 CG1488 AGCGAAACCATTTTAATATTAAGCCATACCAAAATTATAAATATTTCATTTTGACGTCCTTACTTTGCG 69 FBan0001488 FBgn0030367 Cyp311a1 X X electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp311a1 Cyp311a1 "CG1488, 311a1" CDMC20224 1 5 18 DAC28-M24 23-CG1489-RA_4 CG1489 GCAAATGCAGAGTCATACAATAAAGAGGAATTAATTCGACATCTTGCATTGTGGTCCTTCAGTTCGACA 69 FBan0001489 FBgn0020369 Pros45 X X ATP-dependent proteolysis; GO:0006510; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0016887; ; GO:0016887; ; GO:0004175; nucleotide binding; GO:0000166; ; GO:0000166 "proteasome complex (sensu Eukaryota); GO:0000502; proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, base subcomplex (sensu Eukaryota); GO:0008540" Pros45 Pros45 "CG1489, DUG, pros45, p42C, Dm_Rpt6a, dRpt6, Dug, Ug, sug-1, sug1" CDMC20224 1 6 18 DAC28-M24 23-CG1489-RA_4 CG1489 GCAAATGCAGAGTCATACAATAAAGAGGAATTAATTCGACATCTTGCATTGTGGTCCTTCAGTTCGACA 69 FBan0001489 FBgn0020369 Pros45 X X ATP-dependent proteolysis; GO:0006510; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0016887; ; GO:0016887; ; GO:0004175; nucleotide binding; GO:0000166; ; GO:0000166 "proteasome complex (sensu Eukaryota); GO:0000502; proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, base subcomplex (sensu Eukaryota); GO:0008540" Pros45 Pros45 "CG1489, DUG, pros45, p42C, Dm_Rpt6a, dRpt6, Dug, Ug, sug-1, sug1" CDMC20225 1 7 18 DAC29-A12 15-CG6382-RA_1 CG6382 CCGGTTTTGTTCTCTGCGATGCAGCCAATCCCATCAAGACGGGAAAAATCTTTGATGCTCAGGTCGTAA 69 FBan0006382 FBgn0020443 Elf 2 2L regulation of translation; GO:0006445; translational termination; GO:0006415 GTP binding; GO:0005525; ; GO:0005525; translation termination factor activity; GO:0008079; translation release factor activity; GO:0003747; ; GO:0003747; ; GO:0008079; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003747; ; GO:0008079 cytosol; GO:0005829 Elf Ef1alpha-like factor "CG6382, CG6382, delf, dsup35, Dsup35, eRF3, DSUP35, eukaryotic release factor 3, Ef1alpha-like factor" CDMC20225 1 8 18 DAC29-A12 15-CG6382-RA_1 CG6382 CCGGTTTTGTTCTCTGCGATGCAGCCAATCCCATCAAGACGGGAAAAATCTTTGATGCTCAGGTCGTAA 69 FBan0006382 FBgn0020443 Elf 2 2L regulation of translation; GO:0006445; translational termination; GO:0006415 GTP binding; GO:0005525; ; GO:0005525; translation termination factor activity; GO:0008079; translation release factor activity; GO:0003747; ; GO:0003747; ; GO:0008079; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003747; ; GO:0008079 cytosol; GO:0005829 Elf Ef1alpha-like factor "CG6382, CG6382, delf, dsup35, Dsup35, eRF3, DSUP35, eukaryotic release factor 3, Ef1alpha-like factor" CDMC20226 1 9 18 DAC29-A24 13-CG6393-RC_1 CG6393 CCGACAGGCACGCAAAATATGCAAATACCAGGAGTGCATCTCTATTGACCGGTCAAATACTCGGCTTGG 69 FBan0006393 FBgn0034685 CG6393 2 2R CG6393 CG6393 CDMC20226 1 10 18 DAC29-A24 13-CG6393-RC_1 CG6393 CCGACAGGCACGCAAAATATGCAAATACCAGGAGTGCATCTCTATTGACCGGTCAAATACTCGGCTTGG 69 FBan0006393 FBgn0034685 CG6393 2 2R CG6393 CG6393 CDMC20227 1 11 18 DAC29-E12 17-CG6428-RA_1 CG6428 CCGAACCATACATACCTCGTTCCTTGTTCCTGCAGCATGAAGAAAAAAACAAACACTGGAGGCTAGGGT 69 FBan0006428 FBgn0029689 CG6428 X X amino acid catabolism; GO:0009063 lysophospholipase activity; GO:0004622 ; EC:3.1.1.5; asparaginase activity; GO:0004067 ; EC:3.5.1.1; ; GO:0004622 ; EC:3.1.1.5; ; GO:0004067 ; EC:3.5.1.1 CG6428 CG6428 CDMC20227 1 12 18 DAC29-E12 17-CG6428-RA_1 CG6428 CCGAACCATACATACCTCGTTCCTTGTTCCTGCAGCATGAAGAAAAAAACAAACACTGGAGGCTAGGGT 69 FBan0006428 FBgn0029689 CG6428 X X amino acid catabolism; GO:0009063 lysophospholipase activity; GO:0004622 ; EC:3.1.1.5; asparaginase activity; GO:0004067 ; EC:3.5.1.1; ; GO:0004622 ; EC:3.1.1.5; ; GO:0004067 ; EC:3.5.1.1 CG6428 CG6428 CDMC20228 1 13 18 DAC29-E24 16-CG6445-RB_2 CG6445 TCGAACTGGGGAACTGAGAACTGGAGGTTCATTCGCGGATTATGTAGATGGTTACTTCTTAATGCGGGT 69 FBan0006445 FBgn0036715 Cad74A 3 3L calcium-dependent cell-cell adhesion; GO:0016339; homophilic cell adhesion; GO:0007156; signal transduction; GO:0007165 calcium ion binding; GO:0005509; ; GO:0005509 integral to plasma membrane; GO:0005887 Cad74A Cad74A "CG6445, CG6445, CG6445, CT20086, Cad74B, DCad74B" CDMC20228 1 14 18 DAC29-E24 16-CG6445-RB_2 CG6445 TCGAACTGGGGAACTGAGAACTGGAGGTTCATTCGCGGATTATGTAGATGGTTACTTCTTAATGCGGGT 69 FBan0006445 FBgn0036715 Cad74A 3 3L calcium-dependent cell-cell adhesion; GO:0016339; homophilic cell adhesion; GO:0007156; signal transduction; GO:0007165 calcium ion binding; GO:0005509; ; GO:0005509 integral to plasma membrane; GO:0005887 Cad74A Cad74A "CG6445, CG6445, CG6445, CT20086, Cad74B, DCad74B" CDMC20229 1 15 18 DAC29-I12 23-CG6478-RA_1 CG6478 GTCTGCGTTTCTAGGAAGGCTACATCTTGGACTCCATTAACTTAAGCAAATCTCGACTGAAGAACTCAT 69 FBan0006478 FBgn0039436 CG6478 3 3R CG6478 CG6478 CDMC20229 1 16 18 DAC29-I12 23-CG6478-RA_1 CG6478 GTCTGCGTTTCTAGGAAGGCTACATCTTGGACTCCATTAACTTAAGCAAATCTCGACTGAAGAACTCAT 69 FBan0006478 FBgn0039436 CG6478 3 3R CG6478 CG6478 CDMC20230 1 17 18 DAC29-I24 6-CG6486-RA_2 CG6486 GCAGCTGGGATTGTACACTGAAATTGTGGGACTGCAACAGACAGAACTCCATCACCACATTTGTGGGCC 69 FBan0006486 FBgn0035922 CG6486 3 3L peroxisome organization and biogenesis; GO:0007031; protein targeting to peroxisome; GO:0006625 peroxisome targeting signal-2 binding; GO:0005053; ; GO:0005053 peroxisome; GO:0005777 CG6486 CG6486 CDMC20230 1 18 18 DAC29-I24 6-CG6486-RA_2 CG6486 GCAGCTGGGATTGTACACTGAAATTGTGGGACTGCAACAGACAGAACTCCATCACCACATTTGTGGGCC 69 FBan0006486 FBgn0035922 CG6486 3 3L peroxisome organization and biogenesis; GO:0007031; protein targeting to peroxisome; GO:0006625 peroxisome targeting signal-2 binding; GO:0005053; ; GO:0005053 peroxisome; GO:0005777 CG6486 CG6486 CDMC20231 1 19 18 DAC29-M12 18-CG6523-RA_12 CG6523 GGCCAAGATTACTGGCGAAAAACTGCAGTTCATCAGCCTAAACGCTGAACAATTTCCCGAGATTTCCAT 69 FBan0006523 FBgn0032509 CG6523 2 2L electron transport; GO:0006118; regulation of signal transduction; GO:0009966; response to biotic stimulus; GO:0009607; sulfur metabolism; GO:0006790 thiol-disulfide exchange intermediate activity; GO:0030508; electron transporter activity; GO:0005489; ; GO:0030508; ; GO:0005489 CG6523 CG6523 CDMC20231 1 20 18 DAC29-M12 18-CG6523-RA_12 CG6523 GGCCAAGATTACTGGCGAAAAACTGCAGTTCATCAGCCTAAACGCTGAACAATTTCCCGAGATTTCCAT 69 FBan0006523 FBgn0032509 CG6523 2 2L electron transport; GO:0006118; regulation of signal transduction; GO:0009966; response to biotic stimulus; GO:0009607; sulfur metabolism; GO:0006790 thiol-disulfide exchange intermediate activity; GO:0030508; electron transporter activity; GO:0005489; ; GO:0030508; ; GO:0005489 CG6523 CG6523 CDMC20232 1 21 18 DAC29-M24 14-CG6539-RA_1 CG6539 ACGCTCAATCATTGTGGTTGCAGACTTTCAACATGCAGTACCAATTCATTGCATCCCATGTGGCCAAGA 69 FBan0006539 FBgn0011802 Dhh1 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0003676; ; GO:0003724 ; EC:2.7.7.-; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004 Dhh1 DEAD/DEAH RNA helicase 1 "CG6539, l(3)rL562, BcDNA.LD05563, DmRH22, DHH1, BcDNA:LD05563, DEAD/DEAH RNA helicase 1" CDMC20232 1 22 18 DAC29-M24 14-CG6539-RA_1 CG6539 ACGCTCAATCATTGTGGTTGCAGACTTTCAACATGCAGTACCAATTCATTGCATCCCATGTGGCCAAGA 69 FBan0006539 FBgn0011802 Dhh1 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; ; GO:0003676; ; GO:0003724 ; EC:2.7.7.-; ATP-dependent RNA helicase activity; GO:0004004; ; GO:0004004 Dhh1 DEAD/DEAH RNA helicase 1 "CG6539, l(3)rL562, BcDNA.LD05563, DmRH22, DHH1, BcDNA:LD05563, DEAD/DEAH RNA helicase 1" CDMC20233 1 23 18 DAC30-A12 15-CG3770-RA_5 CG3770 GTGCGTGCCCAGACAAAGTAAGAGCGCTTAGAGTCTATTATCTATCCGGCAAGTGCTGACGCGTTGC 67 FBan0003770 FBgn0035085 CG3770 2 2R establishment and/or maintenance of cell polarity; GO:0007163 CG3770 CG3770 CT12588 CDMC20233 1 24 18 DAC30-A12 15-CG3770-RA_5 CG3770 GTGCGTGCCCAGACAAAGTAAGAGCGCTTAGAGTCTATTATCTATCCGGCAAGTGCTGACGCGTTGC 67 FBan0003770 FBgn0035085 CG3770 2 2R establishment and/or maintenance of cell polarity; GO:0007163 CG3770 CG3770 CT12588 CDMC20234 1 25 18 DAC30-A24 23-CG3931-RA_1 CG3931 TCTACCGTCAAATGAAAAATTAACATTTCAATGGGTTCGAAATTGGTGGATTTCAAAATTGCATCAG 67 FBan0003931 FBgn0034879 Rrp4 2 2R mRNA processing; GO:0006397 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729; 3'-5'-exoribonuclease activity; GO:0000175 ; EC:3.1.13.-; ; GO:0000175 ; EC:3.1.13.- cytoplasmic exosome (RNase complex); GO:0000177; nuclear exosome (RNase complex); GO:0000176 Rrp4 Rrp4 "CG3931, CG3931, CG3931, dRrp4, RRP4" CDMC20234 1 26 18 DAC30-A24 23-CG3931-RA_1 CG3931 TCTACCGTCAAATGAAAAATTAACATTTCAATGGGTTCGAAATTGGTGGATTTCAAAATTGCATCAG 67 FBan0003931 FBgn0034879 Rrp4 2 2R mRNA processing; GO:0006397 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729; 3'-5'-exoribonuclease activity; GO:0000175 ; EC:3.1.13.-; ; GO:0000175 ; EC:3.1.13.- cytoplasmic exosome (RNase complex); GO:0000177; nuclear exosome (RNase complex); GO:0000176 Rrp4 Rrp4 "CG3931, CG3931, CG3931, dRrp4, RRP4" CDMC20235 1 1 19 DAC30-E12 1-CG41117-RA_1 CG41117 AACCGTCAGAACAACCCCATCGTATGCTTCAGTGACCTCTTCGAACCGATTTGTGTTGCGTCCAGCG 67 FBgn0069934 CG41117 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41117 CG41117 CDMC20235 1 2 19 DAC30-E12 1-CG41117-RA_1 CG41117 AACCGTCAGAACAACCCCATCGTATGCTTCAGTGACCTCTTCGAACCGATTTGTGTTGCGTCCAGCG 67 FBgn0069934 CG41117 biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG41117 CG41117 CDMC20236 1 3 19 DAC30-E24 3-CG4165-RA_2 CG4165 CGTGCCTCAATAATTTCACCGCTGTCGAGCTGATGACGGGACAGAACAAGGTGGGATGCGATAGCTG 67 FBan0004165 FBgn0029763 CG4165 X X protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 CG4165 CG4165 CDMC20236 1 4 19 DAC30-E24 3-CG4165-RA_2 CG4165 CGTGCCTCAATAATTTCACCGCTGTCGAGCTGATGACGGGACAGAACAAGGTGGGATGCGATAGCTG 67 FBan0004165 FBgn0029763 CG4165 X X protein deubiquitination; GO:0016579; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 ubiquitin-specific protease activity; GO:0004843; ; GO:0004843; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 CG4165 CG4165 CDMC20237 1 5 19 DAC30-I12 2-CG4658-RA_1 CG4658 CGGCGACAAATCATCACGCGAAGTGCAATTGGACATCAAGAAGTGGCAAATCAAGGAGGCCGAACGG 67 FBan0004658 FBgn0032170 CG4658 2 2L CG4658 CG4658 CDMC20237 1 6 19 DAC30-I12 2-CG4658-RA_1 CG4658 CGGCGACAAATCATCACGCGAAGTGCAATTGGACATCAAGAAGTGGCAAATCAAGGAGGCCGAACGG 67 FBan0004658 FBgn0032170 CG4658 2 2L CG4658 CG4658 CDMC20238 1 7 19 DAC30-I24 3-CG4872-RA_4 CG4872 GCCCTCCACATCCTTTGCCTTTCAACCGAAGAGGACTTTTATTCCATGCGGCAAGGAACCTGGCAAG 67 FBan0004872 FBgn0030799 CG4872 X X CG4872 CG4872 CDMC20238 1 8 19 DAC30-I24 3-CG4872-RA_4 CG4872 GCCCTCCACATCCTTTGCCTTTCAACCGAAGAGGACTTTTATTCCATGCGGCAAGGAACCTGGCAAG 67 FBan0004872 FBgn0030799 CG4872 X X CG4872 CG4872 CDMC20239 1 9 19 DAC30-M12 3-CG5254-RA_1 CG5254 CGGATTCCTGGAGGTCTGCATCATGCAACCACTCGATGTAGTCAAAACTCGCATCCAGATCCAGGCC 67 FBan0005254 FBgn0040383 CG5254 X X autophagic cell death; GO:0048102; lipid metabolism; GO:0006629; lipid transport; GO:0006869; salivary gland cell autophagic cell death; GO:0035071 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; tricarboxylate carrier activity; GO:0005371; ; GO:0005371; ; GO:0005371 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG5254 CG5254 "EG:BACR19J1.2, CT16777" CDMC20239 1 10 19 DAC30-M12 3-CG5254-RA_1 CG5254 CGGATTCCTGGAGGTCTGCATCATGCAACCACTCGATGTAGTCAAAACTCGCATCCAGATCCAGGCC 67 FBan0005254 FBgn0040383 CG5254 X X autophagic cell death; GO:0048102; lipid metabolism; GO:0006629; lipid transport; GO:0006869; salivary gland cell autophagic cell death; GO:0035071 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; tricarboxylate carrier activity; GO:0005371; ; GO:0005371; ; GO:0005371 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG5254 CG5254 "EG:BACR19J1.2, CT16777" CDMC20240 1 11 19 DAC30-M24 5-CG5388-RA_1 CG5388 TCCTGCAGGTCAATCACTCGGTGGTAATGGTGCTGAGCTACCGGTTTGATTCCTATATGGCGATGGC 67 FBan0005388 FBgn0038944 CG5388 3 3R CG5388 CG5388 CDMC20240 1 12 19 DAC30-M24 5-CG5388-RA_1 CG5388 TCCTGCAGGTCAATCACTCGGTGGTAATGGTGCTGAGCTACCGGTTTGATTCCTATATGGCGATGGC 67 FBan0005388 FBgn0038944 CG5388 3 3R CG5388 CG5388 CDMC20241 1 13 19 DAC31-A12 15-CG7466-RA_1 CG7466 GTGGTGGCTAGCATTTGCTCAATTAGTTCTTTAGCTCTCTACTGCGCACTCTTACGCACCGGTGTACCT 69 FBan0007466 FBgn0031981 CG7466 2 2L cell adhesion; GO:0007155; cell communication; GO:0007154; cell-cell adhesion; GO:0016337; defense response; GO:0006952; development; GO:0007275; ectoderm development; GO:0007398; nervous system development; GO:0007399; signal transduction; GO:0007165 receptor binding; GO:0005102; structural molecule activity; GO:0005198; receptor activity; GO:0004872; calcium ion binding; GO:0005509; ; GO:0005102; ; GO:0005198; ; GO:0004872; ; GO:0005509 membrane; GO:0016020 CG7466 CG7466 CDMC20241 1 14 19 DAC31-A12 15-CG7466-RA_1 CG7466 GTGGTGGCTAGCATTTGCTCAATTAGTTCTTTAGCTCTCTACTGCGCACTCTTACGCACCGGTGTACCT 69 FBan0007466 FBgn0031981 CG7466 2 2L cell adhesion; GO:0007155; cell communication; GO:0007154; cell-cell adhesion; GO:0016337; defense response; GO:0006952; development; GO:0007275; ectoderm development; GO:0007398; nervous system development; GO:0007399; signal transduction; GO:0007165 receptor binding; GO:0005102; structural molecule activity; GO:0005198; receptor activity; GO:0004872; calcium ion binding; GO:0005509; ; GO:0005102; ; GO:0005198; ; GO:0004872; ; GO:0005509 membrane; GO:0016020 CG7466 CG7466 CDMC20242 1 15 19 DAC31-A24 8-CG7485-RA_1 CG7485 TGGTCGTGTATGCGTTCAGCGGAGATCTCAGTCTATGTACAGTTGGACCCCCAGTTGATGAACTTCCGA 69 FBan0007485 FBgn0004514 TyrR 3 3L muscle contraction; GO:0006936; nerve-nerve synaptic transmission; GO:0007270; octopamine/tyramine signaling pathway; GO:0007211; sensory perception of smell; GO:0007608 amine receptor activity; GO:0008227; octopamine receptor activity; GO:0004989; tyramine receptor activity; GO:0008226; G-protein coupled receptor activity; GO:0004930; ; GO:0004930; ; GO:0008227; ; GO:0004989; ; GO:0008226; ; GO:0008227 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 TyrR Tyramine receptor "CG7485, l(3)neo30, Tyr-dro: Tyramine-receptor, Tyramine receptor, OA-R, OctoR1, Octopamine receptor 1, OctyR99AB, TYR, honoka, Ocr: Octopamine receptor, hono, Dmoct/tyr, OcR, DmTyrR, TyR: Tyramine-receptor, Octopamine receptor, Tyramine-receptor, Ocr, Tyr-dro" CDMC20242 1 16 19 DAC31-A24 8-CG7485-RA_1 CG7485 TGGTCGTGTATGCGTTCAGCGGAGATCTCAGTCTATGTACAGTTGGACCCCCAGTTGATGAACTTCCGA 69 FBan0007485 FBgn0004514 TyrR 3 3L muscle contraction; GO:0006936; nerve-nerve synaptic transmission; GO:0007270; octopamine/tyramine signaling pathway; GO:0007211; sensory perception of smell; GO:0007608 amine receptor activity; GO:0008227; octopamine receptor activity; GO:0004989; tyramine receptor activity; GO:0008226; G-protein coupled receptor activity; GO:0004930; ; GO:0004930; ; GO:0008227; ; GO:0004989; ; GO:0008226; ; GO:0008227 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 TyrR Tyramine receptor "CG7485, l(3)neo30, Tyr-dro: Tyramine-receptor, Tyramine receptor, OA-R, OctoR1, Octopamine receptor 1, OctyR99AB, TYR, honoka, Ocr: Octopamine receptor, hono, Dmoct/tyr, OcR, DmTyrR, TyR: Tyramine-receptor, Octopamine receptor, Tyramine-receptor, Ocr, Tyr-dro" CDMC20243 1 17 19 DAC31-E12 23-CG7525-RA_6 CG7525 GTTGAGACAACAAAATACGTTCTAGGCCTTACGATTAATGAATGGCGCTACCTATGCTTAGTTTAAAGT 69 FBan0007525 FBgn0014073 Tie 3 3L JAK-STAT cascade; GO:0007259; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004715 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112 Tie Tie-like receptor tyrosine kinase "CG7525, CG7525, DPR1, tie, tyrosine kinase, RTK" CDMC20243 1 18 19 DAC31-E12 23-CG7525-RA_6 CG7525 GTTGAGACAACAAAATACGTTCTAGGCCTTACGATTAATGAATGGCGCTACCTATGCTTAGTTTAAAGT 69 FBan0007525 FBgn0014073 Tie 3 3L JAK-STAT cascade; GO:0007259; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004715 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112 Tie Tie-like receptor tyrosine kinase "CG7525, CG7525, DPR1, tie, tyrosine kinase, RTK" CDMC20244 1 19 19 DAC31-E24 23-CG7533-RC_6 CG7533 AACCCCCGGATGGAAGTATAGAGTATTATCCCAATTTGTATGTATGGATGTGTGTACACCATCACCTTG 69 FBan0007533 FBgn0036165 chrb 3 3L negative regulation of growth; GO:0045926 chrb charybde "CG7533, clone 2.51, EP(3)1035, charybdis, char, BcDNA:GH09771, anon-EST:Liang-2.51, charybde" CDMC20244 1 20 19 DAC31-E24 23-CG7533-RC_6 CG7533 AACCCCCGGATGGAAGTATAGAGTATTATCCCAATTTGTATGTATGGATGTGTGTACACCATCACCTTG 69 FBan0007533 FBgn0036165 chrb 3 3L negative regulation of growth; GO:0045926 chrb charybde "CG7533, clone 2.51, EP(3)1035, charybdis, char, BcDNA:GH09771, anon-EST:Liang-2.51, charybde" CDMC20245 1 21 19 DAC31-I12 23-CG7571-RA_13 CG7571 TCCAAATCCCAGCACCATATTCTACATGAAGCCCATGGATTGCGATTTGAATCCTTGTAAATCTCAACG 69 FBan0007571 FBgn0036732 Oatp74D 3 3L anion transport; GO:0006820; organic anion transport; GO:0015711 organic anion transporter activity; GO:0008514; ; GO:0008514; sodium-independent organic anion transporter activity; GO:0015347; ; GO:0015347 membrane; GO:0016020 Oatp74D Organic anion transporting polypeptide 74D "CG7571, CG7571, oatp 74D, Organic anion transporting polypeptide 74D" CDMC20245 1 22 19 DAC31-I12 23-CG7571-RA_13 CG7571 TCCAAATCCCAGCACCATATTCTACATGAAGCCCATGGATTGCGATTTGAATCCTTGTAAATCTCAACG 69 FBan0007571 FBgn0036732 Oatp74D 3 3L anion transport; GO:0006820; organic anion transport; GO:0015711 organic anion transporter activity; GO:0008514; ; GO:0008514; sodium-independent organic anion transporter activity; GO:0015347; ; GO:0015347 membrane; GO:0016020 Oatp74D Organic anion transporting polypeptide 74D "CG7571, CG7571, oatp 74D, Organic anion transporting polypeptide 74D" CDMC20246 1 23 19 DAC31-I24 2-CG7579-RA_3 CG7579 GGCTTTCGATTGGCAGTTGGATCACATTTTTCTGCCCCTGGATCAGCACTCGTGGAATAGCCTTCCCAA 69 FBan0007579 FBgn0036528 CG7579 3 3L oligosaccharide biosynthesis; GO:0009312; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 polypeptide N-acetylgalactosaminyltransferase activity; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41 Golgi stack; GO:0005795 CG7579 CG7579 CDMC20246 1 24 19 DAC31-I24 2-CG7579-RA_3 CG7579 GGCTTTCGATTGGCAGTTGGATCACATTTTTCTGCCCCTGGATCAGCACTCGTGGAATAGCCTTCCCAA 69 FBan0007579 FBgn0036528 CG7579 3 3L oligosaccharide biosynthesis; GO:0009312; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 polypeptide N-acetylgalactosaminyltransferase activity; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41 Golgi stack; GO:0005795 CG7579 CG7579 CDMC20247 1 25 19 DAC31-M12 2-CG7611-RA_1 CG7611 ACGGGCAGCAAAGACTCCACTGTGATTATCTGGGATGTTGATCCGTACAAGCTGACCCTTAAGCACCGT 69 FBan0007611 FBgn0037094 CG7611 3 3L CG7611 CG7611 CDMC20247 1 26 19 DAC31-M12 2-CG7611-RA_1 CG7611 ACGGGCAGCAAAGACTCCACTGTGATTATCTGGGATGTTGATCCGTACAAGCTGACCCTTAAGCACCGT 69 FBan0007611 FBgn0037094 CG7611 3 3L CG7611 CG7611 CDMC20248 1 1 20 DAC31-M24 23-CG7622-RC_1 CG7622 TGTTATTCCGCGAAAATAAGTCTGAATTGTAGTGCAATCACTTGCGAAGTGTGTTAAATCAAGCGCTGA 69 FBan0007622 FBgn0002579 RpL36 X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL36 Ribosomal protein L36 "CG7622, CG7622, CG7622, M(1)Bld: Minute(1)Blond, M(1)1B: Minute(1)1B, l(1)G0471, EG:115C2.7, L36a, BcDNA:AT29875, Vi: Viability, anon-EST:Posey274, l(1)1Bj, Minute(1)1B, Minute(1)Blond, Viability, M(1)1B, M(1)Bld" CDMC20248 1 2 20 DAC31-M24 23-CG7622-RC_1 CG7622 TGTTATTCCGCGAAAATAAGTCTGAATTGTAGTGCAATCACTTGCGAAGTGTGTTAAATCAAGCGCTGA 69 FBan0007622 FBgn0002579 RpL36 X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL36 Ribosomal protein L36 "CG7622, CG7622, CG7622, M(1)Bld: Minute(1)Blond, M(1)1B: Minute(1)1B, l(1)G0471, EG:115C2.7, L36a, BcDNA:AT29875, Vi: Viability, anon-EST:Posey274, l(1)1Bj, Minute(1)1B, Minute(1)Blond, Viability, M(1)1B, M(1)Bld" CDMC20249 1 3 20 DAC32-A12 2-CG14744-RA_4 CG14744 TCTTGGGAAGAGCAGGATGACATTGGGATTAAGGACACCACAAAGTACCGTCGGTCCAGAGACACGGG 68 FBan0014744 FBgn0033324 CG14744 2 2R integral to membrane; GO:0016021 CG14744 CG14744 CDMC20249 1 4 20 DAC32-A12 2-CG14744-RA_4 CG14744 TCTTGGGAAGAGCAGGATGACATTGGGATTAAGGACACCACAAAGTACCGTCGGTCCAGAGACACGGG 68 FBan0014744 FBgn0033324 CG14744 2 2R integral to membrane; GO:0016021 CG14744 CG14744 CDMC20250 1 5 20 DAC32-A24 14-CG14856-RA_1 CG14856 AGTGTGGGCTTGAACTTGACAATGTGTGTTTTTTACGGCCTGGGAATGATATGTGCATCTTGGCAGGG 68 FBan0014856 FBgn0038261 CG14856 3 3R cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 integral to membrane; GO:0016021 CG14856 CG14856 CDMC20250 1 6 20 DAC32-A24 14-CG14856-RA_1 CG14856 AGTGTGGGCTTGAACTTGACAATGTGTGTTTTTTACGGCCTGGGAATGATATGTGCATCTTGGCAGGG 68 FBan0014856 FBgn0038261 CG14856 3 3R cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 integral to membrane; GO:0016021 CG14856 CG14856 CDMC20251 1 7 20 DAC32-E12 23-CG15312-RB_1 CG15312 ACATAGATATAGAAATGAGAGAGAGCTTATCGATCGATCGAATGTTTCGTTTTCATTTCGGTTTCCTG 68 FBan0015312 FBgn0030174 CG15312 X X CG15312 CG15312 CT35293 CDMC20251 1 8 20 DAC32-E12 23-CG15312-RB_1 CG15312 ACATAGATATAGAAATGAGAGAGAGCTTATCGATCGATCGAATGTTTCGTTTTCATTTCGGTTTCCTG 68 FBan0015312 FBgn0030174 CG15312 X X CG15312 CG15312 CT35293 CDMC20252 1 9 20 DAC32-E24 1-CG15357-RA_1 CG15357 CCCAGGGCTGGACACTCTACCTCATCGCCGCCTGCTTCGCATTACTCCTGCTCATGATCATCTATATG 68 FBan0015357 FBgn0040719 CG15357 2 2L CG15357 CG15357 CDMC20252 1 10 20 DAC32-E24 1-CG15357-RA_1 CG15357 CCCAGGGCTGGACACTCTACCTCATCGCCGCCTGCTTCGCATTACTCCTGCTCATGATCATCTATATG 68 FBan0015357 FBgn0040719 CG15357 2 2L CG15357 CG15357 CDMC20253 1 11 20 DAC32-I12 24-CG1577-RA_3 CG1577 TCAGCTGTTTGGTTATGTGAACTACGTTTTTTCACAACTACTTTTTAGTTTTCGATAAATAATGCTGA 68 FBan0001577 FBgn0033208 mRpL52 2 2R structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL52 mitochondrial ribosomal protein L52 "CG1577, MRP-L52, BcDNA:RH01479, mitochondrial ribosomal protein L52" CDMC20253 1 12 20 DAC32-I12 24-CG1577-RA_3 CG1577 TCAGCTGTTTGGTTATGTGAACTACGTTTTTTCACAACTACTTTTTAGTTTTCGATAAATAATGCTGA 68 FBan0001577 FBgn0033208 mRpL52 2 2R structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL52 mitochondrial ribosomal protein L52 "CG1577, MRP-L52, BcDNA:RH01479, mitochondrial ribosomal protein L52" CDMC20254 1 13 20 DAC32-I24 14-CG1663-RA_1 CG1663 CCGGCAATTTCGAGAGAATAGCACCTTGAAGAGTCACATCCGGAAAATTCACGACGGTAACAGTGCGC 68 FBan0001663 FBgn0033449 CG1663 2 2R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG1663 CG1663 CDMC20254 1 14 20 DAC32-I24 14-CG1663-RA_1 CG1663 CCGGCAATTTCGAGAGAATAGCACCTTGAAGAGTCACATCCGGAAAATTCACGACGGTAACAGTGCGC 68 FBan0001663 FBgn0033449 CG1663 2 2R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG1663 CG1663 CDMC20255 1 15 20 DAC32-M12 2-CG17075-RA_1 CG17075 GCCACGTCATCTGAGACCAGCGACTTATCTGCAGTACACCGAGCAATGTACTCTCTGCACATTCCGCC 68 FBan0017075 FBgn0031239 CG17075 2 2L metal ion binding; GO:0046872; ; GO:0046872 CG17075 CG17075 CDMC20255 1 16 20 DAC32-M12 2-CG17075-RA_1 CG17075 GCCACGTCATCTGAGACCAGCGACTTATCTGCAGTACACCGAGCAATGTACTCTCTGCACATTCCGCC 68 FBan0017075 FBgn0031239 CG17075 2 2L metal ion binding; GO:0046872; ; GO:0046872 CG17075 CG17075 CDMC20256 1 17 20 DAC32-M24 1-CG17237-RA_1 CG17237 ACCGATCCAATGATGTCCAGGAAAGGCAATCAACTCCACCCGTCATCAATCCGTCCATCATCGACCAC 68 FBan0017237 FBgn0031410 CG17237 2 2L "ATPase activity, coupled; GO:0042623; calcium ion binding; GO:0005509; ; GO:0042623; ; GO:0005509" myosin; GO:0016459 CG17237 CG17237 "DmAAF51272, BcDNA:AT15471" CDMC20256 1 18 20 DAC32-M24 1-CG17237-RA_1 CG17237 ACCGATCCAATGATGTCCAGGAAAGGCAATCAACTCCACCCGTCATCAATCCGTCCATCATCGACCAC 68 FBan0017237 FBgn0031410 CG17237 2 2L "ATPase activity, coupled; GO:0042623; calcium ion binding; GO:0005509; ; GO:0042623; ; GO:0005509" myosin; GO:0016459 CG17237 CG17237 "DmAAF51272, BcDNA:AT15471" CDMC20257 1 19 20 DAC33-A12 11-CG31439-RA_1 CG31439 CGGTCTGTCGTCCTCTAGTTCTGAGGCTCAGCTTAAGGTTTCGTGCTTGGGCAAACCTGACGGATT 66 FBan0031439 FBgn0051439 CG31439 3 3R chitin metabolism; GO:0006030 chitin binding; GO:0008061; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0008061 extracellular region; GO:0005576 CG31439 CG31439 CDMC20257 1 20 20 DAC33-A12 11-CG31439-RA_1 CG31439 CGGTCTGTCGTCCTCTAGTTCTGAGGCTCAGCTTAAGGTTTCGTGCTTGGGCAAACCTGACGGATT 66 FBan0031439 FBgn0051439 CG31439 3 3R chitin metabolism; GO:0006030 chitin binding; GO:0008061; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0008061 extracellular region; GO:0005576 CG31439 CG31439 CDMC20258 1 21 20 DAC33-A24 3-CG3158-RA_6 CG3158 TCACCACGATCATTTGATAGTGGCCCACGAAATCGCGGAGAGTAGAAACGGGCAGACACTGACAGC 66 FBan0003158 FBgn0003483 spn-E 3 3R "RNA interference; GO:0016246; RNA interference, targeting of mRNA for destruction; GO:0030423; RNA localization; GO:0006403; chromatin silencing; GO:0006342; intracellular mRNA localization; GO:0008298; karyosome formation; GO:0030717; nuclear mRNA splicing, via spliceosome; GO:0000398; oocyte differentiation; GO:0009994; oocyte fate determination (sensu Insecta); GO:0007294; oocyte localization during oogenesis; GO:0030720; oocyte maturation; GO:0001556; oogenesis (sensu Insecta); GO:0009993; polarity specification of anterior/posterior axis; GO:0009949; polarity specification of dorsal/ventral axis; GO:0009951; pole plasm assembly; GO:0007315; pole plasm oskar mRNA localization; GO:0045451; regulation of pole plasm oskar mRNA localization; GO:0007317" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; helicase activity; GO:0004386; ; GO:0003676; ; GO:0003724 ; EC:2.7.7.-; zinc ion binding; GO:0008270; ; GO:0004386; ATP-dependent RNA helicase activity; GO:0004004; RNA-dependent ATPase activity; GO:0008186; ; GO:0004004; ; GO:0008186; ; GO:0008270 cytoplasm; GO:0005737; nucleus; GO:0005634 spn-E spindle E "CG3158 (homeless), fs(1)hls, hls: homeless, homeless, spn-E/hls, spnE, spn E, Homeless, Spindle E, spindle-E, Spn-E, Spindle-E (homeless), fs(1)hls (homeless), fs(3)hls (homeless), hls (homeless), female sterile(3)homeless (homeless), homeless (homeless), hls, Spindle-E" CDMC20258 1 22 20 DAC33-A24 3-CG3158-RA_6 CG3158 TCACCACGATCATTTGATAGTGGCCCACGAAATCGCGGAGAGTAGAAACGGGCAGACACTGACAGC 66 FBan0003158 FBgn0003483 spn-E 3 3R "RNA interference; GO:0016246; RNA interference, targeting of mRNA for destruction; GO:0030423; RNA localization; GO:0006403; chromatin silencing; GO:0006342; intracellular mRNA localization; GO:0008298; karyosome formation; GO:0030717; nuclear mRNA splicing, via spliceosome; GO:0000398; oocyte differentiation; GO:0009994; oocyte fate determination (sensu Insecta); GO:0007294; oocyte localization during oogenesis; GO:0030720; oocyte maturation; GO:0001556; oogenesis (sensu Insecta); GO:0009993; polarity specification of anterior/posterior axis; GO:0009949; polarity specification of dorsal/ventral axis; GO:0009951; pole plasm assembly; GO:0007315; pole plasm oskar mRNA localization; GO:0045451; regulation of pole plasm oskar mRNA localization; GO:0007317" nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; RNA helicase activity; GO:0003724 ; EC:2.7.7.-; helicase activity; GO:0004386; ; GO:0003676; ; GO:0003724 ; EC:2.7.7.-; zinc ion binding; GO:0008270; ; GO:0004386; ATP-dependent RNA helicase activity; GO:0004004; RNA-dependent ATPase activity; GO:0008186; ; GO:0004004; ; GO:0008186; ; GO:0008270 cytoplasm; GO:0005737; nucleus; GO:0005634 spn-E spindle E "CG3158 (homeless), fs(1)hls, hls: homeless, homeless, spn-E/hls, spnE, spn E, Homeless, Spindle E, spindle-E, Spn-E, Spindle-E (homeless), fs(1)hls (homeless), fs(3)hls (homeless), hls (homeless), female sterile(3)homeless (homeless), homeless (homeless), hls, Spindle-E" CDMC20259 1 23 20 DAC33-E12 3-CG32158-RA_2 CG32158 GCGACTCGGTGTGCATTCTGTTCGCCAGCATACCTAACTTCTCCGAGTTCTACGTGGAACTGGAGG 66 FBan0032158 FBgn0052158 CG32158 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cyclic nucleotide biosynthesis; GO:0009190; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2 integral to membrane; GO:0016021 CG32158 CG32158 "CG12243, CG4526, AC, anon-WO0257455.11, anon-WO0118547.377" CDMC20259 1 24 20 DAC33-E12 3-CG32158-RA_2 CG32158 GCGACTCGGTGTGCATTCTGTTCGCCAGCATACCTAACTTCTCCGAGTTCTACGTGGAACTGGAGG 66 FBan0032158 FBgn0052158 CG32158 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; cyclic nucleotide biosynthesis; GO:0009190; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2 integral to membrane; GO:0016021 CG32158 CG32158 "CG12243, CG4526, AC, anon-WO0257455.11, anon-WO0118547.377" CDMC20260 1 25 20 DAC33-E24 2-CG32238-RA_1 CG32238 GGTCGCACGTCGGTCGGTGCAAATCAATCCGTGACGAATGGCAACTCAAATAGTGGCGCAAATAGC 66 FBan0032238 FBgn0052238 CG32238 3 3L C-terminal protein-tyrosinylation; GO:0018166; protein metabolism; GO:0019538 structural constituent of cytoskeleton; GO:0005200; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0005200; ; GO:0016874 ; EC:6.-.-.-; tubulin-tyrosine ligase activity; GO:0004835 ; EC:6.3.2.25; ; GO:0004835 ; EC:6.3.2.25; ; GO:0004835 ; EC:6.3.2.25; ; GO:0004835 ; EC:6.3.2.25 CG32238 CG32238 "CG7474, CG7474, CG7474" CDMC20260 1 26 20 DAC33-E24 2-CG32238-RA_1 CG32238 GGTCGCACGTCGGTCGGTGCAAATCAATCCGTGACGAATGGCAACTCAAATAGTGGCGCAAATAGC 66 FBan0032238 FBgn0052238 CG32238 3 3L C-terminal protein-tyrosinylation; GO:0018166; protein metabolism; GO:0019538 structural constituent of cytoskeleton; GO:0005200; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0005200; ; GO:0016874 ; EC:6.-.-.-; tubulin-tyrosine ligase activity; GO:0004835 ; EC:6.3.2.25; ; GO:0004835 ; EC:6.3.2.25; ; GO:0004835 ; EC:6.3.2.25; ; GO:0004835 ; EC:6.3.2.25 CG32238 CG32238 "CG7474, CG7474, CG7474" CDMC20261 1 1 21 DAC33-I12 2-CG32663-RA_1 CG32663 TGAGCAGAGTCCCAAGTTGATGGATCGCTTCCGACATGGTCACTTGGATTCGGATTATGGCCACGG 66 FBan0032663 FBgn0052663 CG32663 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32663 CG32663 "CG1905, CG1905, CG1905" CDMC20261 1 2 21 DAC33-I12 2-CG32663-RA_1 CG32663 TGAGCAGAGTCCCAAGTTGATGGATCGCTTCCGACATGGTCACTTGGATTCGGATTATGGCCACGG 66 FBan0032663 FBgn0052663 CG32663 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32663 CG32663 "CG1905, CG1905, CG1905" CDMC20262 1 3 21 DAC33-I24 23-CG32796-RA_6 CG32796 TGTGACTAATACACAAAACCCAAGAGAGAAGCATCCTAAACTCGATTTAAGCTCATAGGCGGCAGT 66 FBan0032796 FBgn0040388 CG32796 X X cell adhesion; GO:0007155; defense response; GO:0006952; ectoderm development; GO:0007398; nervous system development; GO:0007399 transmembrane receptor activity; GO:0004888; ; GO:0004888 CG32796 CG32796 "CG13756, CG7894, CG13756, CG7894, CT23737, CT33235, EG:BACH59J11.2" CDMC20262 1 4 21 DAC33-I24 23-CG32796-RA_6 CG32796 TGTGACTAATACACAAAACCCAAGAGAGAAGCATCCTAAACTCGATTTAAGCTCATAGGCGGCAGT 66 FBan0032796 FBgn0040388 CG32796 X X cell adhesion; GO:0007155; defense response; GO:0006952; ectoderm development; GO:0007398; nervous system development; GO:0007399 transmembrane receptor activity; GO:0004888; ; GO:0004888 CG32796 CG32796 "CG13756, CG7894, CG13756, CG7894, CT23737, CT33235, EG:BACH59J11.2" CDMC20263 1 5 21 DAC33-M12 18-CG33281-RA_8 CG33281 CTGAGGGCAAGACTCGAAAGGCATTCCTAATCGGACTCGGACTGATAAGCTTCAATCAGCTGTGCG 66 FBan0033281 FBgn0053281 CG33281 2 2L monosaccharide transport; GO:0015749; transport; GO:0006810 monosaccharide transporter activity; GO:0015145; ; GO:0015145 integral to membrane; GO:0016021; membrane; GO:0016020 CG33281 CG33281 "CG15407, CG15407" CDMC20263 1 6 21 DAC33-M12 18-CG33281-RA_8 CG33281 CTGAGGGCAAGACTCGAAAGGCATTCCTAATCGGACTCGGACTGATAAGCTTCAATCAGCTGTGCG 66 FBan0033281 FBgn0053281 CG33281 2 2L monosaccharide transport; GO:0015749; transport; GO:0006810 monosaccharide transporter activity; GO:0015145; ; GO:0015145 integral to membrane; GO:0016021; membrane; GO:0016020 CG33281 CG33281 "CG15407, CG15407" CDMC20264 1 7 21 DAC33-M24 2-CG3429-RA_1 CG3429 ACTCGATGTCGATGTCGCATTTGGAGGCGCATGACCACTTTAGGAGTAAAAGGACGACACTGGGCA 66 FBan0003429 FBgn0003655 swa X X bicoid mRNA localization; GO:0045450; intracellular mRNA localization; GO:0008298; pole plasm mRNA localization; GO:0019094 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; dynein binding; GO:0045502; ; GO:0045502 swa swallow "CG3429, fs(1)1502, fs(1)1497, fs(1)m44, fs(1)M44, sww: swallow, anon-WO0140519.70, fs(1)M11-999, fs(1)M13C82, swallow, sww" CDMC20264 1 8 21 DAC33-M24 2-CG3429-RA_1 CG3429 ACTCGATGTCGATGTCGCATTTGGAGGCGCATGACCACTTTAGGAGTAAAAGGACGACACTGGGCA 66 FBan0003429 FBgn0003655 swa X X bicoid mRNA localization; GO:0045450; intracellular mRNA localization; GO:0008298; pole plasm mRNA localization; GO:0019094 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; dynein binding; GO:0045502; ; GO:0045502 swa swallow "CG3429, fs(1)1502, fs(1)1497, fs(1)m44, fs(1)M44, sww: swallow, anon-WO0140519.70, fs(1)M11-999, fs(1)M13C82, swallow, sww" CDMC20265 1 9 21 DAC34-A12 2-CG13437-RA_3 CG13437 GAGCGTACGATCGAGCGGACATATCCCACGGATGCGGTGATAAATCCTGCCTATATGCACGACGAGGAC 69 FBan0013437 FBgn0034541 CG13437 2 2R CG13437 CG13437 CDMC20265 1 10 21 DAC34-A12 2-CG13437-RA_3 CG13437 GAGCGTACGATCGAGCGGACATATCCCACGGATGCGGTGATAAATCCTGCCTATATGCACGACGAGGAC 69 FBan0013437 FBgn0034541 CG13437 2 2R CG13437 CG13437 CDMC20266 1 11 21 DAC34-A24 1-CG1344-RA_1 CG1344 ATGAGCTGTGTGCCGATCAGGGTTGGGGTCATGATGAACAGGATGATAAGGACGATATTGTCTGGGGCG 69 FBan0001344 FBgn0027507 CG1344 2 2R protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 CG1344 CG1344 BcDNA:LD22679 CDMC20266 1 12 21 DAC34-A24 1-CG1344-RA_1 CG1344 ATGAGCTGTGTGCCGATCAGGGTTGGGGTCATGATGAACAGGATGATAAGGACGATATTGTCTGGGGCG 69 FBan0001344 FBgn0027507 CG1344 2 2R protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 CG1344 CG1344 BcDNA:LD22679 CDMC20267 1 13 21 DAC34-E12 3-CG13493-RA_1 CG13493 CCCACGAAACGCCAAGCTAAACCCGTACATTCCAGTTCCAGCGAATGCGAAGATTTCAAGCCAGACGAA 69 FBan0013493 FBgn0034667 comr 2 2R positive regulation of transcription from RNA polymerase II promoter; GO:0045944; spermatogenesis; GO:0007283 transcriptional activator activity; GO:0016563; ; GO:0016563 chromatin; GO:0000785; nucleus; GO:0005634 comr cookie monster "CG13493, CG13493, CG13493, zab, zuker-aly-like b, Z2-1340, cookie monster" CDMC20267 1 14 21 DAC34-E12 3-CG13493-RA_1 CG13493 CCCACGAAACGCCAAGCTAAACCCGTACATTCCAGTTCCAGCGAATGCGAAGATTTCAAGCCAGACGAA 69 FBan0013493 FBgn0034667 comr 2 2R positive regulation of transcription from RNA polymerase II promoter; GO:0045944; spermatogenesis; GO:0007283 transcriptional activator activity; GO:0016563; ; GO:0016563 chromatin; GO:0000785; nucleus; GO:0005634 comr cookie monster "CG13493, CG13493, CG13493, zab, zuker-aly-like b, Z2-1340, cookie monster" CDMC20268 1 15 21 DAC34-E24 23-CG13503-RA_8 CG13503 GAGTGAAGTACTGGATAGACAAGACGGTGTACTCCTTTAAGAAGATACTCCATATAAATCGCCAAGGGA 69 FBan0013503 FBgn0034695 CG13503 2 2R actin filament organization; GO:0007015; regulation of cell shape; GO:0008360 CG13503 CG13503 Vrp1 CDMC20268 1 16 21 DAC34-E24 23-CG13503-RA_8 CG13503 GAGTGAAGTACTGGATAGACAAGACGGTGTACTCCTTTAAGAAGATACTCCATATAAATCGCCAAGGGA 69 FBan0013503 FBgn0034695 CG13503 2 2R actin filament organization; GO:0007015; regulation of cell shape; GO:0008360 CG13503 CG13503 Vrp1 CDMC20269 1 17 21 DAC34-I12 1-CG13565-RA_1 CG13565 AGCTTCAGCATCCTCAACCAGCTCGTCTAGTGATACCTTCGACAGCGCGTGAATGTAAATGCCCATGGA 69 FBan0013565 FBgn0034935 CG13565 2 2R CG13565 CG13565 BcDNA:RH09340 CDMC20269 1 18 21 DAC34-I12 1-CG13565-RA_1 CG13565 AGCTTCAGCATCCTCAACCAGCTCGTCTAGTGATACCTTCGACAGCGCGTGAATGTAAATGCCCATGGA 69 FBan0013565 FBgn0034935 CG13565 2 2R CG13565 CG13565 BcDNA:RH09340 CDMC20270 1 19 21 DAC34-I24 2-CG13577-RA_2 CG13577 TGGCCCATCTAAGCGGTCTAAATAGCAAGACTAAGCACACGAGGCTGATGAGTACTTCCAAGCGCTGCA 69 FBan0013577 FBgn0034998 CG13577 2 2R CG13577 CG13577 CDMC20270 1 20 21 DAC34-I24 2-CG13577-RA_2 CG13577 TGGCCCATCTAAGCGGTCTAAATAGCAAGACTAAGCACACGAGGCTGATGAGTACTTCCAAGCGCTGCA 69 FBan0013577 FBgn0034998 CG13577 2 2R CG13577 CG13577 CDMC20271 1 21 21 DAC34-M12 24-CG13607-RA_1 CG13607 CGTTTCTTTAGCGAGAGAGATTACACAGACTGATCAATAATGGAATATATAGAAATCTATATAGCATAT 69 FBan0013607 FBgn0039151 CG13607 3 3R CG13607 CG13607 CDMC20271 1 22 21 DAC34-M12 24-CG13607-RA_1 CG13607 CGTTTCTTTAGCGAGAGAGATTACACAGACTGATCAATAATGGAATATATAGAAATCTATATAGCATAT 69 FBan0013607 FBgn0039151 CG13607 3 3R CG13607 CG13607 CDMC20272 1 23 21 DAC34-M24 3-CG13618-RA_1 CG13618 TTGGCTGTGGCTCTTGGTCAATCGATTTCGTACATCCGATCCGATTTCGTACATCCCCCCGGACGAAAT 69 FBan0013618 FBgn0039203 CG13618 3 3R CG13618 CG13618 CDMC20272 1 24 21 DAC34-M24 3-CG13618-RA_1 CG13618 TTGGCTGTGGCTCTTGGTCAATCGATTTCGTACATCCGATCCGATTTCGTACATCCCCCCGGACGAAAT 69 FBan0013618 FBgn0039203 CG13618 3 3R CG13618 CG13618 CDMC20273 1 25 21 DAC35-A12 2-CG17446-RA_1 CG17446 TCCGAAGGTGAACGATACGGATGTGTGTGGTTCGCCCTTAGTGAACAACGTCTTCAATCCCACGGG 66 FBan0017446 FBgn0030121 CG17446 X X "DNA metabolism; GO:0006259; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 CG17446 CG17446 CDMC20273 1 26 21 DAC35-A12 2-CG17446-RA_1 CG17446 TCCGAAGGTGAACGATACGGATGTGTGTGGTTCGCCCTTAGTGAACAACGTCTTCAATCCCACGGG 66 FBan0017446 FBgn0030121 CG17446 X X "DNA metabolism; GO:0006259; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 CG17446 CG17446 CDMC20274 1 1 22 DAC35-A24 1-CG17807-RA_1 CG17807 GGACTACTTGCTGTAGGTCGTCGGAAGGGACAAAACGTGTTTCGATGCGACTGTCTTGTGGTGCCC 66 FBan0017807 FBgn0034748 CG17807 2 2R CG17807 CG17807 CDMC20274 1 2 22 DAC35-A24 1-CG17807-RA_1 CG17807 GGACTACTTGCTGTAGGTCGTCGGAAGGGACAAAACGTGTTTCGATGCGACTGTCTTGTGGTGCCC 66 FBan0017807 FBgn0034748 CG17807 2 2R CG17807 CG17807 CDMC20275 1 3 22 DAC35-E12 17-CG18549-RA_4 CG18549 GTGCAGCATGTTCATTGGGAATCTGTTCGTGTACTATCAGTTCCAGGACAAGACCCGCATCGACAA 66 FBan0018549 FBgn0038053 CG18549 3 3R CG18549 CG18549 CDMC20275 1 4 22 DAC35-E12 17-CG18549-RA_4 CG18549 GTGCAGCATGTTCATTGGGAATCTGTTCGTGTACTATCAGTTCCAGGACAAGACCCGCATCGACAA 66 FBan0018549 FBgn0038053 CG18549 3 3R CG18549 CG18549 CDMC20276 1 5 22 DAC35-E24 3-CG2097-RA_4 CG2097 AGTGCCCCGATTTAAGGCCAGCATTGTCGGAATACGCGGAGAGCATGCAGGATGAACCAATGAATG 66 FBan0002097 FBgn0037371 CG2097 3 3R mRNA cleavage; GO:0006379 mRNA cleavage stimulating factor complex; GO:0005848; tight junction; GO:0005923 CG2097 CG2097 CDMC20276 1 6 22 DAC35-E24 3-CG2097-RA_4 CG2097 AGTGCCCCGATTTAAGGCCAGCATTGTCGGAATACGCGGAGAGCATGCAGGATGAACCAATGAATG 66 FBan0002097 FBgn0037371 CG2097 3 3R mRNA cleavage; GO:0006379 mRNA cleavage stimulating factor complex; GO:0005848; tight junction; GO:0005923 CG2097 CG2097 CDMC20277 1 7 22 DAC35-I12 2-CG2972-RA_1 CG2972 TCTCTCGGGGATCGATCTGAAAGTGATCTCGCTCACCTACGAACTGGAAGCAGACAACGTGGGCAC 66 FBan0002972 FBgn0030177 CG2972 X X CG2972 CG2972 CDMC20277 1 8 22 DAC35-I12 2-CG2972-RA_1 CG2972 TCTCTCGGGGATCGATCTGAAAGTGATCTCGCTCACCTACGAACTGGAAGCAGACAACGTGGGCAC 66 FBan0002972 FBgn0030177 CG2972 X X CG2972 CG2972 CDMC20278 1 9 22 DAC35-I24 3-CG30104-RA_3 CG30104 GGAGCACATAGATGGACCGTATCCAACGATGGTCAAGCAGAACAGTGGCAAGGAGGTTCCCGTTGT 66 FBan0030104 FBgn0050104 CG30104 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleotide catabolism; GO:0009166" nucleotide phosphatase activity; GO:0019204; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0019204; ; GO:0016791 ; EC:3.1.3.- CG30104 CG30104 "CG4837, CG4837, CG4837" CDMC20278 1 10 22 DAC35-I24 3-CG30104-RA_3 CG30104 GGAGCACATAGATGGACCGTATCCAACGATGGTCAAGCAGAACAGTGGCAAGGAGGTTCCCGTTGT 66 FBan0030104 FBgn0050104 CG30104 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleotide catabolism; GO:0009166" nucleotide phosphatase activity; GO:0019204; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; ; GO:0019204; ; GO:0016791 ; EC:3.1.3.- CG30104 CG30104 "CG4837, CG4837, CG4837" CDMC20279 1 11 22 DAC35-M12 2-CG31112-RA_2 CG31112 GGTTTTGGGAGCCGAACTTGCTCAGAACACGTGGTAGCGATAGGTAGCTCATGATCGAACCCAGCC 66 FBan0031112 FBgn0051112 CG31112 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31112 CG31112 CDMC20279 1 12 22 DAC35-M12 2-CG31112-RA_2 CG31112 GGTTTTGGGAGCCGAACTTGCTCAGAACACGTGGTAGCGATAGGTAGCTCATGATCGAACCCAGCC 66 FBan0031112 FBgn0051112 CG31112 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31112 CG31112 CDMC20280 1 13 22 DAC35-M24 12-CG31187-RA_1 CG31187 CCACGGACGAGGTAATCTCCGAACGTGAATGCTACGTGCTCCTCAACTTCATCGAAGCCGTCAGCT 66 FBan0031187 FBgn0051187 CG31187 3 3R intracellular signaling cascade; GO:0007242; lipid metabolism; GO:0006629; phosphorylation; GO:0016310; protein kinase C activation; GO:0007205 diacylglycerol binding; GO:0019992; diacylglycerol kinase activity; GO:0004143 ; EC:2.7.1.107; ; GO:0004143 ; EC:2.7.1.107; ; GO:0019992; ; GO:0004143 ; EC:2.7.1.107 CG31187 CG31187 "CG2667, CG9851, DGKd" CDMC20280 1 14 22 DAC35-M24 12-CG31187-RA_1 CG31187 CCACGGACGAGGTAATCTCCGAACGTGAATGCTACGTGCTCCTCAACTTCATCGAAGCCGTCAGCT 66 FBan0031187 FBgn0051187 CG31187 3 3R intracellular signaling cascade; GO:0007242; lipid metabolism; GO:0006629; phosphorylation; GO:0016310; protein kinase C activation; GO:0007205 diacylglycerol binding; GO:0019992; diacylglycerol kinase activity; GO:0004143 ; EC:2.7.1.107; ; GO:0004143 ; EC:2.7.1.107; ; GO:0019992; ; GO:0004143 ; EC:2.7.1.107 CG31187 CG31187 "CG2667, CG9851, DGKd" CDMC20281 1 15 22 DAC36-A12 1-CG17540-RB_1 CG17540 ACCAAGCAAGGTTGTTCTTCTACGCAACATGGTAGGACCCGGGGACGTTGACGAAGAATTGGAACCC 67 FBgn0040024 CG17540 "nuclear mRNA splicing, via spliceosome; GO:0000398" spliceosome complex; GO:0005681 CG17540 CG17540 CDMC20281 1 16 22 DAC36-A12 1-CG17540-RB_1 CG17540 ACCAAGCAAGGTTGTTCTTCTACGCAACATGGTAGGACCCGGGGACGTTGACGAAGAATTGGAACCC 67 FBgn0040024 CG17540 "nuclear mRNA splicing, via spliceosome; GO:0000398" spliceosome complex; GO:0005681 CG17540 CG17540 CDMC20282 1 17 22 DAC36-A24 1-CG17829-RA_1 CG17829 GCATTTAGTCCTACCTAGAACCTAGTGCGATTGGATGAGATAGCACCCGGGGACGCGATACCCTGCC 67 FBan0017829 FBgn0025635 CG17829 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG17829 CG17829 EG:115C2.6 CDMC20282 1 18 22 DAC36-A24 1-CG17829-RA_1 CG17829 GCATTTAGTCCTACCTAGAACCTAGTGCGATTGGATGAGATAGCACCCGGGGACGCGATACCCTGCC 67 FBan0017829 FBgn0025635 CG17829 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG17829 CG17829 EG:115C2.6 CDMC20283 1 19 22 DAC36-E12 2-CG18557-RA_7 CG18557 GGCACAGTAGAAGAGGTTGTCGATCAGGCGAAACCCAATGAGTTCCCTTGGACTGTGGCTCTGATGC 67 FBan0018557 FBgn0031470 CG18557 2 2L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG18557 CG18557 c-SPH125 CDMC20283 1 20 22 DAC36-E12 2-CG18557-RA_7 CG18557 GGCACAGTAGAAGAGGTTGTCGATCAGGCGAAACCCAATGAGTTCCCTTGGACTGTGGCTCTGATGC 67 FBan0018557 FBgn0031470 CG18557 2 2L proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG18557 CG18557 c-SPH125 CDMC20284 1 21 22 DAC36-E24 3-CG18678-RA_1 CG18678 GGCTTCTCCCTGACCTACGGAGCTCTGATGCTGAAGACCTGGCGGATATCGGTGATTTTCCGAGTTC 67 FBan0018678 FBgn0040664 CG18678 2 2R CG18678 CG18678 CDMC20284 1 22 22 DAC36-E24 3-CG18678-RA_1 CG18678 GGCTTCTCCCTGACCTACGGAGCTCTGATGCTGAAGACCTGGCGGATATCGGTGATTTTCCGAGTTC 67 FBan0018678 FBgn0040664 CG18678 2 2R CG18678 CG18678 CDMC20285 1 23 22 DAC36-I12 2-CG2750-RA_5 CG2750 CGCTTGGAGGACATTAGCATGCCCTCTGGAGTCTCAAATCGAACCCAGGACAGTGAATGCGTTGAGG 67 FBan0002750 FBgn0030376 CG2750 X X cell cycle; GO:0007049; cell proliferation; GO:0008283; regulation of progression through cell cycle; GO:0000074 CG2750 CG2750 anon-WO0140519.124 CDMC20285 1 24 22 DAC36-I12 2-CG2750-RA_5 CG2750 CGCTTGGAGGACATTAGCATGCCCTCTGGAGTCTCAAATCGAACCCAGGACAGTGAATGCGTTGAGG 67 FBan0002750 FBgn0030376 CG2750 X X cell cycle; GO:0007049; cell proliferation; GO:0008283; regulation of progression through cell cycle; GO:0000074 CG2750 CG2750 anon-WO0140519.124 CDMC20286 1 25 22 DAC36-I24 23-CG2932-RA_1 CG2932 GCGCTGCTAAATATAGTCAGTGTTGGGGAATTCGATAGCACCTATGTGGATACTAGCTTTTCCGGTG 67 FBan0002932 FBgn0025679 Bteb2 X X regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003676; ; GO:0003702; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 Bteb2 Bteb2 CG2932 CDMC20286 1 26 22 DAC36-I24 23-CG2932-RA_1 CG2932 GCGCTGCTAAATATAGTCAGTGTTGGGGAATTCGATAGCACCTATGTGGATACTAGCTTTTCCGGTG 67 FBan0002932 FBgn0025679 Bteb2 X X regulation of transcription from RNA polymerase II promoter; GO:0006357 nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003676; ; GO:0003702; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 Bteb2 Bteb2 CG2932 CDMC20287 1 1 23 DAC36-M12 11-CG30359-RA_1 CG30359 ATGCAGTGCCCCATGTGTTCGAAATAGCGCCGGATAATCAGAATCAGTACCGTGATGAGCCGCGAAA 67 FBan0030359 FBgn0050359 CG30359 2 2R carbohydrate metabolism; GO:0005975 transporter activity; GO:0005215; hydrolase activity; GO:0016787 ; EC:3.-.-.-; glucosidase activity; GO:0015926 ; EC:3.2.1.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0005215; ; GO:0015926 ; EC:3.2.1.-; alpha-amylase activity; GO:0004556 ; EC:3.2.1.1; ; GO:0004556 ; EC:3.2.1.1 CG30359 CG30359 "CG8689, CG8689, CG8689, CG8689, CG8689" CDMC20287 1 2 23 DAC36-M12 11-CG30359-RA_1 CG30359 ATGCAGTGCCCCATGTGTTCGAAATAGCGCCGGATAATCAGAATCAGTACCGTGATGAGCCGCGAAA 67 FBan0030359 FBgn0050359 CG30359 2 2R carbohydrate metabolism; GO:0005975 transporter activity; GO:0005215; hydrolase activity; GO:0016787 ; EC:3.-.-.-; glucosidase activity; GO:0015926 ; EC:3.2.1.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0005215; ; GO:0015926 ; EC:3.2.1.-; alpha-amylase activity; GO:0004556 ; EC:3.2.1.1; ; GO:0004556 ; EC:3.2.1.1 CG30359 CG30359 "CG8689, CG8689, CG8689, CG8689, CG8689" CDMC20288 1 3 23 DAC36-M24 3-CG3040-RA_1 CG3040 GGCAAGCTGACGCTACTCAAGCACCTCAATCTAAGCGGAAATCGACTGGTGGAACTCAACGAGGTGG 67 FBan0003040 FBgn0029925 CG3040 X X CG3040 CG3040 CT9706 CDMC20288 1 4 23 DAC36-M24 3-CG3040-RA_1 CG3040 GGCAAGCTGACGCTACTCAAGCACCTCAATCTAAGCGGAAATCGACTGGTGGAACTCAACGAGGTGG 67 FBan0003040 FBgn0029925 CG3040 X X CG3040 CG3040 CT9706 CDMC20289 1 5 23 DAC37-A12 6-CG7567-RA_2 CG7567 CTCGGGATCCTGGCACTTCGGTACGCTGCTTCGACTACTACATACCCATCATCAACGGGCTGTCG 65 FBan0007567 FBgn0039670 CG7567 3 3R CG7567 CG7567 BcDNA:RE47447 CDMC20289 1 6 23 DAC37-A12 6-CG7567-RA_2 CG7567 CTCGGGATCCTGGCACTTCGGTACGCTGCTTCGACTACTACATACCCATCATCAACGGGCTGTCG 65 FBan0007567 FBgn0039670 CG7567 3 3R CG7567 CG7567 BcDNA:RE47447 CDMC20290 1 7 23 DAC37-A24 3-CG7600-RA_3 CG7600 TGCGTATGTGCTCAATTCCGAGAATTTCCGCAGCCTGAACTCTCAGCTCAAGAACGGCTGTGTGC 65 FBgn0027531 CDMC20290 1 8 23 DAC37-A24 3-CG7600-RA_3 CG7600 TGCGTATGTGCTCAATTCCGAGAATTTCCGCAGCCTGAACTCTCAGCTCAAGAACGGCTGTGTGC 65 FBgn0027531 CDMC20291 1 9 23 DAC37-E12 6-CG7717-RA_2 CG7717 CGGAGAGCCTATCCCAGGAGGGTCACGACTTCATCGATCATTGTCTGCAGCACGATCCCAAGAGG 65 FBan0007717 FBgn0024329 Mekk1 3 3R JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; protein amino acid phosphorylation; GO:0006468; response to stress; GO:0006950 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; MAP kinase kinase kinase activity; GO:0004709 ; EC:2.7.1.-; ; GO:0004709 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004709 ; EC:2.7.1.-; ; GO:0004709 ; EC:2.7.1.- Mekk1 Mekk1 "CG7717, DmMEKK1, MEKK, MEKK4, mekk1a, mekk1b, D-MEKK1, dMEKK, dMEKK4, D-Mekk1, mekk1" CDMC20291 1 10 23 DAC37-E12 6-CG7717-RA_2 CG7717 CGGAGAGCCTATCCCAGGAGGGTCACGACTTCATCGATCATTGTCTGCAGCACGATCCCAAGAGG 65 FBan0007717 FBgn0024329 Mekk1 3 3R JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; protein amino acid phosphorylation; GO:0006468; response to stress; GO:0006950 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; MAP kinase kinase kinase activity; GO:0004709 ; EC:2.7.1.-; ; GO:0004709 ; EC:2.7.1.-; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004709 ; EC:2.7.1.-; ; GO:0004709 ; EC:2.7.1.- Mekk1 Mekk1 "CG7717, DmMEKK1, MEKK, MEKK4, mekk1a, mekk1b, D-MEKK1, dMEKK, dMEKK4, D-Mekk1, mekk1" CDMC20292 1 11 23 DAC37-E24 15-CG7766-RB_5 CG7766 GGTGGCGTCATCTACGTGGAGCATCTGGTGCACAAGGCCAATCAGTTGTTCCTCGAGGATCAGCG 65 FBan0007766 FBgn0030087 CG7766 X X glycogen metabolism; GO:0005977 calmodulin binding; GO:0005516; ; GO:0005516; kinase activator activity; GO:0019209; ; GO:0019209; phosphorylase kinase regulator activity; GO:0008607 ; EC:2.7.1.-; ; GO:0008607 ; EC:2.7.1.- phosphorylase kinase complex; GO:0005964 CG7766 CG7766 CDMC20292 1 12 23 DAC37-E24 15-CG7766-RB_5 CG7766 GGTGGCGTCATCTACGTGGAGCATCTGGTGCACAAGGCCAATCAGTTGTTCCTCGAGGATCAGCG 65 FBan0007766 FBgn0030087 CG7766 X X glycogen metabolism; GO:0005977 calmodulin binding; GO:0005516; ; GO:0005516; kinase activator activity; GO:0019209; ; GO:0019209; phosphorylase kinase regulator activity; GO:0008607 ; EC:2.7.1.-; ; GO:0008607 ; EC:2.7.1.- phosphorylase kinase complex; GO:0005964 CG7766 CG7766 CDMC20293 1 13 23 DAC37-I12 6-CG7915-RA_1 CG7915 GAGTAGCGAACTCGCAGATGGAACGCAAAGTATGCAAAACCTGGCCATTCCAATGACCCCGCAGC 65 FBan0007915 FBgn0035835 Ect4 3 3L biological process unknown; GO:0000004 transmembrane receptor activity; GO:0004888; ; GO:0004888 membrane; GO:0016020 Ect4 Ect4 "CG7915, CG7905, CG7915, CG7915, anon-WO0118547.272" CDMC20293 1 14 23 DAC37-I12 6-CG7915-RA_1 CG7915 GAGTAGCGAACTCGCAGATGGAACGCAAAGTATGCAAAACCTGGCCATTCCAATGACCCCGCAGC 65 FBan0007915 FBgn0035835 Ect4 3 3L biological process unknown; GO:0000004 transmembrane receptor activity; GO:0004888; ; GO:0004888 membrane; GO:0016020 Ect4 Ect4 "CG7915, CG7905, CG7915, CG7915, anon-WO0118547.272" CDMC20294 1 15 23 DAC37-I24 23-CG7938-RA_1 CG7938 GTGCCAGGAACCTTTAAGCCCATCAAGGATATACTGAAATACTTCGAGAAGATCATAAACCAGCG 65 FBan0007938 FBgn0003511 Sry-beta 3 3R DNA binding; GO:0003677; ; GO:0003677; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 Sry-beta Serendipity beta "CG7938, sry beta, Srybeta, srybeta, sry-b, sryb, Sry-beta, sry, serendipity beta, sry beta, sry-beta" CDMC20294 1 16 23 DAC37-I24 23-CG7938-RA_1 CG7938 GTGCCAGGAACCTTTAAGCCCATCAAGGATATACTGAAATACTTCGAGAAGATCATAAACCAGCG 65 FBan0007938 FBgn0003511 Sry-beta 3 3R DNA binding; GO:0003677; ; GO:0003677; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 Sry-beta Serendipity beta "CG7938, sry beta, Srybeta, srybeta, sry-b, sryb, Sry-beta, sry, serendipity beta, sry beta, sry-beta" CDMC20295 1 17 23 DAC37-M12 3-CG8019-RA_1 CG8019 GTGGCAGACACCAGTTTCGATTTGCCCGAGGCTAATGTGCTTATCCAGATCTCTTCGCATGGCGG 65 FBan0008019 FBgn0001179 hay 3 3L "nucleotide-excision repair; GO:0006289; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; transcription initiation from RNA polymerase II promoter; GO:0006367" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0003676; ; GO:0004386; ; GO:0016251; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003; ; GO:0003677 nucleus; GO:0005634; transcription factor TFIIH complex; GO:0005675 hay haywire "CG8019, CG8019, CG8019, ERCC3, nc2, DmXPB, DhR25, DhXPB, hwr, TFIIH, Xpb/hay, i50, ms(3)nc2, haywire" CDMC20295 1 18 23 DAC37-M12 3-CG8019-RA_1 CG8019 GTGGCAGACACCAGTTTCGATTTGCCCGAGGCTAATGTGCTTATCCAGATCTCTTCGCATGGCGG 65 FBan0008019 FBgn0001179 hay 3 3L "nucleotide-excision repair; GO:0006289; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381; transcription initiation from RNA polymerase II promoter; GO:0006367" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0003676; ; GO:0004386; ; GO:0016251; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003; ; GO:0003677 nucleus; GO:0005634; transcription factor TFIIH complex; GO:0005675 hay haywire "CG8019, CG8019, CG8019, ERCC3, nc2, DmXPB, DhR25, DhXPB, hwr, TFIIH, Xpb/hay, i50, ms(3)nc2, haywire" CDMC20296 1 19 23 DAC37-M24 5-CG8043-RA_1 CG8043 CTTCGGAGGCTGTACCCAATCCACATCCAGACTTATTTGTGTCTCCCGACCCGAGGCTGCATGTC 65 FBan0008043 FBgn0037610 CG8043 3 3R aminomethyltransferase activity; GO:0004047 ; EC:2.1.2.10; ; GO:0004047 ; EC:2.1.2.10 CG8043 CG8043 CDMC20296 1 20 23 DAC37-M24 5-CG8043-RA_1 CG8043 CTTCGGAGGCTGTACCCAATCCACATCCAGACTTATTTGTGTCTCCCGACCCGAGGCTGCATGTC 65 FBan0008043 FBgn0037610 CG8043 3 3R aminomethyltransferase activity; GO:0004047 ; EC:2.1.2.10; ; GO:0004047 ; EC:2.1.2.10 CG8043 CG8043 CDMC20297 1 21 23 DAC38-A12 3-CG4148-RA_5 CG4148 CCTGCAAGCAGGACCTCGAGTTCCTGGACATAGACGATACGGAGGATAGGTGTTCCTTGGTAGAGGAGC 69 FBan0004148 FBgn0001990 wek 2 2L "cell proliferation; GO:0008283; maternal determination of dorsal/ventral axis, oocyte, germ-line encoded (sensu Insecta); GO:0048124; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357" transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 wek weckle "CG4148, CG4148, l(2)35Ea: lethal(2)35Ea, l(2)br47, l35Ea, BG:DS09217.5, lethal(2)35Ea, l(2)35Ea, weckle" CDMC20297 1 22 23 DAC38-A12 3-CG4148-RA_5 CG4148 CCTGCAAGCAGGACCTCGAGTTCCTGGACATAGACGATACGGAGGATAGGTGTTCCTTGGTAGAGGAGC 69 FBan0004148 FBgn0001990 wek 2 2L "cell proliferation; GO:0008283; maternal determination of dorsal/ventral axis, oocyte, germ-line encoded (sensu Insecta); GO:0048124; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357" transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 wek weckle "CG4148, CG4148, l(2)35Ea: lethal(2)35Ea, l(2)br47, l35Ea, BG:DS09217.5, lethal(2)35Ea, l(2)35Ea, weckle" CDMC20298 1 23 23 DAC38-A24 12-CG4161-RA_3 CG4161 ACGATGCATTTAGCAAGCTTTTGCGGATTAACCTGTGGGGAAATCACTTTGAAATGCAGATCGGCGCCT 69 FBan0004161 FBgn0028892 CG4161 2 2L CG4161 CG4161 BG:DS03023.2 CDMC20298 1 24 23 DAC38-A24 12-CG4161-RA_3 CG4161 ACGATGCATTTAGCAAGCTTTTGCGGATTAACCTGTGGGGAAATCACTTTGAAATGCAGATCGGCGCCT 69 FBan0004161 FBgn0028892 CG4161 2 2L CG4161 CG4161 BG:DS03023.2 CDMC20299 1 25 23 DAC38-E12 14-CG4201-RA_1 CG4201 GCGGTCTCTGCGGAGATGACTATGAAGGATCTAATTGCGTTGATTGTCCTGGACACTGGAATGGACGAA 69 FBan0004201 FBgn0024222 ird5 3 3R Toll signaling pathway; GO:0008063; antibacterial humoral response (sensu Protostomia); GO:0006961; antibacterial polypeptide induction; GO:0006963; antimicrobial humoral response (sensu Protostomia); GO:0006960; cytokine and chemokine mediated signaling pathway; GO:0019221; dorsal/ventral axis specification; GO:0009950; protein amino acid phosphorylation; GO:0006468; protein catabolism; GO:0030163 ATP binding; GO:0005524; ; GO:0005524; IkappaB kinase activity; GO:0008384 ; EC:2.7.1.-; ; GO:0008384 ; EC:2.7.1.-; ; GO:0008384 ; EC:2.7.1.-; ; GO:0008384 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein binding; GO:0005515; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37; ; GO:0008384 ; EC:2.7.1.-; ; GO:0005515; ; GO:0005515 IkappaB kinase complex; GO:0008385; cytoplasm; GO:0005737 ird5 immune response deficient 5 "CG4201, CG4201, CG4201, DIK, IKK-like protein, DLAK, Lipopolysaccharide activated kinase, LRK, LPS-responsive kinase, DmIKK, ikk, DmIKKbeta, Ik, Ird-5, dLak, ird, DmIKKBeta, Dmikkbeta, IKK, IKKB, dIKK, ird5/DmIkk[beta], dmIKKbeta, DmIkkbeta, DmIKKb, IKK-beta, dIKK-beta, IK, Lak, anon-89Bd, cactus kinase, LPS-responsive-kinase, immune response deficient 5" CDMC20299 1 26 23 DAC38-E12 14-CG4201-RA_1 CG4201 GCGGTCTCTGCGGAGATGACTATGAAGGATCTAATTGCGTTGATTGTCCTGGACACTGGAATGGACGAA 69 FBan0004201 FBgn0024222 ird5 3 3R Toll signaling pathway; GO:0008063; antibacterial humoral response (sensu Protostomia); GO:0006961; antibacterial polypeptide induction; GO:0006963; antimicrobial humoral response (sensu Protostomia); GO:0006960; cytokine and chemokine mediated signaling pathway; GO:0019221; dorsal/ventral axis specification; GO:0009950; protein amino acid phosphorylation; GO:0006468; protein catabolism; GO:0030163 ATP binding; GO:0005524; ; GO:0005524; IkappaB kinase activity; GO:0008384 ; EC:2.7.1.-; ; GO:0008384 ; EC:2.7.1.-; ; GO:0008384 ; EC:2.7.1.-; ; GO:0008384 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; protein kinase activity; GO:0004672 ; EC:2.7.1.37; protein binding; GO:0005515; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37; ; GO:0008384 ; EC:2.7.1.-; ; GO:0005515; ; GO:0005515 IkappaB kinase complex; GO:0008385; cytoplasm; GO:0005737 ird5 immune response deficient 5 "CG4201, CG4201, CG4201, DIK, IKK-like protein, DLAK, Lipopolysaccharide activated kinase, LRK, LPS-responsive kinase, DmIKK, ikk, DmIKKbeta, Ik, Ird-5, dLak, ird, DmIKKBeta, Dmikkbeta, IKK, IKKB, dIKK, ird5/DmIkk[beta], dmIKKbeta, DmIkkbeta, DmIKKb, IKK-beta, dIKK-beta, IK, Lak, anon-89Bd, cactus kinase, LPS-responsive-kinase, immune response deficient 5" CDMC20300 1 1 24 DAC38-E24 2-CG4207-RA_1 CG4207 TCCGCGCGACAAGATGATCAAGGTGCGTCTCAAGGAGCTCATCGACAAACGCAAGAAGTTCCTCAAGTA 69 FBan0004207 FBgn0026261 bonsai 2 2R protein biosynthesis; GO:0006412; regulation of growth; GO:0040008 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763; mitochondrion; GO:0005739 bonsai bonsai "CG4207, CG4207, MRP-S15, DmMRPS15, mRpS15" CDMC20300 1 2 24 DAC38-E24 2-CG4207-RA_1 CG4207 TCCGCGCGACAAGATGATCAAGGTGCGTCTCAAGGAGCTCATCGACAAACGCAAGAAGTTCCTCAAGTA 69 FBan0004207 FBgn0026261 bonsai 2 2R protein biosynthesis; GO:0006412; regulation of growth; GO:0040008 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763; mitochondrion; GO:0005739 bonsai bonsai "CG4207, CG4207, MRP-S15, DmMRPS15, mRpS15" CDMC20301 1 3 24 DAC38-I12 3-CG4238-RA_2 CG4238 GCTGGAGCTGTACTTCGTGGAGGAGATGTACGACTCCAGTAGTGGACAGCTGAGCAAGACCATCGAACT 69 FBan0004238 FBgn0031384 CG4238 2 2L protein modification; GO:0006464; proteolysis; GO:0006508; ubiquitin cycle; GO:0006512 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 intracellular; GO:0005622 CG4238 CG4238 CDMC20301 1 4 24 DAC38-I12 3-CG4238-RA_2 CG4238 GCTGGAGCTGTACTTCGTGGAGGAGATGTACGACTCCAGTAGTGGACAGCTGAGCAAGACCATCGAACT 69 FBan0004238 FBgn0031384 CG4238 2 2L protein modification; GO:0006464; proteolysis; GO:0006508; ubiquitin cycle; GO:0006512 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0004842 ; EC:6.3.2.19 intracellular; GO:0005622 CG4238 CG4238 CDMC20302 1 5 24 DAC38-I24 23-CG4250-RA_3 CG4250 TGTATCTCCACACCTATTGATGGGATCAGATTTGGCACGAATATTCACGAAATACAACTCTGGTTCAAA 69 FBan0004250 FBgn0034761 CG4250 2 2R CG4250 CG4250 "CT13934, BcDNA:RH52355" CDMC20302 1 6 24 DAC38-I24 23-CG4250-RA_3 CG4250 TGTATCTCCACACCTATTGATGGGATCAGATTTGGCACGAATATTCACGAAATACAACTCTGGTTCAAA 69 FBan0004250 FBgn0034761 CG4250 2 2R CG4250 CG4250 "CT13934, BcDNA:RH52355" CDMC20303 1 7 24 DAC38-M12 4-CG4293-RB_1 CG4293 GCCCACAGAGATCCACCAGACTTTCACCACCATATACGCTTTTCAGTATGCCGTCACCGAAAACGTGCG 69 FBan0004293 FBgn0024983 CG4293 X X arginase activity; GO:0004053 ; EC:3.5.3.1; ; GO:0004053 ; EC:3.5.3.1 CG4293 CG4293 EG:65F1.1 CDMC20303 1 8 24 DAC38-M12 4-CG4293-RB_1 CG4293 GCCCACAGAGATCCACCAGACTTTCACCACCATATACGCTTTTCAGTATGCCGTCACCGAAAACGTGCG 69 FBan0004293 FBgn0024983 CG4293 X X arginase activity; GO:0004053 ; EC:3.5.3.1; ; GO:0004053 ; EC:3.5.3.1 CG4293 CG4293 EG:65F1.1 CDMC20304 1 9 24 DAC38-M24 12-CG4314-RA_1 CG4314 ACACGGGTCAGGATGTCCTGGACAAGTACAGCTTCAACGAGAGCAATGTCTATCGGAATTTACTGGCCA 69 FBan0004314 FBgn0003515 st 3 3L eye pigment biosynthesis; GO:0006726; eye pigment precursor transport; GO:0006856; ommochrome biosynthesis; GO:0006727 "ATP binding; GO:0005524; ; GO:0005524; eye pigment precursor transporter activity; GO:0005395; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0005395; ; GO:0042626; nucleotide binding; GO:0000166; permease activity; GO:0015646; ; GO:0000166; ; GO:0015646" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to plasma membrane; GO:0005887 st scarlet "CG4314, CG4314, CG4314, scarlet" CDMC20304 1 10 24 DAC38-M24 12-CG4314-RA_1 CG4314 ACACGGGTCAGGATGTCCTGGACAAGTACAGCTTCAACGAGAGCAATGTCTATCGGAATTTACTGGCCA 69 FBan0004314 FBgn0003515 st 3 3L eye pigment biosynthesis; GO:0006726; eye pigment precursor transport; GO:0006856; ommochrome biosynthesis; GO:0006727 "ATP binding; GO:0005524; ; GO:0005524; eye pigment precursor transporter activity; GO:0005395; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0005395; ; GO:0042626; nucleotide binding; GO:0000166; permease activity; GO:0015646; ; GO:0000166; ; GO:0015646" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to plasma membrane; GO:0005887 st scarlet "CG4314, CG4314, CG4314, scarlet" CDMC20305 1 11 24 DAC39-A12 12-CG6921-RB_1 CG6921 CGTGGGCAACACGGTCATCTTCCTTTACCTGTTCGGCAATTTCTATCGCAAGACCTACAAGAAGGCCAA 69 FBan0006921 FBgn0038985 CG6921 3 3R fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG6921 CG6921 CDMC20305 1 12 24 DAC39-A12 12-CG6921-RB_1 CG6921 CGTGGGCAACACGGTCATCTTCCTTTACCTGTTCGGCAATTTCTATCGCAAGACCTACAAGAAGGCCAA 69 FBan0006921 FBgn0038985 CG6921 3 3R fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG6921 CG6921 CDMC20306 1 13 24 DAC39-A24 24-CG6937-RA_1 CG6937 TGCGGCGATTTTTATTCATTTACTACTTTAATAATCAATTTTAGTGAATTGACACTAATTAAAATGCCG 69 FBan0006937 FBgn0038989 CG6937 3 3R mRNA binding; GO:0003729; ; GO:0003729 CG6937 CG6937 cg6937 CDMC20306 1 14 24 DAC39-A24 24-CG6937-RA_1 CG6937 TGCGGCGATTTTTATTCATTTACTACTTTAATAATCAATTTTAGTGAATTGACACTAATTAAAATGCCG 69 FBan0006937 FBgn0038989 CG6937 3 3R mRNA binding; GO:0003729; ; GO:0003729 CG6937 CG6937 cg6937 CDMC20307 1 15 24 DAC39-E12 3-CG6969-RA_12 CG6969 TGCCCATTTCCTCGAATCCGGCAGATGGCTGCAATCGTGTCCAGATGACTCGACTGGGTAAATACTGTT 69 FBan0006969 FBgn0039005 CG6969 3 3R defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800 peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7 CG6969 CG6969 CDMC20307 1 16 24 DAC39-E12 3-CG6969-RA_12 CG6969 TGCCCATTTCCTCGAATCCGGCAGATGGCTGCAATCGTGTCCAGATGACTCGACTGGGTAAATACTGTT 69 FBan0006969 FBgn0039005 CG6969 3 3R defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800 peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7 CG6969 CG6969 CDMC20308 1 17 24 DAC39-E24 18-CG6978-RA_2 CG6978 GGCCATCGATCTTCTATATCTTCGGGCTGTTCAGCACCATCTGGTGTATCATCTTTATTTGCCTGGTGC 69 FBan0006978 FBgn0029727 CG6978 X X carbohydrate metabolism; GO:0005975; cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 sodium:phosphate symporter activity; GO:0005436; ; GO:0005436 integral to membrane; GO:0016021; membrane; GO:0016020 CG6978 CG6978 CDMC20308 1 18 24 DAC39-E24 18-CG6978-RA_2 CG6978 GGCCATCGATCTTCTATATCTTCGGGCTGTTCAGCACCATCTGGTGTATCATCTTTATTTGCCTGGTGC 69 FBan0006978 FBgn0029727 CG6978 X X carbohydrate metabolism; GO:0005975; cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 sodium:phosphate symporter activity; GO:0005436; ; GO:0005436 integral to membrane; GO:0016021; membrane; GO:0016020 CG6978 CG6978 CDMC20309 1 19 24 DAC39-I12 23-CG7006-RA_4 CG7006 CCTACTCAACACTGAAACATTTCTCACGTGTAAAGTTGAGCAGTTTGTTTTCCTCTTTTTTCCGCTTAA 69 FBan0007006 FBgn0039233 CG7006 3 3R CG7006 CG7006 "anon-WO0118547.410, BcDNA:GM12126" CDMC20309 1 20 24 DAC39-I12 23-CG7006-RA_4 CG7006 CCTACTCAACACTGAAACATTTCTCACGTGTAAAGTTGAGCAGTTTGTTTTCCTCTTTTTTCCGCTTAA 69 FBan0007006 FBgn0039233 CG7006 3 3R CG7006 CG7006 "anon-WO0118547.410, BcDNA:GM12126" CDMC20310 1 21 24 DAC39-I24 11-CG7015-RA_1 CG7015 GGGTCAGGAGGTGGAGTACACTCTTGCTCGTAATGGGAATACATCCGTTTCTGGAAACTGTCTGCCTGC 69 FBan0007015 FBgn0035895 CG7015 3 3L "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003677 CG7015 CG7015 CDMC20310 1 22 24 DAC39-I24 11-CG7015-RA_1 CG7015 GGGTCAGGAGGTGGAGTACACTCTTGCTCGTAATGGGAATACATCCGTTTCTGGAAACTGTCTGCCTGC 69 FBan0007015 FBgn0035895 CG7015 3 3L "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003677 CG7015 CG7015 CDMC20311 1 23 24 DAC39-M12 23-CG7045-RA_1 CG7045 ACCAGGTGCCTTCACTAAGCGTTTACTACATTTGTTAATTTATTGTTGTACTAAAATCCACAAGCTAAT 69 FBan0007045 FBgn0038978 CG7045 3 3R "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 chromatin; GO:0000785; nucleus; GO:0005634 CG7045 CG7045 CDMC20311 1 24 24 DAC39-M12 23-CG7045-RA_1 CG7045 ACCAGGTGCCTTCACTAAGCGTTTACTACATTTGTTAATTTATTGTTGTACTAAAATCCACAAGCTAAT 69 FBan0007045 FBgn0038978 CG7045 3 3R "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 chromatin; GO:0000785; nucleus; GO:0005634 CG7045 CG7045 CDMC20312 1 25 24 DAC39-M24 22-CG7055-RA_1 CG7055 AGTTGTGGTCCCTAACTTATATATGAATCGATCCCTGGTGTTGTAACATAGCTGTCCCCTCCCGGAACT 69 FBan0007055 FBgn0030093 dalao X X "chromatin assembly or disassembly; GO:0006333; chromatin remodeling; GO:0006338; positive regulation of transcription, DNA-dependent; GO:0045893" DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003677; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003682; protein binding; GO:0005515; ; GO:0016251; ; GO:0005515; contributes_to transcription coactivator activity; GO:0003713; ; GO:0003713 brahma complex; GO:0035060; chromatin remodeling complex; GO:0016585; nucleus; GO:0005634 dalao dalao "CG7055, CG7055, CG7055, BAP111, BRM-associated protein 111, clone 1.83, Bap111, Brahma associated protein 111kD, BAF57, anon-EST:Liang-1.83" CDMC20312 1 26 24 DAC39-M24 22-CG7055-RA_1 CG7055 AGTTGTGGTCCCTAACTTATATATGAATCGATCCCTGGTGTTGTAACATAGCTGTCCCCTCCCGGAACT 69 FBan0007055 FBgn0030093 dalao X X "chromatin assembly or disassembly; GO:0006333; chromatin remodeling; GO:0006338; positive regulation of transcription, DNA-dependent; GO:0045893" DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003677; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003682; protein binding; GO:0005515; ; GO:0016251; ; GO:0005515; contributes_to transcription coactivator activity; GO:0003713; ; GO:0003713 brahma complex; GO:0035060; chromatin remodeling complex; GO:0016585; nucleus; GO:0005634 dalao dalao "CG7055, CG7055, CG7055, BAP111, BRM-associated protein 111, clone 1.83, Bap111, Brahma associated protein 111kD, BAF57, anon-EST:Liang-1.83" CDMC20313 1 1 25 DAC40-A12 23-CG33300-RA_2 CG33300 AACATCCGTAGAAACTACTACCAATTCATCGAATCAGAGCAATACGACCACGGAATCAACCACCA 65 FBan0033300 FBgn0053300 CG33300 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33300 CG33300 CDMC20313 1 2 25 DAC40-A12 23-CG33300-RA_2 CG33300 AACATCCGTAGAAACTACTACCAATTCATCGAATCAGAGCAATACGACCACGGAATCAACCACCA 65 FBan0033300 FBgn0053300 CG33300 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33300 CG33300 CDMC20314 1 3 25 DAC40-A24 3-CG3331-RA_3 CG3331 TGACTACTCGCAGGTTCCTGAGGATCTAAAGCTAACGGCACGGGATCTCTTCGAGACAGTGGGCG 65 FBan0003331 FBgn0000527 e 3 3R amino acid adenylylation by nonribosomal peptide synthase; GO:0043042; circadian rhythm; GO:0007623; cuticle pigmentation; GO:0048067; cuticle tanning; GO:0007593; defense response; GO:0006952; dopamine metabolism; GO:0042417; histamine metabolism; GO:0001692; locomotor rhythm; GO:0045475; melanin biosynthesis from tyrosine; GO:0006583; negative regulation of melanin biosynthesis; GO:0048022; pigment metabolism; GO:0042440; pigmentation during development; GO:0048066 beta-alanyl-dopamine synthase activity; GO:0003833; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0003833; ; GO:0016874 ; EC:6.-.-.-; ; GO:0003833; ; GO:0003833; cofactor binding; GO:0048037; ; GO:0048037 e ebony "CG3331, CG3331, ebony" CDMC20314 1 4 25 DAC40-A24 3-CG3331-RA_3 CG3331 TGACTACTCGCAGGTTCCTGAGGATCTAAAGCTAACGGCACGGGATCTCTTCGAGACAGTGGGCG 65 FBan0003331 FBgn0000527 e 3 3R amino acid adenylylation by nonribosomal peptide synthase; GO:0043042; circadian rhythm; GO:0007623; cuticle pigmentation; GO:0048067; cuticle tanning; GO:0007593; defense response; GO:0006952; dopamine metabolism; GO:0042417; histamine metabolism; GO:0001692; locomotor rhythm; GO:0045475; melanin biosynthesis from tyrosine; GO:0006583; negative regulation of melanin biosynthesis; GO:0048022; pigment metabolism; GO:0042440; pigmentation during development; GO:0048066 beta-alanyl-dopamine synthase activity; GO:0003833; ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0003833; ; GO:0016874 ; EC:6.-.-.-; ; GO:0003833; ; GO:0003833; cofactor binding; GO:0048037; ; GO:0048037 e ebony "CG3331, CG3331, ebony" CDMC20315 1 5 25 DAC40-E12 9-CG3362-RA_7 CG3362 CGGCTTCCCCTTCGACCAGTCGGAAATAGATCAGATAGCCAGCAAGTACACGCATGCGCTACGTG 65 FBan0003362 FBgn0034988 CG3362 2 2R CG3362 CG3362 CDMC20315 1 6 25 DAC40-E12 9-CG3362-RA_7 CG3362 CGGCTTCCCCTTCGACCAGTCGGAAATAGATCAGATAGCCAGCAAGTACACGCATGCGCTACGTG 65 FBan0003362 FBgn0034988 CG3362 2 2R CG3362 CG3362 CDMC20316 1 7 25 DAC40-E24 6-CG3416-RA_1 CG3416 GTGGGATGGTATCACACAGGTCCCAAGCTCCACCAAAACGACATAGCCATCAACGAGCTGGTCCG 65 FBan0003416 FBgn0002787 Mov34 2 2R cellular physiological process; GO:0050875; proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 "proteasome complex (sensu Eukaryota); GO:0000502; proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, lid subcomplex (sensu Eukaryota); GO:0008541" Mov34 Mov34 "CG3416, l(2)k08003, PRSC_DROME, p39B" CDMC20316 1 8 25 DAC40-E24 6-CG3416-RA_1 CG3416 GTGGGATGGTATCACACAGGTCCCAAGCTCCACCAAAACGACATAGCCATCAACGAGCTGGTCCG 65 FBan0003416 FBgn0002787 Mov34 2 2R cellular physiological process; GO:0050875; proteolysis; GO:0006508; regulation of progression through cell cycle; GO:0000074; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 "proteasome complex (sensu Eukaryota); GO:0000502; proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, lid subcomplex (sensu Eukaryota); GO:0008541" Mov34 Mov34 "CG3416, l(2)k08003, PRSC_DROME, p39B" CDMC20317 1 9 25 DAC40-I12 24-CG3566-RB_1 CG3566 GGGAACATCAATTTCCTCACACATTTGACACGAAATAAATTGTACAAATTGCTTAAATTACACAA 65 FBan0003566 FBgn0029854 CG3566 X X electron transporter activity; GO:0005489; ; GO:0005489 CG3566 CG3566 BcDNA:RH45308 CDMC20317 1 10 25 DAC40-I12 24-CG3566-RB_1 CG3566 GGGAACATCAATTTCCTCACACATTTGACACGAAATAAATTGTACAAATTGCTTAAATTACACAA 65 FBan0003566 FBgn0029854 CG3566 X X electron transporter activity; GO:0005489; ; GO:0005489 CG3566 CG3566 BcDNA:RH45308 CDMC20318 1 11 25 DAC40-I24 2-CG3609-RA_1 CG3609 CAAGGATGTGGAGGTCAACTTTGGCTTCCCTATGCCTCATGTCGACCGCTTGCAGAAACGCGAAC 65 FBan0003609 FBgn0031418 CG3609 2 2L electron transport; GO:0006118; metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG3609 CG3609 CT12127 CDMC20318 1 12 25 DAC40-I24 2-CG3609-RA_1 CG3609 CAAGGATGTGGAGGTCAACTTTGGCTTCCCTATGCCTCATGTCGACCGCTTGCAGAAACGCGAAC 65 FBan0003609 FBgn0031418 CG3609 2 2L electron transport; GO:0006118; metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG3609 CG3609 CT12127 CDMC20319 1 13 25 DAC40-M12 3-CG3695-RA_4 CG3695 CCGCCCAACTGGAGTGTTAGTGAGCCGTACAAGGTGTATTTGCAAAGCCAAGACTCGCTGTGGAC 65 FBan0003695 FBgn0034795 MED23 2 2R regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; ; GO:0016455 mediator complex; GO:0000119; nucleus; GO:0005634 MED23 Mediator complex subunit 23 "CG3695, CG3695, dTRAP150beta, dSUR2, Gal11/SUR2, Trap150beta, Med23, Mediator complex subunit 23" CDMC20319 1 14 25 DAC40-M12 3-CG3695-RA_4 CG3695 CCGCCCAACTGGAGTGTTAGTGAGCCGTACAAGGTGTATTTGCAAAGCCAAGACTCGCTGTGGAC 65 FBan0003695 FBgn0034795 MED23 2 2R regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; ; GO:0016455 mediator complex; GO:0000119; nucleus; GO:0005634 MED23 Mediator complex subunit 23 "CG3695, CG3695, dTRAP150beta, dSUR2, Gal11/SUR2, Trap150beta, Med23, Mediator complex subunit 23" CDMC20320 1 15 25 DAC40-M24 6-CG3713-RA_1 CG3713 GAGCACCGCATAATCAGAGGTGGGGATGTTTCTGGGCTTCTTGGTGGATCTGCTGTACTGCCGAC 65 FBan0003713 FBgn0040343 CG3713 X X CG3713 CG3713 "EG:BACR7A4.2, BcDNA:GH13231" CDMC20320 1 16 25 DAC40-M24 6-CG3713-RA_1 CG3713 GAGCACCGCATAATCAGAGGTGGGGATGTTTCTGGGCTTCTTGGTGGATCTGCTGTACTGCCGAC 65 FBan0003713 FBgn0040343 CG3713 X X CG3713 CG3713 "EG:BACR7A4.2, BcDNA:GH13231" CDMC20321 1 17 25 DAC41-A12 AutoBlank AutoBlank CDMC20321 1 18 25 DAC41-A12 AutoBlank AutoBlank CDMC20322 1 19 25 DAC41-A24 AutoBlank AutoBlank CDMC20322 1 20 25 DAC41-A24 AutoBlank AutoBlank CDMC20323 1 21 25 DAC41-E12 AutoBlank AutoBlank CDMC20323 1 22 25 DAC41-E12 AutoBlank AutoBlank CDMC20324 1 23 25 DAC41-E24 AutoBlank AutoBlank CDMC20324 1 24 25 DAC41-E24 AutoBlank AutoBlank CDMC20325 1 25 25 DAC41-I12 AutoBlank AutoBlank CDMC20325 1 26 25 DAC41-I12 AutoBlank AutoBlank CDMC20326 1 1 26 DAC41-I24 AutoBlank AutoBlank CDMC20326 1 2 26 DAC41-I24 AutoBlank AutoBlank CDMC20327 1 3 26 DAC41-M12 AutoBlank AutoBlank CDMC20327 1 4 26 DAC41-M12 AutoBlank AutoBlank CDMC20328 1 5 26 DAC41-M24 AutoBlank AutoBlank CDMC20328 1 6 26 DAC41-M24 AutoBlank AutoBlank CDMC20329 1 7 26 DAC42-A12 150mM NaPO4 Blank CDMC20329 1 8 26 DAC42-A12 150mM NaPO4 Blank CDMC20330 1 9 26 DAC42A24 Ambion control 1 Ambion control spot1 CDMC20330 1 10 26 DAC42A24 Ambion control 1 Ambion control spot1 CDMC20331 1 11 26 DAC42E12 Ambion control 3 Ambion control spot3 CDMC20331 1 12 26 DAC42E12 Ambion control 3 Ambion control spot3 CDMC20332 1 13 26 DAC42E24 Ambion control 5 Ambion control spot5 CDMC20332 1 14 26 DAC42E24 Ambion control 5 Ambion control spot5 CDMC20333 1 15 26 DAC42I12 Ambion control 7 Ambion control spot7 CDMC20333 1 16 26 DAC42I12 Ambion control 7 Ambion control spot7 CDMC20334 1 17 26 DAC42-I24 5uM MSP 5uM MSP CDMC20334 1 18 26 DAC42-I24 5uM MSP 5uM MSP CDMC20335 1 19 26 DAC42-M12 10uM MSP 10uM MSP CDMC20335 1 20 26 DAC42-M12 10uM MSP 10uM MSP CDMC20336 1 21 26 DAC42-M24 20uM MSP 20uM MSP CDMC20336 1 22 26 DAC42-M24 20uM MSP 20uM MSP 1 23 26 EMPTY EMPTY 1 24 26 EMPTY EMPTY 1 25 26 EMPTY EMPTY 1 26 26 EMPTY EMPTY CDMC20337 2 1 1 DAC01-B12 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC20337 2 2 1 DAC01-B12 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC20338 2 3 1 DAC01-B24 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC20338 2 4 1 DAC01-B24 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC20339 2 5 1 DAC01-F12 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC20339 2 6 1 DAC01-F12 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC20340 2 7 1 DAC01-F24 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC20340 2 8 1 DAC01-F24 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC20341 2 9 1 DAC01-J12 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC20341 2 10 1 DAC01-J12 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC20342 2 11 1 DAC01-J24 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC20342 2 12 1 DAC01-J24 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC20343 2 13 1 DAC01-N12 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC20343 2 14 1 DAC01-N12 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC20344 2 15 1 DAC01-N24 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC20344 2 16 1 DAC01-N24 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC20345 2 17 1 DAC02-B12 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC20345 2 18 1 DAC02-B12 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC20346 2 19 1 DAC02-B24 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC20346 2 20 1 DAC02-B24 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC20347 2 21 1 DAC02-F12 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC20347 2 22 1 DAC02-F12 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC20348 2 23 1 DAC02-F24 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC20348 2 24 1 DAC02-F24 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC20349 2 25 1 DAC02-J12 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC20349 2 26 1 DAC02-J12 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC20350 2 1 2 DAC02-J24 N/A CG9075 (00240-00478) CDMC20350 2 2 2 DAC02-J24 N/A CG9075 (00240-00478) CDMC20351 2 3 2 DAC02-N12 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC20351 2 4 2 DAC02-N12 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC20352 2 5 2 DAC02-N24 AutoBlank AutoBlank CDMC20352 2 6 2 DAC02-N24 AutoBlank AutoBlank CDMC20353 2 7 2 DAC03-B12 23-CG5435-RA_1 CG5435 TCTTCCGCTATTAGTTCCACAAATCTGTGTTTGCTTTCCCAGAAAGAATACCATTTTGCGTTTTGGGTT 69 FBan0005435 FBgn0032431 CG5435 2 2L CG5435 CG5435 BcDNA:AT11334 CDMC20353 2 8 2 DAC03-B12 23-CG5435-RA_1 CG5435 TCTTCCGCTATTAGTTCCACAAATCTGTGTTTGCTTTCCCAGAAAGAATACCATTTTGCGTTTTGGGTT 69 FBan0005435 FBgn0032431 CG5435 2 2L CG5435 CG5435 BcDNA:AT11334 CDMC20354 2 9 2 DAC03-B24 13-CG5445-RC_1 CG5445 AGGACCCCCCTTTCGTTACTCCTCCCACTATTCCCACTCCTTAATTTCGGTGTCAGACAGATCAGCTTT 69 FBan0005445 FBgn0030838 CG5445 X X CG5445 CG5445 CDMC20354 2 10 2 DAC03-B24 13-CG5445-RC_1 CG5445 AGGACCCCCCTTTCGTTACTCCTCCCACTATTCCCACTCCTTAATTTCGGTGTCAGACAGATCAGCTTT 69 FBan0005445 FBgn0030838 CG5445 X X CG5445 CG5445 CDMC20355 2 11 2 DAC03-F12 23-CG5472-RA_6 CG5472 AATTGCTTGGAAACAATACCACAACAAACATAACCTCAGACTCTTATGTTTTGCACTTTAATGAGCAAA 69 FBan0005472 FBgn0020623 Pal 2 2R peptide metabolism; GO:0006518; protein modification; GO:0006464 peptidylamidoglycolate lyase activity; GO:0004598 ; EC:4.3.2.5; ; GO:0004598 ; EC:4.3.2.5; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; peptidylglycine monooxygenase activity; GO:0004504 ; EC:1.14.17.3; ; GO:0004598 ; EC:4.3.2.5; copper ion binding; GO:0005507; ; GO:0005507; ; GO:0004504 ; EC:1.14.17.3 membrane; GO:0016020 Pal Peptidyl-alpha-hydroxyglycine-alpha-amidating lyase "CG5472, PAL, anon-WO0149856.5, Peptidyl-alpha-hydroxyglycine-alpha-amidating lyase" CDMC20355 2 12 2 DAC03-F12 23-CG5472-RA_6 CG5472 AATTGCTTGGAAACAATACCACAACAAACATAACCTCAGACTCTTATGTTTTGCACTTTAATGAGCAAA 69 FBan0005472 FBgn0020623 Pal 2 2R peptide metabolism; GO:0006518; protein modification; GO:0006464 peptidylamidoglycolate lyase activity; GO:0004598 ; EC:4.3.2.5; ; GO:0004598 ; EC:4.3.2.5; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; peptidylglycine monooxygenase activity; GO:0004504 ; EC:1.14.17.3; ; GO:0004598 ; EC:4.3.2.5; copper ion binding; GO:0005507; ; GO:0005507; ; GO:0004504 ; EC:1.14.17.3 membrane; GO:0016020 Pal Peptidyl-alpha-hydroxyglycine-alpha-amidating lyase "CG5472, PAL, anon-WO0149856.5, Peptidyl-alpha-hydroxyglycine-alpha-amidating lyase" CDMC20356 2 13 2 DAC03-F24 16-CG5475-RB_1 CG5475 GTCGCTTCTGATCGATCTGATCCACTGACGATCTGATTCATGAATGCCTAACACGCATCGGAATGGAGT 69 FBan0005475 FBgn0015765 Mpk2 3 3R JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; attenuation of antimicrobial humoral response; GO:0008348; defense response; GO:0006952; immune response; GO:0006955; protein amino acid phosphorylation; GO:0006468; response to osmotic stress; GO:0006970; response to stress; GO:0006950; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; MAP kinase activity; GO:0004707 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.-; SAP kinase activity; GO:0016909 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004707 ; EC:2.7.1.-; ; GO:0016909 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.- nucleus; GO:0005634 Mpk2 Mpk2 "CG5475, CG5475, group 2, DMPK2, dMPK2, Dp38, DmMPK2, D-p38a, stress-activated kinase P38, p38, p38a MAP kinase, p38a, D-MPK2, D-P38a, p38A, p38 alpha, D-p38, P38, Erk2, Erk-kinase-like" CDMC20356 2 14 2 DAC03-F24 16-CG5475-RB_1 CG5475 GTCGCTTCTGATCGATCTGATCCACTGACGATCTGATTCATGAATGCCTAACACGCATCGGAATGGAGT 69 FBan0005475 FBgn0015765 Mpk2 3 3R JNK cascade; GO:0007254; MAPKKK cascade; GO:0000165; attenuation of antimicrobial humoral response; GO:0008348; defense response; GO:0006952; immune response; GO:0006955; protein amino acid phosphorylation; GO:0006468; response to osmotic stress; GO:0006970; response to stress; GO:0006950; signal transduction; GO:0007165 ATP binding; GO:0005524; ; GO:0005524; MAP kinase activity; GO:0004707 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.-; SAP kinase activity; GO:0016909 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004707 ; EC:2.7.1.-; ; GO:0016909 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.-; ; GO:0004707 ; EC:2.7.1.- nucleus; GO:0005634 Mpk2 Mpk2 "CG5475, CG5475, group 2, DMPK2, dMPK2, Dp38, DmMPK2, D-p38a, stress-activated kinase P38, p38, p38a MAP kinase, p38a, D-MPK2, D-P38a, p38A, p38 alpha, D-p38, P38, Erk2, Erk-kinase-like" CDMC20357 2 15 2 DAC03-J12 23-CG5501-RD_1 CG5501 ATTGATAGTTCAGGCATCTACGTAATTAAAGCTGGAGTTGAGTTCTAGAGCTTCAGCGATGTCACATGC 69 FBgn0051134 CDMC20357 2 16 2 DAC03-J12 23-CG5501-RD_1 CG5501 ATTGATAGTTCAGGCATCTACGTAATTAAAGCTGGAGTTGAGTTCTAGAGCTTCAGCGATGTCACATGC 69 FBgn0051134 CDMC20358 2 17 2 DAC03-J24 23-CG5516-RA_2 CG5516 ACCGATTTGTGGTCTGTAGTATGTAGCTTTACTAGTTTAGTTTTCCCACACTTACACCGAAAATGAACA 69 FBan0005516 FBgn0038389 CG5516 3 3R CG5516 CG5516 CDMC20358 2 18 2 DAC03-J24 23-CG5516-RA_2 CG5516 ACCGATTTGTGGTCTGTAGTATGTAGCTTTACTAGTTTAGTTTTCCCACACTTACACCGAAAATGAACA 69 FBan0005516 FBgn0038389 CG5516 3 3R CG5516 CG5516 CDMC20359 2 19 2 DAC03-N12 23-CG5557-RA_1 CG5557 ATCCTTCCAACTTCCAAATTCATCATGAAACTTGTATACGATTCGGCCAAAATCAACTCCATCACTGCC 69 FBan0005557 FBgn0010768 sqz 3 3R cell proliferation; GO:0008283; oogenesis (sensu Insecta); GO:0009993; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 sqz squeeze "CG5557, CG5557, CG5557, CG5557, CG5557, l(3)02102, anon-WO0118547.697, squeeze" CDMC20359 2 20 2 DAC03-N12 23-CG5557-RA_1 CG5557 ATCCTTCCAACTTCCAAATTCATCATGAAACTTGTATACGATTCGGCCAAAATCAACTCCATCACTGCC 69 FBan0005557 FBgn0010768 sqz 3 3R cell proliferation; GO:0008283; oogenesis (sensu Insecta); GO:0009993; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 sqz squeeze "CG5557, CG5557, CG5557, CG5557, CG5557, l(3)02102, anon-WO0118547.697, squeeze" CDMC20360 2 21 2 DAC03-N24 1-CG5565-RA_1 CG5565 AGGGGTCAGGGATCTGATTCTCCACTTGCACGAATACCGCATACCCTTCTGCATAGCCACAAGTTCGTT 69 FBan0005565 FBgn0031335 CG5565 2 2L metabolism; GO:0008152 catalytic activity; GO:0003824; ; GO:0003824 CG5565 CG5565 CDMC20360 2 22 2 DAC03-N24 1-CG5565-RA_1 CG5565 AGGGGTCAGGGATCTGATTCTCCACTTGCACGAATACCGCATACCCTTCTGCATAGCCACAAGTTCGTT 69 FBan0005565 FBgn0031335 CG5565 2 2L metabolism; GO:0008152 catalytic activity; GO:0003824; ; GO:0003824 CG5565 CG5565 CDMC20361 2 23 2 DAC04-B12 3-CG12362-RB_2 CG12362 GCCAAAATGGATGACATGCAGGAGGAGATGAGCTGGATTGAGGTTCAGTTTCTGCGTGATGCCGTCGAT 69 FBan0012362 FBgn0036082 CG12362 3 3L protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG12362 CG12362 CDMC20361 2 24 2 DAC04-B12 3-CG12362-RB_2 CG12362 GCCAAAATGGATGACATGCAGGAGGAGATGAGCTGGATTGAGGTTCAGTTTCTGCGTGATGCCGTCGAT 69 FBan0012362 FBgn0036082 CG12362 3 3L protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG12362 CG12362 CDMC20362 2 25 2 DAC04-B24 11-CG12373-RA_1 CG12373 CGCAAGCCAGCACTGAATACGTGATCAACCGGAATCCACGGAACTTGGAAAGATTACGCATTGCCTACA 69 FBan0012373 FBgn0026741 mRpL18 2 2R structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL18 mitochondrial ribosomal protein L18 "CG12373, HL, MRP-L18, anon-49Ca, mitochondrial ribosomal protein L18" CDMC20362 2 26 2 DAC04-B24 11-CG12373-RA_1 CG12373 CGCAAGCCAGCACTGAATACGTGATCAACCGGAATCCACGGAACTTGGAAAGATTACGCATTGCCTACA 69 FBan0012373 FBgn0026741 mRpL18 2 2R structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL18 mitochondrial ribosomal protein L18 "CG12373, HL, MRP-L18, anon-49Ca, mitochondrial ribosomal protein L18" CDMC20363 2 1 3 DAC04-F12 23-CG1240-RA_3 CG1240 TGTTCCACAACCTTTGATTAAGATTTAGTTGACGCATGTGTTTAGCATTACCCTAATTAGGACGGGTTT 69 FBan0001240 FBgn0035370 CG1240 3 3L CG1240 CG1240 CDMC20363 2 2 3 DAC04-F12 23-CG1240-RA_3 CG1240 TGTTCCACAACCTTTGATTAAGATTTAGTTGACGCATGTGTTTAGCATTACCCTAATTAGGACGGGTTT 69 FBan0001240 FBgn0035370 CG1240 3 3L CG1240 CG1240 CDMC20364 2 3 3 DAC04-F24 15-CG12420-RA_2 CG12420 AGGCGGAGATCACATGATCATCGCTATCACCACACTGTTGGTTTTGATCTGTTCCCTACATCTCGCCAA 69 FBan0012420 FBgn0037797 CG12420 3 3R CG12420 CG12420 CDMC20364 2 4 3 DAC04-F24 15-CG12420-RA_2 CG12420 AGGCGGAGATCACATGATCATCGCTATCACCACACTGTTGGTTTTGATCTGTTCCCTACATCTCGCCAA 69 FBan0012420 FBgn0037797 CG12420 3 3R CG12420 CG12420 CDMC20365 2 5 3 DAC04-J12 1-CG12460-RA_8 CG12460 GGTGGACCAGAATATCAAGGAGGTGCAGGCAATTAAGGAGGCCAAGGAAATCAAGGAGGAGCCGGAAAT 69 FBgn0040045 CG12460 "RNA splicing; GO:0008380; nuclear mRNA splicing, via spliceosome; GO:0000398" transcription regulator activity; GO:0030528; ; GO:0030528 spliceosome complex; GO:0005681 CG12460 CG12460 "CG40051, CG40051" CDMC20365 2 6 3 DAC04-J12 1-CG12460-RA_8 CG12460 GGTGGACCAGAATATCAAGGAGGTGCAGGCAATTAAGGAGGCCAAGGAAATCAAGGAGGAGCCGGAAAT 69 FBgn0040045 CG12460 "RNA splicing; GO:0008380; nuclear mRNA splicing, via spliceosome; GO:0000398" transcription regulator activity; GO:0030528; ; GO:0030528 spliceosome complex; GO:0005681 CG12460 CG12460 "CG40051, CG40051" CDMC20366 2 7 3 DAC04-J24 13-CG12486-RA_1 CG12486 GCGATGCATTCGAGAATGTGGAAGCTACAGTGAGTAAAGGACACACCAGAATACCACAATCGCTCCCGA 69 FBan0012486 FBgn0036541 CG12486 3 3L CG12486 CG12486 CDMC20366 2 8 3 DAC04-J24 13-CG12486-RA_1 CG12486 GCGATGCATTCGAGAATGTGGAAGCTACAGTGAGTAAAGGACACACCAGAATACCACAATCGCTCCCGA 69 FBan0012486 FBgn0036541 CG12486 3 3L CG12486 CG12486 CDMC20367 2 9 3 DAC04-N12 3-CG12525-RA_1 CG12525 GGGTTCAGAGTGCCGGTATTGTGGAATATTGGAAGCATCAAACTCTGCGCGAGATGATCACCATGGGCA 69 FBan0012525 FBgn0036010 CG12525 3 3L CG12525 CG12525 CDMC20367 2 10 3 DAC04-N12 3-CG12525-RA_1 CG12525 GGGTTCAGAGTGCCGGTATTGTGGAATATTGGAAGCATCAAACTCTGCGCGAGATGATCACCATGGGCA 69 FBan0012525 FBgn0036010 CG12525 3 3L CG12525 CG12525 CDMC20368 2 11 3 DAC04-N24 15-CG12535-RB_5 CG12535 GTTCGAACTGCAGCATATTACCACTCGGATTCGCACACTTTTGCGTAGAACCTTTCACCTGTCCAGCAA 69 FBan0012535 FBgn0029657 CG12535 X X CG12535 CG12535 CDMC20368 2 12 3 DAC04-N24 15-CG12535-RB_5 CG12535 GTTCGAACTGCAGCATATTACCACTCGGATTCGCACACTTTTGCGTAGAACCTTTCACCTGTCCAGCAA 69 FBan0012535 FBgn0029657 CG12535 X X CG12535 CG12535 CDMC20369 2 13 3 DAC05-B12 7-CG5043-RA_1 CG5043 GCTGCTTCAGGACAATGCACTAATTGAAGGTGAGATGAGCTTTGTGGTTGGTCCAGATCAGGATGCCCG 69 FBan0005043 FBgn0032636 CG5043 2 2L CG5043 CG5043 CDMC20369 2 14 3 DAC05-B12 7-CG5043-RA_1 CG5043 GCTGCTTCAGGACAATGCACTAATTGAAGGTGAGATGAGCTTTGTGGTTGGTCCAGATCAGGATGCCCG 69 FBan0005043 FBgn0032636 CG5043 2 2L CG5043 CG5043 CDMC20370 2 15 3 DAC05-B24 14-CG5053-RA_1 CG5053 GGCCAATTGCGAAACAGAGCTGCTACAATGCAAGAACAAAATGCGCTTGCTGATGGATGACATTGAGCT 69 FBan0005053 FBgn0039352 CG5053 3 3R signal transduction; GO:0007165 CG5053 CG5053 CDMC20370 2 16 3 DAC05-B24 14-CG5053-RA_1 CG5053 GGCCAATTGCGAAACAGAGCTGCTACAATGCAAGAACAAAATGCGCTTGCTGATGGATGACATTGAGCT 69 FBan0005053 FBgn0039352 CG5053 3 3R signal transduction; GO:0007165 CG5053 CG5053 CDMC20371 2 17 3 DAC05-F12 2-CG5083-RA_1 CG5083 ACAAGCTCGTCACCTTCGCATAGGAAGCTGTCCACCCATGATCTACCAGCAAGTCTTCCCCTAAGCATT 69 FBan0005083 FBgn0038390 Rbf2 3 3R negative regulation of transcription from RNA polymerase II promoter; GO:0000122; regulation of progression through cell cycle; GO:0000074; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528 Myb complex; GO:0031523; Rb-E2F complex; GO:0035189; nucleus; GO:0005634 Rbf2 Retinoblastoma-family protein 2 "CG5083, rbf2, RBF2, Retinoblastoma-family protein 2" CDMC20371 2 18 3 DAC05-F12 2-CG5083-RA_1 CG5083 ACAAGCTCGTCACCTTCGCATAGGAAGCTGTCCACCCATGATCTACCAGCAAGTCTTCCCCTAAGCATT 69 FBan0005083 FBgn0038390 Rbf2 3 3R negative regulation of transcription from RNA polymerase II promoter; GO:0000122; regulation of progression through cell cycle; GO:0000074; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528 Myb complex; GO:0031523; Rb-E2F complex; GO:0035189; nucleus; GO:0005634 Rbf2 Retinoblastoma-family protein 2 "CG5083, rbf2, RBF2, Retinoblastoma-family protein 2" CDMC20372 2 19 3 DAC05-F24 9-CG5096-RA_1 CG5096 GTTCTGGCCAAAGATGTCAAATGTGGCGGTCCGAACAAGTTAAACGATGTTACGCTGCTCAGAGTGGCG 69 FBan0005096 FBgn0032235 CG5096 2 2L cell adhesion; GO:0007155; development; GO:0007275; transmission of nerve impulse; GO:0019226 receptor activity; GO:0004872; ; GO:0004872 CG5096 CG5096 CT16355 CDMC20372 2 20 3 DAC05-F24 9-CG5096-RA_1 CG5096 GTTCTGGCCAAAGATGTCAAATGTGGCGGTCCGAACAAGTTAAACGATGTTACGCTGCTCAGAGTGGCG 69 FBan0005096 FBgn0032235 CG5096 2 2L cell adhesion; GO:0007155; development; GO:0007275; transmission of nerve impulse; GO:0019226 receptor activity; GO:0004872; ; GO:0004872 CG5096 CG5096 CT16355 CDMC20373 2 21 3 DAC05-J12 3-CG5130-RB_10 CG5130 CGACTTGGAGATCTTTGAGCGAACCTTGGTCACCAAGTTCCCGGAGATCATCAGTTACCACGACCTGCA 69 FBan0005130 FBgn0037000 CG5130 3 3L cation transport; GO:0006812 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; zinc ion transporter activity; GO:0005385; ; GO:0005385 membrane; GO:0016020 CG5130 CG5130 anon-WO0118547.435 CDMC20373 2 22 3 DAC05-J12 3-CG5130-RB_10 CG5130 CGACTTGGAGATCTTTGAGCGAACCTTGGTCACCAAGTTCCCGGAGATCATCAGTTACCACGACCTGCA 69 FBan0005130 FBgn0037000 CG5130 3 3L cation transport; GO:0006812 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; zinc ion transporter activity; GO:0005385; ; GO:0005385 membrane; GO:0016020 CG5130 CG5130 anon-WO0118547.435 CDMC20374 2 23 3 DAC05-J24 7-CG5142-RA_1 CG5142 AGCCCAGGCATTGGATTACACATCCGAGATTGTAGAGCGAGGAATGCGCAATCATCCAGAGCTTGGAAT 69 FBan0005142 FBgn0032470 CG5142 2 2L CG5142 CG5142 CDMC20374 2 24 3 DAC05-J24 7-CG5142-RA_1 CG5142 AGCCCAGGCATTGGATTACACATCCGAGATTGTAGAGCGAGGAATGCGCAATCATCCAGAGCTTGGAAT 69 FBan0005142 FBgn0032470 CG5142 2 2L CG5142 CG5142 CDMC20375 2 25 3 DAC05-N12 2-CG5175-RB_1 CG5175 CGTCGGGTCGTTTTTCGTCAGGAAAATCACCGTTCTGTCACAGATTCCTTGCTGGTTGTCTCCTCGCGA 69 FBan0005175 FBgn0038476 kuk 3 3R kuk kugelkern "CG5175, CG5175, CG5175, kugelkern" CDMC20375 2 26 3 DAC05-N12 2-CG5175-RB_1 CG5175 CGTCGGGTCGTTTTTCGTCAGGAAAATCACCGTTCTGTCACAGATTCCTTGCTGGTTGTCTCCTCGCGA 69 FBan0005175 FBgn0038476 kuk 3 3R kuk kugelkern "CG5175, CG5175, CG5175, kugelkern" CDMC20376 2 1 4 DAC05-N24 3-CG5187-RA_1 CG5187 CTTGTGGATTTGGCATGTACCTACTTTGGGAGACCCCATGAGTATGGAGGAGCGATTCAGGCCTCACCT 69 FBan0005187 FBgn0035956 Doc2 3 3L mesoderm development; GO:0007498; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Doc2 Dorsocross2 "CG5187, CG5187, Dm-DOC2, Dorsocross2" CDMC20376 2 2 4 DAC05-N24 3-CG5187-RA_1 CG5187 CTTGTGGATTTGGCATGTACCTACTTTGGGAGACCCCATGAGTATGGAGGAGCGATTCAGGCCTCACCT 69 FBan0005187 FBgn0035956 Doc2 3 3L mesoderm development; GO:0007498; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Doc2 Dorsocross2 "CG5187, CG5187, Dm-DOC2, Dorsocross2" CDMC20377 2 3 4 DAC06-B12 17-CG9372-RA_7 CG9372 TGAAGGCATTTCTTTGGGCATTGGTGATTTTACTGGGCTATATCCCGCAGAGTACAATCGCCAAGACTG 69 FBan0009372 FBgn0036891 CG9372 3 3L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type peptidase activity; GO:0008236; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0008236; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG9372 CG9372 "SP34, c-SP34" CDMC20377 2 4 4 DAC06-B12 17-CG9372-RA_7 CG9372 TGAAGGCATTTCTTTGGGCATTGGTGATTTTACTGGGCTATATCCCGCAGAGTACAATCGCCAAGACTG 69 FBan0009372 FBgn0036891 CG9372 3 3L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type peptidase activity; GO:0008236; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0008236; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG9372 CG9372 "SP34, c-SP34" CDMC20378 2 5 4 DAC06-B24 23-CG9384-RA_2 CG9384 GCTCTCCCCGACACACTCATTTTGCCAAATTGAAAACAATTAGCAAGCAACAATAATAGTGGATAGTGA 69 FBan0009384 FBgn0036446 CG9384 3 3L carbohydrate metabolism; GO:0005975; protein amino acid glycosylation; GO:0006486 "alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity; GO:0008454 ; EC:2.4.1.145; ; GO:0008454 ; EC:2.4.1.145" membrane; GO:0016020 CG9384 CG9384 CDMC20378 2 6 4 DAC06-B24 23-CG9384-RA_2 CG9384 GCTCTCCCCGACACACTCATTTTGCCAAATTGAAAACAATTAGCAAGCAACAATAATAGTGGATAGTGA 69 FBan0009384 FBgn0036446 CG9384 3 3L carbohydrate metabolism; GO:0005975; protein amino acid glycosylation; GO:0006486 "alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity; GO:0008454 ; EC:2.4.1.145; ; GO:0008454 ; EC:2.4.1.145" membrane; GO:0016020 CG9384 CG9384 CDMC20379 2 7 4 DAC06-F12 15-CG9427-RA_1 CG9427 ACCCGTTTACGAGGAGTTCGGGGACTACATTGATATACTCTTAGTGCCCTTCGGAAAATCGCAGTCGGA 69 FBan0009427 FBgn0037721 CG9427 3 3R CG9427 CG9427 CDMC20379 2 8 4 DAC06-F12 15-CG9427-RA_1 CG9427 ACCCGTTTACGAGGAGTTCGGGGACTACATTGATATACTCTTAGTGCCCTTCGGAAAATCGCAGTCGGA 69 FBan0009427 FBgn0037721 CG9427 3 3R CG9427 CG9427 CDMC20380 2 9 4 DAC06-F24 9-CG9432-RB_3 CG9432 GGGCTTGGAACTGATCGATGACGAATGCGACGTGTTCGGAATTCATATGGTCAAGATCCAGGATCCGCA 69 FBan0009432 FBgn0010482 l(2)01289 2 2R electron transport; GO:0006118 electron transporter activity; GO:0005489; protein disulfide isomerase activity; GO:0003756 ; EC:5.3.4.1; ; GO:0003756 ; EC:5.3.4.1; ; GO:0005489 plasma membrane; GO:0005886 l(2)01289 lethal (2) 01289 "CG9432, CG9435, CG30444, CG9432, Fusion-2, Fusion2" CDMC20380 2 10 4 DAC06-F24 9-CG9432-RB_3 CG9432 GGGCTTGGAACTGATCGATGACGAATGCGACGTGTTCGGAATTCATATGGTCAAGATCCAGGATCCGCA 69 FBan0009432 FBgn0010482 l(2)01289 2 2R electron transport; GO:0006118 electron transporter activity; GO:0005489; protein disulfide isomerase activity; GO:0003756 ; EC:5.3.4.1; ; GO:0003756 ; EC:5.3.4.1; ; GO:0005489 plasma membrane; GO:0005886 l(2)01289 lethal (2) 01289 "CG9432, CG9435, CG30444, CG9432, Fusion-2, Fusion2" CDMC20381 2 11 4 DAC06-J12 14-CG9465-RA_1 CG9465 ACGTGAATTGATGAAACGTGTGAAGGATAAACGCGAGGACTTCGTTTCCGACTTAAGCCGACAGCCTGT 69 FBan0009465 FBgn0032067 CG9465 2 2L carbohydrate metabolism; GO:0005975 "alpha-mannosidase activity; GO:0004559 ; EC:3.2.1.24; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004559 ; EC:3.2.1.24" lysosome; GO:0005764 CG9465 CG9465 CDMC20381 2 12 4 DAC06-J12 14-CG9465-RA_1 CG9465 ACGTGAATTGATGAAACGTGTGAAGGATAAACGCGAGGACTTCGTTTCCGACTTAAGCCGACAGCCTGT 69 FBan0009465 FBgn0032067 CG9465 2 2L carbohydrate metabolism; GO:0005975 "alpha-mannosidase activity; GO:0004559 ; EC:3.2.1.24; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004559 ; EC:3.2.1.24" lysosome; GO:0005764 CG9465 CG9465 CDMC20382 2 13 4 DAC06-J24 3-CG9475-RA_1 CG9475 CCACCAATCGTGCAGATACCTTAGATCCGGCTCTGTTACGACCCGGCCGTTTGGATCGGAAAATTGAGT 69 FBan0009475 FBgn0037742 Rpt3R 3 3R proteolysis; GO:0006508 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; nucleotide binding; GO:0000166; ; GO:0016887; ; GO:0000166 "proteasome complex (sensu Eukaryota); GO:0000502; proteasome regulatory particle, base subcomplex (sensu Eukaryota); GO:0008540" Rpt3R Rpt3R "CG9475, CG9475, DmCG9475, Dm_Rpt3b" CDMC20382 2 14 4 DAC06-J24 3-CG9475-RA_1 CG9475 CCACCAATCGTGCAGATACCTTAGATCCGGCTCTGTTACGACCCGGCCGTTTGGATCGGAAAATTGAGT 69 FBan0009475 FBgn0037742 Rpt3R 3 3R proteolysis; GO:0006508 ATP binding; GO:0005524; ; GO:0005524; ATPase activity; GO:0016887; nucleotide binding; GO:0000166; ; GO:0016887; ; GO:0000166 "proteasome complex (sensu Eukaryota); GO:0000502; proteasome regulatory particle, base subcomplex (sensu Eukaryota); GO:0008540" Rpt3R Rpt3R "CG9475, CG9475, DmCG9475, Dm_Rpt3b" CDMC20383 2 15 4 DAC06-N12 3-CG9511-RA_1 CG9511 GGCTTGGCATATCAGACGAACTAACCGCATCACCGACTTGACTACTGACCCCAATCTAAGCCCCTTCGT 69 FBan0009511 FBgn0031810 CG9511 2 2L CG9511 CG9511 CT26922 CDMC20383 2 16 4 DAC06-N12 3-CG9511-RA_1 CG9511 GGCTTGGCATATCAGACGAACTAACCGCATCACCGACTTGACTACTGACCCCAATCTAAGCCCCTTCGT 69 FBan0009511 FBgn0031810 CG9511 2 2L CG9511 CG9511 CT26922 CDMC20384 2 17 4 DAC06-N24 23-CG9520-RB_10 CG9520 AAGAGATCCGCCGAGACAAAGACGCAATAATAGAGACACACGGGTAGACACCTAATGTACATATAGCTT 69 FBan0009520 FBgn0032078 CG9520 2 2L glycolipid biosynthesis; GO:0009247; protein amino acid glycosylation; GO:0006486; protein metabolism; GO:0019538; protein modification; GO:0006464 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-; beta-1,3-galactosyltransferase activity; GO:0048531; ; GO:0048531" CG9520 CG9520 anon-WO0144478.18 CDMC20384 2 18 4 DAC06-N24 23-CG9520-RB_10 CG9520 AAGAGATCCGCCGAGACAAAGACGCAATAATAGAGACACACGGGTAGACACCTAATGTACATATAGCTT 69 FBan0009520 FBgn0032078 CG9520 2 2L glycolipid biosynthesis; GO:0009247; protein amino acid glycosylation; GO:0006486; protein metabolism; GO:0019538; protein modification; GO:0006464 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-; beta-1,3-galactosyltransferase activity; GO:0048531; ; GO:0048531" CG9520 CG9520 anon-WO0144478.18 CDMC20385 2 19 4 DAC07-B12 23-CG6571-RA_2 CG6571 ATAAGAAGCACCTGTACCCTATTTGTATTTTGAGCCACATTTCATCGATAGACGGACTATTTTCCTGGA 69 FBan0006571 FBgn0004366 rdgC 3 3L calcium-mediated signaling; GO:0019722; deactivation of rhodopsin mediated signaling; GO:0016059; photoreceptor maintenance; GO:0045494; phototransduction; GO:0007602; protein amino acid dephosphorylation; GO:0006470; visual perception; GO:0007601 calmodulin binding; GO:0005516; ; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; calcium-dependent protein serine/threonine phosphatase activity; GO:0004723; protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722; ; GO:0005509; ; GO:0004723 rdgC retinal degeneration C "CG6571, CG6571, CG6571, RdgC 77B, RDGC/PP5, RDGC" CDMC20385 2 20 4 DAC07-B12 23-CG6571-RA_2 CG6571 ATAAGAAGCACCTGTACCCTATTTGTATTTTGAGCCACATTTCATCGATAGACGGACTATTTTCCTGGA 69 FBan0006571 FBgn0004366 rdgC 3 3L calcium-mediated signaling; GO:0019722; deactivation of rhodopsin mediated signaling; GO:0016059; photoreceptor maintenance; GO:0045494; phototransduction; GO:0007602; protein amino acid dephosphorylation; GO:0006470; visual perception; GO:0007601 calmodulin binding; GO:0005516; ; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; calcium-dependent protein serine/threonine phosphatase activity; GO:0004723; protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722; ; GO:0005509; ; GO:0004723 rdgC retinal degeneration C "CG6571, CG6571, CG6571, RdgC 77B, RDGC/PP5, RDGC" CDMC20386 2 21 4 DAC07-B24 8-CG6582-RA_1 CG6582 ACGGAGGAGAACCAACTGAAGCAGACGGCACTGAAGACGACATCAAACATCAACATTCTGATCCGGGAT 69 FBan0006582 FBgn0027885 Aac11 2 2L anti-apoptosis; GO:0006916 Aac11 Aac11 "CG6582, BcDNA.LD09852, l(2)k06710, BcDNA:LD09852" CDMC20386 2 22 4 DAC07-B24 8-CG6582-RA_1 CG6582 ACGGAGGAGAACCAACTGAAGCAGACGGCACTGAAGACGACATCAAACATCAACATTCTGATCCGGGAT 69 FBan0006582 FBgn0027885 Aac11 2 2L anti-apoptosis; GO:0006916 Aac11 Aac11 "CG6582, BcDNA.LD09852, l(2)k06710, BcDNA:LD09852" CDMC20387 2 23 4 DAC07-F12 2-CG6608-RA_1 CG6608 GGCCCCCACACTCCTTAAGTCAAGCATGACGACGGCCCTGTACTTCAGCATTTACGATAAGCTCAAGCA 69 FBan0006608 FBgn0037852 CG6608 3 3R cation transport; GO:0006812 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG6608 CG6608 CDMC20387 2 24 4 DAC07-F12 2-CG6608-RA_1 CG6608 GGCCCCCACACTCCTTAAGTCAAGCATGACGACGGCCCTGTACTTCAGCATTTACGATAAGCTCAAGCA 69 FBan0006608 FBgn0037852 CG6608 3 3R cation transport; GO:0006812 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG6608 CG6608 CDMC20388 2 25 4 DAC07-F24 17-CG6621-RA_1 CG6621 CGCCACCAATGAAAAAAACAGCAGTCTCATCTAGAAAGTCAAGCTTTGACAATGTGGGACCCAGCACAT 69 FBan0006621 FBgn0037855 CG6621 3 3R CG6621 CG6621 CDMC20388 2 26 4 DAC07-F24 17-CG6621-RA_1 CG6621 CGCCACCAATGAAAAAAACAGCAGTCTCATCTAGAAAGTCAAGCTTTGACAATGTGGGACCCAGCACAT 69 FBan0006621 FBgn0037855 CG6621 3 3R CG6621 CG6621 CDMC20389 2 1 5 DAC07-J12 17-CG6656-RA_1 CG6656 CCGACCGATTGCAAAACATAAGATGCCTTCCAGACTTTGTTGAAAGTGTGTGTCGTTCTGGGTTGTTGT 69 FBan0006656 FBgn0038912 CG6656 3 3R phosphate metabolism; GO:0006796 acid phosphatase activity; GO:0003993 ; EC:3.1.3.2; ; GO:0003993 ; EC:3.1.3.2 CG6656 CG6656 CDMC20389 2 2 5 DAC07-J12 17-CG6656-RA_1 CG6656 CCGACCGATTGCAAAACATAAGATGCCTTCCAGACTTTGTTGAAAGTGTGTGTCGTTCTGGGTTGTTGT 69 FBan0006656 FBgn0038912 CG6656 3 3R phosphate metabolism; GO:0006796 acid phosphatase activity; GO:0003993 ; EC:3.1.3.2; ; GO:0003993 ; EC:3.1.3.2 CG6656 CG6656 CDMC20390 2 3 5 DAC07-J24 23-CG6664-RA_8 CG6664 CTCTCGCACAGGGATACAGAAAAATCATGACTTATTCACACACTTTCACACGAAAACACACTATATTCA 69 FBan0006664 FBgn0036685 CG6664 3 3L CG6664 CG6664 CDMC20390 2 4 5 DAC07-J24 23-CG6664-RA_8 CG6664 CTCTCGCACAGGGATACAGAAAAATCATGACTTATTCACACACTTTCACACGAAAACACACTATATTCA 69 FBan0006664 FBgn0036685 CG6664 3 3L CG6664 CG6664 CDMC20391 2 5 5 DAC07-N12 2-CG6691-RA_2 CG6691 GGGGTCCCATAGAAGATGAGTTCAGTCAGCTTCCCTGGTTCCGCCAGTACATAATGAGGATGTGGCACA 69 FBan0006691 FBgn0032971 CG6691 2 2L CG6691 CG6691 CDMC20391 2 6 5 DAC07-N12 2-CG6691-RA_2 CG6691 GGGGTCCCATAGAAGATGAGTTCAGTCAGCTTCCCTGGTTCCGCCAGTACATAATGAGGATGTGGCACA 69 FBan0006691 FBgn0032971 CG6691 2 2L CG6691 CG6691 CDMC20392 2 7 5 DAC07-N24 3-CG6701-RA_4 CG6701 AGTCCAGGACGCCAAGATCTTCTACAGCAAGAATGAGCTGCTTAACCTCGGGAATGAGTGTCAGCGGAA 69 FBan0006701 FBgn0033889 CG6701 2 2R "DNA metabolism; GO:0006259; DNA replication; GO:0006260; cell cycle; GO:0007049; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ; GO:0003676; DNA helicase activity; GO:0003678; helicase activity; GO:0004386; zinc ion binding; GO:0008270; ; GO:0004386; ; GO:0003678; ; GO:0008270 nucleus; GO:0005634 CG6701 CG6701 "EP(2)2054, EP2054" CDMC20392 2 8 5 DAC07-N24 3-CG6701-RA_4 CG6701 AGTCCAGGACGCCAAGATCTTCTACAGCAAGAATGAGCTGCTTAACCTCGGGAATGAGTGTCAGCGGAA 69 FBan0006701 FBgn0033889 CG6701 2 2R "DNA metabolism; GO:0006259; DNA replication; GO:0006260; cell cycle; GO:0007049; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" nucleic acid binding; GO:0003676; ; GO:0003676; DNA helicase activity; GO:0003678; helicase activity; GO:0004386; zinc ion binding; GO:0008270; ; GO:0004386; ; GO:0003678; ; GO:0008270 nucleus; GO:0005634 CG6701 CG6701 "EP(2)2054, EP2054" CDMC20393 2 9 5 DAC08-B12 16-CG31861-RA_1 CG31861 TGAGCGTCGAAGAAAAGCAAGCCTTTCAAAGAATCGGCACAATTCAAGAAACTCCAACACACGTGCATT 69 FBan0031861 FBgn0051861 CG31861 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31861 CG31861 "CG17215, CG17215" CDMC20393 2 10 5 DAC08-B12 16-CG31861-RA_1 CG31861 TGAGCGTCGAAGAAAAGCAAGCCTTTCAAAGAATCGGCACAATTCAAGAAACTCCAACACACGTGCATT 69 FBan0031861 FBgn0051861 CG31861 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31861 CG31861 "CG17215, CG17215" CDMC20394 2 11 5 DAC08-B24 6-CG3186-RA_3 CG3186 CGCGGCCATGCAAGATTGTCGAGATGTCTACTTCAAAGACTGGAAAGCACGGACACGCCAAGGTTCATA 69 FBan0003186 FBgn0034967 eIF-5A 2 2R autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071; translational initiation; GO:0006413 translation initiation factor activity; GO:0003743; translation regulator activity; GO:0045182; ; GO:0003743; ; GO:0045182 cytosol; GO:0005829 eIF-5A eIF-5A "CG3186, CG3186, CG3186, l(2)01296, 1296, anon-EST:fe2H10, anon-fast-evolving-2H10" CDMC20394 2 12 5 DAC08-B24 6-CG3186-RA_3 CG3186 CGCGGCCATGCAAGATTGTCGAGATGTCTACTTCAAAGACTGGAAAGCACGGACACGCCAAGGTTCATA 69 FBan0003186 FBgn0034967 eIF-5A 2 2R autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071; translational initiation; GO:0006413 translation initiation factor activity; GO:0003743; translation regulator activity; GO:0045182; ; GO:0003743; ; GO:0045182 cytosol; GO:0005829 eIF-5A eIF-5A "CG3186, CG3186, CG3186, l(2)01296, 1296, anon-EST:fe2H10, anon-fast-evolving-2H10" CDMC20395 2 13 5 DAC08-F12 12-CG31901-RA_1 CG31901 TCCTCCACCACAAATGCAGGTTCAACCGCCAGTTCTACAACTTCTTCGCCATCCATAAGCACTTCAACT 69 FBan0031901 FBgn0051901 CG31901 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31901 CG31901 BcDNA:LP08232 CDMC20395 2 14 5 DAC08-F12 12-CG31901-RA_1 CG31901 TCCTCCACCACAAATGCAGGTTCAACCGCCAGTTCTACAACTTCTTCGCCATCCATAAGCACTTCAACT 69 FBan0031901 FBgn0051901 CG31901 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31901 CG31901 BcDNA:LP08232 CDMC20396 2 15 5 DAC08-F24 3-CG31908-RA_3 CG31908 TCCCAAGTGACGCCGATGTATAATAACTACAACAGCTACTTCCCGGGACTGCACAATCAGCCTGGCCTT 69 FBan0031908 FBgn0051908 CG31908 2 2L CG31908 CG31908 "CG8761, CG8761" CDMC20396 2 16 5 DAC08-F24 3-CG31908-RA_3 CG31908 TCCCAAGTGACGCCGATGTATAATAACTACAACAGCTACTTCCCGGGACTGCACAATCAGCCTGGCCTT 69 FBan0031908 FBgn0051908 CG31908 2 2L CG31908 CG31908 "CG8761, CG8761" CDMC20397 2 17 5 DAC08-J12 12-CG31937-RA_1 CG31937 GCTCGATCTCGACGAGCATAAGACGCATCTCAACACGGTGCTCAATCACTTTCATCGACTGGATGTCCT 69 FBgn0051937 CDMC20397 2 18 5 DAC08-J12 12-CG31937-RA_1 CG31937 GCTCGATCTCGACGAGCATAAGACGCATCTCAACACGGTGCTCAATCACTTTCATCGACTGGATGTCCT 69 FBgn0051937 CDMC20398 2 19 5 DAC08-J24 3-CG31960-RA_1 CG31960 TGCCATCACCTCGAAGGAATTGGGAATGGTAATCCGAGCATTAGGTCGACAGCCCAATGAATCGGAGGT 69 FBan0031960 FBgn0051960 CG31960 2 2L calcium-mediated signaling; GO:0019722; muscle contraction; GO:0006936 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG31960 CG31960 CG10022 CDMC20398 2 20 5 DAC08-J24 3-CG31960-RA_1 CG31960 TGCCATCACCTCGAAGGAATTGGGAATGGTAATCCGAGCATTAGGTCGACAGCCCAATGAATCGGAGGT 69 FBan0031960 FBgn0051960 CG31960 2 2L calcium-mediated signaling; GO:0019722; muscle contraction; GO:0006936 calmodulin binding; GO:0005516; ; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509 CG31960 CG31960 CG10022 CDMC20399 2 21 5 DAC08-N12 23-CG32006-RA_7 CG32006 ATGATAGCGCTGGGTATGATCGAAACGACGATATCTTAGAAAACCTTCTTGATGTTTGTGTTACGCCTT 69 FBan0032006 FBgn0052006 CG32006 4 4 "regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG32006 CG32006 "DmCg32006, BcDNA:RE51913" CDMC20399 2 22 5 DAC08-N12 23-CG32006-RA_7 CG32006 ATGATAGCGCTGGGTATGATCGAAACGACGATATCTTAGAAAACCTTCTTGATGTTTGTGTTACGCCTT 69 FBan0032006 FBgn0052006 CG32006 4 4 "regulation of transcription, DNA-dependent; GO:0006355" transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG32006 CG32006 "DmCg32006, BcDNA:RE51913" CDMC20400 2 23 5 DAC08-N24 23-CG3201-RA_1 CG3201 CAATGGAAGGAAGGAAAGCCAGAGTATCACGAAAAAGTATTTCTAAATTAAAGCTGATATGCGTCGGTG 69 FBan0003201 FBgn0004687 Mlc-c X X muscle contraction; GO:0006936 "cytoskeletal protein binding; GO:0008092; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; calcium ion binding; GO:0005509; ; GO:0005200; ; GO:0042623; ; GO:0005509" myosin; GO:0016459; unconventional myosin; GO:0016461 Mlc-c Myosin light chain cytoplasmic "CG3201, CG3201, alkali light chain of non-muscle myosin-II, DmMLC_C, nmELC" CDMC20400 2 24 5 DAC08-N24 23-CG3201-RA_1 CG3201 CAATGGAAGGAAGGAAAGCCAGAGTATCACGAAAAAGTATTTCTAAATTAAAGCTGATATGCGTCGGTG 69 FBan0003201 FBgn0004687 Mlc-c X X muscle contraction; GO:0006936 "cytoskeletal protein binding; GO:0008092; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; calcium ion binding; GO:0005509; ; GO:0005200; ; GO:0042623; ; GO:0005509" myosin; GO:0016459; unconventional myosin; GO:0016461 Mlc-c Myosin light chain cytoplasmic "CG3201, CG3201, alkali light chain of non-muscle myosin-II, DmMLC_C, nmELC" CDMC20401 2 25 5 DAC09-B13 3-CG5389-RA_1 CG5389 TAGGCGAGGAGCACTACAATGTGGCTCGAGCAGTTCAGAAGACTCTGCAGGCTTACAAGTCGCTG 65 FBan0005389 FBgn0036568 CG5389 3 3L ATP biosynthesis; GO:0006754; ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992; purine base metabolism; GO:0006144 "ATP binding; GO:0005524; ; GO:0005524; hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; nucleotide binding; GO:0000166; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0000166; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "proton-transporting ATP synthase complex, catalytic core F(1) (sensu Eukaryota); GO:0000275" CG5389 CG5389 CDMC20401 2 26 5 DAC09-B13 3-CG5389-RA_1 CG5389 TAGGCGAGGAGCACTACAATGTGGCTCGAGCAGTTCAGAAGACTCTGCAGGCTTACAAGTCGCTG 65 FBan0005389 FBgn0036568 CG5389 3 3L ATP biosynthesis; GO:0006754; ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992; purine base metabolism; GO:0006144 "ATP binding; GO:0005524; ; GO:0005524; hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; nucleotide binding; GO:0000166; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0000166; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" "proton-transporting ATP synthase complex, catalytic core F(1) (sensu Eukaryota); GO:0000275" CG5389 CG5389 CDMC20402 2 1 6 DAC09-C01 6-CG5423-RA_3 CG5423 GGCAGCAATAACAACAATCACCAGGGCAATGACTACCAGTCGACCGGGATGTACTCCGCTCCACC 65 FBan0005423 FBgn0041097 robo3 2 2L axon guidance; GO:0007411; cell-cell adhesion; GO:0016337; defense response; GO:0006952; ectoderm development; GO:0007398; neuron recognition; GO:0008038; signal transduction; GO:0007165; ventral cord development; GO:0007419 axon guidance receptor activity; GO:0008046; ; GO:0008046 plasma membrane; GO:0005886 robo3 robo3 "CG5423, CG14345, dRobo-3, Robo3, CT17158, Robo-3" CDMC20402 2 2 6 DAC09-C01 6-CG5423-RA_3 CG5423 GGCAGCAATAACAACAATCACCAGGGCAATGACTACCAGTCGACCGGGATGTACTCCGCTCCACC 65 FBan0005423 FBgn0041097 robo3 2 2L axon guidance; GO:0007411; cell-cell adhesion; GO:0016337; defense response; GO:0006952; ectoderm development; GO:0007398; neuron recognition; GO:0008038; signal transduction; GO:0007165; ventral cord development; GO:0007419 axon guidance receptor activity; GO:0008046; ; GO:0008046 plasma membrane; GO:0005886 robo3 robo3 "CG5423, CG14345, dRobo-3, Robo3, CT17158, Robo-3" CDMC20403 2 3 6 DAC09-F13 3-CG5569-RA_3 CG5569 TTCAGCAAGGCCTACGACCACGACGGGAAGACCAAAGTCACCATCTTCAACACCGAAACGGATCT 65 FBan0005569 FBgn0034919 CG5569 2 2R CG5569 CG5569 BcDNA:SD18780 CDMC20403 2 4 6 DAC09-F13 3-CG5569-RA_3 CG5569 TTCAGCAAGGCCTACGACCACGACGGGAAGACCAAAGTCACCATCTTCAACACCGAAACGGATCT 65 FBan0005569 FBgn0034919 CG5569 2 2R CG5569 CG5569 BcDNA:SD18780 CDMC20404 2 5 6 DAC09-G01 3-CG5599-RA_1 CG5599 TTCCTCCCGGTACTAACGTTCCACATCCCACACTATTGGCGAAAACGCCTAGTGCTGCTCCAAGT 65 FBan0005599 FBgn0030612 CG5599 X X tricarboxylic acid cycle; GO:0006099 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; acetyltransferase activity; GO:0016407 ; EC:2.3.1.-; protein binding; GO:0005515; ; GO:0016491 ; EC:1.-.-.-; ; GO:0016407 ; EC:2.3.1.-; dihydrolipoamide branched chain acyltransferase activity; GO:0004147 ; EC:2.3.1.-; ; GO:0004147 ; EC:2.3.1.-; ; GO:0005515 oxoglutarate dehydrogenase complex (sensu Eukaryota); GO:0009353 CG5599 CG5599 CDMC20404 2 6 6 DAC09-G01 3-CG5599-RA_1 CG5599 TTCCTCCCGGTACTAACGTTCCACATCCCACACTATTGGCGAAAACGCCTAGTGCTGCTCCAAGT 65 FBan0005599 FBgn0030612 CG5599 X X tricarboxylic acid cycle; GO:0006099 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; acetyltransferase activity; GO:0016407 ; EC:2.3.1.-; protein binding; GO:0005515; ; GO:0016491 ; EC:1.-.-.-; ; GO:0016407 ; EC:2.3.1.-; dihydrolipoamide branched chain acyltransferase activity; GO:0004147 ; EC:2.3.1.-; ; GO:0004147 ; EC:2.3.1.-; ; GO:0005515 oxoglutarate dehydrogenase complex (sensu Eukaryota); GO:0009353 CG5599 CG5599 CDMC20405 2 7 6 DAC09-J13 23-CG5725-RC_1 CG5725 TTGTAAATGCATGAAATTACGTATGTATGGATAAAGTGCCTGCTAGAAAGCAACGAATTTTGGCC 65 FBan0005725 FBgn0011205 fbl 3 3L chromosome segregation; GO:0007059; coenzyme A biosynthesis; GO:0015937; coenzyme metabolism; GO:0006732; cytokinesis; GO:0000910; meiosis; GO:0007126; membrane organization and biogenesis; GO:0016044; mitosis; GO:0007067; spermatogenesis; GO:0007283 pantothenate kinase activity; GO:0004594 ; EC:2.7.1.33; ; GO:0004594 ; EC:2.7.1.33 cytoplasm; GO:0005737; plasma membrane; GO:0005886; spindle; GO:0005819 fbl fumble "CG5725, CG5725" CDMC20405 2 8 6 DAC09-J13 23-CG5725-RC_1 CG5725 TTGTAAATGCATGAAATTACGTATGTATGGATAAAGTGCCTGCTAGAAAGCAACGAATTTTGGCC 65 FBan0005725 FBgn0011205 fbl 3 3L chromosome segregation; GO:0007059; coenzyme A biosynthesis; GO:0015937; coenzyme metabolism; GO:0006732; cytokinesis; GO:0000910; meiosis; GO:0007126; membrane organization and biogenesis; GO:0016044; mitosis; GO:0007067; spermatogenesis; GO:0007283 pantothenate kinase activity; GO:0004594 ; EC:2.7.1.33; ; GO:0004594 ; EC:2.7.1.33 cytoplasm; GO:0005737; plasma membrane; GO:0005886; spindle; GO:0005819 fbl fumble "CG5725, CG5725" CDMC20406 2 9 6 DAC09-K01 3-CG5747-RA_3 CG5747 CTCTTCAAGCGCAAGGTCATCAACGGCTGGTTTCCGCTGCAAAGTAATGCACATCCATCGCAACG 65 FBan0005747 FBgn0035935 mfr 3 3L development; GO:0007275; mesoderm development; GO:0007498; spermatogenesis; GO:0007283 mfr misfire "CG5747, CG5747" CDMC20406 2 10 6 DAC09-K01 3-CG5747-RA_3 CG5747 CTCTTCAAGCGCAAGGTCATCAACGGCTGGTTTCCGCTGCAAAGTAATGCACATCCATCGCAACG 65 FBan0005747 FBgn0035935 mfr 3 3L development; GO:0007275; mesoderm development; GO:0007498; spermatogenesis; GO:0007283 mfr misfire "CG5747, CG5747" CDMC20407 2 11 6 DAC09-N13 3-CG5905-RB_1 CG5905 GAACATGACCCACGATCAGCTGTTCTTTCTCAACTACGCCCAAATCTGGTGCGGATCCATGCGGC 65 FBan0005905 FBgn0029843 Nep1 X X proteolysis; GO:0006508; signal transduction; GO:0007165 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; metallopeptidase activity; GO:0008237; ; GO:0008237; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008237; ; GO:0004222 ; EC:3.4.24.-; sugar binding; GO:0005529; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0008270; ; GO:0005529; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 Nep1 Neprilysin 1 "CG5894, CG5905, CG5914, CG5894, NEP, dNEP1, Neprilysin 1" CDMC20407 2 12 6 DAC09-N13 3-CG5905-RB_1 CG5905 GAACATGACCCACGATCAGCTGTTCTTTCTCAACTACGCCCAAATCTGGTGCGGATCCATGCGGC 65 FBan0005905 FBgn0029843 Nep1 X X proteolysis; GO:0006508; signal transduction; GO:0007165 metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; metallopeptidase activity; GO:0008237; ; GO:0008237; zinc ion binding; GO:0008270; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008237; ; GO:0004222 ; EC:3.4.24.-; sugar binding; GO:0005529; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0008270; ; GO:0005529; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 Nep1 Neprilysin 1 "CG5894, CG5905, CG5914, CG5894, NEP, dNEP1, Neprilysin 1" CDMC20408 2 13 6 DAC09-O01 14-CG5925-RA_1 CG5925 CTACAAGACGGCCGAATGGGGTTGCTACTCCCTGAATATAACGACGGCCTTCATCGACTTGTTCG 65 FBan0005925 FBgn0043043 desat2 3 3R cuticle hydrocarbon biosynthesis; GO:0006723; fatty acid biosynthesis; GO:0006633 stearoyl-CoA 9-desaturase activity; GO:0004768 ; EC:1.14.19.1; ; GO:0004768 ; EC:1.14.19.1; iron ion binding; GO:0005506; ; GO:0005506 endoplasmic reticulum; GO:0005783; membrane; GO:0016020 desat2 desat2 "CG5925, CG5925, desat, desaturase, 7-11HD, 7,11-heptacosadiene modifier, ds2, desaturase2, desat2/Fad, Fad, Fatty acid desaturase" CDMC20408 2 14 6 DAC09-O01 14-CG5925-RA_1 CG5925 CTACAAGACGGCCGAATGGGGTTGCTACTCCCTGAATATAACGACGGCCTTCATCGACTTGTTCG 65 FBan0005925 FBgn0043043 desat2 3 3R cuticle hydrocarbon biosynthesis; GO:0006723; fatty acid biosynthesis; GO:0006633 stearoyl-CoA 9-desaturase activity; GO:0004768 ; EC:1.14.19.1; ; GO:0004768 ; EC:1.14.19.1; iron ion binding; GO:0005506; ; GO:0005506 endoplasmic reticulum; GO:0005783; membrane; GO:0016020 desat2 desat2 "CG5925, CG5925, desat, desaturase, 7-11HD, 7,11-heptacosadiene modifier, ds2, desaturase2, desat2/Fad, Fad, Fatty acid desaturase" CDMC20409 2 15 6 DAC10-B12 15-CG6499-RA_3 CG6499 GCCGATCTAACGGAGCATCGGATTCGGCACTCACAAATCGGTTTATCGCGAGCCATCTCAGCGTT 65 FBan0006499 FBgn0038309 CG6499 3 3R cation transport; GO:0006812 ammonium transporter activity; GO:0008519; ; GO:0008519 CG6499 CG6499 CDMC20409 2 16 6 DAC10-B12 15-CG6499-RA_3 CG6499 GCCGATCTAACGGAGCATCGGATTCGGCACTCACAAATCGGTTTATCGCGAGCCATCTCAGCGTT 65 FBan0006499 FBgn0038309 CG6499 3 3R cation transport; GO:0006812 ammonium transporter activity; GO:0008519; ; GO:0008519 CG6499 CG6499 CDMC20410 2 17 6 DAC10-B24 16-CG6519-RA_1 CG6519 TTCCGCCGCTGCCGTGAATCCCGGAACCTACAAGCAGTACGCCATTCCCTCCTACGAGTTGGATG 65 FBan0006519 FBgn0000355 Cp15 3 3L insect chorion formation; GO:0007306 structural constituent of chorion (sensu Insecta); GO:0005213; ; GO:0005213 chorion; GO:0042600 Cp15 Chorion protein 15 "CG6519, E6, s15-1, s15, Cs15, s15 chorion gene, C.s15, s-15, cp15, S15: Shell-15, Dms15, Shell-15, S15" CDMC20410 2 18 6 DAC10-B24 16-CG6519-RA_1 CG6519 TTCCGCCGCTGCCGTGAATCCCGGAACCTACAAGCAGTACGCCATTCCCTCCTACGAGTTGGATG 65 FBan0006519 FBgn0000355 Cp15 3 3L insect chorion formation; GO:0007306 structural constituent of chorion (sensu Insecta); GO:0005213; ; GO:0005213 chorion; GO:0042600 Cp15 Chorion protein 15 "CG6519, E6, s15-1, s15, Cs15, s15 chorion gene, C.s15, s-15, cp15, S15: Shell-15, Dms15, Shell-15, S15" CDMC20411 2 19 6 DAC10-F12 3-CG6652-RA_2 CG6652 AAGGACAGTGCCGAAGACAAGAGTGGACCCAACACTCCACCTAGTCAAATCGAACGACAGGTGGG 65 FBan0006652 FBgn0036687 CG6652 3 3L CG6652 CG6652 CDMC20411 2 20 6 DAC10-F12 3-CG6652-RA_2 CG6652 AAGGACAGTGCCGAAGACAAGAGTGGACCCAACACTCCACCTAGTCAAATCGAACGACAGGTGGG 65 FBan0006652 FBgn0036687 CG6652 3 3L CG6652 CG6652 CDMC20412 2 21 6 DAC10-F24 3-CG6698-RA_1 CG6698 ATCCTATGAGCTGATGGTCTACGCCAACGGAAGCATCACCCTGTACGCTCAAAACCTCCAGCTGG 65 FBan0006698 FBgn0029147 NtR 2 2R transport; GO:0006810 excitatory extracellular ligand-gated ion channel activity; GO:0005231; ; GO:0005231 membrane; GO:0016020 NtR NtR "CG6698, DNtR, anon-WO0138359.3" CDMC20412 2 22 6 DAC10-F24 3-CG6698-RA_1 CG6698 ATCCTATGAGCTGATGGTCTACGCCAACGGAAGCATCACCCTGTACGCTCAAAACCTCCAGCTGG 65 FBan0006698 FBgn0029147 NtR 2 2R transport; GO:0006810 excitatory extracellular ligand-gated ion channel activity; GO:0005231; ; GO:0005231 membrane; GO:0016020 NtR NtR "CG6698, DNtR, anon-WO0138359.3" CDMC20413 2 23 6 DAC10-J12 3-CG6789-RA_4 CG6789 ATTTTGTCAGCGGGTCAATGAATTGATTGCCAGTGGTGAACGCCAAAGGGATGAGATTGCGGCGG 65 FBan0006789 FBgn0029745 CG6789 X X CG6789 CG6789 CDMC20413 2 24 6 DAC10-J12 3-CG6789-RA_4 CG6789 ATTTTGTCAGCGGGTCAATGAATTGATTGCCAGTGGTGAACGCCAAAGGGATGAGATTGCGGCGG 65 FBan0006789 FBgn0029745 CG6789 X X CG6789 CG6789 CDMC20414 2 25 6 DAC10-J24 1-CG6835-RA_4 CG6835 TATCGCAAGGTGCTGGCGCACGGATTCACCCAGATTGTTGCCTAGAGTTTTCATTTGCTGACGCT 65 FBan0006835 FBgn0030882 GS X X glutathione biosynthesis; GO:0006750; protein biosynthesis; GO:0006412 ATP binding; GO:0005524; ; GO:0005524; glutathione synthase activity; GO:0004363 ; EC:6.3.2.3; ; GO:0004363 ; EC:6.3.2.3 GS Glutathione Synthetase "CG6835, CG33065, CG32497, Glutathione Synthetase" CDMC20414 2 26 6 DAC10-J24 1-CG6835-RA_4 CG6835 TATCGCAAGGTGCTGGCGCACGGATTCACCCAGATTGTTGCCTAGAGTTTTCATTTGCTGACGCT 65 FBan0006835 FBgn0030882 GS X X glutathione biosynthesis; GO:0006750; protein biosynthesis; GO:0006412 ATP binding; GO:0005524; ; GO:0005524; glutathione synthase activity; GO:0004363 ; EC:6.3.2.3; ; GO:0004363 ; EC:6.3.2.3 GS Glutathione Synthetase "CG6835, CG33065, CG32497, Glutathione Synthetase" CDMC20415 2 1 7 DAC10-N12 2-CG6906-RA_2 CG6906 CGCCTTGCAGTGAGGAGGTCACCTGGATTGATTTCACAACGCCCATTGACATCACGGAGAAGCAG 65 FBgn0036261 CDMC20415 2 2 7 DAC10-N12 2-CG6906-RA_2 CG6906 CGCCTTGCAGTGAGGAGGTCACCTGGATTGATTTCACAACGCCCATTGACATCACGGAGAAGCAG 65 FBgn0036261 CDMC20416 2 3 7 DAC10-N24 3-CG6946-RA_9 CG6946 TTGTTCAGTTCGAAAGCCAGGACGACACTGAGCAAGCCTTGGGCCGAAATCGGGAAAAAATTGGG 65 FBan0006946 FBgn0037954 CG6946 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729 CG6946 CG6946 "0110/46, 110/46, l(3)S011046, cg6946, l(3)S11046, anon-WO0118547.328" CDMC20416 2 4 7 DAC10-N24 3-CG6946-RA_9 CG6946 TTGTTCAGTTCGAAAGCCAGGACGACACTGAGCAAGCCTTGGGCCGAAATCGGGAAAAAATTGGG 65 FBan0006946 FBgn0037954 CG6946 3 3R "nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729 CG6946 CG6946 "0110/46, 110/46, l(3)S011046, cg6946, l(3)S11046, anon-WO0118547.328" CDMC20417 2 5 7 DAC11-B12 15-CG10000-RA_1 CG10000 AGACAGTGGCAGTTAGAGCAACAGTAGCAGAAAATGCCAGCAGAAAACAGAAGTTCATGGTGTGGCTGC 69 FBan0010000 FBgn0039596 CG10000 3 3R oligosaccharide biosynthesis; GO:0009312; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 polypeptide N-acetylgalactosaminyltransferase activity; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41 Golgi stack; GO:0005795 CG10000 CG10000 CDMC20417 2 6 7 DAC11-B12 15-CG10000-RA_1 CG10000 AGACAGTGGCAGTTAGAGCAACAGTAGCAGAAAATGCCAGCAGAAAACAGAAGTTCATGGTGTGGCTGC 69 FBan0010000 FBgn0039596 CG10000 3 3R oligosaccharide biosynthesis; GO:0009312; polysaccharide metabolism; GO:0005976; protein amino acid glycosylation; GO:0006486 polypeptide N-acetylgalactosaminyltransferase activity; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41; ; GO:0004653 ; EC:2.4.1.41 Golgi stack; GO:0005795 CG10000 CG10000 CDMC20418 2 7 7 DAC11-B24 1-CG10013-RA_1 CG10013 GCAACTCCATGCCCCAAACAGGAGATGAAGAATTAGCTCCAACACCCAGATCCACTACCCCCAGAGGAA 69 FBan0010013 FBgn0038012 CG10013 3 3R CG10013 CG10013 CDMC20418 2 8 7 DAC11-B24 1-CG10013-RA_1 CG10013 GCAACTCCATGCCCCAAACAGGAGATGAAGAATTAGCTCCAACACCCAGATCCACTACCCCCAGAGGAA 69 FBan0010013 FBgn0038012 CG10013 3 3R CG10013 CG10013 CDMC20419 2 9 7 DAC11-F12 14-CG10050-RA_1 CG10050 CTGCGACAGGTGAAACTCATCGCCGTGGGTATAAGTGACTACATCATCCGTACACAGCCTACTGAAGGA 69 FBan0010050 FBgn0037492 CG10050 3 3R CG10050 CG10050 CDMC20419 2 10 7 DAC11-F12 14-CG10050-RA_1 CG10050 CTGCGACAGGTGAAACTCATCGCCGTGGGTATAAGTGACTACATCATCCGTACACAGCCTACTGAAGGA 69 FBan0010050 FBgn0037492 CG10050 3 3R CG10050 CG10050 CDMC20420 2 11 7 DAC11-F24 2-CG10062-RA_1 CG10062 CGGTGTTGATCGTTCGATGTCCTGGTTCACCTCATCATGGACTATCTTTGGCCTGTACTTGGCGCCCAT 69 FBan0010062 FBgn0034439 CG10062 2 2R CG10062 CG10062 anon-WO0140519.226 CDMC20420 2 12 7 DAC11-F24 2-CG10062-RA_1 CG10062 CGGTGTTGATCGTTCGATGTCCTGGTTCACCTCATCATGGACTATCTTTGGCCTGTACTTGGCGCCCAT 69 FBan0010062 FBgn0034439 CG10062 2 2R CG10062 CG10062 anon-WO0140519.226 CDMC20421 2 13 7 DAC11-J12 5-CG10090-RA_1 CG10090 CAGTGGGAGGCCATACTGGAGACTATTGATCCGAAGAGAGCGTCATCCACTCAAGATTTCGCACTGGCG 69 FBan0010090 FBgn0038018 Tim17a1 3 3R protein import into mitochondrial inner membrane; GO:0045039; protein targeting to mitochondrion; GO:0006626 protein translocase activity; GO:0015450; ; GO:0015450; protein transporter activity; GO:0008565; ; GO:0008565 mitochondrial inner membrane presequence translocase complex; GO:0005744 Tim17a1 Tim17a1 CG10090 CDMC20421 2 14 7 DAC11-J12 5-CG10090-RA_1 CG10090 CAGTGGGAGGCCATACTGGAGACTATTGATCCGAAGAGAGCGTCATCCACTCAAGATTTCGCACTGGCG 69 FBan0010090 FBgn0038018 Tim17a1 3 3R protein import into mitochondrial inner membrane; GO:0045039; protein targeting to mitochondrion; GO:0006626 protein translocase activity; GO:0015450; ; GO:0015450; protein transporter activity; GO:0008565; ; GO:0008565 mitochondrial inner membrane presequence translocase complex; GO:0005744 Tim17a1 Tim17a1 CG10090 CDMC20422 2 15 7 DAC11-J24 2-CG10098-RA_1 CG10098 CGCGAGAAAAGCACGGATAAAAATGACCAACGGTGACTGCTTTGTTGTTCTGCCCGAGAACTGTGCCGA 69 FBan0010098 FBgn0037472 CG10098 3 3R CG10098 CG10098 CDMC20422 2 16 7 DAC11-J24 2-CG10098-RA_1 CG10098 CGCGAGAAAAGCACGGATAAAAATGACCAACGGTGACTGCTTTGTTGTTCTGCCCGAGAACTGTGCCGA 69 FBan0010098 FBgn0037472 CG10098 3 3R CG10098 CG10098 CDMC20423 2 17 7 DAC11-N12 23-CG10130-RA_2 CG10130 CGTTCTTAAGCCATGCATTTCGTAGCCAATAAAATACTTTCACCTCAACGAGCGTGAACAATGTCGACG 69 FBan0010130 FBgn0010638 Sec61beta 2 2R "SRP-dependent cotranslational protein targeting to membrane, translocation; GO:0006616" protein transporter activity; GO:0008565; ; GO:0008565 translocon complex; GO:0005784 Sec61beta Sec61beta "CG10130, l(2)07214, DSec61beta, Sec61beta, Sec61" CDMC20423 2 18 7 DAC11-N12 23-CG10130-RA_2 CG10130 CGTTCTTAAGCCATGCATTTCGTAGCCAATAAAATACTTTCACCTCAACGAGCGTGAACAATGTCGACG 69 FBan0010130 FBgn0010638 Sec61beta 2 2R "SRP-dependent cotranslational protein targeting to membrane, translocation; GO:0006616" protein transporter activity; GO:0008565; ; GO:0008565 translocon complex; GO:0005784 Sec61beta Sec61beta "CG10130, l(2)07214, DSec61beta, Sec61beta, Sec61" CDMC20424 2 19 7 DAC11-N24 8-CG10139-RA_1 CG10139 TGCATCGGATCAGTCCGTCGACTACGAGGAAATCATTGAGAACCTGGCACTTTACGAACCAGAGCAGGT 69 FBan0010139 FBgn0033951 CG10139 2 2R CG10139 CG10139 CDMC20424 2 20 7 DAC11-N24 8-CG10139-RA_1 CG10139 TGCATCGGATCAGTCCGTCGACTACGAGGAAATCATTGAGAACCTGGCACTTTACGAACCAGAGCAGGT 69 FBan0010139 FBgn0033951 CG10139 2 2R CG10139 CG10139 CDMC20425 2 21 7 DAC12-B12 18-CG30096-RA_2 CG30096 CGCCCACATCAAGAAGTGCTTCAGCATCAAGAGACGAGGTCCTTTGTACAGGATTTATGGATATGCGGA 69 FBan0030096 FBgn0050096 CG30096 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30096 CG30096 CDMC20425 2 22 7 DAC12-B12 18-CG30096-RA_2 CG30096 CGCCCACATCAAGAAGTGCTTCAGCATCAAGAGACGAGGTCCTTTGTACAGGATTTATGGATATGCGGA 69 FBan0030096 FBgn0050096 CG30096 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30096 CG30096 CDMC20426 2 23 7 DAC12-B24 14-CG30103-RA_1 CG30103 TGTACTTTTGTCACCGATTTCTCGTTGTCTAGTCTTTCCACGTACGGATTGCGTCTCCATGGGGCATCA 69 FBan0030103 FBgn0050103 CG30103 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleotide catabolism; GO:0009166" hydrolase activity; GO:0016787 ; EC:3.-.-.-; nucleotide phosphatase activity; GO:0019204; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; phosphoric diester hydrolase activity; GO:0008081 ; EC:3.1.4.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0019204; ; GO:0016791 ; EC:3.1.3.-; ; GO:0008081 ; EC:3.1.4.- CG30103 CG30103 "CG4837, CG4837, BcDNA:AT08275" CDMC20426 2 24 7 DAC12-B24 14-CG30103-RA_1 CG30103 TGTACTTTTGTCACCGATTTCTCGTTGTCTAGTCTTTCCACGTACGGATTGCGTCTCCATGGGGCATCA 69 FBan0030103 FBgn0050103 CG30103 2 2R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleotide catabolism; GO:0009166" hydrolase activity; GO:0016787 ; EC:3.-.-.-; nucleotide phosphatase activity; GO:0019204; phosphoric monoester hydrolase activity; GO:0016791 ; EC:3.1.3.-; phosphoric diester hydrolase activity; GO:0008081 ; EC:3.1.4.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0019204; ; GO:0016791 ; EC:3.1.3.-; ; GO:0008081 ; EC:3.1.4.- CG30103 CG30103 "CG4837, CG4837, BcDNA:AT08275" CDMC20427 2 25 7 DAC12-F12 18-CG30147-RB_5 CG30147 ACGAATACGACGATCACTACTTTCTCACGGATCCTCGGGAGTTCATATACGAGTTCTATCCGCTGCAGG 69 FBan0030147 FBgn0050147 Hil 2 2R zinc ion binding; GO:0008270; ; GO:0008270 Hil Hillarin "CG13435, CG30147, CG10439, CG13435, CG13435, CG30147, CG30147, D-hillarin, Hillarin" CDMC20427 2 26 7 DAC12-F12 18-CG30147-RB_5 CG30147 ACGAATACGACGATCACTACTTTCTCACGGATCCTCGGGAGTTCATATACGAGTTCTATCCGCTGCAGG 69 FBan0030147 FBgn0050147 Hil 2 2R zinc ion binding; GO:0008270; ; GO:0008270 Hil Hillarin "CG13435, CG30147, CG10439, CG13435, CG13435, CG30147, CG30147, D-hillarin, Hillarin" CDMC20428 2 1 8 DAC12-F24 23-CG30153-RA_7 CG30153 TCGTGTTTCGTGCTTAAATATAGCCTTAGCCCATCTATAGATCTCTCTGTATGTCCTGTATGCGCTAGC 69 FBan0030153 FBgn0050153 CG30153 2 2R CG30153 CG30153 CDMC20428 2 2 8 DAC12-F24 23-CG30153-RA_7 CG30153 TCGTGTTTCGTGCTTAAATATAGCCTTAGCCCATCTATAGATCTCTCTGTATGTCCTGTATGCGCTAGC 69 FBan0030153 FBgn0050153 CG30153 2 2R CG30153 CG30153 CDMC20429 2 3 8 DAC12-J12 1-CG30184-RA_1 CG30184 GCTCGGTGATCATATGCTTCATATCACTGATTGGAGCTTTCTACGCCGAGCGGCCGACGATGAAGCACG 69 FBan0030184 FBgn0050184 CG30184 2 2R carbohydrate metabolism; GO:0005975; lipid catabolism; GO:0016042 calcium ion binding; GO:0005509; ; GO:0005509; phospholipase A2 activity; GO:0004623 ; EC:3.1.1.4; ; GO:0004623 ; EC:3.1.1.4 cellular component unknown; GO:0008372 CG30184 CG30184 CDMC20429 2 4 8 DAC12-J12 1-CG30184-RA_1 CG30184 GCTCGGTGATCATATGCTTCATATCACTGATTGGAGCTTTCTACGCCGAGCGGCCGACGATGAAGCACG 69 FBan0030184 FBgn0050184 CG30184 2 2R carbohydrate metabolism; GO:0005975; lipid catabolism; GO:0016042 calcium ion binding; GO:0005509; ; GO:0005509; phospholipase A2 activity; GO:0004623 ; EC:3.1.1.4; ; GO:0004623 ; EC:3.1.1.4 cellular component unknown; GO:0008372 CG30184 CG30184 CDMC20430 2 5 8 DAC12-J24 23-CG30193-RB_5 CG30193 TCAGCGAACAATCGGATTTTACACACTCAGCGAAACACTTACACTTCATCACATTAACACTGTCGCCCA 69 FBan0030193 FBgn0050193 CG30193 2 2R CG30193 CG30193 "CG9848, CG9848, anon-WO0118547.113, BcDNA:LD42159, BcDNA:RE29641" CDMC20430 2 6 8 DAC12-J24 23-CG30193-RB_5 CG30193 TCAGCGAACAATCGGATTTTACACACTCAGCGAAACACTTACACTTCATCACATTAACACTGTCGCCCA 69 FBan0030193 FBgn0050193 CG30193 2 2R CG30193 CG30193 "CG9848, CG9848, anon-WO0118547.113, BcDNA:LD42159, BcDNA:RE29641" CDMC20431 2 7 8 DAC12-N12 15-CG30281-RA_5 CG30281 AGCTGCCGGAATCAACAGTAATGGCATCCATGTTATTGAAGTTCCGGGTCTGGAACCTTTTCCGGTTTA 69 FBan0030281 FBgn0050281 CG30281 2 2R defense response; GO:0006952; defense response to bacteria; GO:0042742 receptor binding; GO:0005102; ; GO:0005102 CG30281 CG30281 "CG6676, CG6676" CDMC20431 2 8 8 DAC12-N12 15-CG30281-RA_5 CG30281 AGCTGCCGGAATCAACAGTAATGGCATCCATGTTATTGAAGTTCCGGGTCTGGAACCTTTTCCGGTTTA 69 FBan0030281 FBgn0050281 CG30281 2 2R defense response; GO:0006952; defense response to bacteria; GO:0042742 receptor binding; GO:0005102; ; GO:0005102 CG30281 CG30281 "CG6676, CG6676" CDMC20432 2 9 8 DAC12-N24 7-CG30289-RA_1 CG30289 GGAGGCCCATTGAGCTCGAAATTTCATTATGGCAACAGGCTTCTGAGTTTCCAGTACGGCTTGGTCAGC 69 FBan0030289 FBgn0050289 CG30289 2 2R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG30289 CG30289 CDMC20432 2 10 8 DAC12-N24 7-CG30289-RA_1 CG30289 GGAGGCCCATTGAGCTCGAAATTTCATTATGGCAACAGGCTTCTGAGTTTCCAGTACGGCTTGGTCAGC 69 FBan0030289 FBgn0050289 CG30289 2 2R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG30289 CG30289 CDMC20433 2 11 8 DAC13-B12 3-CG1322-RB_1 CG1322 TTTCGGTTAAGCCAGGCTGGGTTGACATTGCACAACCGCTCGAAAGGAATTTTCCACCCACAACC 65 FBan0001322 FBgn0004606 zfh1 3 3R central nervous system development; GO:0007417; ectoderm development; GO:0007398; germ cell migration; GO:0008354; gonad development; GO:0008406; heart development; GO:0007507; mesoderm development; GO:0007498; muscle development; GO:0007517; nervous system development; GO:0007399; pole cell migration; GO:0007280; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; transcription factor activity; GO:0003700; zinc ion binding; GO:0008270; ; GO:0003700; ; GO:0008270 nucleus; GO:0005634 zfh1 Zn finger homeodomain 1 "CG1322, zfh-1, Zfh-1, Zfh1, l(3)00865, ZFH-1, zfl-1" CDMC20433 2 12 8 DAC13-B12 3-CG1322-RB_1 CG1322 TTTCGGTTAAGCCAGGCTGGGTTGACATTGCACAACCGCTCGAAAGGAATTTTCCACCCACAACC 65 FBan0001322 FBgn0004606 zfh1 3 3R central nervous system development; GO:0007417; ectoderm development; GO:0007398; germ cell migration; GO:0008354; gonad development; GO:0008406; heart development; GO:0007507; mesoderm development; GO:0007498; muscle development; GO:0007517; nervous system development; GO:0007399; pole cell migration; GO:0007280; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; transcription factor activity; GO:0003700; zinc ion binding; GO:0008270; ; GO:0003700; ; GO:0008270 nucleus; GO:0005634 zfh1 Zn finger homeodomain 1 "CG1322, zfh-1, Zfh-1, Zfh1, l(3)00865, ZFH-1, zfl-1" CDMC20434 2 13 8 DAC13-B24 2-CG13243-RA_2 CG13243 TATCATTTCGGCGCTATTGAGACCGATTGAGCCCTCGGACGATCAGTACAAGGTGTGCGACTGGG 65 FBan0013243 FBgn0028903 CG13243 2 2L CG13243 CG13243 BG:DS02252.1 CDMC20434 2 14 8 DAC13-B24 2-CG13243-RA_2 CG13243 TATCATTTCGGCGCTATTGAGACCGATTGAGCCCTCGGACGATCAGTACAAGGTGTGCGACTGGG 65 FBan0013243 FBgn0028903 CG13243 2 2L CG13243 CG13243 BG:DS02252.1 CDMC20435 2 15 8 DAC13-F12 15-CG1341-RA_3 CG1341 CGCTGCCTCCCAAGATTGATCCTACGGTTACCATGATGCAGGTTGAGGACAAGCCGGACGTCACC 65 FBan0001341 FBgn0028687 Rpt1 2 2R cellular physiological process; GO:0050875; proteolysis; GO:0006508 ATP binding; GO:0005524; ; GO:0005524; endopeptidase activity; GO:0004175; ATPase activity; GO:0016887; ; GO:0016887; ; GO:0004175; nucleotide binding; GO:0000166; ; GO:0000166 "proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, base subcomplex (sensu Eukaryota); GO:0008540" Rpt1 Rpt1 "CG1341, CG1341, CG1341, CG1341, l(2)43Ed, l(2)05643, p48B, AAA ATPase, Dmp48B, Dm_Rpt1, dRpt1, anon-WO0118547.90, lethal(2)43Ed" CDMC20435 2 16 8 DAC13-F12 15-CG1341-RA_3 CG1341 CGCTGCCTCCCAAGATTGATCCTACGGTTACCATGATGCAGGTTGAGGACAAGCCGGACGTCACC 65 FBan0001341 FBgn0028687 Rpt1 2 2R cellular physiological process; GO:0050875; proteolysis; GO:0006508 ATP binding; GO:0005524; ; GO:0005524; endopeptidase activity; GO:0004175; ATPase activity; GO:0016887; ; GO:0016887; ; GO:0004175; nucleotide binding; GO:0000166; ; GO:0000166 "proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, base subcomplex (sensu Eukaryota); GO:0008540" Rpt1 Rpt1 "CG1341, CG1341, CG1341, CG1341, l(2)43Ed, l(2)05643, p48B, AAA ATPase, Dmp48B, Dm_Rpt1, dRpt1, anon-WO0118547.90, lethal(2)43Ed" CDMC20436 2 17 8 DAC13-F24 5-CG13455-RA_1 CG13455 GTGGGAAAGGACCAAGGATGAACCTGAGCACCCTTCTGAGGAGTGTGAGCAACGGTCTTGGCTTC 65 FBan0013455 FBgn0036498 CG13455 3 3L CG13455 CG13455 CDMC20436 2 18 8 DAC13-F24 5-CG13455-RA_1 CG13455 GTGGGAAAGGACCAAGGATGAACCTGAGCACCCTTCTGAGGAGTGTGAGCAACGGTCTTGGCTTC 65 FBan0013455 FBgn0036498 CG13455 3 3L CG13455 CG13455 CDMC20437 2 19 8 DAC13-J12 4-CG13542-RA_1 CG13542 GATGAGGATGAAGTGGAGGCTGGGCATGCTACAGTCCATCTGGGAGCGGGATCCACATTCGAATG 65 FBan0013542 FBgn0034809 CG13542 2 2R CG13542 CG13542 CDMC20437 2 20 8 DAC13-J12 4-CG13542-RA_1 CG13542 GATGAGGATGAAGTGGAGGCTGGGCATGCTACAGTCCATCTGGGAGCGGGATCCACATTCGAATG 65 FBan0013542 FBgn0034809 CG13542 2 2R CG13542 CG13542 CDMC20438 2 21 8 DAC13-J24 3-CG13576-RA_4 CG13576 TATACGCCTTTCCCAACAACGTTTTCAGCAGTCCGGTGCAGATGATCATGAAGGCGGGATTCCCC 65 FBan0013576 FBgn0034994 CG13576 2 2R CG13576 CG13576 CDMC20438 2 22 8 DAC13-J24 3-CG13576-RA_4 CG13576 TATACGCCTTTCCCAACAACGTTTTCAGCAGTCCGGTGCAGATGATCATGAAGGCGGGATTCCCC 65 FBan0013576 FBgn0034994 CG13576 2 2R CG13576 CG13576 CDMC20439 2 23 8 DAC13-N12 15-CG13672-RA_1 CG13672 GAGACCAGCCAGTTTGTAAATGGACTGGATCTACAGGGACCGATTTTTCTCCATGAGCCACCGCA 65 FBan0013672 FBgn0035862 CG13672 3 3L CG13672 CG13672 CDMC20439 2 24 8 DAC13-N12 15-CG13672-RA_1 CG13672 GAGACCAGCCAGTTTGTAAATGGACTGGATCTACAGGGACCGATTTTTCTCCATGAGCCACCGCA 65 FBan0013672 FBgn0035862 CG13672 3 3L CG13672 CG13672 CDMC20440 2 25 8 DAC13-N24 6-CG13687-RA_1 CG13687 CAGCAGCCCGATCGCAGTACATCGAAAATGCTCAGTGCCCTATTCGGATTCAGTCCCAGCACTCC 65 FBgn0031269 CDMC20440 2 26 8 DAC13-N24 6-CG13687-RA_1 CG13687 CAGCAGCCCGATCGCAGTACATCGAAAATGCTCAGTGCCCTATTCGGATTCAGTCCCAGCACTCC 65 FBgn0031269 CDMC20441 2 1 9 DAC14-B12 23-CG1656-RA_1 CG1656 CCAATGGACATTTAGGGAACCGAGGAATATTTGAGCTTTCACCAAATAAATTTGAGTTTTAACAACATG 69 FBan0001656 FBgn0040093 lectin-46Ca 2 2R galactose binding; GO:0005534; sugar binding; GO:0005529; ; GO:0005534; ; GO:0005529 lectin-46Ca lectin-46Ca "CG1656, CG1656, AC 007330A, AC007330a, lectin-44Ca" CDMC20441 2 2 9 DAC14-B12 23-CG1656-RA_1 CG1656 CCAATGGACATTTAGGGAACCGAGGAATATTTGAGCTTTCACCAAATAAATTTGAGTTTTAACAACATG 69 FBan0001656 FBgn0040093 lectin-46Ca 2 2R galactose binding; GO:0005534; sugar binding; GO:0005529; ; GO:0005534; ; GO:0005529 lectin-46Ca lectin-46Ca "CG1656, CG1656, AC 007330A, AC007330a, lectin-44Ca" CDMC20442 2 3 9 DAC14-B24 11-CG1664-RA_2 CG1664 ATGATGGTTTTCACCGTGACGGGATTATTCAAAGAGCTGAACGACGAGACCAACAATCCCGCCTCCATG 69 FBan0001664 FBgn0003321 sbr X X adult behavior; GO:0030534; long-term memory; GO:0007616; mRNA export from nucleus; GO:0006406; poly(A)+ mRNA export from nucleus; GO:0016973; protein import into nucleus; GO:0006606 mRNA binding; GO:0003729; ; GO:0003729; protein transporter activity; GO:0008565; ; GO:0008565 nuclear membrane; GO:0005635; nucleoplasm; GO:0005654 sbr small bristles "CG1664, CG17335, CG1664, CG1664, CG1664, locus 1, l(1)ts403, sbt: shorter bristles, shorter-bristles, l(1)ts, CT4634, nxf1, nuclear export factor 1, NXF1, DmNXF1, PABPr, dTap, l(1)9Fd, l(1)G1, sbt" CDMC20442 2 4 9 DAC14-B24 11-CG1664-RA_2 CG1664 ATGATGGTTTTCACCGTGACGGGATTATTCAAAGAGCTGAACGACGAGACCAACAATCCCGCCTCCATG 69 FBan0001664 FBgn0003321 sbr X X adult behavior; GO:0030534; long-term memory; GO:0007616; mRNA export from nucleus; GO:0006406; poly(A)+ mRNA export from nucleus; GO:0016973; protein import into nucleus; GO:0006606 mRNA binding; GO:0003729; ; GO:0003729; protein transporter activity; GO:0008565; ; GO:0008565 nuclear membrane; GO:0005635; nucleoplasm; GO:0005654 sbr small bristles "CG1664, CG17335, CG1664, CG1664, CG1664, locus 1, l(1)ts403, sbt: shorter bristles, shorter-bristles, l(1)ts, CT4634, nxf1, nuclear export factor 1, NXF1, DmNXF1, PABPr, dTap, l(1)9Fd, l(1)G1, sbt" CDMC20443 2 5 9 DAC14-F12 8-CG16732-RA_2 CG16732 ACATCCTGGGTATATTTCCCTACCGCCACATTTCACCCTTTTTTGTGATGCAGCCTTTGGTGCGGACTT 69 FBan0016732 FBgn0039086 CG16732 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity; GO:0003851 ; EC:2.4.1.45; ; GO:0003851 ; EC:2.4.1.45 CG16732 CG16732 CDMC20443 2 6 9 DAC14-F12 8-CG16732-RA_2 CG16732 ACATCCTGGGTATATTTCCCTACCGCCACATTTCACCCTTTTTTGTGATGCAGCCTTTGGTGCGGACTT 69 FBan0016732 FBgn0039086 CG16732 3 3R defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity; GO:0003851 ; EC:2.4.1.45; ; GO:0003851 ; EC:2.4.1.45 CG16732 CG16732 CDMC20444 2 7 9 DAC14-F24 3-CG16739-RA_3 CG16739 GCCGCCATGAAGTTCTATCCGAATGCAGATGTCTGGTTCTGTGTGGACAAGACCAGCTGCTTGAACAGC 69 FBan0016739 FBgn0034505 CG16739 2 2R CG16739 CG16739 CDMC20444 2 8 9 DAC14-F24 3-CG16739-RA_3 CG16739 GCCGCCATGAAGTTCTATCCGAATGCAGATGTCTGGTTCTGTGTGGACAAGACCAGCTGCTTGAACAGC 69 FBan0016739 FBgn0034505 CG16739 2 2R CG16739 CG16739 CDMC20445 2 9 9 DAC14-J12 3-CG16781-RA_2 CG16781 TGCCCTTACATACGGAGCATTCACTATCATCCAGGTGGTGGGTCAAGATCGCGCAATGCAGTTGATGGA 69 FBan0016781 FBgn0029661 CG16781 X X CG16781 CG16781 CDMC20445 2 10 9 DAC14-J12 3-CG16781-RA_2 CG16781 TGCCCTTACATACGGAGCATTCACTATCATCCAGGTGGTGGGTCAAGATCGCGCAATGCAGTTGATGGA 69 FBan0016781 FBgn0029661 CG16781 X X CG16781 CG16781 CDMC20446 2 11 9 DAC14-J24 2-CG16788-RA_2 CG16788 TGCGCATTCATGTCGGTCGGCTTACCCGCAACGTTACCAAGGACCATGTGTTCGAGATATTTAGCAGCT 69 FBan0016788 FBgn0037707 RnpS1 3 3R "mRNA catabolism, nonsense-mediated decay; GO:0000184; nuclear mRNA splicing, via spliceosome; GO:0000398; transcription from RNA polymerase II promoter; GO:0006366" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 RnpS1 RNA-binding protein S1 "CG16788, CG16788, CG16788, cg16788, RRM-domain protein, DEK" CDMC20446 2 12 9 DAC14-J24 2-CG16788-RA_2 CG16788 TGCGCATTCATGTCGGTCGGCTTACCCGCAACGTTACCAAGGACCATGTGTTCGAGATATTTAGCAGCT 69 FBan0016788 FBgn0037707 RnpS1 3 3R "mRNA catabolism, nonsense-mediated decay; GO:0000184; nuclear mRNA splicing, via spliceosome; GO:0000398; transcription from RNA polymerase II promoter; GO:0006366" mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729 RnpS1 RNA-binding protein S1 "CG16788, CG16788, CG16788, cg16788, RRM-domain protein, DEK" CDMC20447 2 13 9 DAC14-N12 17-CG16837-RA_3 CG16837 TCCAGAAGTTCGAGGTTATCAGTAACTGAAACTCAGCGCAAAAGCACTCCAGTGGTAAAGAAGGCGGTT 69 FBan0016837 FBgn0035009 CG16837 2 2R microtubule-based movement; GO:0007018 "ATPase activity, coupled; GO:0042623; ; GO:0042623" dynein complex; GO:0030286 CG16837 CG16837 CDMC20447 2 14 9 DAC14-N12 17-CG16837-RA_3 CG16837 TCCAGAAGTTCGAGGTTATCAGTAACTGAAACTCAGCGCAAAAGCACTCCAGTGGTAAAGAAGGCGGTT 69 FBan0016837 FBgn0035009 CG16837 2 2R microtubule-based movement; GO:0007018 "ATPase activity, coupled; GO:0042623; ; GO:0042623" dynein complex; GO:0030286 CG16837 CG16837 CDMC20448 2 15 9 DAC14-N24 1-CG16852-RA_1 CG16852 TGGCTGGAATGCTGAGCACAAAGATGTTCAGATTCCAAGGGACCAACTAACCCACAGGCAGATCAGCAA 69 FBan0016852 FBgn0028942 CG16852 2 2L CG16852 CG16852 "BG:BACR48E02.2, BcDNA:AT28681" CDMC20448 2 16 9 DAC14-N24 1-CG16852-RA_1 CG16852 TGGCTGGAATGCTGAGCACAAAGATGTTCAGATTCCAAGGGACCAACTAACCCACAGGCAGATCAGCAA 69 FBan0016852 FBgn0028942 CG16852 2 2L CG16852 CG16852 "BG:BACR48E02.2, BcDNA:AT28681" CDMC20449 2 17 9 DAC15-B12 23-CG18628-RA_1 CG18628 TGACGGCAACTTCATCGATCTTAAACCGCCTTTAACTTTTAATAAAGAGCAATATTGAACAAAGAACAT 69 FBan0018628 FBgn0036091 CG18628 3 3L CG18628 CG18628 BcDNA:GH08251 CDMC20449 2 18 9 DAC15-B12 23-CG18628-RA_1 CG18628 TGACGGCAACTTCATCGATCTTAAACCGCCTTTAACTTTTAATAAAGAGCAATATTGAACAAAGAACAT 69 FBan0018628 FBgn0036091 CG18628 3 3L CG18628 CG18628 BcDNA:GH08251 CDMC20450 2 19 9 DAC15-B24 16-CG18646-RA_1 CG18646 GGCGGCGCTACTAATTGGATGGATGTGTTCCCGTATGACTGGTCCTAAGACTTATGGCTAACACACATA 69 FBan0018646 FBgn0030444 CG18646 X X cell adhesion; GO:0007155 protein binding; GO:0005515; GTPase activator activity; GO:0005096; ; GO:0005515; ; GO:0005096 CG18646 CG18646 CG4368 CDMC20450 2 20 9 DAC15-B24 16-CG18646-RA_1 CG18646 GGCGGCGCTACTAATTGGATGGATGTGTTCCCGTATGACTGGTCCTAAGACTTATGGCTAACACACATA 69 FBan0018646 FBgn0030444 CG18646 X X cell adhesion; GO:0007155 protein binding; GO:0005515; GTPase activator activity; GO:0005096; ; GO:0005515; ; GO:0005096 CG18646 CG18646 CG4368 CDMC20451 2 21 9 DAC15-F12 8-CG18741-RA_1 CG18741 ATGGATGGTCCAAGGGATGGTTAGGTGGGGAGGGAACAGAGATGGGGGAATTTCAAACAAATGGCAATT 69 FBan0018741 FBgn0015129 DopR2 3 3R dopamine receptor signaling pathway; GO:0007212; metabolism; GO:0008152; transmission of nerve impulse; GO:0019226 ATP binding; GO:0005524; ; GO:0005524; amine receptor activity; GO:0008227; dopamine receptor activity; GO:0004952; ; GO:0004952; kinase activity; GO:0016301; ; GO:0016301; ; GO:0008227; ; GO:0004952; dopamine D1 receptor activity; GO:0001590; ; GO:0001590; ; GO:0001590; ; GO:0001590; ; GO:0001590; adrenoceptor activity; GO:0004935; ; GO:0004935 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 DopR2 Dopamine receptor 2 "CG7569, CG18741, CG7569, Dar2, DopR99B, DAMB, dopamine receptor in mushroom bodies, DOPR99B, DopRII, DopD1" CDMC20451 2 22 9 DAC15-F12 8-CG18741-RA_1 CG18741 ATGGATGGTCCAAGGGATGGTTAGGTGGGGAGGGAACAGAGATGGGGGAATTTCAAACAAATGGCAATT 69 FBan0018741 FBgn0015129 DopR2 3 3R dopamine receptor signaling pathway; GO:0007212; metabolism; GO:0008152; transmission of nerve impulse; GO:0019226 ATP binding; GO:0005524; ; GO:0005524; amine receptor activity; GO:0008227; dopamine receptor activity; GO:0004952; ; GO:0004952; kinase activity; GO:0016301; ; GO:0016301; ; GO:0008227; ; GO:0004952; dopamine D1 receptor activity; GO:0001590; ; GO:0001590; ; GO:0001590; ; GO:0001590; ; GO:0001590; adrenoceptor activity; GO:0004935; ; GO:0004935 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 DopR2 Dopamine receptor 2 "CG7569, CG18741, CG7569, Dar2, DopR99B, DAMB, dopamine receptor in mushroom bodies, DOPR99B, DopRII, DopD1" CDMC20452 2 23 9 DAC15-F24 3-CG18765-RA_1 CG18765 CGGATAGGATCGTGCACTTTGGACCACCAGTCATCCAGGCAAAGCTGAAATCCAGCCACATATATGGCG 69 FBan0018765 FBgn0042110 CG18765 3 3R CG18765 CG18765 CDMC20452 2 24 9 DAC15-F24 3-CG18765-RA_1 CG18765 CGGATAGGATCGTGCACTTTGGACCACCAGTCATCCAGGCAAAGCTGAAATCCAGCCACATATATGGCG 69 FBan0018765 FBgn0042110 CG18765 3 3R CG18765 CG18765 CDMC20453 2 25 9 DAC15-J12 17-CG18814-RA_1 CG18814 TCCACGAATTGGATATACCGAACCTGTGGAATCCCCAGTTAGATGATTGCGTATTCGTCTGCTTGAGCT 69 FBan0018814 FBgn0042137 CG18814 3 3L lipid metabolism; GO:0006629; metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG18814 CG18814 CDMC20453 2 26 9 DAC15-J12 17-CG18814-RA_1 CG18814 TCCACGAATTGGATATACCGAACCTGTGGAATCCCCAGTTAGATGATTGCGTATTCGTCTGCTTGAGCT 69 FBan0018814 FBgn0042137 CG18814 3 3L lipid metabolism; GO:0006629; metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG18814 CG18814 CDMC20454 2 1 10 DAC15-J24 23-CG1883-RC_2 CG1883 GTGCAGCGAAATAATAAGAGAAAAGGCCGCAATGATAATGGCAAATTACGATTTTCTTGTGAATCCAGA 69 FBan0001883 FBgn0039757 RpS7 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS7 Ribosomal protein S7 "CG1883, Ribosomal protein S7" CDMC20454 2 2 10 DAC15-J24 23-CG1883-RC_2 CG1883 GTGCAGCGAAATAATAAGAGAAAAGGCCGCAATGATAATGGCAAATTACGATTTTCTTGTGAATCCAGA 69 FBan0001883 FBgn0039757 RpS7 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843 RpS7 Ribosomal protein S7 "CG1883, Ribosomal protein S7" CDMC20455 2 3 10 DAC15-N12 47-CG1906-RE_4 CG1906 TAGTAGGCGATGAAAATCAAGTGGAAAACGATCGTTTTTTCTTCTTAAACTTTTACTTACGGCAGACAC 69 FBan0001906 FBgn0039672 CG1906 3 3R protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722 protein serine/threonine phosphatase complex; GO:0008287 CG1906 CG1906 PP2Cb CDMC20455 2 4 10 DAC15-N12 47-CG1906-RE_4 CG1906 TAGTAGGCGATGAAAATCAAGTGGAAAACGATCGTTTTTTCTTCTTAAACTTTTACTTACGGCAGACAC 69 FBan0001906 FBgn0039672 CG1906 3 3R protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722 protein serine/threonine phosphatase complex; GO:0008287 CG1906 CG1906 PP2Cb CDMC20456 2 5 10 DAC15-N24 13-CG1919-RA_1 CG1919 CGTTGACGACCTCACAAAACGGCTGATCGATCCACTGACGAAGCCTGCTAAAATACTCAGTACCACAGT 69 FBan0001919 FBgn0035281 CG1919 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG1919 CG1919 CDMC20456 2 6 10 DAC15-N24 13-CG1919-RA_1 CG1919 CGTTGACGACCTCACAAAACGGCTGATCGATCCACTGACGAAGCCTGCTAAAATACTCAGTACCACAGT 69 FBan0001919 FBgn0035281 CG1919 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG1919 CG1919 CDMC20457 2 7 10 DAC16-B12 23-CG32743-RA_4 CG32743 GGGCTTTTGACATACACCACACATCAAAAATTTGGAGCGGAGAAAGACTACTACATTCAACATTGGGGC 69 FBan0032743 FBgn0052743 Smg1 X X "intracellular signaling cascade; GO:0007242; mRNA catabolism, nonsense-mediated decay; GO:0000184; phosphorylation; GO:0016310; protein amino acid phosphorylation; GO:0006468" ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 Smg1 Smg1 "CG4549, CG32743, CG4555, CG4549, CG4549, CG4549, CG32743, CG32743, CG4549, CG4555, clone 1.24, FRAP-related, SMG1, anon-WO0170980.133, anon-EST:Liang-1.24" CDMC20457 2 8 10 DAC16-B12 23-CG32743-RA_4 CG32743 GGGCTTTTGACATACACCACACATCAAAAATTTGGAGCGGAGAAAGACTACTACATTCAACATTGGGGC 69 FBan0032743 FBgn0052743 Smg1 X X "intracellular signaling cascade; GO:0007242; mRNA catabolism, nonsense-mediated decay; GO:0000184; phosphorylation; GO:0016310; protein amino acid phosphorylation; GO:0006468" ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37 Smg1 Smg1 "CG4549, CG32743, CG4555, CG4549, CG4549, CG4549, CG32743, CG32743, CG4549, CG4555, clone 1.24, FRAP-related, SMG1, anon-WO0170980.133, anon-EST:Liang-1.24" CDMC20458 2 9 10 DAC16-B24 3-CG32754-RA_6 CG32754 TCCTTGGGTACAGCGACGGAGAATGGTAGCTACTATAGCTATCGATTGGGAACCTACGATGGCTGGCGC 69 FBan0032754 FBgn0040069 vanin-like X X cell motility; GO:0006928; cell-cell adhesion; GO:0016337; coenzyme metabolism; GO:0006732; cytoskeleton organization and biogenesis; GO:0007010; nitrogen compound metabolism; GO:0006807; prosthetic group metabolism; GO:0051189; signal transduction; GO:0007165; vitamin biosynthesis; GO:0009110 hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; pantetheinase activity; GO:0017159 ; EC:3.5.1.-; ; GO:0017159 ; EC:3.5.1.- extrinsic to membrane; GO:0019898 vanin-like vanin-like "CG3648, CG32754, CG3648, CG3648" CDMC20458 2 10 10 DAC16-B24 3-CG32754-RA_6 CG32754 TCCTTGGGTACAGCGACGGAGAATGGTAGCTACTATAGCTATCGATTGGGAACCTACGATGGCTGGCGC 69 FBan0032754 FBgn0040069 vanin-like X X cell motility; GO:0006928; cell-cell adhesion; GO:0016337; coenzyme metabolism; GO:0006732; cytoskeleton organization and biogenesis; GO:0007010; nitrogen compound metabolism; GO:0006807; prosthetic group metabolism; GO:0051189; signal transduction; GO:0007165; vitamin biosynthesis; GO:0009110 hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; pantetheinase activity; GO:0017159 ; EC:3.5.1.-; ; GO:0017159 ; EC:3.5.1.- extrinsic to membrane; GO:0019898 vanin-like vanin-like "CG3648, CG32754, CG3648, CG3648" CDMC20459 2 11 10 DAC16-F12 3-CG32793-RA_6 CG32793 GGGCCTGAACTCTCCCTATCCCTACGCTTATGTCCAGGGTCAGACGAAGAAACAAAGGGTTCCCATCAA 69 FBan0032793 FBgn0052793 CG32793 X X CG32793 CG32793 "CG18089, CG18852, CG3591, EG:100G7.1, EG:100G7.2, anon-3Ca, anon-3Cb" CDMC20459 2 12 10 DAC16-F12 3-CG32793-RA_6 CG32793 GGGCCTGAACTCTCCCTATCCCTACGCTTATGTCCAGGGTCAGACGAAGAAACAAAGGGTTCCCATCAA 69 FBan0032793 FBgn0052793 CG32793 X X CG32793 CG32793 "CG18089, CG18852, CG3591, EG:100G7.1, EG:100G7.2, anon-3Ca, anon-3Cb" CDMC20460 2 13 10 DAC16-F24 23-CG32800-RA_1 CG32800 GCCCTTTGTTGCTATTTTATTCGTAGTCACTTAAGAATCCAATAAACACCGAATCCTTTCGAACTATAT 69 FBgn0023548 CDMC20460 2 14 10 DAC16-F24 23-CG32800-RA_1 CG32800 GCCCTTTGTTGCTATTTTATTCGTAGTCACTTAAGAATCCAATAAACACCGAATCCTTTCGAACTATAT 69 FBgn0023548 CDMC20461 2 15 10 DAC16-J12 1-CG32834-RA_1 CG32834 ACGCCAATGTACCTTGGTTCACAGGTTGGATTGCCGAGAACACCGAAGATGAGGATACAACCGCTTCGA 69 FBan0032834 FBgn0052834 CG32834 2 2R proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type peptidase activity; GO:0008236; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0008236; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG32834 CG32834 "CG9898, CG30331, CG9898, SPH196" CDMC20461 2 16 10 DAC16-J12 1-CG32834-RA_1 CG32834 ACGCCAATGTACCTTGGTTCACAGGTTGGATTGCCGAGAACACCGAAGATGAGGATACAACCGCTTCGA 69 FBan0032834 FBgn0052834 CG32834 2 2R proteolysis; GO:0006508 chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type peptidase activity; GO:0008236; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0008236; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG32834 CG32834 "CG9898, CG30331, CG9898, SPH196" CDMC20462 2 17 10 DAC16-J24 14-CG32847-RB_1 CG32847 TGCTGATCACGGCATAAGGGATGGGCAGAACGAAACACTCCTTTCTAAGTTCTTTCTCTACGTGGCCAT 69 FBan0032847 FBgn0052847 CG32847 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; protein ubiquitination; GO:0016567; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG32847 CG32847 CDMC20462 2 18 10 DAC16-J24 14-CG32847-RB_1 CG32847 TGCTGATCACGGCATAAGGGATGGGCAGAACGAAACACTCCTTTCTAAGTTCTTTCTCTACGTGGCCAT 69 FBan0032847 FBgn0052847 CG32847 3 3L "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; protein ubiquitination; GO:0016567; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG32847 CG32847 CDMC20463 2 19 10 DAC16-N12 1-CG32922-RA_1 CG32922 GCGTTCGGTCGCGAGATACCTGGCTAAGTGGAACCCCAAAAAAAGATCCCTGGATCGGTACAAACTCGA 69 FBgn0052922 CDMC20463 2 20 10 DAC16-N12 1-CG32922-RA_1 CG32922 GCGTTCGGTCGCGAGATACCTGGCTAAGTGGAACCCCAAAAAAAGATCCCTGGATCGGTACAAACTCGA 69 FBgn0052922 CDMC20464 2 21 10 DAC16-N24 8-CG32944-RB_1 CG32944 CCTCCCGAAGACCACCTCAACTGTGATCCTTGCCTAGAACTGGAGGAAATGATTGTAGAATCGCGGCCC 69 FBan0032944 FBgn0052944 CG32944 3 3R actin filament organization; GO:0007015; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004674 CG32944 CG32944 "CG10532, CG9818" CDMC20464 2 22 10 DAC16-N24 8-CG32944-RB_1 CG32944 CCTCCCGAAGACCACCTCAACTGTGATCCTTGCCTAGAACTGGAGGAAATGATTGTAGAATCGCGGCCC 69 FBan0032944 FBgn0052944 CG32944 3 3R actin filament organization; GO:0007015; protein amino acid phosphorylation; GO:0006468; regulation of cell shape; GO:0008360 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004674 CG32944 CG32944 "CG10532, CG9818" CDMC20465 2 23 10 DAC17-B12 3-CG12286-RA_2 CG12286 ATTGCCGATATGCCGGGTGTGAACCGTATGTACCTGCAACAATTGTCCTTGGTGTCCATTGGCCT 65 FBan0012286 FBgn0001296 kar 3 3R cation transport; GO:0006812; ommochrome biosynthesis; GO:0006727 monocarboxylic acid transporter activity; GO:0008028; ; GO:0008028; ; GO:0008028 plasma membrane; GO:0005886 kar karmoisin CG12286 CDMC20465 2 24 10 DAC17-B12 3-CG12286-RA_2 CG12286 ATTGCCGATATGCCGGGTGTGAACCGTATGTACCTGCAACAATTGTCCTTGGTGTCCATTGGCCT 65 FBan0012286 FBgn0001296 kar 3 3R cation transport; GO:0006812; ommochrome biosynthesis; GO:0006727 monocarboxylic acid transporter activity; GO:0008028; ; GO:0008028; ; GO:0008028 plasma membrane; GO:0005886 kar karmoisin CG12286 CDMC20466 2 25 10 DAC17-B24 6-CG12363-RA_1 CG12363 GACACCGACGGATCGTGCACAGTACGCTGGGAGAACAAGACCATGTACTGCATCGTTTCGGTCTT 65 FBan0012363 FBgn0024432 Dlc90F 3 3R RNA localization; GO:0006403; cell cycle; GO:0007049; intracellular protein transport; GO:0006886; microtubule-based movement; GO:0007018; spermatid development; GO:0007286; vesicle-mediated transport; GO:0016192 "structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623" dynein complex; GO:0030286; microtubule associated complex; GO:0005875 Dlc90F Dynein light chain 90F "CG12363, CG12363, CG12363, Tctex, tctex-1, tctex, dynein light chain; tctex-1, dynein light chain; tctex-1., bs35g12.y1, dtctex-1, Tctex-1, l(3)04091, Dynein light chain 90F" CDMC20466 2 26 10 DAC17-B24 6-CG12363-RA_1 CG12363 GACACCGACGGATCGTGCACAGTACGCTGGGAGAACAAGACCATGTACTGCATCGTTTCGGTCTT 65 FBan0012363 FBgn0024432 Dlc90F 3 3R RNA localization; GO:0006403; cell cycle; GO:0007049; intracellular protein transport; GO:0006886; microtubule-based movement; GO:0007018; spermatid development; GO:0007286; vesicle-mediated transport; GO:0016192 "structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623" dynein complex; GO:0030286; microtubule associated complex; GO:0005875 Dlc90F Dynein light chain 90F "CG12363, CG12363, CG12363, Tctex, tctex-1, tctex, dynein light chain; tctex-1, dynein light chain; tctex-1., bs35g12.y1, dtctex-1, Tctex-1, l(3)04091, Dynein light chain 90F" CDMC20467 2 1 11 DAC17-F12 1-CG12490-RA_2 CG12490 GTTTTGGGGTGTCTTTGTATCTGGTGTCTGCAGTGCATTGACCCCGCTCTTCATCGGTTTTGGCG 65 FBan0012490 FBgn0034782 CG12490 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858; ion transport; GO:0006811; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021 CG12490 CG12490 CDMC20467 2 2 11 DAC17-F12 1-CG12490-RA_2 CG12490 GTTTTGGGGTGTCTTTGTATCTGGTGTCTGCAGTGCATTGACCCCGCTCTTCATCGGTTTTGGCG 65 FBan0012490 FBgn0034782 CG12490 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858; ion transport; GO:0006811; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021 CG12490 CG12490 CDMC20468 2 3 11 DAC17-F24 1-CG12511-RA_1 CG12511 CAGGATCAGTCCCGGGGGCAGCTAGAGGTCAGAGAAATATCCCTGGAGCCAGTGAATCTTAACCG 65 FBan0012511 FBgn0031729 CG12511 2 2L CG12511 CG12511 CDMC20468 2 4 11 DAC17-F24 1-CG12511-RA_1 CG12511 CAGGATCAGTCCCGGGGGCAGCTAGAGGTCAGAGAAATATCCCTGGAGCCAGTGAATCTTAACCG 65 FBan0012511 FBgn0031729 CG12511 2 2L CG12511 CG12511 CDMC20469 2 5 11 DAC17-J12 12-CG12626-RA_1 CG12626 TCCAGAAGGCTCCCATCAATGCCATCATCGAGGATCTCAGCGACAAGCCCTGCTACTGTGACCAC 65 FBan0012626 FBgn0040851 CG12626 X X CG12626 CG12626 CDMC20469 2 6 11 DAC17-J12 12-CG12626-RA_1 CG12626 TCCAGAAGGCTCCCATCAATGCCATCATCGAGGATCTCAGCGACAAGCCCTGCTACTGTGACCAC 65 FBan0012626 FBgn0040851 CG12626 X X CG12626 CG12626 CDMC20470 2 7 11 DAC17-J24 17-CG1265-RB_6 CG1265 CTCAGAAGCTGCAAATTTCGAATTTCGACGGTCGCTATGAGTGGAGCTCTCGGAGATGTGGTGTC 65 FBan0001265 FBgn0035517 CG1265 3 3L CG1265 CG1265 BcDNA:RE09466 CDMC20470 2 8 11 DAC17-J24 17-CG1265-RB_6 CG1265 CTCAGAAGCTGCAAATTTCGAATTTCGACGGTCGCTATGAGTGGAGCTCTCGGAGATGTGGTGTC 65 FBan0001265 FBgn0035517 CG1265 3 3L CG1265 CG1265 BcDNA:RE09466 CDMC20471 2 9 11 DAC17-N12 11-CG12768-RA_1 CG12768 GCTGCAGCCCGAACCAAAGAGTAGTCTGCCAGTGACTATTCCCAGTCTAAGTCTCACCCTCAGCC 65 FBan0012768 FBgn0037206 CG12768 3 3L CG12768 CG12768 CDMC20471 2 10 11 DAC17-N12 11-CG12768-RA_1 CG12768 GCTGCAGCCCGAACCAAAGAGTAGTCTGCCAGTGACTATTCCCAGTCTAAGTCTCACCCTCAGCC 65 FBan0012768 FBgn0037206 CG12768 3 3L CG12768 CG12768 CDMC20472 2 11 11 DAC17-N24 3-CG12811-RA_1 CG12811 AACTTGATGGTGGACTGTGTGAAGCTGTCCGTTCAACTGGAGACGCGTATTTCGGACACGGAGCA 65 FBan0012811 FBgn0037779 CG12811 3 3R CG12811 CG12811 CDMC20472 2 12 11 DAC17-N24 3-CG12811-RA_1 CG12811 AACTTGATGGTGGACTGTGTGAAGCTGTCCGTTCAACTGGAGACGCGTATTTCGGACACGGAGCA 65 FBan0012811 FBgn0037779 CG12811 3 3R CG12811 CG12811 CDMC20473 2 13 11 DAC18-B12 14-CG5738-RB_1 CG5738 TCCGCTGCGAATTAAGACCATCTAACGGTGAACCTTTCGGTCACTAGTCCAAATTAAGCCTCCTGCC 67 FBan0005738 FBgn0022238 lolal 2 2R chromatin assembly or disassembly; GO:0006333; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 protein binding; GO:0005515; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0005515 nucleus; GO:0005634 lolal lola like "CG5738, CG5738, CG5738, l(2)k02512, 25/12, batman, EP647, l(2)kO2512, Batman, Ban, anon-WO0172774.186, EP0647, anon-EST:fe3D3, anon-fast-evolving-3D3, lola like" CDMC20473 2 14 11 DAC18-B12 14-CG5738-RB_1 CG5738 TCCGCTGCGAATTAAGACCATCTAACGGTGAACCTTTCGGTCACTAGTCCAAATTAAGCCTCCTGCC 67 FBan0005738 FBgn0022238 lolal 2 2R chromatin assembly or disassembly; GO:0006333; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 protein binding; GO:0005515; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0005515 nucleus; GO:0005634 lolal lola like "CG5738, CG5738, CG5738, l(2)k02512, 25/12, batman, EP647, l(2)kO2512, Batman, Ban, anon-WO0172774.186, EP0647, anon-EST:fe3D3, anon-fast-evolving-3D3, lola like" CDMC20474 2 15 11 DAC18-B24 2-CG5948-RA_3 CG5948 CCCTACAACTCGGACATTAGGGTGACGATCAATGTGACTGGATTGCCACCCGGTAAACATGCCCTGC 67 FBan0005948 FBgn0039386 CG5948 3 3R superoxide metabolism; GO:0006801 "metal ion binding; GO:0046872; copper, zinc superoxide dismutase activity; GO:0004785; ; GO:0046872; ; GO:0004785" CG5948 CG5948 CDMC20474 2 16 11 DAC18-B24 2-CG5948-RA_3 CG5948 CCCTACAACTCGGACATTAGGGTGACGATCAATGTGACTGGATTGCCACCCGGTAAACATGCCCTGC 67 FBan0005948 FBgn0039386 CG5948 3 3R superoxide metabolism; GO:0006801 "metal ion binding; GO:0046872; copper, zinc superoxide dismutase activity; GO:0004785; ; GO:0046872; ; GO:0004785" CG5948 CG5948 CDMC20475 2 17 11 DAC18-F12 2-CG6527-RA_3 CG6527 GATGCGGCATTTTCACCCTTCAGACCAACAGACTGGAGTGTCAATTATCCCGCCCGAGCATTTTGCC 67 FBan0006527 FBgn0036085 CG6527 3 3L CG6527 CG6527 BcDNA:AT13283 CDMC20475 2 18 11 DAC18-F12 2-CG6527-RA_3 CG6527 GATGCGGCATTTTCACCCTTCAGACCAACAGACTGGAGTGTCAATTATCCCGCCCGAGCATTTTGCC 67 FBan0006527 FBgn0036085 CG6527 3 3L CG6527 CG6527 BcDNA:AT13283 CDMC20476 2 19 11 DAC18-F24 2-CG6612-RB_3 CG6612 CGGCAGGGTGTACAATATTGGCTTCAAGAATCCCAAAGTGCCTGGCAAAGATGATGTGACGGGGGAG 67 FBan0006612 FBgn0042094 Adk3 3 3R ADP biosynthesis; GO:0006172; purine base metabolism; GO:0006144 ATP binding; GO:0005524; ; GO:0005524; adenylate kinase activity; GO:0004017 ; EC:2.7.4.3; ; GO:0004017 ; EC:2.7.4.3; ; GO:0004017 ; EC:2.7.4.3; nucleoside triphosphate adenylate kinase activity; GO:0046899 ; EC:2.7.4.10; ; GO:0046899 ; EC:2.7.4.10 mitochondrial matrix; GO:0005759 Adk3 Adenylate kinase-3 "CG6612, AK3, bs12h03.y1, DAK3, Adenylate kinase-3" CDMC20476 2 20 11 DAC18-F24 2-CG6612-RB_3 CG6612 CGGCAGGGTGTACAATATTGGCTTCAAGAATCCCAAAGTGCCTGGCAAAGATGATGTGACGGGGGAG 67 FBan0006612 FBgn0042094 Adk3 3 3R ADP biosynthesis; GO:0006172; purine base metabolism; GO:0006144 ATP binding; GO:0005524; ; GO:0005524; adenylate kinase activity; GO:0004017 ; EC:2.7.4.3; ; GO:0004017 ; EC:2.7.4.3; ; GO:0004017 ; EC:2.7.4.3; nucleoside triphosphate adenylate kinase activity; GO:0046899 ; EC:2.7.4.10; ; GO:0046899 ; EC:2.7.4.10 mitochondrial matrix; GO:0005759 Adk3 Adenylate kinase-3 "CG6612, AK3, bs12h03.y1, DAK3, Adenylate kinase-3" CDMC20477 2 21 11 DAC18-J12 3-CG7158-RA_1 CG7158 GCTACACTACACTGAAGGCCGCATATGAGCACGTGACGTCGAGAGCTCTGCAAAAAATCCCCTGAGC 67 FBan0007158 FBgn0037116 CG7158 3 3L CG7158 CG7158 CDMC20477 2 22 11 DAC18-J12 3-CG7158-RA_1 CG7158 GCTACACTACACTGAAGGCCGCATATGAGCACGTGACGTCGAGAGCTCTGCAAAAAATCCCCTGAGC 67 FBan0007158 FBgn0037116 CG7158 3 3L CG7158 CG7158 CDMC20478 2 23 11 DAC18-J24 3-CG7275-RA_1 CG7275 AGCACACCAAGAAGAGCAAGAAGGTGCCCTACGTCAGCGAGAAAAAGAAGCATGTGCTGAAGGAGGA 67 FBan0007275 FBgn0036500 CG7275 3 3L CG7275 CG7275 CDMC20478 2 24 11 DAC18-J24 3-CG7275-RA_1 CG7275 AGCACACCAAGAAGAGCAAGAAGGTGCCCTACGTCAGCGAGAAAAAGAAGCATGTGCTGAAGGAGGA 67 FBan0007275 FBgn0036500 CG7275 3 3L CG7275 CG7275 CDMC20479 2 25 11 DAC18-N12 3-CG7886-RA_3 CG7886 GACATGCACATGGAGTCGTCGTATATGTCCCGCTCCGAAGAACTCTCCTCAACGGACGTTACGCTGG 67 FBan0007886 FBgn0038248 CG7886 3 3R CG7886 CG7886 anon-WO0140519.200 CDMC20479 2 26 11 DAC18-N12 3-CG7886-RA_3 CG7886 GACATGCACATGGAGTCGTCGTATATGTCCCGCTCCGAAGAACTCTCCTCAACGGACGTTACGCTGG 67 FBan0007886 FBgn0038248 CG7886 3 3R CG7886 CG7886 anon-WO0140519.200 CDMC20480 2 1 12 DAC18-N24 17-CG7992-RA_2 CG7992 TCATATGCATCTCGTATGTGCTCAAGTTGATCTGCACCAGCATCGTGTACTTCTACTTTGTGGCGGA 67 FBan0007992 FBgn0031004 CG7992 X X CG7992 CG7992 CDMC20480 2 2 12 DAC18-N24 17-CG7992-RA_2 CG7992 TCATATGCATCTCGTATGTGCTCAAGTTGATCTGCACCAGCATCGTGTACTTCTACTTTGTGGCGGA 67 FBan0007992 FBgn0031004 CG7992 X X CG7992 CG7992 CDMC20481 2 3 12 DAC19-B12 1-CG7896-RA_1 CG7896 GCTGAAGCATCCACGACTCAAGAGCCTGGGAATCAGAGGTGATCGACTGAAGTCCATATCCTCTGGCA 68 FBan0007896 FBgn0039728 CG7896 3 3R cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 receptor activity; GO:0004872; ; GO:0004872 CG7896 CG7896 "CT23878, tartan/capricious-like" CDMC20481 2 4 12 DAC19-B12 1-CG7896-RA_1 CG7896 GCTGAAGCATCCACGACTCAAGAGCCTGGGAATCAGAGGTGATCGACTGAAGTCCATATCCTCTGGCA 68 FBan0007896 FBgn0039728 CG7896 3 3R cell adhesion; GO:0007155; cell surface receptor linked signal transduction; GO:0007166; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 receptor activity; GO:0004872; ; GO:0004872 CG7896 CG7896 "CT23878, tartan/capricious-like" CDMC20482 2 5 12 DAC19-B24 1-CG8032-RA_1 CG8032 GTCGAGTGTTCCATGCAGCCCATGTGATATGCACCATACCGCTAGGCGTACTGAAAAACACCCATCGC 68 FBan0008032 FBgn0037606 CG8032 3 3R electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG8032 CG8032 CDMC20482 2 6 12 DAC19-B24 1-CG8032-RA_1 CG8032 GTCGAGTGTTCCATGCAGCCCATGTGATATGCACCATACCGCTAGGCGTACTGAAAAACACCCATCGC 68 FBan0008032 FBgn0037606 CG8032 3 3R electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG8032 CG8032 CDMC20483 2 7 12 DAC19-F12 3-CG8602-RA_1 CG8602 GCTTACGTTCACCCAGCTGACACCCTATGTGGGCATGATCATCATGGGACTGTCGTATTCCATGCTGG 68 FBan0008602 FBgn0035763 CG8602 3 3L cation transport; GO:0006812; extracellular transport; GO:0006858; ion transport; GO:0006811; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021 CG8602 CG8602 "anon-WO0118547.349, anon-WO0118547.382" CDMC20483 2 8 12 DAC19-F12 3-CG8602-RA_1 CG8602 GCTTACGTTCACCCAGCTGACACCCTATGTGGGCATGATCATCATGGGACTGTCGTATTCCATGCTGG 68 FBan0008602 FBgn0035763 CG8602 3 3L cation transport; GO:0006812; extracellular transport; GO:0006858; ion transport; GO:0006811; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215 integral to membrane; GO:0016021 CG8602 CG8602 "anon-WO0118547.349, anon-WO0118547.382" CDMC20484 2 9 12 DAC19-F24 2-CG8771-RA_1 CG8771 GGTCGCTTCGCAAGCCATCTGTATAATTCGCTCACCGAACCTCGAAACGCTCTGGAAGCAAATCGTGC 68 FBan0008771 FBgn0033766 CG8771 2 2R CG8771 CG8771 CDMC20484 2 10 12 DAC19-F24 2-CG8771-RA_1 CG8771 GGTCGCTTCGCAAGCCATCTGTATAATTCGCTCACCGAACCTCGAAACGCTCTGGAAGCAAATCGTGC 68 FBan0008771 FBgn0033766 CG8771 2 2R CG8771 CG8771 CDMC20485 2 11 12 DAC19-J12 6-CG9201-RB_4 CG9201 TGGAGATTGTGCGCTTCTGGTTAATTTTCCTCATCAACAACCTGCACGCGCACATTATGGAGGCCGTG 68 FBan0009201 FBgn0026433 Grip128 X X amino acid metabolism; GO:0006520; electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; gamma-tubulin binding; GO:0043015; ; GO:0043015 centrosome; GO:0005813; gamma-tubulin ring complex; GO:0008274 Grip128 Grip128 "CG9201, CG9201, Dgrip128, grip128, Dgrips128" CDMC20485 2 12 12 DAC19-J12 6-CG9201-RB_4 CG9201 TGGAGATTGTGCGCTTCTGGTTAATTTTCCTCATCAACAACCTGCACGCGCACATTATGGAGGCCGTG 68 FBan0009201 FBgn0026433 Grip128 X X amino acid metabolism; GO:0006520; electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; gamma-tubulin binding; GO:0043015; ; GO:0043015 centrosome; GO:0005813; gamma-tubulin ring complex; GO:0008274 Grip128 Grip128 "CG9201, CG9201, Dgrip128, grip128, Dgrips128" CDMC20486 2 13 12 DAC19-J24 12-CG9336-RA_1 CG9336 TCGAAAAGCAATTCCCACACTCGAAGTATTCGCGAAAATGGTGTCCGCTCTGAAATGCAGTTTGGCCG 68 FBan0009336 FBgn0032897 CG9336 2 2L CG9336 CG9336 BcDNA:RE71975 CDMC20486 2 14 12 DAC19-J24 12-CG9336-RA_1 CG9336 TCGAAAAGCAATTCCCACACTCGAAGTATTCGCGAAAATGGTGTCCGCTCTGAAATGCAGTTTGGCCG 68 FBan0009336 FBgn0032897 CG9336 2 2L CG9336 CG9336 BcDNA:RE71975 CDMC20487 2 15 12 DAC19-N12 3-CG9890-RA_1 CG9890 CCTGGAGGAGAACTTGAATCGGTTAATGTGCCTCTACTGCGAGAAGATCTTCAGGGATCGGCCCACGC 68 FBan0009890 FBgn0034814 CG9890 2 2R cell proliferation; GO:0008283 nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG9890 CG9890 "ld46465, anon-EST:Posey169" CDMC20487 2 16 12 DAC19-N12 3-CG9890-RA_1 CG9890 CCTGGAGGAGAACTTGAATCGGTTAATGTGCCTCTACTGCGAGAAGATCTTCAGGGATCGGCCCACGC 68 FBan0009890 FBgn0034814 CG9890 2 2R cell proliferation; GO:0008283 nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG9890 CG9890 "ld46465, anon-EST:Posey169" CDMC20488 2 17 12 DAC19-N24 2-CG9926-RA_3 CG9926 CCAAAGTGGCTCGCAAAGAGGTCGTCGACTACGAGAAGAATCTGCATCGACTTGGAGTGGTCCAGCAA 68 FBan0009926 FBgn0038190 CG9926 3 3R CG9926 CG9926 CDMC20488 2 18 12 DAC19-N24 2-CG9926-RA_3 CG9926 CCAAAGTGGCTCGCAAAGAGGTCGTCGACTACGAGAAGAATCTGCATCGACTTGGAGTGGTCCAGCAA 68 FBan0009926 FBgn0038190 CG9926 3 3R CG9926 CG9926 CDMC20489 2 19 12 DAC20-B12 22-CG18041-RA_1 CG18041 ACGAAAATGTCAGTTGGTTTTGTACTCAGCCATTGTAGTTTTTGGTGCATTCGGGTGTAAGGAACCCCT 69 FBan0018041 FBgn0039710 CG18041 3 3R CG18041 CG18041 CDMC20489 2 20 12 DAC20-B12 22-CG18041-RA_1 CG18041 ACGAAAATGTCAGTTGGTTTTGTACTCAGCCATTGTAGTTTTTGGTGCATTCGGGTGTAAGGAACCCCT 69 FBan0018041 FBgn0039710 CG18041 3 3R CG18041 CG18041 CDMC20490 2 21 12 DAC20-B24 12-CG18067-RA_1 CG18067 CCGGCTCAGGTGGAGTACTCCAATGGTGATATAGTCATCGAACTGGCCGATCATACGGTGATTGCCAAG 69 FBan0018067 FBgn0034512 CG18067 2 2R CG18067 CG18067 CT40493 CDMC20490 2 22 12 DAC20-B24 12-CG18067-RA_1 CG18067 CCGGCTCAGGTGGAGTACTCCAATGGTGATATAGTCATCGAACTGGCCGATCATACGGTGATTGCCAAG 69 FBan0018067 FBgn0034512 CG18067 2 2R CG18067 CG18067 CT40493 CDMC20491 2 23 12 DAC20-F12 14-CG18110-RA_6 CG18110 TCTACTACTGGGTGCAGACCTCCATCGAAAGGACTGACATGCATGTATCCGAGATCGATTTCCCAGCCG 69 FBan0018110 FBgn0039677 CG18110 3 3R sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; ; GO:0005272 membrane; GO:0016020 CG18110 CG18110 CDMC20491 2 24 12 DAC20-F12 14-CG18110-RA_6 CG18110 TCTACTACTGGGTGCAGACCTCCATCGAAAGGACTGACATGCATGTATCCGAGATCGATTTCCCAGCCG 69 FBan0018110 FBgn0039677 CG18110 3 3R sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; ; GO:0005272 membrane; GO:0016020 CG18110 CG18110 CDMC20492 2 25 12 DAC20-F24 1-CG18140-RA_1 CG18140 GCGGCAAGCACCCATTACTCAGGACTCTTAGTCAGGAGCTCCTAGGCATTCCTGGACAAAAGGCTAAGG 69 CDMC20492 2 26 12 DAC20-F24 1-CG18140-RA_1 CG18140 GCGGCAAGCACCCATTACTCAGGACTCTTAGTCAGGAGCTCCTAGGCATTCCTGGACAAAAGGCTAAGG 69 CDMC20493 2 1 13 DAC20-J12 27-CG18208-RA_1 CG18208 GGGATGGCCGGTATCCCAGTGGATATACGCTTACGCACATCGTGATCGCCTCCATTATTGTGACGATCC 69 FBan0018208 FBgn0038653 CG18208 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cell surface receptor linked signal transduction; GO:0007166; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 receptor activity; GO:0004872; G-protein coupled receptor activity; GO:0004930; ; GO:0004872; ; GO:0004930; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 integral to membrane; GO:0016021 CG18208 CG18208 CDMC20493 2 2 13 DAC20-J12 27-CG18208-RA_1 CG18208 GGGATGGCCGGTATCCCAGTGGATATACGCTTACGCACATCGTGATCGCCTCCATTATTGTGACGATCC 69 FBan0018208 FBgn0038653 CG18208 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; cell surface receptor linked signal transduction; GO:0007166; signal transduction; GO:0007165; transmission of nerve impulse; GO:0019226 receptor activity; GO:0004872; G-protein coupled receptor activity; GO:0004930; ; GO:0004872; ; GO:0004930; rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 integral to membrane; GO:0016021 CG18208 CG18208 CDMC20494 2 3 13 DAC20-J24 23-CG18214-RF_12 CG18214 TTGGCGAAAGAATTCCAAATGATAAGGCAGGAAGCTTAAAGGCAAGCAAGAACAACAAACGAAAGTATG 69 FBan0018214 FBgn0024277 trio 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; Rho protein signal transduction; GO:0007266; actin cytoskeleton organization and biogenesis; GO:0030036; axon guidance; GO:0007411; central nervous system development; GO:0007417; peripheral nervous system development; GO:0007422; regulation of axonogenesis; GO:0050770; transmission of nerve impulse; GO:0019226 Rho guanyl-nucleotide exchange factor activity; GO:0005089; ; GO:0005089; ; GO:0005089; ; GO:0005089 plasma membrane; GO:0005886 trio trio "CG18214, CG9208, CG18214, M89, 0368/10, 0959/14, 1372/03, 1386/06, Trio, DTrio, l(3)S036810, l(3)S095914, l(3)S137203, l(3)S138606, l(3)S[1372/3], l(3)S[1386/06], UNC-73/Trio, l(3)036810, BEST:LD36950" CDMC20494 2 4 13 DAC20-J24 23-CG18214-RF_12 CG18214 TTGGCGAAAGAATTCCAAATGATAAGGCAGGAAGCTTAAAGGCAAGCAAGAACAACAAACGAAAGTATG 69 FBan0018214 FBgn0024277 trio 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; Rho protein signal transduction; GO:0007266; actin cytoskeleton organization and biogenesis; GO:0030036; axon guidance; GO:0007411; central nervous system development; GO:0007417; peripheral nervous system development; GO:0007422; regulation of axonogenesis; GO:0050770; transmission of nerve impulse; GO:0019226 Rho guanyl-nucleotide exchange factor activity; GO:0005089; ; GO:0005089; ; GO:0005089; ; GO:0005089 plasma membrane; GO:0005886 trio trio "CG18214, CG9208, CG18214, M89, 0368/10, 0959/14, 1372/03, 1386/06, Trio, DTrio, l(3)S036810, l(3)S095914, l(3)S137203, l(3)S138606, l(3)S[1372/3], l(3)S[1386/06], UNC-73/Trio, l(3)036810, BEST:LD36950" CDMC20495 2 5 13 DAC20-N12 17-CG18265-RA_1 CG18265 AGAATTTGTTCTTTGGCGAGAAGAGTTGCCCAAAATGAGTTGATCGCTCCGAGAAGAATTGGGATCGGC 69 FBan0018265 FBgn0036725 CG18265 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG18265 CG18265 CDMC20495 2 6 13 DAC20-N12 17-CG18265-RA_1 CG18265 AGAATTTGTTCTTTGGCGAGAAGAGTTGCCCAAAATGAGTTGATCGCTCCGAGAAGAATTGGGATCGGC 69 FBan0018265 FBgn0036725 CG18265 3 3L nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG18265 CG18265 CDMC20496 2 7 13 DAC20-N24 14-CG18273-RA_1 CG18273 CGCCAGGATGTACGAAGGATTGGTGAAGGATCACGAGAAGTACCACAAATTTAGGGGCAAGGTGTAGGT 69 FBan0018273 FBgn0029525 CG18273 X X CG18273 CG18273 "CG13372, CG13372, EG:171D11.6" CDMC20496 2 8 13 DAC20-N24 14-CG18273-RA_1 CG18273 CGCCAGGATGTACGAAGGATTGGTGAAGGATCACGAGAAGTACCACAAATTTAGGGGCAAGGTGTAGGT 69 FBan0018273 FBgn0029525 CG18273 X X CG18273 CG18273 "CG13372, CG13372, EG:171D11.6" CDMC20497 2 9 13 DAC21-B12 23-CG3902-RA_1 CG3902 CCGTTATCGGTTCTCACCATGTTAACGTAGCATTTACCACTTAGTTGATTCTGTTATGCATATTGTATA 69 FBan0003902 FBgn0036824 CG3902 3 3L acyl-CoA metabolism; GO:0006637; electron transport; GO:0006118 short-branched-chain-acyl-CoA dehydrogenase activity; GO:0016937 ; EC:1.3.99.-; ; GO:0016937 ; EC:1.3.99.- CG3902 CG3902 "CG18168, CT12987" CDMC20497 2 10 13 DAC21-B12 23-CG3902-RA_1 CG3902 CCGTTATCGGTTCTCACCATGTTAACGTAGCATTTACCACTTAGTTGATTCTGTTATGCATATTGTATA 69 FBan0003902 FBgn0036824 CG3902 3 3L acyl-CoA metabolism; GO:0006637; electron transport; GO:0006118 short-branched-chain-acyl-CoA dehydrogenase activity; GO:0016937 ; EC:1.3.99.-; ; GO:0016937 ; EC:1.3.99.- CG3902 CG3902 "CG18168, CT12987" CDMC20498 2 11 13 DAC21-B24 3-CG3918-RA_1 CG3918 GGCCCCAAAACAACTTCTCCATGAACTCTTCCCACGGATTATGAGACGCGCAAACCGTAGACTTGTCCC 69 FBan0003918 FBgn0029873 CG3918 X X CG3918 CG3918 CDMC20498 2 12 13 DAC21-B24 3-CG3918-RA_1 CG3918 GGCCCCAAAACAACTTCTCCATGAACTCTTCCCACGGATTATGAGACGCGCAAACCGTAGACTTGTCCC 69 FBan0003918 FBgn0029873 CG3918 X X CG3918 CG3918 CDMC20499 2 13 13 DAC21-F12 12-CG3948-RA_1 CG3948 CAGGTTCTGCAATCGGCACGTGAACAACTCAAATGGTCCATTCTGAAGTGATGTGAAATGGGGTGGCGG 69 FBan0003948 FBgn0040512 zetaCOP 3 3L intracellular protein transport; GO:0006886; vesicle-mediated transport; GO:0016192 COPI vesicle coat; GO:0030126; clathrin vesicle coat; GO:0030125 zetaCOP zetaCOP "CG3948, copz1, CT13124, zetaCOP" CDMC20499 2 14 13 DAC21-F12 12-CG3948-RA_1 CG3948 CAGGTTCTGCAATCGGCACGTGAACAACTCAAATGGTCCATTCTGAAGTGATGTGAAATGGGGTGGCGG 69 FBan0003948 FBgn0040512 zetaCOP 3 3L intracellular protein transport; GO:0006886; vesicle-mediated transport; GO:0016192 COPI vesicle coat; GO:0030126; clathrin vesicle coat; GO:0030125 zetaCOP zetaCOP "CG3948, copz1, CT13124, zetaCOP" CDMC20500 2 15 13 DAC21-F24 23-CG3959-RA_12 CG3959 TAGGAACTTAACTAGCGAGCGATATACAAGTAGACTAATAGGAACCACGACAGACTTGGACGTCAGGGC 69 FBan0003959 FBgn0011207 pelo 2 2L compound eye morphogenesis (sensu Endopterygota); GO:0001745; eye development (sensu Endopterygota); GO:0007456; male meiosis; GO:0007140; male meiosis I; GO:0007141; male meiosis I spindle assembly (sensu Metazoa); GO:0007054; meiosis; GO:0007126; meiotic G2/MI transition; GO:0008315; meiotic nuclear envelope disassembly; GO:0051078; meiotic spindle organization and biogenesis; GO:0000212; mitosis; GO:0007067; protein biosynthesis; GO:0006412; spermatocyte division; GO:0048137; spermatogenesis; GO:0007283 nucleus; GO:0005634 pelo pelota "CG3959, ms(2)01559" CDMC20500 2 16 13 DAC21-F24 23-CG3959-RA_12 CG3959 TAGGAACTTAACTAGCGAGCGATATACAAGTAGACTAATAGGAACCACGACAGACTTGGACGTCAGGGC 69 FBan0003959 FBgn0011207 pelo 2 2L compound eye morphogenesis (sensu Endopterygota); GO:0001745; eye development (sensu Endopterygota); GO:0007456; male meiosis; GO:0007140; male meiosis I; GO:0007141; male meiosis I spindle assembly (sensu Metazoa); GO:0007054; meiosis; GO:0007126; meiotic G2/MI transition; GO:0008315; meiotic nuclear envelope disassembly; GO:0051078; meiotic spindle organization and biogenesis; GO:0000212; mitosis; GO:0007067; protein biosynthesis; GO:0006412; spermatocyte division; GO:0048137; spermatogenesis; GO:0007283 nucleus; GO:0005634 pelo pelota "CG3959, ms(2)01559" CDMC20501 2 17 13 DAC21-J12 6-CG3996-RA_3 CG3996 AGCAGGGGAAGGAGTATTCATAGATCTGGAGACTATGCACCTTCGATTAGGGTCACCTCCGAGCACCGA 69 FBan0003996 FBgn0037800 CG3996 3 3R cell cycle; GO:0007049; cell proliferation; GO:0008283; regulation of progression through cell cycle; GO:0000074 DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG3996 CG3996 CDMC20501 2 18 13 DAC21-J12 6-CG3996-RA_3 CG3996 AGCAGGGGAAGGAGTATTCATAGATCTGGAGACTATGCACCTTCGATTAGGGTCACCTCCGAGCACCGA 69 FBan0003996 FBgn0037800 CG3996 3 3R cell cycle; GO:0007049; cell proliferation; GO:0008283; regulation of progression through cell cycle; GO:0000074 DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG3996 CG3996 CDMC20502 2 19 13 DAC21-J24 17-CG40044-RA_1 CG40044 GCCAGAAGATACACGAGCTGAACGCAATGAAGTCAGAAGATTAGAACAACGACAGTCACGCCGTTTCAC 69 FBgn0058044 CG40044 CG40044 CG40044 CDMC20502 2 20 13 DAC21-J24 17-CG40044-RA_1 CG40044 GCCAGAAGATACACGAGCTGAACGCAATGAAGTCAGAAGATTAGAACAACGACAGTCACGCCGTTTCAC 69 FBgn0058044 CG40044 CG40044 CG40044 CDMC20503 2 21 13 DAC21-N12 1-CG4009-RA_1 CG4009 TGGCAACTGCTTACCTGGATCTCTCCTCCATCTATGGCAACAATCCCTCGCAAAACAGAAAGGTCCGCT 69 FBan0004009 FBgn0038469 CG4009 3 3R defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800 peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7 CG4009 CG4009 CDMC20503 2 22 13 DAC21-N12 1-CG4009-RA_1 CG4009 TGGCAACTGCTTACCTGGATCTCTCCTCCATCTATGGCAACAATCCCTCGCAAAACAGAAAGGTCCGCT 69 FBan0004009 FBgn0038469 CG4009 3 3R defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800 peroxidase activity; GO:0004601 ; EC:1.11.1.7; ; GO:0004601 ; EC:1.11.1.7 CG4009 CG4009 CDMC20504 2 23 13 DAC21-N24 15-CG40115-RA_1 CG40115 CGCGTCGAGTTGCGAAAGTGCGTCGAAAAATTTTAACTTGCGGTCATACGGAATTTTTTTGTCGCGCGA 69 FBgn0058115 CG40115 CG40115 CG40115 CDMC20504 2 24 13 DAC21-N24 15-CG40115-RA_1 CG40115 CGCGTCGAGTTGCGAAAGTGCGTCGAAAAATTTTAACTTGCGGTCATACGGAATTTTTTTGTCGCGCGA 69 FBgn0058115 CG40115 CG40115 CG40115 CDMC20505 2 25 13 DAC22-B12 18-CG13744-RA_6 CG13744 GCGGACATAACCGTGTACCTGGGAGAGCTGGACACGCAGGATCTGGGTCACATACACGAACCGCT 65 FBan0013744 FBgn0033363 CG13744 2 2R defense response; GO:0006952; proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG13744 CG13744 "SP67, c-SP67" CDMC20505 2 26 13 DAC22-B12 18-CG13744-RA_6 CG13744 GCGGACATAACCGTGTACCTGGGAGAGCTGGACACGCAGGATCTGGGTCACATACACGAACCGCT 65 FBan0013744 FBgn0033363 CG13744 2 2R defense response; GO:0006952; proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004263 ; EC:3.4.21.1 CG13744 CG13744 "SP67, c-SP67" CDMC20506 2 1 14 DAC22-B24 3-CG13784-RA_3 CG13784 AGCATAAACGCGGATCTTCACCAGTGGACAACTCCTTATGACGAAGTGTCTCGCTGGTCGCCTGG 65 FBan0013784 FBgn0031897 CG13784 2 2L CG13784 CG13784 BcDNA:SD10385 CDMC20506 2 2 14 DAC22-B24 3-CG13784-RA_3 CG13784 AGCATAAACGCGGATCTTCACCAGTGGACAACTCCTTATGACGAAGTGTCTCGCTGGTCGCCTGG 65 FBan0013784 FBgn0031897 CG13784 2 2L CG13784 CG13784 BcDNA:SD10385 CDMC20507 2 3 14 DAC22-F12 2-CG13847-RA_1 CG13847 CTCTACAGAAATCGAACGAAAGCCCCCAGGTTCAGCCCTCCAATCAGTTCAACTTTGCACCGGCC 65 FBan0013847 FBgn0038967 CG13847 3 3R CG13847 CG13847 CDMC20507 2 4 14 DAC22-F12 2-CG13847-RA_1 CG13847 CTCTACAGAAATCGAACGAAAGCCCCCAGGTTCAGCCCTCCAATCAGTTCAACTTTGCACCGGCC 65 FBan0013847 FBgn0038967 CG13847 3 3R CG13847 CG13847 CDMC20508 2 5 14 DAC22-F24 3-CG13870-RA_3 CG13870 GACATCCCATTTCCATTCGGGCGTATCCGGTTCCTCCGTACGTGCCCAAGATCACCTACAACTGT 65 FBan0013870 FBgn0034506 CG13870 2 2R CG13870 CG13870 CDMC20508 2 6 14 DAC22-F24 3-CG13870-RA_3 CG13870 GACATCCCATTTCCATTCGGGCGTATCCGGTTCCTCCGTACGTGCCCAAGATCACCTACAACTGT 65 FBan0013870 FBgn0034506 CG13870 2 2R CG13870 CG13870 CDMC20509 2 7 14 DAC22-J12 6-CG13942-RA_2 CG13942 CAGTACACCCAATATGGGGGAGCAGAGTCCCACGAACAGCATCGATTCCTACCGCAGCAACCATC 65 FBan0013942 FBgn0033922 CG13942 2 2R CG13942 CG13942 CDMC20509 2 8 14 DAC22-J12 6-CG13942-RA_2 CG13942 CAGTACACCCAATATGGGGGAGCAGAGTCCCACGAACAGCATCGATTCCTACCGCAGCAACCATC 65 FBan0013942 FBgn0033922 CG13942 2 2R CG13942 CG13942 CDMC20510 2 9 14 DAC22-J24 15-CG13953-RA_1 CG13953 CGCCTATGCTCACCACCAATCGATGACGGCTATGTCGAACAACGGTATTATCTATCAGTCGGCGG 65 FBan0013953 FBgn0033416 CG13953 2 2R CG13953 CG13953 CDMC20510 2 10 14 DAC22-J24 15-CG13953-RA_1 CG13953 CGCCTATGCTCACCACCAATCGATGACGGCTATGTCGAACAACGGTATTATCTATCAGTCGGCGG 65 FBan0013953 FBgn0033416 CG13953 2 2R CG13953 CG13953 CDMC20511 2 11 14 DAC22-N12 3-CG14031-RA_1 CG14031 CATCATGAGAGACGCACGGCATTTCCCGAAACCAAATCAATTCCTGCCCGAACGTTTTCTGCCCG 65 FBan0014031 FBgn0031695 Cyp4ac3 2 2L electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4ac3 Cyp4ac3 "CG14031, CG14031, 4ac3" CDMC20511 2 12 14 DAC22-N12 3-CG14031-RA_1 CG14031 CATCATGAGAGACGCACGGCATTTCCCGAAACCAAATCAATTCCTGCCCGAACGTTTTCTGCCCG 65 FBan0014031 FBgn0031695 Cyp4ac3 2 2L electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4ac3 Cyp4ac3 "CG14031, CG14031, 4ac3" CDMC20512 2 13 14 DAC22-N24 22-CG14069-RA_1 CG14069 TGAACACAGCGACCACAATTGCCATCGGATTGTTAATGTTCATCCCACTGATCCTGATGCAGCTG 65 FBan0014069 FBgn0032315 CG14069 2 2L CG14069 CG14069 CDMC20512 2 14 14 DAC22-N24 22-CG14069-RA_1 CG14069 TGAACACAGCGACCACAATTGCCATCGGATTGTTAATGTTCATCCCACTGATCCTGATGCAGCTG 65 FBan0014069 FBgn0032315 CG14069 2 2L CG14069 CG14069 CDMC20513 2 15 14 DAC23-B12 1-CG4653-RA_1 CG4653 GAACTACTCCAGTTCGGATGCAGTTGGCTCTAATGACTTGGCCTTGCTGGAGCTGGAAACGTCGG 65 FBan0004653 FBgn0030776 CG4653 X X proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG4653 CG4653 SPH179 CDMC20513 2 16 14 DAC23-B12 1-CG4653-RA_1 CG4653 GAACTACTCCAGTTCGGATGCAGTTGGCTCTAATGACTTGGCCTTGCTGGAGCTGGAAACGTCGG 65 FBan0004653 FBgn0030776 CG4653 X X proteolysis; GO:0006508 NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG4653 CG4653 SPH179 CDMC20514 2 17 14 DAC23-B24 3-CG4711-RA_1 CG4711 GAGCTAGAGGCGTTAGCCATGATGCGTCACTTCGGAATGATGTCCATGGCAACAGATTCGCTGCC 65 FBgn0032594 CDMC20514 2 18 14 DAC23-B24 3-CG4711-RA_1 CG4711 GAGCTAGAGGCGTTAGCCATGATGCGTCACTTCGGAATGATGTCCATGGCAACAGATTCGCTGCC 65 FBgn0032594 CDMC20515 2 19 14 DAC23-F12 2-CG4882-RA_2 CG4882 GATATCGGTGCTCCGTAATCCCATCCAGTACGGGCTCTTTGTGGACCAGTTCTCTGGCTGCTTCC 65 FBan0004882 FBgn0025336 CG4882 2 2R transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG4882 CG4882 "UD1, undefined 1, LD24471, GM14313, anon-60Aa" CDMC20515 2 20 14 DAC23-F12 2-CG4882-RA_2 CG4882 GATATCGGTGCTCCGTAATCCCATCCAGTACGGGCTCTTTGTGGACCAGTTCTCTGGCTGCTTCC 65 FBan0004882 FBgn0025336 CG4882 2 2R transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG4882 CG4882 "UD1, undefined 1, LD24471, GM14313, anon-60Aa" CDMC20516 2 21 14 DAC23-F24 2-CG4913-RA_2 CG4913 AAACAGCATGTGACCGGTTCAGAGAAGTCATCAACGGTCGACCCATCGCCTAAACTAGAGGGGGC 65 FBan0004913 FBgn0026441 ear 3 3R regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251 transcription factor TFIID complex; GO:0005669; transcription factor TFIIF complex; GO:0005674 ear ENL/AF9-related "CG4913, CG4913, dENL/AF9, ENL/AF9, ENL/AF-9, ENL/AF9-related" CDMC20516 2 22 14 DAC23-F24 2-CG4913-RA_2 CG4913 AAACAGCATGTGACCGGTTCAGAGAAGTCATCAACGGTCGACCCATCGCCTAAACTAGAGGGGGC 65 FBan0004913 FBgn0026441 ear 3 3R regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription initiation from RNA polymerase II promoter; GO:0006367 general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251 transcription factor TFIID complex; GO:0005669; transcription factor TFIIF complex; GO:0005674 ear ENL/AF9-related "CG4913, CG4913, dENL/AF9, ENL/AF9, ENL/AF-9, ENL/AF9-related" CDMC20517 2 23 14 DAC23-J12 3-CG5122-RA_1 CG5122 GAATTCTTTCGGTCCAAGGGTTACGTCCGATCGGTGACCTTCCAGCTCTTCACCTCCCAGGTAGC 65 FBan0005122 FBgn0032471 CG5122 2 2L amino acid metabolism; GO:0006520 carnitine O-acetyltransferase activity; GO:0004092 ; EC:2.3.1.7; ; GO:0004092 ; EC:2.3.1.7 CG5122 CG5122 CDMC20517 2 24 14 DAC23-J12 3-CG5122-RA_1 CG5122 GAATTCTTTCGGTCCAAGGGTTACGTCCGATCGGTGACCTTCCAGCTCTTCACCTCCCAGGTAGC 65 FBan0005122 FBgn0032471 CG5122 2 2L amino acid metabolism; GO:0006520 carnitine O-acetyltransferase activity; GO:0004092 ; EC:2.3.1.7; ; GO:0004092 ; EC:2.3.1.7 CG5122 CG5122 CDMC20518 2 25 14 DAC23-J24 2-CG5165-RA_2 CG5165 GGTTCCCACTGGATGGAAGTACTTCGGTAATCTCATGGACGCCGGAAGGTTGTGTCTGTGCGGAG 65 FBan0005165 FBgn0003076 Pgm 3 3L detection of light stimulus during visual perception; GO:0050908; monosaccharide metabolism; GO:0005996 protein binding; GO:0005515; phosphoglucomutase activity; GO:0004614 ; EC:5.4.2.2; ; GO:0004614 ; EC:5.4.2.2; ; GO:0005515; ; GO:0005515 inaD signaling complex; GO:0016027 Pgm Phosphogluconate mutase "CG5165, CG5165, PGM, PGM-1, pgm" CDMC20518 2 26 14 DAC23-J24 2-CG5165-RA_2 CG5165 GGTTCCCACTGGATGGAAGTACTTCGGTAATCTCATGGACGCCGGAAGGTTGTGTCTGTGCGGAG 65 FBan0005165 FBgn0003076 Pgm 3 3L detection of light stimulus during visual perception; GO:0050908; monosaccharide metabolism; GO:0005996 protein binding; GO:0005515; phosphoglucomutase activity; GO:0004614 ; EC:5.4.2.2; ; GO:0004614 ; EC:5.4.2.2; ; GO:0005515; ; GO:0005515 inaD signaling complex; GO:0016027 Pgm Phosphogluconate mutase "CG5165, CG5165, PGM, PGM-1, pgm" CDMC20519 2 1 15 DAC23-N12 3-CG5263-RA_1 CG5263 GGGAGTGCTCACCAACAACGGATCTAACGACAACCTGGTATTGGAACGCAATCAGCAGTCGCAGC 65 FBan0005263 FBgn0016070 smg 3 3L negative regulation of translation; GO:0016478 "mRNA binding; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0003729; translation repressor activity, nucleic acid binding; GO:0000900; translation repressor activity; GO:0030371; ; GO:0030371; ; GO:0005515; mRNA 3'-UTR binding; GO:0003730; ; GO:0003730; ; GO:0030371; ; GO:0000900; ; GO:0030371" cytoplasm; GO:0005737 smg smaug "CG5263, D69, Smg, anon-D69, anonD69" CDMC20519 2 2 15 DAC23-N12 3-CG5263-RA_1 CG5263 GGGAGTGCTCACCAACAACGGATCTAACGACAACCTGGTATTGGAACGCAATCAGCAGTCGCAGC 65 FBan0005263 FBgn0016070 smg 3 3L negative regulation of translation; GO:0016478 "mRNA binding; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0003729; translation repressor activity, nucleic acid binding; GO:0000900; translation repressor activity; GO:0030371; ; GO:0030371; ; GO:0005515; mRNA 3'-UTR binding; GO:0003730; ; GO:0003730; ; GO:0030371; ; GO:0000900; ; GO:0030371" cytoplasm; GO:0005737 smg smaug "CG5263, D69, Smg, anon-D69, anonD69" CDMC20520 2 3 15 DAC23-N24 2-CG5292-RA_3 CG5292 TGCACACTCTGGGCGTCAAGGAGATCATCTACGGCTGTGAGAACGATCGTTTCGGAGGAAAGACG 65 FBan0005292 FBgn0038491 CG5292 3 3R pyrimidine base metabolism; GO:0006206 cytosine deaminase activity; GO:0004131 ; EC:3.5.4.1; zinc ion binding; GO:0008270; ; GO:0004131 ; EC:3.5.4.1; ; GO:0008270 CG5292 CG5292 BcDNA:RE41712 CDMC20520 2 4 15 DAC23-N24 2-CG5292-RA_3 CG5292 TGCACACTCTGGGCGTCAAGGAGATCATCTACGGCTGTGAGAACGATCGTTTCGGAGGAAAGACG 65 FBan0005292 FBgn0038491 CG5292 3 3R pyrimidine base metabolism; GO:0006206 cytosine deaminase activity; GO:0004131 ; EC:3.5.4.1; zinc ion binding; GO:0008270; ; GO:0004131 ; EC:3.5.4.1; ; GO:0008270 CG5292 CG5292 BcDNA:RE41712 CDMC20521 2 5 15 DAC24-B12 2-CG9188-RB_2 CG9188 AGCGTCGCCAAAATCAGATAAAGCAGCCATACGCCAACATAGTCAGTCCCATACGCACCTACACCCAGA 69 FBan0009188 FBgn0031878 sip2 2 2L biological process unknown; GO:0000004 protein binding; GO:0005515; ; GO:0005515; ; GO:0005515 cellular component unknown; GO:0008372 sip2 septin interacting protein 2 "CG9188, CG9188, CG9188, CG9188, CG9188, septin interacting protein 2" CDMC20521 2 6 15 DAC24-B12 2-CG9188-RB_2 CG9188 AGCGTCGCCAAAATCAGATAAAGCAGCCATACGCCAACATAGTCAGTCCCATACGCACCTACACCCAGA 69 FBan0009188 FBgn0031878 sip2 2 2L biological process unknown; GO:0000004 protein binding; GO:0005515; ; GO:0005515; ; GO:0005515 cellular component unknown; GO:0008372 sip2 septin interacting protein 2 "CG9188, CG9188, CG9188, CG9188, CG9188, septin interacting protein 2" CDMC20522 2 7 15 DAC24-B24 3-CG9204-RB_3 CG9204 GCTGGGAGACTCGGCCTCCTACTCAACGAAATCCCTTACCCAGGAAAAGACACTTCGCGACTTCTTGAA 69 FBan0009204 FBgn0025720 Ate1 2 2R protein arginylation; GO:0016598; regulation of protein catabolism; GO:0042176; ubiquitin-dependent protein catabolism; GO:0006511 arginyltransferase activity; GO:0004057 ; EC:2.3.2.8; ; GO:0004057 ; EC:2.3.2.8 Ate1 Ate1 "CG9204, CG9204, CG9204, Dm-Ate1, l(2)k10809, ate1, ATE1, Ate" CDMC20522 2 8 15 DAC24-B24 3-CG9204-RB_3 CG9204 GCTGGGAGACTCGGCCTCCTACTCAACGAAATCCCTTACCCAGGAAAAGACACTTCGCGACTTCTTGAA 69 FBan0009204 FBgn0025720 Ate1 2 2R protein arginylation; GO:0016598; regulation of protein catabolism; GO:0042176; ubiquitin-dependent protein catabolism; GO:0006511 arginyltransferase activity; GO:0004057 ; EC:2.3.2.8; ; GO:0004057 ; EC:2.3.2.8 Ate1 Ate1 "CG9204, CG9204, CG9204, Dm-Ate1, l(2)k10809, ate1, ATE1, Ate" CDMC20523 2 9 15 DAC24-F12 3-CG9243-RA_1 CG9243 TGACGCAACGCAAGGAACTAGGTGTGCTGGCCAGAAATTGTCCCCATCTTGCTCTAGATCTGGGAAAGA 69 FBan0009243 FBgn0032926 CG9243 2 2L lipid metabolism; GO:0006629; phospholipid metabolism; GO:0006644 hydrolase activity; GO:0016787 ; EC:3.-.-.-; lipase activity; GO:0016298 ; EC:3.1.1.-; phospholipase activity; GO:0004620 ; EC:3.1.1.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016298 ; EC:3.1.1.-; ; GO:0004620 ; EC:3.1.1.- CG9243 CG9243 CDMC20523 2 10 15 DAC24-F12 3-CG9243-RA_1 CG9243 TGACGCAACGCAAGGAACTAGGTGTGCTGGCCAGAAATTGTCCCCATCTTGCTCTAGATCTGGGAAAGA 69 FBan0009243 FBgn0032926 CG9243 2 2L lipid metabolism; GO:0006629; phospholipid metabolism; GO:0006644 hydrolase activity; GO:0016787 ; EC:3.-.-.-; lipase activity; GO:0016298 ; EC:3.1.1.-; phospholipase activity; GO:0004620 ; EC:3.1.1.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016298 ; EC:3.1.1.-; ; GO:0004620 ; EC:3.1.1.- CG9243 CG9243 CDMC20524 2 11 15 DAC24-F24 16-CG9249-RA_1 CG9249 TGCGAATGCTATGATGCGGTGATAGTGTCTGAAGTTCTGGAGCACGTCAAAGATAAAGTGTCCCTGCTG 69 FBan0009249 FBgn0032922 CG9249 2 2L ubiquinone metabolism; GO:0006743 hexaprenyldihydroxybenzoate methyltransferase activity; GO:0004395 ; EC:2.1.1.114; ; GO:0004395 ; EC:2.1.1.114 CG9249 CG9249 CDMC20524 2 12 15 DAC24-F24 16-CG9249-RA_1 CG9249 TGCGAATGCTATGATGCGGTGATAGTGTCTGAAGTTCTGGAGCACGTCAAAGATAAAGTGTCCCTGCTG 69 FBan0009249 FBgn0032922 CG9249 2 2L ubiquinone metabolism; GO:0006743 hexaprenyldihydroxybenzoate methyltransferase activity; GO:0004395 ; EC:2.1.1.114; ; GO:0004395 ; EC:2.1.1.114 CG9249 CG9249 CDMC20525 2 13 15 DAC24-J12 1-CG9289-RA_1 CG9289 AGACGGGACCCTACATGAAGATCGATCGGACTGTCAGTTTCGGGGACAATTACCTGGATGAGTACCGCA 69 FBan0009289 FBgn0032058 CG9289 2 2L carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 CG9289 CG9289 "CT26467, glutactin-like" CDMC20525 2 14 15 DAC24-J12 1-CG9289-RA_1 CG9289 AGACGGGACCCTACATGAAGATCGATCGGACTGTCAGTTTCGGGGACAATTACCTGGATGAGTACCGCA 69 FBan0009289 FBgn0032058 CG9289 2 2L carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 CG9289 CG9289 "CT26467, glutactin-like" CDMC20526 2 15 15 DAC24-J24 15-CG9302-RA_1 CG9302 GGACCGCACAGAGCTGTGATACGCTGTTGCAAAGTATAACGATGCTTCTCCCACAACACTTTGCAATCT 69 FBan0009302 FBgn0032514 CG9302 2 2L electron transport; GO:0006118; protein modification; GO:0006464 protein disulfide isomerase activity; GO:0003756 ; EC:5.3.4.1; electron transporter activity; GO:0005489; ; GO:0003756 ; EC:5.3.4.1; ; GO:0003756 ; EC:5.3.4.1; ; GO:0005489 CG9302 CG9302 anon-WO0118547.80 CDMC20526 2 16 15 DAC24-J24 15-CG9302-RA_1 CG9302 GGACCGCACAGAGCTGTGATACGCTGTTGCAAAGTATAACGATGCTTCTCCCACAACACTTTGCAATCT 69 FBan0009302 FBgn0032514 CG9302 2 2L electron transport; GO:0006118; protein modification; GO:0006464 protein disulfide isomerase activity; GO:0003756 ; EC:5.3.4.1; electron transporter activity; GO:0005489; ; GO:0003756 ; EC:5.3.4.1; ; GO:0003756 ; EC:5.3.4.1; ; GO:0005489 CG9302 CG9302 anon-WO0118547.80 CDMC20527 2 17 15 DAC24-N12 15-CG9327-RA_2 CG9327 AGCGTGTGGACAATAAGACCGTATACAGTGTCCTGGAGAAACCCGATGTGGAGAAGCTGATCGAGAAGT 69 FBan0009327 FBgn0003150 Pros29 2 2R ATP-dependent proteolysis; GO:0006510; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 proteasome complex (sensu Eukaryota); GO:0000502; proteasome core complex (sensu Eukaryota); GO:0005839 Pros29 Proteasome 29kD subunit "CG9327, PROS-29, alpha3_dm, 20S proteasome, 20s proteasome, pros29, Proteasome subunit alpha-type 4" CDMC20527 2 18 15 DAC24-N12 15-CG9327-RA_2 CG9327 AGCGTGTGGACAATAAGACCGTATACAGTGTCCTGGAGAAACCCGATGTGGAGAAGCTGATCGAGAAGT 69 FBan0009327 FBgn0003150 Pros29 2 2R ATP-dependent proteolysis; GO:0006510; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 proteasome complex (sensu Eukaryota); GO:0000502; proteasome core complex (sensu Eukaryota); GO:0005839 Pros29 Proteasome 29kD subunit "CG9327, PROS-29, alpha3_dm, 20S proteasome, 20s proteasome, pros29, Proteasome subunit alpha-type 4" CDMC20528 2 19 15 DAC24-N24 2-CG9338-RA_4 CG9338 TCCGAGTGTGGAAAGGACATCAAGTCAGACAGTAGCCTCGTTTTGGATTGCACCAAGATGGCTCCACCT 69 FBan0009338 FBgn0032899 CG9338 2 2L CG9338 CG9338 BcDNA:GH07967 CDMC20528 2 20 15 DAC24-N24 2-CG9338-RA_4 CG9338 TCCGAGTGTGGAAAGGACATCAAGTCAGACAGTAGCCTCGTTTTGGATTGCACCAAGATGGCTCCACCT 69 FBan0009338 FBgn0032899 CG9338 2 2L CG9338 CG9338 BcDNA:GH07967 CDMC20529 2 21 15 DAC25-B12 12-CG10572-RA_1 CG10572 GCCGCCAGGAGGACATAAAGACCAGTAATCCGTACCATCACGATCAGCTAGACCGCATCTTCAATGTGA 69 FBan0010572 FBgn0015618 Cdk8 3 3L G1/S transition of mitotic cell cycle; GO:0000082; cell cycle; GO:0007049; mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074; transcription initiation from RNA polymerase II promoter; GO:0006367 ATP binding; GO:0005524; ; GO:0005524; RNA polymerase II transcription mediator activity; GO:0016455; cyclin-dependent protein kinase activity; GO:0004693 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0016455; ; GO:0004693 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.- mediator complex; GO:0000119; nucleus; GO:0005634 Cdk8 Cyclin-dependent kinase 8 "CG10572, CG10572, CG10572, DmCdk8, CDK8, dTRAP56, p58, cdk8, Cyclin-dependent kinase 8" CDMC20529 2 22 15 DAC25-B12 12-CG10572-RA_1 CG10572 GCCGCCAGGAGGACATAAAGACCAGTAATCCGTACCATCACGATCAGCTAGACCGCATCTTCAATGTGA 69 FBan0010572 FBgn0015618 Cdk8 3 3L G1/S transition of mitotic cell cycle; GO:0000082; cell cycle; GO:0007049; mitosis; GO:0007067; protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074; transcription initiation from RNA polymerase II promoter; GO:0006367 ATP binding; GO:0005524; ; GO:0005524; RNA polymerase II transcription mediator activity; GO:0016455; cyclin-dependent protein kinase activity; GO:0004693 ; EC:2.7.1.-; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0016455; ; GO:0004693 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.-; ; GO:0004693 ; EC:2.7.1.- mediator complex; GO:0000119; nucleus; GO:0005634 Cdk8 Cyclin-dependent kinase 8 "CG10572, CG10572, CG10572, DmCdk8, CDK8, dTRAP56, p58, cdk8, Cyclin-dependent kinase 8" CDMC20530 2 23 15 DAC25-B24 3-CG10580-RA_3 CG10580 GCCGGTCACCGAGTTGGATGACATTTTCATCAGCGTAAAGACGACGAAGAACTATCACGACACCCGGCT 69 FBan0010580 FBgn0011591 fng 3 3L "Notch signaling pathway; GO:0007219; cell fate specification; GO:0001708; compound eye morphogenesis (sensu Endopterygota); GO:0001745; dorsal/ventral lineage restriction, imaginal disc; GO:0007451; dorsal/ventral pattern formation, imaginal disc; GO:0007450; ectoderm development; GO:0007398; egg chamber formation (sensu Insecta); GO:0007293; eye development (sensu Endopterygota); GO:0007456; fucose metabolism; GO:0006004; leg joint morphogenesis; GO:0035111; leg segmentation; GO:0035286; negative regulation of Notch signaling pathway; GO:0045746; nervous system development; GO:0007399; oogenesis (sensu Insecta); GO:0009993; positive regulation of Notch signaling pathway; GO:0045747; regulation of Notch signaling pathway; GO:0008593; segment specification; GO:0007379; wing margin morphogenesis; GO:0008587; wing morphogenesis; GO:0007476" "acetylglucosaminyltransferase activity; GO:0008375 ; EC:2.4.1.-; UDP-glycosyltransferase activity; GO:0008194; transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; ; GO:0016757 ; EC:2.4.-.-; ; GO:0008375 ; EC:2.4.1.-; ; GO:0008375 ; EC:2.4.1.-; receptor binding; GO:0005102; ; GO:0005102; ; GO:0008375 ; EC:2.4.1.-; ; GO:0016757 ; EC:2.4.-.-; ; GO:0008194" Golgi apparatus; GO:0005794; Golgi stack; GO:0005795; endoplasmic reticulum; GO:0005783; integral to membrane; GO:0016021 fng fringe "CG10580, CG10580, l(3)rG554, D-fng, Frg, fg: flag, frg, D-Fng, Dfng, fringe, fg" CDMC20530 2 24 15 DAC25-B24 3-CG10580-RA_3 CG10580 GCCGGTCACCGAGTTGGATGACATTTTCATCAGCGTAAAGACGACGAAGAACTATCACGACACCCGGCT 69 FBan0010580 FBgn0011591 fng 3 3L "Notch signaling pathway; GO:0007219; cell fate specification; GO:0001708; compound eye morphogenesis (sensu Endopterygota); GO:0001745; dorsal/ventral lineage restriction, imaginal disc; GO:0007451; dorsal/ventral pattern formation, imaginal disc; GO:0007450; ectoderm development; GO:0007398; egg chamber formation (sensu Insecta); GO:0007293; eye development (sensu Endopterygota); GO:0007456; fucose metabolism; GO:0006004; leg joint morphogenesis; GO:0035111; leg segmentation; GO:0035286; negative regulation of Notch signaling pathway; GO:0045746; nervous system development; GO:0007399; oogenesis (sensu Insecta); GO:0009993; positive regulation of Notch signaling pathway; GO:0045747; regulation of Notch signaling pathway; GO:0008593; segment specification; GO:0007379; wing margin morphogenesis; GO:0008587; wing morphogenesis; GO:0007476" "acetylglucosaminyltransferase activity; GO:0008375 ; EC:2.4.1.-; UDP-glycosyltransferase activity; GO:0008194; transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; ; GO:0016757 ; EC:2.4.-.-; ; GO:0008375 ; EC:2.4.1.-; ; GO:0008375 ; EC:2.4.1.-; receptor binding; GO:0005102; ; GO:0005102; ; GO:0008375 ; EC:2.4.1.-; ; GO:0016757 ; EC:2.4.-.-; ; GO:0008194" Golgi apparatus; GO:0005794; Golgi stack; GO:0005795; endoplasmic reticulum; GO:0005783; integral to membrane; GO:0016021 fng fringe "CG10580, CG10580, l(3)rG554, D-fng, Frg, fg: flag, frg, D-Fng, Dfng, fringe, fg" CDMC20531 2 25 15 DAC25-F12 9-CG10616-RA_1 CG10616 AGGGACTCCCGGATGATACGCACTTCAACAATTGCAAGATGGACGCTGATTGCATAGACGATTCTGGGA 69 FBan0010616 FBgn0036286 CG10616 3 3L CG10616 CG10616 CDMC20531 2 26 15 DAC25-F12 9-CG10616-RA_1 CG10616 AGGGACTCCCGGATGATACGCACTTCAACAATTGCAAGATGGACGCTGATTGCATAGACGATTCTGGGA 69 FBan0010616 FBgn0036286 CG10616 3 3L CG10616 CG10616 CDMC20532 2 1 16 DAC25-F24 2-CG10623-RA_1 CG10623 CGTCGATGGCCTCAACATAAAGCCGTAATCGGGAGAGAACTCCGGTCACTGATAGCAGCCTTGTCGCTA 69 FBan0010623 FBgn0032727 CG10623 2 2L amino acid biosynthesis; GO:0008652 selenocysteine methyltransferase activity; GO:0016205 ; EC:2.1.1.-; ; GO:0016205 ; EC:2.1.1.-; homocysteine S-methyltransferase activity; GO:0008898 ; EC:2.1.1.10; ; GO:0008898 ; EC:2.1.1.10 CG10623 CG10623 selenocysteine methyltransferase CDMC20532 2 2 16 DAC25-F24 2-CG10623-RA_1 CG10623 CGTCGATGGCCTCAACATAAAGCCGTAATCGGGAGAGAACTCCGGTCACTGATAGCAGCCTTGTCGCTA 69 FBan0010623 FBgn0032727 CG10623 2 2L amino acid biosynthesis; GO:0008652 selenocysteine methyltransferase activity; GO:0016205 ; EC:2.1.1.-; ; GO:0016205 ; EC:2.1.1.-; homocysteine S-methyltransferase activity; GO:0008898 ; EC:2.1.1.10; ; GO:0008898 ; EC:2.1.1.10 CG10623 CG10623 selenocysteine methyltransferase CDMC20533 2 3 16 DAC25-J12 3-CG1064-RA_1 CG1064 CCGAGGAGTTTGCCATTAAACTCTGTGCGGAATTGGGATTGGGAGGAGAGTTTGTTACGGCCATTGCCT 69 FBan0001064 FBgn0011715 Snr1 3 3R "chromatin remodeling; GO:0006338; embryonic development (sensu Insecta); GO:0001700; larval or pupal development (sensu Insecta); GO:0002165; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription; GO:0045449; wing vein specification; GO:0007474" RNA polymerase II transcription factor activity; GO:0003702; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003702; ; GO:0016251; contributes_to transcription coactivator activity; GO:0003713; ; GO:0003713 brahma complex; GO:0035060; nuclear chromosome; GO:0000228; nucleus; GO:0005634 Snr1 Snf5-related 1 "CG1064, snr1, snf5-related 1, BAP45, snr, SNR1, l(3)01319" CDMC20533 2 4 16 DAC25-J12 3-CG1064-RA_1 CG1064 CCGAGGAGTTTGCCATTAAACTCTGTGCGGAATTGGGATTGGGAGGAGAGTTTGTTACGGCCATTGCCT 69 FBan0001064 FBgn0011715 Snr1 3 3R "chromatin remodeling; GO:0006338; embryonic development (sensu Insecta); GO:0001700; larval or pupal development (sensu Insecta); GO:0002165; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription; GO:0045449; wing vein specification; GO:0007474" RNA polymerase II transcription factor activity; GO:0003702; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0003702; ; GO:0016251; contributes_to transcription coactivator activity; GO:0003713; ; GO:0003713 brahma complex; GO:0035060; nuclear chromosome; GO:0000228; nucleus; GO:0005634 Snr1 Snf5-related 1 "CG1064, snr1, snf5-related 1, BAP45, snr, SNR1, l(3)01319" CDMC20534 2 5 16 DAC25-J24 2-CG10658-RA_1 CG10658 GCCTGGATAAACAGCGACCTCATGTACCATAAGACTCCCGATAAGTTGCTCGTCGAGGTTCTTCCCGGC 69 FBan0010658 FBgn0014000 Os9 2 2L nucleus; GO:0005634 Os9 Olfactory-specific 9 "CG10658, OS9" CDMC20534 2 6 16 DAC25-J24 2-CG10658-RA_1 CG10658 GCCTGGATAAACAGCGACCTCATGTACCATAAGACTCCCGATAAGTTGCTCGTCGAGGTTCTTCCCGGC 69 FBan0010658 FBgn0014000 Os9 2 2L nucleus; GO:0005634 Os9 Olfactory-specific 9 "CG10658, OS9" CDMC20535 2 7 16 DAC25-N12 23-CG10691-RB_5 CG10691 TCGCGCAGTAGCTGGGTGCATCTAGTTCCGTTAAGTTGTAACTACCTATAGCATTTACTAAGTACTTTT 69 FBan0010691 FBgn0002031 l(2)37Cc 2 2L DNA replication; GO:0006260; larval or pupal development (sensu Insecta); GO:0002165; regulation of progression through cell cycle; GO:0000074 mitochondrial membrane; GO:0005740; mitochondrion; GO:0005739 l(2)37Cc lethal (2) 37Cc "CG10691, transcription unit No. 4, l(2)Cc, Cc, fs(2)HH32" CDMC20535 2 8 16 DAC25-N12 23-CG10691-RB_5 CG10691 TCGCGCAGTAGCTGGGTGCATCTAGTTCCGTTAAGTTGTAACTACCTATAGCATTTACTAAGTACTTTT 69 FBan0010691 FBgn0002031 l(2)37Cc 2 2L DNA replication; GO:0006260; larval or pupal development (sensu Insecta); GO:0002165; regulation of progression through cell cycle; GO:0000074 mitochondrial membrane; GO:0005740; mitochondrion; GO:0005739 l(2)37Cc lethal (2) 37Cc "CG10691, transcription unit No. 4, l(2)Cc, Cc, fs(2)HH32" CDMC20536 2 9 16 DAC25-N24 11-CG10699-RA_1 CG10699 ACTTCGGTTTGCCAAAAGGTGGGCTTAGCTTGAAGATACACCTGACACGGCTTGAATGTTACTAGGCGT 69 FBan0010699 FBgn0002023 Lim3 2 2L "ectoderm development; GO:0007398; motor axon guidance; GO:0008045; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; zinc ion binding; GO:0008270; ; GO:0003700; ; GO:0008270 nucleus; GO:0005634 Lim3 Lim3 "CG10699, CG15174, CG10699, l(2)37Bd: lethal(2)37Bd, l(2)Bd, lim3, lethal(2)37Bd, l(2)37Bd" CDMC20536 2 10 16 DAC25-N24 11-CG10699-RA_1 CG10699 ACTTCGGTTTGCCAAAAGGTGGGCTTAGCTTGAAGATACACCTGACACGGCTTGAATGTTACTAGGCGT 69 FBan0010699 FBgn0002023 Lim3 2 2L "ectoderm development; GO:0007398; motor axon guidance; GO:0008045; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; zinc ion binding; GO:0008270; ; GO:0003700; ; GO:0008270 nucleus; GO:0005634 Lim3 Lim3 "CG10699, CG15174, CG10699, l(2)37Bd: lethal(2)37Bd, l(2)Bd, lim3, lethal(2)37Bd, l(2)37Bd" CDMC20537 2 11 16 DAC26-B12 9-CG8028-RA_1 CG8028 TCCTTGGGTCCTCGAAGTGCTGATCGTCAAGTTTCGGAGGCGTAACAAAATCGAACGCAACAACGTTGA 69 FBan0008028 FBgn0031010 CG8028 X X monocarboxylic acid transporter activity; GO:0008028; ; GO:0008028 CG8028 CG8028 CDMC20537 2 12 16 DAC26-B12 9-CG8028-RA_1 CG8028 TCCTTGGGTCCTCGAAGTGCTGATCGTCAAGTTTCGGAGGCGTAACAAAATCGAACGCAACAACGTTGA 69 FBan0008028 FBgn0031010 CG8028 X X monocarboxylic acid transporter activity; GO:0008028; ; GO:0008028 CG8028 CG8028 CDMC20538 2 13 16 DAC26-B24 2-CG8046-RB_2 CG8046 TGGTGTCTTGCAAGCACTTTCCCCCCTCATATCTTCCACCTTGTACGTTGCGATCTACACCCGTACACT 69 FBan0008046 FBgn0033388 CG8046 2 2R glycerol-3-phosphate metabolism; GO:0006072; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215; glycerol-3-phosphate dehydrogenase activity; GO:0004368 ; EC:1.1.99.5; ; GO:0004368 ; EC:1.1.99.5 glycerol-3-phosphate dehydrogenase complex; GO:0009331; membrane; GO:0016020 CG8046 CG8046 CDMC20538 2 14 16 DAC26-B24 2-CG8046-RB_2 CG8046 TGGTGTCTTGCAAGCACTTTCCCCCCTCATATCTTCCACCTTGTACGTTGCGATCTACACCCGTACACT 69 FBan0008046 FBgn0033388 CG8046 2 2R glycerol-3-phosphate metabolism; GO:0006072; transport; GO:0006810 transporter activity; GO:0005215; ; GO:0005215; glycerol-3-phosphate dehydrogenase activity; GO:0004368 ; EC:1.1.99.5; ; GO:0004368 ; EC:1.1.99.5 glycerol-3-phosphate dehydrogenase complex; GO:0009331; membrane; GO:0016020 CG8046 CG8046 CDMC20539 2 15 16 DAC26-F12 23-CG8083-RA_1 CG8083 AGTTGGGTCGAAAGAATGTTACTCAGTTTTAGTTCCTTAAAGTTGTAGTTCGTGATAATTAGCTGATCA 69 FBan0008083 FBgn0025709 CG8083 2 2R cation transport; GO:0006812 nucleoside:sodium symporter activity; GO:0005415; transporter activity; GO:0005215; ; GO:0005215; ; GO:0005415 membrane; GO:0016020 CG8083 CG8083 "CK00459, BEST:CK00459" CDMC20539 2 16 16 DAC26-F12 23-CG8083-RA_1 CG8083 AGTTGGGTCGAAAGAATGTTACTCAGTTTTAGTTCCTTAAAGTTGTAGTTCGTGATAATTAGCTGATCA 69 FBan0008083 FBgn0025709 CG8083 2 2R cation transport; GO:0006812 nucleoside:sodium symporter activity; GO:0005415; transporter activity; GO:0005215; ; GO:0005215; ; GO:0005415 membrane; GO:0016020 CG8083 CG8083 "CK00459, BEST:CK00459" CDMC20540 2 17 16 DAC26-F24 10-CG8089-RA_1 CG8089 CCTCACTGCACATGGAGATTCCAACTGAAGTCTGCCCTCGATTCACATGTACTGCGAATCCATGAACGC 69 FBan0008089 FBgn0033993 CG8089 2 2R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG8089 CG8089 CDMC20540 2 18 16 DAC26-F24 10-CG8089-RA_1 CG8089 CCTCACTGCACATGGAGATTCCAACTGAAGTCTGCCCTCGATTCACATGTACTGCGAATCCATGAACGC 69 FBan0008089 FBgn0033993 CG8089 2 2R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG8089 CG8089 CDMC20541 2 19 16 DAC26-J12 23-CG8127-RB_2 CG8127 GGCGGGAGTTGAATTAAATTATTTTACCATTTAATTGAGACGTGTACAAAGTTTGAAAGCAAAACCAAC 69 FBan0008127 FBgn0000568 Eip75B 3 3L "cell proliferation; GO:0008283; cell-cell signaling; GO:0007267; ecdysis (sensu Insecta); GO:0018990; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; intracellular signaling cascade; GO:0007242; molting cycle (sensu Insecta); GO:0007591; oogenesis (sensu Insecta); GO:0009993; regulation of ecdysteroid metabolism; GO:0007553; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ligand-dependent nuclear receptor activity; GO:0004879; ; GO:0004879; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0004879; steroid hormone receptor activity; GO:0003707; ; GO:0003700; ; GO:0003677; ; GO:0003707; thyroid hormone receptor activity; GO:0004887; ; GO:0004887 nucleus; GO:0005634 Eip75B Ecdysone-induced protein 75B "CG8127, CG8127, l(3)neo25, E75, E75A, E75B, E75C, dE75, DmE75A, DmE75B, E75-C, 57B, l(3)07041, NR1D3, EP1121b, anon-WO0172774.31, anon-WO0172774.32, BcDNA:GM02640, Eip75, l(3)j11A6, l(3)j12E8, l(3)j3A6, l(3)j5E1" CDMC20541 2 20 16 DAC26-J12 23-CG8127-RB_2 CG8127 GGCGGGAGTTGAATTAAATTATTTTACCATTTAATTGAGACGTGTACAAAGTTTGAAAGCAAAACCAAC 69 FBan0008127 FBgn0000568 Eip75B 3 3L "cell proliferation; GO:0008283; cell-cell signaling; GO:0007267; ecdysis (sensu Insecta); GO:0018990; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; intracellular signaling cascade; GO:0007242; molting cycle (sensu Insecta); GO:0007591; oogenesis (sensu Insecta); GO:0009993; regulation of ecdysteroid metabolism; GO:0007553; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ligand-dependent nuclear receptor activity; GO:0004879; ; GO:0004879; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0004879; steroid hormone receptor activity; GO:0003707; ; GO:0003700; ; GO:0003677; ; GO:0003707; thyroid hormone receptor activity; GO:0004887; ; GO:0004887 nucleus; GO:0005634 Eip75B Ecdysone-induced protein 75B "CG8127, CG8127, l(3)neo25, E75, E75A, E75B, E75C, dE75, DmE75A, DmE75B, E75-C, 57B, l(3)07041, NR1D3, EP1121b, anon-WO0172774.31, anon-WO0172774.32, BcDNA:GM02640, Eip75, l(3)j11A6, l(3)j12E8, l(3)j3A6, l(3)j5E1" CDMC20542 2 21 16 DAC26-J24 15-CG8136-RB_4 CG8136 TGCACAGCGAGGTTCTGTTTCACAAGGAACTGCAGATCAAGGAGAACATGATCAAGGTGTACGAGGACA 69 FBan0008136 FBgn0037616 CG8136 3 3R CG8136 CG8136 "anon-WO0140519.254, anon-WO0140519.56" CDMC20542 2 22 16 DAC26-J24 15-CG8136-RB_4 CG8136 TGCACAGCGAGGTTCTGTTTCACAAGGAACTGCAGATCAAGGAGAACATGATCAAGGTGTACGAGGACA 69 FBan0008136 FBgn0037616 CG8136 3 3R CG8136 CG8136 "anon-WO0140519.254, anon-WO0140519.56" CDMC20543 2 23 16 DAC26-N12 16-CG8178-RC_1 CG8178 AACCTGTGAACACATTGATTACGACGTACAGTTGACGAATTTTCCCCTGGAACTGAATATGCCGGTGGC 69 FBan0008178 FBgn0024319 Nach 2 2R cation transport; GO:0006812; sodium ion transport; GO:0006814; tracheal liquid clearance; GO:0035002 sodium channel activity; GO:0005272; ; GO:0005272 integral to membrane; GO:0016021 Nach Nach "CG8178, PPK4, pickpocket 4, ppk4" CDMC20543 2 24 16 DAC26-N12 16-CG8178-RC_1 CG8178 AACCTGTGAACACATTGATTACGACGTACAGTTGACGAATTTTCCCCTGGAACTGAATATGCCGGTGGC 69 FBan0008178 FBgn0024319 Nach 2 2R cation transport; GO:0006812; sodium ion transport; GO:0006814; tracheal liquid clearance; GO:0035002 sodium channel activity; GO:0005272; ; GO:0005272 integral to membrane; GO:0016021 Nach Nach "CG8178, PPK4, pickpocket 4, ppk4" CDMC20544 2 25 16 DAC26-N24 23-CG8186-RA_8 CG8186 TTAGTCCAGCCAATTACCATCCGAAAAAAACAGCAAAATGTCCGGAAAAGATAGGCTACCGATTTTCCC 69 FBan0008186 FBgn0022097 Vha36 2 2R ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992; purine base metabolism; GO:0006144 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V1 domain; GO:0000221; proton-transporting two-sector ATPase complex; GO:0016469 Vha36 Vha36 "CG8186, l(2)k07207, vha36, VhaD, Vacuolar H-ATPase subunit D, V-ATPase, anon-WO0153538.20, anon-WO0153538.21, anon-WO0153538.28, anon-WO02059370.27" CDMC20544 2 26 16 DAC26-N24 23-CG8186-RA_8 CG8186 TTAGTCCAGCCAATTACCATCCGAAAAAAACAGCAAAATGTCCGGAAAAGATAGGCTACCGATTTTCCC 69 FBan0008186 FBgn0022097 Vha36 2 2R ATP synthesis coupled proton transport; GO:0015986; proton transport; GO:0015992; purine base metabolism; GO:0006144 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V1 domain; GO:0000221; proton-transporting two-sector ATPase complex; GO:0016469 Vha36 Vha36 "CG8186, l(2)k07207, vha36, VhaD, Vacuolar H-ATPase subunit D, V-ATPase, anon-WO0153538.20, anon-WO0153538.21, anon-WO0153538.28, anon-WO02059370.27" CDMC20545 2 1 17 DAC27-B12 2-CG8421-RA_1 CG8421 TGGCTGTGGAGACCCTGAAACTTTGGCCCAACAATGCAGTGGCTCAACTTCATTATGGACTAGCACTCA 69 FBan0008421 FBgn0034075 Asph 2 2R peptidyl-amino acid modification; GO:0018193; proteolysis; GO:0006508; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 peptide-aspartate beta-dioxygenase activity; GO:0004597 ; EC:1.14.11.16; metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0004597 ; EC:1.14.11.16; ; GO:0008270 integral to endoplasmic reticulum membrane; GO:0030176 Asph Aspartyl beta-hydroxylase "CG8421, CG18658, BAH/humbug, Aspartyl beta-hydroxylase" CDMC20545 2 2 17 DAC27-B12 2-CG8421-RA_1 CG8421 TGGCTGTGGAGACCCTGAAACTTTGGCCCAACAATGCAGTGGCTCAACTTCATTATGGACTAGCACTCA 69 FBan0008421 FBgn0034075 Asph 2 2R peptidyl-amino acid modification; GO:0018193; proteolysis; GO:0006508; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 peptide-aspartate beta-dioxygenase activity; GO:0004597 ; EC:1.14.11.16; metallopeptidase activity; GO:0008237; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0004597 ; EC:1.14.11.16; ; GO:0008270 integral to endoplasmic reticulum membrane; GO:0030176 Asph Aspartyl beta-hydroxylase "CG8421, CG18658, BAH/humbug, Aspartyl beta-hydroxylase" CDMC20546 2 3 17 DAC27-B24 23-CG8434-RA_3 CG8434 GCCTTTGCTATGGAAATAGGACAGCTAGAGAAACATACCAGTGTCTTCGTAATTTATGAAATTAATCGT 69 FBan0008434 FBgn0034083 lbk 2 2R bristle morphogenesis; GO:0008407; cell adhesion; GO:0007155; oogenesis (sensu Insecta); GO:0009993; transmission of nerve impulse; GO:0019226 lbk lambik "CG8434, CG8434, CG8434, kekkon-like, Lbk, lambik" CDMC20546 2 4 17 DAC27-B24 23-CG8434-RA_3 CG8434 GCCTTTGCTATGGAAATAGGACAGCTAGAGAAACATACCAGTGTCTTCGTAATTTATGAAATTAATCGT 69 FBan0008434 FBgn0034083 lbk 2 2R bristle morphogenesis; GO:0008407; cell adhesion; GO:0007155; oogenesis (sensu Insecta); GO:0009993; transmission of nerve impulse; GO:0019226 lbk lambik "CG8434, CG8434, CG8434, kekkon-like, Lbk, lambik" CDMC20547 2 5 17 DAC27-F12 2-CG8475-RA_1 CG8475 GGTCCTCATTTTGAGGTAAACGGTCTGAACGTAAACACGGCCTTGACGCAGCTATACCATCGCGCTGGT 69 FBan0008475 FBgn0031995 CG8475 2 2L glycogen metabolism; GO:0005977 calmodulin binding; GO:0005516; ; GO:0005516; kinase activator activity; GO:0019209; ; GO:0019209; phosphorylase kinase regulator activity; GO:0008607 ; EC:2.7.1.-; ; GO:0008607 ; EC:2.7.1.- phosphorylase kinase complex; GO:0005964 CG8475 CG8475 CDMC20547 2 6 17 DAC27-F12 2-CG8475-RA_1 CG8475 GGTCCTCATTTTGAGGTAAACGGTCTGAACGTAAACACGGCCTTGACGCAGCTATACCATCGCGCTGGT 69 FBan0008475 FBgn0031995 CG8475 2 2L glycogen metabolism; GO:0005977 calmodulin binding; GO:0005516; ; GO:0005516; kinase activator activity; GO:0019209; ; GO:0019209; phosphorylase kinase regulator activity; GO:0008607 ; EC:2.7.1.-; ; GO:0008607 ; EC:2.7.1.- phosphorylase kinase complex; GO:0005964 CG8475 CG8475 CDMC20548 2 7 17 DAC27-F24 12-CG8487-RB_1 CG8487 GCAGCAGCGGACATCTATCAGGAGTATGTGCAAAATCCGTACAACCTTACGTTGCAACAGCATCCCCAA 69 FBan0008487 FBgn0033714 garz 2 2R ER to Golgi transport; GO:0006888; exocytosis; GO:0006887; intra-Golgi transport; GO:0006891; intracellular protein transport; GO:0006886 guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085; ; GO:0005085; ; GO:0005085 Golgi vesicle; GO:0005798 garz gartenzwerg "CG8487, CG8487, CG8487, CG 8487, sec7-family GEF, Gartenzwerg, GBF1, gartenzwerg" CDMC20548 2 8 17 DAC27-F24 12-CG8487-RB_1 CG8487 GCAGCAGCGGACATCTATCAGGAGTATGTGCAAAATCCGTACAACCTTACGTTGCAACAGCATCCCCAA 69 FBan0008487 FBgn0033714 garz 2 2R ER to Golgi transport; GO:0006888; exocytosis; GO:0006887; intra-Golgi transport; GO:0006891; intracellular protein transport; GO:0006886 guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085; ; GO:0005085; ; GO:0005085 Golgi vesicle; GO:0005798 garz gartenzwerg "CG8487, CG8487, CG8487, CG 8487, sec7-family GEF, Gartenzwerg, GBF1, gartenzwerg" CDMC20549 2 9 17 DAC27-J12 2-CG8531-RA_2 CG8531 GCCGCACTCTTAGCCAAAAGCTGACGTTGAATGGAGGCACCAATCTGAACTTTCGTGACCAAGGTGTCA 69 FBan0008531 FBgn0033918 CG8531 2 2R protein folding; GO:0006457; protein metabolism; GO:0019538 CG8531 CG8531 CDMC20549 2 10 17 DAC27-J12 2-CG8531-RA_2 CG8531 GCCGCACTCTTAGCCAAAAGCTGACGTTGAATGGAGGCACCAATCTGAACTTTCGTGACCAAGGTGTCA 69 FBan0008531 FBgn0033918 CG8531 2 2R protein folding; GO:0006457; protein metabolism; GO:0019538 CG8531 CG8531 CDMC20550 2 11 17 DAC27-J24 1-CG8541-RA_1 CG8541 GTGGACACCCCCTACTCCAGTGTGAGGAAGAGCGACACGAGGATCCAGAACAATGTATACACTCCTGCT 69 FBan0008541 FBgn0035788 CG8541 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG8541 CG8541 CDMC20550 2 12 17 DAC27-J24 1-CG8541-RA_1 CG8541 GTGGACACCCCCTACTCCAGTGTGAGGAAGAGCGACACGAGGATCCAGAACAATGTATACACTCCTGCT 69 FBan0008541 FBgn0035788 CG8541 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG8541 CG8541 CDMC20551 2 13 17 DAC27-N12 1-CG8573-RB_1 CG8573 GCCGCATGCGAGAGTACTGCAAACTGCTCTTTACCGTGGTCATTCACAACGATTCCATCAAGTCGCTGC 69 FBan0008573 FBgn0003567 su(Hw) 3 3R cell proliferation; GO:0008283; negative regulation of transcription; GO:0016481; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0030528; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0005515; ; GO:0008270 nucleus; GO:0005634 su(Hw) suppressor of Hairy wing "CG8573, Su(Hw), Su[Hw], su(hw), Su(hw), suppressor of hairy-wing, Su(HW)" CDMC20551 2 14 17 DAC27-N12 1-CG8573-RB_1 CG8573 GCCGCATGCGAGAGTACTGCAAACTGCTCTTTACCGTGGTCATTCACAACGATTCCATCAAGTCGCTGC 69 FBan0008573 FBgn0003567 su(Hw) 3 3R cell proliferation; GO:0008283; negative regulation of transcription; GO:0016481; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0030528; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0005515; ; GO:0008270 nucleus; GO:0005634 su(Hw) suppressor of Hairy wing "CG8573, Su(Hw), Su[Hw], su(hw), Su(hw), suppressor of hairy-wing, Su(HW)" CDMC20552 2 15 17 DAC27-N24 14-CG8584-RA_4 CG8584 GGACGGGATATAATGTAAGACAGCGAGCCGACTCCACTAGCCTGTGCATTGAAAAAGAAAGGACTCGGG 69 FBan0008584 FBgn0033322 CG8584 2 2R development; GO:0007275; ectoderm development; GO:0007398; nervous system development; GO:0007399 CG8584 CG8584 BEST:LP01468 CDMC20552 2 16 17 DAC27-N24 14-CG8584-RA_4 CG8584 GGACGGGATATAATGTAAGACAGCGAGCCGACTCCACTAGCCTGTGCATTGAAAAAGAAAGGACTCGGG 69 FBan0008584 FBgn0033322 CG8584 2 2R development; GO:0007275; ectoderm development; GO:0007398; nervous system development; GO:0007399 CG8584 CG8584 BEST:LP01468 CDMC20553 2 17 17 DAC28-B12 16-CG30342-RA_1 CG30342 CGGAAAAGGACATCGTAGTGGAGTTTATCAAGAACGAGGAGTTCAAGTACGTTCGAGCATTGGGAGCCT 69 FBan0030342 FBgn0050342 CG30342 2 2R CG30342 CG30342 CG8054 CDMC20553 2 18 17 DAC28-B12 16-CG30342-RA_1 CG30342 CGGAAAAGGACATCGTAGTGGAGTTTATCAAGAACGAGGAGTTCAAGTACGTTCGAGCATTGGGAGCCT 69 FBan0030342 FBgn0050342 CG30342 2 2R CG30342 CG30342 CG8054 CDMC20554 2 19 17 DAC28-B24 12-CG30355-RA_2 CG30355 ACCCTAACGCCCTTGACTTGTGTGCAACAATGCAATGCTTTACTAGGCTCAACATCAGGAAAGCCGAGA 69 FBan0030355 FBgn0050355 CG30355 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30355 CG30355 "NEST:bs10b08, BcDNA:AT24812, NEST:bs04f07, NEST:bs06e10, NEST:bs23e07, NEST:bs23a07" CDMC20554 2 20 17 DAC28-B24 12-CG30355-RA_2 CG30355 ACCCTAACGCCCTTGACTTGTGTGCAACAATGCAATGCTTTACTAGGCTCAACATCAGGAAAGCCGAGA 69 FBan0030355 FBgn0050355 CG30355 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30355 CG30355 "NEST:bs10b08, BcDNA:AT24812, NEST:bs04f07, NEST:bs06e10, NEST:bs23e07, NEST:bs23a07" CDMC20555 2 21 17 DAC28-F12 18-CG30387-RC_1 CG30387 TGGAACAGCAGGAGGAAGAGGAATCAGCCCCTTTCGTCTTTACAGTGCGAAAATGACACAATCTTCTCT 69 FBan0030387 FBgn0050387 CG30387 2 2R receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; ; GO:0005102; ; GO:0005057 CG30387 CG30387 "CG15665, CG10074, CG15665" CDMC20555 2 22 17 DAC28-F12 18-CG30387-RC_1 CG30387 TGGAACAGCAGGAGGAAGAGGAATCAGCCCCTTTCGTCTTTACAGTGCGAAAATGACACAATCTTCTCT 69 FBan0030387 FBgn0050387 CG30387 2 2R receptor binding; GO:0005102; receptor signaling protein activity; GO:0005057; ; GO:0005102; ; GO:0005057 CG30387 CG30387 "CG15665, CG10074, CG15665" CDMC20556 2 23 17 DAC28-F24 18-CG30395-RA_7 CG30395 CCCAAATTTCTTTGCATTCCACCATTTGTGGCCATTAATGGAAGCTGCCTTATTCCAACCCCCAAAGAA 69 FBan0030395 FBgn0050395 CG30395 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30395 CG30395 CDMC20556 2 24 17 DAC28-F24 18-CG30395-RA_7 CG30395 CCCAAATTTCTTTGCATTCCACCATTTGTGGCCATTAATGGAAGCTGCCTTATTCCAACCCCCAAAGAA 69 FBan0030395 FBgn0050395 CG30395 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30395 CG30395 CDMC20557 2 25 17 DAC28-J12 22-CG30440-RA_4 CG30440 GCGCCAGGAAGTTTATACGTTGCAAGCATCGACAATCGGTGTAAAAGAAATGTGGGTTGCCGAGATTAA 69 FBan0030440 FBgn0050440 CG30440 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; MAPKKK cascade; GO:0000165 guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085 CG30440 CG30440 "CG10412, CG10416, CG12183, CG10412" CDMC20557 2 26 17 DAC28-J12 22-CG30440-RA_4 CG30440 GCGCCAGGAAGTTTATACGTTGCAAGCATCGACAATCGGTGTAAAAGAAATGTGGGTTGCCGAGATTAA 69 FBan0030440 FBgn0050440 CG30440 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186; MAPKKK cascade; GO:0000165 guanyl-nucleotide exchange factor activity; GO:0005085; ; GO:0005085 CG30440 CG30440 "CG10412, CG10416, CG12183, CG10412" CDMC20558 2 1 18 DAC28-J24 6-CG3044-RA_1 CG3044 CCGCCACTTTGGATAATGCCACCATAGTCCTTCCCGATACCCTCAGACAGGTACTACAGAACGACACCC 69 FBan0003044 FBgn0029913 CG3044 X X polysaccharide metabolism; GO:0005976 "hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; chitinase activity; GO:0004568 ; EC:3.2.1.14; ; GO:0004568 ; EC:3.2.1.14" CG3044 CG3044 CDMC20558 2 2 18 DAC28-J24 6-CG3044-RA_1 CG3044 CCGCCACTTTGGATAATGCCACCATAGTCCTTCCCGATACCCTCAGACAGGTACTACAGAACGACACCC 69 FBan0003044 FBgn0029913 CG3044 X X polysaccharide metabolism; GO:0005976 "hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; ; GO:0016799 ; EC:3.2.2.-; chitinase activity; GO:0004568 ; EC:3.2.1.14; ; GO:0004568 ; EC:3.2.1.14" CG3044 CG3044 CDMC20559 2 3 18 DAC28-N12 3-CG30487-RA_1 CG30487 TGACGGTCCCAAGGGTGGACAAACTACAGGATCTGGCTAAATCGATCCCAACGGATCCCGATACAGTCT 69 FBan0030487 FBgn0050487 CG30487 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30487 CG30487 "bs33e02.y1, NEST:bs16h04" CDMC20559 2 4 18 DAC28-N12 3-CG30487-RA_1 CG30487 TGACGGTCCCAAGGGTGGACAAACTACAGGATCTGGCTAAATCGATCCCAACGGATCCCGATACAGTCT 69 FBan0030487 FBgn0050487 CG30487 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30487 CG30487 "bs33e02.y1, NEST:bs16h04" CDMC20560 2 5 18 DAC28-N24 22-CG30493-RB_1 CG30493 TAACGTTGCCAATTTTCTGAATAGTTGGCTCTGTCCAATCGCTGACTAATCAAGCGCATGACCTTCGTG 69 FBan0030493 FBgn0050493 CG30493 2 2R CG30493 CG30493 "CG1952, CG1952, CG1952" CDMC20560 2 6 18 DAC28-N24 22-CG30493-RB_1 CG30493 TAACGTTGCCAATTTTCTGAATAGTTGGCTCTGTCCAATCGCTGACTAATCAAGCGCATGACCTTCGTG 69 FBan0030493 FBgn0050493 CG30493 2 2R CG30493 CG30493 "CG1952, CG1952, CG1952" CDMC20561 2 7 18 DAC29-B12 14-CG9973-RA_1 CG9973 CGAGAAGCTCACCGAGAAGAAGGTAAGTCTGCTCACTGGTTTTCCATTCTCAGATCCTGTCCCACCGAA 69 FBan0009973 FBgn0035378 CG9973 3 3L DNA binding; GO:0003677; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 CG9973 CG9973 CDMC20561 2 8 18 DAC29-B12 14-CG9973-RA_1 CG9973 CGAGAAGCTCACCGAGAAGAAGGTAAGTCTGCTCACTGGTTTTCCATTCTCAGATCCTGTCCCACCGAA 69 FBan0009973 FBgn0035378 CG9973 3 3L DNA binding; GO:0003677; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 CG9973 CG9973 CDMC20562 2 9 18 DAC29-B24 2-CG9988-RA_3 CG9988 CACCACCCAAAGGACTCTCGCTGAAACCGTCCAAGAGGAAGCCAAGTGTCCTTATGTTCGGCATAGACA 69 FBan0009988 FBgn0039591 CG9988 3 3R CG9988 CG9988 CDMC20562 2 10 18 DAC29-B24 2-CG9988-RA_3 CG9988 CACCACCCAAAGGACTCTCGCTGAAACCGTCCAAGAGGAAGCCAAGTGTCCTTATGTTCGGCATAGACA 69 FBan0009988 FBgn0039591 CG9988 3 3R CG9988 CG9988 CDMC20563 2 11 18 DAC29-F12 3-CR30298-RA_1 CR30298 CGTGGCTTAGTTGGTTAAAGCGCCTGTCTAGTAAACAGGAGATCGTGAGTTCGAATTTCGCCGGGGCCT 69 FBan0030298 FBgn0050298 CR30298 2 2R protein biosynthesis; GO:0006412 triplet codon-amino acid adaptor activity; GO:0030533; ; GO:0030533 cytosol; GO:0005829 CR30298 CR30298 "tRNA[Thr][[3]], AE002787.trna28-ThrAGT, tRNA:T:AGT:AE002787-b, tRNA:T3:47F, tRNA:thr3:47F, transfer RNA:thr3:47F" CDMC20563 2 12 18 DAC29-F12 3-CR30298-RA_1 CR30298 CGTGGCTTAGTTGGTTAAAGCGCCTGTCTAGTAAACAGGAGATCGTGAGTTCGAATTTCGCCGGGGCCT 69 FBan0030298 FBgn0050298 CR30298 2 2R protein biosynthesis; GO:0006412 triplet codon-amino acid adaptor activity; GO:0030533; ; GO:0030533 cytosol; GO:0005829 CR30298 CR30298 "tRNA[Thr][[3]], AE002787.trna28-ThrAGT, tRNA:T:AGT:AE002787-b, tRNA:T3:47F, tRNA:thr3:47F, transfer RNA:thr3:47F" CDMC20564 2 13 18 DAC29-F24 23-CR31273-RA_9 CR31273 TGCAACGAAATGGGTCCATGTGTTAAAGATGTGCTTGCCAAGTAAAAAAAACCGAAAAGTAGAGGGGGT 69 FBan0031273 FBgn0020556 bxd 3 3R bxd bxd "CR31273, CR31277" CDMC20564 2 14 18 DAC29-F24 23-CR31273-RA_9 CR31273 TGCAACGAAATGGGTCCATGTGTTAAAGATGTGCTTGCCAAGTAAAAAAAACCGAAAAGTAGAGGGGGT 69 FBan0031273 FBgn0020556 bxd 3 3R bxd bxd "CR31273, CR31277" CDMC20565 2 15 18 DAC29-J12 14-CR32028-RA_1 CR32028 GGGAAGTGGGAGACAGAGCGATAAATGGAGGAGAAGCGAGGAGAGCTGAATAAAACCGATCAAGCAACA 69 FBan0032028 FBgn0062463 CR32028 3 3L CR32028 CR32028 BcDNA:LD13080 CDMC20565 2 16 18 DAC29-J12 14-CR32028-RA_1 CR32028 GGGAAGTGGGAGACAGAGCGATAAATGGAGGAGAAGCGAGGAGAGCTGAATAAAACCGATCAAGCAACA 69 FBan0032028 FBgn0062463 CR32028 3 3L CR32028 CR32028 BcDNA:LD13080 CDMC20566 2 17 18 DAC29-J24 17-CR32646-RA_1 CR32646 TCGTACGTGTTCGTTCGTTGCTTTCGTTCGGTTTGATTCCATTCGGTTGTGTTTCTCGTTCGAGAACAT 69 FBan0032646 FBgn0047242 CR32646 X X CR32646 CR32646 "BcDNA:HL02010, BcDNA:RE25290, BEST:HL02010" CDMC20566 2 18 18 DAC29-J24 17-CR32646-RA_1 CR32646 TCGTACGTGTTCGTTCGTTGCTTTCGTTCGGTTTGATTCCATTCGGTTGTGTTTCTCGTTCGAGAACAT 69 FBan0032646 FBgn0047242 CR32646 X X CR32646 CR32646 "BcDNA:HL02010, BcDNA:RE25290, BEST:HL02010" CDMC20567 2 19 18 DAC29-N12 23-CR32957-RA_2 CR32957 CTCTTTCTTTTTAGATAATGCTGAAACCCGAATTTCTCTGACAGAAACCCTACGTAAGAAGGATTTCCA 69 FBan0032957 FBgn0047311 pncr012:2L 2 2L pncr012:2L putative noncoding RNA 012:2L "CR32957, BcDNA:GH14469, putative noncoding RNA 012:2L" CDMC20567 2 20 18 DAC29-N12 23-CR32957-RA_2 CR32957 CTCTTTCTTTTTAGATAATGCTGAAACCCGAATTTCTCTGACAGAAACCCTACGTAAGAAGGATTTCCA 69 FBan0032957 FBgn0047311 pncr012:2L 2 2L pncr012:2L putative noncoding RNA 012:2L "CR32957, BcDNA:GH14469, putative noncoding RNA 012:2L" CDMC20568 2 21 18 DAC29-N24 15-CR33328-RA_1 CR33328 CCGAGGGTCCTTGGTGAGAACAACACCAGTAGAGCCACTATATCCATCTACTATCCACCGACATCCGAA 69 FBan0033328 FBgn0053328 CR33328 3 3R CR33328 CR33328 BcDNA:GM03761 CDMC20568 2 22 18 DAC29-N24 15-CR33328-RA_1 CR33328 CCGAGGGTCCTTGGTGAGAACAACACCAGTAGAGCCACTATATCCATCTACTATCCACCGACATCCGAA 69 FBan0033328 FBgn0053328 CR33328 3 3R CR33328 CR33328 BcDNA:GM03761 CDMC20569 2 23 18 DAC30-B12 17-CG11987-RA_2 CG11987 TCCCGCGAACAACATTGACACCATTTCCCATTAATTTTCGCTCATTTTTCGCCAAGGCAATCAGACGTA 69 FBan0011987 FBgn0015014 tgo 3 3R ectoderm development; GO:0007398; nervous system development; GO:0007399; oxygen and reactive oxygen species metabolism; GO:0006800; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165; tracheal epithelial cell fate determination (sensu Insecta); GO:0007425; tracheal system development (sensu Insecta); GO:0007424 DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0003702; ; GO:0003702; ; GO:0003702; ; GO:0003702; ; GO:0003702; transcription factor activity; GO:0003700; protein heterodimerization activity; GO:0046982; ; GO:0003702; ; GO:0003700; signal transducer activity; GO:0004871; ; GO:0046982; ; GO:0004871 nucleus; GO:0005634 tgo tango "CG11987, PRD gene 7, ARNT, darnt, DARNT, dARNT, Arnt, Tango, arnt, TGO, Hif1, HIF-1beta, HIF1b, prd7, paired-like 7" CDMC20569 2 24 18 DAC30-B12 17-CG11987-RA_2 CG11987 TCCCGCGAACAACATTGACACCATTTCCCATTAATTTTCGCTCATTTTTCGCCAAGGCAATCAGACGTA 69 FBan0011987 FBgn0015014 tgo 3 3R ectoderm development; GO:0007398; nervous system development; GO:0007399; oxygen and reactive oxygen species metabolism; GO:0006800; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165; tracheal epithelial cell fate determination (sensu Insecta); GO:0007425; tracheal system development (sensu Insecta); GO:0007424 DNA binding; GO:0003677; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0003702; ; GO:0003702; ; GO:0003702; ; GO:0003702; ; GO:0003702; transcription factor activity; GO:0003700; protein heterodimerization activity; GO:0046982; ; GO:0003702; ; GO:0003700; signal transducer activity; GO:0004871; ; GO:0046982; ; GO:0004871 nucleus; GO:0005634 tgo tango "CG11987, PRD gene 7, ARNT, darnt, DARNT, dARNT, Arnt, Tango, arnt, TGO, Hif1, HIF-1beta, HIF1b, prd7, paired-like 7" CDMC20570 2 25 18 DAC30-B24 17-CG11997-RA_1 CG11997 CCCACTGCCAATTCCTTTAACAATTCCTCAAAAGGGCCAAAATCAAGACCTGCAATATCAAGGGGTCGA 69 FBan0011997 FBgn0037662 CG11997 3 3R CG11997 CG11997 CDMC20570 2 26 18 DAC30-B24 17-CG11997-RA_1 CG11997 CCCACTGCCAATTCCTTTAACAATTCCTCAAAAGGGCCAAAATCAAGACCTGCAATATCAAGGGGTCGA 69 FBan0011997 FBgn0037662 CG11997 3 3R CG11997 CG11997 CDMC20571 2 1 19 DAC30-F12 16-CG12024-RA_1 CG12024 AGTTCCCCAGTCCAAAGTAATCTCCGGGCAAGAACGAAATCTGAAATCTCCTATCCCAATCTCGACACA 69 FBan0012024 FBgn0035283 CG12024 3 3L CG12024 CG12024 CDMC20571 2 2 19 DAC30-F12 16-CG12024-RA_1 CG12024 AGTTCCCCAGTCCAAAGTAATCTCCGGGCAAGAACGAAATCTGAAATCTCCTATCCCAATCTCGACACA 69 FBan0012024 FBgn0035283 CG12024 3 3L CG12024 CG12024 CDMC20572 2 3 19 DAC30-F24 13-CG12030-RA_2 CG12030 CGGGTTAGCACACGATAGCACTCAACGGTCAGCGATCTTTGGCATCTTCATCTACACCATCATCTGCAA 69 FBan0012030 FBgn0035147 CG12030 3 3L galactose metabolism; GO:0006012; nucleotide-sugar metabolism; GO:0009225 UDP-glucose 4-epimerase activity; GO:0003978 ; EC:5.1.3.2; ; GO:0003978 ; EC:5.1.3.2; ; GO:0003978 ; EC:5.1.3.2 CG12030 CG12030 CDMC20572 2 4 19 DAC30-F24 13-CG12030-RA_2 CG12030 CGGGTTAGCACACGATAGCACTCAACGGTCAGCGATCTTTGGCATCTTCATCTACACCATCATCTGCAA 69 FBan0012030 FBgn0035147 CG12030 3 3L galactose metabolism; GO:0006012; nucleotide-sugar metabolism; GO:0009225 UDP-glucose 4-epimerase activity; GO:0003978 ; EC:5.1.3.2; ; GO:0003978 ; EC:5.1.3.2; ; GO:0003978 ; EC:5.1.3.2 CG12030 CG12030 CDMC20573 2 5 19 DAC30-J12 23-CG12065-RA_1 CG12065 GGGGACCACTATTCGTAAACCAAAATGTGCATAGATTGCATCATATATAATGTATGTTCGCGTAATATT 69 FBan0012065 FBgn0030052 CG12065 X X CG12065 CG12065 CDMC20573 2 6 19 DAC30-J12 23-CG12065-RA_1 CG12065 GGGGACCACTATTCGTAAACCAAAATGTGCATAGATTGCATCATATATAATGTATGTTCGCGTAATATT 69 FBan0012065 FBgn0030052 CG12065 X X CG12065 CG12065 CDMC20574 2 7 19 DAC30-J24 13-CG12073-RA_1 CG12073 AGTGCGTATCTCTGTATATGTGCACCCCCTGAAACTTGCAGCAATGTGCGAATTGTAGACGACTCCTCT 69 FBan0012073 FBgn0004573 5-HT7 3 3R "nerve-nerve synaptic transmission; GO:0007270; serotonin receptor signaling pathway; GO:0007210; serotonin receptor, adenylate cyclase activating pathway; GO:0007192" amine receptor activity; GO:0008227; G-protein coupled serotonin receptor activity; GO:0016609; ; GO:0016609; serotonin receptor activity; GO:0004993; ; GO:0008227; dopamine receptor activity; GO:0004952; ; GO:0016609; ; GO:0004993; ; GO:0004993; ; GO:0004952 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 5-HT7 Serotonin receptor 7 "CG12073, 5HT-dro, 5HT-dro1, 5-HT7Dro, 5-HT[[dro1]], 5htdror, DRO1, Serotonin receptor, 5-HT-dro1, 5-HT[[7Dro]], 5-HT-dro, 5-HTdro1, 5-HT[[7]], Dm5HTdro1, 5HT[[7Dro]], 5HT-R1: Serotonin receptor 1, Serotonin receptor 1" CDMC20574 2 8 19 DAC30-J24 13-CG12073-RA_1 CG12073 AGTGCGTATCTCTGTATATGTGCACCCCCTGAAACTTGCAGCAATGTGCGAATTGTAGACGACTCCTCT 69 FBan0012073 FBgn0004573 5-HT7 3 3R "nerve-nerve synaptic transmission; GO:0007270; serotonin receptor signaling pathway; GO:0007210; serotonin receptor, adenylate cyclase activating pathway; GO:0007192" amine receptor activity; GO:0008227; G-protein coupled serotonin receptor activity; GO:0016609; ; GO:0016609; serotonin receptor activity; GO:0004993; ; GO:0008227; dopamine receptor activity; GO:0004952; ; GO:0016609; ; GO:0004993; ; GO:0004993; ; GO:0004952 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 5-HT7 Serotonin receptor 7 "CG12073, 5HT-dro, 5HT-dro1, 5-HT7Dro, 5-HT[[dro1]], 5htdror, DRO1, Serotonin receptor, 5-HT-dro1, 5-HT[[7Dro]], 5-HT-dro, 5-HTdro1, 5-HT[[7]], Dm5HTdro1, 5HT[[7Dro]], 5HT-R1: Serotonin receptor 1, Serotonin receptor 1" CDMC20575 2 9 19 DAC30-N12 6-CG12113-RA_4 CG12113 CGGCGGAGTACCTGCAGATGATTCTCAGTCACATCGAAGAGATCTTCACCATGACTGACGAGCGCTTGG 69 FBgn0030047 CDMC20575 2 10 19 DAC30-N12 6-CG12113-RA_4 CG12113 CGGCGGAGTACCTGCAGATGATTCTCAGTCACATCGAAGAGATCTTCACCATGACTGACGAGCGCTTGG 69 FBgn0030047 CDMC20576 2 11 19 DAC30-N24 16-CG12124-RA_1 CG12124 GCTCCGGAAGATCTCTCCAAATCCACTGAAGGAGCAAAGACGAAGACCCAAATCAAGGCAAATACCAAG 69 FBan0012124 FBgn0030112 CG12124 X X "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG12124 CG12124 CDMC20576 2 12 19 DAC30-N24 16-CG12124-RA_1 CG12124 GCTCCGGAAGATCTCTCCAAATCCACTGAAGGAGCAAAGACGAAGACCCAAATCAAGGCAAATACCAAG 69 FBan0012124 FBgn0030112 CG12124 X X "regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG12124 CG12124 CDMC20577 2 13 19 DAC31-B12 8-CG3680-RA_1 CG3680 GGGGCGGTGAAGATACCTCCTCGCATACGCTGGCTAACGATATGAAGGCGAACAACGGTAGCGAAC 66 FBan0003680 FBgn0037027 CG3680 3 3L CG3680 CG3680 CDMC20577 2 14 19 DAC31-B12 8-CG3680-RA_1 CG3680 GGGGCGGTGAAGATACCTCCTCGCATACGCTGGCTAACGATATGAAGGCGAACAACGGTAGCGAAC 66 FBan0003680 FBgn0037027 CG3680 3 3L CG3680 CG3680 CDMC20578 2 15 19 DAC31-B24 2-CG3861-RB_1 CG3861 GCTGCTGCAGTACTACGGCATGAAGGAGATGAACTACTACACCGTGTTGTTCGGCGTTTCCCGTGC 66 FBgn0029869 CDMC20578 2 16 19 DAC31-B24 2-CG3861-RB_1 CG3861 GCTGCTGCAGTACTACGGCATGAAGGAGATGAACTACTACACCGTGTTGTTCGGCGTTTCCCGTGC 66 FBgn0029869 CDMC20579 2 17 19 DAC31-F12 3-CG4076-RA_3 CG4076 CCTCCGACGAAGGACCGGATGAAGAGCCCTTCCAGCGAGTGACCGAAACTATAACAGCGTCAGATC 66 FBan0004076 FBgn0036812 Nufip 3 3L mRNA binding; GO:0003729; ; GO:0003729; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 Nufip Nufip "CG4076, CG4076, NUFIP" CDMC20579 2 18 19 DAC31-F12 3-CG4076-RA_3 CG4076 CCTCCGACGAAGGACCGGATGAAGAGCCCTTCCAGCGAGTGACCGAAACTATAACAGCGTCAGATC 66 FBan0004076 FBgn0036812 Nufip 3 3L mRNA binding; GO:0003729; ; GO:0003729; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 Nufip Nufip "CG4076, CG4076, NUFIP" CDMC20580 2 19 19 DAC31-F24 2-CG4324-RA_1 CG4324 AACAAGGAGAGCCATCCCAATGAGTGCGTCACCTTCATGACCTCCGACTTTATGGACCTGCTGTGG 66 FBan0004324 FBgn0034956 CG4324 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation transporter activity; GO:0015101; carbohydrate transporter activity; GO:0015144; ; GO:0015101; ; GO:0015144 integral to membrane; GO:0016021 CG4324 CG4324 CDMC20580 2 20 19 DAC31-F24 2-CG4324-RA_1 CG4324 AACAAGGAGAGCCATCCCAATGAGTGCGTCACCTTCATGACCTCCGACTTTATGGACCTGCTGTGG 66 FBan0004324 FBgn0034956 CG4324 2 2R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation transporter activity; GO:0015101; carbohydrate transporter activity; GO:0015144; ; GO:0015101; ; GO:0015144 integral to membrane; GO:0016021 CG4324 CG4324 CDMC20581 2 21 19 DAC31-J12 6-CG4818-RA_3 CG4818 GCCACTAATCTGCCAAAGGCTAAAGTTCCCCAGGAGTCGCTAGAATTTAGTCCCAGGAGCGCGTCG 66 FBan0004818 FBgn0036617 CG4818 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG4818 CG4818 CDMC20581 2 22 19 DAC31-J12 6-CG4818-RA_3 CG4818 GCCACTAATCTGCCAAAGGCTAAAGTTCCCCAGGAGTCGCTAGAATTTAGTCCCAGGAGCGCGTCG 66 FBan0004818 FBgn0036617 CG4818 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG4818 CG4818 CDMC20582 2 23 19 DAC31-J24 12-CG4875-RA_4 CG4875 GCACCCACTTCAATGGAAACCAAGTCCAATCCGACACCAGATGGAGAAAACCTCGGGTAGCAGCCG 66 FBan0004875 FBgn0030801 CG4875 X X G-protein coupled receptor activity; GO:0004930; ; GO:0004930 CG4875 CG4875 CDMC20582 2 24 19 DAC31-J24 12-CG4875-RA_4 CG4875 GCACCCACTTCAATGGAAACCAAGTCCAATCCGACACCAGATGGAGAAAACCTCGGGTAGCAGCCG 66 FBan0004875 FBgn0030801 CG4875 X X G-protein coupled receptor activity; GO:0004930; ; GO:0004930 CG4875 CG4875 CDMC20583 2 25 19 DAC31-N12 24-CG5210-RA_2 CG5210 AGAAAATGCTTGATCAAGAAATATATTTGTCCCATTTATATTTGTAATGTCATAAAGTGCCTCAGA 66 FBan0005210 FBgn0013763 Chit 2 2R cell-cell signaling; GO:0007267; cuticle chitin catabolism; GO:0006036; signal transduction; GO:0007165 "chitinase activity; GO:0004568 ; EC:3.2.1.14; ; GO:0004568 ; EC:3.2.1.14; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; growth factor activity; GO:0008083; ; GO:0008083; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004568 ; EC:3.2.1.14" extracellular region; GO:0005576 Chit Chitinase-like "CG5210, CG5210, DS47, chitinase-related, ds47, chitinase-like, chit" CDMC20583 2 26 19 DAC31-N12 24-CG5210-RA_2 CG5210 AGAAAATGCTTGATCAAGAAATATATTTGTCCCATTTATATTTGTAATGTCATAAAGTGCCTCAGA 66 FBan0005210 FBgn0013763 Chit 2 2R cell-cell signaling; GO:0007267; cuticle chitin catabolism; GO:0006036; signal transduction; GO:0007165 "chitinase activity; GO:0004568 ; EC:3.2.1.14; ; GO:0004568 ; EC:3.2.1.14; hydrolase activity, hydrolyzing N-glycosyl compounds; GO:0016799 ; EC:3.2.2.-; growth factor activity; GO:0008083; ; GO:0008083; ; GO:0016799 ; EC:3.2.2.-; ; GO:0004568 ; EC:3.2.1.14" extracellular region; GO:0005576 Chit Chitinase-like "CG5210, CG5210, DS47, chitinase-related, ds47, chitinase-like, chit" CDMC20584 2 1 20 DAC31-N24 9-CG5362-RA_1 CG5362 AAGGTGACCGCCAATGGTACCGTTAAGTCCGTGGTGGATGCGATCAACGATAATGGCTACCTGCAG 66 FBan0005362 FBgn0032237 CG5362 2 2L malate metabolism; GO:0006108; tricarboxylic acid cycle; GO:0006099; tricarboxylic acid cycle intermediate metabolism; GO:0006100 L-malate dehydrogenase activity; GO:0030060 ; EC:1.1.1.37; ; GO:0030060 ; EC:1.1.1.37 cytosol; GO:0005829 CG5362 CG5362 CT17038 CDMC20584 2 2 20 DAC31-N24 9-CG5362-RA_1 CG5362 AAGGTGACCGCCAATGGTACCGTTAAGTCCGTGGTGGATGCGATCAACGATAATGGCTACCTGCAG 66 FBan0005362 FBgn0032237 CG5362 2 2L malate metabolism; GO:0006108; tricarboxylic acid cycle; GO:0006099; tricarboxylic acid cycle intermediate metabolism; GO:0006100 L-malate dehydrogenase activity; GO:0030060 ; EC:1.1.1.37; ; GO:0030060 ; EC:1.1.1.37 cytosol; GO:0005829 CG5362 CG5362 CT17038 CDMC20585 2 3 20 DAC32-B12 15-CG11138-RB_1 CG11138 GGCGACAACACACTCCCCGGATAATATCTGGCATCTAAAAACTCTCGACACTTCTCTGTTGGGGTCACA 69 FBan0011138 FBgn0030400 CG11138 X X CG11138 CG11138 "CG1855, CG1855, EP(X)1313, RE18684, BcDNA:RE48052, BEST:RE18684" CDMC20585 2 4 20 DAC32-B12 15-CG11138-RB_1 CG11138 GGCGACAACACACTCCCCGGATAATATCTGGCATCTAAAAACTCTCGACACTTCTCTGTTGGGGTCACA 69 FBan0011138 FBgn0030400 CG11138 X X CG11138 CG11138 "CG1855, CG1855, EP(X)1313, RE18684, BcDNA:RE48052, BEST:RE18684" CDMC20586 2 5 20 DAC32-B24 2-CG11147-RB_3 CG11147 GGCCACAACCGTTGGCTATTTGCACTTTGCCCAGAACTTCAGCGATTCGATTCTCTCGGTAATGGAGGA 69 FBan0011147 FBgn0031734 CG11147 2 2L transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; ; GO:0042626; ; GO:0005215" ATP-binding cassette (ABC) transporter complex; GO:0043190; membrane; GO:0016020 CG11147 CG11147 CDMC20586 2 6 20 DAC32-B24 2-CG11147-RB_3 CG11147 GGCCACAACCGTTGGCTATTTGCACTTTGCCCAGAACTTCAGCGATTCGATTCTCTCGGTAATGGAGGA 69 FBan0011147 FBgn0031734 CG11147 2 2L transport; GO:0006810 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; transporter activity; GO:0005215; ; GO:0042626; ; GO:0005215" ATP-binding cassette (ABC) transporter complex; GO:0043190; membrane; GO:0016020 CG11147 CG11147 CDMC20587 2 7 20 DAC32-F12 3-CG11182-RA_2 CG11182 CGCAATCCGGGGTTCCCTCAACCAGGAGTCGAGCTTATTGTTCTCCAAAATCACCACTGTCTCCGAGTT 69 FBan0011182 FBgn0025334 PHDP 2 2R ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 PHDP Putative homeodomain protein "CG11182, anon-60Ac, Putative homeodomain protein" CDMC20587 2 8 20 DAC32-F12 3-CG11182-RA_2 CG11182 CGCAATCCGGGGTTCCCTCAACCAGGAGTCGAGCTTATTGTTCTCCAAAATCACCACTGTCTCCGAGTT 69 FBan0011182 FBgn0025334 PHDP 2 2R ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 PHDP Putative homeodomain protein "CG11182, anon-60Ac, Putative homeodomain protein" CDMC20588 2 9 20 DAC32-F24 2-CG1119-RA_1 CG1119 ACGGCAGATGCCCTAAGCTTGGGTGACCTTGTTGAAAAGCGTATTCGTGCGAATTCTGCTTGGAGTCTT 69 FBan0001119 FBgn0004913 Gnf1 3 3R DNA replication; GO:0006260 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; DNA polymerase processivity factor activity; GO:0030337; DNA ligase activity; GO:0003909 ; EC:6.5.1.-; ; GO:0030337; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0003909 ; EC:6.5.1.-; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 DNA replication factor C complex; GO:0005663; nucleus; GO:0005634 Gnf1 Germ line transcription factor 1 "CG1119, GTF-1, ONF-CAACAA, RF-C 140, RFC, dRF-Cp140, germline transcription factor, Gnf-1, Gtf1: Germ line transcription factor 1, RfC140, gtf1, Germ line transcription factor 1, Replication-factor-C 140kD subunit" CDMC20588 2 10 20 DAC32-F24 2-CG1119-RA_1 CG1119 ACGGCAGATGCCCTAAGCTTGGGTGACCTTGTTGAAAAGCGTATTCGTGCGAATTCTGCTTGGAGTCTT 69 FBan0001119 FBgn0004913 Gnf1 3 3R DNA replication; GO:0006260 DNA binding; GO:0003677; ; GO:0003677; ; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; DNA polymerase processivity factor activity; GO:0030337; DNA ligase activity; GO:0003909 ; EC:6.5.1.-; ; GO:0030337; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0003909 ; EC:6.5.1.-; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15 DNA replication factor C complex; GO:0005663; nucleus; GO:0005634 Gnf1 Germ line transcription factor 1 "CG1119, GTF-1, ONF-CAACAA, RF-C 140, RFC, dRF-Cp140, germline transcription factor, Gnf-1, Gtf1: Germ line transcription factor 1, RfC140, gtf1, Germ line transcription factor 1, Replication-factor-C 140kD subunit" CDMC20589 2 11 20 DAC32-J12 8-CG11257-RA_1 CG11257 GCAGCCTCCGGAAATAGTGCCACGCTTTGATTGGATTCAGCAGAGGAGCGAACTTACCCTGATCTTCTA 69 FBan0011257 FBgn0034442 CG11257 2 2R electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG11257 CG11257 CDMC20589 2 12 20 DAC32-J12 8-CG11257-RA_1 CG11257 GCAGCCTCCGGAAATAGTGCCACGCTTTGATTGGATTCAGCAGAGGAGCGAACTTACCCTGATCTTCTA 69 FBan0011257 FBgn0034442 CG11257 2 2R electron transport; GO:0006118 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG11257 CG11257 CDMC20590 2 13 20 DAC32-J24 17-CG11265-RA_1 CG11265 GGAGAGCGACGCAGACCTACTAAGCCTAGTGTTAGGAACTTTGCCTCTGATCGCGCTAAATGTATTTCA 69 FBan0011265 FBgn0030049 CG11265 X X DNA replication; GO:0006260; sister chromatid cohesion; GO:0007062 nucleic acid binding; GO:0003676; DNA topoisomerase activity; GO:0003916 ; EC:5.99.1.-; ; GO:0003676; sigma DNA polymerase activity; GO:0019984; ; GO:0003916 ; EC:5.99.1.-; ; GO:0019984 CG11265 CG11265 AAF46390 CDMC20590 2 14 20 DAC32-J24 17-CG11265-RA_1 CG11265 GGAGAGCGACGCAGACCTACTAAGCCTAGTGTTAGGAACTTTGCCTCTGATCGCGCTAAATGTATTTCA 69 FBan0011265 FBgn0030049 CG11265 X X DNA replication; GO:0006260; sister chromatid cohesion; GO:0007062 nucleic acid binding; GO:0003676; DNA topoisomerase activity; GO:0003916 ; EC:5.99.1.-; ; GO:0003676; sigma DNA polymerase activity; GO:0019984; ; GO:0003916 ; EC:5.99.1.-; ; GO:0019984 CG11265 CG11265 AAF46390 CDMC20591 2 15 20 DAC32-N12 16-CG11301-RA_1 CG11301 GCTGTGGACAGTTTGCTATTCCTTGATGGAGCCATGAACTTTTGAACACCCCCACAAATGAAACTGGAT 69 FBan0011301 FBgn0034726 Mes4 2 2R DNA replication; GO:0006260 epsilon DNA polymerase activity; GO:0003893; ; GO:0003893 epsilon DNA polymerase complex; GO:0008622; nucleus; GO:0005634 Mes4 Mes4 "CG11301, CG11301, CG11301, CG11301, NF-YC-like, BcDNA:GM21739" CDMC20591 2 16 20 DAC32-N12 16-CG11301-RA_1 CG11301 GCTGTGGACAGTTTGCTATTCCTTGATGGAGCCATGAACTTTTGAACACCCCCACAAATGAAACTGGAT 69 FBan0011301 FBgn0034726 Mes4 2 2R DNA replication; GO:0006260 epsilon DNA polymerase activity; GO:0003893; ; GO:0003893 epsilon DNA polymerase complex; GO:0008622; nucleus; GO:0005634 Mes4 Mes4 "CG11301, CG11301, CG11301, CG11301, NF-YC-like, BcDNA:GM21739" CDMC20592 2 17 20 DAC32-N24 2-CG11312-RA_1 CG11312 CGTGACCCGTTTGGACTCGCTCCCTTAGTCGCTTATCCTTGCTGTATCCTTGCTGCTGGATGTAAACGA 69 FBan0011312 FBgn0011674 insc 2 2R RNA localization; GO:0006403; apical protein localization; GO:0045176; asymmetric cell division; GO:0008356; asymmetric protein localization; GO:0008105; asymmetric protein localization during cell fate commitment; GO:0045167; basal protein localization; GO:0045175; cytoskeleton organization and biogenesis; GO:0007010; establishment of mitotic spindle localization; GO:0040001; neuroblast division; GO:0045034; neuroblast fate determination; GO:0007400; peripheral nervous system development; GO:0007422; protein localization; GO:0008104; sensory organ development; GO:0007423; somatic muscle development; GO:0007525 cytoskeletal adaptor activity; GO:0008093; ; GO:0008093; ; GO:0008093; protein binding; GO:0005515; ; GO:0008093; ; GO:0005515 apical cortex; GO:0045179; apical part of cell; GO:0045177; cell cortex; GO:0005938; cytoplasm; GO:0005737 insc inscuteable "CG11312, fam, nem, inscrutable, 25/17, l(2)05475, l(2)k12405, Inscuteable, Ins, Inscutable, fata morgana, not enough muscles, inscuteable" CDMC20592 2 18 20 DAC32-N24 2-CG11312-RA_1 CG11312 CGTGACCCGTTTGGACTCGCTCCCTTAGTCGCTTATCCTTGCTGTATCCTTGCTGCTGGATGTAAACGA 69 FBan0011312 FBgn0011674 insc 2 2R RNA localization; GO:0006403; apical protein localization; GO:0045176; asymmetric cell division; GO:0008356; asymmetric protein localization; GO:0008105; asymmetric protein localization during cell fate commitment; GO:0045167; basal protein localization; GO:0045175; cytoskeleton organization and biogenesis; GO:0007010; establishment of mitotic spindle localization; GO:0040001; neuroblast division; GO:0045034; neuroblast fate determination; GO:0007400; peripheral nervous system development; GO:0007422; protein localization; GO:0008104; sensory organ development; GO:0007423; somatic muscle development; GO:0007525 cytoskeletal adaptor activity; GO:0008093; ; GO:0008093; ; GO:0008093; protein binding; GO:0005515; ; GO:0008093; ; GO:0005515 apical cortex; GO:0045179; apical part of cell; GO:0045177; cell cortex; GO:0005938; cytoplasm; GO:0005737 insc inscuteable "CG11312, fam, nem, inscrutable, 25/17, l(2)05475, l(2)k12405, Inscuteable, Ins, Inscutable, fata morgana, not enough muscles, inscuteable" CDMC20593 2 19 20 DAC33-B12 1-CG12585-RA_1 CG12585 GCCCTCGATTTCAATAAGACCGTCGTCCTGTGGCCCTGTCCGCGAATGAAAGTGAGTACGTCCTTAGTT 69 FBan0012585 FBgn0037258 CG12585 3 3R CG12585 CG12585 CDMC20593 2 20 20 DAC33-B12 1-CG12585-RA_1 CG12585 GCCCTCGATTTCAATAAGACCGTCGTCCTGTGGCCCTGTCCGCGAATGAAAGTGAGTACGTCCTTAGTT 69 FBan0012585 FBgn0037258 CG12585 3 3R CG12585 CG12585 CDMC20594 2 21 20 DAC33-B24 3-CG12594-RA_1 CG12594 GCTGGCATCAAGTGGCCATCAGCATACAGAACGGCGATTTCATATCGATTTACGTCGATTGCGCGTGGA 69 FBan0012594 FBgn0037941 CG12594 3 3R cell adhesion; GO:0007155 structural molecule activity; GO:0005198; ; GO:0005198 CG12594 CG12594 CDMC20594 2 22 20 DAC33-B24 3-CG12594-RA_1 CG12594 GCTGGCATCAAGTGGCCATCAGCATACAGAACGGCGATTTCATATCGATTTACGTCGATTGCGCGTGGA 69 FBan0012594 FBgn0037941 CG12594 3 3R cell adhesion; GO:0007155 structural molecule activity; GO:0005198; ; GO:0005198 CG12594 CG12594 CDMC20595 2 23 20 DAC33-F12 7-CG12643-RA_1 CG12643 TGGAGGTGACCCATCAATCCACACAATCAGCCATCACCTGTAATCAGCCACTTCAATAGAGGACGCACT 69 FBan0012643 FBgn0040942 CG12643 X X CG12643 CG12643 CDMC20595 2 24 20 DAC33-F12 7-CG12643-RA_1 CG12643 TGGAGGTGACCCATCAATCCACACAATCAGCCATCACCTGTAATCAGCCACTTCAATAGAGGACGCACT 69 FBan0012643 FBgn0040942 CG12643 X X CG12643 CG12643 CDMC20596 2 25 20 DAC33-F24 6-CG12661-RA_1 CG12661 TTGTGACAATTCGAGTTTGGAGGAGAAGCGAGAACGCGTTGACAATGCAATCCTAACCGCCATGGAGGA 69 FBan0012661 FBgn0030071 CG12661 X X CG12661 CG12661 CDMC20596 2 26 20 DAC33-F24 6-CG12661-RA_1 CG12661 TTGTGACAATTCGAGTTTGGAGGAGAAGCGAGAACGCGTTGACAATGCAATCCTAACCGCCATGGAGGA 69 FBan0012661 FBgn0030071 CG12661 X X CG12661 CG12661 CDMC20597 2 1 21 DAC33-J12 9-CG12698-RA_3 CG12698 AGCGACTCTGCGACGAAATAAAGAAACCAGTATCTAGGAGATCCACCAAGGAATCAGCACGCCAACGGC 69 FBan0012698 FBgn0030721 CG12698 X X CG12698 CG12698 CDMC20597 2 2 21 DAC33-J12 9-CG12698-RA_3 CG12698 AGCGACTCTGCGACGAAATAAAGAAACCAGTATCTAGGAGATCCACCAAGGAATCAGCACGCCAACGGC 69 FBan0012698 FBgn0030721 CG12698 X X CG12698 CG12698 CDMC20598 2 3 21 DAC33-J24 23-CG12721-RA_3 CG12721 CCTTTGTCATCAAACGGGGACTATTGAATAAGCACATTAACTGGCAGATTCTCGACAAGATCATGGCAG 69 FBan0012721 FBgn0030373 CG12721 X X CG12721 CG12721 BcDNA:RE60404 CDMC20598 2 4 21 DAC33-J24 23-CG12721-RA_3 CG12721 CCTTTGTCATCAAACGGGGACTATTGAATAAGCACATTAACTGGCAGATTCTCGACAAGATCATGGCAG 69 FBan0012721 FBgn0030373 CG12721 X X CG12721 CG12721 BcDNA:RE60404 CDMC20599 2 5 21 DAC33-N12 2-CG12763-RA_2 CG12763 GCCACGAGATTGGACTGAATGGAGGATATGGACAGCACTTGGGAGGACCATATGGCAACTCAGAACCGA 69 FBan0012763 FBgn0004240 Dpt 2 2R antibacterial humoral response (sensu Protostomia); GO:0006961; defense response to Gram-negative bacteria; GO:0050829; defense response to bacteria; GO:0042742; innate immune response; GO:0045087 extracellular region; GO:0005576 Dpt Diptericin "CG12763, CG12763, CG12763, diptericin, Dipt, dip, Dip, dipt, DptA, DIPT, dpt, DPT, Diptericin" CDMC20599 2 6 21 DAC33-N12 2-CG12763-RA_2 CG12763 GCCACGAGATTGGACTGAATGGAGGATATGGACAGCACTTGGGAGGACCATATGGCAACTCAGAACCGA 69 FBan0012763 FBgn0004240 Dpt 2 2R antibacterial humoral response (sensu Protostomia); GO:0006961; defense response to Gram-negative bacteria; GO:0050829; defense response to bacteria; GO:0042742; innate immune response; GO:0045087 extracellular region; GO:0005576 Dpt Diptericin "CG12763, CG12763, CG12763, diptericin, Dipt, dip, Dip, dipt, DptA, DIPT, dpt, DPT, Diptericin" CDMC20600 2 7 21 DAC33-N24 3-CG12773-RA_1 CG12773 CCAACTACCACCACTCGTCCGTTATCGAGGGTCGCCTCATAGATGACATCTAGACCGAGTCCAGGGTCT 69 FBan0012773 FBgn0024365 CG12773 X X amino acid transport; GO:0006865; cation transport; GO:0006812 cation transporter activity; GO:0008324; ; GO:0008324; sodium:potassium:chloride symporter activity; GO:0008511; ; GO:0008511; amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 CG12773 CG12773 EG:8D8.3 CDMC20600 2 8 21 DAC33-N24 3-CG12773-RA_1 CG12773 CCAACTACCACCACTCGTCCGTTATCGAGGGTCGCCTCATAGATGACATCTAGACCGAGTCCAGGGTCT 69 FBan0012773 FBgn0024365 CG12773 X X amino acid transport; GO:0006865; cation transport; GO:0006812 cation transporter activity; GO:0008324; ; GO:0008324; sodium:potassium:chloride symporter activity; GO:0008511; ; GO:0008511; amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 CG12773 CG12773 EG:8D8.3 CDMC20601 2 9 21 DAC34-B12 23-CG4347-RA_8 CG4347 GCATCTTGGACCACTAAATCAAATCCTGTACAATTGGATATCGTCTCACTAACTGTAGTCTAATTGTCT 69 FBan0004347 FBgn0035978 UGP 3 3L polysaccharide metabolism; GO:0005976 UTP:glucose-1-phosphate uridylyltransferase activity; GO:0003983 ; EC:2.7.7.9; ; GO:0003983 ; EC:2.7.7.9 UGP UGP "CG4347, CG4347, CG4347, UTP-G-1-P uridyiyltransferase, UDPGPP, UDP-glucose pyrophosphorylase, UGPase" CDMC20601 2 10 21 DAC34-B12 23-CG4347-RA_8 CG4347 GCATCTTGGACCACTAAATCAAATCCTGTACAATTGGATATCGTCTCACTAACTGTAGTCTAATTGTCT 69 FBan0004347 FBgn0035978 UGP 3 3L polysaccharide metabolism; GO:0005976 UTP:glucose-1-phosphate uridylyltransferase activity; GO:0003983 ; EC:2.7.7.9; ; GO:0003983 ; EC:2.7.7.9 UGP UGP "CG4347, CG4347, CG4347, UTP-G-1-P uridyiyltransferase, UDPGPP, UDP-glucose pyrophosphorylase, UGPase" CDMC20602 2 11 21 DAC34-B24 18-CG4356-RB_3 CG4356 GGGCCTGGTGCGAATCAAGCCGAAATCAAAGCGACATTTGTAGTGTCTGTGACACAGTACGCATATTTA 69 FBan0004356 FBgn0000037 mAcR-60C 2 2R "acetylcholine receptor signaling, muscarinic pathway; GO:0007213; neuromuscular synaptic transmission; GO:0007274" muscarinic acetylcholine receptor activity; GO:0004981; ; GO:0004981; amine receptor activity; GO:0008227; ligand-gated ion channel activity; GO:0015276; G-protein coupled receptor activity; GO:0004930; ; GO:0004930; ; GO:0015276; ; GO:0008227; ; GO:0004981 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 mAcR-60C muscarinic Acetylcholine Receptor 60C "CG4356, muscarinic receptor, mAChR-1, mAChR, Acr60C, Dm1, DM1, AcrC" CDMC20602 2 12 21 DAC34-B24 18-CG4356-RB_3 CG4356 GGGCCTGGTGCGAATCAAGCCGAAATCAAAGCGACATTTGTAGTGTCTGTGACACAGTACGCATATTTA 69 FBan0004356 FBgn0000037 mAcR-60C 2 2R "acetylcholine receptor signaling, muscarinic pathway; GO:0007213; neuromuscular synaptic transmission; GO:0007274" muscarinic acetylcholine receptor activity; GO:0004981; ; GO:0004981; amine receptor activity; GO:0008227; ligand-gated ion channel activity; GO:0015276; G-protein coupled receptor activity; GO:0004930; ; GO:0004930; ; GO:0015276; ; GO:0008227; ; GO:0004981 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 mAcR-60C muscarinic Acetylcholine Receptor 60C "CG4356, muscarinic receptor, mAChR-1, mAChR, Acr60C, Dm1, DM1, AcrC" CDMC20603 2 13 21 DAC34-F12 2-CG4389-RB_1 CG4389 ACATGGCTAAGGACCCGTCGAAGAAGTTCTACCCCAAGACTGGCTCCTCGAAGTTGTAGATCCGATCCA 69 FBan0004389 FBgn0028479 CG4389 2 2L fatty acid beta-oxidation; GO:0006635 long-chain-3-hydroxyacyl-CoA dehydrogenase activity; GO:0016509 ; EC:1.1.1.211; long-chain-enoyl-CoA hydratase activity; GO:0016508 ; EC:4.2.1.74; ; GO:0016509 ; EC:1.1.1.211; ; GO:0016508 ; EC:4.2.1.74; ; GO:0016509 ; EC:1.1.1.211 fatty acid beta-oxidation multienzyme complex; GO:0016507 CG4389 CG4389 BcDNA:GH12558 CDMC20603 2 14 21 DAC34-F12 2-CG4389-RB_1 CG4389 ACATGGCTAAGGACCCGTCGAAGAAGTTCTACCCCAAGACTGGCTCCTCGAAGTTGTAGATCCGATCCA 69 FBan0004389 FBgn0028479 CG4389 2 2L fatty acid beta-oxidation; GO:0006635 long-chain-3-hydroxyacyl-CoA dehydrogenase activity; GO:0016509 ; EC:1.1.1.211; long-chain-enoyl-CoA hydratase activity; GO:0016508 ; EC:4.2.1.74; ; GO:0016509 ; EC:1.1.1.211; ; GO:0016508 ; EC:4.2.1.74; ; GO:0016509 ; EC:1.1.1.211 fatty acid beta-oxidation multienzyme complex; GO:0016507 CG4389 CG4389 BcDNA:GH12558 CDMC20604 2 15 21 DAC34-F24 3-CG4413-RA_2 CG4413 AGCCGGTGCCAAATGAGATCGAGGAGGCTGAAACCTATGCTGAATACGAGGAATACGAACTGCTCACCA 69 FBan0004413 FBgn0038767 CG4413 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG4413 CG4413 CDMC20604 2 16 21 DAC34-F24 3-CG4413-RA_2 CG4413 AGCCGGTGCCAAATGAGATCGAGGAGGCTGAAACCTATGCTGAATACGAGGAATACGAACTGCTCACCA 69 FBan0004413 FBgn0038767 CG4413 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG4413 CG4413 CDMC20605 2 17 21 DAC34-J12 23-CG4440-RA_3 CG4440 GCAGTTTTATCCTCAAAGACGATTCATCATATACTCTTACTCCAGTATCGCTAAAGAAGCTAAAAGTGT 69 FBan0004440 FBgn0040984 CG4440 2 2L CG4440 CG4440 BcDNA:RE16123 CDMC20605 2 18 21 DAC34-J12 23-CG4440-RA_3 CG4440 GCAGTTTTATCCTCAAAGACGATTCATCATATACTCTTACTCCAGTATCGCTAAAGAAGCTAAAAGTGT 69 FBan0004440 FBgn0040984 CG4440 2 2L CG4440 CG4440 BcDNA:RE16123 CDMC20606 2 19 21 DAC34-J24 23-CG4452-RA_2 CG4452 CTGTTCCAACTCCCTCCTTCCAAATGTAACCCAATCATCAGTTAGAAAATGTAATTCGAATTCAACTTA 69 FBan0004452 FBgn0035981 CG4452 3 3L CG4452 CG4452 "cg4452, anon-WO0172774.118" CDMC20606 2 20 21 DAC34-J24 23-CG4452-RA_2 CG4452 CTGTTCCAACTCCCTCCTTCCAAATGTAACCCAATCATCAGTTAGAAAATGTAATTCGAATTCAACTTA 69 FBan0004452 FBgn0035981 CG4452 3 3L CG4452 CG4452 "cg4452, anon-WO0172774.118" CDMC20607 2 21 21 DAC34-N12 6-CG4488-RA_2 CG4488 TGGCATGGACAGCGTCTATGAAGAACTGCGCCATTCAGAGAATCTGGTTACGTACAAGATCGGCGACCT 69 FBan0004488 FBgn0011737 wee 2 2L "cell cycle; GO:0007049; embryonic development (sensu Insecta); GO:0001700; mitotic cell cycle, embryonic; GO:0045448; mitotic checkpoint; GO:0007093; negative regulation of cyclin dependent protein kinase activity; GO:0045736; nuclear division; GO:0000280; protein amino acid phosphorylation; GO:0006468; regulation of mitosis; GO:0007088" ATP binding; GO:0005524; ; GO:0005524; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; protein kinase activity; GO:0004672 ; EC:2.7.1.37; non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004715 ; EC:2.7.1.- nucleus; GO:0005634 wee wee "CG4488, CG4488, Dwee1, Wee1, Wee, WEE1, wee1, Dwee, dwee1, Wee 1, dWee1" CDMC20607 2 22 21 DAC34-N12 6-CG4488-RA_2 CG4488 TGGCATGGACAGCGTCTATGAAGAACTGCGCCATTCAGAGAATCTGGTTACGTACAAGATCGGCGACCT 69 FBan0004488 FBgn0011737 wee 2 2L "cell cycle; GO:0007049; embryonic development (sensu Insecta); GO:0001700; mitotic cell cycle, embryonic; GO:0045448; mitotic checkpoint; GO:0007093; negative regulation of cyclin dependent protein kinase activity; GO:0045736; nuclear division; GO:0000280; protein amino acid phosphorylation; GO:0006468; regulation of mitosis; GO:0007088" ATP binding; GO:0005524; ; GO:0005524; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; protein kinase activity; GO:0004672 ; EC:2.7.1.37; non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004715 ; EC:2.7.1.- nucleus; GO:0005634 wee wee "CG4488, CG4488, Dwee1, Wee1, Wee, WEE1, wee1, Dwee, dwee1, Wee 1, dWee1" CDMC20608 2 23 21 DAC34-N24 13-CG4511-RA_1 CG4511 GGCCGACGAAAAAGAGTTCTTCGAGATGTCGAAAAAGTCGCCCAACATTGTTTGCCACTTTTACCGCGA 69 FBan0004511 FBgn0037843 CG4511 3 3R electron transport; GO:0006118 ATP binding; GO:0005524; ; GO:0005524; electron transporter activity; GO:0005489; ; GO:0005489 CG4511 CG4511 CDMC20608 2 24 21 DAC34-N24 13-CG4511-RA_1 CG4511 GGCCGACGAAAAAGAGTTCTTCGAGATGTCGAAAAAGTCGCCCAACATTGTTTGCCACTTTTACCGCGA 69 FBan0004511 FBgn0037843 CG4511 3 3R electron transport; GO:0006118 ATP binding; GO:0005524; ; GO:0005524; electron transporter activity; GO:0005489; ; GO:0005489 CG4511 CG4511 CDMC20609 2 25 21 DAC35-B12 8-CG8807-RA_2 CG8807 AACTTCCGCATCTGGTTCCCCCGGAAATGATGGAGATGTCCAGGAAATCCGTTGAAGCTTGTCGGGATA 69 FBan0008807 FBgn0020277 lush 3 3L NOT response to ethanol; GO:0045471; olfactory behavior; GO:0042048; response to ethanol; GO:0045471; response to pheromone; GO:0019236; sensory perception of smell; GO:0007608; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549; NOT ethanol binding; GO:0035276; dibutyl phthalate binding; GO:0035275; diphenyl phthalate binding; GO:0035274; ; GO:0035276; ; GO:0035275; ; GO:0035274 extracellular region; GO:0005576 lush lush "CG8807, LUSH, 76c, 76c(LUSH), 76a, Obp76a" CDMC20609 2 26 21 DAC35-B12 8-CG8807-RA_2 CG8807 AACTTCCGCATCTGGTTCCCCCGGAAATGATGGAGATGTCCAGGAAATCCGTTGAAGCTTGTCGGGATA 69 FBan0008807 FBgn0020277 lush 3 3L NOT response to ethanol; GO:0045471; olfactory behavior; GO:0042048; response to ethanol; GO:0045471; response to pheromone; GO:0019236; sensory perception of smell; GO:0007608; transport; GO:0006810 odorant binding; GO:0005549; ; GO:0005549; ; GO:0005549; NOT ethanol binding; GO:0035276; dibutyl phthalate binding; GO:0035275; diphenyl phthalate binding; GO:0035274; ; GO:0035276; ; GO:0035275; ; GO:0035274 extracellular region; GO:0005576 lush lush "CG8807, LUSH, 76c, 76c(LUSH), 76a, Obp76a" CDMC20610 2 1 22 DAC35-B24 13-CG8816-RA_1 CG8816 CCTGGAGCGGGGAAATCGTATTTATGCGAACGTATAGCCTCCGAACTAAAGTTTGAGTGGCTGGACTGC 69 FBan0008816 FBgn0033754 CG8816 2 2R CG8816 CG8816 CDMC20610 2 2 22 DAC35-B24 13-CG8816-RA_1 CG8816 CCTGGAGCGGGGAAATCGTATTTATGCGAACGTATAGCCTCCGAACTAAAGTTTGAGTGGCTGGACTGC 69 FBan0008816 FBgn0033754 CG8816 2 2R CG8816 CG8816 CDMC20611 2 3 22 DAC35-F12 1-CG8850-RB_1 CG8850 GGCACCTGGTCTGATGTTCCTGGTCCTCGTCTATATGCTCTTCAGCTACGAACCTCTGACGTACCGAGG 69 FBan0008850 FBgn0033708 CG8850 2 2R amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; cation transport; GO:0006812; extracellular transport; GO:0006858; neurotransmitter transport; GO:0006836 cation transporter activity; GO:0008324; neurotransmitter:sodium symporter activity; GO:0005328; ; GO:0008324; ; GO:0005328; potassium:amino acid symporter activity; GO:0017032; ; GO:0017032 integral to plasma membrane; GO:0005887; membrane; GO:0016020 CG8850 CG8850 CDMC20611 2 4 22 DAC35-F12 1-CG8850-RB_1 CG8850 GGCACCTGGTCTGATGTTCCTGGTCCTCGTCTATATGCTCTTCAGCTACGAACCTCTGACGTACCGAGG 69 FBan0008850 FBgn0033708 CG8850 2 2R amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; cation transport; GO:0006812; extracellular transport; GO:0006858; neurotransmitter transport; GO:0006836 cation transporter activity; GO:0008324; neurotransmitter:sodium symporter activity; GO:0005328; ; GO:0008324; ; GO:0005328; potassium:amino acid symporter activity; GO:0017032; ; GO:0017032 integral to plasma membrane; GO:0005887; membrane; GO:0016020 CG8850 CG8850 CDMC20612 2 5 22 DAC35-F24 3-CG8859-RA_4 CG8859 GGAGGAGATCAAGGATGCACTGGTCGAAAGTGGAGGTCAGGTGACGCTGAAGATGATCGAGTCACTGGA 69 FBan0008859 FBgn0033696 Cyp6g2 2 2R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6g2 Cyp6g2 "CG8859, 6g2" CDMC20612 2 6 22 DAC35-F24 3-CG8859-RA_4 CG8859 GGAGGAGATCAAGGATGCACTGGTCGAAAGTGGAGGTCAGGTGACGCTGAAGATGATCGAGTCACTGGA 69 FBan0008859 FBgn0033696 Cyp6g2 2 2R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6g2 Cyp6g2 "CG8859, 6g2" CDMC20613 2 7 22 DAC35-J12 2-CG8907-RA_1 CG8907 CCTGGCTGAGTAGATTGGAGAGCCGAAATGTCAAGATCGCCGAGGTTACCTTCAATAAGTCGGCCACCA 69 FBan0008907 FBgn0038466 CG8907 3 3R development; GO:0007275 CG8907 CG8907 LP01469p CDMC20613 2 8 22 DAC35-J12 2-CG8907-RA_1 CG8907 CCTGGCTGAGTAGATTGGAGAGCCGAAATGTCAAGATCGCCGAGGTTACCTTCAATAAGTCGGCCACCA 69 FBan0008907 FBgn0038466 CG8907 3 3R development; GO:0007275 CG8907 CG8907 LP01469p CDMC20614 2 9 22 DAC35-J24 3-CG8916-RA_2 CG8916 CGCGATTGCATCAGATGTGGATGTGCCTGAAGAGCGACAACAGTTTCCGGAAACAACGAGAACGCAACG 69 FBan0008916 FBgn0030707 CG8916 X X anion transport; GO:0006820; nerve-nerve synaptic transmission; GO:0007270; signal transduction; GO:0007165 GABA-A receptor activity; GO:0004890; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; ; GO:0004890; extracellular ligand-gated ion channel activity; GO:0005230; ; GO:0005230 integral to membrane; GO:0016021; membrane; GO:0016020; postsynaptic membrane; GO:0045211 CG8916 CG8916 CDMC20614 2 10 22 DAC35-J24 3-CG8916-RA_2 CG8916 CGCGATTGCATCAGATGTGGATGTGCCTGAAGAGCGACAACAGTTTCCGGAAACAACGAGAACGCAACG 69 FBan0008916 FBgn0030707 CG8916 X X anion transport; GO:0006820; nerve-nerve synaptic transmission; GO:0007270; signal transduction; GO:0007165 GABA-A receptor activity; GO:0004890; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; ; GO:0004890; extracellular ligand-gated ion channel activity; GO:0005230; ; GO:0005230 integral to membrane; GO:0016021; membrane; GO:0016020; postsynaptic membrane; GO:0045211 CG8916 CG8916 CDMC20615 2 11 22 DAC35-N12 5-CG8954-RA_3 CG8954 CCCCATTTGTGGTGGTCGATTCGAAGGCATTGACCGAATACAATGGCATAGTCAAGTCGCTGGTGAGGA 69 FBan0008954 FBgn0019890 Smg5 2 2L "mRNA catabolism, nonsense-mediated decay; GO:0000184" Smg5 Smg5 "CG8954, CG8954, CG8954, CG8954, BG:DS08220.2, anon-34Ea, SMG5" CDMC20615 2 12 22 DAC35-N12 5-CG8954-RA_3 CG8954 CCCCATTTGTGGTGGTCGATTCGAAGGCATTGACCGAATACAATGGCATAGTCAAGTCGCTGGTGAGGA 69 FBan0008954 FBgn0019890 Smg5 2 2L "mRNA catabolism, nonsense-mediated decay; GO:0000184" Smg5 Smg5 "CG8954, CG8954, CG8954, CG8954, BG:DS08220.2, anon-34Ea, SMG5" CDMC20616 2 13 22 DAC35-N24 10-CG8964-RA_2 CG8964 TCCGAAATCCTCGATTACCATCAAGGAACAAAGTTCGTTGCAATTGCCCTGTGACTACCAACTGCCGGA 69 FBan0008964 FBgn0033674 CG8964 2 2R cell communication; GO:0007154; cell surface receptor linked signal transduction; GO:0007166; cell-cell adhesion; GO:0016337; defense response; GO:0006952; protein amino acid phosphorylation; GO:0006468; protein metabolism; GO:0019538; protein modification; GO:0006464; signal transduction; GO:0007165; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; receptor activity; GO:0004872; transmembrane receptor activity; GO:0004888; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; kinase activity; GO:0016301; protein kinase activity; GO:0004672 ; EC:2.7.1.37; transmembrane receptor protein kinase activity; GO:0019199 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004715 ; EC:2.7.1.-; ; GO:0004888; ; GO:0016301; ; GO:0004872; ; GO:0004714 ; EC:2.7.1.-; ; GO:0019199 ; EC:2.7.1.- CG8964 CG8964 CT25760 CDMC20616 2 14 22 DAC35-N24 10-CG8964-RA_2 CG8964 TCCGAAATCCTCGATTACCATCAAGGAACAAAGTTCGTTGCAATTGCCCTGTGACTACCAACTGCCGGA 69 FBan0008964 FBgn0033674 CG8964 2 2R cell communication; GO:0007154; cell surface receptor linked signal transduction; GO:0007166; cell-cell adhesion; GO:0016337; defense response; GO:0006952; protein amino acid phosphorylation; GO:0006468; protein metabolism; GO:0019538; protein modification; GO:0006464; signal transduction; GO:0007165; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 non-membrane spanning protein tyrosine kinase activity; GO:0004715 ; EC:2.7.1.-; receptor activity; GO:0004872; transmembrane receptor activity; GO:0004888; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; kinase activity; GO:0016301; protein kinase activity; GO:0004672 ; EC:2.7.1.37; transmembrane receptor protein kinase activity; GO:0019199 ; EC:2.7.1.-; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004715 ; EC:2.7.1.-; ; GO:0004888; ; GO:0016301; ; GO:0004872; ; GO:0004714 ; EC:2.7.1.-; ; GO:0019199 ; EC:2.7.1.- CG8964 CG8964 CT25760 CDMC20617 2 15 22 DAC36-B12 18-CG7056-RA_1 CG7056 AAAGGCGGCCAGATCAGATTCACCTCCCAGCAGACCAAAAATCTCGAGGCTCGCTTCGCCAGCTC 65 FBan0007056 FBgn0038852 CG7056 3 3R hemopoiesis; GO:0030097; mesoderm development; GO:0007498; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG7056 CG7056 CDMC20617 2 16 22 DAC36-B12 18-CG7056-RA_1 CG7056 AAAGGCGGCCAGATCAGATTCACCTCCCAGCAGACCAAAAATCTCGAGGCTCGCTTCGCCAGCTC 65 FBan0007056 FBgn0038852 CG7056 3 3R hemopoiesis; GO:0030097; mesoderm development; GO:0007498; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 CG7056 CG7056 CDMC20618 2 17 22 DAC36-B24 1-CG7076-RA_3 CG7076 CTATCCGTTGGAGCACCAGTACTACGAGGAGAGCCATGGATATGAGCACCTGGCCCATCACGAAC 65 FBan0007076 FBgn0035875 CG7076 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG7076 CG7076 CDMC20618 2 18 22 DAC36-B24 1-CG7076-RA_3 CG7076 CTATCCGTTGGAGCACCAGTACTACGAGGAGAGCCATGGATATGAGCACCTGGCCCATCACGAAC 65 FBan0007076 FBgn0035875 CG7076 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG7076 CG7076 CDMC20619 2 19 22 DAC36-F12 2-CG7216-RA_1 CG7216 AGAACAAGAGTTCAACCAGAGCGCAACCCAAAACCCACAAACAGCACCATGAAATTCGCCGTCGC 65 FBan0007216 FBgn0014454 Acp1 2 2L structural constituent of adult cuticle (sensu Insecta); GO:0008012; ; GO:0008012 Acp1 Adult cuticle protein 1 "CG7216, Dacp-1" CDMC20619 2 20 22 DAC36-F12 2-CG7216-RA_1 CG7216 AGAACAAGAGTTCAACCAGAGCGCAACCCAAAACCCACAAACAGCACCATGAAATTCGCCGTCGC 65 FBan0007216 FBgn0014454 Acp1 2 2L structural constituent of adult cuticle (sensu Insecta); GO:0008012; ; GO:0008012 Acp1 Adult cuticle protein 1 "CG7216, Dacp-1" CDMC20620 2 21 22 DAC36-F24 3-CG7242-RA_1 CG7242 TCCGTGGCGATAAACGCGACCAGTTGATACCCTTTGATCTGAAGGCGACCGATGTGGAAGGACTG 65 FBan0007242 FBgn0040494 CG7242 3 3R CG7242 CG7242 "BcDNA:LD37196, l(3)c00064, lethal (3) c00064" CDMC20620 2 22 22 DAC36-F24 3-CG7242-RA_1 CG7242 TCCGTGGCGATAAACGCGACCAGTTGATACCCTTTGATCTGAAGGCGACCGATGTGGAAGGACTG 65 FBan0007242 FBgn0040494 CG7242 3 3R CG7242 CG7242 "BcDNA:LD37196, l(3)c00064, lethal (3) c00064" CDMC20621 2 23 22 DAC36-J12 1-CG7345-RA_1 CG7345 GTACCGGCATCTCATCCTACGGATGCGTCAAGTCAGAGAAGTCCTCACCAAATGCGGTAGTGGCC 65 FBan0007345 FBgn0036411 Sox21a 3 3L ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; visual perception; GO:0007601 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Sox21a Sox21a "CG7345, CG7345, SOXB2.3, Sox B2-3, SoxB2.3" CDMC20621 2 24 22 DAC36-J12 1-CG7345-RA_1 CG7345 GTACCGGCATCTCATCCTACGGATGCGTCAAGTCAGAGAAGTCCTCACCAAATGCGGTAGTGGCC 65 FBan0007345 FBgn0036411 Sox21a 3 3L ectoderm development; GO:0007398; nervous system development; GO:0007399; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; visual perception; GO:0007601 transcription factor activity; GO:0003700; ; GO:0003700 nucleus; GO:0005634 Sox21a Sox21a "CG7345, CG7345, SOXB2.3, Sox B2-3, SoxB2.3" CDMC20622 2 25 22 DAC36-J24 1-CG7377-RA_1 CG7377 GAAGTACTCCTGTGTTTTGCTCCTTTTGGCCACTGTCGCCTGTTTCCTGGTGAGCCTGTCCAGTG 65 FBan0007377 FBgn0036176 CG7377 3 3L CG7377 CG7377 HDC09644 CDMC20622 2 26 22 DAC36-J24 1-CG7377-RA_1 CG7377 GAAGTACTCCTGTGTTTTGCTCCTTTTGGCCACTGTCGCCTGTTTCCTGGTGAGCCTGTCCAGTG 65 FBan0007377 FBgn0036176 CG7377 3 3L CG7377 CG7377 HDC09644 CDMC20623 2 1 23 DAC36-N12 3-CG7439-RC_2 CG7439 GAACCGTGGTCGATCGCACCATTGTGCATCCTAACGAGATGCAGTTCTTCATGGTCAGCCACCAG 65 FBan0007439 FBgn0046812 AGO2 3 3L "RNA interference; GO:0016246; RNA interference, production of siRNA; GO:0030422; RNA interference, siRNA loading onto RISC; GO:0035087; RNA interference, targeting of mRNA for destruction; GO:0030423; autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071; translational initiation; GO:0006413" protein binding; GO:0005515; ; GO:0005515; ; GO:0005515; translation initiation factor activity; GO:0003743; ; GO:0003743 RNA-induced silencing complex; GO:0016442 AGO2 Argonaute 2 "CG7439, CG13452, CG7439, CG7439, CG7439, CG7439, CG7439, Ago-2, ago2, Dm Ago2, dAgo2, Ago2, Argonaute2, AGO 2, Argonaute 2" CDMC20623 2 2 23 DAC36-N12 3-CG7439-RC_2 CG7439 GAACCGTGGTCGATCGCACCATTGTGCATCCTAACGAGATGCAGTTCTTCATGGTCAGCCACCAG 65 FBan0007439 FBgn0046812 AGO2 3 3L "RNA interference; GO:0016246; RNA interference, production of siRNA; GO:0030422; RNA interference, siRNA loading onto RISC; GO:0035087; RNA interference, targeting of mRNA for destruction; GO:0030423; autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071; translational initiation; GO:0006413" protein binding; GO:0005515; ; GO:0005515; ; GO:0005515; translation initiation factor activity; GO:0003743; ; GO:0003743 RNA-induced silencing complex; GO:0016442 AGO2 Argonaute 2 "CG7439, CG13452, CG7439, CG7439, CG7439, CG7439, CG7439, Ago-2, ago2, Dm Ago2, dAgo2, Ago2, Argonaute2, AGO 2, Argonaute 2" CDMC20624 2 3 23 DAC36-N24 1-CG7476-RA_1 CG7476 CAGTTTGGGGACGGTTCGATTACGCCGATTGAAAAGCATTTAAGGGCCTGTGTTTGCAGCGTGCG 65 FBan0007476 FBgn0035847 mthl7 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; determination of adult life span; GO:0008340; response to stress; GO:0006950 G-protein coupled receptor activity; GO:0004930; ; GO:0004930 integral to membrane; GO:0016021 mthl7 methuselah-like 7 "CG7476, CG7476, mth-like 7, Mth-like 7, anon-WO0170980.86, anon-WO0170980.85" CDMC20624 2 4 23 DAC36-N24 1-CG7476-RA_1 CG7476 CAGTTTGGGGACGGTTCGATTACGCCGATTGAAAAGCATTTAAGGGCCTGTGTTTGCAGCGTGCG 65 FBan0007476 FBgn0035847 mthl7 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; determination of adult life span; GO:0008340; response to stress; GO:0006950 G-protein coupled receptor activity; GO:0004930; ; GO:0004930 integral to membrane; GO:0016021 mthl7 methuselah-like 7 "CG7476, CG7476, mth-like 7, Mth-like 7, anon-WO0170980.86, anon-WO0170980.85" CDMC20625 2 5 23 DAC37-B12 2-CG12892-RA_2 CG12892 AGCAAGCTACTCCCATTGCAGTGAGGAGAACTCCACGCGTACTCATCGAAATGCCGGTGAACTCG 65 FBan0012892 FBgn0033526 Caf1-105 2 2R chromatin assembly or disassembly; GO:0006333; nucleosome assembly; GO:0006334 DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003677; ; GO:0003682 chromatin assembly complex; GO:0005678 Caf1-105 Caf1-105 "CG12892, CG12892, Caf1-10" CDMC20625 2 6 23 DAC37-B12 2-CG12892-RA_2 CG12892 AGCAAGCTACTCCCATTGCAGTGAGGAGAACTCCACGCGTACTCATCGAAATGCCGGTGAACTCG 65 FBan0012892 FBgn0033526 Caf1-105 2 2R chromatin assembly or disassembly; GO:0006333; nucleosome assembly; GO:0006334 DNA binding; GO:0003677; chromatin binding; GO:0003682; ; GO:0003677; ; GO:0003682 chromatin assembly complex; GO:0005678 Caf1-105 Caf1-105 "CG12892, CG12892, Caf1-10" CDMC20626 2 7 23 DAC37-B24 2-CG12923-RA_1 CG12923 ACACTCGCACCTGGATAGTCACATCCCGTTGGTGGTGCTAATTTCCCAGACATTGCCCAATACGG 65 FBan0012923 FBgn0033461 CG12923 2 2R CG12923 CG12923 CDMC20626 2 8 23 DAC37-B24 2-CG12923-RA_1 CG12923 ACACTCGCACCTGGATAGTCACATCCCGTTGGTGGTGCTAATTTCCCAGACATTGCCCAATACGG 65 FBan0012923 FBgn0033461 CG12923 2 2R CG12923 CG12923 CDMC20627 2 9 23 DAC37-F12 12-CG13005-RA_3 CG13005 GCACGAATTGCACGAGTTTTGGGCATACCCGAGGGTCAGTATGCGTTGGATATGTCCGCCATGGA 65 FBan0013005 FBgn0030794 CG13005 X X CG13005 CG13005 CDMC20627 2 10 23 DAC37-F12 12-CG13005-RA_3 CG13005 GCACGAATTGCACGAGTTTTGGGCATACCCGAGGGTCAGTATGCGTTGGATATGTCCGCCATGGA 65 FBan0013005 FBgn0030794 CG13005 X X CG13005 CG13005 CDMC20628 2 11 23 DAC37-F24 12-CG13031-RA_1 CG13031 CAGCTGTGGATCCAGCACTGTTTCCTTCGGCCTCTACTTTCGGACTCTATCCAGGATCAGGTGGA 65 FBan0013031 FBgn0036655 CG13031 3 3L CG13031 CG13031 CDMC20628 2 12 23 DAC37-F24 12-CG13031-RA_1 CG13031 CAGCTGTGGATCCAGCACTGTTTCCTTCGGCCTCTACTTTCGGACTCTATCCAGGATCAGGTGGA 65 FBan0013031 FBgn0036655 CG13031 3 3L CG13031 CG13031 CDMC20629 2 13 23 DAC37-J12 1-CG13063-RA_1 CG13063 TCTGCTCTCCTCGCCGTAGCTGTCGCTCGTCCCGGTCATCTTTATGAGTCTCCTCTGGTTTATGC 65 FBan0013063 FBgn0036601 CG13063 3 3L CG13063 CG13063 CDMC20629 2 14 23 DAC37-J12 1-CG13063-RA_1 CG13063 TCTGCTCTCCTCGCCGTAGCTGTCGCTCGTCCCGGTCATCTTTATGAGTCTCCTCTGGTTTATGC 65 FBan0013063 FBgn0036601 CG13063 3 3L CG13063 CG13063 CDMC20630 2 15 23 DAC37-J24 12-CG13087-RA_1 CG13087 CGAACAGGACGAGCGCAGTGGTGGAAAGGTTCGCCAAATTCTCAGCCATTTACACGCTCCCAGTG 65 FBan0013087 FBgn0032045 CG13087 2 2L CG13087 CG13087 CDMC20630 2 16 23 DAC37-J24 12-CG13087-RA_1 CG13087 CGAACAGGACGAGCGCAGTGGTGGAAAGGTTCGCCAAATTCTCAGCCATTTACACGCTCCCAGTG 65 FBan0013087 FBgn0032045 CG13087 2 2L CG13087 CG13087 CDMC20631 2 17 23 DAC37-N12 3-CG13162-RA_3 CG13162 CACAAGCGGATCCTGTGCCTTCGAATACTCCGCAACATGTGCTTCTTCAATGGTAATCGCCCCCG 65 FBan0013162 FBgn0033718 CG13162 2 2R CG13162 CG13162 CDMC20631 2 18 23 DAC37-N12 3-CG13162-RA_3 CG13162 CACAAGCGGATCCTGTGCCTTCGAATACTCCGCAACATGTGCTTCTTCAATGGTAATCGCCCCCG 65 FBan0013162 FBgn0033718 CG13162 2 2R CG13162 CG13162 CDMC20632 2 19 23 DAC37-N24 23-CG13176-RA_2 CG13176 CAACCTAGGTTCTCTAGCTTAAAGCATACAAATTTCTAAAACGAATTCCAAATTCTGTGCCCAAG 65 FBan0013176 FBgn0033692 CG13176 2 2R transcription factor complex; GO:0005667 CG13176 CG13176 "p65, p63" CDMC20632 2 20 23 DAC37-N24 23-CG13176-RA_2 CG13176 CAACCTAGGTTCTCTAGCTTAAAGCATACAAATTTCTAAAACGAATTCCAAATTCTGTGCCCAAG 65 FBan0013176 FBgn0033692 CG13176 2 2R transcription factor complex; GO:0005667 CG13176 CG13176 "p65, p63" CDMC20633 2 21 23 DAC38-B12 23-CG32572-RA_4 CG32572 ACATTGTAGGCCACAAAGTGAACTAATTATTGCAACATCCTGCGATTCTTATCTCTACTGCCAATCTTT 69 FBan0032572 FBgn0052572 CG32572 X X CG32572 CG32572 "CG13006, CG13007" CDMC20633 2 22 23 DAC38-B12 23-CG32572-RA_4 CG32572 ACATTGTAGGCCACAAAGTGAACTAATTATTGCAACATCCTGCGATTCTTATCTCTACTGCCAATCTTT 69 FBan0032572 FBgn0052572 CG32572 X X CG32572 CG32572 "CG13006, CG13007" CDMC20634 2 23 23 DAC38-B24 1-CG32581-RA_1 CG32581 CGCGTCCCAATCGCAAACTCTGTCCCGTTTGTAAGGCTGCCGTTGATAAGGATAAGGTCATACCGCTGT 69 FBan0032581 FBgn0052581 CG32581 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; protein ubiquitination; GO:0016567; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG32581 CG32581 CDMC20634 2 24 23 DAC38-B24 1-CG32581-RA_1 CG32581 CGCGTCCCAATCGCAAACTCTGTCCCGTTTGTAAGGCTGCCGTTGATAAGGATAAGGTCATACCGCTGT 69 FBan0032581 FBgn0052581 CG32581 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; protein ubiquitination; GO:0016567; transcription from RNA polymerase II promoter; GO:0006366" transcription regulator activity; GO:0030528; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG32581 CG32581 CDMC20635 2 25 23 DAC38-F12 1-CG32606-RA_1 CG32606 GCGGGGGATGACAATTTGCTGTTGCTTTGGCCGTTGCTGACTCAAAACAGTTGCAAAGTTGTTGCTGAA 69 FBan0032606 FBgn0052606 CG32606 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32606 CG32606 CDMC20635 2 26 23 DAC38-F12 1-CG32606-RA_1 CG32606 GCGGGGGATGACAATTTGCTGTTGCTTTGGCCGTTGCTGACTCAAAACAGTTGCAAAGTTGTTGCTGAA 69 FBan0032606 FBgn0052606 CG32606 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32606 CG32606 CDMC20636 2 1 24 DAC38-F24 23-CG32631-RA_1 CG32631 ATTTAAAAAATACAATTGAGCAACCAAACATGGCCAACATTCTAAGTTTTACCATCTTTATGGCTGCCA 69 FBan0032631 FBgn0052631 CG32631 X X CG32631 CG32631 "CG1733, CG1733, CG1733" CDMC20636 2 2 24 DAC38-F24 23-CG32631-RA_1 CG32631 ATTTAAAAAATACAATTGAGCAACCAAACATGGCCAACATTCTAAGTTTTACCATCTTTATGGCTGCCA 69 FBan0032631 FBgn0052631 CG32631 X X CG32631 CG32631 "CG1733, CG1733, CG1733" CDMC20637 2 3 24 DAC38-J12 23-CG32654-RC_7 CG32654 GCAGGGGAAAAGTTGGTCCTACGATATTTTCAAGATTCTACAGTTTGTTCAACTTCTGTCTGTCTGTGC 69 FBan0032654 FBgn0052654 CG32654 X X CG32654 CG32654 "CG18079, CG2551, BcDNA:RE70141" CDMC20637 2 4 24 DAC38-J12 23-CG32654-RC_7 CG32654 GCAGGGGAAAAGTTGGTCCTACGATATTTTCAAGATTCTACAGTTTGTTCAACTTCTGTCTGTCTGTGC 69 FBan0032654 FBgn0052654 CG32654 X X CG32654 CG32654 "CG18079, CG2551, BcDNA:RE70141" CDMC20638 2 5 24 DAC38-J24 22-CG32670-RA_1 CG32670 TCAACATGTTGTCAGTTGGCATATACAATCGTCTTGTGATTCATACCCCAAATCGCTTGTCAGGTGGGC 69 FBan0032670 FBgn0052670 CG32670 X X endocytosis; GO:0006897; intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG32670 CG32670 "CG2532, CG2532, CG2532, DmRabX3" CDMC20638 2 6 24 DAC38-J24 22-CG32670-RA_1 CG32670 TCAACATGTTGTCAGTTGGCATATACAATCGTCTTGTGATTCATACCCCAAATCGCTTGTCAGGTGGGC 69 FBan0032670 FBgn0052670 CG32670 X X endocytosis; GO:0006897; intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG32670 CG32670 "CG2532, CG2532, CG2532, DmRabX3" CDMC20639 2 7 24 DAC38-N12 9-CG32700-RB_1 CG32700 ACGGATGAATTCGGTTGGACACTGGGCAATACAAACAACCAAATGCCTGGAAACTCCGAACCAACTCGA 69 FBan0032700 FBgn0052700 CG32700 X X metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG32700 CG32700 "CG12651, CG12652, CG2994, CG18429, CG12651, CG12652, CG2994, CG2994, BcDNA:GH19985" CDMC20639 2 8 24 DAC38-N12 9-CG32700-RB_1 CG32700 ACGGATGAATTCGGTTGGACACTGGGCAATACAAACAACCAAATGCCTGGAAACTCCGAACCAACTCGA 69 FBan0032700 FBgn0052700 CG32700 X X metabolism; GO:0008152 oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG32700 CG32700 "CG12651, CG12652, CG2994, CG18429, CG12651, CG12652, CG2994, CG2994, BcDNA:GH19985" CDMC20640 2 9 24 DAC38-N24 1-CG32708-RA_7 CG32708 AGACCACCTTCTTCCAGAACAATCTCGACAAGAGCGAGTTCATCAGGAAGCAGGCGAAGAAGGCCAAGA 69 FBan0032708 FBgn0052708 CG32708 X X CG32708 CG32708 CG6997 CDMC20640 2 10 24 DAC38-N24 1-CG32708-RA_7 CG32708 AGACCACCTTCTTCCAGAACAATCTCGACAAGAGCGAGTTCATCAGGAAGCAGGCGAAGAAGGCCAAGA 69 FBan0032708 FBgn0052708 CG32708 X X CG32708 CG32708 CG6997 CDMC20641 2 11 24 DAC39-B12 1-CG13661-RA_1 CG13661 TGCAACAGCGTCTGACTCTGACCCATGAGGAGTCCCAGAAGAAATACGAAGTGGTCAAGAACTCCCTGC 69 FBan0013661 FBgn0039285 CG13661 3 3R CG13661 CG13661 CDMC20641 2 12 24 DAC39-B12 1-CG13661-RA_1 CG13661 TGCAACAGCGTCTGACTCTGACCCATGAGGAGTCCCAGAAGAAATACGAAGTGGTCAAGAACTCCCTGC 69 FBan0013661 FBgn0039285 CG13661 3 3R CG13661 CG13661 CDMC20642 2 13 24 DAC39-B24 8-CG13676-RA_1 CG13676 GCAGCGGCAATATGCTAGCGCCTATAATCCATTTGCCTATCAGCCAGCGTATCAATCACCAACATCCGC 69 FBan0013676 FBgn0035844 CG13676 3 3L CG13676 CG13676 CDMC20642 2 14 24 DAC39-B24 8-CG13676-RA_1 CG13676 GCAGCGGCAATATGCTAGCGCCTATAATCCATTTGCCTATCAGCCAGCGTATCAATCACCAACATCCGC 69 FBan0013676 FBgn0035844 CG13676 3 3L CG13676 CG13676 CDMC20643 2 15 24 DAC39-F12 14-CG13724-RA_1 CG13724 AGGTTCAGACTATACCCACAGCATTATTGTCCGCCTTGACTACCAAGAAACCACATACGGTGACCACCA 69 FBan0013724 FBgn0036707 CG13724 3 3L CG13724 CG13724 CDMC20643 2 16 24 DAC39-F12 14-CG13724-RA_1 CG13724 AGGTTCAGACTATACCCACAGCATTATTGTCCGCCTTGACTACCAAGAAACCACATACGGTGACCACCA 69 FBan0013724 FBgn0036707 CG13724 3 3L CG13724 CG13724 CDMC20644 2 17 24 DAC39-F24 23-CG1373-RA_2 CG1373 TGTCCATCAAAGGACTCTACCAGGATAACGCGCGTTTAATTATACACACTTATTTATTTACCAGCCATA 69 FBan0001373 FBgn0000279 CecC 3 3R antibacterial humoral response (sensu Protostomia); GO:0006961; defense response to Gram-negative bacteria; GO:0050829; defense response to Gram-positive bacteria; GO:0050830; defense response to bacteria; GO:0042742; defense response to fungi; GO:0050832 extracellular region; GO:0005576 CecC Cecropin C "CG1373, CG1373, CG1373, Cecropin, cecropin, cecropin C, Cec-C, cec, cecC, Cec, BcDNA:RH33561" CDMC20644 2 18 24 DAC39-F24 23-CG1373-RA_2 CG1373 TGTCCATCAAAGGACTCTACCAGGATAACGCGCGTTTAATTATACACACTTATTTATTTACCAGCCATA 69 FBan0001373 FBgn0000279 CecC 3 3R antibacterial humoral response (sensu Protostomia); GO:0006961; defense response to Gram-negative bacteria; GO:0050829; defense response to Gram-positive bacteria; GO:0050830; defense response to bacteria; GO:0042742; defense response to fungi; GO:0050832 extracellular region; GO:0005576 CecC Cecropin C "CG1373, CG1373, CG1373, Cecropin, cecropin, cecropin C, Cec-C, cec, cecC, Cec, BcDNA:RH33561" CDMC20645 2 19 24 DAC39-J12 23-CG13779-RA_3 CG13779 AATAGCGTCAAAAACATTGTTTTATCGCCGTTGGAATTAATAAAAGCACACAAAATGTCTGCCCCAGAT 69 FBan0013779 FBgn0040954 CG13779 2 2L proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.- proteasome complex (sensu Eukaryota); GO:0000502 CG13779 CG13779 BcDNA:RH34416 CDMC20645 2 20 24 DAC39-J12 23-CG13779-RA_3 CG13779 AATAGCGTCAAAAACATTGTTTTATCGCCGTTGGAATTAATAAAAGCACACAAAATGTCTGCCCCAGAT 69 FBan0013779 FBgn0040954 CG13779 2 2L proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.- proteasome complex (sensu Eukaryota); GO:0000502 CG13779 CG13779 BcDNA:RH34416 CDMC20646 2 21 24 DAC39-J24 9-CG13788-RA_2 CG13788 CAGGTGGTCCTGGTCATATTGGCGGTAGTTCTCCTGGATACCGTCCTTCTGACAACTGGCTTAGTTTGC 69 FBan0013788 FBgn0045495 Gr28b 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr28b Gustatory receptor 28b "CG13788, CG13788, CG13788, LU.2, Gustatory receptor LU.2, Gr28A3, 28A3, Gr28A4, GrLU2, Gustatory receptor 28A4, Gr28b.a, Gr28b.b, Gr28b.c, Gr28b.d, Gr28b.e, Gr28be, GRLU.2, Gustatory receptor 28b" CDMC20646 2 22 24 DAC39-J24 9-CG13788-RA_2 CG13788 CAGGTGGTCCTGGTCATATTGGCGGTAGTTCTCCTGGATACCGTCCTTCTGACAACTGGCTTAGTTTGC 69 FBan0013788 FBgn0045495 Gr28b 2 2L sensory perception of taste; GO:0050909 taste receptor activity; GO:0008527; ; GO:0008527; ; GO:0008527 integral to membrane; GO:0016021 Gr28b Gustatory receptor 28b "CG13788, CG13788, CG13788, LU.2, Gustatory receptor LU.2, Gr28A3, 28A3, Gr28A4, GrLU2, Gustatory receptor 28A4, Gr28b.a, Gr28b.b, Gr28b.c, Gr28b.d, Gr28b.e, Gr28be, GRLU.2, Gustatory receptor 28b" CDMC20647 2 23 24 DAC39-N12 3-CG13830-RA_3 CG13830 TTGCAGGACAAAGAGGACAATAACCGGCACAACAACCACATCAATGCCCAGTACACTTTCACGCCCGAG 69 FBan0013830 FBgn0039054 CG13830 3 3R calcium ion binding; GO:0005509; protease inhibitor activity; GO:0030414; cysteine protease inhibitor activity; GO:0004869; ; GO:0005509; ; GO:0004869; ; GO:0030414 CG13830 CG13830 CDMC20647 2 24 24 DAC39-N12 3-CG13830-RA_3 CG13830 TTGCAGGACAAAGAGGACAATAACCGGCACAACAACCACATCAATGCCCAGTACACTTTCACGCCCGAG 69 FBan0013830 FBgn0039054 CG13830 3 3R calcium ion binding; GO:0005509; protease inhibitor activity; GO:0030414; cysteine protease inhibitor activity; GO:0004869; ; GO:0005509; ; GO:0004869; ; GO:0030414 CG13830 CG13830 CDMC20648 2 25 24 DAC39-N24 9-CG13852-RA_1 CG13852 GCCCATCTCAACACGTCCTTCAAGCACTTCATCTTCTTCGTGCAGGAGTTCAATCTGATTGAGCGGCGC 69 FBan0013852 FBgn0038965 mats 3 3R cell cycle; GO:0007049; cytokinesis; GO:0000910; mitosis; GO:0007067 kinase regulator activity; GO:0019207; ; GO:0019207 mats mob as tumor suppressor "CG13852, CG13852, CG13852, CG13852, anon-WO0118547.303, mob as tumor suppressor" CDMC20648 2 26 24 DAC39-N24 9-CG13852-RA_1 CG13852 GCCCATCTCAACACGTCCTTCAAGCACTTCATCTTCTTCGTGCAGGAGTTCAATCTGATTGAGCGGCGC 69 FBan0013852 FBgn0038965 mats 3 3R cell cycle; GO:0007049; cytokinesis; GO:0000910; mitosis; GO:0007067 kinase regulator activity; GO:0019207; ; GO:0019207 mats mob as tumor suppressor "CG13852, CG13852, CG13852, CG13852, anon-WO0118547.303, mob as tumor suppressor" CDMC20649 2 1 25 DAC40-B12 17-CG14133-RA_1 CG14133 TCAAGAAGGAAATGCAGGGCGTCTATCAGCGCACCAAAGAGTTAAAGAAACGAGCCGCTAACGTG 65 FBan0014133 FBgn0036192 CG14133 3 3L CG14133 CG14133 CDMC20649 2 2 25 DAC40-B12 17-CG14133-RA_1 CG14133 TCAAGAAGGAAATGCAGGGCGTCTATCAGCGCACCAAAGAGTTAAAGAAACGAGCCGCTAACGTG 65 FBan0014133 FBgn0036192 CG14133 3 3L CG14133 CG14133 CDMC20650 2 3 25 DAC40-B24 23-CG14157-RA_3 CG14157 GGCGCCTTTGTCGATGAACACAGCTTTGCAATTGACGAAAGGCATATATAGTTTCAGCATGATGT 65 FBan0014157 FBgn0036080 Or67d 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or67d Or67d "CG14157, CG14157, 67d" CDMC20650 2 4 25 DAC40-B24 23-CG14157-RA_3 CG14157 GGCGCCTTTGTCGATGAACACAGCTTTGCAATTGACGAAAGGCATATATAGTTTCAGCATGATGT 65 FBan0014157 FBgn0036080 Or67d 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or67d Or67d "CG14157, CG14157, 67d" CDMC20651 2 5 25 DAC40-F12 6-CG1422-RA_3 CG1422 TGGTGGCCAAAAGCCTATCACGCTACTCGAGCAGTGCACTAATCTCATGCAGCAGGAACGCTACC 65 FBan0001422 FBgn0040087 p115 X X Golgi organization and biogenesis; GO:0007030; intracellular protein transport; GO:0006886; vesicle docking during exocytosis; GO:0006904 protein transporter activity; GO:0008565; ; GO:0008565 Golgi stack; GO:0005795; endoplasmic reticulum; GO:0005783; membrane; GO:0016020 p115 p115 "CG1422, CG1422, CG1422, CG1422, CG1422, l(1)G0306, dp115" CDMC20651 2 6 25 DAC40-F12 6-CG1422-RA_3 CG1422 TGGTGGCCAAAAGCCTATCACGCTACTCGAGCAGTGCACTAATCTCATGCAGCAGGAACGCTACC 65 FBan0001422 FBgn0040087 p115 X X Golgi organization and biogenesis; GO:0007030; intracellular protein transport; GO:0006886; vesicle docking during exocytosis; GO:0006904 protein transporter activity; GO:0008565; ; GO:0008565 Golgi stack; GO:0005795; endoplasmic reticulum; GO:0005783; membrane; GO:0016020 p115 p115 "CG1422, CG1422, CG1422, CG1422, CG1422, l(1)G0306, dp115" CDMC20652 2 7 25 DAC40-F24 14-CG14249-RB_1 CG14249 CAGCAGGTGACACTGAAGGATGTCCAGTTCGATCTATCCGGCCAATTCTACTGCGAGGTCTCCAC 65 FBan0014249 FBgn0039447 beat-VII 3 3R calcium ion binding; GO:0005509; ; GO:0005509 extracellular region; GO:0005576 beat-VII beat-VII "CG14249, beat VII" CDMC20652 2 8 25 DAC40-F24 14-CG14249-RB_1 CG14249 CAGCAGGTGACACTGAAGGATGTCCAGTTCGATCTATCCGGCCAATTCTACTGCGAGGTCTCCAC 65 FBan0014249 FBgn0039447 beat-VII 3 3R calcium ion binding; GO:0005509; ; GO:0005509 extracellular region; GO:0005576 beat-VII beat-VII "CG14249, beat VII" CDMC20653 2 9 25 DAC40-J12 2-CG14325-RA_1 CG14325 CTGAGGCATGTTCCCCTCGAGAAACTGGTGCTTCGCTTGAATCCCATTCAAAGTGACGGAGCTGC 65 FBan0014325 FBgn0038531 CG14325 3 3R amino acid metabolism; GO:0006520 carboxy-lyase activity; GO:0016831 ; EC:4.1.1.-; ; GO:0016831 ; EC:4.1.1.- CG14325 CG14325 CDMC20653 2 10 25 DAC40-J12 2-CG14325-RA_1 CG14325 CTGAGGCATGTTCCCCTCGAGAAACTGGTGCTTCGCTTGAATCCCATTCAAAGTGACGGAGCTGC 65 FBan0014325 FBgn0038531 CG14325 3 3R amino acid metabolism; GO:0006520 carboxy-lyase activity; GO:0016831 ; EC:4.1.1.-; ; GO:0016831 ; EC:4.1.1.- CG14325 CG14325 CDMC20654 2 11 25 DAC40-J24 23-CG14363-RA_1 CG14363 CGACTGGAGTTCATAATTTAGCGTTTATTTATGAGTTGTCAAGTTGCTTGGTACGTGACTGGTCG 65 FBan0014363 FBgn0038185 CG14363 3 3R CG14363 CG14363 CDMC20654 2 12 25 DAC40-J24 23-CG14363-RA_1 CG14363 CGACTGGAGTTCATAATTTAGCGTTTATTTATGAGTTGTCAAGTTGCTTGGTACGTGACTGGTCG 65 FBan0014363 FBgn0038185 CG14363 3 3R CG14363 CG14363 CDMC20655 2 13 25 DAC40-N12 2-CG14430-RA_1 CG14430 AGTGGTTCGAGCGATACGACATACCGGACATTCAACCCCAAAATTGTTCCAGTGTCCATGGCGCC 65 FBan0014430 FBgn0029927 CG14430 X X CG14430 CG14430 BcDNA:RE28342 CDMC20655 2 14 25 DAC40-N12 2-CG14430-RA_1 CG14430 AGTGGTTCGAGCGATACGACATACCGGACATTCAACCCCAAAATTGTTCCAGTGTCCATGGCGCC 65 FBan0014430 FBgn0029927 CG14430 X X CG14430 CG14430 BcDNA:RE28342 CDMC20656 2 15 25 DAC40-N24 3-CG14462-RA_1 CG14462 TGCCTGTAGTTCCGGTAGCATTTCCCCGGTGCCCATCATACCCATCATCTCCATCAGTCACGATG 65 FBan0014462 FBgn0040523 CG14462 3 3R CG14462 CG14462 CDMC20656 2 16 25 DAC40-N24 3-CG14462-RA_1 CG14462 TGCCTGTAGTTCCGGTAGCATTTCCCCGGTGCCCATCATACCCATCATCTCCATCAGTCACGATG 65 FBan0014462 FBgn0040523 CG14462 3 3R CG14462 CG14462 CDMC20657 2 17 25 DAC41-B12 AutoBlank AutoBlank CDMC20657 2 18 25 DAC41-B12 AutoBlank AutoBlank CDMC20658 2 19 25 DAC41-B24 AutoBlank AutoBlank CDMC20658 2 20 25 DAC41-B24 AutoBlank AutoBlank CDMC20659 2 21 25 DAC41-F12 AutoBlank AutoBlank CDMC20659 2 22 25 DAC41-F12 AutoBlank AutoBlank CDMC20660 2 23 25 DAC41-F24 AutoBlank AutoBlank CDMC20660 2 24 25 DAC41-F24 AutoBlank AutoBlank CDMC20661 2 25 25 DAC41-J12 AutoBlank AutoBlank CDMC20661 2 26 25 DAC41-J12 AutoBlank AutoBlank CDMC20662 2 1 26 DAC41-J24 AutoBlank AutoBlank CDMC20662 2 2 26 DAC41-J24 AutoBlank AutoBlank CDMC20663 2 3 26 DAC41-N12 AutoBlank AutoBlank CDMC20663 2 4 26 DAC41-N12 AutoBlank AutoBlank CDMC20664 2 5 26 DAC41-N24 AutoBlank AutoBlank CDMC20664 2 6 26 DAC41-N24 AutoBlank AutoBlank CDMC20665 2 7 26 DAC42-B12 150mM NaPO4 Blank CDMC20665 2 8 26 DAC42-B12 150mM NaPO4 Blank CDMC20666 2 9 26 DAC42B24 Ambion control 2 Ambion control spot2 CDMC20666 2 10 26 DAC42B24 Ambion control 2 Ambion control spot2 CDMC20667 2 11 26 DAC42F12 Ambion control 4 Ambion control spot4 CDMC20667 2 12 26 DAC42F12 Ambion control 4 Ambion control spot4 CDMC20668 2 13 26 DAC42F24 Ambion control 6 Ambion control spot6 CDMC20668 2 14 26 DAC42F24 Ambion control 6 Ambion control spot6 CDMC20669 2 15 26 DAC42J12 Ambion control 8 Ambion control spot8 CDMC20669 2 16 26 DAC42J12 Ambion control 8 Ambion control spot8 CDMC20670 2 17 26 DAC42-J24 5uM MSP 5uM MSP CDMC20670 2 18 26 DAC42-J24 5uM MSP 5uM MSP CDMC20671 2 19 26 DAC42-N12 10uM MSP 10uM MSP CDMC20671 2 20 26 DAC42-N12 10uM MSP 10uM MSP CDMC20672 2 21 26 DAC42-N24 20uM MSP 20uM MSP CDMC20672 2 22 26 DAC42-N24 20uM MSP 20uM MSP 2 23 26 EMPTY EMPTY 2 24 26 EMPTY EMPTY 2 25 26 EMPTY EMPTY 2 26 26 EMPTY EMPTY CDMC20673 3 1 1 DAC01-C12 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC20673 3 2 1 DAC01-C12 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC20674 3 3 1 DAC01-C24 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC20674 3 4 1 DAC01-C24 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC20675 3 5 1 DAC01-G12 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC20675 3 6 1 DAC01-G12 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC20676 3 7 1 DAC01-G24 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC20676 3 8 1 DAC01-G24 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC20677 3 9 1 DAC01-K12 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC20677 3 10 1 DAC01-K12 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC20678 3 11 1 DAC01-K24 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC20678 3 12 1 DAC01-K24 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC20679 3 13 1 DAC01-O12 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC20679 3 14 1 DAC01-O12 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC20680 3 15 1 DAC01-O24 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC20680 3 16 1 DAC01-O24 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC20681 3 17 1 DAC02-C12 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC20681 3 18 1 DAC02-C12 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC20682 3 19 1 DAC02-C24 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC20682 3 20 1 DAC02-C24 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC20683 3 21 1 DAC02-G12 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC20683 3 22 1 DAC02-G12 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC20684 3 23 1 DAC02-G24 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC20684 3 24 1 DAC02-G24 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC20685 3 25 1 DAC02-K12 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC20685 3 26 1 DAC02-K12 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC20686 3 1 2 DAC02-K24 N/A CG9075 (00240-00478) CDMC20686 3 2 2 DAC02-K24 N/A CG9075 (00240-00478) CDMC20687 3 3 2 DAC02-O12 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC20687 3 4 2 DAC02-O12 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC20688 3 5 2 DAC02-O24 AutoBlank AutoBlank CDMC20688 3 6 2 DAC02-O24 AutoBlank AutoBlank CDMC20689 3 7 2 DAC03-C12 23-CG32230-RA_2 CG32230 CACTTGGAATCGCACATCAAATCCCGAACCATGGCAAGAGTACAAAGAAAAGCAATACAAGTTTTATTC 69 FBan0032230 FBgn0052230 CG32230 3 3L "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG32230 CG32230 "BcDNA:RE56733, BEST:GH04411" CDMC20689 3 8 2 DAC03-C12 23-CG32230-RA_2 CG32230 CACTTGGAATCGCACATCAAATCCCGAACCATGGCAAGAGTACAAAGAAAAGCAATACAAGTTTTATTC 69 FBan0032230 FBgn0052230 CG32230 3 3L "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG32230 CG32230 "BcDNA:RE56733, BEST:GH04411" CDMC20690 3 9 2 DAC03-C24 16-CG32240-RA_1 CG32240 CCGGATGGTATTCGACCCTTTATAGAACACATGGAGCAGCTATATCCACTCAGGCATAACTTGGCCGAT 69 FBan0032240 FBgn0052240 CG32240 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32240 CG32240 "BcDNA:GH04494, BEST:GH04494" CDMC20690 3 10 2 DAC03-C24 16-CG32240-RA_1 CG32240 CCGGATGGTATTCGACCCTTTATAGAACACATGGAGCAGCTATATCCACTCAGGCATAACTTGGCCGAT 69 FBan0032240 FBgn0052240 CG32240 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32240 CG32240 "BcDNA:GH04494, BEST:GH04494" CDMC20691 3 11 2 DAC03-G12 23-CG32264-RA_1 CG32264 GCAGCAATTGTATTTCATGCAGCATAAAATTGTCAACAAATGTTTAAAAGCAAAAAATTAAGCCAGCAA 69 FBan0032264 FBgn0052264 CG32264 3 3L CG32264 CG32264 "CG10860, CG14978, CG10857, CG12604, CG10860, CG14978" CDMC20691 3 12 2 DAC03-G12 23-CG32264-RA_1 CG32264 GCAGCAATTGTATTTCATGCAGCATAAAATTGTCAACAAATGTTTAAAAGCAAAAAATTAAGCCAGCAA 69 FBan0032264 FBgn0052264 CG32264 3 3L CG32264 CG32264 "CG10860, CG14978, CG10857, CG12604, CG10860, CG14978" CDMC20692 3 13 2 DAC03-G24 9-CG32277-RA_1 CG32277 GCGTCTACACCCGCCTCAGTAGTCCATCGATTACGTACTGGCTGAAGGACTTTATCGAGCGACATTGCT 69 FBan0032277 FBgn0052277 CG32277 3 3L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG32277 CG32277 "CG11531, CG11531, SP183" CDMC20692 3 14 2 DAC03-G24 9-CG32277-RA_1 CG32277 GCGTCTACACCCGCCTCAGTAGTCCATCGATTACGTACTGGCTGAAGGACTTTATCGAGCGACATTGCT 69 FBan0032277 FBgn0052277 CG32277 3 3L proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG32277 CG32277 "CG11531, CG11531, SP183" CDMC20693 3 15 2 DAC03-K12 1-CG32318-RA_1 CG32318 CCCCAAAAGAAGTCCAACCAAAACATCCAGGTGTATGTGCGCGTCAGACCCCTTAATTCTCGGGAACGT 69 FBan0032318 FBgn0052318 CG32318 3 3L CG32318 CG32318 CR32318 CDMC20693 3 16 2 DAC03-K12 1-CG32318-RA_1 CG32318 CCCCAAAAGAAGTCCAACCAAAACATCCAGGTGTATGTGCGCGTCAGACCCCTTAATTCTCGGGAACGT 69 FBan0032318 FBgn0052318 CG32318 3 3L CG32318 CG32318 CR32318 CDMC20694 3 17 2 DAC03-K24 6-CG32336-RA_1 CG32336 CCCACCACATCCCCTCATCGTCAAAGTACCGCGCATAACACCAGCGAGTTTATTATGTCTGCACTTGGG 69 FBan0032336 FBgn0052336 CG32336 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32336 CG32336 CDMC20694 3 18 2 DAC03-K24 6-CG32336-RA_1 CG32336 CCCACCACATCCCCTCATCGTCAAAGTACCGCGCATAACACCAGCGAGTTTATTATGTCTGCACTTGGG 69 FBan0032336 FBgn0052336 CG32336 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32336 CG32336 CDMC20695 3 19 2 DAC03-O12 23-CG32381-RA_20 CG32381 TTAGCAAGGAATCGAAATTCAAATGGTGCAAATGTGACGAGTGACTAAAAATCGGGGAATTCAGATTCC 69 FBan0032381 FBgn0035756 unc-13-4A 3 3L neurotransmitter secretion; GO:0007269; synaptic vesicle priming; GO:0016082 synaptic vesicle; GO:0008021 unc-13-4A unc-13-4A "CG8608, CG14833, CG32381, CG14831, CG14832, CG8608, CG14833, dunc-13-4A" CDMC20695 3 20 2 DAC03-O12 23-CG32381-RA_20 CG32381 TTAGCAAGGAATCGAAATTCAAATGGTGCAAATGTGACGAGTGACTAAAAATCGGGGAATTCAGATTCC 69 FBan0032381 FBgn0035756 unc-13-4A 3 3L neurotransmitter secretion; GO:0007269; synaptic vesicle priming; GO:0016082 synaptic vesicle; GO:0008021 unc-13-4A unc-13-4A "CG8608, CG14833, CG32381, CG14831, CG14832, CG8608, CG14833, dunc-13-4A" CDMC20696 3 21 2 DAC03-O24 16-CG32390-RA_2 CG32390 ACGGGTGCGTGGATATCTCGAAATAGCCAATGGTACTCAGGTCCAATCTCCTCATCAGCATAACAACAA 69 FBan0032390 FBgn0052390 CG32390 3 3L CG32390 CG32390 CG8621 CDMC20696 3 22 2 DAC03-O24 16-CG32390-RA_2 CG32390 ACGGGTGCGTGGATATCTCGAAATAGCCAATGGTACTCAGGTCCAATCTCCTCATCAGCATAACAACAA 69 FBan0032390 FBgn0052390 CG32390 3 3L CG32390 CG32390 CG8621 CDMC20697 3 23 2 DAC04-C12 22-CG2957-RA_1 CG2957 TGCCCAAGGACCAGTTGGAACTTTTGCTAGTTGAGAGCATTGCCGATATCGAATACTCCAACTTTACCA 69 FBan0002957 FBgn0037529 mRpS9 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS9 mitochondrial ribosomal protein S9 "CG2957, CG2957, MRP-S9, mitochondrial ribosomal protein S9" CDMC20697 3 24 2 DAC04-C12 22-CG2957-RA_1 CG2957 TGCCCAAGGACCAGTTGGAACTTTTGCTAGTTGAGAGCATTGCCGATATCGAATACTCCAACTTTACCA 69 FBan0002957 FBgn0037529 mRpS9 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS9 mitochondrial ribosomal protein S9 "CG2957, CG2957, MRP-S9, mitochondrial ribosomal protein S9" CDMC20698 3 25 2 DAC04-C24 24-CG2973-RA_2 CG2973 TACGCACTCCTTGTATATTCCTTCATTGTGCTTCATCTATTGCTAGTTTTTTAAAAAATAAATACAAAT 69 FBan0002973 FBgn0031467 CG2973 2 2L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG2973 CG2973 CDMC20698 3 26 2 DAC04-C24 24-CG2973-RA_2 CG2973 TACGCACTCCTTGTATATTCCTTCATTGTGCTTCATCTATTGCTAGTTTTTTAAAAAATAAATACAAAT 69 FBan0002973 FBgn0031467 CG2973 2 2L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG2973 CG2973 CDMC20699 3 1 3 DAC04-G12 8-CG30001-RA_1 CG30001 TGCTGAATCTGCGTTGAAGCTAACCTTGATACTGACAAGCGCTTTGGGGAATCTCTATTCCGGCCTCGT 69 FBan0030001 FBgn0050001 CG30001 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30001 CG30001 CDMC20699 3 2 3 DAC04-G12 8-CG30001-RA_1 CG30001 TGCTGAATCTGCGTTGAAGCTAACCTTGATACTGACAAGCGCTTTGGGGAATCTCTATTCCGGCCTCGT 69 FBan0030001 FBgn0050001 CG30001 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30001 CG30001 CDMC20700 3 3 3 DAC04-G24 23-CG30010-RA_5 CG30010 TCTCCAAGCATATCTTGCCGTTACGTACAATATAACCAAGGTCAATCTCCGGAGCCAAAAATTCGCGAA 69 FBan0030010 FBgn0050010 CG30010 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30010 CG30010 BcDNA:SD18306 CDMC20700 3 4 3 DAC04-G24 23-CG30010-RA_5 CG30010 TCTCCAAGCATATCTTGCCGTTACGTACAATATAACCAAGGTCAATCTCCGGAGCCAAAAATTCGCGAA 69 FBan0030010 FBgn0050010 CG30010 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30010 CG30010 BcDNA:SD18306 CDMC20701 3 5 3 DAC04-K12 14-CG30039-RA_1 CG30039 AGCCGCAACTGATGAAGGAGGTCCTCCATTACCGCAATCACCTGAAAACGTTGAGGAAAATGTGAAAGA 69 FBan0030039 FBgn0050039 CG30039 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30039 CG30039 "BcDNA:AT09538, NEST:bs15e10, NEST:bs25c07" CDMC20701 3 6 3 DAC04-K12 14-CG30039-RA_1 CG30039 AGCCGCAACTGATGAAGGAGGTCCTCCATTACCGCAATCACCTGAAAACGTTGAGGAAAATGTGAAAGA 69 FBan0030039 FBgn0050039 CG30039 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30039 CG30039 "BcDNA:AT09538, NEST:bs15e10, NEST:bs25c07" CDMC20702 3 7 3 DAC04-K24 2-CG30049-RA_1 CG30049 TCCGTCCGCTCAAGGATTACGCCGTAAACCTGACCGGACTAACATCAGTGGATGGATACTGCGATAGGT 69 FBan0030049 FBgn0050049 CG30049 2 2R proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.- cellular component unknown; GO:0008372 CG30049 CG30049 CDMC20702 3 8 3 DAC04-K24 2-CG30049-RA_1 CG30049 TCCGTCCGCTCAAGGATTACGCCGTAAACCTGACCGGACTAACATCAGTGGATGGATACTGCGATAGGT 69 FBan0030049 FBgn0050049 CG30049 2 2R proteolysis; GO:0006508 peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.- cellular component unknown; GO:0008372 CG30049 CG30049 CDMC20703 3 9 3 DAC04-O12 5-CG30079-RA_2 CG30079 CGGCGCATCCGTACCGATTCATTAAGCAGAGCTCCAACGAGACGAACACTTCACTGACGGGCTCTTATA 69 FBan0030079 FBgn0050079 CG30079 2 2R CG30079 CG30079 "CG16805, BcDNA:GH04950" CDMC20703 3 10 3 DAC04-O12 5-CG30079-RA_2 CG30079 CGGCGCATCCGTACCGATTCATTAAGCAGAGCTCCAACGAGACGAACACTTCACTGACGGGCTCTTATA 69 FBan0030079 FBgn0050079 CG30079 2 2R CG30079 CG30079 "CG16805, BcDNA:GH04950" CDMC20704 3 11 3 DAC04-O24 AutoBlank AutoBlank CDMC20704 3 12 3 DAC04-O24 AutoBlank AutoBlank CDMC20705 3 13 3 DAC05-C12 8-CG1856-RA_1 CG1856 AGCCGCCATGTTGAGCCTGCAACAAGACGTAATCATCAAGGATGAGATACAGATCTCTCCGTCGCCCT 68 FBan0001856 FBgn0003870 ttk 3 3R R7 development; GO:0045467; cell fate determination; GO:0001709; chromatin assembly or disassembly; GO:0006333; dorsal appendage formation; GO:0046843; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; peripheral nervous system development; GO:0007422; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; specific RNA polymerase II transcription factor activity; GO:0003704; transcriptional repressor activity; GO:0016564; ; GO:0003676; ; GO:0003704; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0016564; ; GO:0008270; ; GO:0003677; ; GO:0005515 nucleus; GO:0005634; polytene chromosome; GO:0005700 ttk tramtrack "CG11558, CG1856, CG11558, CG1856, CG1856, oss, oversensitive, osn, ttk/FTZ-F2, FTZ-F2, Ttk, E(yan)100D, Enhancer of yan at 100D, schmal, 0037/17, 0250/25, 0438/31, 0702/07, 1049/07, 1119/04, 1184/16, 1209/05, 1209/10, 1260/10, 1281/04, 1325/15, 1372/08, 1396/14, 1418/06, 3540, 5125, 5311, clone 2.9, Ttk69, ftzf2/ttk, tramtrack69, TTK88, ttk69, ttkp69, Tramtrack69, twk, tramtrak, tramtrack-69, anon-EST:Liang-2.9, ftz-f2, l(3)02667, l(3)j2A1, l(3)j7B8, ovs, tramtrack" CDMC20705 3 14 3 DAC05-C12 8-CG1856-RA_1 CG1856 AGCCGCCATGTTGAGCCTGCAACAAGACGTAATCATCAAGGATGAGATACAGATCTCTCCGTCGCCCT 68 FBan0001856 FBgn0003870 ttk 3 3R R7 development; GO:0045467; cell fate determination; GO:0001709; chromatin assembly or disassembly; GO:0006333; dorsal appendage formation; GO:0046843; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; peripheral nervous system development; GO:0007422; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; specific RNA polymerase II transcription factor activity; GO:0003704; transcriptional repressor activity; GO:0016564; ; GO:0003676; ; GO:0003704; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0016564; ; GO:0008270; ; GO:0003677; ; GO:0005515 nucleus; GO:0005634; polytene chromosome; GO:0005700 ttk tramtrack "CG11558, CG1856, CG11558, CG1856, CG1856, oss, oversensitive, osn, ttk/FTZ-F2, FTZ-F2, Ttk, E(yan)100D, Enhancer of yan at 100D, schmal, 0037/17, 0250/25, 0438/31, 0702/07, 1049/07, 1119/04, 1184/16, 1209/05, 1209/10, 1260/10, 1281/04, 1325/15, 1372/08, 1396/14, 1418/06, 3540, 5125, 5311, clone 2.9, Ttk69, ftzf2/ttk, tramtrack69, TTK88, ttk69, ttkp69, Tramtrack69, twk, tramtrak, tramtrack-69, anon-EST:Liang-2.9, ftz-f2, l(3)02667, l(3)j2A1, l(3)j7B8, ovs, tramtrack" CDMC20706 3 15 3 DAC05-C24 5-CG1946-RA_2 CG1946 TGGAACTTGCATTAACATGAGCCTGGACATCGACAATTGGCTATCCCTTTACCCGCACGTTCGACCCA 68 FBan0001946 FBgn0033216 CG1946 2 2R CG1946 CG1946 CDMC20706 3 16 3 DAC05-C24 5-CG1946-RA_2 CG1946 TGGAACTTGCATTAACATGAGCCTGGACATCGACAATTGGCTATCCCTTTACCCGCACGTTCGACCCA 68 FBan0001946 FBgn0033216 CG1946 2 2R CG1946 CG1946 CDMC20707 3 17 3 DAC05-G12 3-CG2816-RA_1 CG2816 GCAGCCCATGATCAGTGGTCGGTGCTTTGGATACGTTGAGAGCTATGCCTACAATCCCATTAAGCGCC 68 FBan0002816 FBgn0031564 CG2816 2 2L serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG2816 CG2816 CDMC20707 3 18 3 DAC05-G12 3-CG2816-RA_1 CG2816 GCAGCCCATGATCAGTGGTCGGTGCTTTGGATACGTTGAGAGCTATGCCTACAATCCCATTAAGCGCC 68 FBan0002816 FBgn0031564 CG2816 2 2L serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG2816 CG2816 CDMC20708 3 19 3 DAC05-G24 3-CG2976-RA_4 CG2976 TGGCCACCAAACACGATGTGATTCGTCGCAAGTACTGGCAGTATGTGGCCAACCATCTGAAGAACCAG 68 FBan0002976 FBgn0031633 CG2976 2 2L protein amino acid prenylation; GO:0018346; protein lipidation; GO:0006497 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; protein farnesyltransferase activity; GO:0004660 ; EC:2.5.1.58; ; GO:0004660 ; EC:2.5.1.58 protein farnesyltransferase complex; GO:0005965 CG2976 CG2976 CDMC20708 3 20 3 DAC05-G24 3-CG2976-RA_4 CG2976 TGGCCACCAAACACGATGTGATTCGTCGCAAGTACTGGCAGTATGTGGCCAACCATCTGAAGAACCAG 68 FBan0002976 FBgn0031633 CG2976 2 2L protein amino acid prenylation; GO:0018346; protein lipidation; GO:0006497 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; ; GO:0008415 ; EC:2.3.1.-; protein farnesyltransferase activity; GO:0004660 ; EC:2.5.1.58; ; GO:0004660 ; EC:2.5.1.58 protein farnesyltransferase complex; GO:0005965 CG2976 CG2976 CDMC20709 3 21 3 DAC05-K12 3-CG3058-RA_1 CG3058 GCCGTGGTCTGGTAGTCTCGCCCAAGGACTACTCTACCAAGTACAGATACTAAGGTGGGTCGCGTACC 68 FBan0003058 FBgn0031601 CG3058 2 2L "chromosome segregation; GO:0007059; electron transport; GO:0006118; mitosis; GO:0007067; nuclear mRNA splicing, via spliceosome; GO:0000398" electron transporter activity; GO:0005489; ; GO:0005489 small nuclear ribonucleoprotein complex; GO:0030532; snRNP U5; GO:0005682 CG3058 CG3058 BcDNA:RE13747 CDMC20709 3 22 3 DAC05-K12 3-CG3058-RA_1 CG3058 GCCGTGGTCTGGTAGTCTCGCCCAAGGACTACTCTACCAAGTACAGATACTAAGGTGGGTCGCGTACC 68 FBan0003058 FBgn0031601 CG3058 2 2L "chromosome segregation; GO:0007059; electron transport; GO:0006118; mitosis; GO:0007067; nuclear mRNA splicing, via spliceosome; GO:0000398" electron transporter activity; GO:0005489; ; GO:0005489 small nuclear ribonucleoprotein complex; GO:0030532; snRNP U5; GO:0005682 CG3058 CG3058 BcDNA:RE13747 CDMC20710 3 23 3 DAC05-K24 3-CG31160-RA_2 CG31160 GCGCCGAGTACCCCAACGAACTGTATATGCCCAACGATTACTCCAAGAGCTTTGCCAACCACATGGAC 68 FBan0031160 FBgn0051160 CG31160 3 3R chromatin assembly or disassembly; GO:0006333; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 protein binding; GO:0005515; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0005515 CG31160 CG31160 "CG13846, CG13851" CDMC20710 3 24 3 DAC05-K24 3-CG31160-RA_2 CG31160 GCGCCGAGTACCCCAACGAACTGTATATGCCCAACGATTACTCCAAGAGCTTTGCCAACCACATGGAC 68 FBan0031160 FBgn0051160 CG31160 3 3R chromatin assembly or disassembly; GO:0006333; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 protein binding; GO:0005515; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0005515 CG31160 CG31160 "CG13846, CG13851" CDMC20711 3 25 3 DAC05-O12 12-CG31561-RA_7 CG31561 GGAAAAGCTTGCCGAACAGGAGGAACTAAACGTTTTGCCAGGAATCAGCGTGGTCAAGGATGAGAACG 68 FBan0031561 FBgn0051561 Osi16 3 3R Osi16 Osiris 16 "CG31561, CG10314, CG31561, Osiris, Osiris 16" CDMC20711 3 26 3 DAC05-O12 12-CG31561-RA_7 CG31561 GGAAAAGCTTGCCGAACAGGAGGAACTAAACGTTTTGCCAGGAATCAGCGTGGTCAAGGATGAGAACG 68 FBan0031561 FBgn0051561 Osi16 3 3R Osi16 Osiris 16 "CG31561, CG10314, CG31561, Osiris, Osiris 16" CDMC20712 3 1 4 DAC05-O24 AutoBlank AutoBlank CDMC20712 3 2 4 DAC05-O24 AutoBlank AutoBlank CDMC20713 3 3 4 DAC06-C12 13-CG5262-RA_1 CG5262 TGTCGCAATATGAATCCTATAGCGTTATCCTACGCCTGTGCTTCCCTTTGCTCGCCATAATTCCGCCTT 69 FBan0005262 FBgn0036988 CG5262 3 3L CG5262 CG5262 anon-WO0118547.347 CDMC20713 3 4 4 DAC06-C12 13-CG5262-RA_1 CG5262 TGTCGCAATATGAATCCTATAGCGTTATCCTACGCCTGTGCTTCCCTTTGCTCGCCATAATTCCGCCTT 69 FBan0005262 FBgn0036988 CG5262 3 3L CG5262 CG5262 anon-WO0118547.347 CDMC20714 3 5 4 DAC06-C24 22-CG5269-RA_2 CG5269 AGATCTACCATCTGCAATCAAAAGTTCCAGCCTACATAAGACTATTGGCACCCAAGGGCTCATTGGAGA 69 FBan0005269 FBgn0026158 vib 3 3R intracellular protein transport; GO:0006886; lipid metabolism; GO:0006629; lipid transport; GO:0006869; vesicle-mediated transport; GO:0016192 phospholipid transporter activity; GO:0005548; ; GO:0005548; carrier activity; GO:0005386; ; GO:0005386; phosphoinositide binding; GO:0035091; ; GO:0005548; ; GO:0035091 intracellular; GO:0005622 vib vibrator "CG5269, anon-WO0142479.3, anon-WO0172774.12, anon-WO0172774.16, anon-WO0172774.28, vibrator" CDMC20714 3 6 4 DAC06-C24 22-CG5269-RA_2 CG5269 AGATCTACCATCTGCAATCAAAAGTTCCAGCCTACATAAGACTATTGGCACCCAAGGGCTCATTGGAGA 69 FBan0005269 FBgn0026158 vib 3 3R intracellular protein transport; GO:0006886; lipid metabolism; GO:0006629; lipid transport; GO:0006869; vesicle-mediated transport; GO:0016192 phospholipid transporter activity; GO:0005548; ; GO:0005548; carrier activity; GO:0005386; ; GO:0005386; phosphoinositide binding; GO:0035091; ; GO:0005548; ; GO:0035091 intracellular; GO:0005622 vib vibrator "CG5269, anon-WO0142479.3, anon-WO0172774.12, anon-WO0172774.16, anon-WO0172774.28, vibrator" CDMC20715 3 7 4 DAC06-G12 2-CG5316-RB_1 CG5316 CCGTGTCATCAACAGCAGAACAGATTCAGGCCTCCAGGATTTAACGCATGTCGGCAACCTTATCCACCC 69 FBan0005316 FBgn0038704 CG5316 3 3R single strand break repair; GO:0000012 damaged DNA binding; GO:0003684; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003684 nucleus; GO:0005634 CG5316 CG5316 CDMC20715 3 8 4 DAC06-G12 2-CG5316-RB_1 CG5316 CCGTGTCATCAACAGCAGAACAGATTCAGGCCTCCAGGATTTAACGCATGTCGGCAACCTTATCCACCC 69 FBan0005316 FBgn0038704 CG5316 3 3R single strand break repair; GO:0000012 damaged DNA binding; GO:0003684; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003684 nucleus; GO:0005634 CG5316 CG5316 CDMC20716 3 9 4 DAC06-G24 1-CG5326-RB_1 CG5326 GAGCTGGAGATCTCGAGATCAGCCTCCTCGTGTGTTCTGTGTGTTCTGATCTGATCGACAACGACGCGT 69 FBan0005326 FBgn0038983 CG5326 3 3R fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG5326 CG5326 CDMC20716 3 10 4 DAC06-G24 1-CG5326-RB_1 CG5326 GAGCTGGAGATCTCGAGATCAGCCTCCTCGTGTGTTCTGTGTGTTCTGATCTGATCGACAACGACGCGT 69 FBan0005326 FBgn0038983 CG5326 3 3R fatty acid metabolism; GO:0006631; lipid metabolism; GO:0006629 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- integral to membrane; GO:0016021 CG5326 CG5326 CDMC20717 3 11 4 DAC06-K12 13-CG5367-RA_1 CG5367 TTCAAGCGAACCGGGAAAATATTGAGCCTGAGTAAGCAACAAATCGTGGACTGCAGTGTGTCCCATGGA 69 FBan0005367 FBgn0032228 CG5367 2 2L proteolysis; GO:0006508 cathepsin L activity; GO:0004217 ; EC:3.4.22.15; ; GO:0004217 ; EC:3.4.22.15 CG5367 CG5367 CDMC20717 3 12 4 DAC06-K12 13-CG5367-RA_1 CG5367 TTCAAGCGAACCGGGAAAATATTGAGCCTGAGTAAGCAACAAATCGTGGACTGCAGTGTGTCCCATGGA 69 FBan0005367 FBgn0032228 CG5367 2 2L proteolysis; GO:0006508 cathepsin L activity; GO:0004217 ; EC:3.4.22.15; ; GO:0004217 ; EC:3.4.22.15 CG5367 CG5367 CDMC20718 3 13 4 DAC06-K24 11-CG5378-RA_1 CG5378 TCCGCTTGGGACTGTTTTACCTTGACCACGATCTCATCACTCGCAACATCGACAAGGCCAAGTATCTGA 69 FBan0005378 FBgn0028688 Rpn7 3 3R cellular physiological process; GO:0050875; proteolysis; GO:0006508 endopeptidase activity; GO:0004175; ; GO:0004175 "proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, lid subcomplex (sensu Eukaryota); GO:0008541" Rpn7 Rpn7 "CG5378, p42A, anon-WO0172774.103, anon-WO0172774.106" CDMC20718 3 14 4 DAC06-K24 11-CG5378-RA_1 CG5378 TCCGCTTGGGACTGTTTTACCTTGACCACGATCTCATCACTCGCAACATCGACAAGGCCAAGTATCTGA 69 FBan0005378 FBgn0028688 Rpn7 3 3R cellular physiological process; GO:0050875; proteolysis; GO:0006508 endopeptidase activity; GO:0004175; ; GO:0004175 "proteasome regulatory particle (sensu Eukaryota); GO:0005838; proteasome regulatory particle, lid subcomplex (sensu Eukaryota); GO:0008541" Rpn7 Rpn7 "CG5378, p42A, anon-WO0172774.103, anon-WO0172774.106" CDMC20719 3 15 4 DAC06-O12 24-CG5408-RA_4 CG5408 TACAATACATTTAACATTTTAATTTTTTTGCAAACTGTTGATCTTATCAAAGGACAGTCGCCCTGATTT 69 FBan0005408 FBgn0028978 trbl 3 3L gastrulation; GO:0007369; negative regulation of mitosis; GO:0045839; protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074; signal transduction; GO:0007165; ventral furrow formation; GO:0007370 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; NOT protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; ; GO:0004674 trbl tribbles "CG5408, CG5408, CG5408, CG5408, CG5408, tribbles" CDMC20719 3 16 4 DAC06-O12 24-CG5408-RA_4 CG5408 TACAATACATTTAACATTTTAATTTTTTTGCAAACTGTTGATCTTATCAAAGGACAGTCGCCCTGATTT 69 FBan0005408 FBgn0028978 trbl 3 3L gastrulation; GO:0007369; negative regulation of mitosis; GO:0045839; protein amino acid phosphorylation; GO:0006468; regulation of progression through cell cycle; GO:0000074; signal transduction; GO:0007165; ventral furrow formation; GO:0007370 ATP binding; GO:0005524; ; GO:0005524; protein serine/threonine kinase activity; GO:0004674; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; NOT protein serine/threonine kinase activity; GO:0004674; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004674; ; GO:0004674 trbl tribbles "CG5408, CG5408, CG5408, CG5408, CG5408, tribbles" CDMC20720 3 17 4 DAC06-O24 23-CG5424-RA_5 CG5424 TTTTTTTTCGCCAAAACGAATATTGTTATTCCTAGTGGGCAGTACAGTATCTCAAGGCGAATCAAACGT 69 FBan0005424 FBgn0000630 f X X actin filament bundle formation; GO:0051017; antennal morphogenesis; GO:0007469; bristle morphogenesis; GO:0008407 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779 f forked "CG5424, CG5424, X1, forked" CDMC20720 3 18 4 DAC06-O24 23-CG5424-RA_5 CG5424 TTTTTTTTCGCCAAAACGAATATTGTTATTCCTAGTGGGCAGTACAGTATCTCAAGGCGAATCAAACGT 69 FBan0005424 FBgn0000630 f X X actin filament bundle formation; GO:0051017; antennal morphogenesis; GO:0007469; bristle morphogenesis; GO:0008407 actin binding; GO:0003779; ; GO:0003779; ; GO:0003779 f forked "CG5424, CG5424, X1, forked" CDMC20721 3 19 4 DAC07-C12 3-CG9826-RB_1 CG9826 TACGGTGGCGAACGTTATTCCCATCCTCACACCACTGATTGCGGGTGAGATCGTGGCTGATAAGG 65 FBan0009826 FBgn0034784 CG9826 2 2R cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316 integral to membrane; GO:0016021 CG9826 CG9826 CDMC20721 3 20 4 DAC07-C12 3-CG9826-RB_1 CG9826 TACGGTGGCGAACGTTATTCCCATCCTCACACCACTGATTGCGGGTGAGATCGTGGCTGATAAGG 65 FBan0009826 FBgn0034784 CG9826 2 2R cation transport; GO:0006812; extracellular transport; GO:0006858; phosphate metabolism; GO:0006796; phosphate transport; GO:0006817 high affinity inorganic phosphate:sodium symporter activity; GO:0005316; ; GO:0005316 integral to membrane; GO:0016021 CG9826 CG9826 CDMC20722 3 21 4 DAC07-C24 3-CG9871-RA_3 CG9871 GTTGGTCTCGAAGGCGAAGAAAGGCCAGAATGCTTCACGCAAGAACTTGATGCAAGTGCCGGAAC 65 FBan0009871 FBgn0034837 CG9871 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 CG9871 CG9871 CDMC20722 3 22 4 DAC07-C24 3-CG9871-RA_3 CG9871 GTTGGTCTCGAAGGCGAAGAAAGGCCAGAATGCTTCACGCAAGAACTTGATGCAAGTGCCGGAAC 65 FBan0009871 FBgn0034837 CG9871 2 2R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 CG9871 CG9871 CDMC20723 3 23 4 DAC07-G12 2-CG9984-RA_1 CG9984 CCATCGACTTGATACGAAACCCCCAGTTTCTGGAGCTACTGGTAGACGCGCTCTTTCGTTCCGGC 65 FBan0009984 FBgn0010416 TH1 X X "negative regulation of transcription from RNA polymerase II promoter, mitotic; GO:0007070" mRNA binding; GO:0003729; ; GO:0003729 transcriptional repressor complex; GO:0017053 TH1 TH1 "CG9984, CG9984, CG9984, NELF-D, NELF" CDMC20723 3 24 4 DAC07-G12 2-CG9984-RA_1 CG9984 CCATCGACTTGATACGAAACCCCCAGTTTCTGGAGCTACTGGTAGACGCGCTCTTTCGTTCCGGC 65 FBan0009984 FBgn0010416 TH1 X X "negative regulation of transcription from RNA polymerase II promoter, mitotic; GO:0007070" mRNA binding; GO:0003729; ; GO:0003729 transcriptional repressor complex; GO:0017053 TH1 TH1 "CG9984, CG9984, CG9984, NELF-D, NELF" CDMC20724 3 25 4 DAC07-G24 20-CR30241-RA_1 CR30241 GTCTAAGGCGCTGGTTTAAGGCACCAGTCTCCTCGGAGGCGTGGGTTCGAATCCCACCGCTGCCA 65 FBan0030241 FBgn0050241 CR30241 2 2R CR30241 CR30241 "AE002787.trna15-LeuAAG, tRNA:L:AAG:AE002787-b" CDMC20724 3 26 4 DAC07-G24 20-CR30241-RA_1 CR30241 GTCTAAGGCGCTGGTTTAAGGCACCAGTCTCCTCGGAGGCGTGGGTTCGAATCCCACCGCTGCCA 65 FBan0030241 FBgn0050241 CR30241 2 2R CR30241 CR30241 "AE002787.trna15-LeuAAG, tRNA:L:AAG:AE002787-b" CDMC20725 3 1 5 DAC07-K12 3-CR32525-RA_1 CR32525 TAGCTCAGTTGGTAGAGCGGTGGACTGTAGATCCATAGGTCGCTGGTTCAAGTCCGGCTCGAAGG 65 FBan0032525 FBgn0052525 CR32525 X X protein biosynthesis; GO:0006412 triplet codon-amino acid adaptor activity; GO:0030533; ; GO:0030533 cytosol; GO:0005829 CR32525 CR32525 "tRNA[Tyr][[1gamma]], AE002620.trna4-TyrGTA, tRNA:Y:GTA:AE002620-b, tRNA:Y1:19F, tRNA:tyr1:19F, transfer RNA:tyr1:19F" CDMC20725 3 2 5 DAC07-K12 3-CR32525-RA_1 CR32525 TAGCTCAGTTGGTAGAGCGGTGGACTGTAGATCCATAGGTCGCTGGTTCAAGTCCGGCTCGAAGG 65 FBan0032525 FBgn0052525 CR32525 X X protein biosynthesis; GO:0006412 triplet codon-amino acid adaptor activity; GO:0030533; ; GO:0030533 cytosol; GO:0005829 CR32525 CR32525 "tRNA[Tyr][[1gamma]], AE002620.trna4-TyrGTA, tRNA:Y:GTA:AE002620-b, tRNA:Y1:19F, tRNA:tyr1:19F, transfer RNA:tyr1:19F" CDMC20726 3 3 5 DAC07-K24 1-CR32868-RA_1 CR32868 TTCCCAGCAGGAAACCTGTGTGATTGCAGGGCGAAAGTACCAGAAATCCTGCTACCAGGTGTTGC 65 FBan0032868 FBgn0046696 RNaseP:RNA 3 3R ribonuclease P activity; GO:0004526 ; EC:3.1.26.5; ; GO:0004526 ; EC:3.1.26.5 ribonuclease P complex; GO:0030677 RNaseP:RNA Ribonuclease P RNA "RNase P RNA, CR32868, Ribonuclease P RNA" CDMC20726 3 4 5 DAC07-K24 1-CR32868-RA_1 CR32868 TTCCCAGCAGGAAACCTGTGTGATTGCAGGGCGAAAGTACCAGAAATCCTGCTACCAGGTGTTGC 65 FBan0032868 FBgn0046696 RNaseP:RNA 3 3R ribonuclease P activity; GO:0004526 ; EC:3.1.26.5; ; GO:0004526 ; EC:3.1.26.5 ribonuclease P complex; GO:0030677 RNaseP:RNA Ribonuclease P RNA "RNase P RNA, CR32868, Ribonuclease P RNA" CDMC20727 3 5 5 DAC07-O12 1-CR33315-RA_2 CR33315 AGTCTGGATCTGTCTGGACCAGTCTGGATCAGCTCGGAGTCACTAGATCAGCATCGGGATGGACC 65 FBan0033315 FBgn0053315 CR33315 2 2L CR33315 CR33315 CDMC20727 3 6 5 DAC07-O12 1-CR33315-RA_2 CR33315 AGTCTGGATCTGTCTGGACCAGTCTGGATCAGCTCGGAGTCACTAGATCAGCATCGGGATGGACC 65 FBan0033315 FBgn0053315 CR33315 2 2L CR33315 CR33315 CDMC20728 3 7 5 DAC07-O24 12-CR7249-RA_1 CR7249 CGCAAGTACCCGGCTCTTAGTTCACTTACACGTCTCGCCTCCGAGGACTATGAGATCCCCTCGCC 65 FBan0007249 FBgn0031726 Cyp6a16Psi 2 2L electron transporter activity; GO:0005489; ; GO:0005489; ; GO:0005489 membrane; GO:0016020 Cyp6a16Psi Cyp6a16Psi "CG7249, Cyp6a16p, 6a16, CR7249, Cyp6a16" CDMC20728 3 8 5 DAC07-O24 12-CR7249-RA_1 CR7249 CGCAAGTACCCGGCTCTTAGTTCACTTACACGTCTCGCCTCCGAGGACTATGAGATCCCCTCGCC 65 FBan0007249 FBgn0031726 Cyp6a16Psi 2 2L electron transporter activity; GO:0005489; ; GO:0005489; ; GO:0005489 membrane; GO:0016020 Cyp6a16Psi Cyp6a16Psi "CG7249, Cyp6a16p, 6a16, CR7249, Cyp6a16" CDMC20729 3 9 5 DAC08-C12 3-CG5623-RA_1 CG5623 AGCGAGGTTATCACTACGAGACCCTGGAACTTGACCAGCAGTGGAAGATCATCGTGTTCCCCTACAGCA 69 FBan0005623 FBgn0038357 CG5623 3 3R CG5623 CG5623 BcDNA:AT10995 CDMC20729 3 10 5 DAC08-C12 3-CG5623-RA_1 CG5623 AGCGAGGTTATCACTACGAGACCCTGGAACTTGACCAGCAGTGGAAGATCATCGTGTTCCCCTACAGCA 69 FBan0005623 FBgn0038357 CG5623 3 3R CG5623 CG5623 BcDNA:AT10995 CDMC20730 3 11 5 DAC08-C24 23-CG5638-RA_16 CG5638 TAATGAGCTTATGTGATGTTTAGACAGGGGGAGTAGGCGATCAGAGCAGGGAATGGATTAGTTAGCCTA 69 FBan0005638 FBgn0036260 Rh7 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; visual perception; GO:0007601 G-protein coupled photoreceptor activity; GO:0008020; ; GO:0008020 integral to membrane; GO:0016021 Rh7 Rhodopsin 7 "CG5638, CG5638, CG5638, Rh, DMELRH7, rh7, rhodopsin, Rhodopsin, anon-WO0170980.34, anon-WO0170980.35, Rhodopsin 7" CDMC20730 3 12 5 DAC08-C24 23-CG5638-RA_16 CG5638 TAATGAGCTTATGTGATGTTTAGACAGGGGGAGTAGGCGATCAGAGCAGGGAATGGATTAGTTAGCCTA 69 FBan0005638 FBgn0036260 Rh7 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; visual perception; GO:0007601 G-protein coupled photoreceptor activity; GO:0008020; ; GO:0008020 integral to membrane; GO:0016021 Rh7 Rhodopsin 7 "CG5638, CG5638, CG5638, Rh, DMELRH7, rh7, rhodopsin, Rhodopsin, anon-WO0170980.34, anon-WO0170980.35, Rhodopsin 7" CDMC20731 3 13 5 DAC08-G12 9-CG5671-RA_3 CG5671 GCCGACGAGGCATTAGCGTGGTATGATGAGAAGCGTACAAAGGACCGAAAAGGTGTGACAATCCCATCT 69 FBan0005671 FBgn0026379 Pten 2 2L actin filament organization; GO:0007015; apoptosis; GO:0006915; autophagy; GO:0006914; cell adhesion; GO:0007155; cell proliferation; GO:0008283; cellular physiological process; GO:0050875; cytoskeleton organization and biogenesis; GO:0007010; insulin receptor signaling pathway; GO:0008286; negative regulation of body size; GO:0040015; negative regulation of cell growth; GO:0030308; negative regulation of cell size; GO:0045792; negative regulation of growth; GO:0045926; negative regulation of insulin receptor signaling pathway; GO:0046627; negative regulation of organ size; GO:0046621; negative regulation of progression through cell cycle; GO:0045786; organ morphogenesis; GO:0009887; phosphoinositide dephosphorylation; GO:0046856; protein amino acid dephosphorylation; GO:0006470; regulation of body size; GO:0040014; regulation of cell shape; GO:0008360; regulation of cell size; GO:0008361; regulation of organ size; GO:0046620; response to starvation; GO:0042594; tissue development; GO:0009888; tracheal epithelial cell fate determination (sensu Insecta); GO:0007425 "actin binding; GO:0003779; ; GO:0003779; protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.-; non-membrane spanning protein tyrosine phosphatase activity; GO:0004726; protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity; GO:0016314 ; EC:3.1.3.67; ; GO:0016314 ; EC:3.1.3.67; phosphoprotein phosphatase activity; GO:0004721 ; EC:3.1.3.16; ; GO:0004721 ; EC:3.1.3.16; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004721 ; EC:3.1.3.16; ; GO:0004725 ; EC:3.1.3.48; ; GO:0008138 ; EC:3.1.3.-; ; GO:0004726; ; GO:0004867; ; GO:0016314 ; EC:3.1.3.67" Pten Pten "CG5671, CG5671, CG5671, DPTEN, dPTEN, PTEN, PTEN3, pten" CDMC20731 3 14 5 DAC08-G12 9-CG5671-RA_3 CG5671 GCCGACGAGGCATTAGCGTGGTATGATGAGAAGCGTACAAAGGACCGAAAAGGTGTGACAATCCCATCT 69 FBan0005671 FBgn0026379 Pten 2 2L actin filament organization; GO:0007015; apoptosis; GO:0006915; autophagy; GO:0006914; cell adhesion; GO:0007155; cell proliferation; GO:0008283; cellular physiological process; GO:0050875; cytoskeleton organization and biogenesis; GO:0007010; insulin receptor signaling pathway; GO:0008286; negative regulation of body size; GO:0040015; negative regulation of cell growth; GO:0030308; negative regulation of cell size; GO:0045792; negative regulation of growth; GO:0045926; negative regulation of insulin receptor signaling pathway; GO:0046627; negative regulation of organ size; GO:0046621; negative regulation of progression through cell cycle; GO:0045786; organ morphogenesis; GO:0009887; phosphoinositide dephosphorylation; GO:0046856; protein amino acid dephosphorylation; GO:0006470; regulation of body size; GO:0040014; regulation of cell shape; GO:0008360; regulation of cell size; GO:0008361; regulation of organ size; GO:0046620; response to starvation; GO:0042594; tissue development; GO:0009888; tracheal epithelial cell fate determination (sensu Insecta); GO:0007425 "actin binding; GO:0003779; ; GO:0003779; protein tyrosine/serine/threonine phosphatase activity; GO:0008138 ; EC:3.1.3.-; ; GO:0008138 ; EC:3.1.3.-; non-membrane spanning protein tyrosine phosphatase activity; GO:0004726; protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity; GO:0016314 ; EC:3.1.3.67; ; GO:0016314 ; EC:3.1.3.67; phosphoprotein phosphatase activity; GO:0004721 ; EC:3.1.3.16; ; GO:0004721 ; EC:3.1.3.16; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004721 ; EC:3.1.3.16; ; GO:0004725 ; EC:3.1.3.48; ; GO:0008138 ; EC:3.1.3.-; ; GO:0004726; ; GO:0004867; ; GO:0016314 ; EC:3.1.3.67" Pten Pten "CG5671, CG5671, CG5671, DPTEN, dPTEN, PTEN, PTEN3, pten" CDMC20732 3 15 5 DAC08-G24 23-CG5681-RA_8 CG5681 ACGAGTGGAGGTATGAAAGCTGCACCAGAAAAAATGATGAAACATAATGAATCCTCTGAACGGATGTCC 69 FBan0005681 FBgn0032658 CG5681 2 2L CG5681 CG5681 CDMC20732 3 16 5 DAC08-G24 23-CG5681-RA_8 CG5681 ACGAGTGGAGGTATGAAAGCTGCACCAGAAAAAATGATGAAACATAATGAATCCTCTGAACGGATGTCC 69 FBan0005681 FBgn0032658 CG5681 2 2L CG5681 CG5681 CDMC20733 3 17 5 DAC08-K12 23-CG5714-RA_4 CG5714 AGGACAAGGAACAAAAGGATATATCTGAGTCGGCCGTTTAAGCGGGATTACAGGAATTAGTATAGTCTT 69 FBgn0035324 CDMC20733 3 18 5 DAC08-K12 23-CG5714-RA_4 CG5714 AGGACAAGGAACAAAAGGATATATCTGAGTCGGCCGTTTAAGCGGGATTACAGGAATTAGTATAGTCTT 69 FBgn0035324 CDMC20734 3 19 5 DAC08-K24 23-CG5723-RB_3 CG5723 CCGAGAGAAGTGCAGAGGGTATAGGCTATAAATTACAAATCGAATGCAGACAACAAAGACAATTGTACA 69 FBan0005723 FBgn0004449 Ten-m 3 3L cell adhesion; GO:0007155; regulation of cell shape; GO:0008360 structural molecule activity; GO:0005198; ; GO:0005198 extracellular matrix (sensu Metazoa); GO:0005578; integral to plasma membrane; GO:0005887 Ten-m Tenascin major "CG5723, CG11452, ten[m], Ten[m], odz: odd-Oz, odd(Oz), l(3)00844, l(3)05309, odd Oz, odd-Oz, 2017, 5301, ten-m, ten(m), tenascin major, CT16449, odz/ten-m, Ten-mc, BcDNA:AT25108, Ten79E, l(3)05301, l(3)rJ307, l(3)rL201, l(3)rP126, odz" CDMC20734 3 20 5 DAC08-K24 23-CG5723-RB_3 CG5723 CCGAGAGAAGTGCAGAGGGTATAGGCTATAAATTACAAATCGAATGCAGACAACAAAGACAATTGTACA 69 FBan0005723 FBgn0004449 Ten-m 3 3L cell adhesion; GO:0007155; regulation of cell shape; GO:0008360 structural molecule activity; GO:0005198; ; GO:0005198 extracellular matrix (sensu Metazoa); GO:0005578; integral to plasma membrane; GO:0005887 Ten-m Tenascin major "CG5723, CG11452, ten[m], Ten[m], odz: odd-Oz, odd(Oz), l(3)00844, l(3)05309, odd Oz, odd-Oz, 2017, 5301, ten-m, ten(m), tenascin major, CT16449, odz/ten-m, Ten-mc, BcDNA:AT25108, Ten79E, l(3)05301, l(3)rJ307, l(3)rL201, l(3)rP126, odz" CDMC20735 3 21 5 DAC08-O12 2-CG5758-RB_1 CG5758 ACGCGGCGTAAAAATGCTGCTGAACCACTTCGTTAAGGGACGACTGTATAACCGTGATCTGCGCGACAA 69 FBan0005758 FBgn0032666 CG5758 2 2L CG5758 CG5758 CDMC20735 3 22 5 DAC08-O12 2-CG5758-RB_1 CG5758 ACGCGGCGTAAAAATGCTGCTGAACCACTTCGTTAAGGGACGACTGTATAACCGTGATCTGCGCGACAA 69 FBan0005758 FBgn0032666 CG5758 2 2L CG5758 CG5758 CDMC20736 3 23 5 DAC08-O24 10-CG5772-RA_1 CG5772 GGATGTGCATTTGTTCAACGCGACCATACGTGAAAATCTCGATCCACACGGTTACTTCCAGGACCTGCA 69 FBan0005772 FBgn0028675 Sur 2 2L defense response; GO:0006952; extracellular transport; GO:0006858; heart development; GO:0007507; response to toxin; GO:0009636 "ATP binding; GO:0005524; ; GO:0005524; sulfonylurea receptor activity; GO:0008281; ; GO:0008281; transporter activity; GO:0005215; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0005215; ATPase activity; GO:0016887; nucleotide binding; GO:0000166; ; GO:0008281; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15; ; GO:0016887; ; GO:0042626" ATP-sensitive potassium channel complex; GO:0008282 Sur Sulfonylurea receptor "CG5772, CG5772, CK00325, Dsur, SUR, sulfonyl urea receptor, sur, dSUR, BEST:CK00325, Sulfonylurea receptor" CDMC20736 3 24 5 DAC08-O24 10-CG5772-RA_1 CG5772 GGATGTGCATTTGTTCAACGCGACCATACGTGAAAATCTCGATCCACACGGTTACTTCCAGGACCTGCA 69 FBan0005772 FBgn0028675 Sur 2 2L defense response; GO:0006952; extracellular transport; GO:0006858; heart development; GO:0007507; response to toxin; GO:0009636 "ATP binding; GO:0005524; ; GO:0005524; sulfonylurea receptor activity; GO:0008281; ; GO:0008281; transporter activity; GO:0005215; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; ; GO:0005215; ATPase activity; GO:0016887; nucleotide binding; GO:0000166; ; GO:0008281; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0000166; ; GO:0017111 ; EC:3.6.1.15; ; GO:0016887; ; GO:0042626" ATP-sensitive potassium channel complex; GO:0008282 Sur Sulfonylurea receptor "CG5772, CG5772, CK00325, Dsur, SUR, sulfonyl urea receptor, sur, dSUR, BEST:CK00325, Sulfonylurea receptor" CDMC20737 3 25 5 DAC09-C13 2-CG31671-RA_4 CG31671 GCCACCAGATCCGATAAGTTGTCACCCACCTCTCCATCTGGGAATACACAAGGAACAAGGGCTCCAG 67 FBgn0051671 CDMC20737 3 26 5 DAC09-C13 2-CG31671-RA_4 CG31671 GCCACCAGATCCGATAAGTTGTCACCCACCTCTCCATCTGGGAATACACAAGGAACAAGGGCTCCAG 67 FBgn0051671 CDMC20738 3 1 6 DAC09-D01 24-CG31842-RA_1 CG31842 TTAAAAAACACATTTAATTAATTAAAACTTTACCAAAATGGCACAAAGTAGGCTTGAAAAGATTGGC 67 FBan0031842 FBgn0051842 mRpS23 2 2L structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial ribosome; GO:0005761 mRpS23 mRpS23 CG31842 CDMC20738 3 2 6 DAC09-D01 24-CG31842-RA_1 CG31842 TTAAAAAACACATTTAATTAATTAAAACTTTACCAAAATGGCACAAAGTAGGCTTGAAAAGATTGGC 67 FBan0031842 FBgn0051842 mRpS23 2 2L structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial ribosome; GO:0005761 mRpS23 mRpS23 CG31842 CDMC20739 3 3 6 DAC09-G13 2-CG32283-RA_1 CG32283 CCTAATGGAGGCCAACACTGTTTTGGCACGTGATTGCCTATCTGGAACTTTCGGAGGTCCTTGCTGG 67 FBan0032283 FBgn0052283 dro3 3 3L defense response; GO:0006952 dro3 drosomycin-3 "CG10813, CG32283, CG10813, CG10813, CT30310, Dro-3, drosomycin-E" CDMC20739 3 4 6 DAC09-G13 2-CG32283-RA_1 CG32283 CCTAATGGAGGCCAACACTGTTTTGGCACGTGATTGCCTATCTGGAACTTTCGGAGGTCCTTGCTGG 67 FBan0032283 FBgn0052283 dro3 3 3L defense response; GO:0006952 dro3 drosomycin-3 "CG10813, CG32283, CG10813, CG10813, CT30310, Dro-3, drosomycin-E" CDMC20740 3 5 6 DAC09-H01 3-CG32491-RD_3 CG32491 CCTGTGGCTCGATGGGATGAAGTTCTTCCGCAACAACATAAACCGCACGAATTTGTACTGGCGCTGC 67 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC20740 3 6 6 DAC09-H01 3-CG32491-RD_3 CG32491 CCTGTGGCTCGATGGGATGAAGTTCTTCCGCAACAACATAAACCGCACGAATTTGTACTGGCGCTGC 67 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC20741 3 7 6 DAC09-K13 11-CG33087-RC_2 CG33087 GCAATGCGAGCACTGTAGGAATCTAACCTGTGAAAATGGCGGTATTTGCAGGGAAACGCTAACGGGC 67 FBan0033087 FBgn0053087 CG33087 2 2R cholesterol metabolism; GO:0008203; intracellular protein transport; GO:0006886; receptor mediated endocytosis; GO:0006898 ATP binding; GO:0005524; ; GO:0005524; calcium ion binding; GO:0005509; ; GO:0005509; ATPase activity; GO:0016887; low-density lipoprotein receptor activity; GO:0005041; ; GO:0005041; ; GO:0016887 membrane; GO:0016020 CG33087 CG33087 "CG8706, CG30368, CG8706, CG8706, CT9297, LDLR-like" CDMC20741 3 8 6 DAC09-K13 11-CG33087-RC_2 CG33087 GCAATGCGAGCACTGTAGGAATCTAACCTGTGAAAATGGCGGTATTTGCAGGGAAACGCTAACGGGC 67 FBan0033087 FBgn0053087 CG33087 2 2R cholesterol metabolism; GO:0008203; intracellular protein transport; GO:0006886; receptor mediated endocytosis; GO:0006898 ATP binding; GO:0005524; ; GO:0005524; calcium ion binding; GO:0005509; ; GO:0005509; ATPase activity; GO:0016887; low-density lipoprotein receptor activity; GO:0005041; ; GO:0005041; ; GO:0016887 membrane; GO:0016020 CG33087 CG33087 "CG8706, CG30368, CG8706, CG8706, CT9297, LDLR-like" CDMC20742 3 9 6 DAC09-L01 14-CG33269-RA_1 CG33269 GCGGAAGTGCAAGAACCCAAAGAGGTGCCACAAGACCATCGTGATTGTGACCCACAGGAAAAATTAA 67 FBan0033269 FBgn0053269 CG33269 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33269 CG33269 "CG14139, CG6100, CG32084, CG14139, CG6100, CG32084" CDMC20742 3 10 6 DAC09-L01 14-CG33269-RA_1 CG33269 GCGGAAGTGCAAGAACCCAAAGAGGTGCCACAAGACCATCGTGATTGTGACCCACAGGAAAAATTAA 67 FBan0033269 FBgn0053269 CG33269 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33269 CG33269 "CG14139, CG6100, CG32084, CG14139, CG6100, CG32084" CDMC20743 3 11 6 DAC09-O13 14-CG3600-RA_1 CG3600 CCAACAAGCTGACCATTATCAAGACGCCGTTGAACAAGACTCTGCTGAAGAAGTGCAACAGCAACGG 67 FBan0003600 FBgn0026087 CG3600 X X CG3600 CG3600 EG:BACH61I5.1 CDMC20743 3 12 6 DAC09-O13 14-CG3600-RA_1 CG3600 CCAACAAGCTGACCATTATCAAGACGCCGTTGAACAAGACTCTGCTGAAGAAGTGCAACAGCAACGG 67 FBan0003600 FBgn0026087 CG3600 X X CG3600 CG3600 EG:BACH61I5.1 CDMC20744 3 13 6 DAC09-P01 AutoBlank AutoBlank CDMC20744 3 14 6 DAC09-P01 AutoBlank AutoBlank CDMC20745 3 15 6 DAC10-C12 18-CG18361-RA_2 CG18361 GCGCAGCAATTACATCAAGCATACGGTCAATAAGTTGACCTTCTCGGAGCAGTGCTACTACGTGGTGAA 69 FBan0018361 FBgn0000499 dsh X X "R3/R4 cell fate commitment; GO:0007464; Wnt receptor signaling pathway; GO:0016055; cell motility; GO:0006928; compound eye morphogenesis (sensu Endopterygota); GO:0001745; dorsal closure; GO:0007391; dorsal closure, elongation of leading edge cells; GO:0007394; ectoderm development; GO:0007398; establishment and/or maintenance of cell polarity; GO:0007163; establishment of body bristle orientation; GO:0048106; establishment of epithelial cell polarity; GO:0045198; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; establishment of planar polarity; GO:0001736; establishment of tissue polarity; GO:0007164; establishment of wing hair orientation; GO:0001737; female gonad development; GO:0008585; filopodium formation; GO:0046847; frizzled signaling pathway; GO:0007222; heart development; GO:0007507; intracellular signaling cascade; GO:0007242; lamellipodium biogenesis; GO:0030032; mesoderm development; GO:0007498; ommatidial rotation; GO:0016318; oogenesis (sensu Insecta); GO:0009993; protein localization; GO:0008104; segment specification; GO:0007379; sensory organ development; GO:0007423; wing hair organization and biogenesis; GO:0035317; wing morphogenesis; GO:0007476" Notch binding; GO:0005112; protein binding; GO:0005515; ; GO:0005112; ; GO:0005515 adherens junction; GO:0005912; cytoplasm; GO:0005737 dsh dishevelled "CG18361, CG1720, l(1)dsh, l(1)10Bd, l(1)G0267, DSH, disshevelled, Dsh, l(1)G17" CDMC20745 3 16 6 DAC10-C12 18-CG18361-RA_2 CG18361 GCGCAGCAATTACATCAAGCATACGGTCAATAAGTTGACCTTCTCGGAGCAGTGCTACTACGTGGTGAA 69 FBan0018361 FBgn0000499 dsh X X "R3/R4 cell fate commitment; GO:0007464; Wnt receptor signaling pathway; GO:0016055; cell motility; GO:0006928; compound eye morphogenesis (sensu Endopterygota); GO:0001745; dorsal closure; GO:0007391; dorsal closure, elongation of leading edge cells; GO:0007394; ectoderm development; GO:0007398; establishment and/or maintenance of cell polarity; GO:0007163; establishment of body bristle orientation; GO:0048106; establishment of epithelial cell polarity; GO:0045198; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; establishment of planar polarity; GO:0001736; establishment of tissue polarity; GO:0007164; establishment of wing hair orientation; GO:0001737; female gonad development; GO:0008585; filopodium formation; GO:0046847; frizzled signaling pathway; GO:0007222; heart development; GO:0007507; intracellular signaling cascade; GO:0007242; lamellipodium biogenesis; GO:0030032; mesoderm development; GO:0007498; ommatidial rotation; GO:0016318; oogenesis (sensu Insecta); GO:0009993; protein localization; GO:0008104; segment specification; GO:0007379; sensory organ development; GO:0007423; wing hair organization and biogenesis; GO:0035317; wing morphogenesis; GO:0007476" Notch binding; GO:0005112; protein binding; GO:0005515; ; GO:0005112; ; GO:0005515 adherens junction; GO:0005912; cytoplasm; GO:0005737 dsh dishevelled "CG18361, CG1720, l(1)dsh, l(1)10Bd, l(1)G0267, DSH, disshevelled, Dsh, l(1)G17" CDMC20746 3 17 6 DAC10-C24 9-CG18375-RA_1 CG18375 CCGCTCGCCACAAAAACTTCACCTTCAAGTCGCTGCAGAAAAAGTTCTGATTGCAATTTGCAGCCAGGA 69 FBan0018375 FBgn0034606 CG18375 2 2R apoptosis; GO:0006915; cell cycle; GO:0007049; regulation of progression through cell cycle; GO:0000074 transcription regulator activity; GO:0030528; transcription cofactor activity; GO:0003712; ; GO:0030528; ; GO:0003712 CG18375 CG18375 CDMC20746 3 18 6 DAC10-C24 9-CG18375-RA_1 CG18375 CCGCTCGCCACAAAAACTTCACCTTCAAGTCGCTGCAGAAAAAGTTCTGATTGCAATTTGCAGCCAGGA 69 FBan0018375 FBgn0034606 CG18375 2 2R apoptosis; GO:0006915; cell cycle; GO:0007049; regulation of progression through cell cycle; GO:0000074 transcription regulator activity; GO:0030528; transcription cofactor activity; GO:0003712; ; GO:0030528; ; GO:0003712 CG18375 CG18375 CDMC20747 3 19 6 DAC10-G12 2-CG18445-RA_1 CG18445 AGTGCGTAAGAGTGTCTGGACAGGAGTACCGGCATGCTCCACATTTGTATATCCTTTCCAAACCGGCCT 69 FBan0018445 FBgn0033476 CG18445 2 2R CG18445 CG18445 O-acyl transferase CDMC20747 3 20 6 DAC10-G12 2-CG18445-RA_1 CG18445 AGTGCGTAAGAGTGTCTGGACAGGAGTACCGGCATGCTCCACATTTGTATATCCTTTCCAAACCGGCCT 69 FBan0018445 FBgn0033476 CG18445 2 2R CG18445 CG18445 O-acyl transferase CDMC20748 3 21 6 DAC10-G24 23-CG18469-RA_3 CG18469 AGGAAGGCGATTCTGACGAGTCTACAGATACAGATGTGAATCGTAATAGAATTGAAGCTACTGATAATG 69 FBan0018469 FBgn0034206 CG18469 2 2R CG18469 CG18469 BcDNA:AT30190 CDMC20748 3 22 6 DAC10-G24 23-CG18469-RA_3 CG18469 AGGAAGGCGATTCTGACGAGTCTACAGATACAGATGTGAATCGTAATAGAATTGAAGCTACTGATAATG 69 FBan0018469 FBgn0034206 CG18469 2 2R CG18469 CG18469 BcDNA:AT30190 CDMC20749 3 23 6 DAC10-K12 10-CG18516-RA_1 CG18516 GCCAACTGCTATGAATTCACCGATAGCAACTTCAAGCTGAGTGGTCATGCTGTTCTTACGGATGCCCCA 69 FBan0018516 FBgn0038350 CG18516 3 3R "defense response; GO:0006952; electron transport; GO:0006118; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; oxygen and reactive oxygen species metabolism; GO:0006800; purine base metabolism; GO:0006144" oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; electron transporter activity; GO:0005489; ; GO:0005489 CG18516 CG18516 DmAO4 CDMC20749 3 24 6 DAC10-K12 10-CG18516-RA_1 CG18516 GCCAACTGCTATGAATTCACCGATAGCAACTTCAAGCTGAGTGGTCATGCTGTTCTTACGGATGCCCCA 69 FBan0018516 FBgn0038350 CG18516 3 3R "defense response; GO:0006952; electron transport; GO:0006118; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; oxygen and reactive oxygen species metabolism; GO:0006800; purine base metabolism; GO:0006144" oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; electron transporter activity; GO:0005489; ; GO:0005489 CG18516 CG18516 DmAO4 CDMC20750 3 25 6 DAC10-K24 16-CG18538-RA_1 CG18538 TGCCGGTTTTTATCTGATTGTGATCAAATGCTATGGACCAGGTCAACCCACATGGAACACTACGTCAGT 69 FBan0018538 FBgn0034324 CG18538 2 2R CG18538 CG18538 CDMC20750 3 26 6 DAC10-K24 16-CG18538-RA_1 CG18538 TGCCGGTTTTTATCTGATTGTGATCAAATGCTATGGACCAGGTCAACCCACATGGAACACTACGTCAGT 69 FBan0018538 FBgn0034324 CG18538 2 2R CG18538 CG18538 CDMC20751 3 1 7 DAC10-O12 3-CG18594-RA_3 CG18594 GCCGGCAACTTCTTCCAGGCCCAATACGATGACTACGTGAAGACCCTCATCGAGACGGTCCAGTAATCT 69 FBan0018594 FBgn0038973 CG18594 3 3R signal transduction; GO:0007165 kinase regulator activity; GO:0019207; kinase inhibitor activity; GO:0019210; ; GO:0019207; ; GO:0019210 CG18594 CG18594 "T2, BcDNA:LP12095" CDMC20751 3 2 7 DAC10-O12 3-CG18594-RA_3 CG18594 GCCGGCAACTTCTTCCAGGCCCAATACGATGACTACGTGAAGACCCTCATCGAGACGGTCCAGTAATCT 69 FBan0018594 FBgn0038973 CG18594 3 3R signal transduction; GO:0007165 kinase regulator activity; GO:0019207; kinase inhibitor activity; GO:0019210; ; GO:0019207; ; GO:0019210 CG18594 CG18594 "T2, BcDNA:LP12095" CDMC20752 3 3 7 DAC10-O24 AutoBlank AutoBlank CDMC20752 3 4 7 DAC10-O24 AutoBlank AutoBlank CDMC20753 3 5 7 DAC11-C12 1-CG10546-RA_1 CG10546 GCGCACTTCCTCACCTACGAGTGCTTGATGGAGGATCAGGAAACACAGATCACTGGGCTAACGCATG 67 FBan0010546 FBgn0035636 Cralbp 3 3L coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 retinal binding; GO:0016918; ; GO:0016918; carrier activity; GO:0005386; ; GO:0005386; ; GO:0016918 intracellular; GO:0005622 Cralbp Cellular retinaldehyde binding protein "CG10546, CG10546, CRALBP, Cellular retinaldehyde binding protein" CDMC20753 3 6 7 DAC11-C12 1-CG10546-RA_1 CG10546 GCGCACTTCCTCACCTACGAGTGCTTGATGGAGGATCAGGAAACACAGATCACTGGGCTAACGCATG 67 FBan0010546 FBgn0035636 Cralbp 3 3L coenzyme metabolism; GO:0006732; prosthetic group metabolism; GO:0051189; transport; GO:0006810 retinal binding; GO:0016918; ; GO:0016918; carrier activity; GO:0005386; ; GO:0005386; ; GO:0016918 intracellular; GO:0005622 Cralbp Cellular retinaldehyde binding protein "CG10546, CG10546, CRALBP, Cellular retinaldehyde binding protein" CDMC20754 3 7 7 DAC11-C24 3-CG10651-RA_1 CG10651 TGTGAGCCAATCCGAGATCAGTGCGCCATAACCCCAAATTACGGTCATGCGGAAGTCAGCTATTCGC 67 FBan0010651 FBgn0032853 CG10651 2 2L defense response; GO:0006952 extracellular region; GO:0005576 CG10651 CG10651 38C.2 CDMC20754 3 8 7 DAC11-C24 3-CG10651-RA_1 CG10651 TGTGAGCCAATCCGAGATCAGTGCGCCATAACCCCAAATTACGGTCATGCGGAAGTCAGCTATTCGC 67 FBan0010651 FBgn0032853 CG10651 2 2L defense response; GO:0006952 extracellular region; GO:0005576 CG10651 CG10651 38C.2 CDMC20755 3 9 7 DAC11-G12 18-CG10962-RB_1 CG10962 ACCAAGGACATCAACAACATACTACAGACGAATCTCATGGGCAGCATTTACTGCACCAAATTGGCCG 67 FBan0010962 FBgn0030073 CG10962 X X metabolism; GO:0008152 "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; GO:0016616 ; EC:1.1.1.-; ; GO:0016616 ; EC:1.1.1.-" CG10962 CG10962 "CG7090, EP(X)1565, EP1565, BcDNA:RE29909" CDMC20755 3 10 7 DAC11-G12 18-CG10962-RB_1 CG10962 ACCAAGGACATCAACAACATACTACAGACGAATCTCATGGGCAGCATTTACTGCACCAAATTGGCCG 67 FBan0010962 FBgn0030073 CG10962 X X metabolism; GO:0008152 "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; GO:0016616 ; EC:1.1.1.-; ; GO:0016616 ; EC:1.1.1.-" CG10962 CG10962 "CG7090, EP(X)1565, EP1565, BcDNA:RE29909" CDMC20756 3 11 7 DAC11-G24 18-CG11105-RA_1 CG11105 TCAATGGCGACGGCTTCATTACGAGGGAGGAAATGACTGACATTGTAACTGCCATATACGAGCTGAT 67 FBan0011105 FBgn0030281 CG11105 X X calcium-mediated signaling; GO:0019722; synaptic transmission; GO:0007268 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005516; ; GO:0005509 CG11105 CG11105 CDMC20756 3 12 7 DAC11-G24 18-CG11105-RA_1 CG11105 TCAATGGCGACGGCTTCATTACGAGGGAGGAAATGACTGACATTGTAACTGCCATATACGAGCTGAT 67 FBan0011105 FBgn0030281 CG11105 X X calcium-mediated signaling; GO:0019722; synaptic transmission; GO:0007268 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005516; ; GO:0005509 CG11105 CG11105 CDMC20757 3 13 7 DAC11-K12 2-CG11404-RA_2 CG11404 CGCCTTTAAGTGGGTCACCATCAGTCAGGGGCTTAACCTTGCCGCATCTACAAATACACTGGGTCGG 67 FBan0011404 FBgn0037169 CG11404 3 3L CG11404 CG11404 BcDNA:GH11730 CDMC20757 3 14 7 DAC11-K12 2-CG11404-RA_2 CG11404 CGCCTTTAAGTGGGTCACCATCAGTCAGGGGCTTAACCTTGCCGCATCTACAAATACACTGGGTCGG 67 FBan0011404 FBgn0037169 CG11404 3 3L CG11404 CG11404 BcDNA:GH11730 CDMC20758 3 15 7 DAC11-K24 3-CG11619-RA_3 CG11619 CCCAAAACACTGGGACTTCTGGTGGAGATAAAGTGGCCGCAAATAATGGCTTCTGGTGTGCCGGAAT 67 FBan0011619 FBgn0036836 CG11619 3 3L CG11619 CG11619 CDMC20758 3 16 7 DAC11-K24 3-CG11619-RA_3 CG11619 CCCAAAACACTGGGACTTCTGGTGGAGATAAAGTGGCCGCAAATAATGGCTTCTGGTGTGCCGGAAT 67 FBan0011619 FBgn0036836 CG11619 3 3L CG11619 CG11619 CDMC20759 3 17 7 DAC11-O12 3-CG12204-RA_1 CG12204 GGTAGCCACAGACCACAGGACAAAAACGGCGCAACTAAATCGGAGGTGTTAGAGCCATTGCCATTGC 67 FBan0012204 FBgn0031022 CG12204 X X CG12204 CG12204 CDMC20759 3 18 7 DAC11-O12 3-CG12204-RA_1 CG12204 GGTAGCCACAGACCACAGGACAAAAACGGCGCAACTAAATCGGAGGTGTTAGAGCCATTGCCATTGC 67 FBan0012204 FBgn0031022 CG12204 X X CG12204 CG12204 CDMC20760 3 19 7 DAC11-O24 AutoBlank AutoBlank CDMC20760 3 20 7 DAC11-O24 AutoBlank AutoBlank CDMC20761 3 21 7 DAC12-C12 2-CG10308-RA_2 CG10308 CACTGGCTCACCGACTATGCCCGGGATATATTTTTGACCATGAGGGAGCAAGAACTCAGCCGTCGG 66 FBan0010308 FBgn0010317 CycJ 3 3L "mitosis; GO:0007067; mitotic cell cycle, embryonic; GO:0045448; regulation of progression through cell cycle; GO:0000074; regulation of transcription, DNA-dependent; GO:0006355" cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; transcription factor activity; GO:0003700; ; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0003700 intracellular; GO:0005622; nucleus; GO:0005634 CycJ Cyclin J "CG10308, CDI5, Cdi5: Cyclin-dependent kinase interactor 5, cycJ, cyclinJ, cdi5, Cyclin-dependent kinase interactor 5, Cdi5" CDMC20761 3 22 7 DAC12-C12 2-CG10308-RA_2 CG10308 CACTGGCTCACCGACTATGCCCGGGATATATTTTTGACCATGAGGGAGCAAGAACTCAGCCGTCGG 66 FBan0010308 FBgn0010317 CycJ 3 3L "mitosis; GO:0007067; mitotic cell cycle, embryonic; GO:0045448; regulation of progression through cell cycle; GO:0000074; regulation of transcription, DNA-dependent; GO:0006355" cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; transcription factor activity; GO:0003700; ; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0003700 intracellular; GO:0005622; nucleus; GO:0005634 CycJ Cyclin J "CG10308, CDI5, Cdi5: Cyclin-dependent kinase interactor 5, cycJ, cyclinJ, cdi5, Cyclin-dependent kinase interactor 5, Cdi5" CDMC20762 3 23 7 DAC12-C24 42-CG10494-RB_4 CG10494 GAAGAGGTTGATTCGTTTCTACTCATCATTCGGGACAATGGTTTCTTTCGCGCCTTGGATGGCTCA 66 FBan0010494 FBgn0034634 CG10494 2 2R CG10494 CG10494 CDMC20762 3 24 7 DAC12-C24 42-CG10494-RB_4 CG10494 GAAGAGGTTGATTCGTTTCTACTCATCATTCGGGACAATGGTTTCTTTCGCGCCTTGGATGGCTCA 66 FBan0010494 FBgn0034634 CG10494 2 2R CG10494 CG10494 CDMC20763 3 25 7 DAC12-G12 17-CG10997-RA_1 CG10997 CCAGGAGTACTTCATGGACCTATATCTACTGGCCGAACTGAAGACGATCAGCCTGAAGGTGACGAC 66 FBan0010997 FBgn0030529 Clic X X determination of adult life span; GO:0008340; response to oxidative stress; GO:0006979 chloride channel activity; GO:0005254; voltage-gated ion channel activity; GO:0005244; ; GO:0005244; ; GO:0005254 Clic Chloride intracellular channel "CG10997, CG10997, CG10997, CG10997, CG10997, CG10997, CG10997, l(1)G0472, l(1)G0053, DCLIC, Chloride intracellular channel" CDMC20763 3 26 7 DAC12-G12 17-CG10997-RA_1 CG10997 CCAGGAGTACTTCATGGACCTATATCTACTGGCCGAACTGAAGACGATCAGCCTGAAGGTGACGAC 66 FBan0010997 FBgn0030529 Clic X X determination of adult life span; GO:0008340; response to oxidative stress; GO:0006979 chloride channel activity; GO:0005254; voltage-gated ion channel activity; GO:0005244; ; GO:0005244; ; GO:0005254 Clic Chloride intracellular channel "CG10997, CG10997, CG10997, CG10997, CG10997, CG10997, CG10997, l(1)G0472, l(1)G0053, DCLIC, Chloride intracellular channel" CDMC20764 3 1 8 DAC12-G24 2-CG11066-RA_1 CG11066 TGACTGGAGTCAAGACCGTCGATGTCCATCCCGATTACGATCCGTCGACAAACTCCCACGACTTGG 66 FBan0011066 FBgn0033033 scarface 2 2R NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.- scarface scarface "CG15900, CG11066, CG15900, CG11066, CG11066, CG11066, SPH142, scarface" CDMC20764 3 2 8 DAC12-G24 2-CG11066-RA_1 CG11066 TGACTGGAGTCAAGACCGTCGATGTCCATCCCGATTACGATCCGTCGACAAACTCCCACGACTTGG 66 FBan0011066 FBgn0033033 scarface 2 2R NOT serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; ; GO:0004252 ; EC:3.4.21.- scarface scarface "CG15900, CG11066, CG15900, CG11066, CG11066, CG11066, SPH142, scarface" CDMC20765 3 3 8 DAC12-K12 1-CG11299-RA_1 CG11299 ACCGAGAGCATCAACACGTTTCGCATCCAGGACTACTCTTGGGAGGATCACGGCTACTCGCTAGTG 66 FBan0011299 FBgn0034897 CG11299 2 2R cell cycle arrest; GO:0007050; regulation of progression through cell cycle; GO:0000074 nucleus; GO:0005634 CG11299 CG11299 "BcDNA:GH20113, BEST:GH20113" CDMC20765 3 4 8 DAC12-K12 1-CG11299-RA_1 CG11299 ACCGAGAGCATCAACACGTTTCGCATCCAGGACTACTCTTGGGAGGATCACGGCTACTCGCTAGTG 66 FBan0011299 FBgn0034897 CG11299 2 2R cell cycle arrest; GO:0007050; regulation of progression through cell cycle; GO:0000074 nucleus; GO:0005634 CG11299 CG11299 "BcDNA:GH20113, BEST:GH20113" CDMC20766 3 5 8 DAC12-K24 2-CG11475-RA_2 CG11475 ACTGACAGCTGGAACTCGTTCCTCAAGGGTCTTGGAGAGGACAGAAGGCAGTGGTTTTCGGCAATT 66 FBan0011475 FBgn0034687 CG11475 2 2R CG11475 CG11475 CDMC20766 3 6 8 DAC12-K24 2-CG11475-RA_2 CG11475 ACTGACAGCTGGAACTCGTTCCTCAAGGGTCTTGGAGAGGACAGAAGGCAGTGGTTTTCGGCAATT 66 FBan0011475 FBgn0034687 CG11475 2 2R CG11475 CG11475 CDMC20767 3 7 8 DAC12-O12 AutoBlank AutoBlank CDMC20767 3 8 8 DAC12-O12 AutoBlank AutoBlank CDMC20768 3 9 8 DAC12-O24 AutoBlank AutoBlank CDMC20768 3 10 8 DAC12-O24 AutoBlank AutoBlank CDMC20769 3 11 8 DAC13-C12 16-CG14556-RA_1 CG14556 CCTTGACTGTGACGGTTAGACTATCCGATGAGTTCCGGAAGTCACAAATGAAACTTGAAGACAGCGCCA 69 FBan0014556 FBgn0039413 CG14556 3 3R CG14556 CG14556 CDMC20769 3 12 8 DAC13-C12 16-CG14556-RA_1 CG14556 CCTTGACTGTGACGGTTAGACTATCCGATGAGTTCCGGAAGTCACAAATGAAACTTGAAGACAGCGCCA 69 FBan0014556 FBgn0039413 CG14556 3 3R CG14556 CG14556 CDMC20770 3 13 8 DAC13-C24 23-CG14568-RA_4 CG14568 GATCAGTTCTGGTGTACACCATCTGAAATGGGTCAACCCTAATTTGCTAGAAATCAAATGGAATCGACT 69 FBan0014568 FBgn0037124 CG14568 3 3L CG14568 CG14568 BcDNA:RE21944 CDMC20770 3 14 8 DAC13-C24 23-CG14568-RA_4 CG14568 GATCAGTTCTGGTGTACACCATCTGAAATGGGTCAACCCTAATTTGCTAGAAATCAAATGGAATCGACT 69 FBan0014568 FBgn0037124 CG14568 3 3L CG14568 CG14568 BcDNA:RE21944 CDMC20771 3 15 8 DAC13-G12 17-CG14610-RA_1 CG14610 TGCCCTCCCATCTGAAGCAGCGTCTATTTTATCGATTAAACAATGCTGATCCCATTTCCATCTGCCTCT 69 FBan0014610 FBgn0037477 CG14610 3 3R CG14610 CG14610 CDMC20771 3 16 8 DAC13-G12 17-CG14610-RA_1 CG14610 TGCCCTCCCATCTGAAGCAGCGTCTATTTTATCGATTAAACAATGCTGATCCCATTTCCATCTGCCTCT 69 FBan0014610 FBgn0037477 CG14610 3 3R CG14610 CG14610 CDMC20772 3 17 8 DAC13-G24 3-CG14620-RA_1 CG14620 CGGAGGAAGCGTTTCACGGAGGAGTAGTGGACATCAGCAACATTTGTGCACCCGAAGATCTTCCCGATT 69 FBgn0031185 CDMC20772 3 18 8 DAC13-G24 3-CG14620-RA_1 CG14620 CGGAGGAAGCGTTTCACGGAGGAGTAGTGGACATCAGCAACATTTGTGCACCCGAAGATCTTCCCGATT 69 FBgn0031185 CDMC20773 3 19 8 DAC13-K12 1-CG14660-RA_1 CG14660 CGCGGATTGGACTGATTGGACTCCAGATACAACACAGGGTGACCGACAGTTCAAAGGTCATGATGGCGA 69 FBgn0037285 CDMC20773 3 20 8 DAC13-K12 1-CG14660-RA_1 CG14660 CGCGGATTGGACTGATTGGACTCCAGATACAACACAGGGTGACCGACAGTTCAAAGGTCATGATGGCGA 69 FBgn0037285 CDMC20774 3 21 8 DAC13-K24 22-CG14669-RA_1 CG14669 GCCGCTCGATGAGAGATCAGATCTTGGACAGTTTCAGTCATCGTGATTTTAGCATAATTGTGGTCGGCA 69 FBan0014669 FBgn0037326 CG14669 3 3R CG14669 CG14669 CDMC20774 3 22 8 DAC13-K24 22-CG14669-RA_1 CG14669 GCCGCTCGATGAGAGATCAGATCTTGGACAGTTTCAGTCATCGTGATTTTAGCATAATTGTGGTCGGCA 69 FBan0014669 FBgn0037326 CG14669 3 3R CG14669 CG14669 CDMC20775 3 23 8 DAC13-O12 14-CG14709-RA_1 CG14709 CGAGGGCATCATTACCATCGATGAAAGGGATACGGCTGACATGGGACTCTTTGATCTACGCAGCAAGAT 69 FBan0014709 FBgn0025701 CG14709 3 3R defense response; GO:0006952; extracellular transport; GO:0006858; multidrug transport; GO:0006855; response to toxin; GO:0009636 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; nucleotide binding; GO:0000166; organic anion transporter activity; GO:0008514; ; GO:0042626; ; GO:0008514; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to membrane; GO:0016021 CG14709 CG14709 "CK01227, BEST:CK01227, BEST:CK02472" CDMC20775 3 24 8 DAC13-O12 14-CG14709-RA_1 CG14709 CGAGGGCATCATTACCATCGATGAAAGGGATACGGCTGACATGGGACTCTTTGATCTACGCAGCAAGAT 69 FBan0014709 FBgn0025701 CG14709 3 3R defense response; GO:0006952; extracellular transport; GO:0006858; multidrug transport; GO:0006855; response to toxin; GO:0009636 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled to transmembrane movement of substances; GO:0042626; nucleotide binding; GO:0000166; organic anion transporter activity; GO:0008514; ; GO:0042626; ; GO:0008514; ; GO:0000166" ATP-binding cassette (ABC) transporter complex; GO:0043190; integral to membrane; GO:0016021 CG14709 CG14709 "CK01227, BEST:CK01227, BEST:CK02472" CDMC20776 3 25 8 DAC13-O24 AutoBlank AutoBlank CDMC20776 3 26 8 DAC13-O24 AutoBlank AutoBlank CDMC20777 3 1 9 DAC14-C12 5-CG17333-RA_1 CG17333 GCCGCAAAAGCCAGTGTCGTCAAGAGTGTGTTTGTCGATCTGGACAAGAAGTTTCCCGCTGCGTG 65 FBan0017333 FBgn0030239 CG17333 X X pentose-phosphate shunt; GO:0006098 6-phosphogluconolactonase activity; GO:0017057 ; EC:3.1.1.31; ; GO:0017057 ; EC:3.1.1.31; ; GO:0017057 ; EC:3.1.1.31 cellular component unknown; GO:0008372 CG17333 CG17333 CDMC20777 3 2 9 DAC14-C12 5-CG17333-RA_1 CG17333 GCCGCAAAAGCCAGTGTCGTCAAGAGTGTGTTTGTCGATCTGGACAAGAAGTTTCCCGCTGCGTG 65 FBan0017333 FBgn0030239 CG17333 X X pentose-phosphate shunt; GO:0006098 6-phosphogluconolactonase activity; GO:0017057 ; EC:3.1.1.31; ; GO:0017057 ; EC:3.1.1.31; ; GO:0017057 ; EC:3.1.1.31 cellular component unknown; GO:0008372 CG17333 CG17333 CDMC20778 3 3 9 DAC14-C24 3-CG17369-RB_1 CG17369 TACCGAGGGCCAGATCTACGTCGATCGTCAGCTGCACAACAGACAGATCTACCCACCAGTCAACG 65 FBan0017369 FBgn0005671 Vha55 3 3R "ATP biosynthesis; GO:0006754; ATP synthesis coupled proton transport; GO:0015986; cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010; energy coupled proton transport, against electrochemical gradient; GO:0015988; proton transport; GO:0015992; purine base metabolism; GO:0006144" "ATP binding; GO:0005524; ; GO:0005524; hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V1 domain; GO:0000221; proton-transporting two-sector ATPase complex; GO:0016469 Vha55 Vacuolar H[+]-ATPase 55kD B subunit "CG17369, CG17369, l(3)SzA, vha55, B subunit, 1208/13, l(3)87Ca, VAT-2, l(3)j2E9, SzA, vacuolar ATPase B subunit, V-ATPase" CDMC20778 3 4 9 DAC14-C24 3-CG17369-RB_1 CG17369 TACCGAGGGCCAGATCTACGTCGATCGTCAGCTGCACAACAGACAGATCTACCCACCAGTCAACG 65 FBan0017369 FBgn0005671 Vha55 3 3R "ATP biosynthesis; GO:0006754; ATP synthesis coupled proton transport; GO:0015986; cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010; energy coupled proton transport, against electrochemical gradient; GO:0015988; proton transport; GO:0015992; purine base metabolism; GO:0006144" "ATP binding; GO:0005524; ; GO:0005524; hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V1 domain; GO:0000221; proton-transporting two-sector ATPase complex; GO:0016469 Vha55 Vacuolar H[+]-ATPase 55kD B subunit "CG17369, CG17369, l(3)SzA, vha55, B subunit, 1208/13, l(3)87Ca, VAT-2, l(3)j2E9, SzA, vacuolar ATPase B subunit, V-ATPase" CDMC20779 3 5 9 DAC14-G12 3-CG17568-RA_3 CG17568 CTTGACAGCTGTGAAGGAGACGACGATTTCCTGCCCGTAGATGGCCAGCTAATGGATCTCGTCGC 65 FBan0017568 FBgn0032763 CG17568 2 2L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG17568 CG17568 CDMC20779 3 6 9 DAC14-G12 3-CG17568-RA_3 CG17568 CTTGACAGCTGTGAAGGAGACGACGATTTCCTGCCCGTAGATGGCCAGCTAATGGATCTCGTCGC 65 FBan0017568 FBgn0032763 CG17568 2 2L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG17568 CG17568 CDMC20780 3 7 9 DAC14-G24 23-CG17626-RA_1 CG17626 CATGACTGCATATTGAACCGAAGAATGTGTCTTACTATATCCGACGTATATCCGATGGATCCACG 65 FBgn0040032 CG17626 CG17626 CG17626 CDMC20780 3 8 9 DAC14-G24 23-CG17626-RA_1 CG17626 CATGACTGCATATTGAACCGAAGAATGTGTCTTACTATATCCGACGTATATCCGATGGATCCACG 65 FBgn0040032 CG17626 CG17626 CG17626 CDMC20781 3 9 9 DAC14-K12 18-CG17738-RA_1 CG17738 CCCTGGAGGAGTCCATCAATCAATCCAATGATCTGTCGTCGGTGGAAAAGGATATTGGCCAGGCT 65 FBan0017738 FBgn0038009 CG17738 3 3R CG17738 CG17738 CDMC20781 3 10 9 DAC14-K12 18-CG17738-RA_1 CG17738 CCCTGGAGGAGTCCATCAATCAATCCAATGATCTGTCGTCGGTGGAAAAGGATATTGGCCAGGCT 65 FBan0017738 FBgn0038009 CG17738 3 3R CG17738 CG17738 CDMC20782 3 11 9 DAC14-K24 8-CG17781-RA_1 CG17781 TAGTGCACCAAGTGGTAATGGTCACTCGAATGTCTCGCACACAGTGGTCATCACACCTGCTCCTG 65 FBan0017781 FBgn0039196 CG17781 3 3R CG17781 CG17781 CDMC20782 3 12 9 DAC14-K24 8-CG17781-RA_1 CG17781 TAGTGCACCAAGTGGTAATGGTCACTCGAATGTCTCGCACACAGTGGTCATCACACCTGCTCCTG 65 FBan0017781 FBgn0039196 CG17781 3 3R CG17781 CG17781 CDMC20783 3 13 9 DAC14-O12 2-CG17957-RA_1 CG17957 ATATGCAGGGATAATCTGGAGCCCGATTCCTCAGTTGCTTCCGAAGCTCAAGTGCCCTCAAGTGC 65 FBan0017957 FBgn0003510 Sry-alpha 3 3R "actin filament organization; GO:0007015; cellularization; GO:0007349; cytokinesis; GO:0000910; cytokinesis, contractile ring formation; GO:0000915; cytoskeleton organization and biogenesis; GO:0007010" actin binding; GO:0003779; ; GO:0003779 cytoplasm; GO:0005737; cytosol; GO:0005829; membrane; GO:0016020; plasma membrane; GO:0005886 Sry-alpha Serendipity alpha "CG17957, CG17957, sry alpha, Sry alpha, Sryalpha, sryalpha, sry-alpha, serendipity-alpha, srya, Sry-alpha, sry, serendipity alpha, serendipity alpha" CDMC20783 3 14 9 DAC14-O12 2-CG17957-RA_1 CG17957 ATATGCAGGGATAATCTGGAGCCCGATTCCTCAGTTGCTTCCGAAGCTCAAGTGCCCTCAAGTGC 65 FBan0017957 FBgn0003510 Sry-alpha 3 3R "actin filament organization; GO:0007015; cellularization; GO:0007349; cytokinesis; GO:0000910; cytokinesis, contractile ring formation; GO:0000915; cytoskeleton organization and biogenesis; GO:0007010" actin binding; GO:0003779; ; GO:0003779 cytoplasm; GO:0005737; cytosol; GO:0005829; membrane; GO:0016020; plasma membrane; GO:0005886 Sry-alpha Serendipity alpha "CG17957, CG17957, sry alpha, Sry alpha, Sryalpha, sryalpha, sry-alpha, serendipity-alpha, srya, Sry-alpha, sry, serendipity alpha, serendipity alpha" CDMC20784 3 15 9 DAC14-O24 AutoBlank AutoBlank CDMC20784 3 16 9 DAC14-O24 AutoBlank AutoBlank CDMC20785 3 17 9 DAC15-C12 13-CG12946-RA_1 CG12946 CCAAAGCCAACAATAGTGCCTCATACGAACTCGACGATTTCCAACGGATCACTGTATGCTGTGTCCCC 68 FBan0012946 FBgn0037750 CG12946 3 3R CG12946 CG12946 CDMC20785 3 18 9 DAC15-C12 13-CG12946-RA_1 CG12946 CCAAAGCCAACAATAGTGCCTCATACGAACTCGACGATTTCCAACGGATCACTGTATGCTGTGTCCCC 68 FBan0012946 FBgn0037750 CG12946 3 3R CG12946 CG12946 CDMC20786 3 19 9 DAC15-C24 2-CG1314-RA_1 CG1314 ATGGCTTGTCCGCTGAGCAATTGCGACTTGATGTTCAATCCTGAGCAGCTCCTAAGTCACTGCCTGAT 68 FBan0001314 FBgn0031134 CG1314 X X CG1314 CG1314 anon-WO0140519.251 CDMC20786 3 20 9 DAC15-C24 2-CG1314-RA_1 CG1314 ATGGCTTGTCCGCTGAGCAATTGCGACTTGATGTTCAATCCTGAGCAGCTCCTAAGTCACTGCCTGAT 68 FBan0001314 FBgn0031134 CG1314 X X CG1314 CG1314 anon-WO0140519.251 CDMC20787 3 21 9 DAC15-G12 6-CG1354-RB_1 CG1354 TACGAGACGGAGACCAAGTGCAAAAGTATGCTGGAGAAGATCGTTGTGACCGGCTACAAGGGACTGCA 68 FBan0001354 FBgn0030151 CG1354 X X "GTP binding; GO:0005525; ; GO:0005525; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; ; GO:0016818 ; EC:3.6.1.-" CG1354 CG1354 CDMC20787 3 22 9 DAC15-G12 6-CG1354-RB_1 CG1354 TACGAGACGGAGACCAAGTGCAAAAGTATGCTGGAGAAGATCGTTGTGACCGGCTACAAGGGACTGCA 68 FBan0001354 FBgn0030151 CG1354 X X "GTP binding; GO:0005525; ; GO:0005525; hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides; GO:0016818 ; EC:3.6.1.-; ; GO:0016818 ; EC:3.6.1.-" CG1354 CG1354 CDMC20788 3 23 9 DAC15-G24 3-CG13702-RB_6 CG13702 CCTGAAGCTCATCACGATGATCCTGTACGCACTGGTCTGCATCATTGGACTCTTTGGCAACACCCTGG 68 FBan0013702 FBgn0036789 AlCR2 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186 neuropeptide receptor activity; GO:0008188; somatostatin receptor activity; GO:0004994; allatostatin receptor activity; GO:0008261; G-protein coupled receptor activity; GO:0004930; ; GO:0004994; ; GO:0008261; ; GO:0008261; ; GO:0008188; ; GO:0004994; ; GO:0004930 integral to membrane; GO:0016021 AlCR2 allatostatin C receptor 2 "CG13702, CG13702, CG13702, CG13702, CG13702, CG13702, CG13702, Drostar2, Drosophila allatostatin C receptor 2, anon-WO0170980.154, anon-WO0170980.155" CDMC20788 3 24 9 DAC15-G24 3-CG13702-RB_6 CG13702 CCTGAAGCTCATCACGATGATCCTGTACGCACTGGTCTGCATCATTGGACTCTTTGGCAACACCCTGG 68 FBan0013702 FBgn0036789 AlCR2 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186 neuropeptide receptor activity; GO:0008188; somatostatin receptor activity; GO:0004994; allatostatin receptor activity; GO:0008261; G-protein coupled receptor activity; GO:0004930; ; GO:0004994; ; GO:0008261; ; GO:0008261; ; GO:0008188; ; GO:0004994; ; GO:0004930 integral to membrane; GO:0016021 AlCR2 allatostatin C receptor 2 "CG13702, CG13702, CG13702, CG13702, CG13702, CG13702, CG13702, Drostar2, Drosophila allatostatin C receptor 2, anon-WO0170980.154, anon-WO0170980.155" CDMC20789 3 25 9 DAC15-K12 6-CG13921-RA_2 CG13921 TTCGCCGACGTGAGTAGTTGCTGCAACATGTCTGTGAAGAATGACAGCTACTATGACAACGCCCAGCG 68 FBan0013921 FBgn0035267 CG13921 3 3L CG13921 CG13921 CDMC20789 3 26 9 DAC15-K12 6-CG13921-RA_2 CG13921 TTCGCCGACGTGAGTAGTTGCTGCAACATGTCTGTGAAGAATGACAGCTACTATGACAACGCCCAGCG 68 FBan0013921 FBgn0035267 CG13921 3 3L CG13921 CG13921 CDMC20790 3 1 10 DAC15-K24 18-CG14112-RA_4 CG14112 GGGAAAGAAACATTCCGACAAACCACACAAGGTGAAGACCCACGATCCGCTCAAGAAACAAAAGAAGC 68 FBan0014112 FBgn0036349 SNCF 3 3L positive regulation of transcription from RNA polymerase II promoter; GO:0045944 protein binding; GO:0005515; ; GO:0005515 colocalizes_with nucleolus; GO:0005730; nucleus; GO:0005634 SNCF SoxNeuro Co-Factor "CG14112, HL6, BcDNA:RE54375, SoxNeuro Co-Factor" CDMC20790 3 2 10 DAC15-K24 18-CG14112-RA_4 CG14112 GGGAAAGAAACATTCCGACAAACCACACAAGGTGAAGACCCACGATCCGCTCAAGAAACAAAAGAAGC 68 FBan0014112 FBgn0036349 SNCF 3 3L positive regulation of transcription from RNA polymerase II promoter; GO:0045944 protein binding; GO:0005515; ; GO:0005515 colocalizes_with nucleolus; GO:0005730; nucleus; GO:0005634 SNCF SoxNeuro Co-Factor "CG14112, HL6, BcDNA:RE54375, SoxNeuro Co-Factor" CDMC20791 3 3 10 DAC15-O12 8-CG14527-RA_1 CG14527 TCCACCTTTAAGGAGACCTTGCTATCCAGTCCGGCTCTAGATTGGATCGAGCCATCCACTCGAAGTCT 68 FBan0014527 FBgn0039613 CG14527 3 3R proteolysis; GO:0006508 zinc ion binding; GO:0008270; metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG14527 CG14527 CDMC20791 3 4 10 DAC15-O12 8-CG14527-RA_1 CG14527 TCCACCTTTAAGGAGACCTTGCTATCCAGTCCGGCTCTAGATTGGATCGAGCCATCCACTCGAAGTCT 68 FBan0014527 FBgn0039613 CG14527 3 3R proteolysis; GO:0006508 zinc ion binding; GO:0008270; metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; neprilysin activity; GO:0004245 ; EC:3.4.24.11; ; GO:0004222 ; EC:3.4.24.-; ; GO:0008270; ; GO:0004245 ; EC:3.4.24.11 membrane; GO:0016020 CG14527 CG14527 CDMC20792 3 5 10 DAC15-O24 AutoBlank AutoBlank CDMC20792 3 6 10 DAC15-O24 AutoBlank AutoBlank CDMC20793 3 7 10 DAC16-C12 23-CG3109-RA_3 CG3109 TATATTTTGACATAAACTCACCATGCTCTCATTAAAGTTAGTCTCCCAGCTCTTTAAGCAAAGCC 65 FBan0003109 FBgn0023519 mRpL16 X X protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL16 mitochondrial ribosomal protein L16 "CG3109, CG3109, D-15, EG:63B12.2, anon-2Bd, L16, mitochondrial ribosomal protein L16" CDMC20793 3 8 10 DAC16-C12 23-CG3109-RA_3 CG3109 TATATTTTGACATAAACTCACCATGCTCTCATTAAAGTTAGTCTCCCAGCTCTTTAAGCAAAGCC 65 FBan0003109 FBgn0023519 mRpL16 X X protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL16 mitochondrial ribosomal protein L16 "CG3109, CG3109, D-15, EG:63B12.2, anon-2Bd, L16, mitochondrial ribosomal protein L16" CDMC20794 3 9 10 DAC16-C24 18-CG31146-RD_10 CG31146 AGGACGAGGACCTTAAGGAGCCCCAAATCACACAGAACACTCTCATTGTTGGACCCATTGTGCCC 65 FBan0031146 FBgn0051146 CG31146 3 3R defense response; GO:0006952; ectoderm development; GO:0007398; nervous system development; GO:0007399; neuromuscular synaptic transmission; GO:0007274; response to toxin; GO:0009636 neurexin binding; GO:0042043; NOT carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; receptor binding; GO:0005102; ; GO:0005102; ; GO:0004091 ; EC:3.1.1.1; ; GO:0042043 CG31146 CG31146 "CG12148, CG14596, anon-WO0118547.256" CDMC20794 3 10 10 DAC16-C24 18-CG31146-RD_10 CG31146 AGGACGAGGACCTTAAGGAGCCCCAAATCACACAGAACACTCTCATTGTTGGACCCATTGTGCCC 65 FBan0031146 FBgn0051146 CG31146 3 3R defense response; GO:0006952; ectoderm development; GO:0007398; nervous system development; GO:0007399; neuromuscular synaptic transmission; GO:0007274; response to toxin; GO:0009636 neurexin binding; GO:0042043; NOT carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; receptor binding; GO:0005102; ; GO:0005102; ; GO:0004091 ; EC:3.1.1.1; ; GO:0042043 CG31146 CG31146 "CG12148, CG14596, anon-WO0118547.256" CDMC20795 3 11 10 DAC16-G12 6-CG31259-RA_6 CG31259 CTCGCCAGGCTCCCCTCAACTTCCAAAGCATTTCAGCCTACGTACAGCTCTATGACCGCATGCTG 65 FBan0031259 FBgn0051259 CG31259 3 3R CG31259 CG31259 CG11740 CDMC20795 3 12 10 DAC16-G12 6-CG31259-RA_6 CG31259 CTCGCCAGGCTCCCCTCAACTTCCAAAGCATTTCAGCCTACGTACAGCTCTATGACCGCATGCTG 65 FBan0031259 FBgn0051259 CG31259 3 3R CG31259 CG31259 CG11740 CDMC20796 3 13 10 DAC16-G24 23-CG31289-RA_4 CG31289 ACGACTACAACCACTAATTCCGCTGCGAAATTACCTAATTTAGTGTCTAGGAAATGTTGTCTGTG 65 FBan0031289 FBgn0024558 Dph5 3 3R amino acid metabolism; GO:0006520; peptidyl-diphthamide biosynthesis from peptidyl-histidine; GO:0017183 diphthine synthase activity; GO:0004164 ; EC:2.1.1.98; ; GO:0004164 ; EC:2.1.1.98; transferase activity; GO:0016740 ; EC:2.-.-.-; catalytic activity; GO:0003824; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0003824; ; GO:0008168 ; EC:2.1.1.-; ; GO:0004164 ; EC:2.1.1.98 Dph5 Diphthamide methyltransferase "CG5275, CG31289, CG5275, l(3)L4910, BcDNA.LD12153, BcDNA:LD12153, Diphthamide methyltransferase" CDMC20796 3 14 10 DAC16-G24 23-CG31289-RA_4 CG31289 ACGACTACAACCACTAATTCCGCTGCGAAATTACCTAATTTAGTGTCTAGGAAATGTTGTCTGTG 65 FBan0031289 FBgn0024558 Dph5 3 3R amino acid metabolism; GO:0006520; peptidyl-diphthamide biosynthesis from peptidyl-histidine; GO:0017183 diphthine synthase activity; GO:0004164 ; EC:2.1.1.98; ; GO:0004164 ; EC:2.1.1.98; transferase activity; GO:0016740 ; EC:2.-.-.-; catalytic activity; GO:0003824; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0003824; ; GO:0008168 ; EC:2.1.1.-; ; GO:0004164 ; EC:2.1.1.98 Dph5 Diphthamide methyltransferase "CG5275, CG31289, CG5275, l(3)L4910, BcDNA.LD12153, BcDNA:LD12153, Diphthamide methyltransferase" CDMC20797 3 15 10 DAC16-K12 2-CG31392-RA_1 CG31392 ATCTGCGATCCATGCACCCTGGTTGTGCGTTTGCCAGTACTGTTGAAATGGTTACACCGAGGTCC 65 FBan0031392 FBgn0051392 CG31392 3 3R protein ubiquitination; GO:0016567 nucleic acid binding; GO:0003676; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0003676; ; GO:0008270 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 CG31392 CG31392 "CG12258, CG12258, CG12258" CDMC20797 3 16 10 DAC16-K12 2-CG31392-RA_1 CG31392 ATCTGCGATCCATGCACCCTGGTTGTGCGTTTGCCAGTACTGTTGAAATGGTTACACCGAGGTCC 65 FBan0031392 FBgn0051392 CG31392 3 3R protein ubiquitination; GO:0016567 nucleic acid binding; GO:0003676; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0003676; ; GO:0008270 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 CG31392 CG31392 "CG12258, CG12258, CG12258" CDMC20798 3 17 10 DAC16-K24 1-CG31447-RA_2 CG31447 ATGTCTGGAACATCGACCTCTGAACGCTCCAACTCCGAAGACAGCCCGTTGAATCCCTGCCTAAC 65 FBan0031447 FBgn0043069 MESK4 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 MESK4 Misexpression suppressor of KSR 4 "CG31447, BcDNA:LD15753, Misexpression suppressor of KSR 4" CDMC20798 3 18 10 DAC16-K24 1-CG31447-RA_2 CG31447 ATGTCTGGAACATCGACCTCTGAACGCTCCAACTCCGAAGACAGCCCGTTGAATCCCTGCCTAAC 65 FBan0031447 FBgn0043069 MESK4 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 MESK4 Misexpression suppressor of KSR 4 "CG31447, BcDNA:LD15753, Misexpression suppressor of KSR 4" CDMC20799 3 19 10 DAC16-O12 15-CG31547-RB_6 CG31547 AGCATGGCTAGCTTGTTGACCAAGTTCCGCATCAAGTACTCTGAGCTCATTATGCTGAAGGGCGT 65 FBan0031547 FBgn0051547 CG31547 3 3R amino acid transport; GO:0006865; cation transport; GO:0006812; chloride transport; GO:0006821; sodium ion transport; GO:0006814; transport; GO:0006810 cation transporter activity; GO:0008324; ; GO:0008324; sodium:potassium:chloride symporter activity; GO:0008511; ; GO:0008511; amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 integral to membrane; GO:0016021; membrane; GO:0016020 CG31547 CG31547 "CG10544, CG2509" CDMC20799 3 20 10 DAC16-O12 15-CG31547-RB_6 CG31547 AGCATGGCTAGCTTGTTGACCAAGTTCCGCATCAAGTACTCTGAGCTCATTATGCTGAAGGGCGT 65 FBan0031547 FBgn0051547 CG31547 3 3R amino acid transport; GO:0006865; cation transport; GO:0006812; chloride transport; GO:0006821; sodium ion transport; GO:0006814; transport; GO:0006810 cation transporter activity; GO:0008324; ; GO:0008324; sodium:potassium:chloride symporter activity; GO:0008511; ; GO:0008511; amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 integral to membrane; GO:0016021; membrane; GO:0016020 CG31547 CG31547 "CG10544, CG2509" CDMC20800 3 21 10 DAC16-O24 AutoBlank AutoBlank CDMC20800 3 22 10 DAC16-O24 AutoBlank AutoBlank CDMC20801 3 23 10 DAC17-C12 5-CG32742-RA_1 CG32742 ACCCAGAGCCAGAAGAAACTCGTCCAATGCCCCACTAGGCCACATTTACTTACCTCAAGCCGCAG 65 FBgn0052742 CDMC20801 3 24 10 DAC17-C12 5-CG32742-RA_1 CG32742 ACCCAGAGCCAGAAGAAACTCGTCCAATGCCCCACTAGGCCACATTTACTTACCTCAAGCCGCAG 65 FBgn0052742 CDMC20802 3 25 10 DAC17-C24 2-CG32795-RC_1 CG32795 TATTCCTGTTGGTCTGGTACTACTGCACCCTGACCATTCGCGAGTCCATCCTCAAGGTGAACGGC 65 FBan0032795 FBgn0040384 CG32795 X X carbon utilization by fixation of carbon dioxide; GO:0015977 ribulose-bisphosphate carboxylase activity; GO:0016984 ; EC:4.1.1.39; ; GO:0016984 ; EC:4.1.1.39 ribulose bisphosphate carboxylase complex (sensu Magnoliophyta); GO:0009573 CG32795 CG32795 "CG2766, CG2716, CG2766, CG2766, CG2766, EG:BACN33B1.2" CDMC20802 3 26 10 DAC17-C24 2-CG32795-RC_1 CG32795 TATTCCTGTTGGTCTGGTACTACTGCACCCTGACCATTCGCGAGTCCATCCTCAAGGTGAACGGC 65 FBan0032795 FBgn0040384 CG32795 X X carbon utilization by fixation of carbon dioxide; GO:0015977 ribulose-bisphosphate carboxylase activity; GO:0016984 ; EC:4.1.1.39; ; GO:0016984 ; EC:4.1.1.39 ribulose bisphosphate carboxylase complex (sensu Magnoliophyta); GO:0009573 CG32795 CG32795 "CG2766, CG2716, CG2766, CG2766, CG2766, EG:BACN33B1.2" CDMC20803 3 1 11 DAC17-G12 23-CG3294-RB_1 CG3294 GGTATTTTTCATAGACCCTGTACACGGTATTAATCAGCTGTGTTCTCACAAATGCGTTTCAGCTG 65 FBan0003294 FBgn0031628 CG3294 2 2L "nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729 small nuclear ribonucleoprotein complex; GO:0030532; spliceosome complex; GO:0005681 CG3294 CG3294 cg3294 CDMC20803 3 2 11 DAC17-G12 23-CG3294-RB_1 CG3294 GGTATTTTTCATAGACCCTGTACACGGTATTAATCAGCTGTGTTCTCACAAATGCGTTTCAGCTG 65 FBan0003294 FBgn0031628 CG3294 2 2L "nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729 small nuclear ribonucleoprotein complex; GO:0030532; spliceosome complex; GO:0005681 CG3294 CG3294 cg3294 CDMC20804 3 3 11 DAC17-G24 3-CG33012-RB_2 CG33012 CAGCCTCGGGATGGAGTAAGGATGCTCAGCTGGTCGTTCCTCAAGGGTATGCTGGACAATCCATC 65 FBan0033012 FBgn0053012 CG33012 2 2R CG33012 CG33012 "CG13161, CG30041" CDMC20804 3 4 11 DAC17-G24 3-CG33012-RB_2 CG33012 CAGCCTCGGGATGGAGTAAGGATGCTCAGCTGGTCGTTCCTCAAGGGTATGCTGGACAATCCATC 65 FBan0033012 FBgn0053012 CG33012 2 2R CG33012 CG33012 "CG13161, CG30041" CDMC20805 3 5 11 DAC17-K12 3-CG33140-RA_1 CG33140 CTCACTGAATGCCTCTTCCCAGCAGGATGTCCAAAAGCAACGGTCGCGGTTCATATATGTGCGCG 65 FBan0033140 FBgn0053140 CG33140 2 2R CG33140 CG33140 "CG11074, BcDNA:AT21895" CDMC20805 3 6 11 DAC17-K12 3-CG33140-RA_1 CG33140 CTCACTGAATGCCTCTTCCCAGCAGGATGTCCAAAAGCAACGGTCGCGGTTCATATATGTGCGCG 65 FBan0033140 FBgn0053140 CG33140 2 2R CG33140 CG33140 "CG11074, BcDNA:AT21895" CDMC20806 3 7 11 DAC17-K24 2-CG33161-RA_1 CG33161 CAACGGGAGTGTAGGGATCTGTATCGTGGCTACCGGAACATCACGTCCAGCATGTTCTGTGCCTC 65 FBgn0053161 CDMC20806 3 8 11 DAC17-K24 2-CG33161-RA_1 CG33161 CAACGGGAGTGTAGGGATCTGTATCGTGGCTACCGGAACATCACGTCCAGCATGTTCTGTGCCTC 65 FBgn0053161 CDMC20807 3 9 11 DAC17-O12 1-CG33267-RA_2 CG33267 CACTGTCGCCTGTTTCCTGGTGAGCCTGTCCAGTGCCAGTACCACAACCACAACTACAGATGATG 65 FBan0033267 FBgn0053267 CG33267 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33267 CG33267 CDMC20807 3 10 11 DAC17-O12 1-CG33267-RA_2 CG33267 CACTGTCGCCTGTTTCCTGGTGAGCCTGTCCAGTGCCAGTACCACAACCACAACTACAGATGATG 65 FBan0033267 FBgn0053267 CG33267 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33267 CG33267 CDMC20808 3 11 11 DAC17-O24 AutoBlank AutoBlank CDMC20808 3 12 11 DAC17-O24 AutoBlank AutoBlank CDMC20809 3 13 11 DAC18-C12 2-CG6012-RA_1 CG6012 CGCATCTTCTTCCAGCGCATGAAGGCGTCTAAATTGAAGGGAGCCATTGTGAATGTTGGTTCCGGCAC 68 FBan0006012 FBgn0032615 CG6012 2 2L steroid metabolism; GO:0008202 "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; GO:0016616 ; EC:1.1.1.-; ; GO:0016616 ; EC:1.1.1.-" CG6012 CG6012 CDMC20809 3 14 11 DAC18-C12 2-CG6012-RA_1 CG6012 CGCATCTTCTTCCAGCGCATGAAGGCGTCTAAATTGAAGGGAGCCATTGTGAATGTTGGTTCCGGCAC 68 FBan0006012 FBgn0032615 CG6012 2 2L steroid metabolism; GO:0008202 "oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor; GO:0016616 ; EC:1.1.1.-; ; GO:0016616 ; EC:1.1.1.-" CG6012 CG6012 CDMC20810 3 15 11 DAC18-C24 3-CG6171-RA_4 CG6171 GCTGAGCCAGTGGAGAATGCAGATGAGCCCACAAGCACTACTCCTGCGATCAAGATTAAAGCCGAACC 68 FBan0006171 FBgn0026737 CG6171 3 3R CG6171 CG6171 "Anon-becker2, anon-Becker2" CDMC20810 3 16 11 DAC18-C24 3-CG6171-RA_4 CG6171 GCTGAGCCAGTGGAGAATGCAGATGAGCCCACAAGCACTACTCCTGCGATCAAGATTAAAGCCGAACC 68 FBan0006171 FBgn0026737 CG6171 3 3R CG6171 CG6171 "Anon-becker2, anon-Becker2" CDMC20811 3 17 11 DAC18-G12 1-CG6613-RA_1 CG6613 GTCTGCGTTCTCCAACTACGGACAGATGCAGCTACAATGCTCTGTTGCGGAAACACGAAAGCAACCGG 68 FBan0006613 FBgn0034694 CG6613 2 2R intracellular signaling cascade; GO:0007242; protein ubiquitination; GO:0016567 diacylglycerol binding; GO:0019992; ; GO:0019992; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG6613 CG6613 CDMC20811 3 18 11 DAC18-G12 1-CG6613-RA_1 CG6613 GTCTGCGTTCTCCAACTACGGACAGATGCAGCTACAATGCTCTGTTGCGGAAACACGAAAGCAACCGG 68 FBan0006613 FBgn0034694 CG6613 2 2R intracellular signaling cascade; GO:0007242; protein ubiquitination; GO:0016567 diacylglycerol binding; GO:0019992; ; GO:0019992; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG6613 CG6613 CDMC20812 3 19 11 DAC18-G24 1-CG6706-RB_1 CG6706 TCCACCAACATCTCCACATCGCAATCGGAGTTGAGCAACATGTGTCCACACTCAAAGCCCAGTACTCC 68 FBan0006706 FBgn0027575 GABA-B-R2 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; nerve-nerve synaptic transmission; GO:0007270 GABA-B receptor activity; GO:0004965; ; GO:0004965; ; GO:0004965 integral to membrane; GO:0016021 GABA-B-R2 metabotropic GABA-B receptor subtype 2 "CG6706, CG6706, D-GABA[[B]]R2, D-Gaba2, GH07312, GABA[[B]]R2, GB2, anon-WO0170980.58, anon-WO0170980.59, BcDNA:GH07312, metabotropic GABA-B receptor subtype 2" CDMC20812 3 20 11 DAC18-G24 1-CG6706-RB_1 CG6706 TCCACCAACATCTCCACATCGCAATCGGAGTTGAGCAACATGTGTCCACACTCAAAGCCCAGTACTCC 68 FBan0006706 FBgn0027575 GABA-B-R2 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; nerve-nerve synaptic transmission; GO:0007270 GABA-B receptor activity; GO:0004965; ; GO:0004965; ; GO:0004965 integral to membrane; GO:0016021 GABA-B-R2 metabotropic GABA-B receptor subtype 2 "CG6706, CG6706, D-GABA[[B]]R2, D-Gaba2, GH07312, GABA[[B]]R2, GB2, anon-WO0170980.58, anon-WO0170980.59, BcDNA:GH07312, metabotropic GABA-B receptor subtype 2" CDMC20813 3 21 11 DAC18-K12 3-CG7128-RA_2 CG7128 GCAAACCGGCCTTTCCTCCCTATGCAGCCGCTTTAAATCCCACAGATCAGGTGTTTGACTTCGAGGAG 68 FBan0007128 FBgn0022724 Taf8 X X cellular physiological process; GO:0050875; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; protein binding; GO:0005515; ; GO:0005515 transcription factor TFIID complex; GO:0005669 Taf8 TBP-associated factor 8 "CG7128, CG7128, pds: prodos, prodos, HL-VIII, pro, prod, TAF8, TFIID, TAF[[II]], TAF, l(1)16Fg, pds" CDMC20813 3 22 11 DAC18-K12 3-CG7128-RA_2 CG7128 GCAAACCGGCCTTTCCTCCCTATGCAGCCGCTTTAAATCCCACAGATCAGGTGTTTGACTTCGAGGAG 68 FBan0007128 FBgn0022724 Taf8 X X cellular physiological process; GO:0050875; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; protein binding; GO:0005515; ; GO:0005515 transcription factor TFIID complex; GO:0005669 Taf8 TBP-associated factor 8 "CG7128, CG7128, pds: prodos, prodos, HL-VIII, pro, prod, TAF8, TFIID, TAF[[II]], TAF, l(1)16Fg, pds" CDMC20814 3 23 11 DAC18-K24 3-CG7274-RA_4 CG7274 GCCCTGCACTGTGAGTGTGATGAATCTGGTGAAGCAGGCGTACAAGAAGTTTCTGCAACCATACGGCG 68 FBan0007274 FBgn0030965 CG7274 X X "cell cycle; GO:0007049; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" DNA binding; GO:0003677; transcription regulator activity; GO:0030528; transcription cofactor activity; GO:0003712; ; GO:0030528; ; GO:0003712; ; GO:0003677 intracellular; GO:0005622 CG7274 CG7274 CDMC20814 3 24 11 DAC18-K24 3-CG7274-RA_4 CG7274 GCCCTGCACTGTGAGTGTGATGAATCTGGTGAAGCAGGCGTACAAGAAGTTTCTGCAACCATACGGCG 68 FBan0007274 FBgn0030965 CG7274 X X "cell cycle; GO:0007049; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" DNA binding; GO:0003677; transcription regulator activity; GO:0030528; transcription cofactor activity; GO:0003712; ; GO:0030528; ; GO:0003712; ; GO:0003677 intracellular; GO:0005622 CG7274 CG7274 CDMC20815 3 25 11 DAC18-O12 3-CG7503-RA_2 CG7503 CTTGGGTCATGGCCTAGACCTGGATGACAATCTTAGCTTGCACAAGCAGGGATTCTATGGTGCCGGTT 68 FBan0007503 FBgn0005775 Con 3 3L axonal fasciculation; GO:0007413; cell adhesion; GO:0007155; homophilic cell adhesion; GO:0007156; signal transduction; GO:0007165; synaptic target attraction; GO:0016200 structural molecule activity; GO:0005198; ; GO:0005198 plasma membrane; GO:0005886 Con Connectin "CG7503, connectin, conn, con, CT1840, CON, Ubx-t35, anon-64C, transcript-35" CDMC20815 3 26 11 DAC18-O12 3-CG7503-RA_2 CG7503 CTTGGGTCATGGCCTAGACCTGGATGACAATCTTAGCTTGCACAAGCAGGGATTCTATGGTGCCGGTT 68 FBan0007503 FBgn0005775 Con 3 3L axonal fasciculation; GO:0007413; cell adhesion; GO:0007155; homophilic cell adhesion; GO:0007156; signal transduction; GO:0007165; synaptic target attraction; GO:0016200 structural molecule activity; GO:0005198; ; GO:0005198 plasma membrane; GO:0005886 Con Connectin "CG7503, connectin, conn, con, CT1840, CON, Ubx-t35, anon-64C, transcript-35" CDMC20816 3 1 12 DAC18-O24 AutoBlank AutoBlank CDMC20816 3 2 12 DAC18-O24 AutoBlank AutoBlank CDMC20817 3 3 12 DAC19-C12 16-CG1780-RB_1 CG1780 GCGCCAGGTTAAGAGCAAGTTGTAGAGCTCCTCATCCTTCTGATTCTTTTCCCGAACGAAAGAACAACG 69 FBan0001780 FBgn0026415 Idgf4 X X cell-cell signaling; GO:0007267; imaginal disc development; GO:0007444; metabolism; GO:0008152; signal transduction; GO:0007165 imaginal disc growth factor activity; GO:0008084; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0008084 extracellular region; GO:0005576 Idgf4 Imaginal disc growth factor 4 "CG1780, CG1780, IDGF, IDGF4, IDGF-4" CDMC20817 3 4 12 DAC19-C12 16-CG1780-RB_1 CG1780 GCGCCAGGTTAAGAGCAAGTTGTAGAGCTCCTCATCCTTCTGATTCTTTTCCCGAACGAAAGAACAACG 69 FBan0001780 FBgn0026415 Idgf4 X X cell-cell signaling; GO:0007267; imaginal disc development; GO:0007444; metabolism; GO:0008152; signal transduction; GO:0007165 imaginal disc growth factor activity; GO:0008084; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0008084 extracellular region; GO:0005576 Idgf4 Imaginal disc growth factor 4 "CG1780, CG1780, IDGF, IDGF4, IDGF-4" CDMC20818 3 5 12 DAC19-C24 23-CG17834-RB_4 CG17834 CTCGCAATGCGGATATAATCAATTGGAGAGTGACCAATATCGCCAAAATGTGACTTAATATTATTAACT 69 FBan0017834 FBgn0028394 CG17834 2 2L CG17834 CG17834 "anon-29Da, BcDNA:LP07538" CDMC20818 3 6 12 DAC19-C24 23-CG17834-RB_4 CG17834 CTCGCAATGCGGATATAATCAATTGGAGAGTGACCAATATCGCCAAAATGTGACTTAATATTATTAACT 69 FBan0017834 FBgn0028394 CG17834 2 2L CG17834 CG17834 "anon-29Da, BcDNA:LP07538" CDMC20819 3 7 12 DAC19-G12 15-CG17883-RB_1 CG17883 CCCTGGCGCCTTACGGATTGGTTAATGACGATTTTAGAAGGATTTTATGGCCTCAGTTGGCAGGAGTCG 69 FBgn0040005 CG17883 CG17883 CG17883 "CG40289, CG40289" CDMC20819 3 8 12 DAC19-G12 15-CG17883-RB_1 CG17883 CCCTGGCGCCTTACGGATTGGTTAATGACGATTTTAGAAGGATTTTATGGCCTCAGTTGGCAGGAGTCG 69 FBgn0040005 CG17883 CG17883 CG17883 "CG40289, CG40289" CDMC20820 3 9 12 DAC19-G24 2-CG17904-RA_1 CG17904 CCCGCTATCTGGCCAGAAGTAATCCGGACAGTAACTTCGGCGTGCTTGATATCGACATTTGCGGTCCAT 69 FBan0017904 FBgn0032597 CG17904 2 2L nucleotide binding; GO:0000166; ; GO:0000166 CG17904 CG17904 CDMC20820 3 10 12 DAC19-G24 2-CG17904-RA_1 CG17904 CCCGCTATCTGGCCAGAAGTAATCCGGACAGTAACTTCGGCGTGCTTGATATCGACATTTGCGGTCCAT 69 FBan0017904 FBgn0032597 CG17904 2 2L nucleotide binding; GO:0000166; ; GO:0000166 CG17904 CG17904 CDMC20821 3 11 12 DAC19-K12 6-CG17941-RA_7 CG17941 GCGCATGTGTTTTCCGAAATAGCGAGACTGAAAGATGACACCTTATCGGAGCACAGTGGAAGTGGGGCT 69 FBan0017941 FBgn0000497 ds 2 2L calcium-dependent cell-cell adhesion; GO:0016339; cell proliferation; GO:0008283; cellular morphogenesis during differentiation; GO:0000904; equator specification; GO:0045317; establishment of epithelial cell polarity; GO:0045198; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; establishment of planar polarity; GO:0001736; establishment of tissue polarity; GO:0007164; establishment of wing hair orientation; GO:0001737; homophilic cell adhesion; GO:0007156; ommatidial rotation; GO:0016318; peptide cross-linking; GO:0018149; signal transduction; GO:0007165; wing disc pattern formation; GO:0035222 signal transducer activity; GO:0004871; receptor activity; GO:0004872; cell adhesion molecule binding; GO:0050839; calcium ion binding; GO:0005509; ; GO:0050839; ; GO:0004871; ; GO:0004872; ; GO:0005509; ; GO:0050839 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 ds dachsous "CG17941, l(2)05142, CT39575, Ds, cad2: cadherin-2, cadherin-2, dachsous" CDMC20821 3 12 12 DAC19-K12 6-CG17941-RA_7 CG17941 GCGCATGTGTTTTCCGAAATAGCGAGACTGAAAGATGACACCTTATCGGAGCACAGTGGAAGTGGGGCT 69 FBan0017941 FBgn0000497 ds 2 2L calcium-dependent cell-cell adhesion; GO:0016339; cell proliferation; GO:0008283; cellular morphogenesis during differentiation; GO:0000904; equator specification; GO:0045317; establishment of epithelial cell polarity; GO:0045198; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; establishment of planar polarity; GO:0001736; establishment of tissue polarity; GO:0007164; establishment of wing hair orientation; GO:0001737; homophilic cell adhesion; GO:0007156; ommatidial rotation; GO:0016318; peptide cross-linking; GO:0018149; signal transduction; GO:0007165; wing disc pattern formation; GO:0035222 signal transducer activity; GO:0004871; receptor activity; GO:0004872; cell adhesion molecule binding; GO:0050839; calcium ion binding; GO:0005509; ; GO:0050839; ; GO:0004871; ; GO:0004872; ; GO:0005509; ; GO:0050839 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 ds dachsous "CG17941, l(2)05142, CT39575, Ds, cad2: cadherin-2, cadherin-2, dachsous" CDMC20822 3 13 12 DAC19-K24 23-CG17950-RA_3 CG17950 GACAAAATACACGAAAAACAATACACACACCGCAAATGAATCGAACGAAATTTCGCTCAGGTCTTTTCG 69 FBan0017950 FBgn0004362 HmgD 2 2R "establishment and/or maintenance of chromatin architecture; GO:0006325; regulation of transcription, DNA-dependent; GO:0006355" AT DNA binding; GO:0003680; ; GO:0003680; DNA bending activity; GO:0008301; ; GO:0008301; ; GO:0008301 colocalizes_with nuclear chromatin; GO:0000790 HmgD High mobility group protein D "CG17950, HMG D, dHMG-D, HMG-D, clone 1.9, hmg-D, anon-EST:Liang-1.9" CDMC20822 3 14 12 DAC19-K24 23-CG17950-RA_3 CG17950 GACAAAATACACGAAAAACAATACACACACCGCAAATGAATCGAACGAAATTTCGCTCAGGTCTTTTCG 69 FBan0017950 FBgn0004362 HmgD 2 2R "establishment and/or maintenance of chromatin architecture; GO:0006325; regulation of transcription, DNA-dependent; GO:0006355" AT DNA binding; GO:0003680; ; GO:0003680; DNA bending activity; GO:0008301; ; GO:0008301; ; GO:0008301 colocalizes_with nuclear chromatin; GO:0000790 HmgD High mobility group protein D "CG17950, HMG D, dHMG-D, HMG-D, clone 1.9, hmg-D, anon-EST:Liang-1.9" CDMC20823 3 15 12 DAC19-O12 14-CG18004-RC_1 CG18004 CCCACAACGATGCTCAGCGATGAAAGCCCCTCTAAGTGGTAATAAGTTGTGCAATTCCCACGTTGCAGC 69 FBan0018004 FBgn0033566 CG18004 2 2R CG18004 CG18004 CDMC20823 3 16 12 DAC19-O12 14-CG18004-RC_1 CG18004 CCCACAACGATGCTCAGCGATGAAAGCCCCTCTAAGTGGTAATAAGTTGTGCAATTCCCACGTTGCAGC 69 FBan0018004 FBgn0033566 CG18004 2 2R CG18004 CG18004 CDMC20824 3 17 12 DAC19-O24 AutoBlank AutoBlank CDMC20824 3 18 12 DAC19-O24 AutoBlank AutoBlank CDMC20825 3 19 12 DAC20-C12 2-CG10688-RA_1 CG10688 TCAGATCAGCTTCGATGTCTTCCCGCATGGTTGGGACAAGACCTACTGCCTGCGACACATCGAAG 65 FBan0010688 FBgn0036300 CG10688 3 3L GDP-mannose biosynthesis; GO:0009298 phosphomannomutase activity; GO:0004615 ; EC:5.4.2.8; ; GO:0004615 ; EC:5.4.2.8; ; GO:0004615 ; EC:5.4.2.8 cytoplasm; GO:0005737 CG10688 CG10688 CDMC20825 3 20 12 DAC20-C12 2-CG10688-RA_1 CG10688 TCAGATCAGCTTCGATGTCTTCCCGCATGGTTGGGACAAGACCTACTGCCTGCGACACATCGAAG 65 FBan0010688 FBgn0036300 CG10688 3 3L GDP-mannose biosynthesis; GO:0009298 phosphomannomutase activity; GO:0004615 ; EC:5.4.2.8; ; GO:0004615 ; EC:5.4.2.8; ; GO:0004615 ; EC:5.4.2.8 cytoplasm; GO:0005737 CG10688 CG10688 CDMC20826 3 21 12 DAC20-C24 3-CG10723-RA_3 CG10723 AGAGCGATATGGATATTCTGGCCAACTCCATGTACGAGGACGATCCCAATGGCAACCTAGCGCCC 65 FBan0010723 FBgn0032850 Kua 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Kua Kua "CG10723, CG10723, CG10723, 38B.18" CDMC20826 3 22 12 DAC20-C24 3-CG10723-RA_3 CG10723 AGAGCGATATGGATATTCTGGCCAACTCCATGTACGAGGACGATCCCAATGGCAACCTAGCGCCC 65 FBan0010723 FBgn0032850 Kua 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 Kua Kua "CG10723, CG10723, CG10723, 38B.18" CDMC20827 3 23 12 DAC20-G12 23-CG10851-RD_1 CG10851 GAAAGAGAATCAAATCTAATTGAATCGCTGTGAGAAAGACAAGCTAGTCTAGTGACCGACCGACC 65 FBan0010851 FBgn0004587 B52 3 3R "mRNA splice site selection; GO:0006376; nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" "mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" NOT omega speckle; GO:0035062; nuclear speck; GO:0016607; nucleus; GO:0005634; spliceosome complex; GO:0005681 B52 B52 "CG10851, CG10851, SR55: serine-arginine protein 55, E726, SRp55: Serine/arginine rich protein 55, rrm8, l(3)s2249, B52/dSRp55, E(Dfd): Enhancer of Deformed, dSRp55, RRM8, MabB52: Monoclonal-antibody-B52, RSp55, Rbp8, Enhancer of Deformed, Monoclonal-antibody-B52, RNA-binding protein 8, serine-arginine protein 55, Serine/arginine rich protein 55, SRp55, E(Dfd), SR55" CDMC20827 3 24 12 DAC20-G12 23-CG10851-RD_1 CG10851 GAAAGAGAATCAAATCTAATTGAATCGCTGTGAGAAAGACAAGCTAGTCTAGTGACCGACCGACC 65 FBan0010851 FBgn0004587 B52 3 3R "mRNA splice site selection; GO:0006376; nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" "mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" NOT omega speckle; GO:0035062; nuclear speck; GO:0016607; nucleus; GO:0005634; spliceosome complex; GO:0005681 B52 B52 "CG10851, CG10851, SR55: serine-arginine protein 55, E726, SRp55: Serine/arginine rich protein 55, rrm8, l(3)s2249, B52/dSRp55, E(Dfd): Enhancer of Deformed, dSRp55, RRM8, MabB52: Monoclonal-antibody-B52, RSp55, Rbp8, Enhancer of Deformed, Monoclonal-antibody-B52, RNA-binding protein 8, serine-arginine protein 55, Serine/arginine rich protein 55, SRp55, E(Dfd), SR55" CDMC20828 3 25 12 DAC20-G24 17-CG10883-RA_1 CG10883 CAACTCACGATCATGCGATGCTGCTGATTGCCGTTGGCCAGGCCATCGCCGTTCCCAGTTGTTTC 65 FBan0010883 FBgn0038781 CG10883 3 3R CG10883 CG10883 CDMC20828 3 26 12 DAC20-G24 17-CG10883-RA_1 CG10883 CAACTCACGATCATGCGATGCTGCTGATTGCCGTTGGCCAGGCCATCGCCGTTCCCAGTTGTTTC 65 FBan0010883 FBgn0038781 CG10883 3 3R CG10883 CG10883 CDMC20829 3 1 13 DAC20-K12 15-CG10966-RA_6 CG10966 CCTCCAAGCCATCGATTGATGACGGACTAATGGAGGTTGTTGGCCTGACCACCTACCAGCTGCCC 65 FBan0010966 FBgn0003217 rdgA X X actin filament organization; GO:0007015; deactivation of rhodopsin mediated signaling; GO:0016059; intracellular signaling cascade; GO:0007242; lipid phosphorylation; GO:0046834; phosphatidic acid biosynthesis; GO:0006654; phosphoinositide biosynthesis; GO:0046489; phosphorylation; GO:0016310; photoreceptor maintenance; GO:0045494; phototransduction; GO:0007602; protein kinase C activation; GO:0007205; rhodopsin mediated signaling; GO:0016056; visual perception; GO:0007601 diacylglycerol binding; GO:0019992; ; GO:0019992; diacylglycerol kinase activity; GO:0004143 ; EC:2.7.1.107; ; GO:0004143 ; EC:2.7.1.107; ; GO:0004143 ; EC:2.7.1.107; ; GO:0004143 ; EC:2.7.1.107; ; GO:0019992; ; GO:0004143 ; EC:2.7.1.107 membrane; GO:0016020 rdgA retinal degeneration A "CG10966, CG10966, receptor-degeneration-I, DGK2, dDGK2, x35" CDMC20829 3 2 13 DAC20-K12 15-CG10966-RA_6 CG10966 CCTCCAAGCCATCGATTGATGACGGACTAATGGAGGTTGTTGGCCTGACCACCTACCAGCTGCCC 65 FBan0010966 FBgn0003217 rdgA X X actin filament organization; GO:0007015; deactivation of rhodopsin mediated signaling; GO:0016059; intracellular signaling cascade; GO:0007242; lipid phosphorylation; GO:0046834; phosphatidic acid biosynthesis; GO:0006654; phosphoinositide biosynthesis; GO:0046489; phosphorylation; GO:0016310; photoreceptor maintenance; GO:0045494; phototransduction; GO:0007602; protein kinase C activation; GO:0007205; rhodopsin mediated signaling; GO:0016056; visual perception; GO:0007601 diacylglycerol binding; GO:0019992; ; GO:0019992; diacylglycerol kinase activity; GO:0004143 ; EC:2.7.1.107; ; GO:0004143 ; EC:2.7.1.107; ; GO:0004143 ; EC:2.7.1.107; ; GO:0004143 ; EC:2.7.1.107; ; GO:0019992; ; GO:0004143 ; EC:2.7.1.107 membrane; GO:0016020 rdgA retinal degeneration A "CG10966, CG10966, receptor-degeneration-I, DGK2, dDGK2, x35" CDMC20830 3 3 13 DAC20-K24 12-CG11000-RA_1 CG11000 GTCTACTGGATGCTGGCCAAGTCGGAGCAGGAGGTGAGCGACTGGATCGATGCGATTACCAAGAC 65 FBan0011000 FBgn0037380 CG11000 3 3R CG11000 CG11000 CDMC20830 3 4 13 DAC20-K24 12-CG11000-RA_1 CG11000 GTCTACTGGATGCTGGCCAAGTCGGAGCAGGAGGTGAGCGACTGGATCGATGCGATTACCAAGAC 65 FBan0011000 FBgn0037380 CG11000 3 3R CG11000 CG11000 CDMC20831 3 5 13 DAC20-O12 12-CG11126-RA_1 CG11126 CATGTGCCCATGGCAGAATAGACTGGTGACCCTCAGTCTGCGTGGTAAGCACATTGTGGAGCTGC 65 FBan0011126 FBgn0030265 CG11126 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleotide catabolism; GO:0009166" nucleotide phosphatase activity; GO:0019204; ; GO:0019204; 5'-nucleotidase activity; GO:0008253 ; EC:3.1.3.5; ; GO:0008253 ; EC:3.1.3.5 CG11126 CG11126 CDMC20831 3 6 13 DAC20-O12 12-CG11126-RA_1 CG11126 CATGTGCCCATGGCAGAATAGACTGGTGACCCTCAGTCTGCGTGGTAAGCACATTGTGGAGCTGC 65 FBan0011126 FBgn0030265 CG11126 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleotide catabolism; GO:0009166" nucleotide phosphatase activity; GO:0019204; ; GO:0019204; 5'-nucleotidase activity; GO:0008253 ; EC:3.1.3.5; ; GO:0008253 ; EC:3.1.3.5 CG11126 CG11126 CDMC20832 3 7 13 DAC20-O24 AutoBlank AutoBlank CDMC20832 3 8 13 DAC20-O24 AutoBlank AutoBlank CDMC20833 3 9 13 DAC21-C12 1-CG11269-RA_1 CG11269 CATTGCGATAGTGGCCATTCGTCGGGATAACAAGAGAAGGAAGCGACTCTACAAGCGGGGTCCCG 65 FBan0011269 FBgn0034700 CG11269 2 2R CG11269 CG11269 CDMC20833 3 10 13 DAC21-C12 1-CG11269-RA_1 CG11269 CATTGCGATAGTGGCCATTCGTCGGGATAACAAGAGAAGGAAGCGACTCTACAAGCGGGGTCCCG 65 FBan0011269 FBgn0034700 CG11269 2 2R CG11269 CG11269 CDMC20834 3 11 13 DAC21-C24 23-CG11295-RA_1 CG11295 CGCCCTCTGTACAGAGCCAAAAGATACGAAAGACTAACGTACCCGAATAAAAGTAACTCCATTTT 65 FBan0011295 FBgn0013548 l(2)dtl 2 2R phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401 sugar porter activity; GO:0005351; ; GO:0005351 cytoplasm; GO:0005737 l(2)dtl lethal-(2)-denticleless "CG11295, DTL83" CDMC20834 3 12 13 DAC21-C24 23-CG11295-RA_1 CG11295 CGCCCTCTGTACAGAGCCAAAAGATACGAAAGACTAACGTACCCGAATAAAAGTAACTCCATTTT 65 FBan0011295 FBgn0013548 l(2)dtl 2 2R phosphoenolpyruvate-dependent sugar phosphotransferase system; GO:0009401 sugar porter activity; GO:0005351; ; GO:0005351 cytoplasm; GO:0005737 l(2)dtl lethal-(2)-denticleless "CG11295, DTL83" CDMC20835 3 13 13 DAC21-G12 3-CG11437-RA_1 CG11437 GCCGTCCCATGCCAAGAAATGAACAGATCTACGGCTACGCGGGATACTACACCAGAGCCACCTAC 65 FBan0011437 FBgn0037165 CG11437 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; dephosphorylation; GO:0016311; lipid metabolism; GO:0006629 phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4 CG11437 CG11437 WUN-like CDMC20835 3 14 13 DAC21-G12 3-CG11437-RA_1 CG11437 GCCGTCCCATGCCAAGAAATGAACAGATCTACGGCTACGCGGGATACTACACCAGAGCCACCTAC 65 FBan0011437 FBgn0037165 CG11437 3 3L G-protein coupled receptor protein signaling pathway; GO:0007186; dephosphorylation; GO:0016311; lipid metabolism; GO:0006629 phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4; ; GO:0008195 ; EC:3.1.3.4 CG11437 CG11437 WUN-like CDMC20836 3 15 13 DAC21-G24 23-CG11491-RD_1 CG11491 CAACTCACGCCTATGGACCAGTATATAGAATACGGATATACACTGTTTACACTCTGTGGCCTTCT 65 FBan0011491 FBgn0000210 br X X "autophagy; GO:0006914; catabolism; GO:0009056; cell death; GO:0008219; central nervous system remodeling (sensu Insecta); GO:0035193; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; eclosion; GO:0007562; metamorphosis (sensu Insecta); GO:0046698; metamorphosis; GO:0007552; photoreceptor fate commitment (sensu Endopterygota); GO:0007459; progression of morphogenetic furrow (sensu Endopterygota); GO:0007458; regulation of development, heterochronic; GO:0040034; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; response to ecdysone; GO:0035075; response to pest, pathogen or parasite; GO:0009613; salivary gland cell autophagic cell death; GO:0035071; salivary gland histolysis; GO:0035070; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" "DNA binding; GO:0003677; ; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; ; GO:0003700; ; GO:0003704; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0016788 ; EC:3.1.-.-; ; GO:0008270; ; GO:0005515" nucleus; GO:0005634 br broad "CG11514, CG11511, CG11491, CG11514, CG11511, CG11491, CG11511, CG11514, CG11491, l(1)pp-1, l(1)pp-2, l(1)pp1, l(1)pp2, A18, PP1, PP2, ecs: ecdysone-sensitivity, npr1: non-pupariating-1, l(1)npr-1, l(1)d norm-12, de12, l(1)2Bab, l(1)2Bc, l(1)2Bd, rbp, l(1)PP1, BR-C: Broad-complex, npr-1, l(1)ESHS5, rds, l(1)npr1: lethal(1)non-pupariating-1, uq: unequal wings, unequal wings, BRC, 2B5, Z1, Z2, Z3, Z4, 2Bc, npr, Br-C, nprl, l(1)G0018, l(1)G0318, l(1)G0284a, Broad-complex, l(1)G0401, l(1)G0042, Broad-Complex, Broad Complex, BRC-Z1, BR_C, EG:17A9.1, EG:123F11.1, EG:25D2.1, BrC-Z1, broad complex, BR-C Z1, br-C, BR-c, nrp, broad-complex, BR, br-Z1, br-Z3, l(1)G0284, l(1)2Ba, l(1)2Bad, l(1)2Bb, l(1)d.norm.1, l(1)dn1: lethal(1)discs normal, l(1)n34, l(1)ts132, l(1)ts144, l(1)ts358, l(1)ts376, o.c.c.: overlapping-complementation-complex, rdp, ecdysone-sensitivity, lethal(1)2Bab, lethal(1)2Bc, lethal(1)2Bd, lethal(1)discs normal, lethal(1)non-pupariating-1, non-pupariating-1, non-pupariating, overlapping-complementation-complex, reduced bristles on palps, reduced palps, BR-C, ecs, npr1, broad, uq, l(1)npr1" CDMC20836 3 16 13 DAC21-G24 23-CG11491-RD_1 CG11491 CAACTCACGCCTATGGACCAGTATATAGAATACGGATATACACTGTTTACACTCTGTGGCCTTCT 65 FBan0011491 FBgn0000210 br X X "autophagy; GO:0006914; catabolism; GO:0009056; cell death; GO:0008219; central nervous system remodeling (sensu Insecta); GO:0035193; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; eclosion; GO:0007562; metamorphosis (sensu Insecta); GO:0046698; metamorphosis; GO:0007552; photoreceptor fate commitment (sensu Endopterygota); GO:0007459; progression of morphogenetic furrow (sensu Endopterygota); GO:0007458; regulation of development, heterochronic; GO:0040034; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; response to ecdysone; GO:0035075; response to pest, pathogen or parasite; GO:0009613; salivary gland cell autophagic cell death; GO:0035071; salivary gland histolysis; GO:0035070; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" "DNA binding; GO:0003677; ; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; ; GO:0003700; ; GO:0003704; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0016788 ; EC:3.1.-.-; ; GO:0008270; ; GO:0005515" nucleus; GO:0005634 br broad "CG11514, CG11511, CG11491, CG11514, CG11511, CG11491, CG11511, CG11514, CG11491, l(1)pp-1, l(1)pp-2, l(1)pp1, l(1)pp2, A18, PP1, PP2, ecs: ecdysone-sensitivity, npr1: non-pupariating-1, l(1)npr-1, l(1)d norm-12, de12, l(1)2Bab, l(1)2Bc, l(1)2Bd, rbp, l(1)PP1, BR-C: Broad-complex, npr-1, l(1)ESHS5, rds, l(1)npr1: lethal(1)non-pupariating-1, uq: unequal wings, unequal wings, BRC, 2B5, Z1, Z2, Z3, Z4, 2Bc, npr, Br-C, nprl, l(1)G0018, l(1)G0318, l(1)G0284a, Broad-complex, l(1)G0401, l(1)G0042, Broad-Complex, Broad Complex, BRC-Z1, BR_C, EG:17A9.1, EG:123F11.1, EG:25D2.1, BrC-Z1, broad complex, BR-C Z1, br-C, BR-c, nrp, broad-complex, BR, br-Z1, br-Z3, l(1)G0284, l(1)2Ba, l(1)2Bad, l(1)2Bb, l(1)d.norm.1, l(1)dn1: lethal(1)discs normal, l(1)n34, l(1)ts132, l(1)ts144, l(1)ts358, l(1)ts376, o.c.c.: overlapping-complementation-complex, rdp, ecdysone-sensitivity, lethal(1)2Bab, lethal(1)2Bc, lethal(1)2Bd, lethal(1)discs normal, lethal(1)non-pupariating-1, non-pupariating-1, non-pupariating, overlapping-complementation-complex, reduced bristles on palps, reduced palps, BR-C, ecs, npr1, broad, uq, l(1)npr1" CDMC20837 3 17 13 DAC21-K12 2-CG11589-RA_2 CG11589 GCGGTTGCTTCTTCCGCGTATTTCCGGATCTTAAGCCACATCACACACAGTCGGTGAAACCACGG 65 FBan0011589 FBgn0028664 VhaM9.7-1 3 3L ATP synthesis coupled proton transport; GO:0015986; cation transport; GO:0006812 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; nucleotide phosphatase activity; GO:0019204; ; GO:0008553 ; EC:3.6.3.6; ; GO:0019204; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V0 domain; GO:0000220; integral to membrane; GO:0016021; proton-transporting two-sector ATPase complex; GO:0016469 VhaM9.7-1 VhaM9.7-1 "CG11589, vhaM9.2-1, vhaM9.7-1, V-ATPase" CDMC20837 3 18 13 DAC21-K12 2-CG11589-RA_2 CG11589 GCGGTTGCTTCTTCCGCGTATTTCCGGATCTTAAGCCACATCACACACAGTCGGTGAAACCACGG 65 FBan0011589 FBgn0028664 VhaM9.7-1 3 3L ATP synthesis coupled proton transport; GO:0015986; cation transport; GO:0006812 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; nucleotide phosphatase activity; GO:0019204; ; GO:0008553 ; EC:3.6.3.6; ; GO:0019204; hydrogen-transporting ATP synthase activity, rotational mechanism; GO:0046933; hydrogen-transporting ATPase activity, rotational mechanism; GO:0046961; ; GO:0046933; ; GO:0046961" hydrogen-transporting ATPase V0 domain; GO:0000220; integral to membrane; GO:0016021; proton-transporting two-sector ATPase complex; GO:0016469 VhaM9.7-1 VhaM9.7-1 "CG11589, vhaM9.2-1, vhaM9.7-1, V-ATPase" CDMC20838 3 19 13 DAC21-K24 2-CG11608-RA_2 CG11608 GGGACCCGGTACTCCAGGAAGCATCTCAAACTCAAGGCCTGGCTCTTGCAGTTTTGGCGTTTTAG 65 FBan0011608 FBgn0038069 CG11608 3 3R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG11608 CG11608 CDMC20838 3 20 13 DAC21-K24 2-CG11608-RA_2 CG11608 GGGACCCGGTACTCCAGGAAGCATCTCAAACTCAAGGCCTGGCTCTTGCAGTTTTGGCGTTTTAG 65 FBan0011608 FBgn0038069 CG11608 3 3R lipid metabolism; GO:0006629 triacylglycerol lipase activity; GO:0004806 ; EC:3.1.1.3; ; GO:0004806 ; EC:3.1.1.3 CG11608 CG11608 CDMC20839 3 21 13 DAC21-O12 1-CG11700-RA_4 CG11700 ACGTCAAAGCCAAGATACAGGACAAGGAGGAAAACCCCCCAGAGCATCAGCGTTTGATCTTCGGC 65 FBan0011700 FBgn0029856 CG11700 X X cellular physiological process; GO:0050875; protein metabolism; GO:0019538; proteolysis; GO:0006508 CG11700 CG11700 CDMC20839 3 22 13 DAC21-O12 1-CG11700-RA_4 CG11700 ACGTCAAAGCCAAGATACAGGACAAGGAGGAAAACCCCCCAGAGCATCAGCGTTTGATCTTCGGC 65 FBan0011700 FBgn0029856 CG11700 X X cellular physiological process; GO:0050875; protein metabolism; GO:0019538; proteolysis; GO:0006508 CG11700 CG11700 CDMC20840 3 23 13 DAC21-O24 AutoBlank AutoBlank CDMC20840 3 24 13 DAC21-O24 AutoBlank AutoBlank CDMC20841 3 25 13 DAC22-C12 3-CG3168-RA_2 CG3168 TATGGCCTGTTGATGTGGTTCCCGGAGCTCTTCAATCGCTTCGAGGAGTACGAGAAGGCATTCCC 65 FBan0003168 FBgn0029896 CG3168 X X DNA metabolism; GO:0006259; DNA topological change; GO:0006265; carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; neurotransmitter secretion; GO:0007269; synaptic transmission; GO:0007268; transmission of nerve impulse; GO:0019226; transport; GO:0006810 DNA binding; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; transporter activity; GO:0005215; carbohydrate transporter activity; GO:0015144; ; GO:0005215; DNA topoisomerase (ATP-hydrolyzing) activity; GO:0003918 ; EC:5.99.1.3; ; GO:0015144; ; GO:0003677; ; GO:0003918 ; EC:5.99.1.3 integral to membrane; GO:0016021; membrane; GO:0016020 CG3168 CG3168 "LP06294.5prime, BEST:LP06294" CDMC20841 3 26 13 DAC22-C12 3-CG3168-RA_2 CG3168 TATGGCCTGTTGATGTGGTTCCCGGAGCTCTTCAATCGCTTCGAGGAGTACGAGAAGGCATTCCC 65 FBan0003168 FBgn0029896 CG3168 X X DNA metabolism; GO:0006259; DNA topological change; GO:0006265; carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643; neurotransmitter secretion; GO:0007269; synaptic transmission; GO:0007268; transmission of nerve impulse; GO:0019226; transport; GO:0006810 DNA binding; GO:0003677; ATP binding; GO:0005524; ; GO:0005524; transporter activity; GO:0005215; carbohydrate transporter activity; GO:0015144; ; GO:0005215; DNA topoisomerase (ATP-hydrolyzing) activity; GO:0003918 ; EC:5.99.1.3; ; GO:0015144; ; GO:0003677; ; GO:0003918 ; EC:5.99.1.3 integral to membrane; GO:0016021; membrane; GO:0016020 CG3168 CG3168 "LP06294.5prime, BEST:LP06294" CDMC20842 3 1 14 DAC22-C24 2-CG31710-RA_1 CG31710 ATCGAGTCAAATCAGGCGGATCCAAGATGCTCACCAGACAACCCGACTACACCATCTCCGAGCTG 65 FBan0031710 FBgn0051710 CG31710 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31710 CG31710 CDMC20842 3 2 14 DAC22-C24 2-CG31710-RA_1 CG31710 ATCGAGTCAAATCAGGCGGATCCAAGATGCTCACCAGACAACCCGACTACACCATCTCCGAGCTG 65 FBan0031710 FBgn0051710 CG31710 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31710 CG31710 CDMC20843 3 3 14 DAC22-G12 3-CG31805-RA_3 CG31805 CTTGCCCGACTACCAAGCGTTGCTCAAGGAAAAGCACTTGTGTGCCGAAAACCACTCGAATGTGC 65 FBan0031805 FBgn0051805 CG31805 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31805 CG31805 CDMC20843 3 4 14 DAC22-G12 3-CG31805-RA_3 CG31805 CTTGCCCGACTACCAAGCGTTGCTCAAGGAAAAGCACTTGTGTGCCGAAAACCACTCGAATGTGC 65 FBan0031805 FBgn0051805 CG31805 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG31805 CG31805 CDMC20844 3 5 14 DAC22-G24 3-CG31869-RA_1 CG31869 GGTGGTGGCGACATCGATCTCTACCAGGATAAGTCTTCTACCACCGAGGAAATGATGGCGTCCGG 65 FBan0031869 FBgn0051869 CG31869 2 2L CG31869 CG31869 "CG17130, CG18499" CDMC20844 3 6 14 DAC22-G24 3-CG31869-RA_1 CG31869 GGTGGTGGCGACATCGATCTCTACCAGGATAAGTCTTCTACCACCGAGGAAATGATGGCGTCCGG 65 FBan0031869 FBgn0051869 CG31869 2 2L CG31869 CG31869 "CG17130, CG18499" CDMC20845 3 7 14 DAC22-K12 2-CG31961-RB_1 CG31961 CACTGCGCATATGATACGTGCCCAGTAAGAAAGCCGCGTTTTCCATGCATTTCTCTGCAGCTGCG 65 FBan0031961 FBgn0051961 CG31961 2 2L tubulin folding; GO:0007021 membrane; GO:0016020 CG31961 CG31961 "CG3381, BcDNA:LD34582" CDMC20845 3 8 14 DAC22-K12 2-CG31961-RB_1 CG31961 CACTGCGCATATGATACGTGCCCAGTAAGAAAGCCGCGTTTTCCATGCATTTCTCTGCAGCTGCG 65 FBan0031961 FBgn0051961 CG31961 2 2L tubulin folding; GO:0007021 membrane; GO:0016020 CG31961 CG31961 "CG3381, BcDNA:LD34582" CDMC20846 3 9 14 DAC22-K24 18-CG32031-RA_1 CG32031 GAGGCTGAGGGTGGTGTCTACGACATCTCCAACAAGCGTCGCATGGGTCTGACCGAGTTCGAGGC 65 FBan0032031 FBgn0000116 Argk 3 3L phosphorylation; GO:0016310 arginine kinase activity; GO:0004054 ; EC:2.7.3.3; ; GO:0004054 ; EC:2.7.3.3; ; GO:0004054 ; EC:2.7.3.3 Argk Arginine kinase "CG4929, CG5173, CG32031, CG4929, CG5173, CG4929, CG32031, ARK, AK, AK-1, ArgK, argK, insect intestinal mucin iim22, argk, Arginine kinase" CDMC20846 3 10 14 DAC22-K24 18-CG32031-RA_1 CG32031 GAGGCTGAGGGTGGTGTCTACGACATCTCCAACAAGCGTCGCATGGGTCTGACCGAGTTCGAGGC 65 FBan0032031 FBgn0000116 Argk 3 3L phosphorylation; GO:0016310 arginine kinase activity; GO:0004054 ; EC:2.7.3.3; ; GO:0004054 ; EC:2.7.3.3; ; GO:0004054 ; EC:2.7.3.3 Argk Arginine kinase "CG4929, CG5173, CG32031, CG4929, CG5173, CG4929, CG32031, ARK, AK, AK-1, ArgK, argK, insect intestinal mucin iim22, argk, Arginine kinase" CDMC20847 3 11 14 DAC22-O12 23-CG32143-RB_1 CG32143 CATAAGTTCTGGAATAATCAAATCATTTCGGGAACGTTTCCTCAGCAACTCATCTGGGGACTCCG 65 FBan0032143 FBgn0052143 CG32143 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32143 CG32143 CDMC20847 3 12 14 DAC22-O12 23-CG32143-RB_1 CG32143 CATAAGTTCTGGAATAATCAAATCATTTCGGGAACGTTTCCTCAGCAACTCATCTGGGGACTCCG 65 FBan0032143 FBgn0052143 CG32143 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32143 CG32143 CDMC20848 3 13 14 DAC22-O24 AutoBlank AutoBlank CDMC20848 3 14 14 DAC22-O24 AutoBlank AutoBlank CDMC20849 3 15 14 DAC23-C12 23-CG10757-RB_1 CG10757 ACGTCGCCTCTGAATTTTTTGAAGTAACTTCAGGTTTTATTCAATTAAAATGTTGCCGATTGCACGTGG 69 FBan0010757 FBgn0032849 mRpS18B 2 2L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS18B mitochondrial ribosomal protein S18B "CG10757, CG10757, CG10757, CG10757, MRP-S18-(2), mitochondrial ribosomal protein S18b, 38B.17, mRpS18b, mitochondrial ribosomal protein S18B" CDMC20849 3 16 14 DAC23-C12 23-CG10757-RB_1 CG10757 ACGTCGCCTCTGAATTTTTTGAAGTAACTTCAGGTTTTATTCAATTAAAATGTTGCCGATTGCACGTGG 69 FBan0010757 FBgn0032849 mRpS18B 2 2L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS18B mitochondrial ribosomal protein S18B "CG10757, CG10757, CG10757, CG10757, MRP-S18-(2), mitochondrial ribosomal protein S18b, 38B.17, mRpS18b, mitochondrial ribosomal protein S18B" CDMC20850 3 17 14 DAC23-C24 23-CG10778-RA_6 CG10778 GTGTAAATAGCGTATACCTGTACGTACAGATGCTACTGTTTTCCGGCCTATGCAATAAGGCTATCCGCC 69 FBan0010778 FBgn0029980 CG10778 X X metabolism; GO:0008152 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- CG10778 CG10778 CDMC20850 3 18 14 DAC23-C24 23-CG10778-RA_6 CG10778 GTGTAAATAGCGTATACCTGTACGTACAGATGCTACTGTTTTCCGGCCTATGCAATAAGGCTATCCGCC 69 FBan0010778 FBgn0029980 CG10778 X X metabolism; GO:0008152 acyltransferase activity; GO:0008415 ; EC:2.3.1.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008415 ; EC:2.3.1.- CG10778 CG10778 CDMC20851 3 19 14 DAC23-G12 23-CG10811-RA_1 CG10811 TATGATGCCTTTGTAATACAGAAGGAATCGCTTTGTAAGTGGCGAGATTCAAAGGATCAGTCTGCTGGC 69 FBan0010811 FBgn0023213 eIF-4G 4 4 regulation of translation; GO:0006445; regulation of translational initiation; GO:0006446; translational initiation; GO:0006413 mRNA binding; GO:0003729; translation initiation factor activity; GO:0003743; ; GO:0003729; ; GO:0003743 cytosol; GO:0005829; eukaryotic translation initiation factor 4F complex; GO:0016281 eIF-4G Eukaryotic-initiation-factor-4G "CG10811, CG10811, CG10811, eIF4G, translation initiation factor eIF4G, eIF4g, Eif4G" CDMC20851 3 20 14 DAC23-G12 23-CG10811-RA_1 CG10811 TATGATGCCTTTGTAATACAGAAGGAATCGCTTTGTAAGTGGCGAGATTCAAAGGATCAGTCTGCTGGC 69 FBan0010811 FBgn0023213 eIF-4G 4 4 regulation of translation; GO:0006445; regulation of translational initiation; GO:0006446; translational initiation; GO:0006413 mRNA binding; GO:0003729; translation initiation factor activity; GO:0003743; ; GO:0003729; ; GO:0003743 cytosol; GO:0005829; eukaryotic translation initiation factor 4F complex; GO:0016281 eIF-4G Eukaryotic-initiation-factor-4G "CG10811, CG10811, CG10811, eIF4G, translation initiation factor eIF4G, eIF4g, Eif4G" CDMC20852 3 21 14 DAC23-G24 16-CG10823-RA_1 CG10823 AGAACAGGACGAAGGAGTAGGTTGTCCGCTAAGTGAGCACAAAGCAGTCAAAGATTTCGCACTAAACGT 69 FBan0010823 FBgn0038880 CG10823 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186 "G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; peptide receptor activity, G-protein coupled; GO:0008528; ; GO:0008188; ; GO:0004930; ; GO:0008528" integral to membrane; GO:0016021 CG10823 CG10823 "anon-WO0170980.43, anon-WO0170980.44" CDMC20852 3 22 14 DAC23-G24 16-CG10823-RA_1 CG10823 AGAACAGGACGAAGGAGTAGGTTGTCCGCTAAGTGAGCACAAAGCAGTCAAAGATTTCGCACTAAACGT 69 FBan0010823 FBgn0038880 CG10823 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186 "G-protein coupled receptor activity; GO:0004930; neuropeptide receptor activity; GO:0008188; peptide receptor activity, G-protein coupled; GO:0008528; ; GO:0008188; ; GO:0004930; ; GO:0008528" integral to membrane; GO:0016021 CG10823 CG10823 "anon-WO0170980.43, anon-WO0170980.44" CDMC20853 3 23 14 DAC23-K12 17-CG10851-RB_1 CG10851 GGCTGAATGTGCCGATTTGGATTCAAGGAGTACATATAGGCCACGAAATTACTGCGACTTGTACACCGG 69 FBan0010851 FBgn0004587 B52 3 3R "mRNA splice site selection; GO:0006376; nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" "mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" NOT omega speckle; GO:0035062; nuclear speck; GO:0016607; nucleus; GO:0005634; spliceosome complex; GO:0005681 B52 B52 "CG10851, CG10851, SR55: serine-arginine protein 55, E726, SRp55: Serine/arginine rich protein 55, rrm8, l(3)s2249, B52/dSRp55, E(Dfd): Enhancer of Deformed, dSRp55, RRM8, MabB52: Monoclonal-antibody-B52, RSp55, Rbp8, Enhancer of Deformed, Monoclonal-antibody-B52, RNA-binding protein 8, serine-arginine protein 55, Serine/arginine rich protein 55, SRp55, E(Dfd), SR55" CDMC20853 3 24 14 DAC23-K12 17-CG10851-RB_1 CG10851 GGCTGAATGTGCCGATTTGGATTCAAGGAGTACATATAGGCCACGAAATTACTGCGACTTGTACACCGG 69 FBan0010851 FBgn0004587 B52 3 3R "mRNA splice site selection; GO:0006376; nuclear mRNA splicing, via spliceosome; GO:0000398; regulation of alternative nuclear mRNA splicing, via spliceosome; GO:0000381" "mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515; RNA splicing factor activity, transesterification mechanism; GO:0031202; ; GO:0031202" NOT omega speckle; GO:0035062; nuclear speck; GO:0016607; nucleus; GO:0005634; spliceosome complex; GO:0005681 B52 B52 "CG10851, CG10851, SR55: serine-arginine protein 55, E726, SRp55: Serine/arginine rich protein 55, rrm8, l(3)s2249, B52/dSRp55, E(Dfd): Enhancer of Deformed, dSRp55, RRM8, MabB52: Monoclonal-antibody-B52, RSp55, Rbp8, Enhancer of Deformed, Monoclonal-antibody-B52, RNA-binding protein 8, serine-arginine protein 55, Serine/arginine rich protein 55, SRp55, E(Dfd), SR55" CDMC20854 3 25 14 DAC23-K24 2-CG10862-RA_2 CG10862 GATCCCCTCACCATCACTAGGCTCCGTCGAGAGATCTCAGAGTTCTCAACCGATCAAACGGAAGGGTGT 69 FBan0010862 FBgn0035455 CG10862 3 3L protein metabolism; GO:0019538; protein modification; GO:0006464; ubiquitin cycle; GO:0006512 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840 CG10862 CG10862 CDMC20854 3 26 14 DAC23-K24 2-CG10862-RA_2 CG10862 GATCCCCTCACCATCACTAGGCTCCGTCGAGAGATCTCAGAGTTCTCAACCGATCAAACGGAAGGGTGT 69 FBan0010862 FBgn0035455 CG10862 3 3L protein metabolism; GO:0019538; protein modification; GO:0006464; ubiquitin cycle; GO:0006512 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.-; ubiquitin conjugating enzyme activity; GO:0004840; ; GO:0004840 CG10862 CG10862 CDMC20855 3 1 15 DAC23-O12 6-CG10914-RA_2 CG10914 GCGGTTTGGCCAGATTGGATCTGCTGGAAATAACAAGCCCAAGGAAACACTTTGACTGGCTGAAGGTGT 69 FBan0010914 FBgn0034307 CG10914 2 2R CG10914 CG10914 CDMC20855 3 2 15 DAC23-O12 6-CG10914-RA_2 CG10914 GCGGTTTGGCCAGATTGGATCTGCTGGAAATAACAAGCCCAAGGAAACACTTTGACTGGCTGAAGGTGT 69 FBan0010914 FBgn0034307 CG10914 2 2R CG10914 CG10914 CDMC20856 3 3 15 DAC23-O24 AutoBlank AutoBlank CDMC20856 3 4 15 DAC23-O24 AutoBlank AutoBlank CDMC20857 3 5 15 DAC24-C12 1-CG14944-RA_1 CG14944 TCCGCCGGGTATCGTCGAGCTTGAAAAAATCAGCTCTGGACTTCGCATCGCGTTTCTTCAACAAATGCA 69 FBan0014944 FBgn0032384 CG14944 2 2L CG14944 CG14944 CDMC20857 3 6 15 DAC24-C12 1-CG14944-RA_1 CG14944 TCCGCCGGGTATCGTCGAGCTTGAAAAAATCAGCTCTGGACTTCGCATCGCGTTTCTTCAACAAATGCA 69 FBan0014944 FBgn0032384 CG14944 2 2L CG14944 CG14944 CDMC20858 3 7 15 DAC24-C24 14-CG14957-RA_1 CG14957 TGCGGATGAGGCGTGTCAGAATGTGGATAAATCGGTCATAATAGCGAACCAGAATGACTCCACATGCGT 69 FBan0014957 FBgn0035412 CG14957 3 3L CG14957 CG14957 CDMC20858 3 8 15 DAC24-C24 14-CG14957-RA_1 CG14957 TGCGGATGAGGCGTGTCAGAATGTGGATAAATCGGTCATAATAGCGAACCAGAATGACTCCACATGCGT 69 FBan0014957 FBgn0035412 CG14957 3 3L CG14957 CG14957 CDMC20859 3 9 15 DAC24-G12 3-CG14982-RB_2 CG14982 TCCCCAAAGGTTTCTCCTCGGAGGTGTACCACAATAGCTTGGATATGGAAAGGGAGGCTCTGAATGCCA 69 FBan0014982 FBgn0035477 CG14982 3 3L CG14982 CG14982 CDMC20859 3 10 15 DAC24-G12 3-CG14982-RB_2 CG14982 TCCCCAAAGGTTTCTCCTCGGAGGTGTACCACAATAGCTTGGATATGGAAAGGGAGGCTCTGAATGCCA 69 FBan0014982 FBgn0035477 CG14982 3 3L CG14982 CG14982 CDMC20860 3 11 15 DAC24-G24 18-CG14995-RA_1 CG14995 AGCGGCGTTGCAAAATACAAATGACCAGGAAAACTGAACACACATAAAAGACAAGACACGAGCAGCTGT 69 FBan0014995 FBgn0035497 CG14995 3 3L autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071 CG14995 CG14995 "CT34848, anon-WO0140519.252, NEST:bs17f06, NEST:bs15f01, bs17f06.y1, Gandalf" CDMC20860 3 12 15 DAC24-G24 18-CG14995-RA_1 CG14995 AGCGGCGTTGCAAAATACAAATGACCAGGAAAACTGAACACACATAAAAGACAAGACACGAGCAGCTGT 69 FBan0014995 FBgn0035497 CG14995 3 3L autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071 CG14995 CG14995 "CT34848, anon-WO0140519.252, NEST:bs17f06, NEST:bs15f01, bs17f06.y1, Gandalf" CDMC20861 3 13 15 DAC24-K12 11-CG15018-RA_1 CG15018 AGCAGCTGTTCAACATGTTCAAGCCAATGATGTCCAAGAAAATGCAGTCTCGCCTATTTGTGCACGGCA 69 FBgn0035536 CDMC20861 3 14 15 DAC24-K12 11-CG15018-RA_1 CG15018 AGCAGCTGTTCAACATGTTCAAGCCAATGATGTCCAAGAAAATGCAGTCTCGCCTATTTGTGCACGGCA 69 FBgn0035536 CDMC20862 3 15 15 DAC24-K24 3-CG15031-RA_2 CG15031 ACCACTCGTAGCCCTCACCAAGGATCCCAAGATGAAGAAGTCACAGAAGAAGTCATCAATGGTGGCCGT 69 FBan0015031 FBgn0030623 CG15031 X X CG15031 CG15031 BcDNA:AT19571 CDMC20862 3 16 15 DAC24-K24 3-CG15031-RA_2 CG15031 ACCACTCGTAGCCCTCACCAAGGATCCCAAGATGAAGAAGTCACAGAAGAAGTCATCAATGGTGGCCGT 69 FBan0015031 FBgn0030623 CG15031 X X CG15031 CG15031 BcDNA:AT19571 CDMC20863 3 17 15 DAC24-O12 3-CG15072-RA_1 CG15072 CCAGAGGTTTTCCAAGGCTTGGAATACGATGGACCCAAGTCGGATATCTGGAGTTTGGGCGTTGTGCTG 69 FBan0015072 FBgn0034376 CG15072 2 2R cytoskeleton organization and biogenesis; GO:0007010; gametogenesis; GO:0007276; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112 CG15072 CG15072 EMK/KIAA0999 CDMC20863 3 18 15 DAC24-O12 3-CG15072-RA_1 CG15072 CCAGAGGTTTTCCAAGGCTTGGAATACGATGGACCCAAGTCGGATATCTGGAGTTTGGGCGTTGTGCTG 69 FBan0015072 FBgn0034376 CG15072 2 2R cytoskeleton organization and biogenesis; GO:0007010; gametogenesis; GO:0007276; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein serine/threonine kinase activity; GO:0004674; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004674; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112 CG15072 CG15072 EMK/KIAA0999 CDMC20864 3 19 15 DAC24-O24 AutoBlank AutoBlank CDMC20864 3 20 15 DAC24-O24 AutoBlank AutoBlank CDMC20865 3 21 15 DAC25-C12 1-CG14330-RA_1 CG14330 TGCCAGCCAGTGACGTTTTTTGGGGCCAAACTGACTAATTACACCGCGACGTAATCAAGTGACACGGAT 69 FBan0014330 FBgn0038512 CG14330 3 3R CG14330 CG14330 CDMC20865 3 22 15 DAC25-C12 1-CG14330-RA_1 CG14330 TGCCAGCCAGTGACGTTTTTTGGGGCCAAACTGACTAATTACACCGCGACGTAATCAAGTGACACGGAT 69 FBan0014330 FBgn0038512 CG14330 3 3R CG14330 CG14330 CDMC20866 3 23 15 DAC25-C24 3-CG14346-RA_1 CG14346 CCCACAAGACCAAGTAGTCGCACTGAAACTCAACCTCCTCCCACGGAACTGTGTGCCTCCAAAACATTG 69 FBan0014346 FBgn0031337 CG14346 2 2L CG14346 CG14346 CDMC20866 3 24 15 DAC25-C24 3-CG14346-RA_1 CG14346 CCCACAAGACCAAGTAGTCGCACTGAAACTCAACCTCCTCCCACGGAACTGTGTGCCTCCAAAACATTG 69 FBan0014346 FBgn0031337 CG14346 2 2L CG14346 CG14346 CDMC20867 3 25 15 DAC25-G12 1-CG14391-RA_1 CG14391 TCCCCTGATTCCGAACAAGAGCATGTTTTTGGGTGGTAGCATTCCCATGGGGTCACAAACATCCCAAGT 69 FBan0014391 FBgn0038078 CG14391 3 3R CG14391 CG14391 BcDNA:AT22529 CDMC20867 3 26 15 DAC25-G12 1-CG14391-RA_1 CG14391 TCCCCTGATTCCGAACAAGAGCATGTTTTTGGGTGGTAGCATTCCCATGGGGTCACAAACATCCCAAGT 69 FBan0014391 FBgn0038078 CG14391 3 3R CG14391 CG14391 BcDNA:AT22529 CDMC20868 3 1 16 DAC25-G24 13-CG14406-RA_1 CG14406 GCTGCAAGCAGAACCGTATTTGGTGATGATCAATTGCCCATCAACGATCCATCGGATCTAAGTGCTGGT 69 FBan0014406 FBgn0030595 CG14406 X X CG14406 CG14406 CDMC20868 3 2 16 DAC25-G24 13-CG14406-RA_1 CG14406 GCTGCAAGCAGAACCGTATTTGGTGATGATCAATTGCCCATCAACGATCCATCGGATCTAAGTGCTGGT 69 FBan0014406 FBgn0030595 CG14406 X X CG14406 CG14406 CDMC20869 3 3 16 DAC25-K12 2-CG14444-RA_4 CG14444 GCCTCTACTACAACGGCGATTACTTTCAAGCGGAGGATATCTTCTCGTCGACGCTGTGTGCCAATCCGG 69 FBan0014444 FBgn0029879 APC7 X X cell cycle; GO:0007049; mitosis; GO:0007067; regulation of progression through cell cycle; GO:0000074 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.- APC7 Anaphase Promoting Complex 7 "CG14444, CG14444, Anaphase Promoting Complex 7" CDMC20869 3 4 16 DAC25-K12 2-CG14444-RA_4 CG14444 GCCTCTACTACAACGGCGATTACTTTCAAGCGGAGGATATCTTCTCGTCGACGCTGTGTGCCAATCCGG 69 FBan0014444 FBgn0029879 APC7 X X cell cycle; GO:0007049; mitosis; GO:0007067; regulation of progression through cell cycle; GO:0000074 ligase activity; GO:0016874 ; EC:6.-.-.-; ; GO:0016874 ; EC:6.-.-.- APC7 Anaphase Promoting Complex 7 "CG14444, CG14444, Anaphase Promoting Complex 7" CDMC20870 3 5 16 DAC25-K24 3-CG14458-RA_3 CG14458 AGGAGTCGATATATCGACGGTGGTTTACGTCCATGCTGAAGGTGGGAAACTTCGCTACGAGCTGTCCCA 69 FBgn0037173 CDMC20870 3 6 16 DAC25-K24 3-CG14458-RA_3 CG14458 AGGAGTCGATATATCGACGGTGGTTTACGTCCATGCTGAAGGTGGGAAACTTCGCTACGAGCTGTCCCA 69 FBgn0037173 CDMC20871 3 7 16 DAC25-O12 8-CG14508-RA_1 CG14508 AACATATTTCCCCAAGTGGTGACAACCCCAGTCGACAGAGCTTTCCAACACTGGTTGCGTTGACATTGT 69 FBan0014508 FBgn0039651 CG14508 3 3R "mitochondrial electron transport, ubiquinol to cytochrome c; GO:0006122; oxidative phosphorylation; GO:0006119" "electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity; GO:0045153; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0045153; ; GO:0045153" respiratory chain complex III (sensu Eukaryota); GO:0005750 CG14508 CG14508 CDMC20871 3 8 16 DAC25-O12 8-CG14508-RA_1 CG14508 AACATATTTCCCCAAGTGGTGACAACCCCAGTCGACAGAGCTTTCCAACACTGGTTGCGTTGACATTGT 69 FBan0014508 FBgn0039651 CG14508 3 3R "mitochondrial electron transport, ubiquinol to cytochrome c; GO:0006122; oxidative phosphorylation; GO:0006119" "electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity; GO:0045153; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0045153; ; GO:0045153" respiratory chain complex III (sensu Eukaryota); GO:0005750 CG14508 CG14508 CDMC20872 3 9 16 DAC25-O24 AutoBlank AutoBlank CDMC20872 3 10 16 DAC25-O24 AutoBlank AutoBlank CDMC20873 3 11 16 DAC26-C12 3-CG4734-RA_2 CG4734 AGCACGCCACCTACTTCTGTGGCTCCATTAAGAAGGATGTGGTCATATCGAGCAACAATCCCGGTCCTT 69 FBan0004734 FBgn0033826 CG4734 2 2R CG4734 CG4734 CDMC20873 3 12 16 DAC26-C12 3-CG4734-RA_2 CG4734 AGCACGCCACCTACTTCTGTGGCTCCATTAAGAAGGATGTGGTCATATCGAGCAACAATCCCGGTCCTT 69 FBan0004734 FBgn0033826 CG4734 2 2R CG4734 CG4734 CDMC20874 3 13 16 DAC26-C24 12-CG4744-RA_2 CG4744 TCCTTGCCGAGGATTTCAGTCAGGATGTGCGATTGCTCGATCCGAGTAAGATCAGCCAAAAGTCGAGAA 69 FBan0004744 FBgn0033834 CG4744 2 2R CG4744 CG4744 CDMC20874 3 14 16 DAC26-C24 12-CG4744-RA_2 CG4744 TCCTTGCCGAGGATTTCAGTCAGGATGTGCGATTGCTCGATCCGAGTAAGATCAGCCAAAAGTCGAGAA 69 FBan0004744 FBgn0033834 CG4744 2 2R CG4744 CG4744 CDMC20875 3 15 16 DAC26-G12 23-CG4769-RA_2 CG4769 CGCAACCACCAAGTCAATGTTCTCTCCGCTGAAAAATATAAACACAAATACTATCCCAATATGCGAGAG 69 FBan0004769 FBgn0035600 CG4769 3 3L "mitochondrial electron transport, ubiquinol to cytochrome c; GO:0006122; oxidative phosphorylation; GO:0006119" "electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity; GO:0045153; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0045153; ; GO:0045153" respiratory chain complex III (sensu Eukaryota); GO:0005750 CG4769 CG4769 anon-EST:Posey141 CDMC20875 3 16 16 DAC26-G12 23-CG4769-RA_2 CG4769 CGCAACCACCAAGTCAATGTTCTCTCCGCTGAAAAATATAAACACAAATACTATCCCAATATGCGAGAG 69 FBan0004769 FBgn0035600 CG4769 3 3L "mitochondrial electron transport, ubiquinol to cytochrome c; GO:0006122; oxidative phosphorylation; GO:0006119" "electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity; GO:0045153; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0045153; ; GO:0045153" respiratory chain complex III (sensu Eukaryota); GO:0005750 CG4769 CG4769 anon-EST:Posey141 CDMC20876 3 17 16 DAC26-G24 10-CG4779-RA_1 CG4779 TGGTGATTAACTCGGTTAGCTTTGACCATTGTGACCCCAGCATTTTTACCGTGCTCACTTGTCCCAGCT 69 FBan0004779 FBgn0040211 hgo 2 2L L-phenylalanine catabolism; GO:0006559; tyrosine catabolism; GO:0006572 "homogentisate 1,2-dioxygenase activity; GO:0004411 ; EC:1.13.11.5; ; GO:0004411 ; EC:1.13.11.5; ; GO:0004411 ; EC:1.13.11.5" hgo "homogentisate 1,2-dioxygenase" "CG4779, homogentisate 1,2-dioxygenase" CDMC20876 3 18 16 DAC26-G24 10-CG4779-RA_1 CG4779 TGGTGATTAACTCGGTTAGCTTTGACCATTGTGACCCCAGCATTTTTACCGTGCTCACTTGTCCCAGCT 69 FBan0004779 FBgn0040211 hgo 2 2L L-phenylalanine catabolism; GO:0006559; tyrosine catabolism; GO:0006572 "homogentisate 1,2-dioxygenase activity; GO:0004411 ; EC:1.13.11.5; ; GO:0004411 ; EC:1.13.11.5; ; GO:0004411 ; EC:1.13.11.5" hgo "homogentisate 1,2-dioxygenase" "CG4779, homogentisate 1,2-dioxygenase" CDMC20877 3 19 16 DAC26-K12 9-CG4807-RA_2 CG4807 CCCCGAAACGAACCTCAGACTTCCATGAGTTGTGACTGGTCCTGCACTCCATCTTCATGAAACTTGCCA 69 FBan0004807 FBgn0000011 ab 2 2L axon choice point recognition; GO:0016198; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 nucleic acid binding; GO:0003676; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003676; ; GO:0003704; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 nucleus; GO:0005634 ab abrupt "CG4807, CG4807, clu: clueless, clueless, l(2)k02807, ptd, parted, clu" CDMC20877 3 20 16 DAC26-K12 9-CG4807-RA_2 CG4807 CCCCGAAACGAACCTCAGACTTCCATGAGTTGTGACTGGTCCTGCACTCCATCTTCATGAAACTTGCCA 69 FBan0004807 FBgn0000011 ab 2 2L axon choice point recognition; GO:0016198; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 nucleic acid binding; GO:0003676; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003676; ; GO:0003704; protein binding; GO:0005515; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0005515 nucleus; GO:0005634 ab abrupt "CG4807, CG4807, clu: clueless, clueless, l(2)k02807, ptd, parted, clu" CDMC20878 3 21 16 DAC26-K24 3-CG4817-RA_1 CG4817 GCGGATCCACGCGATCTTTCGACTTCGAAGTGACGCTCAAGAACGGAACTGTTCACATCTTCTCCTCCA 69 FBan0004817 FBgn0010278 Ssrp 2 2R regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357 single-stranded DNA binding; GO:0003697; single-stranded RNA binding; GO:0003727; ; GO:0003697; ; GO:0003727; transcription regulator activity; GO:0030528; ; GO:0030528; protein binding; GO:0005515; DNA secondary structure binding; GO:0000217; ; GO:0000217; ; GO:0003697; ; GO:0005515 FACT complex; GO:0035101; nucleolus; GO:0005730; nucleus; GO:0005634 Ssrp Structure specific recognition protein "CG4817, DssRP, SSRP1, dSSRP, SSRP, dSSRP1, Cf5: Chorion factor, Chorion factor" CDMC20878 3 22 16 DAC26-K24 3-CG4817-RA_1 CG4817 GCGGATCCACGCGATCTTTCGACTTCGAAGTGACGCTCAAGAACGGAACTGTTCACATCTTCTCCTCCA 69 FBan0004817 FBgn0010278 Ssrp 2 2R regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357 single-stranded DNA binding; GO:0003697; single-stranded RNA binding; GO:0003727; ; GO:0003697; ; GO:0003727; transcription regulator activity; GO:0030528; ; GO:0030528; protein binding; GO:0005515; DNA secondary structure binding; GO:0000217; ; GO:0000217; ; GO:0003697; ; GO:0005515 FACT complex; GO:0035101; nucleolus; GO:0005730; nucleus; GO:0005634 Ssrp Structure specific recognition protein "CG4817, DssRP, SSRP1, dSSRP, SSRP, dSSRP1, Cf5: Chorion factor, Chorion factor" CDMC20879 3 23 16 DAC26-O12 11-CG4857-RB_1 CG4857 TCGGCAGCAATCTAACGAGAGCATCCAACGTCGGCTGAAATCAGGAGAGCAGATTGGTTGGAATAGAGT 69 FBan0004857 FBgn0026083 CG4857 X X CG4857 CG4857 "EG:EG0007.12, EG:EG0007.4" CDMC20879 3 24 16 DAC26-O12 11-CG4857-RB_1 CG4857 TCGGCAGCAATCTAACGAGAGCATCCAACGTCGGCTGAAATCAGGAGAGCAGATTGGTTGGAATAGAGT 69 FBan0004857 FBgn0026083 CG4857 X X CG4857 CG4857 "EG:EG0007.12, EG:EG0007.4" CDMC20880 3 25 16 DAC26-O24 1-CG4863-RC_1 CG4863 CGCGGCTAAGAAGTTGGAGTTGTTGCGACACCCCAATGGATTGCTACATTACGCTCGTTTCTGACCACT 69 FBan0004863 FBgn0020910 RpL3 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; cytosolic ribosome (sensu Eukaryota); GO:0005830 RpL3 Ribosomal protein L3 "CG4863, CG4863, rpL3, anon-EST:GressD4" CDMC20880 3 26 16 DAC26-O24 1-CG4863-RC_1 CG4863 CGCGGCTAAGAAGTTGGAGTTGTTGCGACACCCCAATGGATTGCTACATTACGCTCGTTTCTGACCACT 69 FBan0004863 FBgn0020910 RpL3 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; cytosolic ribosome (sensu Eukaryota); GO:0005830 RpL3 Ribosomal protein L3 "CG4863, CG4863, rpL3, anon-EST:GressD4" CDMC20881 3 1 17 DAC27-C12 6-CG3499-RB_1 CG3499 AGGCGCTTCTCAAGTACGAGACTCTTGACGCCGACGACATCAAGGCAATACTGAATGAAAGCCAGACGT 69 FBan0003499 FBgn0034792 CG3499 2 2R mitosis; GO:0007067; proteolysis; GO:0006508 ATP binding; GO:0005524; ; GO:0005524; ATP-dependent peptidase activity; GO:0004176; metallopeptidase activity; GO:0008237; metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ; GO:0008237; ; GO:0004176; ; GO:0004222 ; EC:3.4.24.- mitochondrial inner membrane; GO:0005743 CG3499 CG3499 DmCG3499 CDMC20881 3 2 17 DAC27-C12 6-CG3499-RB_1 CG3499 AGGCGCTTCTCAAGTACGAGACTCTTGACGCCGACGACATCAAGGCAATACTGAATGAAAGCCAGACGT 69 FBan0003499 FBgn0034792 CG3499 2 2R mitosis; GO:0007067; proteolysis; GO:0006508 ATP binding; GO:0005524; ; GO:0005524; ATP-dependent peptidase activity; GO:0004176; metallopeptidase activity; GO:0008237; metalloendopeptidase activity; GO:0004222 ; EC:3.4.24.-; ; GO:0008237; ; GO:0004176; ; GO:0004222 ; EC:3.4.24.- mitochondrial inner membrane; GO:0005743 CG3499 CG3499 DmCG3499 CDMC20882 3 3 17 DAC27-C24 2-CG3510-RA_1 CG3510 ACCTGCATCACCCATCCCTAAGATATCGTAATCTGCTGGAGTCCCTTGAGCAGTTTTCGGCTACTGCCA 69 FBan0003510 FBgn0000405 CycB 2 2R G2/M transition of mitotic cell cycle; GO:0000086; attachment of spindle microtubules to kinetochore; GO:0008608; cellular physiological process; GO:0050875; cytokinesis; GO:0000910; cytokinesis after mitosis; GO:0000281; embryonic development (sensu Insecta); GO:0001700; mitotic anaphase B; GO:0000092; mitotic chromosome movement towards spindle pole; GO:0007079; regulation of progression through cell cycle; GO:0000074 kinase activator activity; GO:0019209; cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0019209; ; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.- "chromosome, pericentric region; GO:0000775; cytoplasm; GO:0005737; nuclear cyclin-dependent protein kinase holoenzyme complex; GO:0019908; pole plasm; GO:0045495; spindle; GO:0005819" CycB Cyclin B "CG3510, CG3510, CG3510, cycB, cyclinB, cyc-B, cyclin B, Cyclin-B, 2g, CyclinB, cyc B, mAbF2F4, DmcycB, Cyclin B" CDMC20882 3 4 17 DAC27-C24 2-CG3510-RA_1 CG3510 ACCTGCATCACCCATCCCTAAGATATCGTAATCTGCTGGAGTCCCTTGAGCAGTTTTCGGCTACTGCCA 69 FBan0003510 FBgn0000405 CycB 2 2R G2/M transition of mitotic cell cycle; GO:0000086; attachment of spindle microtubules to kinetochore; GO:0008608; cellular physiological process; GO:0050875; cytokinesis; GO:0000910; cytokinesis after mitosis; GO:0000281; embryonic development (sensu Insecta); GO:0001700; mitotic anaphase B; GO:0000092; mitotic chromosome movement towards spindle pole; GO:0007079; regulation of progression through cell cycle; GO:0000074 kinase activator activity; GO:0019209; cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0019209; ; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.- "chromosome, pericentric region; GO:0000775; cytoplasm; GO:0005737; nuclear cyclin-dependent protein kinase holoenzyme complex; GO:0019908; pole plasm; GO:0045495; spindle; GO:0005819" CycB Cyclin B "CG3510, CG3510, CG3510, cycB, cyclinB, cyc-B, cyclin B, Cyclin-B, 2g, CyclinB, cyc B, mAbF2F4, DmcycB, Cyclin B" CDMC20883 3 5 17 DAC27-G12 14-CG3548-RA_1 CG3548 GCCGGACGCGCATACAATACTCATCGACACACTCAAGTTGCCACTCGGACGAATGGACTGTTGTTTATT 69 FBan0003548 FBgn0035033 CG3548 2 2R CG3548 CG3548 CDMC20883 3 6 17 DAC27-G12 14-CG3548-RA_1 CG3548 GCCGGACGCGCATACAATACTCATCGACACACTCAAGTTGCCACTCGGACGAATGGACTGTTGTTTATT 69 FBan0003548 FBgn0035033 CG3548 2 2R CG3548 CG3548 CDMC20884 3 7 17 DAC27-G24 9-CG3568-RA_7 CG3568 CGCTAACGACTATTACCGTACAATGCAGGGAAATATTGGTAACGAGGGCTTCGAGGCAGTGGGTACGCC 69 FBan0003568 FBgn0029710 CG3568 X X CG3568 CG3568 CDMC20884 3 8 17 DAC27-G24 9-CG3568-RA_7 CG3568 CGCTAACGACTATTACCGTACAATGCAGGGAAATATTGGTAACGAGGGCTTCGAGGCAGTGGGTACGCC 69 FBan0003568 FBgn0029710 CG3568 X X CG3568 CG3568 CDMC20885 3 9 17 DAC27-K12 3-CG3606-RA_1 CG3606 TCGACCACCGAGCAGGACATTGAGACACACTTTGGAGCAATTGGCATCATCAAGGCAAACAAGCGTACA 69 FBan0003606 FBgn0011571 caz X X transcription initiation from RNA polymerase II promoter; GO:0006367 mRNA binding; GO:0003729; ; GO:0003729; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251 nucleus; GO:0005634; transcription factor TFIID complex; GO:0005669 caz cabeza "CG3606, CG3606, p19, P19, SARFH, Sarcoma-associated RNA-binding fly homolog, cas, TFIID, BcDNA:GM09207, Pen19, Sarfh: Sarcoma-associated RNA-binding fly homolog, anon-Pen19, pen19, cabeza" CDMC20885 3 10 17 DAC27-K12 3-CG3606-RA_1 CG3606 TCGACCACCGAGCAGGACATTGAGACACACTTTGGAGCAATTGGCATCATCAAGGCAAACAAGCGTACA 69 FBan0003606 FBgn0011571 caz X X transcription initiation from RNA polymerase II promoter; GO:0006367 mRNA binding; GO:0003729; ; GO:0003729; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251 nucleus; GO:0005634; transcription factor TFIID complex; GO:0005669 caz cabeza "CG3606, CG3606, p19, P19, SARFH, Sarcoma-associated RNA-binding fly homolog, cas, TFIID, BcDNA:GM09207, Pen19, Sarfh: Sarcoma-associated RNA-binding fly homolog, anon-Pen19, pen19, cabeza" CDMC20886 3 11 17 DAC27-K24 2-CG3618-RA_1 CG3618 TGGATCTGGTGGCATAAGGAGCGATCAGCCCGAAAAGTTGATGCCTATGACTTCCCAGTTATCCTGCCT 69 FBan0003618 FBgn0037028 CG3618 3 3L actin filament organization; GO:0007015; cell adhesion; GO:0007155; regulation of cell shape; GO:0008360 guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2 CG3618 CG3618 GYCb100B CDMC20886 3 12 17 DAC27-K24 2-CG3618-RA_1 CG3618 TGGATCTGGTGGCATAAGGAGCGATCAGCCCGAAAAGTTGATGCCTATGACTTCCCAGTTATCCTGCCT 69 FBan0003618 FBgn0037028 CG3618 3 3L actin filament organization; GO:0007015; cell adhesion; GO:0007155; regulation of cell shape; GO:0008360 guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2 CG3618 CG3618 GYCb100B CDMC20887 3 13 17 DAC27-O12 3-CG3664-RB_1 CG3664 AGCATAAGGCCGACTGGAACCGAAACAAATCGACCGACGAACAACTGCTGCAAGTGATGTCCCTTCGTA 69 FBan0003664 FBgn0014010 Rab5 2 2L cellularization (sensu Metazoa); GO:0009796; establishment and/or maintenance of chromatin architecture; GO:0006325; female meiosis chromosome segregation; GO:0016321; intracellular protein transport; GO:0006886; lysosomal transport; GO:0007041; mitosis; GO:0007067; receptor mediated endocytosis; GO:0006898; regulation of exocytosis; GO:0017157; regulation of synapse structure and function; GO:0050803; signal transduction; GO:0007165; small GTPase mediated signal transduction; GO:0007264; synaptic vesicle endocytosis; GO:0048488; synaptic vesicle to endosome fusion; GO:0016189 GTP binding; GO:0005525; ; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924 early endosome; GO:0005769; plasma membrane; GO:0005886 Rab5 Rab-protein 5 "CG3664, CG3664, CG3664, l(2)k08232, Drab5, DRab5, rab5, DmRab5, AAF51265, BAA88244, Rab, Dm Rab5" CDMC20887 3 14 17 DAC27-O12 3-CG3664-RB_1 CG3664 AGCATAAGGCCGACTGGAACCGAAACAAATCGACCGACGAACAACTGCTGCAAGTGATGTCCCTTCGTA 69 FBan0003664 FBgn0014010 Rab5 2 2L cellularization (sensu Metazoa); GO:0009796; establishment and/or maintenance of chromatin architecture; GO:0006325; female meiosis chromosome segregation; GO:0016321; intracellular protein transport; GO:0006886; lysosomal transport; GO:0007041; mitosis; GO:0007067; receptor mediated endocytosis; GO:0006898; regulation of exocytosis; GO:0017157; regulation of synapse structure and function; GO:0050803; signal transduction; GO:0007165; small GTPase mediated signal transduction; GO:0007264; synaptic vesicle endocytosis; GO:0048488; synaptic vesicle to endosome fusion; GO:0016189 GTP binding; GO:0005525; ; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0003924 early endosome; GO:0005769; plasma membrane; GO:0005886 Rab5 Rab-protein 5 "CG3664, CG3664, CG3664, l(2)k08232, Drab5, DRab5, rab5, DmRab5, AAF51265, BAA88244, Rab, Dm Rab5" CDMC20888 3 15 17 DAC27-O24 2-CG3671-RC_1 CG3671 CGTTCACGTTCCTGTTTCTGGACAAGTACGGTCTACGCAAGCTGGAGTTCCTATTCGGCACCCTCATCA 69 FBan0003671 FBgn0011672 Mvl 3 3R cation transport; GO:0006812 cation transporter activity; GO:0008324; ; GO:0008324 integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 Mvl Malvolio "CG3671, mvl, NRM2, malvolio" CDMC20888 3 16 17 DAC27-O24 2-CG3671-RC_1 CG3671 CGTTCACGTTCCTGTTTCTGGACAAGTACGGTCTACGCAAGCTGGAGTTCCTATTCGGCACCCTCATCA 69 FBan0003671 FBgn0011672 Mvl 3 3R cation transport; GO:0006812 cation transporter activity; GO:0008324; ; GO:0008324 integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 Mvl Malvolio "CG3671, mvl, NRM2, malvolio" CDMC20889 3 17 17 DAC28-C12 16-CG14763-RA_1 CG14763 AGCGAGGAAATCAAGAACCGCATCAAACTCGACAACTACGACAGATATCGCTACATAGTGCTGGTCACT 69 FBan0014763 FBgn0033243 CG14763 2 2R microtubule-based movement; GO:0007018 "ATPase activity, coupled; GO:0042623; ; GO:0042623" dynein complex; GO:0030286; microtubule associated complex; GO:0005875 CG14763 CG14763 CDMC20889 3 18 17 DAC28-C12 16-CG14763-RA_1 CG14763 AGCGAGGAAATCAAGAACCGCATCAAACTCGACAACTACGACAGATATCGCTACATAGTGCTGGTCACT 69 FBan0014763 FBgn0033243 CG14763 2 2R microtubule-based movement; GO:0007018 "ATPase activity, coupled; GO:0042623; ; GO:0042623" dynein complex; GO:0030286; microtubule associated complex; GO:0005875 CG14763 CG14763 CDMC20890 3 19 17 DAC28-C24 5-CG14789-RA_1 CG14789 CGACAGCGAGGAAGATTCCGACCCGTACTGATCCATCTGTAGCTCCCACCTGACATCTCAAGACCTAGT 69 FBan0014789 FBgn0027791 O-fut2 X X tRNA aminoacylation for protein translation; GO:0006418 ATP binding; GO:0005524; ; GO:0005524; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; fucosyltransferase activity; GO:0008417 ; EC:2.4.1.-; ; GO:0008417 ; EC:2.4.1.-; ; GO:0004812 ; EC:6.1.1.- O-fut2 O-fucosyltransferase 2 "CG14789, CG14789, CG14789, EG:BACN32G11.6, O-FUT2, O-fucosyltransferase 2" CDMC20890 3 20 17 DAC28-C24 5-CG14789-RA_1 CG14789 CGACAGCGAGGAAGATTCCGACCCGTACTGATCCATCTGTAGCTCCCACCTGACATCTCAAGACCTAGT 69 FBan0014789 FBgn0027791 O-fut2 X X tRNA aminoacylation for protein translation; GO:0006418 ATP binding; GO:0005524; ; GO:0005524; tRNA ligase activity; GO:0004812 ; EC:6.1.1.-; fucosyltransferase activity; GO:0008417 ; EC:2.4.1.-; ; GO:0008417 ; EC:2.4.1.-; ; GO:0004812 ; EC:6.1.1.- O-fut2 O-fucosyltransferase 2 "CG14789, CG14789, CG14789, EG:BACN32G11.6, O-FUT2, O-fucosyltransferase 2" CDMC20891 3 21 17 DAC28-G12 23-CG14823-RC_1 CG14823 GCTGACTGATTAGAATTGCCATTAGATGAACCAGCAGATTTCAACGTTTCGAAATTATAGCGATAATAA 69 FBan0014823 FBgn0035734 CG14823 3 3L CG14823 CG14823 CDMC20891 3 22 17 DAC28-G12 23-CG14823-RC_1 CG14823 GCTGACTGATTAGAATTGCCATTAGATGAACCAGCAGATTTCAACGTTTCGAAATTATAGCGATAATAA 69 FBan0014823 FBgn0035734 CG14823 3 3L CG14823 CG14823 CDMC20892 3 23 17 DAC28-G24 5-CG14835-RA_1 CG14835 GCGAAGTCCAGGGATTGGAAGTACCAGGTGTACCAGGTATACATCCCAATTTCACTGGGAAAACCCGCC 69 FBan0014835 FBgn0035782 CG14835 3 3L CG14835 CG14835 CDMC20892 3 24 17 DAC28-G24 5-CG14835-RA_1 CG14835 GCGAAGTCCAGGGATTGGAAGTACCAGGTGTACCAGGTATACATCCCAATTTCACTGGGAAAACCCGCC 69 FBan0014835 FBgn0035782 CG14835 3 3L CG14835 CG14835 CDMC20893 3 25 17 DAC28-K12 6-CG14876-RA_1 CG14876 TGTTGGCTCTTTCCACGATTCCACTGCGCATGGACCAACAAATCCAGTGCATCAAGACAATTCAGCAGG 69 FBan0014876 FBgn0038368 CG14876 3 3R CG14876 CG14876 CDMC20893 3 26 17 DAC28-K12 6-CG14876-RA_1 CG14876 TGTTGGCTCTTTCCACGATTCCACTGCGCATGGACCAACAAATCCAGTGCATCAAGACAATTCAGCAGG 69 FBan0014876 FBgn0038368 CG14876 3 3R CG14876 CG14876 CDMC20894 3 1 18 DAC28-K24 23-CG14883-RA_15 CG14883 CTCACCCAACGAGAAAAGATACTTCCAAAAGACCATGAAGATCCAGTACCTTACAGACTCGTTGCGGTC 69 FBan0014883 FBgn0038432 CG14883 3 3R CG14883 CG14883 CDMC20894 3 2 18 DAC28-K24 23-CG14883-RA_15 CG14883 CTCACCCAACGAGAAAAGATACTTCCAAAAGACCATGAAGATCCAGTACCTTACAGACTCGTTGCGGTC 69 FBan0014883 FBgn0038432 CG14883 3 3R CG14883 CG14883 CDMC20895 3 3 18 DAC28-O12 9-CG14905-RA_1 CG14905 ACGCCGGGTCAACCTGATCATCAGCGCCATCAATATCGAGGATAACTCCAACAAAATACTGGCCCGAAA 69 FBan0014905 FBgn0038452 CG14905 3 3R CG14905 CG14905 CDMC20895 3 4 18 DAC28-O12 9-CG14905-RA_1 CG14905 ACGCCGGGTCAACCTGATCATCAGCGCCATCAATATCGAGGATAACTCCAACAAAATACTGGCCCGAAA 69 FBan0014905 FBgn0038452 CG14905 3 3R CG14905 CG14905 CDMC20896 3 5 18 DAC28-O24 AutoBlank AutoBlank CDMC20896 3 6 18 DAC28-O24 AutoBlank AutoBlank CDMC20897 3 7 18 DAC29-C12 16-CG6405-RA_1 CG6405 ACGAGCGCATAAACATAACAGAAAGGCATCTAATGGAGATGTGCTCTTCGTTTGCTTTGGTAACGCGGA 69 FBan0006405 FBgn0032428 CG6405 2 2L CG6405 CG6405 CDMC20897 3 8 18 DAC29-C12 16-CG6405-RA_1 CG6405 ACGAGCGCATAAACATAACAGAAAGGCATCTAATGGAGATGTGCTCTTCGTTTGCTTTGGTAACGCGGA 69 FBan0006405 FBgn0032428 CG6405 2 2L CG6405 CG6405 CDMC20898 3 9 18 DAC29-C24 23-CG6416-RH_2 CG6416 AACACACACATTGCAAAAATGGAGTACGTTCAGTTCAAAAACGGATCCCCAGTCTACTACAAGGAGCAG 69 FBan0006416 FBgn0035917 CG6416 3 3L mesoderm development; GO:0007498 protein binding; GO:0005515; ; GO:0005515 CG6416 CG6416 anon-WO0153538.30 CDMC20898 3 10 18 DAC29-C24 23-CG6416-RH_2 CG6416 AACACACACATTGCAAAAATGGAGTACGTTCAGTTCAAAAACGGATCCCCAGTCTACTACAAGGAGCAG 69 FBan0006416 FBgn0035917 CG6416 3 3L mesoderm development; GO:0007498 protein binding; GO:0005515; ; GO:0005515 CG6416 CG6416 anon-WO0153538.30 CDMC20899 3 11 18 DAC29-G12 3-CG6451-RA_2 CG6451 CGTGGGAGTCACTCCGTCCGCTACTCTCAACGAGTCGTCTGTTCATCTGCTAAACGATCTCTGCTGGTT 69 FBan0006451 FBgn0041161 blue 3 3L oocyte microtubule cytoskeleton polarization; GO:0008103; pole plasm oskar mRNA localization; GO:0045451; protein localization; GO:0008104; regulation of pole plasm oskar mRNA localization; GO:0007317 blue bluestreak "CG6451, CG6451, bls, bluestreak" CDMC20899 3 12 18 DAC29-G12 3-CG6451-RA_2 CG6451 CGTGGGAGTCACTCCGTCCGCTACTCTCAACGAGTCGTCTGTTCATCTGCTAAACGATCTCTGCTGGTT 69 FBan0006451 FBgn0041161 blue 3 3L oocyte microtubule cytoskeleton polarization; GO:0008103; pole plasm oskar mRNA localization; GO:0045451; protein localization; GO:0008104; regulation of pole plasm oskar mRNA localization; GO:0007317 blue bluestreak "CG6451, CG6451, bls, bluestreak" CDMC20900 3 13 18 DAC29-G24 2-CG6461-RA_1 CG6461 TGGAGAGCGTAAGGAAGCTGATCCACGACAATAGCACTTCGGAGGACTACCTCTACTATGGCGCCAACT 69 FBan0006461 FBgn0030932 CG6461 X X amino acid metabolism; GO:0006520; lipid metabolism; GO:0006629; protein modification; GO:0006464; proteolysis; GO:0006508 gamma-glutamyltransferase activity; GO:0003840 ; EC:2.3.2.2; acyltransferase activity; GO:0008415 ; EC:2.3.1.-; peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008415 ; EC:2.3.1.-; ; GO:0003840 ; EC:2.3.2.2 CG6461 CG6461 CDMC20900 3 14 18 DAC29-G24 2-CG6461-RA_1 CG6461 TGGAGAGCGTAAGGAAGCTGATCCACGACAATAGCACTTCGGAGGACTACCTCTACTATGGCGCCAACT 69 FBan0006461 FBgn0030932 CG6461 X X amino acid metabolism; GO:0006520; lipid metabolism; GO:0006629; protein modification; GO:0006464; proteolysis; GO:0006508 gamma-glutamyltransferase activity; GO:0003840 ; EC:2.3.2.2; acyltransferase activity; GO:0008415 ; EC:2.3.1.-; peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; ; GO:0008415 ; EC:2.3.1.-; ; GO:0003840 ; EC:2.3.2.2 CG6461 CG6461 CDMC20901 3 15 18 DAC29-K12 3-CG6502-RA_1 CG6502 CCGAGAGCGTTTCCCGGGAAAGGACTATGCACTCCTTTCACACGCTCTTCTGTCGTCGTTGCTTCAAAT 69 FBan0006502 FBgn0000629 E(z) 3 3L chromatin silencing; GO:0006342; histone methylation; GO:0016571; pheromone metabolism; GO:0042810; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; histone lysine N-methyltransferase activity (H3-K27 specific); GO:0046976; histone lysine N-methyltransferase activity (H3-K9 specific); GO:0046974; histone methyltransferase activity; GO:0042054; transcription cofactor activity; GO:0003712; ; GO:0046976; protein binding; GO:0005515; ; GO:0042054; ; GO:0003712; ; GO:0005515; ; GO:0046974; ; GO:0008168 ; EC:2.1.1.-; ; GO:0046976 ESC/E(Z) complex; GO:0035098; nuclear chromatin; GO:0000790; nucleus; GO:0005634 E(z) Enhancer of zeste "CG6502, l(3)1902, Su(z)301, pco: polycombeotic, l(3)67Fa, polycombeotic, E(z)1, E[z], Ez, E(Z), EZ, enhancer of zeste, Enhancer-of-zeste, l(3)B12, l(3)SG17, l(3)ds12, pco/E(z), pco" CDMC20901 3 16 18 DAC29-K12 3-CG6502-RA_1 CG6502 CCGAGAGCGTTTCCCGGGAAAGGACTATGCACTCCTTTCACACGCTCTTCTGTCGTCGTTGCTTCAAAT 69 FBan0006502 FBgn0000629 E(z) 3 3L chromatin silencing; GO:0006342; histone methylation; GO:0016571; pheromone metabolism; GO:0042810; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; ; GO:0003677; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; histone lysine N-methyltransferase activity (H3-K27 specific); GO:0046976; histone lysine N-methyltransferase activity (H3-K9 specific); GO:0046974; histone methyltransferase activity; GO:0042054; transcription cofactor activity; GO:0003712; ; GO:0046976; protein binding; GO:0005515; ; GO:0042054; ; GO:0003712; ; GO:0005515; ; GO:0046974; ; GO:0008168 ; EC:2.1.1.-; ; GO:0046976 ESC/E(Z) complex; GO:0035098; nuclear chromatin; GO:0000790; nucleus; GO:0005634 E(z) Enhancer of zeste "CG6502, l(3)1902, Su(z)301, pco: polycombeotic, l(3)67Fa, polycombeotic, E(z)1, E[z], Ez, E(Z), EZ, enhancer of zeste, Enhancer-of-zeste, l(3)B12, l(3)SG17, l(3)ds12, pco/E(z), pco" CDMC20902 3 17 18 DAC29-K24 3-CG6513-RA_1 CG6513 AGTCGGCACGCTAATTGGCAAAACCGATTCGATTCCAGGGAAGGAGACACACTGATAGACGGGTGAAGA 69 FBgn0036401 CDMC20902 3 18 18 DAC29-K24 3-CG6513-RA_1 CG6513 AGTCGGCACGCTAATTGGCAAAACCGATTCGATTCCAGGGAAGGAGACACACTGATAGACGGGTGAAGA 69 FBgn0036401 CDMC20903 3 19 18 DAC29-O12 3-CG6549-RC_8 CG6549 ACGGCTCTCGAGCAGATCAACCAGTTTGGCTATACATCAGAATCATCGGATCAGTGCATTCCGCAGCGT 69 FBan0006549 FBgn0024689 fws 2 2L "cytokinesis after meiosis I; GO:0007110; cytokinesis after meiosis II; GO:0007111; cytokinesis, contractile ring contraction; GO:0000916; intracellular protein transport; GO:0006886; meiotic spindle stabilization; GO:0043147; membrane organization and biogenesis; GO:0016044; protein biosynthesis; GO:0006412; vesicle-mediated transport; GO:0016192" structural constituent of ribosome; GO:0003735; ; GO:0003735 Golgi transport complex; GO:0017119; ribosome; GO:0005840 fws four way stop "CG6549, CG6549, CG6549, Drosophila Cog5, dCOG5, anon-EST:Posey162, anon-EST:Posey186, four way stop" CDMC20903 3 20 18 DAC29-O12 3-CG6549-RC_8 CG6549 ACGGCTCTCGAGCAGATCAACCAGTTTGGCTATACATCAGAATCATCGGATCAGTGCATTCCGCAGCGT 69 FBan0006549 FBgn0024689 fws 2 2L "cytokinesis after meiosis I; GO:0007110; cytokinesis after meiosis II; GO:0007111; cytokinesis, contractile ring contraction; GO:0000916; intracellular protein transport; GO:0006886; meiotic spindle stabilization; GO:0043147; membrane organization and biogenesis; GO:0016044; protein biosynthesis; GO:0006412; vesicle-mediated transport; GO:0016192" structural constituent of ribosome; GO:0003735; ; GO:0003735 Golgi transport complex; GO:0017119; ribosome; GO:0005840 fws four way stop "CG6549, CG6549, CG6549, Drosophila Cog5, dCOG5, anon-EST:Posey162, anon-EST:Posey186, four way stop" CDMC20904 3 21 18 DAC29-O24 6-CG6560-RA_1 CG6560 CCCGAGGCGGGTAGTGAACTATTCGAAATGCTCATGGACAATCGGTTGAAGCAAGTTCCCGTGCTGATT 69 FBan0006560 FBgn0038916 CG6560 3 3R cell surface receptor linked signal transduction; GO:0007166; intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG6560 CG6560 CDMC20904 3 22 18 DAC29-O24 6-CG6560-RA_1 CG6560 CCCGAGGCGGGTAGTGAACTATTCGAAATGCTCATGGACAATCGGTTGAAGCAAGTTCCCGTGCTGATT 69 FBan0006560 FBgn0038916 CG6560 3 3R cell surface receptor linked signal transduction; GO:0007166; intracellular protein transport; GO:0006886; regulation of exocytosis; GO:0017157; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0005525 CG6560 CG6560 CDMC20905 3 23 18 DAC30-C12 2-CG4016-RB_1 CG4016 TGGCCTTGCGTCAGAAGTACAAGCTGCGTTTGTTCATCGACGAAAGCATCTCCTTTGGCACATTGGG 67 FBan0004016 FBgn0033800 Spt-I 2 2R lipid metabolism; GO:0006629 serine C-palmitoyltransferase activity; GO:0004758 ; EC:2.3.1.50; ; GO:0004758 ; EC:2.3.1.50 serine C-palmitoyltransferase complex; GO:0017059 Spt-I Serine palmitoyltransferase subunit I "CG4016, CG4016, SPT-I, lcb1, Serine palmitoyltransferase subunit I" CDMC20905 3 24 18 DAC30-C12 2-CG4016-RB_1 CG4016 TGGCCTTGCGTCAGAAGTACAAGCTGCGTTTGTTCATCGACGAAAGCATCTCCTTTGGCACATTGGG 67 FBan0004016 FBgn0033800 Spt-I 2 2R lipid metabolism; GO:0006629 serine C-palmitoyltransferase activity; GO:0004758 ; EC:2.3.1.50; ; GO:0004758 ; EC:2.3.1.50 serine C-palmitoyltransferase complex; GO:0017059 Spt-I Serine palmitoyltransferase subunit I "CG4016, CG4016, SPT-I, lcb1, Serine palmitoyltransferase subunit I" CDMC20906 3 25 18 DAC30-C24 1-CG40354-RA_1 CG40354 CGTCTACTCCACCAATGTGACTCGCAATACTCAAAAATCGAGGAGCTCTGCACAGGTGCCGCCAACT 67 FBgn0058354 CG40354 cell cycle; GO:0007049; regulation of progression through cell cycle; GO:0000074 receptor binding; GO:0005102; ; GO:0005102 CG40354 CG40354 CDMC20906 3 26 18 DAC30-C24 1-CG40354-RA_1 CG40354 CGTCTACTCCACCAATGTGACTCGCAATACTCAAAAATCGAGGAGCTCTGCACAGGTGCCGCCAACT 67 FBgn0058354 CG40354 cell cycle; GO:0007049; regulation of progression through cell cycle; GO:0000074 receptor binding; GO:0005102; ; GO:0005102 CG40354 CG40354 CDMC20907 3 1 19 DAC30-G12 8-CG4338-RA_3 CG4338 GCCATAGCCGCCACTCTATACATCTGTGGATTCACGGAAGAGGCTCGCTGGTTTCTGGGCAAGTTCT 67 FBan0004338 FBgn0038313 CG4338 3 3R CG4338 CG4338 CDMC20907 3 2 19 DAC30-G12 8-CG4338-RA_3 CG4338 GCCATAGCCGCCACTCTATACATCTGTGGATTCACGGAAGAGGCTCGCTGGTTTCTGGGCAAGTTCT 67 FBan0004338 FBgn0038313 CG4338 3 3R CG4338 CG4338 CDMC20908 3 3 19 DAC30-G24 2-CG4509-RB_8 CG4509 GTGTCCATCTCGAAGTACGAGTCCACGGTGACAGAGAATGGCAGGAAGCTCATGTCCACCTCAACGG 67 FBan0004509 FBgn0037840 CG4509 3 3R calcium-dependent cell-cell adhesion; GO:0016339; homophilic cell adhesion; GO:0007156; signal transduction; GO:0007165; transport; GO:0006810 transporter activity; GO:0005215; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005215 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 CG4509 CG4509 "CG33112, CG31393, CG31425, CT14654, DCad86C" CDMC20908 3 4 19 DAC30-G24 2-CG4509-RB_8 CG4509 GTGTCCATCTCGAAGTACGAGTCCACGGTGACAGAGAATGGCAGGAAGCTCATGTCCACCTCAACGG 67 FBan0004509 FBgn0037840 CG4509 3 3R calcium-dependent cell-cell adhesion; GO:0016339; homophilic cell adhesion; GO:0007156; signal transduction; GO:0007165; transport; GO:0006810 transporter activity; GO:0005215; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005215 integral to membrane; GO:0016021; integral to plasma membrane; GO:0005887 CG4509 CG4509 "CG33112, CG31393, CG31425, CT14654, DCad86C" CDMC20909 3 5 19 DAC30-K12 2-CG5003-RA_2 CG5003 CCGCGTCCGAACTACGATCAGGTTGTTCAGCATCCGATGTTTTGGAACATGCTCGAGCCACTGGATC 67 FBan0005003 FBgn0039554 CG5003 3 3R CG5003 CG5003 CDMC20909 3 6 19 DAC30-K12 2-CG5003-RA_2 CG5003 CCGCGTCCGAACTACGATCAGGTTGTTCAGCATCCGATGTTTTGGAACATGCTCGAGCCACTGGATC 67 FBan0005003 FBgn0039554 CG5003 3 3R CG5003 CG5003 CDMC20910 3 7 19 DAC30-K24 3-CG5155-RA_4 CG5155 ACCGAGGGCATGATTCCCGACATTGTGAGCCATCTGAGTTCCGAAAATACCGAGCTGAAGATGGAGG 67 FBan0005155 FBgn0031905 CG5155 2 2L CG5155 CG5155 CDMC20910 3 8 19 DAC30-K24 3-CG5155-RA_4 CG5155 ACCGAGGGCATGATTCCCGACATTGTGAGCCATCTGAGTTCCGAAAATACCGAGCTGAAGATGGAGG 67 FBan0005155 FBgn0031905 CG5155 2 2L CG5155 CG5155 CDMC20911 3 9 19 DAC30-O12 23-CG5626-RA_11 CG5626 ACGTATGGCTGTGGAAAAACCAATCGAAGAACCTGCTAGTAAAAAAGAAAAATTCTCCACAACGGGC 67 FBan0005626 FBgn0036266 CG5626 3 3L tRNA splicing; GO:0006388 adenylate kinase activity; GO:0004017 ; EC:2.7.4.3; ; GO:0004017 ; EC:2.7.4.3; tRNA-intron endonuclease activity; GO:0000213 ; EC:3.1.27.9; ; GO:0000213 ; EC:3.1.27.9 tRNA-intron endonuclease complex; GO:0000214 CG5626 CG5626 CDMC20911 3 10 19 DAC30-O12 23-CG5626-RA_11 CG5626 ACGTATGGCTGTGGAAAAACCAATCGAAGAACCTGCTAGTAAAAAAGAAAAATTCTCCACAACGGGC 67 FBan0005626 FBgn0036266 CG5626 3 3L tRNA splicing; GO:0006388 adenylate kinase activity; GO:0004017 ; EC:2.7.4.3; ; GO:0004017 ; EC:2.7.4.3; tRNA-intron endonuclease activity; GO:0000213 ; EC:3.1.27.9; ; GO:0000213 ; EC:3.1.27.9 tRNA-intron endonuclease complex; GO:0000214 CG5626 CG5626 CDMC20912 3 11 19 DAC30-O24 AutoBlank AutoBlank CDMC20912 3 12 19 DAC30-O24 AutoBlank AutoBlank CDMC20913 3 13 19 DAC31-C12 12-CG7499-RA_1 CG7499 GGTGCCGTTTTGAAGTACACCAACTTCCGGAACCTGAAGAAGGACGAACATCACCAGGACGAGCACTAC 69 FBan0007499 FBgn0028699 Rh50 3 3L Rh50 Rh50 "CG7499, BcDNA:GH03016, Rh-like" CDMC20913 3 14 19 DAC31-C12 12-CG7499-RA_1 CG7499 GGTGCCGTTTTGAAGTACACCAACTTCCGGAACCTGAAGAAGGACGAACATCACCAGGACGAGCACTAC 69 FBan0007499 FBgn0028699 Rh50 3 3L Rh50 Rh50 "CG7499, BcDNA:GH03016, Rh-like" CDMC20914 3 15 19 DAC31-C24 9-CG7514-RA_1 CG7514 GGCCATGGCGTACAGCATCGAAAAGAAATCCATACCCGGCTACATGATGTACATTAATGGCGGTCTGGC 69 FBan0007514 FBgn0035567 CG7514 3 3L alpha-ketoglutarate transport; GO:0015742; cation transport; GO:0006812; malate transport; GO:0015743; mitochondrial transport; GO:0006839 carrier activity; GO:0005386; oxoglutarate:malate antiporter activity; GO:0015367; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0015367; ; GO:0015367 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG7514 CG7514 CDMC20914 3 16 19 DAC31-C24 9-CG7514-RA_1 CG7514 GGCCATGGCGTACAGCATCGAAAAGAAATCCATACCCGGCTACATGATGTACATTAATGGCGGTCTGGC 69 FBan0007514 FBgn0035567 CG7514 3 3L alpha-ketoglutarate transport; GO:0015742; cation transport; GO:0006812; malate transport; GO:0015743; mitochondrial transport; GO:0006839 carrier activity; GO:0005386; oxoglutarate:malate antiporter activity; GO:0015367; binding; GO:0005488; ; GO:0005488; ; GO:0005386; ; GO:0015367; ; GO:0015367 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG7514 CG7514 CDMC20915 3 17 19 DAC31-G12 3-CG7548-RA_1 CG7548 CCAGCTCCGGTTTACACGCACCAGGCTCATCAGGAACCAAAAAATCTGTTTACTCAGGCATCGCCAGTT 69 FBan0007548 FBgn0035792 CG7548 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG7548 CG7548 CDMC20915 3 18 19 DAC31-G12 3-CG7548-RA_1 CG7548 CCAGCTCCGGTTTACACGCACCAGGCTCATCAGGAACCAAAAAATCTGTTTACTCAGGCATCGCCAGTT 69 FBan0007548 FBgn0035792 CG7548 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG7548 CG7548 CDMC20916 3 19 19 DAC31-G24 1-CG7557-RA_1 CG7557 CCCTGGCCAAGAAATGCTCACTCCTACTCCTGGAGCACACAAGTGTCGGATGAAGCGAGTAAATTCCGA 69 FBan0007557 FBgn0036159 CG7557 3 3L CG7557 CG7557 anon-WO0140519.44 CDMC20916 3 20 19 DAC31-G24 1-CG7557-RA_1 CG7557 CCCTGGCCAAGAAATGCTCACTCCTACTCCTGGAGCACACAAGTGTCGGATGAAGCGAGTAAATTCCGA 69 FBan0007557 FBgn0036159 CG7557 3 3L CG7557 CG7557 anon-WO0140519.44 CDMC20917 3 21 19 DAC31-K12 17-CG7589-RA_1 CG7589 CGCTGAGCTTTACGGTCAATCTGAAGCGAGAAATTGGCTTCTATTTGCTCGACTATTACCTGCCCTCCA 69 FBan0007589 FBgn0036727 CG7589 3 3L anion transport; GO:0006820; nerve-nerve synaptic transmission; GO:0007270; signal transduction; GO:0007165 glycine-gated ion channel activity; GO:0016933; GABA receptor activity; GO:0016917; GABA-A receptor activity; GO:0004890; ; GO:0016933; ; GO:0016917; ; GO:0004890 integral to membrane; GO:0016021; membrane; GO:0016020; postsynaptic membrane; GO:0045211 CG7589 CG7589 CDMC20917 3 22 19 DAC31-K12 17-CG7589-RA_1 CG7589 CGCTGAGCTTTACGGTCAATCTGAAGCGAGAAATTGGCTTCTATTTGCTCGACTATTACCTGCCCTCCA 69 FBan0007589 FBgn0036727 CG7589 3 3L anion transport; GO:0006820; nerve-nerve synaptic transmission; GO:0007270; signal transduction; GO:0007165 glycine-gated ion channel activity; GO:0016933; GABA receptor activity; GO:0016917; GABA-A receptor activity; GO:0004890; ; GO:0016933; ; GO:0016917; ; GO:0004890 integral to membrane; GO:0016021; membrane; GO:0016020; postsynaptic membrane; GO:0045211 CG7589 CG7589 CDMC20918 3 23 19 DAC31-K24 1-CG7599-RA_1 CG7599 GTTCATGAACGAGGGATGCCGTGAGAAAGTCCGTGGCAGATACATCTGGAAGAATCAGACTCGCTGCGA 69 FBan0007599 FBgn0004593 Eig71Ef 3 3L autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071 Eig71Ef Ecdysone-induced gene 71Ef "CG7599, gene V, V: transcript group V, Gene V, 71E-Gene-V, L71-5, L71, gene-V" CDMC20918 3 24 19 DAC31-K24 1-CG7599-RA_1 CG7599 GTTCATGAACGAGGGATGCCGTGAGAAAGTCCGTGGCAGATACATCTGGAAGAATCAGACTCGCTGCGA 69 FBan0007599 FBgn0004593 Eig71Ef 3 3L autophagic cell death; GO:0048102; salivary gland cell autophagic cell death; GO:0035071 Eig71Ef Ecdysone-induced gene 71Ef "CG7599, gene V, V: transcript group V, Gene V, 71E-Gene-V, L71-5, L71, gene-V" CDMC20919 3 25 19 DAC31-O12 2-CG7632-RA_1 CG7632 ACCTGGCACTTCCTACCACTCCATTGACCTCGTGCTGATCACTCGCCGACTAATGGAGGAGTACAACTG 69 FBan0007632 FBgn0037071 CG7632 3 3L calcium-dependent phospholipid binding; GO:0005544; calcium ion binding; GO:0005509; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0005509; ; GO:0005544 CG7632 CG7632 CDMC20919 3 26 19 DAC31-O12 2-CG7632-RA_1 CG7632 ACCTGGCACTTCCTACCACTCCATTGACCTCGTGCTGATCACTCGCCGACTAATGGAGGAGTACAACTG 69 FBan0007632 FBgn0037071 CG7632 3 3L calcium-dependent phospholipid binding; GO:0005544; calcium ion binding; GO:0005509; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0005509; ; GO:0005544 CG7632 CG7632 CDMC20920 3 1 20 DAC31-O24 14-CG7641-RA_1 CG7641 GCGGGGCAAACTCGAGCAGAAACTCAAATGGGCATTCTCAATGTACGATCTTGATGGGAACGGATACAT 69 FBan0007641 FBgn0013303 Nca 3 3L calcium-mediated signaling; GO:0019722; negative regulation of phosphorylation; GO:0042326; visual perception; GO:0007601 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005516; ; GO:0005509; ; GO:0005509 Nca Neurocalcin "CG7641, nca, neurocalcin, Ncalc" CDMC20920 3 2 20 DAC31-O24 14-CG7641-RA_1 CG7641 GCGGGGCAAACTCGAGCAGAAACTCAAATGGGCATTCTCAATGTACGATCTTGATGGGAACGGATACAT 69 FBan0007641 FBgn0013303 Nca 3 3L calcium-mediated signaling; GO:0019722; negative regulation of phosphorylation; GO:0042326; visual perception; GO:0007601 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005509; ; GO:0005516; ; GO:0005509; ; GO:0005509 Nca Neurocalcin "CG7641, nca, neurocalcin, Ncalc" CDMC20921 3 3 20 DAC32-C12 14-CG15028-RB_1 CG15028 GGCGATGAGATTTTGGTAGTTGAGATCATCGACAGTGGTGCGGACAATAGTAGCTCGGAATCGGGTGG 68 FBan0015028 FBgn0030618 CG15028 X X CG15028 CG15028 CDMC20921 3 4 20 DAC32-C12 14-CG15028-RB_1 CG15028 GGCGATGAGATTTTGGTAGTTGAGATCATCGACAGTGGTGCGGACAATAGTAGCTCGGAATCGGGTGG 68 FBan0015028 FBgn0030618 CG15028 X X CG15028 CG15028 CDMC20922 3 5 20 DAC32-C24 2-CG15134-RA_1 CG15134 GGTGGCCCTACATGGAATGATGACTCGAAGCTCTAAGCAGTTGTCGTCCACTCTACAGGAGCTGCGTG 68 FBan0015134 FBgn0032621 CG15134 2 2L CG15134 CG15134 CDMC20922 3 6 20 DAC32-C24 2-CG15134-RA_1 CG15134 GGTGGCCCTACATGGAATGATGACTCGAAGCTCTAAGCAGTTGTCGTCCACTCTACAGGAGCTGCGTG 68 FBan0015134 FBgn0032621 CG15134 2 2L CG15134 CG15134 CDMC20923 3 7 20 DAC32-G12 3-CG15538-RA_5 CG15538 CGACCATGACCGCTAAAAGAAACCGTTAGGGATCCCAGAAGAGGGTTTCCACATCTGCCCCAATGACC 68 FBan0015538 FBgn0039771 Osi23 3 3R Osi23 Osiris 23 "CG15538, CG15538, Osiris, Osiris 23" CDMC20923 3 8 20 DAC32-G12 3-CG15538-RA_5 CG15538 CGACCATGACCGCTAAAAGAAACCGTTAGGGATCCCAGAAGAGGGTTTCCACATCTGCCCCAATGACC 68 FBan0015538 FBgn0039771 Osi23 3 3R Osi23 Osiris 23 "CG15538, CG15538, Osiris, Osiris 23" CDMC20924 3 9 20 DAC32-G24 1-CG15650-RA_1 CG15650 GCCCGGGGTCTTTGACTTCTCCAATGTGGATCTGGTGAACTTCCAGTACTTCAAGAACCTGGCATCGC 68 FBan0015650 FBgn0034565 CG15650 2 2R CG15650 CG15650 CDMC20924 3 10 20 DAC32-G24 1-CG15650-RA_1 CG15650 GCCCGGGGTCTTTGACTTCTCCAATGTGGATCTGGTGAACTTCCAGTACTTCAAGAACCTGGCATCGC 68 FBan0015650 FBgn0034565 CG15650 2 2R CG15650 CG15650 CDMC20925 3 11 20 DAC32-K12 1-CG16890-RA_1 CG16890 CCGAATGAGACGGAATCACGTCGGCACAAGCGAGACATCGATGTAATCCGAGAGAATCACCGCTTCCT 68 FBan0016890 FBgn0028932 CG16890 2 2L CG16890 CG16890 BG:DS00797.4 CDMC20925 3 12 20 DAC32-K12 1-CG16890-RA_1 CG16890 CCGAATGAGACGGAATCACGTCGGCACAAGCGAGACATCGATGTAATCCGAGAGAATCACCGCTTCCT 68 FBan0016890 FBgn0028932 CG16890 2 2L CG16890 CG16890 BG:DS00797.4 CDMC20926 3 13 20 DAC32-K24 3-CG17003-RA_1 CG17003 AGGCAGGACCAGAAAATCGTGGTAGGTACATCGATCTATCGACGTCGCTGGAAATCACCACGCACACT 68 FBan0017003 FBgn0031082 CG17003 X X CG17003 CG17003 CDMC20926 3 14 20 DAC32-K24 3-CG17003-RA_1 CG17003 AGGCAGGACCAGAAAATCGTGGTAGGTACATCGATCTATCGACGTCGCTGGAAATCACCACGCACACT 68 FBan0017003 FBgn0031082 CG17003 X X CG17003 CG17003 CDMC20927 3 15 20 DAC32-O12 8-CG17359-RA_1 CG17359 AGGGCGAGATCCTACTCGGACAATGACTCATGGAGCCCGGATAGTGAGCTTGAACACGAAGATGATGA 68 FBan0017359 FBgn0036396 CG17359 3 3L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG17359 CG17359 CDMC20927 3 16 20 DAC32-O12 8-CG17359-RA_1 CG17359 AGGGCGAGATCCTACTCGGACAATGACTCATGGAGCCCGGATAGTGAGCTTGAACACGAAGATGATGA 68 FBan0017359 FBgn0036396 CG17359 3 3L "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG17359 CG17359 CDMC20928 3 17 20 DAC32-O24 AutoBlank AutoBlank CDMC20928 3 18 20 DAC32-O24 AutoBlank AutoBlank CDMC20929 3 19 20 DAC33-C12 11-CG31719-RB_2 CG31719 ACAAATGCAGTCAAGGAGTATCAAGTTGCGGCACAGAAGTCTTCCTCGGAAATTTGCCCAGCTCCA 66 FBan0031719 FBgn0051719 RluA-1 2 2L RNA processing; GO:0006396; rRNA metabolism; GO:0016072; riboflavin biosynthesis; GO:0009231 mRNA binding; GO:0003729; lyase activity; GO:0016829 ; EC:4.-.-.-; ; GO:0003729; ; GO:0016829 ; EC:4.-.-.-; pseudouridylate synthase activity; GO:0004730 ; EC:4.2.1.70; ; GO:0004730 ; EC:4.2.1.70; diaminohydroxyphosphoribosylaminopyrimidine deaminase activity; GO:0008835 ; EC:3.5.4.26; ; GO:0008835 ; EC:3.5.4.26; pseudouridine synthase activity; GO:0009982 ; EC:5.4.99.-; ; GO:0009982 ; EC:5.4.99.- RluA-1 RluA-1 "CG31719, CG13143, CG7475, CG31719, CG31719, CG31719, multiple" CDMC20929 3 20 20 DAC33-C12 11-CG31719-RB_2 CG31719 ACAAATGCAGTCAAGGAGTATCAAGTTGCGGCACAGAAGTCTTCCTCGGAAATTTGCCCAGCTCCA 66 FBan0031719 FBgn0051719 RluA-1 2 2L RNA processing; GO:0006396; rRNA metabolism; GO:0016072; riboflavin biosynthesis; GO:0009231 mRNA binding; GO:0003729; lyase activity; GO:0016829 ; EC:4.-.-.-; ; GO:0003729; ; GO:0016829 ; EC:4.-.-.-; pseudouridylate synthase activity; GO:0004730 ; EC:4.2.1.70; ; GO:0004730 ; EC:4.2.1.70; diaminohydroxyphosphoribosylaminopyrimidine deaminase activity; GO:0008835 ; EC:3.5.4.26; ; GO:0008835 ; EC:3.5.4.26; pseudouridine synthase activity; GO:0009982 ; EC:5.4.99.-; ; GO:0009982 ; EC:5.4.99.- RluA-1 RluA-1 "CG31719, CG13143, CG7475, CG31719, CG31719, CG31719, multiple" CDMC20930 3 21 20 DAC33-C24 23-CG31814-RA_1 CG31814 TGTGACATATTTGTATGTAAATGTACGCAAAAGTTTACAGCAAAAATAAAGCCCAAAAACAAGCCC 66 FBan0031814 FBgn0051814 CG31814 2 2L cell adhesion; GO:0007155; cell communication; GO:0007154; cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 CG31814 CG31814 BG:DS08249.1 CDMC20930 3 22 20 DAC33-C24 23-CG31814-RA_1 CG31814 TGTGACATATTTGTATGTAAATGTACGCAAAAGTTTACAGCAAAAATAAAGCCCAAAAACAAGCCC 66 FBan0031814 FBgn0051814 CG31814 2 2L cell adhesion; GO:0007155; cell communication; GO:0007154; cell-cell adhesion; GO:0016337; signal transduction; GO:0007165 CG31814 CG31814 BG:DS08249.1 CDMC20931 3 23 20 DAC33-G12 2-CG32452-RA_1 CG32452 CGATCTGCGGCACCATATCCAGGGAATATACTCGCACCAACCCGCCTTTAATGCCTACACCGAGTG 66 FBan0032452 FBgn0052452 CG32452 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32452 CG32452 BcDNA:SD04526 CDMC20931 3 24 20 DAC33-G12 2-CG32452-RA_1 CG32452 CGATCTGCGGCACCATATCCAGGGAATATACTCGCACCAACCCGCCTTTAATGCCTACACCGAGTG 66 FBan0032452 FBgn0052452 CG32452 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32452 CG32452 BcDNA:SD04526 CDMC20932 3 25 20 DAC33-G24 3-CG32562-RA_1 CG32562 AGGTCACATAAGTCGAGGAAGAGGAGAGACGCATCGGACCACAAACATGCCAGTAAGCACAAGCGC 66 FBan0032562 FBgn0028974 xmas-2 X X embryonic development; GO:0009790; intracellular protein transport; GO:0006886; oogenesis (sensu Insecta); GO:0009993; spermatogenesis; GO:0007283 mRNA binding; GO:0003729; ; GO:0003729 cellular component unknown; GO:0008372 xmas-2 xmas-2 "CG8919, CG32562, CG8919, CG8919" CDMC20932 3 26 20 DAC33-G24 3-CG32562-RA_1 CG32562 AGGTCACATAAGTCGAGGAAGAGGAGAGACGCATCGGACCACAAACATGCCAGTAAGCACAAGCGC 66 FBan0032562 FBgn0028974 xmas-2 X X embryonic development; GO:0009790; intracellular protein transport; GO:0006886; oogenesis (sensu Insecta); GO:0009993; spermatogenesis; GO:0007283 mRNA binding; GO:0003729; ; GO:0003729 cellular component unknown; GO:0008372 xmas-2 xmas-2 "CG8919, CG32562, CG8919, CG8919" CDMC20933 3 1 21 DAC33-K12 1-CG32946-RA_1 CG32946 GAGCCCGAAGAAAGTGCCCATCATCTCGCTGAAGCCCGCGAAAAAGGTGTTAATGTACAGGTGGTC 66 FBan0032946 FBgn0052946 CG32946 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32946 CG32946 CDMC20933 3 2 21 DAC33-K12 1-CG32946-RA_1 CG32946 GAGCCCGAAGAAAGTGCCCATCATCTCGCTGAAGCCCGCGAAAAAGGTGTTAATGTACAGGTGGTC 66 FBan0032946 FBgn0052946 CG32946 3 3R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32946 CG32946 CDMC20934 3 3 21 DAC33-K24 3-CG33234-RA_1 CG33234 CGAATGAACAAGGGCAAGAAGGTTACTCTGAATAGTCTGGGAGTGGAGTCGCTAACCCAGCCGCGC 66 FBan0033234 FBgn0053234 CG33234 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33234 CG33234 CG12036 CDMC20934 3 4 21 DAC33-K24 3-CG33234-RA_1 CG33234 CGAATGAACAAGGGCAAGAAGGTTACTCTGAATAGTCTGGGAGTGGAGTCGCTAACCCAGCCGCGC 66 FBan0033234 FBgn0053234 CG33234 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33234 CG33234 CG12036 CDMC20935 3 5 21 DAC33-O12 AutoBlank AutoBlank CDMC20935 3 6 21 DAC33-O12 AutoBlank AutoBlank CDMC20936 3 7 21 DAC33-O24 AutoBlank AutoBlank CDMC20936 3 8 21 DAC33-O24 AutoBlank AutoBlank CDMC20937 3 9 21 DAC34-C12 2-CG13466-RA_3 CG13466 GGTCTCCTCCACGATCCTCGACAGTGATTCGGTGGACTATCCGTAGTGCTGAGTACGAGGGATATCGGA 69 FBan0013466 FBgn0036456 CG13466 3 3L intracellular signaling cascade; GO:0007242; microtubule-based process; GO:0007017; mitosis; GO:0007067 microtubule binding; GO:0008017; ; GO:0008017; ; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0008017 CG13466 CG13466 anon-71Aa CDMC20937 3 10 21 DAC34-C12 2-CG13466-RA_3 CG13466 GGTCTCCTCCACGATCCTCGACAGTGATTCGGTGGACTATCCGTAGTGCTGAGTACGAGGGATATCGGA 69 FBan0013466 FBgn0036456 CG13466 3 3L intracellular signaling cascade; GO:0007242; microtubule-based process; GO:0007017; mitosis; GO:0007067 microtubule binding; GO:0008017; ; GO:0008017; ; GO:0008017; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0008017 CG13466 CG13466 anon-71Aa CDMC20938 3 11 21 DAC34-C24 15-CG13477-RA_2 CG13477 TCTCCGAGCAGGTATTCTCGAACATTCAGGAGCGTCTGAACCGAATCATTAATCGCATTAGCATGGCCA 69 FBan0013477 FBgn0036438 CG13477 3 3L CG13477 CG13477 CDMC20938 3 12 21 DAC34-C24 15-CG13477-RA_2 CG13477 TCTCCGAGCAGGTATTCTCGAACATTCAGGAGCGTCTGAACCGAATCATTAATCGCATTAGCATGGCCA 69 FBan0013477 FBgn0036438 CG13477 3 3L CG13477 CG13477 CDMC20939 3 13 21 DAC34-G12 3-CG13531-RB_3 CG13531 CGCTGCACTTCCTCATGTACAAAGAGTTGGCGGAGATGTGGACTACGGAGGCCCAAGAGATTGTTACCA 69 FBan0013531 FBgn0034786 CG13531 2 2R CG13531 CG13531 CDMC20939 3 14 21 DAC34-G12 3-CG13531-RB_3 CG13531 CGCTGCACTTCCTCATGTACAAAGAGTTGGCGGAGATGTGGACTACGGAGGCCCAAGAGATTGTTACCA 69 FBan0013531 FBgn0034786 CG13531 2 2R CG13531 CG13531 CDMC20940 3 15 21 DAC34-G24 23-CG13551-RA_1 CG13551 GACGGATGAACTCGAGACATTTACTAAAATGCATTTCACTCTCTTTTGTATGTTCCCAAGTGCTCACTA 69 FBan0013551 FBgn0040660 CG13551 2 2R CG13551 CG13551 BcDNA:RE33866 CDMC20940 3 16 21 DAC34-G24 23-CG13551-RA_1 CG13551 GACGGATGAACTCGAGACATTTACTAAAATGCATTTCACTCTCTTTTGTATGTTCCCAAGTGCTCACTA 69 FBan0013551 FBgn0040660 CG13551 2 2R CG13551 CG13551 BcDNA:RE33866 CDMC20941 3 17 21 DAC34-K12 13-CG1358-RA_1 CG1358 CGACCTTTAGGCCAAGTGACAAACGCAAGGAAGTTACAATCTTCCACCCAGAGTCAATTGAGATGGCCA 69 FBan0001358 FBgn0033196 CG1358 2 2R development; GO:0007275 transporter activity; GO:0005215; ; GO:0005215 CG1358 CG1358 CDMC20941 3 18 21 DAC34-K12 13-CG1358-RA_1 CG1358 CGACCTTTAGGCCAAGTGACAAACGCAAGGAAGTTACAATCTTCCACCCAGAGTCAATTGAGATGGCCA 69 FBan0001358 FBgn0033196 CG1358 2 2R development; GO:0007275 transporter activity; GO:0005215; ; GO:0005215 CG1358 CG1358 CDMC20942 3 19 21 DAC34-K24 18-CG1359-RA_5 CG1359 AGGGCTTCCTTTACTACAAGACCAATCGCTACGCCCTGCATTATCTGGAAACTCCCTCTGGATTAAAGT 69 FBan0001359 FBgn0039753 CG1359 3 3R CG1359 CG1359 CDMC20942 3 20 21 DAC34-K24 18-CG1359-RA_5 CG1359 AGGGCTTCCTTTACTACAAGACCAATCGCTACGCCCTGCATTATCTGGAAACTCCCTCTGGATTAAAGT 69 FBan0001359 FBgn0039753 CG1359 3 3R CG1359 CG1359 CDMC20943 3 21 21 DAC34-O12 9-CG13628-RA_1 CG13628 TGGGCCACGTGGATCTTATCGAAAAACTGCTCAACTATGCTCCTCTGGAGAAGTGAACGGCACAATGGA 69 FBan0013628 FBgn0039218 Rpb10 3 3R transcription; GO:0006350; transcription from RNA polymerase II promoter; GO:0006366 nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6 "DNA-directed RNA polymerase II, core complex; GO:0005665; nucleus; GO:0005634" Rpb10 Rpb10 "CG13628, CG13628, CG13628, RPB10, BcDNA:SD08670" CDMC20943 3 22 21 DAC34-O12 9-CG13628-RA_1 CG13628 TGGGCCACGTGGATCTTATCGAAAAACTGCTCAACTATGCTCCTCTGGAGAAGTGAACGGCACAATGGA 69 FBan0013628 FBgn0039218 Rpb10 3 3R transcription; GO:0006350; transcription from RNA polymerase II promoter; GO:0006366 nucleic acid binding; GO:0003676; DNA-directed RNA polymerase activity; GO:0003899 ; EC:2.7.7.6; ; GO:0003676; ; GO:0003899 ; EC:2.7.7.6; ; GO:0003899 ; EC:2.7.7.6 "DNA-directed RNA polymerase II, core complex; GO:0005665; nucleus; GO:0005634" Rpb10 Rpb10 "CG13628, CG13628, CG13628, RPB10, BcDNA:SD08670" CDMC20944 3 23 21 DAC34-O24 AutoBlank AutoBlank CDMC20944 3 24 21 DAC34-O24 AutoBlank AutoBlank CDMC20945 3 25 21 DAC35-C12 3-CG18005-RA_4 CG18005 GGACGGATGGCCTATGTGATCGACCTGGATGACGAGCTAGGGGAGTCGGATATTCCAACCACACTG 66 FBan0018005 FBgn0037660 CG18005 3 3R cell communication; GO:0007154; cell-cell signaling; GO:0007267; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; signal transduction; GO:0007165 receptor binding; GO:0005102; cytokine activity; GO:0005125; ; GO:0005102; ; GO:0005125 CG18005 CG18005 CDMC20945 3 26 21 DAC35-C12 3-CG18005-RA_4 CG18005 GGACGGATGGCCTATGTGATCGACCTGGATGACGAGCTAGGGGAGTCGGATATTCCAACCACACTG 66 FBan0018005 FBgn0037660 CG18005 3 3R cell communication; GO:0007154; cell-cell signaling; GO:0007267; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; signal transduction; GO:0007165 receptor binding; GO:0005102; cytokine activity; GO:0005125; ; GO:0005102; ; GO:0005125 CG18005 CG18005 CDMC20946 3 1 22 DAC35-C24 1-CG18372-RA_3 CG18372 GCAGAAGACAAGCATCCTTATCTTGGCACTTTTCGCCATCGCAGAGGCAGTTCCCACAACAGGACC 66 FBan0018372 FBgn0041581 AttB 2 2R antibacterial humoral response (sensu Protostomia); GO:0006961; defense response; GO:0006952; defense response to bacteria; GO:0042742 extracellular region; GO:0005576 AttB Attacin-B "CG18372, Attacin, attacin B, attacin, Attacin B, att, Attackin, Att, AttB1, Attacin B1, AttBn, AttB2, Attacin-B" CDMC20946 3 2 22 DAC35-C24 1-CG18372-RA_3 CG18372 GCAGAAGACAAGCATCCTTATCTTGGCACTTTTCGCCATCGCAGAGGCAGTTCCCACAACAGGACC 66 FBan0018372 FBgn0041581 AttB 2 2R antibacterial humoral response (sensu Protostomia); GO:0006961; defense response; GO:0006952; defense response to bacteria; GO:0042742 extracellular region; GO:0005576 AttB Attacin-B "CG18372, Attacin, attacin B, attacin, Attacin B, att, Attackin, Att, AttB1, Attacin B1, AttBn, AttB2, Attacin-B" CDMC20947 3 3 22 DAC35-G12 8-CG2691-RA_1 CG2691 TGATGATATGCTAGCTGACTCCGATTCGGATCTGCCCGAAGATATGGACGCTAAGGATGAGGCCGG 66 FBan0002691 FBgn0030504 CG2691 X X CG2691 CG2691 CDMC20947 3 4 22 DAC35-G12 8-CG2691-RA_1 CG2691 TGATGATATGCTAGCTGACTCCGATTCGGATCTGCCCGAAGATATGGACGCTAAGGATGAGGCCGG 66 FBan0002691 FBgn0030504 CG2691 X X CG2691 CG2691 CDMC20948 3 5 22 DAC35-G24 2-CG2857-RA_1 CG2857 GCCAGGTTCTGAGCATTTCGTACGCTCTGGTACAGTTCTGGTCCTACGAACAGCTTCGCTCCATGG 66 FBan0002857 FBgn0035078 CG2857 2 2R cation transport; GO:0006812 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; oxidative phosphorylation uncoupler activity; GO:0017077; ; GO:0017077 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG2857 CG2857 CDMC20948 3 6 22 DAC35-G24 2-CG2857-RA_1 CG2857 GCCAGGTTCTGAGCATTTCGTACGCTCTGGTACAGTTCTGGTCCTACGAACAGCTTCGCTCCATGG 66 FBan0002857 FBgn0035078 CG2857 2 2R cation transport; GO:0006812 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386; oxidative phosphorylation uncoupler activity; GO:0017077; ; GO:0017077 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG2857 CG2857 CDMC20949 3 7 22 DAC35-K12 2-CG3032-RA_1 CG3032 CGAAGCCCATGTGAGAGCAGTCCACTTAAAGCTGAAACCCTTTCCCTGTCACCACTGTCCGGAGAG 66 FBan0003032 FBgn0029928 CG3032 X X "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; proteolysis; GO:0006508; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; metallopeptidase activity; GO:0008237; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0008270 nucleus; GO:0005634 CG3032 CG3032 CDMC20949 3 8 22 DAC35-K12 2-CG3032-RA_1 CG3032 CGAAGCCCATGTGAGAGCAGTCCACTTAAAGCTGAAACCCTTTCCCTGTCACCACTGTCCGGAGAG 66 FBan0003032 FBgn0029928 CG3032 X X "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; proteolysis; GO:0006508; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; metallopeptidase activity; GO:0008237; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008237; ; GO:0008270 nucleus; GO:0005634 CG3032 CG3032 CDMC20950 3 9 22 DAC35-K24 6-CG3047-RA_1 CG3047 GATGCCCGGATATCCAAATCAGTGGCCACAATTACCAGGTTATCCCCAGCAATTACCACCGCCGTT 66 FBan0003047 FBgn0003372 Sgs1 2 2L puparial adhesion; GO:0007594 structural molecule activity; GO:0005198; ; GO:0005198 extracellular region; GO:0005576 Sgs1 Salivary gland secretion 1 "CG3047, Sgs-1, Sgs, sgs-1, sgs1" CDMC20950 3 10 22 DAC35-K24 6-CG3047-RA_1 CG3047 GATGCCCGGATATCCAAATCAGTGGCCACAATTACCAGGTTATCCCCAGCAATTACCACCGCCGTT 66 FBan0003047 FBgn0003372 Sgs1 2 2L puparial adhesion; GO:0007594 structural molecule activity; GO:0005198; ; GO:0005198 extracellular region; GO:0005576 Sgs1 Salivary gland secretion 1 "CG3047, Sgs-1, Sgs, sgs-1, sgs1" CDMC20951 3 11 22 DAC35-O12 AutoBlank AutoBlank CDMC20951 3 12 22 DAC35-O12 AutoBlank AutoBlank CDMC20952 3 13 22 DAC35-O24 AutoBlank AutoBlank CDMC20952 3 14 22 DAC35-O24 AutoBlank AutoBlank CDMC20953 3 15 22 DAC36-C12 3-CG1795-RA_2 CG1795 GCTGCCAAGTTCGGTTATCGGGCCAAGTTCATAGCACAAACGCTGCAAGAGATCCAGAAAAAGGGGG 67 FBan0001795 FBgn0027864 Ogg1 X X DNA repair; GO:0006281; base-excision repair; GO:0006284 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; DNA-(apurinic or apyrimidinic site) lyase activity; GO:0003906 ; EC:4.2.99.18; purine-specific oxidized base lesion DNA N-glycosylase activity; GO:0008534 ; EC:3.2.2.23; ; GO:0008534 ; EC:3.2.2.23; ; GO:0003676; ; GO:0003906 ; EC:4.2.99.18; ; GO:0008534 ; EC:3.2.2.23; ; GO:0003677 nucleus; GO:0005634 Ogg1 Ogg1 "CG1795, CG1795, dOGG1, BcDNA:LD19945" CDMC20953 3 16 22 DAC36-C12 3-CG1795-RA_2 CG1795 GCTGCCAAGTTCGGTTATCGGGCCAAGTTCATAGCACAAACGCTGCAAGAGATCCAGAAAAAGGGGG 67 FBan0001795 FBgn0027864 Ogg1 X X DNA repair; GO:0006281; base-excision repair; GO:0006284 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; DNA-(apurinic or apyrimidinic site) lyase activity; GO:0003906 ; EC:4.2.99.18; purine-specific oxidized base lesion DNA N-glycosylase activity; GO:0008534 ; EC:3.2.2.23; ; GO:0008534 ; EC:3.2.2.23; ; GO:0003676; ; GO:0003906 ; EC:4.2.99.18; ; GO:0008534 ; EC:3.2.2.23; ; GO:0003677 nucleus; GO:0005634 Ogg1 Ogg1 "CG1795, CG1795, dOGG1, BcDNA:LD19945" CDMC20954 3 17 22 DAC36-C24 2-CG18347-RA_1 CG18347 GGCCTGTGCCGAATGATTGTGATTGCTCCTCTGTTCGGAATCGCTCAAACGGTCTACTATCTGGGCG 67 FBan0018347 FBgn0037969 CG18347 3 3R lipid metabolism; GO:0006629; lipid transport; GO:0006869 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG18347 CG18347 CDMC20954 3 18 22 DAC36-C24 2-CG18347-RA_1 CG18347 GGCCTGTGCCGAATGATTGTGATTGCTCCTCTGTTCGGAATCGCTCAAACGGTCTACTATCTGGGCG 67 FBan0018347 FBgn0037969 CG18347 3 3R lipid metabolism; GO:0006629; lipid transport; GO:0006869 carrier activity; GO:0005386; binding; GO:0005488; ; GO:0005488; ; GO:0005386 mitochondrial inner membrane; GO:0005743; mitochondrial membrane; GO:0005740 CG18347 CG18347 CDMC20955 3 19 22 DAC36-G12 2-CG2038-RA_1 CG2038 CCGGACTCCAAGCACTTCGAGACCCTGAACCTATTCGCATACGGCACATACAAGGAATACCGTGCAC 67 FBgn0033291 CDMC20955 3 20 22 DAC36-G12 2-CG2038-RA_1 CG2038 CCGGACTCCAAGCACTTCGAGACCCTGAACCTATTCGCATACGGCACATACAAGGAATACCGTGCAC 67 FBgn0033291 CDMC20956 3 21 22 DAC36-G24 23-CG2249-RB_2 CG2249 GCAGGCCATTACAGTGTGTTACAGCTTAAATTTAAGTAAAAAGTGGAAACGAAATAAAGTTACCCGT 67 FBan0002249 FBgn0040773 CG2249 2 2R "mitochondrial electron transport, cytochrome c to oxygen; GO:0006123" cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 respiratory chain complex IV (sensu Eukaryota); GO:0005751 CG2249 CG2249 "VIIc, BcDNA:LD14731, anon-EST:fe3A1, anon-fast-evolving-3A1" CDMC20956 3 22 22 DAC36-G24 23-CG2249-RB_2 CG2249 GCAGGCCATTACAGTGTGTTACAGCTTAAATTTAAGTAAAAAGTGGAAACGAAATAAAGTTACCCGT 67 FBan0002249 FBgn0040773 CG2249 2 2R "mitochondrial electron transport, cytochrome c to oxygen; GO:0006123" cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 respiratory chain complex IV (sensu Eukaryota); GO:0005751 CG2249 CG2249 "VIIc, BcDNA:LD14731, anon-EST:fe3A1, anon-fast-evolving-3A1" CDMC20957 3 23 22 DAC36-K12 2-CG30053-RA_3 CG30053 CACGGATATCTGGAGCCTAAGTTATGGTCTGGAGAAACCCCACGGAAAGCTGACCTCCCTGGCTAGC 67 FBan0030053 FBgn0050053 CG30053 2 2R CG30053 CG30053 "CG8769, CG8769" CDMC20957 3 24 22 DAC36-K12 2-CG30053-RA_3 CG30053 CACGGATATCTGGAGCCTAAGTTATGGTCTGGAGAAACCCCACGGAAAGCTGACCTCCCTGGCTAGC 67 FBan0030053 FBgn0050053 CG30053 2 2R CG30053 CG30053 "CG8769, CG8769" CDMC20958 3 25 22 DAC36-K24 9-CG30193-RD_1 CG30193 GCTCGAGGACCAGCCAGAGGACGTGATACCCGTGTATCCAAAGTTTATCTACGCCCCACAACAGCAG 67 FBan0030193 FBgn0050193 CG30193 2 2R CG30193 CG30193 "CG9848, CG9848, anon-WO0118547.113, BcDNA:LD42159, BcDNA:RE29641" CDMC20958 3 26 22 DAC36-K24 9-CG30193-RD_1 CG30193 GCTCGAGGACCAGCCAGAGGACGTGATACCCGTGTATCCAAAGTTTATCTACGCCCCACAACAGCAG 67 FBan0030193 FBgn0050193 CG30193 2 2R CG30193 CG30193 "CG9848, CG9848, anon-WO0118547.113, BcDNA:LD42159, BcDNA:RE29641" CDMC20959 3 1 23 DAC36-O12 3-CG31003-RA_1 CG31003 GGCCATAGATCTGGTCTCCAAGATGCTGATATACTCGCCCAATGCCAGGGTTTCTCCGTTGATGGGC 67 FBgn0051003 CDMC20959 3 2 23 DAC36-O12 3-CG31003-RA_1 CG31003 GGCCATAGATCTGGTCTCCAAGATGCTGATATACTCGCCCAATGCCAGGGTTTCTCCGTTGATGGGC 67 FBgn0051003 CDMC20960 3 3 23 DAC36-O24 AutoBlank AutoBlank CDMC20960 3 4 23 DAC36-O24 AutoBlank AutoBlank CDMC20961 3 5 23 DAC37-C12 3-CG7629-RA_1 CG7629 CCAGGCTTCTGGCACAGCAAATCTGTATACCTCTCCAAGTGGCAATCTCAACCTCAACGCCACCG 65 FBan0007629 FBgn0038530 AttD 3 3R antibacterial humoral response (sensu Protostomia); GO:0006961 extracellular region; GO:0005576 AttD Attacin-D "CG7629, attacin, Attacin, att, Attackin, Att, Attacin D, Attacin-D" CDMC20961 3 6 23 DAC37-C12 3-CG7629-RA_1 CG7629 CCAGGCTTCTGGCACAGCAAATCTGTATACCTCTCCAAGTGGCAATCTCAACCTCAACGCCACCG 65 FBan0007629 FBgn0038530 AttD 3 3R antibacterial humoral response (sensu Protostomia); GO:0006961 extracellular region; GO:0005576 AttD Attacin-D "CG7629, attacin, Attacin, att, Attackin, Att, Attacin D, Attacin-D" CDMC20962 3 7 23 DAC37-C24 12-CG7685-RA_1 CG7685 CAAGTTCCGGTGTCTGGACGGCTCCAAAGAGATCCCGTTCGACCACCTGAACGACAACTACTGCG 65 FBan0007685 FBgn0038619 CG7685 3 3R signal transduction; GO:0007165 alpha-glucosidase activity; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20 alpha-glucosidase II complex; GO:0017177 CG7685 CG7685 CDMC20962 3 8 23 DAC37-C24 12-CG7685-RA_1 CG7685 CAAGTTCCGGTGTCTGGACGGCTCCAAAGAGATCCCGTTCGACCACCTGAACGACAACTACTGCG 65 FBan0007685 FBgn0038619 CG7685 3 3R signal transduction; GO:0007165 alpha-glucosidase activity; GO:0004558 ; EC:3.2.1.20; ; GO:0004558 ; EC:3.2.1.20 alpha-glucosidase II complex; GO:0017177 CG7685 CG7685 CDMC20963 3 9 23 DAC37-G12 18-CG7843-RD_2 CG7843 GCGTCCGCAACTTCCCGAACATCCAGGCACCTCTAAGCGTCCAGAATCGGAATCTGCTCGTGGAG 65 FBan0007843 FBgn0033062 CG7843 2 2R defense response; GO:0006952; response to arsenic; GO:0046685; response to toxin; GO:0009636 CG7843 CG7843 anon-WO0118547.166 CDMC20963 3 10 23 DAC37-G12 18-CG7843-RD_2 CG7843 GCGTCCGCAACTTCCCGAACATCCAGGCACCTCTAAGCGTCCAGAATCGGAATCTGCTCGTGGAG 65 FBan0007843 FBgn0033062 CG7843 2 2R defense response; GO:0006952; response to arsenic; GO:0046685; response to toxin; GO:0009636 CG7843 CG7843 anon-WO0118547.166 CDMC20964 3 11 23 DAC37-G24 2-CG7888-RA_2 CG7888 GCGAAGGCCCCAAATGTTTCCGGGTTTTTGCTCCCTACATTGGCACAGTGGTTAACACCTTCCTG 65 FBan0007888 FBgn0036116 CG7888 3 3L amino acid transport; GO:0006865 amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 CG7888 CG7888 CDMC20964 3 12 23 DAC37-G24 2-CG7888-RA_2 CG7888 GCGAAGGCCCCAAATGTTTCCGGGTTTTTGCTCCCTACATTGGCACAGTGGTTAACACCTTCCTG 65 FBan0007888 FBgn0036116 CG7888 3 3L amino acid transport; GO:0006865 amino acid-polyamine transporter activity; GO:0005279; ; GO:0005279 membrane; GO:0016020 CG7888 CG7888 CDMC20965 3 13 23 DAC37-K12 3-CG7958-RA_5 CG7958 CACCGATACCCTGGAGATCGATCAGTACATCTGGGCCATACTCAACACGCTGGGCAACTCGGATG 65 FBgn0036103 CDMC20965 3 14 23 DAC37-K12 3-CG7958-RA_5 CG7958 CACCGATACCCTGGAGATCGATCAGTACATCTGGGCCATACTCAACACGCTGGGCAACTCGGATG 65 FBgn0036103 CDMC20966 3 15 23 DAC37-K24 18-CG7994-RA_5 CG7994 TGCGACCATCAGCGCGACCTTCGAGGACGTACCCTTCGATGCGAACAACTACTGGGCCCTATTGG 65 FBan0007994 FBgn0037599 CG7994 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; transmission of nerve impulse; GO:0019226 amine receptor activity; GO:0008227; ; GO:0008227 integral to membrane; GO:0016021 CG7994 CG7994 "anon-WO0170980.94, anon-WO0170980.95" CDMC20966 3 16 23 DAC37-K24 18-CG7994-RA_5 CG7994 TGCGACCATCAGCGCGACCTTCGAGGACGTACCCTTCGATGCGAACAACTACTGGGCCCTATTGG 65 FBan0007994 FBgn0037599 CG7994 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; transmission of nerve impulse; GO:0019226 amine receptor activity; GO:0008227; ; GO:0008227 integral to membrane; GO:0016021 CG7994 CG7994 "anon-WO0170980.94, anon-WO0170980.95" CDMC20967 3 17 23 DAC37-O12 23-CG8087-RA_1 CG8087 CGGGCCAATGGAAACGTTATTGTTGTCGGCTAAGTACGCGGAATTCAATAAAATGCTCAACAAGA 65 FBan0008087 FBgn0038241 CG8087 3 3R CG8087 CG8087 CDMC20967 3 18 23 DAC37-O12 23-CG8087-RA_1 CG8087 CGGGCCAATGGAAACGTTATTGTTGTCGGCTAAGTACGCGGAATTCAATAAAATGCTCAACAAGA 65 FBan0008087 FBgn0038241 CG8087 3 3R CG8087 CG8087 CDMC20968 3 19 23 DAC37-O24 AutoBlank AutoBlank CDMC20968 3 20 23 DAC37-O24 AutoBlank AutoBlank CDMC20969 3 21 23 DAC38-C12 23-CG4178-RA_1 CG4178 GGATGTTTTTAGAGTGTCTGATACCTAGCTAGTAAGGTGTGCAAAAAGTCTAATAAACTTTCGAAAACC 69 FBan0004178 FBgn0002563 Lsp1beta 2 2L transport; GO:0006810 nutrient reservoir activity; GO:0045735; oxygen transporter activity; GO:0005344; ; GO:0045735; ; GO:0005344 extracellular region; GO:0005576; larval serum protein complex; GO:0005616 Lsp1beta Larval serum protein 1 beta "CG4178, CG4178, CG4178, LSP-1beta, LSP-1 beta, LSP-1, Lsp1-beta, LSP1beta, Lsp-1beta, LSP 1, Lsp1, DmeLSP1b, Lsp-1b, Lsp1b" CDMC20969 3 22 23 DAC38-C12 23-CG4178-RA_1 CG4178 GGATGTTTTTAGAGTGTCTGATACCTAGCTAGTAAGGTGTGCAAAAAGTCTAATAAACTTTCGAAAACC 69 FBan0004178 FBgn0002563 Lsp1beta 2 2L transport; GO:0006810 nutrient reservoir activity; GO:0045735; oxygen transporter activity; GO:0005344; ; GO:0045735; ; GO:0005344 extracellular region; GO:0005576; larval serum protein complex; GO:0005616 Lsp1beta Larval serum protein 1 beta "CG4178, CG4178, CG4178, LSP-1beta, LSP-1 beta, LSP-1, Lsp1-beta, LSP1beta, Lsp-1beta, LSP 1, Lsp1, DmeLSP1b, Lsp-1b, Lsp1b" CDMC20970 3 23 23 DAC38-C24 2-CG4187-RA_2 CG4187 CGCCAGTGATTTCCTCATGGGCATTTACCTCACATTGATTGCCTGTGCGGATATCAGTTTTCGCGGCGA 69 FBan0004187 FBgn0030458 CG4187 X X G-protein coupled receptor protein signaling pathway; GO:0007186; intracellular protein transport; GO:0006886; protein targeting; GO:0006605 neuropeptide receptor activity; GO:0008188; protein-hormone receptor activity; GO:0016500; ; GO:0008188; ; GO:0016500 integral to membrane; GO:0016021 CG4187 CG4187 "anon-WO0170980.19, anon-WO0170980.20" CDMC20970 3 24 23 DAC38-C24 2-CG4187-RA_2 CG4187 CGCCAGTGATTTCCTCATGGGCATTTACCTCACATTGATTGCCTGTGCGGATATCAGTTTTCGCGGCGA 69 FBan0004187 FBgn0030458 CG4187 X X G-protein coupled receptor protein signaling pathway; GO:0007186; intracellular protein transport; GO:0006886; protein targeting; GO:0006605 neuropeptide receptor activity; GO:0008188; protein-hormone receptor activity; GO:0016500; ; GO:0008188; ; GO:0016500 integral to membrane; GO:0016021 CG4187 CG4187 "anon-WO0170980.19, anon-WO0170980.20" CDMC20971 3 25 23 DAC38-G12 3-CG4213-RA_3 CG4213 CGGCCCAAATCCTCAGCTGGATCAGGATCGAAGCTCCACTAGCATGTCGCAGACTTTAGAGCAACGATT 69 FBan0004213 FBgn0031251 CG4213 2 2L CG4213 CG4213 CDMC20971 3 26 23 DAC38-G12 3-CG4213-RA_3 CG4213 CGGCCCAAATCCTCAGCTGGATCAGGATCGAAGCTCCACTAGCATGTCGCAGACTTTAGAGCAACGATT 69 FBan0004213 FBgn0031251 CG4213 2 2L CG4213 CG4213 CDMC20972 3 1 24 DAC38-G24 23-CG4221-RA_5 CG4221 GCACAGATATAAAGGGAATTTATGGGCAAAGAAAACTCTTGAAAAACAAAATAGTTGATGAAGTGGCAG 69 FBan0004221 FBgn0038385 CG4221 3 3R protein metabolism; GO:0019538; proteolysis; GO:0006508 CG4221 CG4221 CDMC20972 3 2 24 DAC38-G24 23-CG4221-RA_5 CG4221 GCACAGATATAAAGGGAATTTATGGGCAAAGAAAACTCTTGAAAAACAAAATAGTTGATGAAGTGGCAG 69 FBan0004221 FBgn0038385 CG4221 3 3R protein metabolism; GO:0019538; proteolysis; GO:0006508 CG4221 CG4221 CDMC20973 3 3 24 DAC38-K12 8-CG4260-RA_1 CG4260 CGGGCAAGCAAGGAGACCGTAACTCGGGAAATCTGCGATCTGTTGACGGATCAATTCTAAGCCACAACA 69 FBan0004260 FBgn0015567 alpha-Adaptin 2 2L asymmetric cell division; GO:0008356; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; protein complex assembly; GO:0006461; synaptic vesicle coating; GO:0016183; synaptic vesicle transport; GO:0048489; vesicle coating; GO:0006901; vesicle-mediated transport; GO:0016192 structural molecule activity; GO:0005198; ; GO:0005198 AP-2 adaptor complex; GO:0030122; clathrin coat of trans-Golgi network vesicle; GO:0030130; coated vesicle; GO:0030135; plasma membrane; GO:0005886; synaptic vesicle; GO:0008021 alpha-Adaptin alpha-Adaptin "CG4260, CG31654, CG4260, CG4260, CG4260, CG4260, dAP-2a, D-alphaAda, alpha-adaptin, D-Ada, alpha-adaptin, alpha-Ada, alpha adaptin, alpha adaptin, AP-2, alpha, cg4260, ada, alpha-Adaptin, AP2, l(2)06694, alpha-Adaptin" CDMC20973 3 4 24 DAC38-K12 8-CG4260-RA_1 CG4260 CGGGCAAGCAAGGAGACCGTAACTCGGGAAATCTGCGATCTGTTGACGGATCAATTCTAAGCCACAACA 69 FBan0004260 FBgn0015567 alpha-Adaptin 2 2L asymmetric cell division; GO:0008356; intracellular protein transport; GO:0006886; neurotransmitter secretion; GO:0007269; protein complex assembly; GO:0006461; synaptic vesicle coating; GO:0016183; synaptic vesicle transport; GO:0048489; vesicle coating; GO:0006901; vesicle-mediated transport; GO:0016192 structural molecule activity; GO:0005198; ; GO:0005198 AP-2 adaptor complex; GO:0030122; clathrin coat of trans-Golgi network vesicle; GO:0030130; coated vesicle; GO:0030135; plasma membrane; GO:0005886; synaptic vesicle; GO:0008021 alpha-Adaptin alpha-Adaptin "CG4260, CG31654, CG4260, CG4260, CG4260, CG4260, dAP-2a, D-alphaAda, alpha-adaptin, D-Ada, alpha-adaptin, alpha-Ada, alpha adaptin, alpha adaptin, AP-2, alpha, cg4260, ada, alpha-Adaptin, AP2, l(2)06694, alpha-Adaptin" CDMC20974 3 5 24 DAC38-K24 15-CG4269-RA_1 CG4269 ACCTCGTCCGGGTACTTAGCGAATAGCGAATTGACCGTGGAGTGGATAAAGTGTTAGTGGAGCAACAGA 69 FBan0004269 FBgn0034741 CG4269 2 2R CG4269 CG4269 CDMC20974 3 6 24 DAC38-K24 15-CG4269-RA_1 CG4269 ACCTCGTCCGGGTACTTAGCGAATAGCGAATTGACCGTGGAGTGGATAAAGTGTTAGTGGAGCAACAGA 69 FBan0004269 FBgn0034741 CG4269 2 2R CG4269 CG4269 CDMC20975 3 7 24 DAC38-O12 9-CG4321-RA_2 CG4321 ATGATGCTGGCCAAGATTGTCAGGGAATACGAACTGCTTCCGATGGGTCAAAGGGTTGAGTGCATTGTT 69 FBan0004321 FBgn0015033 Cyp4d8 3 3L electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4d8 Cytochrome P450-4d8 "CG4321, P450, P-450, 4d8" CDMC20975 3 8 24 DAC38-O12 9-CG4321-RA_2 CG4321 ATGATGCTGGCCAAGATTGTCAGGGAATACGAACTGCTTCCGATGGGTCAAAGGGTTGAGTGCATTGTT 69 FBan0004321 FBgn0015033 Cyp4d8 3 3L electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp4d8 Cytochrome P450-4d8 "CG4321, P450, P-450, 4d8" CDMC20976 3 9 24 DAC38-O24 23-CG4334-RA_1 CG4334 CTCTTGTGTAAGACTTGTTACTTGTGCATTTCCAACTAATCTTGTTTTAGGTACATTGTCGATCTGCCG 69 FBan0004334 FBgn0038312 CG4334 3 3R metal ion transport; GO:0030001 metal ion transporter activity; GO:0046873; ; GO:0046873 membrane; GO:0016020 CG4334 CG4334 CDMC20976 3 10 24 DAC38-O24 23-CG4334-RA_1 CG4334 CTCTTGTGTAAGACTTGTTACTTGTGCATTTCCAACTAATCTTGTTTTAGGTACATTGTCGATCTGCCG 69 FBan0004334 FBgn0038312 CG4334 3 3R metal ion transport; GO:0030001 metal ion transporter activity; GO:0046873; ; GO:0046873 membrane; GO:0016020 CG4334 CG4334 CDMC20977 3 11 24 DAC39-C12 3-CG6951-RA_1 CG6951 GCAGCGATGACGTGTTTCCGTGGTCAAAAGCTAAGAAAGGCTCGCAGGAATTTGATCCCCTGGAAGACA 69 FBan0006951 FBgn0036959 CG6951 3 3L pyrimidine base metabolism; GO:0006206 dCMP deaminase activity; GO:0004132 ; EC:3.5.4.12; zinc ion binding; GO:0008270; ; GO:0004132 ; EC:3.5.4.12; ; GO:0008270; ; GO:0004132 ; EC:3.5.4.12 CG6951 CG6951 anon-WO0118547.579 CDMC20977 3 12 24 DAC39-C12 3-CG6951-RA_1 CG6951 GCAGCGATGACGTGTTTCCGTGGTCAAAAGCTAAGAAAGGCTCGCAGGAATTTGATCCCCTGGAAGACA 69 FBan0006951 FBgn0036959 CG6951 3 3L pyrimidine base metabolism; GO:0006206 dCMP deaminase activity; GO:0004132 ; EC:3.5.4.12; zinc ion binding; GO:0008270; ; GO:0004132 ; EC:3.5.4.12; ; GO:0008270; ; GO:0004132 ; EC:3.5.4.12 CG6951 CG6951 anon-WO0118547.579 CDMC20978 3 13 24 DAC39-C24 18-CG6958-RA_9 CG6958 GGACAAGGAGCGACTGGAAGATTACACCCGCAAGTACGAGGAATATGACTTCTCACAGTTTGCCATCAA 69 FBan0006958 FBgn0039004 CG6958 3 3R RNA transport; GO:0050658; glycolysis; GO:0006096 transporter activity; GO:0005215; ; GO:0005215; glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity; GO:0004365 ; EC:1.2.1.12; ; GO:0004365 ; EC:1.2.1.12 nuclear pore; GO:0005643 CG6958 CG6958 CDMC20978 3 14 24 DAC39-C24 18-CG6958-RA_9 CG6958 GGACAAGGAGCGACTGGAAGATTACACCCGCAAGTACGAGGAATATGACTTCTCACAGTTTGCCATCAA 69 FBan0006958 FBgn0039004 CG6958 3 3R RNA transport; GO:0050658; glycolysis; GO:0006096 transporter activity; GO:0005215; ; GO:0005215; glyceraldehyde-3-phosphate dehydrogenase (phosphorylating) activity; GO:0004365 ; EC:1.2.1.12; ; GO:0004365 ; EC:1.2.1.12 nuclear pore; GO:0005643 CG6958 CG6958 CDMC20979 3 15 24 DAC39-G12 23-CG6987-RA_11 CG6987 CTCTGAAAATCGAAATAGATCGAAGCGTCTGATTTAAACTGGAGAAAATGGGATCACGCAACGAGTGCC 69 FBan0006987 FBgn0040284 SF2 3 3R "mRNA splice site selection; GO:0006376; nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515 nucleus; GO:0005634; spliceosome complex; GO:0005681 SF2 SF2 "CG6987, CG6987, CG6987, cg6987, ASF/SF2, dSF2/ASF, dASF, dmSF2/p28, ASF" CDMC20979 3 16 24 DAC39-G12 23-CG6987-RA_11 CG6987 CTCTGAAAATCGAAATAGATCGAAGCGTCTGATTTAAACTGGAGAAAATGGGATCACGCAACGAGTGCC 69 FBan0006987 FBgn0040284 SF2 3 3R "mRNA splice site selection; GO:0006376; nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515 nucleus; GO:0005634; spliceosome complex; GO:0005681 SF2 SF2 "CG6987, CG6987, CG6987, cg6987, ASF/SF2, dSF2/ASF, dASF, dmSF2/p28, ASF" CDMC20980 3 17 24 DAC39-G24 7-CG6998-RB_1 CG6998 TCGGGAACACGTCACATAGGGCATTCTCTTTCACAATATGGAGAGAGAGGCTACACACGAGCACACCGT 69 FBan0006998 FBgn0011760 ctp X X RNA localization; GO:0006403; bristle morphogenesis; GO:0008407; cell cycle; GO:0007049; intracellular protein transport; GO:0006886; microtubule-based movement; GO:0007018; spermatogenesis; GO:0007283; vesicle-mediated transport; GO:0016192; wing morphogenesis; GO:0007476 "microtubule motor activity; GO:0003777; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; ; GO:0003777" cytoplasmic dynein complex; GO:0005868; cytoskeleton; GO:0005856; dynein complex; GO:0030286 ctp cut up "CG6998, CG6998, CG6998, CG6998, CG6998, dynein light chain, ddlc1, dynein light-chain 1, Cytoplasmic dynein 8kD light chain, Cdlc1, l(1)G0207, l(1)G0153, l(1)G0432, l(1)G0371, l(1)G0387, l(1)G0338, l(1)G0248, Ddlc1, 8kd dynein light chain, l(1)G0204, Ddlc-1, cytoplasmic dynein light chain 1, LC8, cytoplasmic dynein, dlc, Cytoplasmic dynein, dynein, anon-WO03040301.128, Dlc, l(1)G0244, l(1)G0445, Cytoplasmic dynein light chain 1, Dynein light chain" CDMC20980 3 18 24 DAC39-G24 7-CG6998-RB_1 CG6998 TCGGGAACACGTCACATAGGGCATTCTCTTTCACAATATGGAGAGAGAGGCTACACACGAGCACACCGT 69 FBan0006998 FBgn0011760 ctp X X RNA localization; GO:0006403; bristle morphogenesis; GO:0008407; cell cycle; GO:0007049; intracellular protein transport; GO:0006886; microtubule-based movement; GO:0007018; spermatogenesis; GO:0007283; vesicle-mediated transport; GO:0016192; wing morphogenesis; GO:0007476 "microtubule motor activity; GO:0003777; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0005200; ; GO:0042623; ; GO:0003777" cytoplasmic dynein complex; GO:0005868; cytoskeleton; GO:0005856; dynein complex; GO:0030286 ctp cut up "CG6998, CG6998, CG6998, CG6998, CG6998, dynein light chain, ddlc1, dynein light-chain 1, Cytoplasmic dynein 8kD light chain, Cdlc1, l(1)G0207, l(1)G0153, l(1)G0432, l(1)G0371, l(1)G0387, l(1)G0338, l(1)G0248, Ddlc1, 8kd dynein light chain, l(1)G0204, Ddlc-1, cytoplasmic dynein light chain 1, LC8, cytoplasmic dynein, dlc, Cytoplasmic dynein, dynein, anon-WO03040301.128, Dlc, l(1)G0244, l(1)G0445, Cytoplasmic dynein light chain 1, Dynein light chain" CDMC20981 3 19 24 DAC39-K12 12-CG7025-RA_4 CG7025 CCCGTCAACCCTCCGAAATTTCTAGTTGCATTGGAGCAGACCCCAATCGAAACTACGATTCGCATTGGA 69 FBan0007025 FBgn0031930 CG7025 2 2L proteolysis; GO:0006508 metallocarboxypeptidase activity; GO:0004181 ; EC:3.4.17.-; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1; ; GO:0004181 ; EC:3.4.17.- CG7025 CG7025 CDMC20981 3 20 24 DAC39-K12 12-CG7025-RA_4 CG7025 CCCGTCAACCCTCCGAAATTTCTAGTTGCATTGGAGCAGACCCCAATCGAAACTACGATTCGCATTGGA 69 FBan0007025 FBgn0031930 CG7025 2 2L proteolysis; GO:0006508 metallocarboxypeptidase activity; GO:0004181 ; EC:3.4.17.-; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1; ; GO:0004181 ; EC:3.4.17.- CG7025 CG7025 CDMC20982 3 21 24 DAC39-K24 23-CG7037-RB_5 CG7037 GCGAACCCATCGTTAAACGCTAGTGTTACTTAGCTAAACACATAAAACTAAGTTGGAGAAGTTCGACCG 69 FBan0007037 FBgn0020224 Cbl 3 3L "cellular defense response; GO:0006968; dorsal/ventral axis determination, follicular epithelium (sensu Insecta); GO:0008069; dorsal/ventral axis specification; GO:0009950; epidermal growth factor receptor signaling pathway; GO:0007173; negative regulation of epidermal growth factor receptor activity; GO:0007175; negative regulation of epidermal growth factor receptor signaling pathway; GO:0042059; protein ubiquitination; GO:0016567; proteolysis; GO:0006508" ligase activity; GO:0016874 ; EC:6.-.-.-; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; signal transducer activity; GO:0004871; ; GO:0016874 ; EC:6.-.-.-; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0016874 ; EC:6.-.-.-; ; GO:0008270; ; GO:0004871 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 Cbl Cbl "CG7037, CG7043, CG7037, D-cbl, D-Cbl, Dv-cbl, Dcbl, cbl, dCbl, Dv-Cbl, d-cbl, DCbl, D-cblL, anon-WO0118547.68, F165" CDMC20982 3 22 24 DAC39-K24 23-CG7037-RB_5 CG7037 GCGAACCCATCGTTAAACGCTAGTGTTACTTAGCTAAACACATAAAACTAAGTTGGAGAAGTTCGACCG 69 FBan0007037 FBgn0020224 Cbl 3 3L "cellular defense response; GO:0006968; dorsal/ventral axis determination, follicular epithelium (sensu Insecta); GO:0008069; dorsal/ventral axis specification; GO:0009950; epidermal growth factor receptor signaling pathway; GO:0007173; negative regulation of epidermal growth factor receptor activity; GO:0007175; negative regulation of epidermal growth factor receptor signaling pathway; GO:0042059; protein ubiquitination; GO:0016567; proteolysis; GO:0006508" ligase activity; GO:0016874 ; EC:6.-.-.-; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; signal transducer activity; GO:0004871; ; GO:0016874 ; EC:6.-.-.-; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0016874 ; EC:6.-.-.-; ; GO:0008270; ; GO:0004871 nucleus; GO:0005634; ubiquitin ligase complex; GO:0000151 Cbl Cbl "CG7037, CG7043, CG7037, D-cbl, D-Cbl, Dv-cbl, Dcbl, cbl, dCbl, Dv-Cbl, d-cbl, DCbl, D-cblL, anon-WO0118547.68, F165" CDMC20983 3 23 24 DAC39-O12 11-CG7068-RA_1 CG7068 CTGGTGAGCAACAATCACCCTGGTATAATGCCACTCGTAGCGTCAACATTGAGATCTCCGCTTACGCCG 69 FBan0007068 FBgn0041181 TepIII 2 2L endopeptidase inhibitor activity; GO:0004866; ; GO:0004866 TepIII Thiolester containing protein III "CG7068, dTEPIII, Tep3, Thiolester containing protein III" CDMC20983 3 24 24 DAC39-O12 11-CG7068-RA_1 CG7068 CTGGTGAGCAACAATCACCCTGGTATAATGCCACTCGTAGCGTCAACATTGAGATCTCCGCTTACGCCG 69 FBan0007068 FBgn0041181 TepIII 2 2L endopeptidase inhibitor activity; GO:0004866; ; GO:0004866 TepIII Thiolester containing protein III "CG7068, dTEPIII, Tep3, Thiolester containing protein III" CDMC20984 3 25 24 DAC39-O24 18-CG7075-RA_2 CG7075 TTAGATGTCGAGTTTATGCTCGGAAAACGGCCAACTCTATATTGGAGAATCGTGTGGCAGGTCGTCACA 69 FBan0007075 FBgn0031934 CG7075 2 2L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; extracellular transport; GO:0006858; ion transport; GO:0006811; neurotransmitter transport; GO:0006836 amino acid transporter activity; GO:0015171; ; GO:0015171; neurotransmitter:sodium symporter activity; GO:0005328; glycine transporter activity; GO:0015187; ; GO:0005328; ; GO:0015187 Nebenkern; GO:0016006; integral to plasma membrane; GO:0005887; membrane; GO:0016020; mitochondrial derivative; GO:0016007; nucleus; GO:0005634 CG7075 CG7075 CDMC20984 3 26 24 DAC39-O24 18-CG7075-RA_2 CG7075 TTAGATGTCGAGTTTATGCTCGGAAAACGGCCAACTCTATATTGGAGAATCGTGTGGCAGGTCGTCACA 69 FBan0007075 FBgn0031934 CG7075 2 2L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865; extracellular transport; GO:0006858; ion transport; GO:0006811; neurotransmitter transport; GO:0006836 amino acid transporter activity; GO:0015171; ; GO:0015171; neurotransmitter:sodium symporter activity; GO:0005328; glycine transporter activity; GO:0015187; ; GO:0005328; ; GO:0015187 Nebenkern; GO:0016006; integral to plasma membrane; GO:0005887; membrane; GO:0016020; mitochondrial derivative; GO:0016007; nucleus; GO:0005634 CG7075 CG7075 CDMC20985 3 1 25 DAC40-C12 3-CG33347-RA_2 CG33347 TTTGCGTAAAGAGGACCACATTTTGGACCGCCCACACAGTCGGGTTGAAGGTGTCATGGTATGGG 65 FBan0033347 FBgn0053347 CG33347 2 2R CG33347 CG33347 CDMC20985 3 2 25 DAC40-C12 3-CG33347-RA_2 CG33347 TTTGCGTAAAGAGGACCACATTTTGGACCGCCCACACAGTCGGGTTGAAGGTGTCATGGTATGGG 65 FBan0033347 FBgn0053347 CG33347 2 2R CG33347 CG33347 CDMC20986 3 3 25 DAC40-C24 3-CG33474-RA_3 CG33474 TAAACAATGTGGGTTCAGAAGACTCTGGGGAGCCACCTGTGCTTCGGTACACTGTGGACAGCGAA 65 FBan0033474 FBgn0053474 CG33474 2 2R CG33474 CG33474 CDMC20986 3 4 25 DAC40-C24 3-CG33474-RA_3 CG33474 TAAACAATGTGGGTTCAGAAGACTCTGGGGAGCCACCTGTGCTTCGGTACACTGTGGACAGCGAA 65 FBan0033474 FBgn0053474 CG33474 2 2R CG33474 CG33474 CDMC20987 3 5 25 DAC40-G12 23-CG3450-RA_1 CG3450 GGTACACAATCTTCAAGGACCCGATTCGCCTATCTGACTATGAAATTCACGATGGCATGAATCTG 65 FBgn0033105 CDMC20987 3 6 25 DAC40-G12 23-CG3450-RA_1 CG3450 GGTACACAATCTTCAAGGACCCGATTCGCCTATCTGACTATGAAATTCACGATGGCATGAATCTG 65 FBgn0033105 CDMC20988 3 7 25 DAC40-G24 2-CG3523-RA_2 CG3523 GAATGTGGCATAGGCCCACTACCCACACGATCATCACCCTCTCACCGTCACTCACCCAATACTCG 65 FBan0003523 FBgn0027571 CG3523 2 2L fatty acid biosynthesis; GO:0006633 "fatty-acid synthase activity; GO:0004312 ; EC:2.3.1.85; hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; zinc ion binding; GO:0008270; ; GO:0016788 ; EC:3.1.-.-; ; GO:0004312 ; EC:2.3.1.85; ; GO:0008270; alcohol dehydrogenase activity, zinc-dependent; GO:0004024; cofactor binding; GO:0048037; ; GO:0004024; ; GO:0048037" CG3523 CG3523 "Fatty acid synthase, Fatty acid synthetase, BcDNA:GH07626, DM_7295848, BcDNA:gh07626, anon-WO0138581.1, anon-EST:Posey235, anon-EST:Posey43" CDMC20988 3 8 25 DAC40-G24 2-CG3523-RA_2 CG3523 GAATGTGGCATAGGCCCACTACCCACACGATCATCACCCTCTCACCGTCACTCACCCAATACTCG 65 FBan0003523 FBgn0027571 CG3523 2 2L fatty acid biosynthesis; GO:0006633 "fatty-acid synthase activity; GO:0004312 ; EC:2.3.1.85; hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; zinc ion binding; GO:0008270; ; GO:0016788 ; EC:3.1.-.-; ; GO:0004312 ; EC:2.3.1.85; ; GO:0008270; alcohol dehydrogenase activity, zinc-dependent; GO:0004024; cofactor binding; GO:0048037; ; GO:0004024; ; GO:0048037" CG3523 CG3523 "Fatty acid synthase, Fatty acid synthetase, BcDNA:GH07626, DM_7295848, BcDNA:gh07626, anon-WO0138581.1, anon-EST:Posey235, anon-EST:Posey43" CDMC20989 3 9 25 DAC40-K12 18-CG3629-RA_2 CG3629 GCGGCTCACCCTCACATTATCTACCTCCCGGACACAGTCCAACGCCATCGAGTACACCCGTGTCC 65 FBan0003629 FBgn0000157 Dll 2 2R "analia morphogenesis (sensu Endopterygota); GO:0007487; antennal morphogenesis; GO:0007469; ectoderm development; GO:0007398; genital disc development; GO:0035215; genitalia morphogenesis (sensu Endopterygota); GO:0007484; leg disc proximal/distal pattern formation; GO:0007479; leg morphogenesis; GO:0035110; limb morphogenesis (sensu Endopterygota); GO:0035109; nervous system development; GO:0007399; proximal/distal pattern formation; GO:0009954; proximal/distal pattern formation, imaginal disc; GO:0007449; regulation of transcription from RNA polymerase II promoter; GO:0006357; specification of organ identity; GO:0010092" DNA binding; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 Dll Distal-less "CG3629, Ba: Brista, Brista, En(Arp), dll, l(2)01092, 2.7, Distalless, BcDNA:LP01770, Art, E(Arp): Enhancer of Arp, l(2)387, Enhancer of Arp, Ba, Distal-less" CDMC20989 3 10 25 DAC40-K12 18-CG3629-RA_2 CG3629 GCGGCTCACCCTCACATTATCTACCTCCCGGACACAGTCCAACGCCATCGAGTACACCCGTGTCC 65 FBan0003629 FBgn0000157 Dll 2 2R "analia morphogenesis (sensu Endopterygota); GO:0007487; antennal morphogenesis; GO:0007469; ectoderm development; GO:0007398; genital disc development; GO:0035215; genitalia morphogenesis (sensu Endopterygota); GO:0007484; leg disc proximal/distal pattern formation; GO:0007479; leg morphogenesis; GO:0035110; limb morphogenesis (sensu Endopterygota); GO:0035109; nervous system development; GO:0007399; proximal/distal pattern formation; GO:0009954; proximal/distal pattern formation, imaginal disc; GO:0007449; regulation of transcription from RNA polymerase II promoter; GO:0006357; specification of organ identity; GO:0010092" DNA binding; GO:0003677; specific RNA polymerase II transcription factor activity; GO:0003704; transcription factor activity; GO:0003700; ; GO:0003704; ; GO:0003700; ; GO:0003677 nucleus; GO:0005634 Dll Distal-less "CG3629, Ba: Brista, Brista, En(Arp), dll, l(2)01092, 2.7, Distalless, BcDNA:LP01770, Art, E(Arp): Enhancer of Arp, l(2)387, Enhancer of Arp, Ba, Distal-less" CDMC20990 3 11 25 DAC40-K24 2-CG3654-RD_1 CG3654 CTCCGAAGCCCTGCATCAAATGTTGCCAATGCTAAACGATGTTTGCGAGAAGGAATCCGCTGCCC 65 FBan0003654 FBgn0036004 CG3654 3 3L cell proliferation; GO:0008283; ectoderm development; GO:0007398; heart development; GO:0007507; mesoderm development; GO:0007498; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0003677 nucleus; GO:0005634 CG3654 CG3654 CDMC20990 3 12 25 DAC40-K24 2-CG3654-RD_1 CG3654 CTCCGAAGCCCTGCATCAAATGTTGCCAATGCTAAACGATGTTTGCGAGAAGGAATCCGCTGCCC 65 FBan0003654 FBgn0036004 CG3654 3 3L cell proliferation; GO:0008283; ectoderm development; GO:0007398; heart development; GO:0007507; mesoderm development; GO:0007498; nervous system development; GO:0007399; regulation of transcription from RNA polymerase II promoter; GO:0006357 DNA binding; GO:0003677; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0003677 nucleus; GO:0005634 CG3654 CG3654 CDMC20991 3 13 25 DAC40-O12 15-CG3740-RA_2 CG3740 CGTTGCGAAATTCGGGCCAACTCCACGTAGCCTAAATATGCCCATAGATACGCGCGAGTTGATGG 65 FBan0003740 FBgn0023530 CG3740 X X CG3740 CG3740 EG:171E4.4 CDMC20991 3 14 25 DAC40-O12 15-CG3740-RA_2 CG3740 CGTTGCGAAATTCGGGCCAACTCCACGTAGCCTAAATATGCCCATAGATACGCGCGAGTTGATGG 65 FBan0003740 FBgn0023530 CG3740 X X CG3740 CG3740 EG:171E4.4 CDMC20992 3 15 25 DAC40-O24 AutoBlank AutoBlank CDMC20992 3 16 25 DAC40-O24 AutoBlank AutoBlank CDMC20993 3 17 25 DAC41-C12 AutoBlank AutoBlank CDMC20993 3 18 25 DAC41-C12 AutoBlank AutoBlank CDMC20994 3 19 25 DAC41-C24 AutoBlank AutoBlank CDMC20994 3 20 25 DAC41-C24 AutoBlank AutoBlank CDMC20995 3 21 25 DAC41-G12 AutoBlank AutoBlank CDMC20995 3 22 25 DAC41-G12 AutoBlank AutoBlank CDMC20996 3 23 25 DAC41-G24 AutoBlank AutoBlank CDMC20996 3 24 25 DAC41-G24 AutoBlank AutoBlank CDMC20997 3 25 25 DAC41-K12 AutoBlank AutoBlank CDMC20997 3 26 25 DAC41-K12 AutoBlank AutoBlank CDMC20998 3 1 26 DAC41-K24 AutoBlank AutoBlank CDMC20998 3 2 26 DAC41-K24 AutoBlank AutoBlank CDMC20999 3 3 26 DAC41-O12 AutoBlank AutoBlank CDMC20999 3 4 26 DAC41-O12 AutoBlank AutoBlank CDMC21000 3 5 26 DAC41-O24 AutoBlank AutoBlank CDMC21000 3 6 26 DAC41-O24 AutoBlank AutoBlank CDMC21001 3 7 26 DAC42-C12 1-CG18743-RA_1 hsp70Ab CTTCTTCCACGGCAAGAACCTCAACCTATCCATCAACCCAGACGAGGCAGTTGCATACGGAGCTG 65 FBan0018743 FBgn0013276 Hsp70Ab 3 3R defense response; GO:0006952; protein complex assembly; GO:0006461; protein folding; GO:0006457; response to heat; GO:0009408 ATP binding; GO:0005524; ; GO:0005524 Hsp70Ab Heat-shock-protein-70Ab "CG18743, hsp70, hsp70 87A, Hsp70, 87A locus, hsp-70, Protein 70, hs70, Hsp70A, HSP70, dhsp70, Hsp 70, DMHSP7A2, hsp70Ab, hsp70(87A), heat shock 70, GRP78, hsp70A, hsp 70" CDMC21001 3 8 26 DAC42-C12 1-CG18743-RA_1 hsp70Ab CTTCTTCCACGGCAAGAACCTCAACCTATCCATCAACCCAGACGAGGCAGTTGCATACGGAGCTG 65 FBan0018743 FBgn0013276 Hsp70Ab 3 3R defense response; GO:0006952; protein complex assembly; GO:0006461; protein folding; GO:0006457; response to heat; GO:0009408 ATP binding; GO:0005524; ; GO:0005524 Hsp70Ab Heat-shock-protein-70Ab "CG18743, hsp70, hsp70 87A, Hsp70, 87A locus, hsp-70, Protein 70, hs70, Hsp70A, HSP70, dhsp70, Hsp 70, DMHSP7A2, hsp70Ab, hsp70(87A), heat shock 70, GRP78, hsp70A, hsp 70" CDMC21002 3 9 26 DAC42-C24 23-CG7939-RB_2 Rp49 GTGCCGAGTTCAATTGTCATTTCTGAGATTGGGATAGCAGCACCATTGATAACATGTGCATTATC 65 FBan0007939 FBgn0002626 RpL32 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL32 Ribosomal protein L32 "CG7939, rp49, RP49, r-protein 49, Rp49, M(3)99D: Minute(3)99D, Rp49/RpL32, bs30a02.y1, RP-49, L32, Rp-49, BcDNA:RH03940, Minute(3)99D, M(3)99D" CDMC21002 3 10 26 DAC42-C24 23-CG7939-RB_2 Rp49 GTGCCGAGTTCAATTGTCATTTCTGAGATTGGGATAGCAGCACCATTGATAACATGTGCATTATC 65 FBan0007939 FBgn0002626 RpL32 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL32 Ribosomal protein L32 "CG7939, rp49, RP49, r-protein 49, Rp49, M(3)99D: Minute(3)99D, Rp49/RpL32, bs30a02.y1, RP-49, L32, Rp-49, BcDNA:RH03940, Minute(3)99D, M(3)99D" CDMC21003 3 11 26 DAC42-G12 22-CG7939-RC_2 Rp49 GGGCCCACGTGTATTTCCATTAATTTTAAGCCGTAATTGTCGTTTTTGGCGGTTTCGAGTTGAACTGCG 69 FBan0007939 FBgn0002626 RpL32 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL32 Ribosomal protein L32 "CG7939, rp49, RP49, r-protein 49, Rp49, M(3)99D: Minute(3)99D, Rp49/RpL32, bs30a02.y1, RP-49, L32, Rp-49, BcDNA:RH03940, Minute(3)99D, M(3)99D" CDMC21003 3 12 26 DAC42-G12 22-CG7939-RC_2 Rp49 GGGCCCACGTGTATTTCCATTAATTTTAAGCCGTAATTGTCGTTTTTGGCGGTTTCGAGTTGAACTGCG 69 FBan0007939 FBgn0002626 RpL32 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL32 Ribosomal protein L32 "CG7939, rp49, RP49, r-protein 49, Rp49, M(3)99D: Minute(3)99D, Rp49/RpL32, bs30a02.y1, RP-49, L32, Rp-49, BcDNA:RH03940, Minute(3)99D, M(3)99D" CDMC21004 3 13 26 DAC42-G24 12-CG10578-RA_4 DroJ1 GACGCCAGCTGACATCGTCTTCATCATTCGCGACAAACCGCATTCGCTGTTCAAACGCGAGGGAATCG 68 FBan0010578 FBgn0015657 DnaJ-1 3 3L defense response; GO:0006952; protein folding; GO:0006457; response to heat; GO:0009408; response to stress; GO:0006950 unfolded protein binding; GO:0051082; ; GO:0051082 cytoplasm; GO:0005737 DnaJ-1 DnaJ-like-1 "CG10578, CG10578, DROJ1, EU3500, dHDJ1, DnaJ1 64EF, dHdj1, dnaJ like1, HSP40/HDJ1, droj1, dhdj-1, Hsp-40, DNAJ1, HSP40, dHDJ1/HSP40, anon-WO0140519.166, anon-WO0172774.135, DroJ1" CDMC21004 3 14 26 DAC42-G24 12-CG10578-RA_4 DroJ1 GACGCCAGCTGACATCGTCTTCATCATTCGCGACAAACCGCATTCGCTGTTCAAACGCGAGGGAATCG 68 FBan0010578 FBgn0015657 DnaJ-1 3 3L defense response; GO:0006952; protein folding; GO:0006457; response to heat; GO:0009408; response to stress; GO:0006950 unfolded protein binding; GO:0051082; ; GO:0051082 cytoplasm; GO:0005737 DnaJ-1 DnaJ-like-1 "CG10578, CG10578, DROJ1, EU3500, dHDJ1, DnaJ1 64EF, dHdj1, dnaJ like1, HSP40/HDJ1, droj1, dhdj-1, Hsp-40, DNAJ1, HSP40, dHDJ1/HSP40, anon-WO0140519.166, anon-WO0172774.135, DroJ1" CDMC21005 3 15 26 DAC42-K12 Oligo GAL4 control GAL4 (S. cerevisiae) CDMC21005 3 16 26 DAC42-K12 Oligo GAL4 control GAL4 (S. cerevisiae) CDMC21006 3 17 26 DAC42-K24 5uM MSP 5uM MSP CDMC21006 3 18 26 DAC42-K24 5uM MSP 5uM MSP CDMC21007 3 19 26 DAC42-O12 10uM MSP 10uM MSP CDMC21007 3 20 26 DAC42-O12 10uM MSP 10uM MSP CDMC21008 3 21 26 DAC42-O24 20uM MSP 20uM MSP CDMC21008 3 22 26 DAC42-O24 20uM MSP 20uM MSP 3 23 26 EMPTY EMPTY 3 24 26 EMPTY EMPTY 3 25 26 EMPTY EMPTY 3 26 26 EMPTY EMPTY CDMC21009 4 1 1 DAC01-D12 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC21009 4 2 1 DAC01-D12 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC21010 4 3 1 DAC01-D24 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC21010 4 4 1 DAC01-D24 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC21011 4 5 1 DAC01-H12 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC21011 4 6 1 DAC01-H12 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC21012 4 7 1 DAC01-H24 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC21012 4 8 1 DAC01-H24 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC21013 4 9 1 DAC01-L12 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC21013 4 10 1 DAC01-L12 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC21014 4 11 1 DAC01-L24 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC21014 4 12 1 DAC01-L24 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC21015 4 13 1 DAC01-P12 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC21015 4 14 1 DAC01-P12 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC21016 4 15 1 DAC01-P24 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC21016 4 16 1 DAC01-P24 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC21017 4 17 1 DAC02-D12 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC21017 4 18 1 DAC02-D12 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC21018 4 19 1 DAC02-D24 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC21018 4 20 1 DAC02-D24 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC21019 4 21 1 DAC02-H12 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC21019 4 22 1 DAC02-H12 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC21020 4 23 1 DAC02-H24 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC21020 4 24 1 DAC02-H24 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC21021 4 25 1 DAC02-L12 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC21021 4 26 1 DAC02-L12 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC21022 4 1 2 DAC02-L24 AutoBlank AutoBlank CDMC21022 4 2 2 DAC02-L24 AutoBlank AutoBlank CDMC21023 4 3 2 DAC02-P12 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC21023 4 4 2 DAC02-P12 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC21024 4 5 2 DAC02-P24 AutoBlank AutoBlank CDMC21024 4 6 2 DAC02-P24 AutoBlank AutoBlank CDMC21025 4 7 2 DAC03-D12 1-CG5455-RA_1 CG5455 CGGCGTGCGGGTTATTGCCTTAAACTACACCACTGATCAGTACCTTTGGAGACCGCTGTGGAAAAGCAA 69 FBan0005455 FBgn0039430 CG5455 3 3R catalytic activity; GO:0003824; ; GO:0003824 CG5455 CG5455 CT17296 CDMC21025 4 8 2 DAC03-D12 1-CG5455-RA_1 CG5455 CGGCGTGCGGGTTATTGCCTTAAACTACACCACTGATCAGTACCTTTGGAGACCGCTGTGGAAAAGCAA 69 FBan0005455 FBgn0039430 CG5455 3 3R catalytic activity; GO:0003824; ; GO:0003824 CG5455 CG5455 CT17296 CDMC21026 4 9 2 DAC03-D24 8-CG5465-RA_1 CG5465 GTGCTGGAGCCCAACTCGATGAAGCAGCTTAATCACACCCAGTTTGATAGGTTATCTGACGCCAGTGGA 69 FBan0005465 FBgn0034707 MED16 2 2R transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367 transcription cofactor activity; GO:0003712; RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; ; GO:0003712; ; GO:0016455 mediator complex; GO:0000119; nucleus; GO:0005634 MED16 Mediator complex subunit 16 "CG5465, CG5465, Trap95, dTRAP95, Sin4/TRAP95, Med16, Mediator complex subunit 16" CDMC21026 4 10 2 DAC03-D24 8-CG5465-RA_1 CG5465 GTGCTGGAGCCCAACTCGATGAAGCAGCTTAATCACACCCAGTTTGATAGGTTATCTGACGCCAGTGGA 69 FBan0005465 FBgn0034707 MED16 2 2R transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367 transcription cofactor activity; GO:0003712; RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; ; GO:0003712; ; GO:0016455 mediator complex; GO:0000119; nucleus; GO:0005634 MED16 Mediator complex subunit 16 "CG5465, CG5465, Trap95, dTRAP95, Sin4/TRAP95, Med16, Mediator complex subunit 16" CDMC21027 4 11 2 DAC03-H12 3-CG5484-RC_3 CG5484 CCATCGTGCAAGACATGGCTATGCAGTACGGTCAGAAACTAGCGGATCAGGGCAAGCAGATCATGGAGA 69 FBan0005484 FBgn0039450 CG5484 3 3R CG5484 CG5484 anon-WO0118547.366 CDMC21027 4 12 2 DAC03-H12 3-CG5484-RC_3 CG5484 CCATCGTGCAAGACATGGCTATGCAGTACGGTCAGAAACTAGCGGATCAGGGCAAGCAGATCATGGAGA 69 FBan0005484 FBgn0039450 CG5484 3 3R CG5484 CG5484 anon-WO0118547.366 CDMC21028 4 13 2 DAC03-H24 1-CG5493-RA_6 CG5493 GGGAGACACCAATCGCCGTCAATGATGTGGCCTACATAAATGACAATCTGGGTCTGCATCGCGTGGAGA 69 FBan0005493 FBgn0034364 CG5493 2 2R amino acid catabolism; GO:0009063 cysteine dioxygenase activity; GO:0017172 ; EC:1.13.11.20; ; GO:0017172 ; EC:1.13.11.20 CG5493 CG5493 CDMC21028 4 14 2 DAC03-H24 1-CG5493-RA_6 CG5493 GGGAGACACCAATCGCCGTCAATGATGTGGCCTACATAAATGACAATCTGGGTCTGCATCGCGTGGAGA 69 FBan0005493 FBgn0034364 CG5493 2 2R amino acid catabolism; GO:0009063 cysteine dioxygenase activity; GO:0017172 ; EC:1.13.11.20; ; GO:0017172 ; EC:1.13.11.20 CG5493 CG5493 CDMC21029 4 15 2 DAC03-L12 8-CG5528-RA_1 CG5528 CCAGTGCCGTCTACGATATCTTCATCAGCTACTGCCAGAATGATCGGACCTGGGTGCTCAATGAACTGC 69 FBan0005528 FBgn0036978 Toll-9 3 3L antifungal polypeptide induction; GO:0006967; cellular defense response; GO:0006968; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response to bacteria; GO:0042742; macrophage activation; GO:0042116; signal transduction; GO:0007165 transmembrane receptor activity; GO:0004888; ; GO:0004888 integral to membrane; GO:0016021 Toll-9 Toll-9 "CG5528, CG5528, Tl-9, CT17508, Tak/Toll-like, Tl-5, dTLR9, toll, dToll9, Toll 9" CDMC21029 4 16 2 DAC03-L12 8-CG5528-RA_1 CG5528 CCAGTGCCGTCTACGATATCTTCATCAGCTACTGCCAGAATGATCGGACCTGGGTGCTCAATGAACTGC 69 FBan0005528 FBgn0036978 Toll-9 3 3L antifungal polypeptide induction; GO:0006967; cellular defense response; GO:0006968; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response to bacteria; GO:0042742; macrophage activation; GO:0042116; signal transduction; GO:0007165 transmembrane receptor activity; GO:0004888; ; GO:0004888 integral to membrane; GO:0016021 Toll-9 Toll-9 "CG5528, CG5528, Tl-9, CT17508, Tak/Toll-like, Tl-5, dTLR9, toll, dToll9, Toll 9" CDMC21030 4 17 2 DAC03-L24 15-CG5546-RA_2 CG5546 GGCGTCGGTGGGAGTCTGCTTATGTCGCAGTTTTAGGCAGGATCCTTTAGCAAAATAGACTTGGCTCAT 69 FBan0005546 FBgn0036761 MED19 3 3L mediator complex; GO:0000119 MED19 Mediator complex subunit 19 "CG5546, CG5546, Mediator complex subunit 19" CDMC21030 4 18 2 DAC03-L24 15-CG5546-RA_2 CG5546 GGCGTCGGTGGGAGTCTGCTTATGTCGCAGTTTTAGGCAGGATCCTTTAGCAAAATAGACTTGGCTCAT 69 FBan0005546 FBgn0036761 MED19 3 3L mediator complex; GO:0000119 MED19 Mediator complex subunit 19 "CG5546, CG5546, Mediator complex subunit 19" CDMC21031 4 19 2 DAC03-P12 7-CG5581-RA_1 CG5581 AGCGACGACACTGATTCCAAGGAAGACCAGTACGAAAGCACATTTGCCAGGAATCTAGCTCGTTTGCGA 69 FBan0005581 FBgn0003022 Ote 2 2R nuclear envelope reassembly; GO:0031468 protein binding; GO:0005515; ; GO:0005515 nuclear inner membrane; GO:0005637 Ote Otefin "CG5581, otefin" CDMC21031 4 20 2 DAC03-P12 7-CG5581-RA_1 CG5581 AGCGACGACACTGATTCCAAGGAAGACCAGTACGAAAGCACATTTGCCAGGAATCTAGCTCGTTTGCGA 69 FBan0005581 FBgn0003022 Ote 2 2R nuclear envelope reassembly; GO:0031468 protein binding; GO:0005515; ; GO:0005515 nuclear inner membrane; GO:0005637 Ote Otefin "CG5581, otefin" CDMC21032 4 21 2 DAC03-P24 2-CG5592-RA_1 CG5592 GTCACATGGATGACTGTGGCCCTAGCATACGATGCCCATGTTCGCGTAGTCGAAATCCTGGACACAGAT 69 FBan0005592 FBgn0035645 CG5592 3 3L cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 integral to membrane; GO:0016021 CG5592 CG5592 CDMC21032 4 22 2 DAC03-P24 2-CG5592-RA_1 CG5592 GTCACATGGATGACTGTGGCCCTAGCATACGATGCCCATGTTCGCGTAGTCGAAATCCTGGACACAGAT 69 FBan0005592 FBgn0035645 CG5592 3 3L cation transport; GO:0006812; extracellular transport; GO:0006858 organic cation porter activity; GO:0008513; carbohydrate transporter activity; GO:0015144; ; GO:0008513; ; GO:0015144 integral to membrane; GO:0016021 CG5592 CG5592 CDMC21033 4 23 2 DAC04-D12 23-CG12385-RA_5 CG12385 GCATACTTTCGGGGATTATATAGCGATTCGAAATCAAAAAGCTTCCCATCTGCCCATCTAATTGTTAAT 69 FBan0012385 FBgn0011555 thetaTry 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 extracellular region; GO:0005576 thetaTry thetaTrypsin "CG12385, CG12385, CG12385, DmThetaTry, thetaTrypsin, SP139" CDMC21033 4 24 2 DAC04-D12 23-CG12385-RA_5 CG12385 GCATACTTTCGGGGATTATATAGCGATTCGAAATCAAAAAGCTTCCCATCTGCCCATCTAATTGTTAAT 69 FBan0012385 FBgn0011555 thetaTry 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 extracellular region; GO:0005576 thetaTry thetaTrypsin "CG12385, CG12385, CG12385, DmThetaTry, thetaTrypsin, SP139" CDMC21034 4 25 2 DAC04-D24 15-CG12395-RA_3 CG12395 TCCGCGCTTGGTGGATCTCTTCAATTATCCGAAGAAGAGTAGTGTTCAGCTGAAGTTGGCCAATTGGGA 69 FBan0012395 FBgn0030722 CG12395 X X CG12395 CG12395 CDMC21034 4 26 2 DAC04-D24 15-CG12395-RA_3 CG12395 TCCGCGCTTGGTGGATCTCTTCAATTATCCGAAGAAGAGTAGTGTTCAGCTGAAGTTGGCCAATTGGGA 69 FBan0012395 FBgn0030722 CG12395 X X CG12395 CG12395 CDMC21035 4 1 3 DAC04-H12 7-CG12433-RA_1 CG12433 GCCACAAGCTTTTACTGAGGATCGTCGAGTGATGGTTCCGCCTCTATTGCAACTCTTCCATGGTCCTGT 69 FBan0012433 FBgn0030811 CG12433 X X CG12433 CG12433 CDMC21035 4 2 3 DAC04-H12 7-CG12433-RA_1 CG12433 GCCACAAGCTTTTACTGAGGATCGTCGAGTGATGGTTCCGCCTCTATTGCAACTCTTCCATGGTCCTGT 69 FBan0012433 FBgn0030811 CG12433 X X CG12433 CG12433 CDMC21036 4 3 3 DAC04-H24 10-CG12444-RB_1 CG12444 CCCGTAACTTGATGGGTTATCCACTGCGTGTTTTAGTGACCAACGACCCACCTCATTGCTTTGTGGACA 69 FBan0012444 FBgn0033651 CG12444 2 2R CG12444 CG12444 CDMC21036 4 4 3 DAC04-H24 10-CG12444-RB_1 CG12444 CCCGTAACTTGATGGGTTATCCACTGCGTGTTTTAGTGACCAACGACCCACCTCATTGCTTTGTGGACA 69 FBan0012444 FBgn0033651 CG12444 2 2R CG12444 CG12444 CDMC21037 4 5 3 DAC04-L12 23-CG12496-RA_3 CG12496 CAGAGGTAATTTCAAACAGATCCTCGGAAAGCCACAAAAATGAGAAGAGAAACTAAATGCGAGATGGAG 69 FBan0012496 FBgn0040385 CG12496 X X CG12496 CG12496 EG:BACH7M4.4 CDMC21037 4 6 3 DAC04-L12 23-CG12496-RA_3 CG12496 CAGAGGTAATTTCAAACAGATCCTCGGAAAGCCACAAAAATGAGAAGAGAAACTAAATGCGAGATGGAG 69 FBan0012496 FBgn0040385 CG12496 X X CG12496 CG12496 EG:BACH7M4.4 CDMC21038 4 7 3 DAC04-L24 1-CG12505-RA_1 CG12505 CGGCGTGCCGGTAAGCCTCGACTAGCTTCTGAAATCCACAAATCCACGCTGTTTGTATTGCTATTCGCA 69 FBan0012505 FBgn0033926 CG12505 2 2R CG12505 CG12505 "anon-WO0153538.31, anon-WO0153538.40, anon-WO0153538.41, anon-WO0153538.43, anon-WO0153538.45" CDMC21038 4 8 3 DAC04-L24 1-CG12505-RA_1 CG12505 CGGCGTGCCGGTAAGCCTCGACTAGCTTCTGAAATCCACAAATCCACGCTGTTTGTATTGCTATTCGCA 69 FBan0012505 FBgn0033926 CG12505 2 2R CG12505 CG12505 "anon-WO0153538.31, anon-WO0153538.40, anon-WO0153538.41, anon-WO0153538.43, anon-WO0153538.45" CDMC21039 4 9 3 DAC04-P12 3-CG12548-RB_5 CG12548 GGGCGGCTCTTCAAGCCTACCTTCAGGTAGTTGGCATTTCTGCCTCTGACATCGATTCAAGGCTGTTTG 69 FBan0012548 FBgn0016919 nompB 2 2L NOT flagellum biogenesis; GO:0009296; intraflagellar transport; GO:0042073; sensory cilium biogenesis; GO:0035058; sensory perception of sound; GO:0007605 nompB no mechanoreceptor potential B "CG14465, CG12548, CG15190, CG4137, CG14465, CG12548, CG12548, nomp, osm-5, no mechanoreceptor potential B" CDMC21039 4 10 3 DAC04-P12 3-CG12548-RB_5 CG12548 GGGCGGCTCTTCAAGCCTACCTTCAGGTAGTTGGCATTTCTGCCTCTGACATCGATTCAAGGCTGTTTG 69 FBan0012548 FBgn0016919 nompB 2 2L NOT flagellum biogenesis; GO:0009296; intraflagellar transport; GO:0042073; sensory cilium biogenesis; GO:0035058; sensory perception of sound; GO:0007605 nompB no mechanoreceptor potential B "CG14465, CG12548, CG15190, CG4137, CG14465, CG12548, CG12548, nomp, osm-5, no mechanoreceptor potential B" CDMC21040 4 11 3 DAC04-P24 AutoBlank AutoBlank CDMC21040 4 12 3 DAC04-P24 AutoBlank AutoBlank CDMC21041 4 13 3 DAC05-D12 17-CG5060-RA_1 CG5060 CCGACTTGGGATTACTGTTATATACGGATGTGTTGCACCAGGGTCGTAACCATGTGATACTCGATGCCA 69 FBan0005060 FBgn0038780 CG5060 3 3R CG5060 CG5060 CDMC21041 4 14 3 DAC05-D12 17-CG5060-RA_1 CG5060 CCGACTTGGGATTACTGTTATATACGGATGTGTTGCACCAGGGTCGTAACCATGTGATACTCGATGCCA 69 FBan0005060 FBgn0038780 CG5060 3 3R CG5060 CG5060 CDMC21042 4 15 3 DAC05-D24 2-CG5074-RA_1 CG5074 GGCATCCGCAGTCGAGCCACGGAACTTACATAATGTGCTTGATTCGTACCTAGAGTGTTGAGCACCGGA 69 FBgn0031311 CDMC21042 4 16 3 DAC05-D24 2-CG5074-RA_1 CG5074 GGCATCCGCAGTCGAGCCACGGAACTTACATAATGTGCTTGATTCGTACCTAGAGTGTTGAGCACCGGA 69 FBgn0031311 CDMC21043 4 17 3 DAC05-H12 23-CG5108-RA_6 CG5108 TCGATTGATGTCGGTGTATCCCACACACTATGTCGAACCAATTGTACAAAAATATAAACAACTAGAGCA 69 FBan0005108 FBgn0032236 mRpS7 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS7 mitochondrial ribosomal protein S7 "CG5108, MRP-S7, RpS7, mRPS7, mitochondrial ribosomal protein S7" CDMC21043 4 18 3 DAC05-H12 23-CG5108-RA_6 CG5108 TCGATTGATGTCGGTGTATCCCACACACTATGTCGAACCAATTGTACAAAAATATAAACAACTAGAGCA 69 FBan0005108 FBgn0032236 mRpS7 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS7 mitochondrial ribosomal protein S7 "CG5108, MRP-S7, RpS7, mRPS7, mitochondrial ribosomal protein S7" CDMC21044 4 19 3 DAC05-H24 3-CG5121-RA_1 CG5121 GCTGAAGCCCTACATGCTGATCAAGGACGAGAATCAGGACCTGAGCATCGAGATTCAACGCAAGGAGGC 69 FBan0005121 FBgn0039337 MED28 3 3R regulation of transcription from RNA polymerase II promoter; GO:0006357 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; ; GO:0016455 mediator complex; GO:0000119 MED28 Mediator complex subunit 28 "CG5121, Med23, dMED23, Med28, BcDNA:GM31575, Mediator complex subunit 28" CDMC21044 4 20 3 DAC05-H24 3-CG5121-RA_1 CG5121 GCTGAAGCCCTACATGCTGATCAAGGACGAGAATCAGGACCTGAGCATCGAGATTCAACGCAAGGAGGC 69 FBan0005121 FBgn0039337 MED28 3 3R regulation of transcription from RNA polymerase II promoter; GO:0006357 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; ; GO:0016455 mediator complex; GO:0000119 MED28 Mediator complex subunit 28 "CG5121, Med23, dMED23, Med28, BcDNA:GM31575, Mediator complex subunit 28" CDMC21045 4 21 3 DAC05-L12 17-CG5160-RA_3 CG5160 TCATCGCTGGTCAAGTTGGGTCTGCATACCAATAAACAAAAGACTCTGAAGGTTATGGTCCTGGGCCAA 69 FBan0005160 FBgn0031906 CG5160 2 2L "regulation of transcription, DNA-dependent; GO:0006355; signal transduction; GO:0007165; small GTPase mediated signal transduction; GO:0007264; synaptic transmission; GO:0007268; two-component signal transduction system (phosphorelay); GO:0000160" DNA binding; GO:0003677; GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003677; ; GO:0005525 CG5160 CG5160 CDMC21045 4 22 3 DAC05-L12 17-CG5160-RA_3 CG5160 TCATCGCTGGTCAAGTTGGGTCTGCATACCAATAAACAAAAGACTCTGAAGGTTATGGTCCTGGGCCAA 69 FBan0005160 FBgn0031906 CG5160 2 2L "regulation of transcription, DNA-dependent; GO:0006355; signal transduction; GO:0007165; small GTPase mediated signal transduction; GO:0007264; synaptic transmission; GO:0007268; two-component signal transduction system (phosphorelay); GO:0000160" DNA binding; GO:0003677; GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003677; ; GO:0005525 CG5160 CG5160 CDMC21046 4 23 3 DAC05-L24 3-CG5169-RA_2 CG5169 CCGGGAGTGAGCGACCTATTTATGAAAGAGCTGATCCACATGCTCGTTCCTGGTTACTCGGAGACGCGA 69 FBan0005169 FBgn0038477 CG5169 3 3R actin filament organization; GO:0007015; induction of apoptosis; GO:0006917; intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112 CG5169 CG5169 STLK3 CDMC21046 4 24 3 DAC05-L24 3-CG5169-RA_2 CG5169 CCGGGAGTGAGCGACCTATTTATGAAAGAGCTGATCCACATGCTCGTTCCTGGTTACTCGGAGACGCGA 69 FBan0005169 FBgn0038477 CG5169 3 3R actin filament organization; GO:0007015; induction of apoptosis; GO:0006917; intracellular signaling cascade; GO:0007242; protein amino acid phosphorylation; GO:0006468 ATP binding; GO:0005524; ; GO:0005524; receptor signaling protein serine/threonine kinase activity; GO:0004702 ; EC:2.7.1.-; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004702 ; EC:2.7.1.-; ; GO:0004713 ; EC:2.7.1.112 CG5169 CG5169 STLK3 CDMC21047 4 25 3 DAC05-P12 16-CG5198-RA_3 CG5198 GGCGAGCAAAAGAAAGCACCAAGCATCCCAGAAAGTGAAAGAGGAATCCTTCAAGAAACACACGCTTGA 69 FBan0005198 FBgn0032250 CG5198 2 2L defense response; GO:0006952 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG5198 CG5198 CDMC21047 4 26 3 DAC05-P12 16-CG5198-RA_3 CG5198 GGCGAGCAAAAGAAAGCACCAAGCATCCCAGAAAGTGAAAGAGGAATCCTTCAAGAAACACACGCTTGA 69 FBan0005198 FBgn0032250 CG5198 2 2L defense response; GO:0006952 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG5198 CG5198 CDMC21048 4 1 4 DAC05-P24 17-CG5213-RA_1 CG5213 GCGTCGCGAGAGGACGAACGATCATCATGTGTCTAAGCGTTCTCGAGATTCGGACTAATCATTATGCGT 69 FBan0005213 FBgn0038345 CG5213 3 3R "cell proliferation; GO:0008283; histone mRNA 3'-end processing; GO:0006398; nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729 CG5213 CG5213 cg5213 CDMC21048 4 2 4 DAC05-P24 17-CG5213-RA_1 CG5213 GCGTCGCGAGAGGACGAACGATCATCATGTGTCTAAGCGTTCTCGAGATTCGGACTAATCATTATGCGT 69 FBan0005213 FBgn0038345 CG5213 3 3R "cell proliferation; GO:0008283; histone mRNA 3'-end processing; GO:0006398; nuclear mRNA splicing, via spliceosome; GO:0000398" mRNA binding; GO:0003729; ; GO:0003729 CG5213 CG5213 cg5213 CDMC21049 4 3 4 DAC06-D12 12-CG9399-RB_1 CG9399 GCGGAAATTGGCACACTCTCCTCAAGGTCAAGGATGTTGTGCGATAGCTAATGAACCTGTGATCGTGCA 69 FBan0009399 FBgn0037715 CG9399 3 3R CG9399 CG9399 CDMC21049 4 4 4 DAC06-D12 12-CG9399-RB_1 CG9399 GCGGAAATTGGCACACTCTCCTCAAGGTCAAGGATGTTGTGCGATAGCTAATGAACCTGTGATCGTGCA 69 FBan0009399 FBgn0037715 CG9399 3 3R CG9399 CG9399 CDMC21050 4 5 4 DAC06-D24 1-CG9414-RA_1 CG9414 GCAGGATACCCAGCAAGAGACTGAGGCAGGTGATTAGGGAGTACACCAAGGAAAACTGCATCCTCGACG 69 FBan0009414 FBgn0028406 Rep4 2 2L DNA fragmentation during apoptosis; GO:0006309 nucleic acid binding; GO:0003676; caspase-activated deoxyribonuclease activity; GO:0004537; ; GO:0003676; protein binding; GO:0005515; ; GO:0004537; ; GO:0004537; ; GO:0005515 intracellular; GO:0005622 Rep4 Rep4 "CG9414, CG9414, CG9414, drep4, dCAD, Caspase-activated DNase, CAD, Drep4" CDMC21050 4 6 4 DAC06-D24 1-CG9414-RA_1 CG9414 GCAGGATACCCAGCAAGAGACTGAGGCAGGTGATTAGGGAGTACACCAAGGAAAACTGCATCCTCGACG 69 FBan0009414 FBgn0028406 Rep4 2 2L DNA fragmentation during apoptosis; GO:0006309 nucleic acid binding; GO:0003676; caspase-activated deoxyribonuclease activity; GO:0004537; ; GO:0003676; protein binding; GO:0005515; ; GO:0004537; ; GO:0004537; ; GO:0005515 intracellular; GO:0005622 Rep4 Rep4 "CG9414, CG9414, CG9414, drep4, dCAD, Caspase-activated DNase, CAD, Drep4" CDMC21051 4 7 4 DAC06-H12 15-CG9441-RB_1 CG9441 AGTGGGCACTAGAGGACGCTACTGAAATCCGAGACCAACTAAACCCCTACAATATTTTTGGAGGCGCTT 69 FBan0009441 FBgn0003162 Pu 2 2R ommochrome biosynthesis; GO:0006727; purine base metabolism; GO:0006144; tetrahydrobiopterin biosynthesis; GO:0006729 GTP cyclohydrolase I activity; GO:0003934 ; EC:3.5.4.16; ; GO:0003934 ; EC:3.5.4.16; ; GO:0003934 ; EC:3.5.4.16 Pu Punch "CG9441, CG9441, upi, unpigmented, GTPCH, GTPC, GTP cyclohydrolase, GTP cyclohydrolase I isoform c, Gr: Glutathione reductase, l(2)57Cf, p[Gr]: pink-Grape, Grape, Punch" CDMC21051 4 8 4 DAC06-H12 15-CG9441-RB_1 CG9441 AGTGGGCACTAGAGGACGCTACTGAAATCCGAGACCAACTAAACCCCTACAATATTTTTGGAGGCGCTT 69 FBan0009441 FBgn0003162 Pu 2 2R ommochrome biosynthesis; GO:0006727; purine base metabolism; GO:0006144; tetrahydrobiopterin biosynthesis; GO:0006729 GTP cyclohydrolase I activity; GO:0003934 ; EC:3.5.4.16; ; GO:0003934 ; EC:3.5.4.16; ; GO:0003934 ; EC:3.5.4.16 Pu Punch "CG9441, CG9441, upi, unpigmented, GTPCH, GTPC, GTP cyclohydrolase, GTP cyclohydrolase I isoform c, Gr: Glutathione reductase, l(2)57Cf, p[Gr]: pink-Grape, Grape, Punch" CDMC21052 4 9 4 DAC06-H24 2-CG9453-RC_1 CG9453 ACGCAGTCGTTGTACGAAACAAAGGTAGCGCTCAAATTGCCCAGGTTCAAGGCAGAGTTCCAAGTGGAA 69 FBan0009453 FBgn0028985 Spn4 2 2R proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867; ; GO:0004867 Spn4 Serine protease inhibitor 4 "CG9453, CG9453, CG9453, sp4: serpin 4, serpin 4, Sp4, neuroserpin, Spn4A, sp4" CDMC21052 4 10 4 DAC06-H24 2-CG9453-RC_1 CG9453 ACGCAGTCGTTGTACGAAACAAAGGTAGCGCTCAAATTGCCCAGGTTCAAGGCAGAGTTCCAAGTGGAA 69 FBan0009453 FBgn0028985 Spn4 2 2R proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867; ; GO:0004867 Spn4 Serine protease inhibitor 4 "CG9453, CG9453, CG9453, sp4: serpin 4, serpin 4, Sp4, neuroserpin, Spn4A, sp4" CDMC21053 4 11 4 DAC06-L12 3-CG9491-RA_5 CG9491 AGGCACCCAAGTTCACCCACCCTTTCGACTACCAGCTCAACGAGTTCTACCAGCGATCATCAAAGAAGA 69 FBgn0031798 CDMC21053 4 12 4 DAC06-L12 3-CG9491-RA_5 CG9491 AGGCACCCAAGTTCACCCACCCTTTCGACTACCAGCTCAACGAGTTCTACCAGCGATCATCAAAGAAGA 69 FBgn0031798 CDMC21054 4 13 4 DAC06-L24 12-CG9500-RA_1 CG9500 TGGCGCACTGAGAGTTATTCCTACAAGGTGATGCAAATGATGGTTCGACCGAAATGCCATTGCTCAGGA 69 FBan0009500 FBgn0031804 CG9500 2 2L defense response to bacteria; GO:0042742; transport; GO:0006810 receptor binding; GO:0005102; transporter activity; GO:0005215; ; GO:0005102; ; GO:0005215 extracellular region; GO:0005576 CG9500 CG9500 CDMC21054 4 14 4 DAC06-L24 12-CG9500-RA_1 CG9500 TGGCGCACTGAGAGTTATTCCTACAAGGTGATGCAAATGATGGTTCGACCGAAATGCCATTGCTCAGGA 69 FBan0009500 FBgn0031804 CG9500 2 2L defense response to bacteria; GO:0042742; transport; GO:0006810 receptor binding; GO:0005102; transporter activity; GO:0005215; ; GO:0005102; ; GO:0005215 extracellular region; GO:0005576 CG9500 CG9500 CDMC21055 4 15 4 DAC06-P12 16-CG9531-RA_1 CG9531 GCGAGATTGCGCCATAGACAGGACGGAATGCTATGACTTTGACAATGCAATTAGCTATAACGTTGCCCA 69 FBan0009531 FBgn0031817 CG9531 2 2L DNA methylation; GO:0006306; porphyrin metabolism; GO:0006778; protein amino acid methylation; GO:0006479 DNA binding; GO:0003677; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; protein methyltransferase activity; GO:0008276 ; EC:2.1.1.-; ; GO:0008168 ; EC:2.1.1.-; protoporphyrinogen oxidase activity; GO:0004729 ; EC:1.3.3.4; ; GO:0004729 ; EC:1.3.3.4; S-adenosylmethionine-dependent methyltransferase activity; GO:0008757; ; GO:0003677; N-methyltransferase activity; GO:0008170 ; EC:2.1.1.-; ; GO:0008170 ; EC:2.1.1.-; ; GO:0008757; ; GO:0008276 ; EC:2.1.1.- CG9531 CG9531 CDMC21055 4 16 4 DAC06-P12 16-CG9531-RA_1 CG9531 GCGAGATTGCGCCATAGACAGGACGGAATGCTATGACTTTGACAATGCAATTAGCTATAACGTTGCCCA 69 FBan0009531 FBgn0031817 CG9531 2 2L DNA methylation; GO:0006306; porphyrin metabolism; GO:0006778; protein amino acid methylation; GO:0006479 DNA binding; GO:0003677; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; protein methyltransferase activity; GO:0008276 ; EC:2.1.1.-; ; GO:0008168 ; EC:2.1.1.-; protoporphyrinogen oxidase activity; GO:0004729 ; EC:1.3.3.4; ; GO:0004729 ; EC:1.3.3.4; S-adenosylmethionine-dependent methyltransferase activity; GO:0008757; ; GO:0003677; N-methyltransferase activity; GO:0008170 ; EC:2.1.1.-; ; GO:0008170 ; EC:2.1.1.-; ; GO:0008757; ; GO:0008276 ; EC:2.1.1.- CG9531 CG9531 CDMC21056 4 17 4 DAC06-P24 3-CG9547-RA_2 CG9547 GCGCCAAATGAGGGACATGCTGGGTGCAAACGGAATCAGCGACGAATATCATGTGATCCGCCATGTAAT 69 FBan0009547 FBgn0031824 CG9547 2 2L acyl-CoA metabolism; GO:0006637; electron transport; GO:0006118; hydroxylysine catabolism; GO:0046948; lysine catabolism; GO:0006554; tryptophan metabolism; GO:0006568 glutaryl-CoA dehydrogenase activity; GO:0004361 ; EC:1.3.99.7; ; GO:0004361 ; EC:1.3.99.7; ; GO:0004361 ; EC:1.3.99.7 mitochondrial matrix; GO:0005759 CG9547 CG9547 CDMC21056 4 18 4 DAC06-P24 3-CG9547-RA_2 CG9547 GCGCCAAATGAGGGACATGCTGGGTGCAAACGGAATCAGCGACGAATATCATGTGATCCGCCATGTAAT 69 FBan0009547 FBgn0031824 CG9547 2 2L acyl-CoA metabolism; GO:0006637; electron transport; GO:0006118; hydroxylysine catabolism; GO:0046948; lysine catabolism; GO:0006554; tryptophan metabolism; GO:0006568 glutaryl-CoA dehydrogenase activity; GO:0004361 ; EC:1.3.99.7; ; GO:0004361 ; EC:1.3.99.7; ; GO:0004361 ; EC:1.3.99.7 mitochondrial matrix; GO:0005759 CG9547 CG9547 CDMC21057 4 19 4 DAC07-D12 11-CG6589-RA_2 CG6589 TGGAGGGGAACCGAAGGGAGTAGGATCTGGAATGTGCAATAACCGGGATGTAAGTGCCTATGTGGATAC 69 FBan0006589 FBgn0032368 CG6589 2 2L CG6589 CG6589 CDMC21057 4 20 4 DAC07-D12 11-CG6589-RA_2 CG6589 TGGAGGGGAACCGAAGGGAGTAGGATCTGGAATGTGCAATAACCGGGATGTAAGTGCCTATGTGGATAC 69 FBan0006589 FBgn0032368 CG6589 2 2L CG6589 CG6589 CDMC21058 4 21 4 DAC07-D24 23-CG6601-RA_3 CG6601 ATTTCCGATACCCCCTAAACCCTCTAAACGAAAAAAAACCCAAGACCATGTACTTATGTCAGGCCAGGC 69 FBan0006601 FBgn0015797 Rab6 2 2L compound eye morphogenesis (sensu Endopterygota); GO:0001745; intracellular protein transport; GO:0006886; receptor mediated endocytosis; GO:0006898; regulation of exocytosis; GO:0017157; signal transduction; GO:0007165; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525 Rab6 Rab-protein 6 "CG6601, CG6601, CG6601, l(2)08323, rab6, wrt, warthog, DRab6, 136/6, Drab6, dRab6, DmRab6, drab6, AAF53168, Dm Rab6" CDMC21058 4 22 4 DAC07-D24 23-CG6601-RA_3 CG6601 ATTTCCGATACCCCCTAAACCCTCTAAACGAAAAAAAACCCAAGACCATGTACTTATGTCAGGCCAGGC 69 FBan0006601 FBgn0015797 Rab6 2 2L compound eye morphogenesis (sensu Endopterygota); GO:0001745; intracellular protein transport; GO:0006886; receptor mediated endocytosis; GO:0006898; regulation of exocytosis; GO:0017157; signal transduction; GO:0007165; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525 Rab6 Rab-protein 6 "CG6601, CG6601, CG6601, l(2)08323, rab6, wrt, warthog, DRab6, 136/6, Drab6, dRab6, DmRab6, drab6, AAF53168, Dm Rab6" CDMC21059 4 23 4 DAC07-H12 8-CG6630-RA_2 CG6630 TGCCTTGGAGAGCTCTACAAACTCATCCTGCCCATGTACGAAAGAGATCGTAGTTACCAGGACCTGGCA 69 FBan0006630 FBgn0031921 CG6630 2 2L CG6630 CG6630 CDMC21059 4 24 4 DAC07-H12 8-CG6630-RA_2 CG6630 TGCCTTGGAGAGCTCTACAAACTCATCCTGCCCATGTACGAAAGAGATCGTAGTTACCAGGACCTGGCA 69 FBan0006630 FBgn0031921 CG6630 2 2L CG6630 CG6630 CDMC21060 4 25 4 DAC07-H24 23-CG6642-RA_1 CG6642 AGGCCAATGAGGAGCCATAATCAATCTCTATTTTACGTCGTTTTTAACTTAAGTGATTTTATGTTGCTT 69 FBan0006642 FBgn0011293 a10 3 3L sensory perception of chemical stimulus; GO:0007606 odorant binding; GO:0005549; pheromone binding; GO:0005550; ; GO:0005549; ; GO:0005550; carrier activity; GO:0005386; ; GO:0005386 a10 antennal protein 10 "CG6642, OS-D, A10, Phk-1, OS-D/A10, Pherokine 1, Os-D" CDMC21060 4 26 4 DAC07-H24 23-CG6642-RA_1 CG6642 AGGCCAATGAGGAGCCATAATCAATCTCTATTTTACGTCGTTTTTAACTTAAGTGATTTTATGTTGCTT 69 FBan0006642 FBgn0011293 a10 3 3L sensory perception of chemical stimulus; GO:0007606 odorant binding; GO:0005549; pheromone binding; GO:0005550; ; GO:0005549; ; GO:0005550; carrier activity; GO:0005386; ; GO:0005386 a10 antennal protein 10 "CG6642, OS-D, A10, Phk-1, OS-D/A10, Pherokine 1, Os-D" CDMC21061 4 1 5 DAC07-L12 8-CG6673-RA_3 CG6673 TGACCCAGGATGAGGTTGTGCAGAAGACAGCTTTGGATGTCCAGTTGCATGCTGAGTTCCAGAAATCGA 69 FBan0006673 FBgn0035906 CG6673 3 3L defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 cytoplasm; GO:0005737 CG6673 CG6673 "CG6673B, CG6673A, CG6673B, CG6673A, CG6673A, CG6673B, anon-EST:Posey29" CDMC21061 4 2 5 DAC07-L12 8-CG6673-RA_3 CG6673 TGACCCAGGATGAGGTTGTGCAGAAGACAGCTTTGGATGTCCAGTTGCATGCTGAGTTCCAGAAATCGA 69 FBan0006673 FBgn0035906 CG6673 3 3L defense response; GO:0006952; oxygen and reactive oxygen species metabolism; GO:0006800; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 cytoplasm; GO:0005737 CG6673 CG6673 "CG6673B, CG6673A, CG6673B, CG6673A, CG6673A, CG6673B, anon-EST:Posey29" CDMC21062 4 3 5 DAC07-L24 23-CG6684-RA_1 CG6684 GTTATACGGCTGGGAATGTAAAATATCATATAGCCCAAAAACTATTGTTCTTACAAATCGAACAGCTGA 69 FBan0006684 FBgn0010413 RpS25 3 3R protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003729; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS25 Ribosomal protein S25 "CG6684, D25, RpS31, anon-EST:Posey260" CDMC21062 4 4 5 DAC07-L24 23-CG6684-RA_1 CG6684 GTTATACGGCTGGGAATGTAAAATATCATATAGCCCAAAAACTATTGTTCTTACAAATCGAACAGCTGA 69 FBan0006684 FBgn0010413 RpS25 3 3R protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003729; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS25 Ribosomal protein S25 "CG6684, D25, RpS31, anon-EST:Posey260" CDMC21063 4 5 5 DAC07-P12 9-CG6713-RA_1 CG6713 GCACGACAAAATACCGCCGGATACTCTAAGGAATCTTCTGGCCCGATTCTTTGATCTGACCACTCCGCC 69 FBan0006713 FBgn0011676 Nos 2 2L defense response; GO:0006952; electron transport; GO:0006118; imaginal disc development; GO:0007444; negative regulation of DNA replication; GO:0008156; negative regulation of cell proliferation; GO:0008285; nitric oxide biosynthesis; GO:0006809; nitric oxide mediated signal transduction; GO:0007263; regulation of organ size; GO:0046620; synaptogenesis; GO:0007416 calmodulin binding; GO:0005516; ; GO:0005516; heme binding; GO:0020037; nitric-oxide synthase activity; GO:0004517 ; EC:1.14.13.39; ; GO:0004517 ; EC:1.14.13.39; ; GO:0004517 ; EC:1.14.13.39; ; GO:0004517 ; EC:1.14.13.39; ; GO:0004517 ; EC:1.14.13.39; electron transporter activity; GO:0005489; ; GO:0020037; ; GO:0004517 ; EC:1.14.13.39; ; GO:0005489; FMN binding; GO:0010181; ; GO:0010181 cellular component unknown; GO:0008372 Nos Nitric oxide synthase "CG6713, dNOS, NOS, DNOS, DNOS1, nitric oxide synthase, nitric oixide synthase" CDMC21063 4 6 5 DAC07-P12 9-CG6713-RA_1 CG6713 GCACGACAAAATACCGCCGGATACTCTAAGGAATCTTCTGGCCCGATTCTTTGATCTGACCACTCCGCC 69 FBan0006713 FBgn0011676 Nos 2 2L defense response; GO:0006952; electron transport; GO:0006118; imaginal disc development; GO:0007444; negative regulation of DNA replication; GO:0008156; negative regulation of cell proliferation; GO:0008285; nitric oxide biosynthesis; GO:0006809; nitric oxide mediated signal transduction; GO:0007263; regulation of organ size; GO:0046620; synaptogenesis; GO:0007416 calmodulin binding; GO:0005516; ; GO:0005516; heme binding; GO:0020037; nitric-oxide synthase activity; GO:0004517 ; EC:1.14.13.39; ; GO:0004517 ; EC:1.14.13.39; ; GO:0004517 ; EC:1.14.13.39; ; GO:0004517 ; EC:1.14.13.39; ; GO:0004517 ; EC:1.14.13.39; electron transporter activity; GO:0005489; ; GO:0020037; ; GO:0004517 ; EC:1.14.13.39; ; GO:0005489; FMN binding; GO:0010181; ; GO:0010181 cellular component unknown; GO:0008372 Nos Nitric oxide synthase "CG6713, dNOS, NOS, DNOS, DNOS1, nitric oxide synthase, nitric oixide synthase" CDMC21064 4 7 5 DAC07-P24 14-CG6727-RA_4 CG6727 GAAGGGAAGTGAAGAGCAAGTACCATGTCCCGATTTTTGATAGCTACCAAAGAGCGTCTCCAGAGGGGA 69 FBan0006727 FBgn0029084 gom 2 2R calcium-mediated signaling; GO:0019722; courtship behavior; GO:0007619; learning; GO:0007612 calcium ion binding; GO:0005509; ; GO:0005509 gom gomdanji "CG6727, CG6727, CG6727" CDMC21064 4 8 5 DAC07-P24 14-CG6727-RA_4 CG6727 GAAGGGAAGTGAAGAGCAAGTACCATGTCCCGATTTTTGATAGCTACCAAAGAGCGTCTCCAGAGGGGA 69 FBan0006727 FBgn0029084 gom 2 2R calcium-mediated signaling; GO:0019722; courtship behavior; GO:0007619; learning; GO:0007612 calcium ion binding; GO:0005509; ; GO:0005509 gom gomdanji "CG6727, CG6727, CG6727" CDMC21065 4 9 5 DAC08-D12 8-CG31875-RA_1 CG31875 TCCTCGGCGTTGGAGACAGATGACCAACAGGCCATCCATAGATGATGCTTTGAATCGGCATTCGTGAAT 69 FBan0031875 FBgn0051875 CG31875 2 2L DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG31875 CG31875 "CG5831, BcDNA:AT29184" CDMC21065 4 10 5 DAC08-D12 8-CG31875-RA_1 CG31875 TCCTCGGCGTTGGAGACAGATGACCAACAGGCCATCCATAGATGATGCTTTGAATCGGCATTCGTGAAT 69 FBan0031875 FBgn0051875 CG31875 2 2L DNA binding; GO:0003677; ; GO:0003677 nucleus; GO:0005634 CG31875 CG31875 "CG5831, BcDNA:AT29184" CDMC21066 4 11 5 DAC08-D24 16-CG31886-RA_1 CG31886 CGCCTCACCGGGAACGTCTCAAAAGACACAATAGGGTAGCCCATAGGAATCAGAAGAGACAGGATCTTT 69 FBgn0051886 CDMC21066 4 12 5 DAC08-D24 16-CG31886-RA_1 CG31886 CGCCTCACCGGGAACGTCTCAAAAGACACAATAGGGTAGCCCATAGGAATCAGAAGAGACAGGATCTTT 69 FBgn0051886 CDMC21067 4 13 5 DAC08-H12 23-CG31919-RB_14 CG31919 GCAAAGGAGCCAACACTTAAGCTGGTCAAGGATAAAAAGGACAAAATTGCATTTGAGTACATCATGGAG 69 FBgn0051919 CDMC21067 4 14 5 DAC08-H12 23-CG31919-RB_14 CG31919 GCAAAGGAGCCAACACTTAAGCTGGTCAAGGATAAAAAGGACAAAATTGCATTTGAGTACATCATGGAG 69 FBgn0051919 CDMC21068 4 15 5 DAC08-H24 1-CG31928-RA_1 CG31928 TGGTCTGGGATTCTCCGAAATCGCCCTGAATGGAGTGGAGACCCCTCTGGACAATATTTTGGAACAGGG 69 FBan0031928 FBgn0051928 CG31928 2 2L proteolysis; GO:0006508 NOT aspartic-type endopeptidase activity; GO:0004190 ; EC:3.4.23.-; ; GO:0004190 ; EC:3.4.23.-; pepsin A activity; GO:0004194 ; EC:3.4.23.1; ; GO:0004194 ; EC:3.4.23.1 CG31928 CG31928 CG10872 CDMC21068 4 16 5 DAC08-H24 1-CG31928-RA_1 CG31928 TGGTCTGGGATTCTCCGAAATCGCCCTGAATGGAGTGGAGACCCCTCTGGACAATATTTTGGAACAGGG 69 FBan0031928 FBgn0051928 CG31928 2 2L proteolysis; GO:0006508 NOT aspartic-type endopeptidase activity; GO:0004190 ; EC:3.4.23.-; ; GO:0004190 ; EC:3.4.23.-; pepsin A activity; GO:0004194 ; EC:3.4.23.1; ; GO:0004194 ; EC:3.4.23.1 CG31928 CG31928 CG10872 CDMC21069 4 17 5 DAC08-L12 22-CG31988-RA_1 CG31988 ACATCGTCCCGGATAACCATGGTGCATCCTTGCTCTTCCTCCAAATTGTTCATTTGCTTGCTTACAATA 69 FBan0031988 FBgn0051988 CG31988 2 2L cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; zinc ion binding; GO:0008270; ; GO:0008270 CG31988 CG31988 "CG17401, CG17401, bs21c01.y1, anon-WO0140519.26" CDMC21069 4 18 5 DAC08-L12 22-CG31988-RA_1 CG31988 ACATCGTCCCGGATAACCATGGTGCATCCTTGCTCTTCCTCCAAATTGTTCATTTGCTTGCTTACAATA 69 FBan0031988 FBgn0051988 CG31988 2 2L cell motility; GO:0006928; cytoskeleton organization and biogenesis; GO:0007010 structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; zinc ion binding; GO:0008270; ; GO:0008270 CG31988 CG31988 "CG17401, CG17401, bs21c01.y1, anon-WO0140519.26" CDMC21070 4 19 5 DAC08-L24 11-CG31998-RA_1 CG31998 GTCGAACCCTTGAGTCACCAATTGCTTCTGCTGAAACTCAACGAATAGTCGCCAATGGATCGCAGACGT 69 FBan0031998 FBgn0051998 CG31998 4 4 CG31998 CG31998 "CG11572, CG11578, CG11572" CDMC21070 4 20 5 DAC08-L24 11-CG31998-RA_1 CG31998 GTCGAACCCTTGAGTCACCAATTGCTTCTGCTGAAACTCAACGAATAGTCGCCAATGGATCGCAGACGT 69 FBan0031998 FBgn0051998 CG31998 4 4 CG31998 CG31998 "CG11572, CG11578, CG11572" CDMC21071 4 21 5 DAC08-P12 47-CG32031-RC_1 CG32031 CTGAAACGAGAATCAATCAATCAATCCCAATCACCGAAAATCAAAAGCAATAGCGTTAAGCCAAGCGTG 69 FBan0032031 FBgn0000116 Argk 3 3L phosphorylation; GO:0016310 arginine kinase activity; GO:0004054 ; EC:2.7.3.3; ; GO:0004054 ; EC:2.7.3.3; ; GO:0004054 ; EC:2.7.3.3 Argk Arginine kinase "CG4929, CG5173, CG32031, CG4929, CG5173, CG4929, CG32031, ARK, AK, AK-1, ArgK, argK, insect intestinal mucin iim22, argk, Arginine kinase" CDMC21071 4 22 5 DAC08-P12 47-CG32031-RC_1 CG32031 CTGAAACGAGAATCAATCAATCAATCCCAATCACCGAAAATCAAAAGCAATAGCGTTAAGCCAAGCGTG 69 FBan0032031 FBgn0000116 Argk 3 3L phosphorylation; GO:0016310 arginine kinase activity; GO:0004054 ; EC:2.7.3.3; ; GO:0004054 ; EC:2.7.3.3; ; GO:0004054 ; EC:2.7.3.3 Argk Arginine kinase "CG4929, CG5173, CG32031, CG4929, CG5173, CG4929, CG32031, ARK, AK, AK-1, ArgK, argK, insect intestinal mucin iim22, argk, Arginine kinase" CDMC21072 4 23 5 DAC08-P24 23-CG32039-RA_3 CG32039 TCAGAAAAGAACATCTTGGATTCAACACCATACAAACTTTTAGCTGGCGACCAAAATGTACAACCAAAA 69 FBan0032039 FBgn0052039 CG32039 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32039 CG32039 "BcDNA:RE03722, BEST:GH02734" CDMC21072 4 24 5 DAC08-P24 23-CG32039-RA_3 CG32039 TCAGAAAAGAACATCTTGGATTCAACACCATACAAACTTTTAGCTGGCGACCAAAATGTACAACCAAAA 69 FBan0032039 FBgn0052039 CG32039 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32039 CG32039 "BcDNA:RE03722, BEST:GH02734" CDMC21073 4 25 5 DAC09-D13 3-CG5458-RA_5 CG5458 ATCGGGGTGTACGTGTTCAAGGATGGTTCACGATACTACGGACAGTATCGCTGCGGGAAGCGTTG 65 FBan0005458 FBgn0032478 CG5458 2 2L CG5458 CG5458 CDMC21073 4 26 5 DAC09-D13 3-CG5458-RA_5 CG5458 ATCGGGGTGTACGTGTTCAAGGATGGTTCACGATACTACGGACAGTATCGCTGCGGGAAGCGTTG 65 FBan0005458 FBgn0032478 CG5458 2 2L CG5458 CG5458 CDMC21074 4 1 6 DAC09-E01 2-CG5515-RA_1 CG5515 CCCGAGAAAGGTCTTGCCTGCAAACTGGTCTTCACATTCACAGCTACCTATCCGGATGGAGCACC 65 FBan0005515 FBgn0039163 CG5515 3 3R CG5515 CG5515 CDMC21074 4 2 6 DAC09-E01 2-CG5515-RA_1 CG5515 CCCGAGAAAGGTCTTGCCTGCAAACTGGTCTTCACATTCACAGCTACCTATCCGGATGGAGCACC 65 FBan0005515 FBgn0039163 CG5515 3 3R CG5515 CG5515 CDMC21075 4 3 6 DAC09-H13 3-CG5643-RA_2 CG5643 ATGCCGATCATGTTCCCGGCCCTATACCGCATCAGCAAGGAACACTGGAATCAAACTATCGTGGC 65 FBan0005643 FBgn0027492 wdb 3 3R intracellular signaling cascade; GO:0007242 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; protein phosphatase type 2A regulator activity; GO:0008601; ; GO:0008601 protein phosphatase type 2A complex; GO:0000159 wdb widerborst "CG5643, CG5643, CG5643, CG5643, CG5643, CG5643, 0318/07, LD02456, EP3559, l(3)S031807, PP2A B subunit, BcDNA:LD34343, PP2-AB, PP2A, BEST:LD02456, widerborst" CDMC21075 4 4 6 DAC09-H13 3-CG5643-RA_2 CG5643 ATGCCGATCATGTTCCCGGCCCTATACCGCATCAGCAAGGAACACTGGAATCAAACTATCGTGGC 65 FBan0005643 FBgn0027492 wdb 3 3R intracellular signaling cascade; GO:0007242 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; protein phosphatase type 2A regulator activity; GO:0008601; ; GO:0008601 protein phosphatase type 2A complex; GO:0000159 wdb widerborst "CG5643, CG5643, CG5643, CG5643, CG5643, CG5643, 0318/07, LD02456, EP3559, l(3)S031807, PP2A B subunit, BcDNA:LD34343, PP2-AB, PP2A, BEST:LD02456, widerborst" CDMC21076 4 5 6 DAC09-I01 2-CG5684-RA_1 CG5684 CAACTTCCACGACAGCAACGGTGAGACGAACAGCGCTTCATGATTCGTACTGATGGGGAACGTGG 65 FBan0005684 FBgn0036239 CG5684 3 3L negative regulation of transcription; GO:0016481; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcriptional repressor activity; GO:0016564; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016564 cytoplasm; GO:0005737; nucleus; GO:0005634 CG5684 CG5684 CAF1 CDMC21076 4 6 6 DAC09-I01 2-CG5684-RA_1 CG5684 CAACTTCCACGACAGCAACGGTGAGACGAACAGCGCTTCATGATTCGTACTGATGGGGAACGTGG 65 FBan0005684 FBgn0036239 CG5684 3 3L negative regulation of transcription; GO:0016481; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcriptional repressor activity; GO:0016564; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016564 cytoplasm; GO:0005737; nucleus; GO:0005634 CG5684 CG5684 CAF1 CDMC21077 4 7 6 DAC09-L13 3-CG5819-RA_6 CG5819 ATGCCGAAACTAGTCAGGCCAGTGAAGTCAATGATGGATCTCTCGGGACCAGAAAGAGCCCGCAA 65 FBan0005819 FBgn0034717 CG5819 2 2R cell adhesion; GO:0007155; transmission of nerve impulse; GO:0019226 CG5819 CG5819 "CT18212, tartan/capricious-like" CDMC21077 4 8 6 DAC09-L13 3-CG5819-RA_6 CG5819 ATGCCGAAACTAGTCAGGCCAGTGAAGTCAATGATGGATCTCTCGGGACCAGAAAGAGCCCGCAA 65 FBan0005819 FBgn0034717 CG5819 2 2R cell adhesion; GO:0007155; transmission of nerve impulse; GO:0019226 CG5819 CG5819 "CT18212, tartan/capricious-like" CDMC21078 4 9 6 DAC09-M01 1-CG5837-RA_1 CG5837 CTGGACAAGCGCATACCCTTCCTGCTTAGCTCAGTGAAGGACTTTCAGGAACATTTGCCCGGAGG 65 FBan0005837 FBgn0011771 Hem 3 3L apoptosis; GO:0006915; axonogenesis; GO:0007409; bristle morphogenesis; GO:0008407; cell projection biogenesis; GO:0030031; central nervous system development; GO:0007417; cortical actin cytoskeleton organization and biogenesis; GO:0030866; cytoskeleton organization and biogenesis; GO:0007010; myoblast fusion; GO:0007520; neuromuscular junction development; GO:0007528; oocyte growth; GO:0001555; regulation of cell shape; GO:0008360 receptor binding; GO:0005102; ; GO:0005102; protein binding; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737; plasma membrane; GO:0005886 Hem HEM-protein "CG5837, dhem-2, kte, kette, dhem, Kette, l(3)03335" CDMC21078 4 10 6 DAC09-M01 1-CG5837-RA_1 CG5837 CTGGACAAGCGCATACCCTTCCTGCTTAGCTCAGTGAAGGACTTTCAGGAACATTTGCCCGGAGG 65 FBan0005837 FBgn0011771 Hem 3 3L apoptosis; GO:0006915; axonogenesis; GO:0007409; bristle morphogenesis; GO:0008407; cell projection biogenesis; GO:0030031; central nervous system development; GO:0007417; cortical actin cytoskeleton organization and biogenesis; GO:0030866; cytoskeleton organization and biogenesis; GO:0007010; myoblast fusion; GO:0007520; neuromuscular junction development; GO:0007528; oocyte growth; GO:0001555; regulation of cell shape; GO:0008360 receptor binding; GO:0005102; ; GO:0005102; protein binding; GO:0005515; ; GO:0005515 cytoplasm; GO:0005737; plasma membrane; GO:0005886 Hem HEM-protein "CG5837, dhem-2, kte, kette, dhem, Kette, l(3)03335" CDMC21079 4 11 6 DAC09-P13 3-CG5964-RA_1 CG5964 ACCGGGACAGGTCCAGAGTGACATTGTGGATCGAATGCTGGACGAAAACATCGAAGCCTCCTACC 65 FBan0005964 FBgn0036206 CG5964 3 3L cell cycle; GO:0007049; cytoskeleton organization and biogenesis; GO:0007010; intracellular protein transport; GO:0006886; mitosis; GO:0007067; protein targeting; GO:0006605 microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; structural molecule activity; GO:0005198; ; GO:0008017; ; GO:0005200; ; GO:0005198 CG5964 CG5964 CDMC21079 4 12 6 DAC09-P13 3-CG5964-RA_1 CG5964 ACCGGGACAGGTCCAGAGTGACATTGTGGATCGAATGCTGGACGAAAACATCGAAGCCTCCTACC 65 FBan0005964 FBgn0036206 CG5964 3 3L cell cycle; GO:0007049; cytoskeleton organization and biogenesis; GO:0007010; intracellular protein transport; GO:0006886; mitosis; GO:0007067; protein targeting; GO:0006605 microtubule binding; GO:0008017; structural constituent of cytoskeleton; GO:0005200; structural molecule activity; GO:0005198; ; GO:0008017; ; GO:0005200; ; GO:0005198 CG5964 CG5964 CDMC21080 4 13 6 DAC08-P24 AutoBlank AutoBlank CDMC21080 4 14 6 DAC08-P24 AutoBlank AutoBlank CDMC21081 4 15 6 DAC10-D12 3-CG6553-RA_1 CG6553 GATGCAATCCTCACTGTAGGATCAAGGGTAGCCAATGGCACCCGTATCTACTACGACTGCCCGGC 65 FBan0006553 FBgn0033880 CG6553 2 2R CG6553 CG6553 CDMC21081 4 16 6 DAC10-D12 3-CG6553-RA_1 CG6553 GATGCAATCCTCACTGTAGGATCAAGGGTAGCCAATGGCACCCGTATCTACTACGACTGCCCGGC 65 FBan0006553 FBgn0033880 CG6553 2 2R CG6553 CG6553 CDMC21082 4 17 6 DAC10-D24 3-CG6619-RA_1 CG6619 CTTTGTTTTGGGATCCCACAAGTGAGACGGCTCAGTCCCGACAGCACTCCACAAAATCCAGGCAG 65 FBan0006619 FBgn0035676 CG6619 3 3L protein binding; GO:0005515; ; GO:0005515 CG6619 CG6619 CDMC21082 4 18 6 DAC10-D24 3-CG6619-RA_1 CG6619 CTTTGTTTTGGGATCCCACAAGTGAGACGGCTCAGTCCCGACAGCACTCCACAAAATCCAGGCAG 65 FBan0006619 FBgn0035676 CG6619 3 3L protein binding; GO:0005515; ; GO:0005515 CG6619 CG6619 CDMC21083 4 19 6 DAC10-H12 1-CG6729-RA_1 CG6729 GTGCGTTAAGGTCAAGCAGTACCAGTTCCCCATTTTCGAGCCATCGGTTAGTGATTACCGGGCGG 65 FBan0006729 FBgn0032296 CG6729 2 2L CG6729 CG6729 CDMC21083 4 20 6 DAC10-H12 1-CG6729-RA_1 CG6729 GTGCGTTAAGGTCAAGCAGTACCAGTTCCCCATTTTCGAGCCATCGGTTAGTGATTACCGGGCGG 65 FBan0006729 FBgn0032296 CG6729 2 2L CG6729 CG6729 CDMC21084 4 21 6 DAC10-H24 5-CG6760-RA_1 CG6760 GTTGAAGGACTGCAGGGAGTTACCGTGATAGCAGCTACCTCCAGACCGGAACTGCTAGATCCCGC 65 FBan0006760 FBgn0013563 l(3)70Da 3 3L mitosis; GO:0007067; peroxisome organization and biogenesis; GO:0007031; protein targeting to peroxisome; GO:0006625 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled; GO:0042623; ; GO:0042623; nucleotide binding; GO:0000166; ; GO:0000166" peroxisome; GO:0005777 l(3)70Da lethal (3) 70Da "CG6760, 0848/07, l(3)S084807, l(3)s4868, l(3)02402, l(3)084807, DmCAB51031.1, anon-WO0172774.100, anon-WO0172774.101, anon-WO0172774.102, anon-WO0172774.96, anon-WO0172774.99, anon-WO0172774.98" CDMC21084 4 22 6 DAC10-H24 5-CG6760-RA_1 CG6760 GTTGAAGGACTGCAGGGAGTTACCGTGATAGCAGCTACCTCCAGACCGGAACTGCTAGATCCCGC 65 FBan0006760 FBgn0013563 l(3)70Da 3 3L mitosis; GO:0007067; peroxisome organization and biogenesis; GO:0007031; protein targeting to peroxisome; GO:0006625 "ATP binding; GO:0005524; ; GO:0005524; ATPase activity, coupled; GO:0042623; ; GO:0042623; nucleotide binding; GO:0000166; ; GO:0000166" peroxisome; GO:0005777 l(3)70Da lethal (3) 70Da "CG6760, 0848/07, l(3)S084807, l(3)s4868, l(3)02402, l(3)084807, DmCAB51031.1, anon-WO0172774.100, anon-WO0172774.101, anon-WO0172774.102, anon-WO0172774.96, anon-WO0172774.99, anon-WO0172774.98" CDMC21085 4 23 6 DAC10-L12 3-CG6854-RB_1 CG6854 TGAGCTCAGCGGTCATCCCTACTTTGTTGCCACCCAATATCATCCAGAGTACTTGTCGCGGCCTC 65 FBan0006854 FBgn0036478 CG6854 3 3L pyrimidine base metabolism; GO:0006206; pyrimidine nucleotide biosynthesis; GO:0006221 transcription factor activity; GO:0003700; ; GO:0003700; CTP synthase activity; GO:0003883 ; EC:6.3.4.2; ; GO:0003883 ; EC:6.3.4.2 CG6854 CG6854 "anon-WO0172774.90, anon-WO0172774.92" CDMC21085 4 24 6 DAC10-L12 3-CG6854-RB_1 CG6854 TGAGCTCAGCGGTCATCCCTACTTTGTTGCCACCCAATATCATCCAGAGTACTTGTCGCGGCCTC 65 FBan0006854 FBgn0036478 CG6854 3 3L pyrimidine base metabolism; GO:0006206; pyrimidine nucleotide biosynthesis; GO:0006221 transcription factor activity; GO:0003700; ; GO:0003700; CTP synthase activity; GO:0003883 ; EC:6.3.4.2; ; GO:0003883 ; EC:6.3.4.2 CG6854 CG6854 "anon-WO0172774.90, anon-WO0172774.92" CDMC21086 4 25 6 DAC10-L24 2-CG6898-RA_1 CG6898 GTCCATTCCCTTCTTGCTTAACCGTTGCTATCGCTGGACGGAAAACCAGACGAACGCACGATCCG 65 FBan0006898 FBgn0038412 Zip3 3 3R cation transport; GO:0006812; metal ion transport; GO:0030001 metal ion transporter activity; GO:0046873; ; GO:0046873 membrane; GO:0016020 Zip3 Zinc/iron regulated transporter-related protein 3 "CG6898, ZIP3, Zinc/iron regulated transporter-related protein 3" CDMC21086 4 26 6 DAC10-L24 2-CG6898-RA_1 CG6898 GTCCATTCCCTTCTTGCTTAACCGTTGCTATCGCTGGACGGAAAACCAGACGAACGCACGATCCG 65 FBan0006898 FBgn0038412 Zip3 3 3R cation transport; GO:0006812; metal ion transport; GO:0030001 metal ion transporter activity; GO:0046873; ; GO:0046873 membrane; GO:0016020 Zip3 Zinc/iron regulated transporter-related protein 3 "CG6898, ZIP3, Zinc/iron regulated transporter-related protein 3" CDMC21087 4 1 7 DAC10-P12 3-CG7003-RA_4 CG7003 TCACTACGACCAGTGGAAGCAATGCATTGACTGCGTCGCCAACCTGGATGTCCTAGGCTCACTAG 65 FBan0007003 FBgn0036486 CG7003 3 3L DNA repair; GO:0006281; mismatch repair; GO:0006298; postreplication repair; GO:0006301 ATP binding; GO:0005524; damaged DNA binding; GO:0003684; ; GO:0005524; ; GO:0003684 CG7003 CG7003 Msh6 CDMC21087 4 2 7 DAC10-P12 3-CG7003-RA_4 CG7003 TCACTACGACCAGTGGAAGCAATGCATTGACTGCGTCGCCAACCTGGATGTCCTAGGCTCACTAG 65 FBan0007003 FBgn0036486 CG7003 3 3L DNA repair; GO:0006281; mismatch repair; GO:0006298; postreplication repair; GO:0006301 ATP binding; GO:0005524; damaged DNA binding; GO:0003684; ; GO:0005524; ; GO:0003684 CG7003 CG7003 Msh6 CDMC21088 4 3 7 DAC10-P24 AutoBlank AutoBlank CDMC21088 4 4 7 DAC10-P24 AutoBlank AutoBlank CDMC21089 4 5 7 DAC11-D12 10-CG10031-RA_1 CG10031 TCGTTGGGGATTCCGACAAACTTGTGAGGAGGCTTGTATTCCCAAAAAGTGATCCATTGATGGCGGTCA 69 FBan0010031 FBgn0031563 CG10031 2 2L serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; protease inhibitor activity; GO:0030414; ; GO:0030414 CG10031 CG10031 CDMC21089 4 6 7 DAC11-D12 10-CG10031-RA_1 CG10031 TCGTTGGGGATTCCGACAAACTTGTGAGGAGGCTTGTATTCCCAAAAAGTGATCCATTGATGGCGGTCA 69 FBan0010031 FBgn0031563 CG10031 2 2L serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; protease inhibitor activity; GO:0030414; ; GO:0030414 CG10031 CG10031 CDMC21090 4 7 7 DAC11-D24 3-CG10041-RA_1 CG10041 TGCCTTCACTCGCATCAACGCATACTCCAGCTGGATTCAGGAATCCATGGACTCTATGGCTGCGAGATT 69 FBan0010041 FBgn0038014 CG10041 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG10041 CG10041 SP178 CDMC21090 4 8 7 DAC11-D24 3-CG10041-RA_1 CG10041 TGCCTTCACTCGCATCAACGCATACTCCAGCTGGATTCAGGAATCCATGGACTCTATGGCTGCGAGATT 69 FBan0010041 FBgn0038014 CG10041 3 3R proteolysis; GO:0006508 serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG10041 CG10041 SP178 CDMC21091 4 9 7 DAC11-H12 2-CG10073-RA_2 CG10073 ACCTTGTTGGCCATAAGCGCTGTGACCATTTACACGGCTAGCTCCACCCAAATTGGTTTTCCATACCGT 69 FBan0010073 FBgn0034440 CG10073 2 2R CG10073 CG10073 CDMC21091 4 10 7 DAC11-H12 2-CG10073-RA_2 CG10073 ACCTTGTTGGCCATAAGCGCTGTGACCATTTACACGGCTAGCTCCACCCAAATTGGTTTTCCATACCGT 69 FBan0010073 FBgn0034440 CG10073 2 2R CG10073 CG10073 CDMC21092 4 11 7 DAC11-H24 2-CG10079-RB_1 CG10079 ACCGACTGCACGGATGAGATACCCAAGCTGAACCGCTACTGCAAGGATCCTAGCAACAAGAATTCGAGT 69 FBan0010079 FBgn0003731 Egfr 2 2R "G2/M transition of mitotic cell cycle; GO:0000086; Malpighian tubule morphogenesis; GO:0007443; R7 cell differentiation; GO:0045466; antennal morphogenesis; GO:0007469; anterior/posterior pattern formation; GO:0009952; anti-apoptosis; GO:0006916; blastoderm segmentation; GO:0007350; border follicle cell migration (sensu Insecta); GO:0007298; brain development; GO:0007420; branched duct epithelial cell fate determination (sensu Insecta); GO:0046845; cell fate commitment; GO:0045165; cell fate determination; GO:0001709; cell projection biogenesis; GO:0030031; compound eye morphogenesis (sensu Endopterygota); GO:0001745; cone cell fate commitment (sensu Endopterygota); GO:0007466; dorsal closure; GO:0007391; dorsal/ventral axis specification; GO:0009950; dorsal/ventral pattern formation; GO:0009953; eggshell pattern formation (sensu Insecta); GO:0030381; embryonic axis specification; GO:0000578; embryonic pattern specification; GO:0009880; epidermal growth factor receptor signaling pathway; GO:0007173; eye development (sensu Endopterygota); GO:0007456; eye development; GO:0001654; female germ-line cyst encapsulation; GO:0048139; gastrulation; GO:0007369; germ-band shortening; GO:0007390; gurken receptor signaling pathway; GO:0008314; imaginal disc development; GO:0007444; imaginal disc pattern formation; GO:0007447; leg disc proximal/distal pattern formation; GO:0007479; male germ-line cyst encapsulation; GO:0048140; maternal determination of dorsal/ventral axis, follicular epithelium, soma encoded (sensu Insecta); GO:0008071; morphogenesis of an epithelium; GO:0002009; morphogenesis of follicular epithelium; GO:0016333; muscle attachment; GO:0016203; muscle cell fate specification; GO:0042694; negative regulation of retinal cell programmed cell death (sensu Endopterygota); GO:0046673; notum cell fate specification; GO:0035310; notum morphogenesis; GO:0007477; oenocyte differentiation; GO:0001742; ommatidial rotation; GO:0016318; oocyte anterior/posterior axis determination (sensu Insecta); GO:0048112; oocyte anterior/posterior axis determination; GO:0007314; oocyte dorsal/ventral axis determination; GO:0007310; oogenesis (sensu Insecta); GO:0009993; peripheral nervous system development; GO:0007422; photoreceptor cell differentiation (sensu Endopterygota); GO:0007467; photoreceptor fate commitment (sensu Endopterygota); GO:0007459; progression of morphogenetic furrow (sensu Endopterygota); GO:0007458; protein amino acid phosphorylation; GO:0006468; regulation of R8 spacing; GO:0045468; regulation of hemocyte differentiation; GO:0045610; regulation of progression through mitotic cell cycle; GO:0007346; salivary gland development; GO:0007431; second mitotic wave (sensu Endopterygota); GO:0016330; stomatogastric nervous system development; GO:0007421; tracheal sac formation (sensu Insecta); GO:0035202; tracheal system development (sensu Insecta); GO:0007424; wing and notum subfield formation; GO:0035309; wing disc morphogenesis; GO:0007472; wing disc proximal/distal pattern formation; GO:0007473; wing morphogenesis; GO:0007476; wing vein morphogenesis; GO:0008586; wing vein specification; GO:0007474" ATP binding; GO:0005524; ; GO:0005524; transmembrane receptor activity; GO:0004888; epidermal growth factor receptor activity; GO:0005006; ; GO:0005006; gurken receptor activity; GO:0008313; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004888; ; GO:0005006; ; GO:0008313; ; GO:0005006 integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 Egfr Epidermal growth factor receptor "CG10079, CG10079, CG10079, CG10079, c-erbB, flb: faint little ball, top: torpedo, DER, torpedo, l(2)57DEFa, Elp, top/flb, Ellipse, top/DER, l(2)05351, Egf-r, DER/top, EGFr, DER/faint little ball, torpedo/DER, EGF-R, EGF receptor, torpedo/Egfr, Ellipse torpedo, Torpedo/DER, EGFR, DER-Ellipse, Degfr, D-Egf, Torpedo/Egfr, Der: Drosophila epidermal growth factor receptor homologue, DmHD-33, DER flb, egfr, faint little ball, Elp-1, Elp-B1, Elp-B1RB1, epidermal growth factor receptor, DER/EGFR, EGF Receptor, EGF-receptor, EgfR, Torpedo, DER\torpedo, EK2-6, Egf, l(2)09261, dEGFR, dEGFR1, D-EGFR, torpedo/egfr, C-erb, El: Ellipse, HD-33, l(2)57EFa, l(2)57Ea, Drosophila epidermal growth factor receptor homologue, top, flb, Der" CDMC21092 4 12 7 DAC11-H24 2-CG10079-RB_1 CG10079 ACCGACTGCACGGATGAGATACCCAAGCTGAACCGCTACTGCAAGGATCCTAGCAACAAGAATTCGAGT 69 FBan0010079 FBgn0003731 Egfr 2 2R "G2/M transition of mitotic cell cycle; GO:0000086; Malpighian tubule morphogenesis; GO:0007443; R7 cell differentiation; GO:0045466; antennal morphogenesis; GO:0007469; anterior/posterior pattern formation; GO:0009952; anti-apoptosis; GO:0006916; blastoderm segmentation; GO:0007350; border follicle cell migration (sensu Insecta); GO:0007298; brain development; GO:0007420; branched duct epithelial cell fate determination (sensu Insecta); GO:0046845; cell fate commitment; GO:0045165; cell fate determination; GO:0001709; cell projection biogenesis; GO:0030031; compound eye morphogenesis (sensu Endopterygota); GO:0001745; cone cell fate commitment (sensu Endopterygota); GO:0007466; dorsal closure; GO:0007391; dorsal/ventral axis specification; GO:0009950; dorsal/ventral pattern formation; GO:0009953; eggshell pattern formation (sensu Insecta); GO:0030381; embryonic axis specification; GO:0000578; embryonic pattern specification; GO:0009880; epidermal growth factor receptor signaling pathway; GO:0007173; eye development (sensu Endopterygota); GO:0007456; eye development; GO:0001654; female germ-line cyst encapsulation; GO:0048139; gastrulation; GO:0007369; germ-band shortening; GO:0007390; gurken receptor signaling pathway; GO:0008314; imaginal disc development; GO:0007444; imaginal disc pattern formation; GO:0007447; leg disc proximal/distal pattern formation; GO:0007479; male germ-line cyst encapsulation; GO:0048140; maternal determination of dorsal/ventral axis, follicular epithelium, soma encoded (sensu Insecta); GO:0008071; morphogenesis of an epithelium; GO:0002009; morphogenesis of follicular epithelium; GO:0016333; muscle attachment; GO:0016203; muscle cell fate specification; GO:0042694; negative regulation of retinal cell programmed cell death (sensu Endopterygota); GO:0046673; notum cell fate specification; GO:0035310; notum morphogenesis; GO:0007477; oenocyte differentiation; GO:0001742; ommatidial rotation; GO:0016318; oocyte anterior/posterior axis determination (sensu Insecta); GO:0048112; oocyte anterior/posterior axis determination; GO:0007314; oocyte dorsal/ventral axis determination; GO:0007310; oogenesis (sensu Insecta); GO:0009993; peripheral nervous system development; GO:0007422; photoreceptor cell differentiation (sensu Endopterygota); GO:0007467; photoreceptor fate commitment (sensu Endopterygota); GO:0007459; progression of morphogenetic furrow (sensu Endopterygota); GO:0007458; protein amino acid phosphorylation; GO:0006468; regulation of R8 spacing; GO:0045468; regulation of hemocyte differentiation; GO:0045610; regulation of progression through mitotic cell cycle; GO:0007346; salivary gland development; GO:0007431; second mitotic wave (sensu Endopterygota); GO:0016330; stomatogastric nervous system development; GO:0007421; tracheal sac formation (sensu Insecta); GO:0035202; tracheal system development (sensu Insecta); GO:0007424; wing and notum subfield formation; GO:0035309; wing disc morphogenesis; GO:0007472; wing disc proximal/distal pattern formation; GO:0007473; wing morphogenesis; GO:0007476; wing vein morphogenesis; GO:0008586; wing vein specification; GO:0007474" ATP binding; GO:0005524; ; GO:0005524; transmembrane receptor activity; GO:0004888; epidermal growth factor receptor activity; GO:0005006; ; GO:0005006; gurken receptor activity; GO:0008313; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004888; ; GO:0005006; ; GO:0008313; ; GO:0005006 integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 Egfr Epidermal growth factor receptor "CG10079, CG10079, CG10079, CG10079, c-erbB, flb: faint little ball, top: torpedo, DER, torpedo, l(2)57DEFa, Elp, top/flb, Ellipse, top/DER, l(2)05351, Egf-r, DER/top, EGFr, DER/faint little ball, torpedo/DER, EGF-R, EGF receptor, torpedo/Egfr, Ellipse torpedo, Torpedo/DER, EGFR, DER-Ellipse, Degfr, D-Egf, Torpedo/Egfr, Der: Drosophila epidermal growth factor receptor homologue, DmHD-33, DER flb, egfr, faint little ball, Elp-1, Elp-B1, Elp-B1RB1, epidermal growth factor receptor, DER/EGFR, EGF Receptor, EGF-receptor, EgfR, Torpedo, DER\torpedo, EK2-6, Egf, l(2)09261, dEGFR, dEGFR1, D-EGFR, torpedo/egfr, C-erb, El: Ellipse, HD-33, l(2)57EFa, l(2)57Ea, Drosophila epidermal growth factor receptor homologue, top, flb, Der" CDMC21093 4 13 7 DAC11-L12 6-CG10112-RA_1 CG10112 GCCAACGTGGAGGGCTCTATGATCGGCAAATACTCCATCAAACTGGATAAGGCCGACGATGACAAGCAC 69 FBan0010112 FBgn0033942 CG10112 2 2R structural constituent of cuticle; GO:0042302; ; GO:0042302 CG10112 CG10112 CDMC21093 4 14 7 DAC11-L12 6-CG10112-RA_1 CG10112 GCCAACGTGGAGGGCTCTATGATCGGCAAATACTCCATCAAACTGGATAAGGCCGACGATGACAAGCAC 69 FBan0010112 FBgn0033942 CG10112 2 2R structural constituent of cuticle; GO:0042302; ; GO:0042302 CG10112 CG10112 CDMC21094 4 15 7 DAC11-L24 23-CG10120-RB_1 CG10120 CGCACATTTGTCGTCTAGCATAATATCCAAATTTGTATCGCGGCTAATTAACCACAACCACACACTATC 69 FBan0010120 FBgn0002719 Men 3 3R malate metabolism; GO:0006108; tricarboxylic acid cycle; GO:0006099 carboxy-lyase activity; GO:0016831 ; EC:4.1.1.-; malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity; GO:0004473 ; EC:1.1.1.40; ; GO:0016831 ; EC:4.1.1.-; ; GO:0004473 ; EC:1.1.1.40; ; GO:0004473 ; EC:1.1.1.40 Men Malic enzyme "CG10120, CG10120, CG10120, CG10120, ME, Mdh-NADP, Me, NADP-malic enzyme, MDH, malic enzyme, anon-WO0118547.278" CDMC21094 4 16 7 DAC11-L24 23-CG10120-RB_1 CG10120 CGCACATTTGTCGTCTAGCATAATATCCAAATTTGTATCGCGGCTAATTAACCACAACCACACACTATC 69 FBan0010120 FBgn0002719 Men 3 3R malate metabolism; GO:0006108; tricarboxylic acid cycle; GO:0006099 carboxy-lyase activity; GO:0016831 ; EC:4.1.1.-; malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity; GO:0004473 ; EC:1.1.1.40; ; GO:0016831 ; EC:4.1.1.-; ; GO:0004473 ; EC:1.1.1.40; ; GO:0004473 ; EC:1.1.1.40 Men Malic enzyme "CG10120, CG10120, CG10120, CG10120, ME, Mdh-NADP, Me, NADP-malic enzyme, MDH, malic enzyme, anon-WO0118547.278" CDMC21095 4 17 7 DAC11-P12 9-CG10153-RA_1 CG10153 CGCAGAGCCGAGTGTTTACAGTCCCAGAATTGCAAACAAGACTCCACGATCTGGGTCAAGATGTAGGCA 69 FBan0010153 FBgn0033962 CG10153 2 2R CG10153 CG10153 CDMC21095 4 18 7 DAC11-P12 9-CG10153-RA_1 CG10153 CGCAGAGCCGAGTGTTTACAGTCCCAGAATTGCAAACAAGACTCCACGATCTGGGTCAAGATGTAGGCA 69 FBan0010153 FBgn0033962 CG10153 2 2R CG10153 CG10153 CDMC21096 4 19 7 DAC11-P24 AutoBlank AutoBlank CDMC21096 4 20 7 DAC11-P24 AutoBlank AutoBlank CDMC21097 4 21 7 DAC12-D12 9-CG30118-RA_1 CG30118 TGCTCCTCAATGGTCAGTAGGCTTCCGAACTGTCCCTGAATCTCTTTTGCACACGCATATTACACGGCA 69 FBan0030118 FBgn0050118 CG30118 2 2R CG30118 CG30118 "CG16859, CG5544, CG16859" CDMC21097 4 22 7 DAC12-D12 9-CG30118-RA_1 CG30118 TGCTCCTCAATGGTCAGTAGGCTTCCGAACTGTCCCTGAATCTCTTTTGCACACGCATATTACACGGCA 69 FBan0030118 FBgn0050118 CG30118 2 2R CG30118 CG30118 "CG16859, CG5544, CG16859" CDMC21098 4 23 7 DAC12-D24 3-CG30127-RA_1 CG30127 CCTCGCCCAGCGATCACTCCTACGCCGAGCTAAACAAGTTCGAGGACATTGCTAGCAAATTTGAGCAGA 69 FBan0030127 FBgn0050127 CG30127 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30127 CG30127 CDMC21098 4 24 7 DAC12-D24 3-CG30127-RA_1 CG30127 CCTCGCCCAGCGATCACTCCTACGCCGAGCTAAACAAGTTCGAGGACATTGCTAGCAAATTTGAGCAGA 69 FBan0030127 FBgn0050127 CG30127 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30127 CG30127 CDMC21099 4 25 7 DAC12-H12 2-CG30164-RA_1 CG30164 CCTTGAGCTGGCGTATGATTCACTGACGACACTTAGCCTGGGTGAGTACGGATGGTTAAGTGCTCCCAT 69 FBan0030164 FBgn0050164 CG30164 2 2R intracellular protein transport; GO:0006886 CG30164 CG30164 CG4556 CDMC21099 4 26 7 DAC12-H12 2-CG30164-RA_1 CG30164 CCTTGAGCTGGCGTATGATTCACTGACGACACTTAGCCTGGGTGAGTACGGATGGTTAAGTGCTCCCAT 69 FBan0030164 FBgn0050164 CG30164 2 2R intracellular protein transport; GO:0006886 CG30164 CG30164 CG4556 CDMC21100 4 1 8 DAC12-H24 18-CG30174-RA_5 CG30174 TGCGTGCAATGCAACAAGACTCTAGACTCAACTCTTCACTGTGATGGTCCGGACAAGGACATTTACTGT 69 FBan0030174 FBgn0050174 CG30174 2 2R cell proliferation; GO:0008283; development; GO:0007275; mesoderm development; GO:0007498; muscle development; GO:0007517 zinc ion binding; GO:0008270; ; GO:0008270 CG30174 CG30174 "CG3220, CG3220, CG3220" CDMC21100 4 2 8 DAC12-H24 18-CG30174-RA_5 CG30174 TGCGTGCAATGCAACAAGACTCTAGACTCAACTCTTCACTGTGATGGTCCGGACAAGGACATTTACTGT 69 FBan0030174 FBgn0050174 CG30174 2 2R cell proliferation; GO:0008283; development; GO:0007275; mesoderm development; GO:0007498; muscle development; GO:0007517 zinc ion binding; GO:0008270; ; GO:0008270 CG30174 CG30174 "CG3220, CG3220, CG3220" CDMC21101 4 3 8 DAC12-L12 22-CG3022-RA_6 CG3022 TCGCGGTCGTTTAAGCTTAGTTTTTGACCAAATCGCATCTCTCTGTGTAGAACCTACTCCGCAATGTGA 69 FBan0003022 FBgn0031275 GABA-B-R3 2 2L "G-protein coupled receptor protein signaling pathway; GO:0007186; calcium-mediated signaling; GO:0019722; nerve-nerve synaptic transmission; GO:0007270; regulation of transcription, DNA-dependent; GO:0006355" GABA-B receptor activity; GO:0004965; ; GO:0004965; ; GO:0004965; transcription factor activity; GO:0003700; ; GO:0004965; ; GO:0003700 integral to membrane; GO:0016021; intracellular; GO:0005622 GABA-B-R3 metabotropic GABA-B receptor subtype 3 "CG3022, CG3022, D-GABA[[B]]R3, D-Gaba3, GB3, anon-WO0170980.13, anon-WO0170980.14, metabotropic GABA-B receptor subtype 3" CDMC21101 4 4 8 DAC12-L12 22-CG3022-RA_6 CG3022 TCGCGGTCGTTTAAGCTTAGTTTTTGACCAAATCGCATCTCTCTGTGTAGAACCTACTCCGCAATGTGA 69 FBan0003022 FBgn0031275 GABA-B-R3 2 2L "G-protein coupled receptor protein signaling pathway; GO:0007186; calcium-mediated signaling; GO:0019722; nerve-nerve synaptic transmission; GO:0007270; regulation of transcription, DNA-dependent; GO:0006355" GABA-B receptor activity; GO:0004965; ; GO:0004965; ; GO:0004965; transcription factor activity; GO:0003700; ; GO:0004965; ; GO:0003700 integral to membrane; GO:0016021; intracellular; GO:0005622 GABA-B-R3 metabotropic GABA-B receptor subtype 3 "CG3022, CG3022, D-GABA[[B]]R3, D-Gaba3, GB3, anon-WO0170980.13, anon-WO0170980.14, metabotropic GABA-B receptor subtype 3" CDMC21102 4 5 8 DAC12-L24 2-CG30270-RA_1 CG30270 TCGCCTTTCCCAACCATTGCATATGGGCGTTCAACAATCGGTACATGAGCGAAGGACATTTCCGCATCT 69 FBan0030270 FBgn0061435 CG30270 2 2R CG30270 CG30270 BcDNA:AT30770 CDMC21102 4 6 8 DAC12-L24 2-CG30270-RA_1 CG30270 TCGCCTTTCCCAACCATTGCATATGGGCGTTCAACAATCGGTACATGAGCGAAGGACATTTCCGCATCT 69 FBan0030270 FBgn0061435 CG30270 2 2R CG30270 CG30270 BcDNA:AT30770 CDMC21103 4 7 8 DAC12-P12 2-CG30321-RA_1 CG30321 ACGGGCCACGAGTGGAATAGAAAAAGTATGCCAAGCTGACCGCATAGCACAGGATAACACAGACCAGGA 69 FBan0030321 FBgn0050321 CG30321 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30321 CG30321 CDMC21103 4 8 8 DAC12-P12 2-CG30321-RA_1 CG30321 ACGGGCCACGAGTGGAATAGAAAAAGTATGCCAAGCTGACCGCATAGCACAGGATAACACAGACCAGGA 69 FBan0030321 FBgn0050321 CG30321 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30321 CG30321 CDMC21104 4 9 8 DAC12-P24 AutoBlank AutoBlank CDMC21104 4 10 8 DAC12-P24 AutoBlank AutoBlank CDMC21105 4 11 8 DAC13-D12 18-CG13290-RA_1 CG13290 GATCATGCAGGATATACGCCTACGCCTGGAACCACAGCACAGTAAAGCCACATTCATATCCTCCT 65 FBgn0035654 CDMC21105 4 12 8 DAC13-D12 18-CG13290-RA_1 CG13290 GATCATGCAGGATATACGCCTACGCCTGGAACCACAGCACAGTAAAGCCACATTCATATCCTCCT 65 FBgn0035654 CDMC21106 4 13 8 DAC13-D24 23-CG13365-RA_1 CG13365 TACATTTTGCATCTTTACATAACGAACTTAGTTATAGCAGCACATAAGCACACAATGGCACTGTT 65 FBan0013365 FBgn0029529 CG13365 X X CG13365 CG13365 BcDNA:LP07417 CDMC21106 4 14 8 DAC13-D24 23-CG13365-RA_1 CG13365 TACATTTTGCATCTTTACATAACGAACTTAGTTATAGCAGCACATAAGCACACAATGGCACTGTT 65 FBan0013365 FBgn0029529 CG13365 X X CG13365 CG13365 BcDNA:LP07417 CDMC21107 4 15 8 DAC13-H12 14-CG13490-RA_1 CG13490 GACGGTGCCCATCTACAGTTTTGGCCTCTGTCTCTCGGAGTGCAGGATGTTCTTTGCTCTGCGGG 65 FBan0013490 FBgn0034673 CG13490 2 2R CG13490 CG13490 CDMC21107 4 16 8 DAC13-H12 14-CG13490-RA_1 CG13490 GACGGTGCCCATCTACAGTTTTGGCCTCTGTCTCTCGGAGTGCAGGATGTTCTTTGCTCTGCGGG 65 FBan0013490 FBgn0034673 CG13490 2 2R CG13490 CG13490 CDMC21108 4 17 8 DAC13-H24 23-CG13517-RA_1 CG13517 GGAGATGAATATGGTAGGTGATCCAAGAGATTCCTTTCAAAGTCGAAATCCTTCAGAGAAGCAGG 65 FBan0013517 FBgn0034766 Obp59a 2 2R sensory perception of chemical stimulus; GO:0007606 odorant binding; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp59a Odorant-binding protein 59a "CG13517, CG13517, CG13517, CG13517, 59a, Obp58a, Odorant-binding protein 59a" CDMC21108 4 18 8 DAC13-H24 23-CG13517-RA_1 CG13517 GGAGATGAATATGGTAGGTGATCCAAGAGATTCCTTTCAAAGTCGAAATCCTTCAGAGAAGCAGG 65 FBan0013517 FBgn0034766 Obp59a 2 2R sensory perception of chemical stimulus; GO:0007606 odorant binding; GO:0005549; ; GO:0005549 cellular component unknown; GO:0008372 Obp59a Odorant-binding protein 59a "CG13517, CG13517, CG13517, CG13517, 59a, Obp58a, Odorant-binding protein 59a" CDMC21109 4 19 8 DAC13-L12 3-CG13617-RA_2 CG13617 TACGCCACTCGAAATCGCATCCGCAAGTTTGTCGAAAAACTGTGCTCCGCCAAGTTCTCGGAACG 65 FBan0013617 FBgn0039201 CG13617 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG13617 CG13617 CDMC21109 4 20 8 DAC13-L12 3-CG13617-RA_2 CG13617 TACGCCACTCGAAATCGCATCCGCAAGTTTGTCGAAAAACTGTGCTCCGCCAAGTTCTCGGAACG 65 FBan0013617 FBgn0039201 CG13617 3 3R nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG13617 CG13617 CDMC21110 4 21 8 DAC13-L24 8-CG1363-RA_1 CG1363 AAGGCAGCGAAAAAGAGCTATTCGAATGGTAGTGAACCGGAGATGCTCTCTCCCCTGACCAGCCC 65 FBan0001363 FBgn0004133 blow 2 2R mesoderm development; GO:0007498; myoblast fusion; GO:0007520; striated muscle development; GO:0007519 cytoplasm; GO:0005737 blow blown fuse "CG1363, CG1363, l(2)43Eb" CDMC21110 4 22 8 DAC13-L24 8-CG1363-RA_1 CG1363 AAGGCAGCGAAAAAGAGCTATTCGAATGGTAGTGAACCGGAGATGCTCTCTCCCCTGACCAGCCC 65 FBan0001363 FBgn0004133 blow 2 2R mesoderm development; GO:0007498; myoblast fusion; GO:0007520; striated muscle development; GO:0007519 cytoplasm; GO:0005737 blow blown fuse "CG1363, CG1363, l(2)43Eb" CDMC21111 4 23 8 DAC13-P12 3-CG13713-RA_1 CG13713 GATGCTGAAGCCCACTGTCACCTATCATCTGTTCCTGTACCGTGTCGAGTTGGCCCGTCGGAATG 65 FBan0013713 FBgn0042199 CG13713 3 3L CG13713 CG13713 "CG18465, HL2" CDMC21111 4 24 8 DAC13-P12 3-CG13713-RA_1 CG13713 GATGCTGAAGCCCACTGTCACCTATCATCTGTTCCTGTACCGTGTCGAGTTGGCCCGTCGGAATG 65 FBan0013713 FBgn0042199 CG13713 3 3L CG13713 CG13713 "CG18465, HL2" CDMC21112 4 25 8 DAC13-P24 AutoBlank AutoBlank CDMC21112 4 26 8 DAC13-P24 AutoBlank AutoBlank CDMC21113 4 1 9 DAC14-D12 13-CG16707-RD_1 CG16707 ACCCCCTGAGCGGATTTAATACGGGCCCAGATAGTAGGAGCAGGCTCTACATTCTTGAATTACTTCCCT 69 FBan0016707 FBgn0045823 vsg 3 3L learning and/or memory; GO:0007611; olfactory learning; GO:0008355 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 vsg visgun "CG16707, GH15083, FBgn0045823, anon-WO0118547.164, BEST:GH15083, visgun" CDMC21113 4 2 9 DAC14-D12 13-CG16707-RD_1 CG16707 ACCCCCTGAGCGGATTTAATACGGGCCCAGATAGTAGGAGCAGGCTCTACATTCTTGAATTACTTCCCT 69 FBan0016707 FBgn0045823 vsg 3 3L learning and/or memory; GO:0007611; olfactory learning; GO:0008355 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 vsg visgun "CG16707, GH15083, FBgn0045823, anon-WO0118547.164, BEST:GH15083, visgun" CDMC21114 4 3 9 DAC14-D24 3-CG16718-RA_1 CG16718 TGGTGCATTCCGGACATGAGCGTTGAACTGCGTGACCAAATCCGACGCGAAGTTTATGTGACCAATGAA 69 FBan0016718 FBgn0038721 CG16718 3 3R CG16718 CG16718 CDMC21114 4 4 9 DAC14-D24 3-CG16718-RA_1 CG16718 TGGTGCATTCCGGACATGAGCGTTGAACTGCGTGACCAAATCCGACGCGAAGTTTATGTGACCAATGAA 69 FBan0016718 FBgn0038721 CG16718 3 3R CG16718 CG16718 CDMC21115 4 5 9 DAC14-H12 23-CG16747-RC_2 CG16747 AGAAAGGGAAACGCATATGCATAGAAGCTAATTACATAGATCAGCAAAAAGGATCCACATACACGCTAT 69 FBan0016747 FBgn0014184 Oda 2 2R cell differentiation; GO:0030154 ornithine decarboxylase inhibitor activity; GO:0008073; ; GO:0008073; ; GO:0008073 Oda Ornithine decarboxylase antizyme "CG16747, CG16747, guf: gut feeling, gut feeling, gutfeeling, ODA, Ornithine Deacarboxylase Antizyme, ornithine decarboxylase antizyme, AZ: Antizyme, antizyme, D-AZ, l(2)02833, l(2)k09037, Antizyme, guf, AZ" CDMC21115 4 6 9 DAC14-H12 23-CG16747-RC_2 CG16747 AGAAAGGGAAACGCATATGCATAGAAGCTAATTACATAGATCAGCAAAAAGGATCCACATACACGCTAT 69 FBan0016747 FBgn0014184 Oda 2 2R cell differentiation; GO:0030154 ornithine decarboxylase inhibitor activity; GO:0008073; ; GO:0008073; ; GO:0008073 Oda Ornithine decarboxylase antizyme "CG16747, CG16747, guf: gut feeling, gut feeling, gutfeeling, ODA, Ornithine Deacarboxylase Antizyme, ornithine decarboxylase antizyme, AZ: Antizyme, antizyme, D-AZ, l(2)02833, l(2)k09037, Antizyme, guf, AZ" CDMC21116 4 7 9 DAC14-H24 23-CG16756-RA_1 CG16756 CCGAAACGCCCAAAATCTGCCTAATCTTAAGGTTATCTGTGGGATCTAGATGTAATTAATTTAATGATT 69 FBan0016756 FBgn0029765 CG16756 X X antimicrobial humoral response (sensu Protostomia); GO:0006960 lysozyme activity; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17 extracellular region; GO:0005576 CG16756 CG16756 BcDNA:RH17440 CDMC21116 4 8 9 DAC14-H24 23-CG16756-RA_1 CG16756 CCGAAACGCCCAAAATCTGCCTAATCTTAAGGTTATCTGTGGGATCTAGATGTAATTAATTTAATGATT 69 FBan0016756 FBgn0029765 CG16756 X X antimicrobial humoral response (sensu Protostomia); GO:0006960 lysozyme activity; GO:0003796 ; EC:3.2.1.17; ; GO:0003796 ; EC:3.2.1.17 extracellular region; GO:0005576 CG16756 CG16756 BcDNA:RH17440 CDMC21117 4 9 9 DAC14-L12 14-CG16801-RA_2 CG16801 TTGCTGCGCATGATCAGCTCCCACAAGATTGAGTCCATCTATTTTCAGCGCACTATTGGGAACACGCCC 69 FBan0016801 FBgn0034012 CG16801 2 2R intracellular signaling cascade; GO:0007242; regulation of transcription from RNA polymerase II promoter; GO:0006357 ligand-dependent nuclear receptor activity; GO:0004879; ; GO:0004879; steroid hormone receptor activity; GO:0003707; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0004879; ; GO:0003707 nucleus; GO:0005634 CG16801 CG16801 "PNR, NR2E3" CDMC21117 4 10 9 DAC14-L12 14-CG16801-RA_2 CG16801 TTGCTGCGCATGATCAGCTCCCACAAGATTGAGTCCATCTATTTTCAGCGCACTATTGGGAACACGCCC 69 FBan0016801 FBgn0034012 CG16801 2 2R intracellular signaling cascade; GO:0007242; regulation of transcription from RNA polymerase II promoter; GO:0006357 ligand-dependent nuclear receptor activity; GO:0004879; ; GO:0004879; steroid hormone receptor activity; GO:0003707; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0004879; ; GO:0003707 nucleus; GO:0005634 CG16801 CG16801 "PNR, NR2E3" CDMC21118 4 11 9 DAC14-L24 3-CG16825-RA_1 CG16825 AGCGTCTGTTTGGTTTTCTTCGGACCCTGGACCATGTACAACTCCCAGAAGTTGTTCCTGCACCACAAG 69 FBan0016825 FBgn0032503 CG16825 2 2L CG16825 CG16825 BcDNA:AT09390 CDMC21118 4 12 9 DAC14-L24 3-CG16825-RA_1 CG16825 AGCGTCTGTTTGGTTTTCTTCGGACCCTGGACCATGTACAACTCCCAGAAGTTGTTCCTGCACCACAAG 69 FBan0016825 FBgn0032503 CG16825 2 2L CG16825 CG16825 BcDNA:AT09390 CDMC21119 4 13 9 DAC14-P12 14-CG16876-RA_5 CG16876 AGTTGTGTACCGACTGCAGTTGCGAACGGACAAGTCAAACTGGAAAATGAAATTCATCTGGGCCCTGAT 69 FBan0016876 FBgn0028876 CG16876 2 2L CG16876 CG16876 "BG:DS05899.3, CT35247" CDMC21119 4 14 9 DAC14-P12 14-CG16876-RA_5 CG16876 AGTTGTGTACCGACTGCAGTTGCGAACGGACAAGTCAAACTGGAAAATGAAATTCATCTGGGCCCTGAT 69 FBan0016876 FBgn0028876 CG16876 2 2L CG16876 CG16876 "BG:DS05899.3, CT35247" CDMC21120 4 15 9 DAC14-P24 AutoBlank AutoBlank CDMC21120 4 16 9 DAC14-P24 AutoBlank AutoBlank CDMC21121 4 17 9 DAC15-D12 23-CG1865-RA_2 CG1865 TGTTCGCCATCAAGTACAAGGACTCAATCGCCTTTATCGGACACATTGCTAACTATGCTTATGTCTAAG 69 FBan0001865 FBgn0024293 Spn43Ab 2 2R proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 Spn43Ab Serine protease inhibitor 43Ab "CG1865, CG1865, SER2, Serine protease inhibitor 2, Ser2: Serine protease 2, anon-WO0118057.2, Ser2" CDMC21121 4 18 9 DAC15-D12 23-CG1865-RA_2 CG1865 TGTTCGCCATCAAGTACAAGGACTCAATCGCCTTTATCGGACACATTGCTAACTATGCTTATGTCTAAG 69 FBan0001865 FBgn0024293 Spn43Ab 2 2R proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 Spn43Ab Serine protease inhibitor 43Ab "CG1865, CG1865, SER2, Serine protease inhibitor 2, Ser2: Serine protease 2, anon-WO0118057.2, Ser2" CDMC21122 4 19 9 DAC15-D24 10-CG1867-RA_1 CG1867 CCGTTTGTGTGGACACACTGTTCTGTTCTCTGAGCCATAATCTCTGTGCCCTATTCCAGATTGCCAGGC 69 FBan0001867 FBgn0039582 Or98b 3 3R sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or98b Odorant receptor 98b "CG1867, CG1867, 98C.1, DOR121, 98b" CDMC21122 4 20 9 DAC15-D24 10-CG1867-RA_1 CG1867 CCGTTTGTGTGGACACACTGTTCTGTTCTCTGAGCCATAATCTCTGTGCCCTATTCCAGATTGCCAGGC 69 FBan0001867 FBgn0039582 Or98b 3 3R sensory perception of smell; GO:0007608 odorant binding; GO:0005549; olfactory receptor activity; GO:0004984; ; GO:0004984; ; GO:0005549 integral to membrane; GO:0016021 Or98b Odorant receptor 98b "CG1867, CG1867, 98C.1, DOR121, 98b" CDMC21123 4 21 9 DAC15-H12 23-CG18779-RA_3 CG18779 TTGCTTTCACTGTAAGCAGCTTTAAACCCACCAATTCTGCAACACTCTTTGTTATCTTCCCCAACACTT 69 FBan0018779 FBgn0042120 CG18779 3 3L CG18779 CG18779 CDMC21123 4 22 9 DAC15-H12 23-CG18779-RA_3 CG18779 TTGCTTTCACTGTAAGCAGCTTTAAACCCACCAATTCTGCAACACTCTTTGTTATCTTCCCCAACACTT 69 FBan0018779 FBgn0042120 CG18779 3 3L CG18779 CG18779 CDMC21124 4 23 9 DAC15-H24 13-CG18801-RA_1 CG18801 GCCCCGCTTAGCAGACGATACCCATCCGGCTACTTTGTATATGCTGGAAGTTTCCTATACGTCTCAGCA 69 FBan0018801 FBgn0041627 Ku80 2 2L DNA recombination; GO:0006310; DNA repair; GO:0006281; double-strand break repair via nonhomologous end-joining; GO:0006303; telomere maintenance; GO:0000723 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003; single-stranded DNA-dependent ATP-dependent DNA helicase activity; GO:0017116; ; GO:0017116; ; GO:0003677 DNA-dependent protein kinase complex; GO:0005958; single-stranded DNA-dependent ATP-dependent DNA helicase complex; GO:0017117 Ku80 Ku80 "CG18801, BG:DS09217.6, DmKu80, KU80" CDMC21124 4 24 9 DAC15-H24 13-CG18801-RA_1 CG18801 GCCCCGCTTAGCAGACGATACCCATCCGGCTACTTTGTATATGCTGGAAGTTTCCTATACGTCTCAGCA 69 FBan0018801 FBgn0041627 Ku80 2 2L DNA recombination; GO:0006310; DNA repair; GO:0006281; double-strand break repair via nonhomologous end-joining; GO:0006303; telomere maintenance; GO:0000723 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003; single-stranded DNA-dependent ATP-dependent DNA helicase activity; GO:0017116; ; GO:0017116; ; GO:0003677 DNA-dependent protein kinase complex; GO:0005958; single-stranded DNA-dependent ATP-dependent DNA helicase complex; GO:0017117 Ku80 Ku80 "CG18801, BG:DS09217.6, DmKu80, KU80" CDMC21125 4 25 9 DAC15-L12 2-CG1889-RB_4 CG1889 ACCCCGCTCGAACGTGGAACCGTTCTTTGTTTTTTGCGATCAGAAGGTCAGAAACGGTGGTTGGACAAT 69 FBan0001889 FBgn0030164 CG1889 X X receptor binding; GO:0005102; ; GO:0005102 CG1889 CG1889 CDMC21125 4 26 9 DAC15-L12 2-CG1889-RB_4 CG1889 ACCCCGCTCGAACGTGGAACCGTTCTTTGTTTTTTGCGATCAGAAGGTCAGAAACGGTGGTTGGACAAT 69 FBan0001889 FBgn0030164 CG1889 X X receptor binding; GO:0005102; ; GO:0005102 CG1889 CG1889 CDMC21126 4 1 10 DAC15-L24 39-CG1898-RA_6 CG1898 GCCGCATCGTGGAGACATCCATGAAATTCGACTATGACATGCAGAAGATCCTGGACGAGATCCTCAACG 69 FBan0001898 FBgn0042712 HBS1 3 3L regulation of translation; GO:0006445; translational termination; GO:0006415 GTP binding; GO:0005525; translation release factor activity; GO:0003747; translation elongation factor activity; GO:0003746; ; GO:0003746; ; GO:0003747; ; GO:0005525 cytosol; GO:0005829 HBS1 HBS1 "CG1898, CG1898" CDMC21126 4 2 10 DAC15-L24 39-CG1898-RA_6 CG1898 GCCGCATCGTGGAGACATCCATGAAATTCGACTATGACATGCAGAAGATCCTGGACGAGATCCTCAACG 69 FBan0001898 FBgn0042712 HBS1 3 3L regulation of translation; GO:0006445; translational termination; GO:0006415 GTP binding; GO:0005525; translation release factor activity; GO:0003747; translation elongation factor activity; GO:0003746; ; GO:0003746; ; GO:0003747; ; GO:0005525 cytosol; GO:0005829 HBS1 HBS1 "CG1898, CG1898" CDMC21127 4 3 10 DAC15-P12 2-CG1927-RA_2 CG1927 CGAAACGGGTGAGTTGGAGTACTTCTACACAGACACCGTCCGCGTTAATAGACCGGCCTTCGATGAGGA 69 FBan0001927 FBgn0027547 CG1927 3 3L CG1927 CG1927 "cDNA A, BcDNA:GH11112, anon-WO0118547.340, anon-62BCb" CDMC21127 4 4 10 DAC15-P12 2-CG1927-RA_2 CG1927 CGAAACGGGTGAGTTGGAGTACTTCTACACAGACACCGTCCGCGTTAATAGACCGGCCTTCGATGAGGA 69 FBan0001927 FBgn0027547 CG1927 3 3L CG1927 CG1927 "cDNA A, BcDNA:GH11112, anon-WO0118547.340, anon-62BCb" CDMC21128 4 5 10 DAC15-P24 AutoBlank AutoBlank CDMC21128 4 6 10 DAC15-P24 AutoBlank AutoBlank CDMC21129 4 7 10 DAC16-D12 15-CG32770-RA_1 CG32770 GGCCCATTCTGGATGGCATATACTTTTGCTTTATGAGCCTGTCCACCATTGGTTTTGGCGATATGCTGC 69 FBan0032770 FBgn0052770 CG32770 X X potassium ion transport; GO:0006813 potassium channel activity; GO:0005267; ; GO:0005267 membrane; GO:0016020 CG32770 CG32770 "CG6952, CG6952" CDMC21129 4 8 10 DAC16-D12 15-CG32770-RA_1 CG32770 GGCCCATTCTGGATGGCATATACTTTTGCTTTATGAGCCTGTCCACCATTGGTTTTGGCGATATGCTGC 69 FBan0032770 FBgn0052770 CG32770 X X potassium ion transport; GO:0006813 potassium channel activity; GO:0005267; ; GO:0005267 membrane; GO:0016020 CG32770 CG32770 "CG6952, CG6952" CDMC21130 4 9 10 DAC16-D24 23-CG32782-RC_12 CG32782 AGCATCAACAAACAAAGCAAAAAACGCAAAAAAGGATTACAAAGACGCAGAGAATAGGGGACATTTGCA 69 FBgn0052782 CDMC21130 4 10 10 DAC16-D24 23-CG32782-RC_12 CG32782 AGCATCAACAAACAAAGCAAAAAACGCAAAAAAGGATTACAAAGACGCAGAGAATAGGGGACATTTGCA 69 FBgn0052782 CDMC21131 4 11 10 DAC16-H12 18-CG32811-RA_1 CG32811 GCCACACCAACCAGAGTATCCGGATTATGAGGCGATGAGAAGACCGGTAGAGTCGTTGCGCATGGTGAA 69 FBan0032811 FBgn0052811 CG32811 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32811 CG32811 CDMC21131 4 12 10 DAC16-H12 18-CG32811-RA_1 CG32811 GCCACACCAACCAGAGTATCCGGATTATGAGGCGATGAGAAGACCGGTAGAGTCGTTGCGCATGGTGAA 69 FBan0032811 FBgn0052811 CG32811 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32811 CG32811 CDMC21132 4 13 10 DAC16-H24 2-CG3281-RA_1 CG3281 TCCGCGTGTCTTTGCCAAAAGTGAATCTCTGACTCGTCATTTTTCCCAAGCCCACAAACTGACAGCGGA 69 FBan0003281 FBgn0037967 CG3281 3 3R "chromosome organization and biogenesis (sensu Eukaryota); GO:0007001; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleosome assembly; GO:0006334; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 nucleosome; GO:0000786; nucleus; GO:0005634 CG3281 CG3281 anon-WO0140519.243 CDMC21132 4 14 10 DAC16-H24 2-CG3281-RA_1 CG3281 TCCGCGTGTCTTTGCCAAAAGTGAATCTCTGACTCGTCATTTTTCCCAAGCCCACAAACTGACAGCGGA 69 FBan0003281 FBgn0037967 CG3281 3 3R "chromosome organization and biogenesis (sensu Eukaryota); GO:0007001; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; nucleosome assembly; GO:0006334; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" DNA binding; GO:0003677; nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270; ; GO:0003677 nucleosome; GO:0000786; nucleus; GO:0005634 CG3281 CG3281 anon-WO0140519.243 CDMC21133 4 15 10 DAC16-L12 15-CG32853-RA_1 CG32853 GGCGCAAGTTGGCTACTTGACCAATTAACGCGATTGGCTGAGGATTCTCACCTTTTGCTGGACACTATA 69 FBgn0052853 CDMC21133 4 16 10 DAC16-L12 15-CG32853-RA_1 CG32853 GGCGCAAGTTGGCTACTTGACCAATTAACGCGATTGGCTGAGGATTCTCACCTTTTGCTGGACACTATA 69 FBgn0052853 CDMC21134 4 17 10 DAC16-L24 15-CG3288-RA_2 CG3288 TCGTCATCCTGTGCTTCGTGGTGGTCTATATCAGCCACAAGATCTATGTCTCCGTCTACGACAACCTGC 69 FBan0003288 FBgn0037030 CG3288 3 3L CG3288 CG3288 CDMC21134 4 18 10 DAC16-L24 15-CG3288-RA_2 CG3288 TCGTCATCCTGTGCTTCGTGGTGGTCTATATCAGCCACAAGATCTATGTCTCCGTCTACGACAACCTGC 69 FBan0003288 FBgn0037030 CG3288 3 3L CG3288 CG3288 CDMC21135 4 19 10 DAC16-P12 17-CG32954-RA_1 CG32954 AGAAGTACTTCGATGAGGTGATGGTCCAAATGGACTACATCGATGTCCTGATCAATGGTGCTACGCTGT 69 FBgn0052954 CDMC21135 4 20 10 DAC16-P12 17-CG32954-RA_1 CG32954 AGAAGTACTTCGATGAGGTGATGGTCCAAATGGACTACATCGATGTCCTGATCAATGGTGCTACGCTGT 69 FBgn0052954 CDMC21136 4 21 10 DAC16-P24 12-CG32971-RA_1 CG32971 AGAGGAGCTGTCCGAACTGGAGTACGAGTACTACGAAAAGAGCGGTGGACCTGACTTGGATTCAAAGGA 69 FBan0032971 FBgn0052971 CG32971 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32971 CG32971 CDMC21136 4 22 10 DAC16-P24 12-CG32971-RA_1 CG32971 AGAGGAGCTGTCCGAACTGGAGTACGAGTACTACGAAAAGAGCGGTGGACCTGACTTGGATTCAAAGGA 69 FBan0032971 FBgn0052971 CG32971 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32971 CG32971 CDMC21137 4 23 10 DAC17-D12 1-CG12426-RA_3 CG12426 AATCTTGCAGTGCAATGGGCGTGGTAACGTATCTGCCTTTGTCCATCAGGTCCTGGAGGTTGTGG 65 FBan0012426 FBgn0039552 CG12426 3 3R CG12426 CG12426 CDMC21137 4 24 10 DAC17-D12 1-CG12426-RA_3 CG12426 AATCTTGCAGTGCAATGGGCGTGGTAACGTATCTGCCTTTGTCCATCAGGTCCTGGAGGTTGTGG 65 FBan0012426 FBgn0039552 CG12426 3 3R CG12426 CG12426 CDMC21138 4 25 10 DAC17-D24 15-CG1245-RA_8 CG1245 AGTTAAATTCCACTCTAACTGCCGTCAAAAACCTGCGGTCCAACGTAAGGCTGTGCTTCGAGCAC 65 FBan0001245 FBgn0037359 MED27 3 3R regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; transcription cofactor activity; GO:0003712; ; GO:0003712; ; GO:0016455 mediator complex; GO:0000119; nucleus; GO:0005634 MED27 Mediator complex subunit 27 "CG1245, dTRAP37, dCRSP34, CRSP34, Trap37, Med27, Mediator complex subunit 27" CDMC21138 4 26 10 DAC17-D24 15-CG1245-RA_8 CG1245 AGTTAAATTCCACTCTAACTGCCGTCAAAAACCTGCGGTCCAACGTAAGGCTGTGCTTCGAGCAC 65 FBan0001245 FBgn0037359 MED27 3 3R regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366; transcription initiation from RNA polymerase II promoter; GO:0006367 RNA polymerase II transcription mediator activity; GO:0016455; ; GO:0016455; transcription cofactor activity; GO:0003712; ; GO:0003712; ; GO:0016455 mediator complex; GO:0000119; nucleus; GO:0005634 MED27 Mediator complex subunit 27 "CG1245, dTRAP37, dCRSP34, CRSP34, Trap37, Med27, Mediator complex subunit 27" CDMC21139 4 1 11 DAC17-H12 18-CG12534-RA_2 CG12534 CAACTACGGCTACGACTACATCAGCCCCACGCACATCGAACTCAGCCGGGAAGCAACTCGCCTGG 65 FBan0012534 FBgn0031068 CG12534 X X electron transport; GO:0006118; oxidative phosphorylation; GO:0006119 flavin-linked sulfhydryl oxidase activity; GO:0016971; ; GO:0016971 mitochondrion; GO:0005739 CG12534 CG12534 CDMC21139 4 2 11 DAC17-H12 18-CG12534-RA_2 CG12534 CAACTACGGCTACGACTACATCAGCCCCACGCACATCGAACTCAGCCGGGAAGCAACTCGCCTGG 65 FBan0012534 FBgn0031068 CG12534 X X electron transport; GO:0006118; oxidative phosphorylation; GO:0006119 flavin-linked sulfhydryl oxidase activity; GO:0016971; ; GO:0016971 mitochondrion; GO:0005739 CG12534 CG12534 CDMC21140 4 3 11 DAC17-H24 3-CG12581-RA_1 CG12581 CTATGGGTCCGAACACACTACAGCGGAAGCATGCCATGACAATGTCAAATGGCGGATTGCATGGC 65 FBan0012581 FBgn0037213 CG12581 3 3R CG12581 CG12581 CDMC21140 4 4 11 DAC17-H24 3-CG12581-RA_1 CG12581 CTATGGGTCCGAACACACTACAGCGGAAGCATGCCATGACAATGTCAAATGGCGGATTGCATGGC 65 FBan0012581 FBgn0037213 CG12581 3 3R CG12581 CG12581 CDMC21141 4 5 11 DAC17-L12 3-CG12688-RA_1 CG12688 CCCTTCGAGGACGCCTACCCACGCTATGCAGGACTTAGAGGACACTCCGATTATCACCATCGACG 65 FBan0012688 FBgn0029707 CG12688 X X CG12688 CG12688 CDMC21141 4 6 11 DAC17-L12 3-CG12688-RA_1 CG12688 CCCTTCGAGGACGCCTACCCACGCTATGCAGGACTTAGAGGACACTCCGATTATCACCATCGACG 65 FBan0012688 FBgn0029707 CG12688 X X CG12688 CG12688 CDMC21142 4 7 11 DAC17-L24 20-CG12724-RA_1 CG12724 CTACCGCAACTCCTACCGCTTCCGGCTCGGCCACGCCCACGCCCTCGCCAACATCACCCAATCCG 65 FBan0012724 FBgn0030470 CG12724 X X CG12724 CG12724 CDMC21142 4 8 11 DAC17-L24 20-CG12724-RA_1 CG12724 CTACCGCAACTCCTACCGCTTCCGGCTCGGCCACGCCCACGCCCTCGCCAACATCACCCAATCCG 65 FBan0012724 FBgn0030470 CG12724 X X CG12724 CG12724 CDMC21143 4 9 11 DAC17-P12 2-CG12841-RA_1 CG12841 CTGTACTGGGATGCTGTGGAATCTGCATGGAGAACGTGTGCATGACCGCAACGTACGGCTTCTTG 65 FBan0012841 FBgn0033133 Tsp42Ek 2 2R ectoderm development; GO:0007398; nervous system development; GO:0007399; transmission of nerve impulse; GO:0019226 receptor signaling protein activity; GO:0005057; ; GO:0005057 integral to membrane; GO:0016021 Tsp42Ek Tetraspanin 42Ek "CG12841, CG12841, CG12841, Dm.Tsp42Ek, tetraspanin 42E, Tetraspanin 42Ek" CDMC21143 4 10 11 DAC17-P12 2-CG12841-RA_1 CG12841 CTGTACTGGGATGCTGTGGAATCTGCATGGAGAACGTGTGCATGACCGCAACGTACGGCTTCTTG 65 FBan0012841 FBgn0033133 Tsp42Ek 2 2R ectoderm development; GO:0007398; nervous system development; GO:0007399; transmission of nerve impulse; GO:0019226 receptor signaling protein activity; GO:0005057; ; GO:0005057 integral to membrane; GO:0016021 Tsp42Ek Tetraspanin 42Ek "CG12841, CG12841, CG12841, Dm.Tsp42Ek, tetraspanin 42E, Tetraspanin 42Ek" CDMC21144 4 11 11 DAC17-P24 AutoBlank AutoBlank CDMC21144 4 12 11 DAC17-P24 AutoBlank AutoBlank CDMC21145 4 13 11 DAC18-D12 3-CG6141-RB_1 CG6141 ACGGTCATTGAGATCCGTAACTTCTTGGGTGAGAAGTACATCCGTCGTGTGGAGATGGCTCCTGGCG 67 FBan0006141 FBgn0015756 RpL9 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL9 Ribosomal protein L9 "CG6141, M(2)32D, rpL9, L9, anon-WO0153538.25, anon-WO0153538.26, anon-WO0153538.27, anon-EST:fe3A6, anon-fast-evolving-3A6" CDMC21145 4 14 11 DAC18-D12 3-CG6141-RB_1 CG6141 ACGGTCATTGAGATCCGTAACTTCTTGGGTGAGAAGTACATCCGTCGTGTGGAGATGGCTCCTGGCG 67 FBan0006141 FBgn0015756 RpL9 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842; ribosome; GO:0005840 RpL9 Ribosomal protein L9 "CG6141, M(2)32D, rpL9, L9, anon-WO0153538.25, anon-WO0153538.26, anon-WO0153538.27, anon-EST:fe3A6, anon-fast-evolving-3A6" CDMC21146 4 15 11 DAC18-D24 2-CG6349-RA_2 CG6349 GGCCTGGATATAGTACGTCGCGATTGGTCTCAGCTGGCTGTAATGGTGGGAAAAGCCGTTCTCGATG 67 FBan0006349 FBgn0004493 DNApol-alpha180 3 3R DNA recombination; GO:0006310; DNA strand elongation; GO:0006271 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; alpha DNA polymerase activity; GO:0003889; ; GO:0003889; 3'-5'-exodeoxyribonuclease activity; GO:0008296; ; GO:0008296; nucleotide binding; GO:0000166; ; GO:0003889; ; GO:0003889; ; GO:0003677; ; GO:0000166 alpha DNA polymerase:primase complex; GO:0005658; nucleus; GO:0005634 DNApol-alpha180 DNA polymerase alpha 180kD "CG6349, CG6349, pol alpha, DNApol-alpha, 183 kDa pol alpha, DNA polymerase alpha, DNApolalpha, DNApola, POLA, DNA-polymerase alpha, Polalpha, polalpha, DNA polymerase-primase 180 kda subunit, DmPolalpha, polalphap180, AAB24152, DNA polymerase 180K, DNA polalpha, DNApol-alpha180" CDMC21146 4 16 11 DAC18-D24 2-CG6349-RA_2 CG6349 GGCCTGGATATAGTACGTCGCGATTGGTCTCAGCTGGCTGTAATGGTGGGAAAAGCCGTTCTCGATG 67 FBan0006349 FBgn0004493 DNApol-alpha180 3 3R DNA recombination; GO:0006310; DNA strand elongation; GO:0006271 DNA binding; GO:0003677; nucleic acid binding; GO:0003676; ; GO:0003676; alpha DNA polymerase activity; GO:0003889; ; GO:0003889; 3'-5'-exodeoxyribonuclease activity; GO:0008296; ; GO:0008296; nucleotide binding; GO:0000166; ; GO:0003889; ; GO:0003889; ; GO:0003677; ; GO:0000166 alpha DNA polymerase:primase complex; GO:0005658; nucleus; GO:0005634 DNApol-alpha180 DNA polymerase alpha 180kD "CG6349, CG6349, pol alpha, DNApol-alpha, 183 kDa pol alpha, DNA polymerase alpha, DNApolalpha, DNApola, POLA, DNA-polymerase alpha, Polalpha, polalpha, DNA polymerase-primase 180 kda subunit, DmPolalpha, polalphap180, AAB24152, DNA polymerase 180K, DNA polalpha, DNApol-alpha180" CDMC21147 4 17 11 DAC18-H12 3-CG6761-RA_3 CG6761 GGAGCTCAAGTCTTGGCGCAAGGTGTACTGGAAGTTATGGGGTCACTGCCATTACCTGTACTGCTGC 67 FBan0006761 FBgn0036031 CG6761 3 3L CG6761 CG6761 CDMC21147 4 18 11 DAC18-H12 3-CG6761-RA_3 CG6761 GGAGCTCAAGTCTTGGCGCAAGGTGTACTGGAAGTTATGGGGTCACTGCCATTACCTGTACTGCTGC 67 FBan0006761 FBgn0036031 CG6761 3 3L CG6761 CG6761 CDMC21148 4 19 11 DAC18-H24 1-CG7009-RA_1 CG7009 CGCTCCCGATTCTACTGGAATGCACGACTTTGACTCGTACGTTCAGGGCGAACTACTTCTCTCCGCC 67 FBan0007009 FBgn0038861 CG7009 3 3R rRNA modification; GO:0000154 nucleic acid binding; GO:0003676; ; GO:0003676; rRNA (uridine-2'-O-)-methyltransferase activity; GO:0008650 ; EC:2.1.1.-; ; GO:0008650 ; EC:2.1.1.- CG7009 CG7009 CDMC21148 4 20 11 DAC18-H24 1-CG7009-RA_1 CG7009 CGCTCCCGATTCTACTGGAATGCACGACTTTGACTCGTACGTTCAGGGCGAACTACTTCTCTCCGCC 67 FBan0007009 FBgn0038861 CG7009 3 3R rRNA modification; GO:0000154 nucleic acid binding; GO:0003676; ; GO:0003676; rRNA (uridine-2'-O-)-methyltransferase activity; GO:0008650 ; EC:2.1.1.-; ; GO:0008650 ; EC:2.1.1.- CG7009 CG7009 CDMC21149 4 21 11 DAC18-L12 1-CG7562-RA_1 CG7562 CACGGGCAGTTTAGTTCCTACGAACCGGAGATGTTTCCAGGCCTAATCTATCGCATGGTCAAGCCGC 67 FBan0007562 FBgn0010287 Trf 2 2L positive regulation of transcription from RNA polymerase II promoter; GO:0045944; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription from RNA polymerase III promoter; GO:0006359; transcription initiation from RNA polymerase II promoter; GO:0006367; transcription initiation from RNA polymerase III promoter; GO:0006384 DNA binding; GO:0003677; ; GO:0003677; transcription factor binding; GO:0008134; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251; RNA polymerase III transcription factor activity; GO:0003709; ; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0016251; ; GO:0016251; ; GO:0003709; ; GO:0003704; ; GO:0008134; ; GO:0003709; ; GO:0008134 NOT transcription factor TFIID complex; GO:0005669; polytene chromosome; GO:0005700; transcription factor TFIID complex; GO:0005669; transcription factor complex; GO:0005667 Trf TBP-related factor "CG7562, CG7562, trf, TRF, TRF1, Trf1, dTRF1, X70838" CDMC21149 4 22 11 DAC18-L12 1-CG7562-RA_1 CG7562 CACGGGCAGTTTAGTTCCTACGAACCGGAGATGTTTCCAGGCCTAATCTATCGCATGGTCAAGCCGC 67 FBan0007562 FBgn0010287 Trf 2 2L positive regulation of transcription from RNA polymerase II promoter; GO:0045944; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription from RNA polymerase III promoter; GO:0006359; transcription initiation from RNA polymerase II promoter; GO:0006367; transcription initiation from RNA polymerase III promoter; GO:0006384 DNA binding; GO:0003677; ; GO:0003677; transcription factor binding; GO:0008134; ; GO:0003677; RNA polymerase II transcription factor activity; GO:0003702; general RNA polymerase II transcription factor activity; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251; ; GO:0016251; RNA polymerase III transcription factor activity; GO:0003709; ; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0016251; ; GO:0016251; ; GO:0003709; ; GO:0003704; ; GO:0008134; ; GO:0003709; ; GO:0008134 NOT transcription factor TFIID complex; GO:0005669; polytene chromosome; GO:0005700; transcription factor TFIID complex; GO:0005669; transcription factor complex; GO:0005667 Trf TBP-related factor "CG7562, CG7562, trf, TRF, TRF1, Trf1, dTRF1, X70838" CDMC21150 4 23 11 DAC18-L24 1-CG7747-RA_1 CG7747 ACCTGGAGCTCTTCTGCGATCAAACTCCTCGAGCCTGCGATAACTTCATCAAGCATTGCGCCAATGG 67 FBan0007747 FBgn0034109 CG7747 2 2R defense response; GO:0006952; protein folding; GO:0006457; protein targeting; GO:0006605 peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8 CG7747 CG7747 CDMC21150 4 24 11 DAC18-L24 1-CG7747-RA_1 CG7747 ACCTGGAGCTCTTCTGCGATCAAACTCCTCGAGCCTGCGATAACTTCATCAAGCATTGCGCCAATGG 67 FBan0007747 FBgn0034109 CG7747 2 2R defense response; GO:0006952; protein folding; GO:0006457; protein targeting; GO:0006605 peptidyl-prolyl cis-trans isomerase activity; GO:0003755 ; EC:5.2.1.8; ; GO:0003755 ; EC:5.2.1.8 CG7747 CG7747 CDMC21151 4 25 11 DAC18-P12 2-CG8100-RA_1 CG8100 TCCTGACGGCACAGGAAGTGACTTGGAACCAATTGAGCCCCATTAGGTTGGTGACACCGAAACGAAG 67 FBan0008100 FBgn0036410 CG8100 3 3L extracellular region; GO:0005576; larval serum protein complex; GO:0005616 CG8100 CG8100 CDMC21151 4 26 11 DAC18-P12 2-CG8100-RA_1 CG8100 TCCTGACGGCACAGGAAGTGACTTGGAACCAATTGAGCCCCATTAGGTTGGTGACACCGAAACGAAG 67 FBan0008100 FBgn0036410 CG8100 3 3L extracellular region; GO:0005576; larval serum protein complex; GO:0005616 CG8100 CG8100 CDMC21152 4 1 12 DAC18-P24 AutoBlank AutoBlank CDMC21152 4 2 12 DAC18-P24 AutoBlank AutoBlank CDMC21153 4 3 12 DAC19-D12 2-CG8194-RA_4 CG8194 TGCAAGACTCGTCGAGGGAGATGTCTGTGCAGGATCACAACTGGGATGTGCTGATTTTCACGCAACAA 68 FBan0008194 FBgn0010406 RNaseX25 3 3L RNA catabolism; GO:0006401 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729; endoribonuclease activity; GO:0004521; ribonuclease activity; GO:0004540; ; GO:0004521; ; GO:0004540 RNaseX25 Ribonuclease X25 "CG8194, CG8194, acid RNase, DmRNase-66B, DmRNase-X25" CDMC21153 4 4 12 DAC19-D12 2-CG8194-RA_4 CG8194 TGCAAGACTCGTCGAGGGAGATGTCTGTGCAGGATCACAACTGGGATGTGCTGATTTTCACGCAACAA 68 FBan0008194 FBgn0010406 RNaseX25 3 3L RNA catabolism; GO:0006401 mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; ; GO:0003729; endoribonuclease activity; GO:0004521; ribonuclease activity; GO:0004540; ; GO:0004521; ; GO:0004540 RNaseX25 Ribonuclease X25 "CG8194, CG8194, acid RNase, DmRNase-66B, DmRNase-X25" CDMC21154 4 5 12 DAC19-D24 2-CG8427-RA_1 CG8427 ACAGACAGCAACACACCAAGCTAGCGAACATGTCTATCGGAGTGCCCATTAAAGTTCTGCACGAGGCC 68 FBan0008427 FBgn0023167 SmD3 2 2R "central nervous system development; GO:0007417; lymph gland development (sensu Arthropoda); GO:0048542; muscle development; GO:0007517; neuron differentiation; GO:0030182; nuclear mRNA splicing, via spliceosome; GO:0000398; peripheral nervous system development; GO:0007422" nucleus; GO:0005634; small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732; spliceosome complex; GO:0005681 SmD3 Small ribonucleoprotein Sm D3 "CG8427, CG8427, l(2)90/37, guf: gut feeling, gut feeling, gutfeeling, l(2)131/7, l(2)154/1, guf2, snRNP Sm D3, Sm D3, guf" CDMC21154 4 6 12 DAC19-D24 2-CG8427-RA_1 CG8427 ACAGACAGCAACACACCAAGCTAGCGAACATGTCTATCGGAGTGCCCATTAAAGTTCTGCACGAGGCC 68 FBan0008427 FBgn0023167 SmD3 2 2R "central nervous system development; GO:0007417; lymph gland development (sensu Arthropoda); GO:0048542; muscle development; GO:0007517; neuron differentiation; GO:0030182; nuclear mRNA splicing, via spliceosome; GO:0000398; peripheral nervous system development; GO:0007422" nucleus; GO:0005634; small nuclear ribonucleoprotein complex; GO:0030532; small nucleolar ribonucleoprotein complex; GO:0005732; spliceosome complex; GO:0005681 SmD3 Small ribonucleoprotein Sm D3 "CG8427, CG8427, l(2)90/37, guf: gut feeling, gut feeling, gutfeeling, l(2)131/7, l(2)154/1, guf2, snRNP Sm D3, Sm D3, guf" CDMC21155 4 7 12 DAC19-H12 3-CG8931-RA_2 CG8931 CGGTCTATTCGATGTATTCCGGGAGGGAAGTCTGCGCTTGTTTTATTGGAGCTCTCCGCAAAAGGGCC 68 FBan0008931 FBgn0030717 CG8931 X X transport; GO:0006810 binding; GO:0005488; ; GO:0005488 membrane; GO:0016020 CG8931 CG8931 CDMC21155 4 8 12 DAC19-H12 3-CG8931-RA_2 CG8931 CGGTCTATTCGATGTATTCCGGGAGGGAAGTCTGCGCTTGTTTTATTGGAGCTCTCCGCAAAAGGGCC 68 FBan0008931 FBgn0030717 CG8931 X X transport; GO:0006810 binding; GO:0005488; ; GO:0005488 membrane; GO:0016020 CG8931 CG8931 CDMC21156 4 9 12 DAC19-H24 15-CG9022-RA_1 CG9022 CGCCTTCTCAATGATGATCGGCGTGTTTGTCTTCTCATTCGTGTTCCTTCACTTCAAGGATGAGCCCG 68 FBan0009022 FBgn0014868 Ost48 X X protein amino acid N-linked glycosylation; GO:0006487; protein amino acid N-linked glycosylation via asparagine; GO:0018279 dolichyl-diphosphooligosaccharide-protein glycotransferase activity; GO:0004579 ; EC:2.4.1.119; ; GO:0004579 ; EC:2.4.1.119 endoplasmic reticulum membrane; GO:0005789 Ost48 Oligosaccharyltransferase 48kD subunit "CG9022, CG9022, DmOST50, OST48, clone 1.11, DrOST, OST48/WBP1, anon-EST:Liang-1.11" CDMC21156 4 10 12 DAC19-H24 15-CG9022-RA_1 CG9022 CGCCTTCTCAATGATGATCGGCGTGTTTGTCTTCTCATTCGTGTTCCTTCACTTCAAGGATGAGCCCG 68 FBan0009022 FBgn0014868 Ost48 X X protein amino acid N-linked glycosylation; GO:0006487; protein amino acid N-linked glycosylation via asparagine; GO:0018279 dolichyl-diphosphooligosaccharide-protein glycotransferase activity; GO:0004579 ; EC:2.4.1.119; ; GO:0004579 ; EC:2.4.1.119 endoplasmic reticulum membrane; GO:0005789 Ost48 Oligosaccharyltransferase 48kD subunit "CG9022, CG9022, DmOST50, OST48, clone 1.11, DrOST, OST48/WBP1, anon-EST:Liang-1.11" CDMC21157 4 11 12 DAC19-L12 3-CG9460-RA_3 CG9460 AATCAAGGACCTCATTGCTCCGGAATCTCTGGACGCAGATACTTCGGCCATCCTGGTCAATGCCATCT 68 FBan0009460 FBgn0033115 CG9460 2 2R defense response; GO:0006952; proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG9460 CG9460 CDMC21157 4 12 12 DAC19-L12 3-CG9460-RA_3 CG9460 AATCAAGGACCTCATTGCTCCGGAATCTCTGGACGCAGATACTTCGGCCATCCTGGTCAATGCCATCT 68 FBan0009460 FBgn0033115 CG9460 2 2R defense response; GO:0006952; proteolysis; GO:0006508 serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867 CG9460 CG9460 CDMC21158 4 13 12 DAC19-L24 2-CG9626-RA_1 CG9626 GCAAATGCGAGCAACAAGATTGAGCACAAGATAGCCAAGACTAGCTCAGGACCCAGTTTCTCCCGGGT 68 FBan0009626 FBgn0037565 CG9626 3 3R CG9626 CG9626 CDMC21158 4 14 12 DAC19-L24 2-CG9626-RA_1 CG9626 GCAAATGCGAGCAACAAGATTGAGCACAAGATAGCCAAGACTAGCTCAGGACCCAGTTTCTCCCGGGT 68 FBan0009626 FBgn0037565 CG9626 3 3R CG9626 CG9626 CDMC21159 4 15 12 DAC19-P12 23-CR31850-RA_1 CR31850 TTATGGCTAAGATCAAAGTGTAGTATCTGTTCTTATCAGCTTAACATCTGATAGTTCCTCCATTGGAG 68 FBan0031850 FBgn0004191 snRNA:U2:34ABa 2 2L nuclear mRNA splicing via U2-type spliceosome; GO:0006374 snRNP U2; GO:0005686 snRNA:U2:34ABa small nuclear RNA U2 at 34ABa "dU2, K6, Dm U2-131A, U2, U2 131A, 131A, D.U2-1, U2-131A, U2 snRNA, U2-34ABa, snRNA:U2, U2snRNA, CR31850, U2snRNA34ABa, snRNA-U2-131A, small nuclear RNA U2" CDMC21159 4 16 12 DAC19-P12 23-CR31850-RA_1 CR31850 TTATGGCTAAGATCAAAGTGTAGTATCTGTTCTTATCAGCTTAACATCTGATAGTTCCTCCATTGGAG 68 FBan0031850 FBgn0004191 snRNA:U2:34ABa 2 2L nuclear mRNA splicing via U2-type spliceosome; GO:0006374 snRNP U2; GO:0005686 snRNA:U2:34ABa small nuclear RNA U2 at 34ABa "dU2, K6, Dm U2-131A, U2, U2 131A, 131A, D.U2-1, U2-131A, U2 snRNA, U2-34ABa, snRNA:U2, U2snRNA, CR31850, U2snRNA34ABa, snRNA-U2-131A, small nuclear RNA U2" CDMC21160 4 17 12 DAC19-P24 AutoBlank AutoBlank CDMC21160 4 18 12 DAC19-P24 AutoBlank AutoBlank CDMC21161 4 19 12 DAC20-D12 3-CG18088-RA_1 CG18088 GGTGCACCTGCGAACCCTACAAGATTATCTCGGGACAAGATTGGACGACTCCTATTGCCCACAGTGTGA 69 FBan0018088 FBgn0032082 CG18088 2 2L CG18088 CG18088 CDMC21161 4 20 12 DAC20-D12 3-CG18088-RA_1 CG18088 GGTGCACCTGCGAACCCTACAAGATTATCTCGGGACAAGATTGGACGACTCCTATTGCCCACAGTGTGA 69 FBan0018088 FBgn0032082 CG18088 2 2L CG18088 CG18088 CDMC21162 4 21 12 DAC20-D24 13-CG18103-RA_2 CG18103 AGGCTGAAAAGTGTGTTCGGTTTGCATCCCAGGAGAAAACAATCGCTCACTCATTTATCCCACTTGCCA 69 FBan0018103 FBgn0013442 fos28F 2 2L fos28F fos-related gene at 28F "CG18103, CG31608, fos500, OrfKD" CDMC21162 4 22 12 DAC20-D24 13-CG18103-RA_2 CG18103 AGGCTGAAAAGTGTGTTCGGTTTGCATCCCAGGAGAAAACAATCGCTCACTCATTTATCCCACTTGCCA 69 FBan0018103 FBgn0013442 fos28F 2 2L fos28F fos-related gene at 28F "CG18103, CG31608, fos500, OrfKD" CDMC21163 4 23 12 DAC20-H12 15-CG1815-RA_1 CG1815 AGCAGCATCAGAAGCAAGTACCAAAAGCTACTGGTCGCTCAGGTAAAAACAATAGCCGAATGCGCCAAA 69 FBan0001815 FBgn0039863 CG1815 3 3R "protein ubiquitination; GO:0016567; regulation of transcription, DNA-dependent; GO:0006355; signal transduction; GO:0007165" DNA binding; GO:0003677; protein kinase C binding; GO:0005080; receptor binding; GO:0005102; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0005102; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0005080; ; GO:0008270; ; GO:0003677 ubiquitin ligase complex; GO:0000151 CG1815 CG1815 CDMC21163 4 24 12 DAC20-H12 15-CG1815-RA_1 CG1815 AGCAGCATCAGAAGCAAGTACCAAAAGCTACTGGTCGCTCAGGTAAAAACAATAGCCGAATGCGCCAAA 69 FBan0001815 FBgn0039863 CG1815 3 3R "protein ubiquitination; GO:0016567; regulation of transcription, DNA-dependent; GO:0006355; signal transduction; GO:0007165" DNA binding; GO:0003677; protein kinase C binding; GO:0005080; receptor binding; GO:0005102; ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; ; GO:0005102; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0005080; ; GO:0008270; ; GO:0003677 ubiquitin ligase complex; GO:0000151 CG1815 CG1815 CDMC21164 4 25 12 DAC20-H24 17-CG1817-RA_1 CG1817 AGGAGCTGTATATGCACGATGAGTTCGAGACCCACATCGATACCAAGTCGAATAATGCCAACGATGACA 69 FBan0001817 FBgn0004370 Ptp10D X X protein amino acid dephosphorylation; GO:0006470 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; transmembrane receptor protein tyrosine phosphatase activity; GO:0005001; receptor signaling protein tyrosine phosphatase activity; GO:0004728; ; GO:0005001; ; GO:0004725 ; EC:3.1.3.48; ; GO:0005001; hematopoietin/interferon-class (D200-domain) cytokine receptor activity; GO:0004896; phosphoprotein phosphatase activity; GO:0004721 ; EC:3.1.3.16; ; GO:0004721 ; EC:3.1.3.16; ; GO:0004725 ; EC:3.1.3.48; ; GO:0004896; ; GO:0005001; ; GO:0004728 plasma membrane; GO:0005886 Ptp10D Protein tyrosine phosphatase 10D "CG1817, CG1817, CG1817, CG1817, CG1817, DPTP[[10D]], DPTP10D, PTP10D, DPTP, R-PTP 10D, CT4920, Ptp10" CDMC21164 4 26 12 DAC20-H24 17-CG1817-RA_1 CG1817 AGGAGCTGTATATGCACGATGAGTTCGAGACCCACATCGATACCAAGTCGAATAATGCCAACGATGACA 69 FBan0001817 FBgn0004370 Ptp10D X X protein amino acid dephosphorylation; GO:0006470 protein tyrosine phosphatase activity; GO:0004725 ; EC:3.1.3.48; ; GO:0004725 ; EC:3.1.3.48; transmembrane receptor protein tyrosine phosphatase activity; GO:0005001; receptor signaling protein tyrosine phosphatase activity; GO:0004728; ; GO:0005001; ; GO:0004725 ; EC:3.1.3.48; ; GO:0005001; hematopoietin/interferon-class (D200-domain) cytokine receptor activity; GO:0004896; phosphoprotein phosphatase activity; GO:0004721 ; EC:3.1.3.16; ; GO:0004721 ; EC:3.1.3.16; ; GO:0004725 ; EC:3.1.3.48; ; GO:0004896; ; GO:0005001; ; GO:0004728 plasma membrane; GO:0005886 Ptp10D Protein tyrosine phosphatase 10D "CG1817, CG1817, CG1817, CG1817, CG1817, DPTP[[10D]], DPTP10D, PTP10D, DPTP, R-PTP 10D, CT4920, Ptp10" CDMC21165 4 1 13 DAC20-L12 2-CG18233-RA_1 CG18233 ATTCAACGCCAGATCCACGATCCCTGCACTCTGTGTGTCCAGTTTTAGTGGGTTCACGATGGAGTGAGT 69 FBan0018233 FBgn0036795 CG18233 3 3L protein metabolism; GO:0019538; protein modification; GO:0006464 "oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; GO:0016706 ; EC:1.14.11.-; ; GO:0016706 ; EC:1.14.11.-" CG18233 CG18233 CDMC21165 4 2 13 DAC20-L12 2-CG18233-RA_1 CG18233 ATTCAACGCCAGATCCACGATCCCTGCACTCTGTGTGTCCAGTTTTAGTGGGTTCACGATGGAGTGAGT 69 FBan0018233 FBgn0036795 CG18233 3 3L protein metabolism; GO:0019538; protein modification; GO:0006464 "oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors; GO:0016706 ; EC:1.14.11.-; ; GO:0016706 ; EC:1.14.11.-" CG18233 CG18233 CDMC21166 4 3 13 DAC20-L24 14-CG18251-RA_1 CG18251 CCCAGGAACGGTGGCTACGGTACAACTGTCAACTGCCGTCATTACTCTAATCAATGAAACATGACCCGT 69 FBgn0010070 CDMC21166 4 4 13 DAC20-L24 14-CG18251-RA_1 CG18251 CCCAGGAACGGTGGCTACGGTACAACTGTCAACTGCCGTCATTACTCTAATCAATGAAACATGACCCGT 69 FBgn0010070 CDMC21167 4 5 13 DAC20-P12 2-CG18287-RA_3 CG18287 GCCGAGACCAGGACTACTGCGCTTCAGGAACAATCCGCGTGGTATTAAGTTTCGGGAAAAACTGTGCAA 69 FBan0018287 FBgn0039679 ppk19 3 3R sensory perception of salty taste; GO:0050914; sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; ; GO:0005272 membrane; GO:0016020 ppk19 pickpocket 19 "CG18287, PPK19" CDMC21167 4 6 13 DAC20-P12 2-CG18287-RA_3 CG18287 GCCGAGACCAGGACTACTGCGCTTCAGGAACAATCCGCGTGGTATTAAGTTTCGGGAAAAACTGTGCAA 69 FBan0018287 FBgn0039679 ppk19 3 3R sensory perception of salty taste; GO:0050914; sodium ion transport; GO:0006814 sodium channel activity; GO:0005272; ; GO:0005272 membrane; GO:0016020 ppk19 pickpocket 19 "CG18287, PPK19" CDMC21168 4 7 13 DAC20-P24 AutoBlank AutoBlank CDMC21168 4 8 13 DAC20-P24 AutoBlank AutoBlank CDMC21169 4 9 13 DAC21-D12 1-CG3927-RA_3 CG3927 GGAAACCCCAAGCGAGTTAACTGAGAAACAGAACCAAGACCAACCTACCTACCAGCCGCGACTGAACGA 69 FBan0003927 FBgn0034739 CG3927 2 2R "apoptosis; GO:0006915; cell proliferation; GO:0008283; development; GO:0007275; gametogenesis; GO:0007276; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; spermatogenesis; GO:0007283" mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ; GO:0003729 CG3927 CG3927 "cg3927, BcDNA:AT29209" CDMC21169 4 10 13 DAC21-D12 1-CG3927-RA_3 CG3927 GGAAACCCCAAGCGAGTTAACTGAGAAACAGAACCAAGACCAACCTACCTACCAGCCGCGACTGAACGA 69 FBan0003927 FBgn0034739 CG3927 2 2R "apoptosis; GO:0006915; cell proliferation; GO:0008283; development; GO:0007275; gametogenesis; GO:0007276; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; spermatogenesis; GO:0007283" mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; ; GO:0003676; ; GO:0003729 CG3927 CG3927 "cg3927, BcDNA:AT29209" CDMC21170 4 11 13 DAC21-D24 22-CG3938-RB_1 CG3938 ACACTATCCAGAATTCAGTGGTGTGACGCTCTCACAAACCAAGTTGGGTGCCTCAAAAATGAAACAACA 69 FBan0003938 FBgn0010382 CycE 2 2L G1/S transition of mitotic cell cycle; GO:0000082; JAK-STAT cascade; GO:0007259; cell adhesion; GO:0007155; cell cycle; GO:0007049; cellular physiological process; GO:0050875; chorion gene amplification; GO:0007307; mitosis; GO:0007067; oogenesis (sensu Insecta); GO:0009993; peripheral nervous system development; GO:0007422; regulation of cell shape; GO:0008360; regulation of progression through cell cycle; GO:0000074; regulation of protein amino acid phosphorylation; GO:0001932; sensory organ development; GO:0007423 kinase activator activity; GO:0019209; cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0019209; ; GO:0016538 ; EC:2.7.1.- nuclear cyclin-dependent protein kinase holoenzyme complex; GO:0019908 CycE Cyclin E "CG3938, l(2)br37, br37, CDI7, cycE, DmcycE, l35Dd, l(2)35Dd, fond, DmcyclinE, cyclinE, DmCycE, cyclin E, l(2)k02602, l(2)k05007, BG:DS07108.3, CyeE, fondue, D-CycE, Cyc E, cycline E, Cdi7, cdi7, l(2)05206, l(2)k02514, Cyclin-dependent kinase interactor 7, Cyclin E" CDMC21170 4 12 13 DAC21-D24 22-CG3938-RB_1 CG3938 ACACTATCCAGAATTCAGTGGTGTGACGCTCTCACAAACCAAGTTGGGTGCCTCAAAAATGAAACAACA 69 FBan0003938 FBgn0010382 CycE 2 2L G1/S transition of mitotic cell cycle; GO:0000082; JAK-STAT cascade; GO:0007259; cell adhesion; GO:0007155; cell cycle; GO:0007049; cellular physiological process; GO:0050875; chorion gene amplification; GO:0007307; mitosis; GO:0007067; oogenesis (sensu Insecta); GO:0009993; peripheral nervous system development; GO:0007422; regulation of cell shape; GO:0008360; regulation of progression through cell cycle; GO:0000074; regulation of protein amino acid phosphorylation; GO:0001932; sensory organ development; GO:0007423 kinase activator activity; GO:0019209; cyclin-dependent protein kinase regulator activity; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0016538 ; EC:2.7.1.-; ; GO:0019209; ; GO:0016538 ; EC:2.7.1.- nuclear cyclin-dependent protein kinase holoenzyme complex; GO:0019908 CycE Cyclin E "CG3938, l(2)br37, br37, CDI7, cycE, DmcycE, l35Dd, l(2)35Dd, fond, DmcyclinE, cyclinE, DmCycE, cyclin E, l(2)k02602, l(2)k05007, BG:DS07108.3, CyeE, fondue, D-CycE, Cyc E, cycline E, Cdi7, cdi7, l(2)05206, l(2)k02514, Cyclin-dependent kinase interactor 7, Cyclin E" CDMC21171 4 13 13 DAC21-H12 22-CG3973-RA_1 CG3973 TCAGAAGACAGGATCCCGGAGAATCAGAAAATGGAATGGGAAAGACGAAGATCGGCCATTGAAAACGAT 69 FBan0003973 FBgn0029881 CG3973 X X CG3973 CG3973 CDMC21171 4 14 13 DAC21-H12 22-CG3973-RA_1 CG3973 TCAGAAGACAGGATCCCGGAGAATCAGAAAATGGAATGGGAAAGACGAAGATCGGCCATTGAAAACGAT 69 FBan0003973 FBgn0029881 CG3973 X X CG3973 CG3973 CDMC21172 4 15 13 DAC21-H24 6-CG3984-RA_6 CG3984 TGCGGAGGTCAAACGGGGATTCAATGCAATCCTTCCAATCCTGTGACTACTGTTGTTCCTGGTACCCCC 69 FBan0003984 FBgn0038291 CG3984 3 3R CG3984 CG3984 CDMC21172 4 16 13 DAC21-H24 6-CG3984-RA_6 CG3984 TGCGGAGGTCAAACGGGGATTCAATGCAATCCTTCCAATCCTGTGACTACTGTTGTTCCTGGTACCCCC 69 FBan0003984 FBgn0038291 CG3984 3 3R CG3984 CG3984 CDMC21173 4 17 13 DAC21-L12 8-CG40057-RA_3 CG40057 GGGCCGACTGAAAGAGTCCCAGAGATACAACATAGAACCATCGTGCCAGAAAGCCCGATTAACGTACGC 69 FBgn0058057 CG40057 CG40057 CG40057 CDMC21173 4 18 13 DAC21-L12 8-CG40057-RA_3 CG40057 GGGCCGACTGAAAGAGTCCCAGAGATACAACATAGAACCATCGTGCCAGAAAGCCCGATTAACGTACGC 69 FBgn0058057 CG40057 CG40057 CG40057 CDMC21174 4 19 13 DAC21-L24 23-CG40081-RA_7 CG40081 GCAAGTTCAGAGGTGAAAATATACTCATACCACGAATTCCTGTTATACCTAGAGATGTGCCAATTCAAT 69 FBgn0058081 CG40081 CG40081 CG40081 CDMC21174 4 20 13 DAC21-L24 23-CG40081-RA_7 CG40081 GCAAGTTCAGAGGTGAAAATATACTCATACCACGAATTCCTGTTATACCTAGAGATGTGCCAATTCAAT 69 FBgn0058081 CG40081 CG40081 CG40081 CDMC21175 4 21 13 DAC21-P12 11-CG40128-RA_1 CG40128 CCCGCGACAAGAAAATCCTCAAGCCCGCAGGTTACGACTTTTTCGACACGCACTTTTCACAACTAGACT 69 FBgn0058128 CG40128 CG40128 CG40128 CDMC21175 4 22 13 DAC21-P12 11-CG40128-RA_1 CG40128 CCCGCGACAAGAAAATCCTCAAGCCCGCAGGTTACGACTTTTTCGACACGCACTTTTCACAACTAGACT 69 FBgn0058128 CG40128 CG40128 CG40128 CDMC21176 4 23 13 DAC21-P24 2-CG40143-RA_1 CG40143 GGCACCCAGTACCTCACACCCCAGGAATCGAAACTCAAAACAGAAGCCGAAATGGAAACTGCACGAGAT 69 FBgn0058143 CG40143 CG40143 CG40143 CDMC21176 4 24 13 DAC21-P24 2-CG40143-RA_1 CG40143 GGCACCCAGTACCTCACACCCCAGGAATCGAAACTCAAAACAGAAGCCGAAATGGAAACTGCACGAGAT 69 FBgn0058143 CG40143 CG40143 CG40143 CDMC21177 4 25 13 DAC22-D12 2-CG13802-RA_1 CG13802 ATGCTGCTGTTTCCACTAACGACATCAGCCTGGTCGAGAAGCTACATTTGCAGCCCAGTCCAAGG 65 FBan0013802 FBgn0035330 CG13802 3 3L CG13802 CG13802 CDMC21177 4 26 13 DAC22-D12 2-CG13802-RA_1 CG13802 ATGCTGCTGTTTCCACTAACGACATCAGCCTGGTCGAGAAGCTACATTTGCAGCCCAGTCCAAGG 65 FBan0013802 FBgn0035330 CG13802 3 3L CG13802 CG13802 CDMC21178 4 1 14 DAC22-D24 9-CG13811-RA_1 CG13811 CGGAGTACGCCTATCAGCACCTGAGCAGCGTTGCCACAACCAATTCGAGCACATCTTTGGAGAGC 65 FBan0013811 FBgn0036944 CG13811 3 3L CG13811 CG13811 CDMC21178 4 2 14 DAC22-D24 9-CG13811-RA_1 CG13811 CGGAGTACGCCTATCAGCACCTGAGCAGCGTTGCCACAACCAATTCGAGCACATCTTTGGAGAGC 65 FBan0013811 FBgn0036944 CG13811 3 3L CG13811 CG13811 CDMC21179 4 3 14 DAC22-H12 1-CG13905-RA_1 CG13905 AGAGCCATTAACTCCCTACCCGCCTATCGATTCTACCGCCAGTTGATCAACCAACCCGAAGTGCG 65 FBan0013905 FBgn0035176 CG13905 3 3L CG13905 CG13905 CDMC21179 4 4 14 DAC22-H12 1-CG13905-RA_1 CG13905 AGAGCCATTAACTCCCTACCCGCCTATCGATTCTACCGCCAGTTGATCAACCAACCCGAAGTGCG 65 FBan0013905 FBgn0035176 CG13905 3 3L CG13905 CG13905 CDMC21180 4 5 14 DAC22-H24 3-CG13928-RA_1 CG13928 CCAGTCAATCCAGGCACCGAGGTTCTCCCTTCATCTTCATTTTCCAACTCACTTCCGGGGTGTGG 65 FBan0013928 FBgn0035246 CG13928 3 3L CG13928 CG13928 CDMC21180 4 6 14 DAC22-H24 3-CG13928-RA_1 CG13928 CCAGTCAATCCAGGCACCGAGGTTCTCCCTTCATCTTCATTTTCCAACTCACTTCCGGGGTGTGG 65 FBan0013928 FBgn0035246 CG13928 3 3L CG13928 CG13928 CDMC21181 4 7 14 DAC22-L12 16-CG13988-RA_1 CG13988 CAGTGAAGCGACCTTCTCCAGCAACATCAGCATGTTCTCCCGCCAGTGCCTTTCCCACCTCACCC 65 FBan0013988 FBgn0040951 CG13988 2 2L CG13988 CG13988 CDMC21181 4 8 14 DAC22-L12 16-CG13988-RA_1 CG13988 CAGTGAAGCGACCTTCTCCAGCAACATCAGCATGTTCTCCCGCCAGTGCCTTTCCCACCTCACCC 65 FBan0013988 FBgn0040951 CG13988 2 2L CG13988 CG13988 CDMC21182 4 9 14 DAC22-L24 1-CG14004-RA_1 CG14004 AGACGGTAAGGGCATGGCAACAGGAATCGGATGTGGAGCACCGAAAACAACATAAGCAGCGATGG 65 FBan0014004 FBgn0031742 CG14004 2 2L CG14004 CG14004 CDMC21182 4 10 14 DAC22-L24 1-CG14004-RA_1 CG14004 AGACGGTAAGGGCATGGCAACAGGAATCGGATGTGGAGCACCGAAAACAACATAAGCAGCGATGG 65 FBan0014004 FBgn0031742 CG14004 2 2L CG14004 CG14004 CDMC21183 4 11 14 DAC22-P12 3-CG14100-RA_3 CG14100 CTGGAGTTTGTGCGTCTCACTCTGCAGGATCCACTTACCAGCACCCTACTAACCACAGTGCGCTC 65 FBan0014100 FBgn0036889 CG14100 3 3L "RNA processing; GO:0006396; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; transferase activity; GO:0016740 ; EC:2.-.-.-; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; ; GO:0003729; RNA methyltransferase activity; GO:0008173 ; EC:2.1.1.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008168 ; EC:2.1.1.-; ; GO:0008173 ; EC:2.1.1.- CG14100 CG14100 CDMC21183 4 12 14 DAC22-P12 3-CG14100-RA_3 CG14100 CTGGAGTTTGTGCGTCTCACTCTGCAGGATCCACTTACCAGCACCCTACTAACCACAGTGCGCTC 65 FBan0014100 FBgn0036889 CG14100 3 3L "RNA processing; GO:0006396; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139" mRNA binding; GO:0003729; nucleic acid binding; GO:0003676; ; GO:0003676; transferase activity; GO:0016740 ; EC:2.-.-.-; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; ; GO:0003729; RNA methyltransferase activity; GO:0008173 ; EC:2.1.1.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008168 ; EC:2.1.1.-; ; GO:0008173 ; EC:2.1.1.- CG14100 CG14100 CDMC21184 4 13 14 DAC22-P24 AutoBlank AutoBlank CDMC21184 4 14 14 DAC22-P24 AutoBlank AutoBlank CDMC21185 4 15 14 DAC23-D12 8-CG4747-RA_2 CG4747 GGCCGCTACATCGGTCAAGTCGACAAAGGGATCGGCAAAATCAGCACAGAAACGGCGTACCTCTG 65 FBan0004747 FBgn0043456 CG4747 2 2L pentose-phosphate shunt; GO:0006098 3-hydroxyisobutyrate dehydrogenase activity; GO:0008442 ; EC:1.1.1.31; phosphogluconate dehydrogenase (decarboxylating) activity; GO:0004616 ; EC:1.1.1.44; ; GO:0008442 ; EC:1.1.1.31; ; GO:0004616 ; EC:1.1.1.44 CG4747 CG4747 "LD29743, Dm_AI388468, BEST:LD22483, BEST:LD29743, BEST:GH19401" CDMC21185 4 16 14 DAC23-D12 8-CG4747-RA_2 CG4747 GGCCGCTACATCGGTCAAGTCGACAAAGGGATCGGCAAAATCAGCACAGAAACGGCGTACCTCTG 65 FBan0004747 FBgn0043456 CG4747 2 2L pentose-phosphate shunt; GO:0006098 3-hydroxyisobutyrate dehydrogenase activity; GO:0008442 ; EC:1.1.1.31; phosphogluconate dehydrogenase (decarboxylating) activity; GO:0004616 ; EC:1.1.1.44; ; GO:0008442 ; EC:1.1.1.31; ; GO:0004616 ; EC:1.1.1.44 CG4747 CG4747 "LD29743, Dm_AI388468, BEST:LD22483, BEST:LD29743, BEST:GH19401" CDMC21186 4 17 14 DAC23-D24 6-CG4824-RA_1 CG4824 CTCCAGTCAACCGACGGATGCAGCTAGCCAAGCACAAGGACATCCAGACTCTGCTCACCAGTTTG 65 FBan0004824 FBgn0000182 BicC 2 2L follicle cell migration (sensu Insecta); GO:0007297; negative regulation of oskar mRNA translation; GO:0007319; oogenesis (sensu Insecta); GO:0009993 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515 integral to plasma membrane; GO:0005887 BicC Bicaudal C "CG4824, l(2)br34, br34, Bic-C, BG:DS00913.2, Bicaudal-C" CDMC21186 4 18 14 DAC23-D24 6-CG4824-RA_1 CG4824 CTCCAGTCAACCGACGGATGCAGCTAGCCAAGCACAAGGACATCCAGACTCTGCTCACCAGTTTG 65 FBan0004824 FBgn0000182 BicC 2 2L follicle cell migration (sensu Insecta); GO:0007297; negative regulation of oskar mRNA translation; GO:0007319; oogenesis (sensu Insecta); GO:0009993 mRNA binding; GO:0003729; ; GO:0003729; ; GO:0003729; ; GO:0003729; protein binding; GO:0005515; ; GO:0005515 integral to plasma membrane; GO:0005887 BicC Bicaudal C "CG4824, l(2)br34, br34, Bic-C, BG:DS00913.2, Bicaudal-C" CDMC21187 4 19 14 DAC23-H12 2-CG4999-RC_1 CG4999 GTGAAGAGCGACGATCCCTCCTAGAACTCCCCCAAAAAATACAACGCCCTACCGAACACCGCGAC 65 FBan0004999 FBgn0035936 Tsp66E 3 3L cell-cell adhesion; GO:0016337; defense response; GO:0006952; signal transduction; GO:0007165 receptor binding; GO:0005102; ; GO:0005102 integral to membrane; GO:0016021 Tsp66E Tetraspanin 66E "CG4999, CG4999, CG4999, CG4999, Dm.Tsp66E, Tetraspanin 66E" CDMC21187 4 20 14 DAC23-H12 2-CG4999-RC_1 CG4999 GTGAAGAGCGACGATCCCTCCTAGAACTCCCCCAAAAAATACAACGCCCTACCGAACACCGCGAC 65 FBan0004999 FBgn0035936 Tsp66E 3 3L cell-cell adhesion; GO:0016337; defense response; GO:0006952; signal transduction; GO:0007165 receptor binding; GO:0005102; ; GO:0005102 integral to membrane; GO:0016021 Tsp66E Tetraspanin 66E "CG4999, CG4999, CG4999, CG4999, Dm.Tsp66E, Tetraspanin 66E" CDMC21188 4 21 14 DAC23-H24 1-CG5070-RA_1 CG5070 GATCAGGATATGGCGCCGGCTATGGATACGCTCCCGAGAACGTGGTGAAGGTGATCAAGGTATCG 65 FBan0005070 FBgn0030824 CG5070 X X CG5070 CG5070 CDMC21188 4 22 14 DAC23-H24 1-CG5070-RA_1 CG5070 GATCAGGATATGGCGCCGGCTATGGATACGCTCCCGAGAACGTGGTGAAGGTGATCAAGGTATCG 65 FBan0005070 FBgn0030824 CG5070 X X CG5070 CG5070 CDMC21189 4 23 14 DAC23-L12 23-CG5192-RB_2 CG5192 TAGGGAACTGACAGCTCTAGATCTACAAAAGACTCAACTATTTTGCAAATGGCACCTCAAGGAAA 65 FBan0005192 FBgn0019940 Rh6 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; phototransduction; GO:0007602; sensory perception; GO:0007600; visual perception; GO:0007601 G-protein coupled photoreceptor activity; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020 integral to membrane; GO:0016021; rhabdomere; GO:0016028 Rh6 Rhodopsin 6 "CG5192, rh6, Dm Rh6, rhodopsin, Rh, DMELRH6, RH6, Rhodopsin" CDMC21189 4 24 14 DAC23-L12 23-CG5192-RB_2 CG5192 TAGGGAACTGACAGCTCTAGATCTACAAAAGACTCAACTATTTTGCAAATGGCACCTCAAGGAAA 65 FBan0005192 FBgn0019940 Rh6 3 3R G-protein coupled receptor protein signaling pathway; GO:0007186; phototransduction; GO:0007602; sensory perception; GO:0007600; visual perception; GO:0007601 G-protein coupled photoreceptor activity; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020; ; GO:0008020 integral to membrane; GO:0016021; rhabdomere; GO:0016028 Rh6 Rhodopsin 6 "CG5192, rh6, Dm Rh6, rhodopsin, Rh, DMELRH6, RH6, Rhodopsin" CDMC21190 4 25 14 DAC23-L24 6-CG5219-RA_1 CG5219 CAGGACCGCCTAGTTCTGGCCCAGAAGTACGGCTATCAGCTGCCCAAAATTGAGGAAGATTCCGC 65 FBan0005219 FBgn0036990 mRpL15 3 3L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL15 mitochondrial ribosomal protein L15 "CG5219, CG5219, 50S ribosomal protein L15, l(3)77CDc, L15, mitochondrial ribosomal protein L15" CDMC21190 4 26 14 DAC23-L24 6-CG5219-RA_1 CG5219 CAGGACCGCCTAGTTCTGGCCCAGAAGTACGGCTATCAGCTGCCCAAAATTGAGGAAGATTCCGC 65 FBan0005219 FBgn0036990 mRpL15 3 3L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL15 mitochondrial ribosomal protein L15 "CG5219, CG5219, 50S ribosomal protein L15, l(3)77CDc, L15, mitochondrial ribosomal protein L15" CDMC21191 4 1 15 DAC23-P12 18-CG5344-RB_3 CG5344 CATCATCAACAATATGATGCGACTGAATCTGCGCGTAGAGGACTTCCAGATCGAGCACACACGCC 65 FBan0005344 FBgn0037917 wkd 3 3R "chromosome segregation; GO:0007059; mitosis; GO:0007067; terminal branching of trachea, cytoplasmic projection extension (sensu Insecta); GO:0007430" hormone activity; GO:0005179; ; GO:0005179; Rab GTPase activator activity; GO:0005097; ; GO:0005097 extracellular region; GO:0005576 wkd whacked "CG5344, CG5344, CG5344, whacked" CDMC21191 4 2 15 DAC23-P12 18-CG5344-RB_3 CG5344 CATCATCAACAATATGATGCGACTGAATCTGCGCGTAGAGGACTTCCAGATCGAGCACACACGCC 65 FBan0005344 FBgn0037917 wkd 3 3R "chromosome segregation; GO:0007059; mitosis; GO:0007067; terminal branching of trachea, cytoplasmic projection extension (sensu Insecta); GO:0007430" hormone activity; GO:0005179; ; GO:0005179; Rab GTPase activator activity; GO:0005097; ; GO:0005097 extracellular region; GO:0005576 wkd whacked "CG5344, CG5344, CG5344, whacked" CDMC21192 4 3 15 DAC23-P24 AutoBlank AutoBlank CDMC21192 4 4 15 DAC23-P24 AutoBlank AutoBlank CDMC21193 4 5 15 DAC24-D12 2-CG9210-RA_3 CG9210 ACCAGACCATCCGTCGTCGACAACCACAAGTGGCTAAGAGTATGGAGCTGTTGCCAGAAAACCAAACCA 69 FBan0009210 FBgn0022710 Ac13E X X G-protein coupled receptor protein signaling pathway; GO:0007186; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2 Ac13E Adenylyl cyclase 35C "CG9210, CG9210, adenylyl cyclase, DAC9, AC 13E, Ac35C, Adenylyl cyclase 35C" CDMC21193 4 6 15 DAC24-D12 2-CG9210-RA_3 CG9210 ACCAGACCATCCGTCGTCGACAACCACAAGTGGCTAAGAGTATGGAGCTGTTGCCAGAAAACCAAACCA 69 FBan0009210 FBgn0022710 Ac13E X X G-protein coupled receptor protein signaling pathway; GO:0007186; cyclic nucleotide metabolism; GO:0009187; intracellular signaling cascade; GO:0007242 adenylate cyclase activity; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; ; GO:0004016 ; EC:4.6.1.1; guanylate cyclase activity; GO:0004383 ; EC:4.6.1.2; ; GO:0004383 ; EC:4.6.1.2 Ac13E Adenylyl cyclase 35C "CG9210, CG9210, adenylyl cyclase, DAC9, AC 13E, Ac35C, Adenylyl cyclase 35C" CDMC21194 4 7 15 DAC24-D24 18-CG9224-RA_4 CG9224 GCGCACACAGACTTGTGCAAGGAGTTGCATAGATCGTTGTTGCTATCTTATCATGTGGCAGCAATGAGA 69 FBan0009224 FBgn0003463 sog X X "BMP signaling pathway; GO:0030509; amnioserosa formation; GO:0007378; dorsal/ventral axis specification; GO:0009950; ectoderm development; GO:0007398; negative regulation of transforming growth factor beta receptor signaling pathway; GO:0030512; positive regulation of transforming growth factor beta receptor signaling pathway; GO:0030511; regulation of BMP signaling pathway; GO:0030510; ring gland development; GO:0035271; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293; wing vein morphogenesis; GO:0008586; zygotic determination of anterior/posterior axis, embryo; GO:0007354" growth factor activity; GO:0008083; ; GO:0008083 integral to membrane; GO:0016021; plasma membrane; GO:0005886 sog short gastrulation "CG9224, CG9224, CG9224, l(1)G0395, l(1)G0160, l(1)G0479, Sog" CDMC21194 4 8 15 DAC24-D24 18-CG9224-RA_4 CG9224 GCGCACACAGACTTGTGCAAGGAGTTGCATAGATCGTTGTTGCTATCTTATCATGTGGCAGCAATGAGA 69 FBan0009224 FBgn0003463 sog X X "BMP signaling pathway; GO:0030509; amnioserosa formation; GO:0007378; dorsal/ventral axis specification; GO:0009950; ectoderm development; GO:0007398; negative regulation of transforming growth factor beta receptor signaling pathway; GO:0030512; positive regulation of transforming growth factor beta receptor signaling pathway; GO:0030511; regulation of BMP signaling pathway; GO:0030510; ring gland development; GO:0035271; terminal region determination; GO:0007362; torso signaling pathway; GO:0008293; wing vein morphogenesis; GO:0008586; zygotic determination of anterior/posterior axis, embryo; GO:0007354" growth factor activity; GO:0008083; ; GO:0008083 integral to membrane; GO:0016021; plasma membrane; GO:0005886 sog short gastrulation "CG9224, CG9224, CG9224, l(1)G0395, l(1)G0160, l(1)G0479, Sog" CDMC21195 4 9 15 DAC24-H12 16-CG9261-RA_1 CG9261 TCAGAGGTGTGTGAGGACGATAAGTCTCGTCTAAGACAATCCTACCAGAGGCAAACCACCAGATGTTGT 69 FBan0009261 FBgn0015777 nrv2 2 2L cation transport; GO:0006812; potassium ion transport; GO:0006813; regulation of tracheal tube diameter; GO:0035158; regulation of tracheal tube length; GO:0035159; regulation of tracheal tube size; GO:0035151; septate junction assembly; GO:0019991; sodium ion transport; GO:0006814; tracheal system development (sensu Insecta); GO:0007424 "hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances; GO:0016820 ; EC:3.6.3.-; sodium:potassium-exchanging ATPase activity; GO:0005391 ; EC:3.6.3.9; ; GO:0005391 ; EC:3.6.3.9; ; GO:0016820 ; EC:3.6.3.-; ; GO:0005391 ; EC:3.6.3.9" plasma membrane; GO:0005886; sodium:potassium-exchanging ATPase complex; GO:0005890 nrv2 nervana 2 "CG9261, nervana, Nrv2: Nervana 2, 42kDa, l(2)k13315, l(2)k04223, ectatic, Nervana, Na[+]/K[+]-ATPase, nervana2, Na[+]/K[+]ATPase, Na,K-ATPase, NaK ATPase, Na[+]/K[+] ATPase, l(2)SH2 0329, Nrv: Nirvana, NEST:bs13c10, ecta, l(2)SH0329, Nervana 2, Nirvana, Nrv2" CDMC21195 4 10 15 DAC24-H12 16-CG9261-RA_1 CG9261 TCAGAGGTGTGTGAGGACGATAAGTCTCGTCTAAGACAATCCTACCAGAGGCAAACCACCAGATGTTGT 69 FBan0009261 FBgn0015777 nrv2 2 2L cation transport; GO:0006812; potassium ion transport; GO:0006813; regulation of tracheal tube diameter; GO:0035158; regulation of tracheal tube length; GO:0035159; regulation of tracheal tube size; GO:0035151; septate junction assembly; GO:0019991; sodium ion transport; GO:0006814; tracheal system development (sensu Insecta); GO:0007424 "hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances; GO:0016820 ; EC:3.6.3.-; sodium:potassium-exchanging ATPase activity; GO:0005391 ; EC:3.6.3.9; ; GO:0005391 ; EC:3.6.3.9; ; GO:0016820 ; EC:3.6.3.-; ; GO:0005391 ; EC:3.6.3.9" plasma membrane; GO:0005886; sodium:potassium-exchanging ATPase complex; GO:0005890 nrv2 nervana 2 "CG9261, nervana, Nrv2: Nervana 2, 42kDa, l(2)k13315, l(2)k04223, ectatic, Nervana, Na[+]/K[+]-ATPase, nervana2, Na[+]/K[+]ATPase, Na,K-ATPase, NaK ATPase, Na[+]/K[+] ATPase, l(2)SH2 0329, Nrv: Nirvana, NEST:bs13c10, ecta, l(2)SH0329, Nervana 2, Nirvana, Nrv2" CDMC21196 4 11 15 DAC24-H24 8-CG9279-RA_2 CG9279 ACGTGAAAAACCTCGAGCTGACTGTGGCTGAACGGGAGAAGGAAATCAAAAGCCTCAAGTACACAGCCA 69 FBan0009279 FBgn0036882 CG9279 3 3L intracellular protein transport; GO:0006886; microtubule-based movement; GO:0007018; vesicle-mediated transport; GO:0016192 structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0003777 dynactin complex; GO:0005869 CG9279 CG9279 CDMC21196 4 12 15 DAC24-H24 8-CG9279-RA_2 CG9279 ACGTGAAAAACCTCGAGCTGACTGTGGCTGAACGGGAGAAGGAAATCAAAAGCCTCAAGTACACAGCCA 69 FBan0009279 FBgn0036882 CG9279 3 3L intracellular protein transport; GO:0006886; microtubule-based movement; GO:0007018; vesicle-mediated transport; GO:0016192 structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0003777 dynactin complex; GO:0005869 CG9279 CG9279 CDMC21197 4 13 15 DAC24-L12 2-CG9310-RA_2 CG9310 TTGCAATAGGACACCCCTTAAGCACACAACCCATACACATACAGGCCCTCTCTTGCTGTACTCCCCACC 69 FBan0009310 FBgn0004914 Hnf4 2 2L endoderm development; GO:0007492; lipid biosynthesis; GO:0008610; mesoderm development; GO:0007498; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165 ligand-dependent nuclear receptor activity; GO:0004879; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0004879; steroid hormone receptor activity; GO:0003707; ; GO:0004879; ; GO:0003700; steroid binding; GO:0005496; ; GO:0003707; ; GO:0005496 nucleus; GO:0005634 Hnf4 Hepatocyte nuclear factor 4 "CG9310, Hnf-4h, Hepatocyte nuclear factor 4 homologue, HNF4, HNF-4(D), dHNF4, DmHNF4, NR2A4, hepatocyte nuclear factor 4, HNF-4" CDMC21197 4 14 15 DAC24-L12 2-CG9310-RA_2 CG9310 TTGCAATAGGACACCCCTTAAGCACACAACCCATACACATACAGGCCCTCTCTTGCTGTACTCCCCACC 69 FBan0009310 FBgn0004914 Hnf4 2 2L endoderm development; GO:0007492; lipid biosynthesis; GO:0008610; mesoderm development; GO:0007498; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165 ligand-dependent nuclear receptor activity; GO:0004879; transcription factor activity; GO:0003700; ; GO:0003700; ; GO:0004879; steroid hormone receptor activity; GO:0003707; ; GO:0004879; ; GO:0003700; steroid binding; GO:0005496; ; GO:0003707; ; GO:0005496 nucleus; GO:0005634 Hnf4 Hepatocyte nuclear factor 4 "CG9310, Hnf-4h, Hepatocyte nuclear factor 4 homologue, HNF4, HNF-4(D), dHNF4, DmHNF4, NR2A4, hepatocyte nuclear factor 4, HNF-4" CDMC21198 4 15 15 DAC24-L24 18-CG9324-RA_1 CG9324 CGCTGTGGTGGAGAAATCTCTGGGAATTTACCAATAAGTCCCTGCAAATGAAGTTGCTAAATGCCTGGC 69 FBan0009324 FBgn0032884 Pomp 2 2L proteolysis; GO:0006508 proteasome complex (sensu Eukaryota); GO:0000502 Pomp Pomp "CG9324, 38E.20, POMP, Pomp" CDMC21198 4 16 15 DAC24-L24 18-CG9324-RA_1 CG9324 CGCTGTGGTGGAGAAATCTCTGGGAATTTACCAATAAGTCCCTGCAAATGAAGTTGCTAAATGCCTGGC 69 FBan0009324 FBgn0032884 Pomp 2 2L proteolysis; GO:0006508 proteasome complex (sensu Eukaryota); GO:0000502 Pomp Pomp "CG9324, 38E.20, POMP, Pomp" CDMC21199 4 17 15 DAC24-P12 17-CG9354-RA_1 CG9354 GCAGCCCAAACTGCACCCACCCTAGTGTAACTCCAAACTAATAATGATTTTCACCGCTTTTGCACATGT 69 FBan0009354 FBgn0037686 RpL34b 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL34b RpL34b "CG9354, anon-EST:fe1C10, anon-EST:fe1E8, anon-fast-evolving-1C10, anon-fast-evolving-1E8" CDMC21199 4 18 15 DAC24-P12 17-CG9354-RA_1 CG9354 GCAGCCCAAACTGCACCCACCCTAGTGTAACTCCAAACTAATAATGATTTTCACCGCTTTTGCACATGT 69 FBan0009354 FBgn0037686 RpL34b 3 3R protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL34b RpL34b "CG9354, anon-EST:fe1C10, anon-EST:fe1E8, anon-fast-evolving-1C10, anon-fast-evolving-1E8" CDMC21200 4 19 15 DAC24-P24 12-CG9361-RA_2 CG9361 TTGGTTTCGGCGATTATGTGGCATTGCAGAACGACCAAGCTCTAACTAATAAGCCTGGCTATGTGGCGC 69 FBan0009361 FBgn0037690 Task7 3 3R cation transport; GO:0006812; potassium ion transport; GO:0006813; transmission of nerve impulse; GO:0019226 open rectifier potassium channel activity; GO:0005252; ; GO:0005252 membrane; GO:0016020 Task7 Task7 "CG9361, CG9361, K2P-TASK7, dTASK-7" CDMC21200 4 20 15 DAC24-P24 12-CG9361-RA_2 CG9361 TTGGTTTCGGCGATTATGTGGCATTGCAGAACGACCAAGCTCTAACTAATAAGCCTGGCTATGTGGCGC 69 FBan0009361 FBgn0037690 Task7 3 3R cation transport; GO:0006812; potassium ion transport; GO:0006813; transmission of nerve impulse; GO:0019226 open rectifier potassium channel activity; GO:0005252; ; GO:0005252 membrane; GO:0016020 Task7 Task7 "CG9361, CG9361, K2P-TASK7, dTASK-7" CDMC21201 4 21 15 DAC25-D12 3-CG10595-RB_1 CG10595 TCCGCCGTCTCGTTCCTACACGATCACCGGGAATTCGAAAATAAGCTATCCCCAAAACCGGGTCATGAA 69 FBan0010595 FBgn0000410 d 2 2L intracellular protein transport; GO:0006886; sensory perception of sound; GO:0007605; vesicle-mediated transport; GO:0016192; visual perception; GO:0007601 "ATP binding; GO:0005524; cytoskeletal protein binding; GO:0008092; ; GO:0005524; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0042623; ; GO:0005200; ; GO:0042623; motor activity; GO:0003774; ; GO:0003774" myosin; GO:0016459 d dachs "CG10595, CG31610, CG10595, clone 1.78, 29C3-D1, AAF52683, 29CD, Myo29D, unconventional myosin 29D, myosin 29D, anon-EST:Liang-1.78" CDMC21201 4 22 15 DAC25-D12 3-CG10595-RB_1 CG10595 TCCGCCGTCTCGTTCCTACACGATCACCGGGAATTCGAAAATAAGCTATCCCCAAAACCGGGTCATGAA 69 FBan0010595 FBgn0000410 d 2 2L intracellular protein transport; GO:0006886; sensory perception of sound; GO:0007605; vesicle-mediated transport; GO:0016192; visual perception; GO:0007601 "ATP binding; GO:0005524; cytoskeletal protein binding; GO:0008092; ; GO:0005524; ; GO:0008092; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; ; GO:0042623; ; GO:0005200; ; GO:0042623; motor activity; GO:0003774; ; GO:0003774" myosin; GO:0016459 d dachs "CG10595, CG31610, CG10595, clone 1.78, 29C3-D1, AAF52683, 29CD, Myo29D, unconventional myosin 29D, myosin 29D, anon-EST:Liang-1.78" CDMC21202 4 23 15 DAC25-D24 23-CG10601-RA_6 CG10601 ACGATTATATCATTGCTTTTTTGATCGATTTGAGTTCGAAAAAACTAGCGGTACCCCTTCAAGGTCCTG 69 FBan0010601 FBgn0014343 mirr 3 3L "compound eye morphogenesis (sensu Endopterygota); GO:0001745; ectoderm development; GO:0007398; embryonic development (sensu Insecta); GO:0001700; equator specification; GO:0045317; nervous system development; GO:0007399; peripheral nervous system development; GO:0007422; positive regulation of transcription; GO:0045941; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; smoothened signaling pathway; GO:0007224; wing morphogenesis; GO:0007476" protein binding; GO:0005515; transcription factor activity; GO:0003700; transcriptional activator activity; GO:0016563; ; GO:0016563; ; GO:0003700; ; GO:0003700; ; GO:0005515; ; GO:0016563 nucleus; GO:0005634 mirr mirror "CG10601, l(3)A5-3-42, l(3)6D1, Sai, Sail, mir, De1, De3, cre: crepuscule, crepuscule, mrr, Mrr, DH1, IRO-C, iroquois, Iroquis complex, Iro-C, iro-C, Iro, iro, caupalican, Iroquois, Group F, group F, crep, l(3)69Ca, l(3)69Da, cre, mirror" CDMC21202 4 24 15 DAC25-D24 23-CG10601-RA_6 CG10601 ACGATTATATCATTGCTTTTTTGATCGATTTGAGTTCGAAAAAACTAGCGGTACCCCTTCAAGGTCCTG 69 FBan0010601 FBgn0014343 mirr 3 3L "compound eye morphogenesis (sensu Endopterygota); GO:0001745; ectoderm development; GO:0007398; embryonic development (sensu Insecta); GO:0001700; equator specification; GO:0045317; nervous system development; GO:0007399; peripheral nervous system development; GO:0007422; positive regulation of transcription; GO:0045941; regulation of transcription from RNA polymerase II promoter; GO:0006357; regulation of transcription, DNA-dependent; GO:0006355; smoothened signaling pathway; GO:0007224; wing morphogenesis; GO:0007476" protein binding; GO:0005515; transcription factor activity; GO:0003700; transcriptional activator activity; GO:0016563; ; GO:0016563; ; GO:0003700; ; GO:0003700; ; GO:0005515; ; GO:0016563 nucleus; GO:0005634 mirr mirror "CG10601, l(3)A5-3-42, l(3)6D1, Sai, Sail, mir, De1, De3, cre: crepuscule, crepuscule, mrr, Mrr, DH1, IRO-C, iroquois, Iroquis complex, Iro-C, iro-C, Iro, iro, caupalican, Iroquois, Group F, group F, crep, l(3)69Ca, l(3)69Da, cre, mirror" CDMC21203 4 25 15 DAC25-H12 18-CG10629-RA_2 CG10629 AGTCATGGAAATGAAGCACTTGAAGATCTACCGCACATTTGACGATGAAACTCTGGAGAAGATGCGGCA 69 FBan0010629 FBgn0035609 CG10629 3 3L oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG10629 CG10629 CDMC21203 4 26 15 DAC25-H12 18-CG10629-RA_2 CG10629 AGTCATGGAAATGAAGCACTTGAAGATCTACCGCACATTTGACGATGAAACTCTGGAGAAGATGCGGCA 69 FBan0010629 FBgn0035609 CG10629 3 3L oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG10629 CG10629 CDMC21204 4 1 16 DAC25-H24 18-CG10638-RB_5 CG10638 GGGACATATACCACGAACCCAAGATGGTGAAATACGCCTGTGATATGCAATTAAAGCTACTGGGCGTGG 69 FBan0010638 FBgn0036290 CG10638 3 3L aldehyde metabolism; GO:0006081 aldehyde reductase activity; GO:0004032 ; EC:1.1.1.21; ; GO:0004032 ; EC:1.1.1.21 CG10638 CG10638 "CG32101, anon-WO0172774.89" CDMC21204 4 2 16 DAC25-H24 18-CG10638-RB_5 CG10638 GGGACATATACCACGAACCCAAGATGGTGAAATACGCCTGTGATATGCAATTAAAGCTACTGGGCGTGG 69 FBan0010638 FBgn0036290 CG10638 3 3L aldehyde metabolism; GO:0006081 aldehyde reductase activity; GO:0004032 ; EC:1.1.1.21; ; GO:0004032 ; EC:1.1.1.21 CG10638 CG10638 "CG32101, anon-WO0172774.89" CDMC21205 4 3 16 DAC25-L12 2-CG10670-RA_1 CG10670 GGTCACCAGCTTCATTACGAACCCATGGCGGAAGATTTGAGCTTACGTCTGGCGCAGATGAGTCTAGGA 69 FBan0010670 FBgn0027914 Gen 3 3L "DNA catabolism, endonucleolytic; GO:0000737; DNA catabolism, exonucleolytic; GO:0000738; DNA replication; GO:0006260; base-excision repair; GO:0006284" damaged DNA binding; GO:0003684; endodeoxyribonuclease activity; GO:0004520; endonuclease activity; GO:0004519; flap endonuclease activity; GO:0048256; exodeoxyribonuclease activity; GO:0004529; ; GO:0004520; ; GO:0004529; single-stranded DNA specific endodeoxyribonuclease activity; GO:0000014; ; GO:0004519; double-stranded DNA specific 3'-5' exodeoxyribonuclease activity; GO:0008311; ; GO:0048256; single-stranded DNA specific 3'-5' exodeoxyribonuclease activity; GO:0008310; ; GO:0003684; ; GO:0000014; 5'-3' exodeoxyribonuclease activity; GO:0035312; ; GO:0035312; ; GO:0008311; ; GO:0008310 nucleus; GO:0005634 Gen XPG-like endonuclease "CG10670, CG10670, BcDNA:GM10765, DmGEN, XPG-like endonuclease" CDMC21205 4 4 16 DAC25-L12 2-CG10670-RA_1 CG10670 GGTCACCAGCTTCATTACGAACCCATGGCGGAAGATTTGAGCTTACGTCTGGCGCAGATGAGTCTAGGA 69 FBan0010670 FBgn0027914 Gen 3 3L "DNA catabolism, endonucleolytic; GO:0000737; DNA catabolism, exonucleolytic; GO:0000738; DNA replication; GO:0006260; base-excision repair; GO:0006284" damaged DNA binding; GO:0003684; endodeoxyribonuclease activity; GO:0004520; endonuclease activity; GO:0004519; flap endonuclease activity; GO:0048256; exodeoxyribonuclease activity; GO:0004529; ; GO:0004520; ; GO:0004529; single-stranded DNA specific endodeoxyribonuclease activity; GO:0000014; ; GO:0004519; double-stranded DNA specific 3'-5' exodeoxyribonuclease activity; GO:0008311; ; GO:0048256; single-stranded DNA specific 3'-5' exodeoxyribonuclease activity; GO:0008310; ; GO:0003684; ; GO:0000014; 5'-3' exodeoxyribonuclease activity; GO:0035312; ; GO:0035312; ; GO:0008311; ; GO:0008310 nucleus; GO:0005634 Gen XPG-like endonuclease "CG10670, CG10670, BcDNA:GM10765, DmGEN, XPG-like endonuclease" CDMC21206 4 5 16 DAC25-L24 23-CG10681-RA_1 CG10681 AATGCCTGAGCGAAATGAAGAAGGATCTGGATTACATATTCCGCAAGATACGGATCATCAAGCAGAAGC 69 FBan0010681 FBgn0036291 CG10681 3 3L CG10681 CG10681 CDMC21206 4 6 16 DAC25-L24 23-CG10681-RA_1 CG10681 AATGCCTGAGCGAAATGAAGAAGGATCTGGATTACATATTCCGCAAGATACGGATCATCAAGCAGAAGC 69 FBan0010681 FBgn0036291 CG10681 3 3L CG10681 CG10681 CDMC21207 4 7 16 DAC25-P12 5-CG10718-RA_1 CG10718 GGCCCAACAACAGGAACACACTCCGCTAAGGCATGAAGATGCAGTATCAACTCCAGCACAGAAGTCGAC 69 FBan0010718 FBgn0004374 neb 2 2L "chromosome segregation; GO:0007059; intracellular protein transport; GO:0006886; meiosis; GO:0007126; microtubule-based movement; GO:0007018; mitotic cell cycle, embryonic; GO:0045448; mitotic chromosome condensation; GO:0007076; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707; protein targeting; GO:0006605; regulation of progression through cell cycle; GO:0000074" chromatin binding; GO:0003682; protein phosphatase 1 binding; GO:0008157; ; GO:0003682; ATP binding; GO:0005524; ; GO:0008157; ; GO:0005524; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0003777; plus-end-directed microtubule motor activity; GO:0008574 ; EC:3.6.4.4; ; GO:0005200; ; GO:0003777; ; GO:0008574 ; EC:3.6.4.4 kinesin complex; GO:0005871 neb nebbish "CG10718, CG10718, CG10718, Mot, Mothra, KLP-38B, klp38B, Kinesin-like protein at 38B, KLP38B, tio, tiovivo, Klp38, KLP 38B, Klp38B, l(2)k00802, Dm0332, DmKlp38B, KIF14, Neb, 38B.10, 38B.12, l(2)03552, l(2)k07614, sl(2)ry, sl(2)ry3" CDMC21207 4 8 16 DAC25-P12 5-CG10718-RA_1 CG10718 GGCCCAACAACAGGAACACACTCCGCTAAGGCATGAAGATGCAGTATCAACTCCAGCACAGAAGTCGAC 69 FBan0010718 FBgn0004374 neb 2 2L "chromosome segregation; GO:0007059; intracellular protein transport; GO:0006886; meiosis; GO:0007126; microtubule-based movement; GO:0007018; mitotic cell cycle, embryonic; GO:0045448; mitotic chromosome condensation; GO:0007076; oogenesis (sensu Insecta); GO:0009993; ovarian follicle cell development (sensu Insecta); GO:0030707; protein targeting; GO:0006605; regulation of progression through cell cycle; GO:0000074" chromatin binding; GO:0003682; protein phosphatase 1 binding; GO:0008157; ; GO:0003682; ATP binding; GO:0005524; ; GO:0008157; ; GO:0005524; structural constituent of cytoskeleton; GO:0005200; microtubule motor activity; GO:0003777; ; GO:0003777; plus-end-directed microtubule motor activity; GO:0008574 ; EC:3.6.4.4; ; GO:0005200; ; GO:0003777; ; GO:0008574 ; EC:3.6.4.4 kinesin complex; GO:0005871 neb nebbish "CG10718, CG10718, CG10718, Mot, Mothra, KLP-38B, klp38B, Kinesin-like protein at 38B, KLP38B, tio, tiovivo, Klp38, KLP 38B, Klp38B, l(2)k00802, Dm0332, DmKlp38B, KIF14, Neb, 38B.10, 38B.12, l(2)03552, l(2)k07614, sl(2)ry, sl(2)ry3" CDMC21208 4 9 16 DAC25-P24 AutoBlank AutoBlank CDMC21208 4 10 16 DAC25-P24 AutoBlank AutoBlank CDMC21209 4 11 16 DAC26-D12 2-CG8058-RA_1 CG8058 GCGCTGCAAGACGATCAAAGAGTTCGACGCGCTTTTTACGGCTAAGCAGTTCGGATATGCCCATGTGAA 69 FBan0008058 FBgn0033382 CG8058 2 2R CG8058 CG8058 CDMC21209 4 12 16 DAC26-D12 2-CG8058-RA_1 CG8058 GCGCTGCAAGACGATCAAAGAGTTCGACGCGCTTTTTACGGCTAAGCAGTTCGGATATGCCCATGTGAA 69 FBan0008058 FBgn0033382 CG8058 2 2R CG8058 CG8058 CDMC21210 4 13 16 DAC26-D24 6-CG8067-RA_2 CG8067 GGTCATCGGCTATCCCAGCATGTTCGAACTGATGTGGGATCTCAAGGGTATGGCAGAGAACAATGCTGC 69 FBan0008067 FBgn0033891 CG8067 2 2R CG8067 CG8067 CDMC21210 4 14 16 DAC26-D24 6-CG8067-RA_2 CG8067 GGTCATCGGCTATCCCAGCATGTTCGAACTGATGTGGGATCTCAAGGGTATGGCAGAGAACAATGCTGC 69 FBan0008067 FBgn0033891 CG8067 2 2R CG8067 CG8067 CDMC21211 4 15 16 DAC26-H12 2-CG8102-RA_1 CG8102 GCCCGCTTTGTTAAGGGTCAGACACATCCCCACGAGATCGATTGGACGCTGGTCATTGCCGATAAAATG 69 FBan0008102 FBgn0034007 CG8102 2 2R "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG8102 CG8102 CDMC21211 4 16 16 DAC26-H12 2-CG8102-RA_1 CG8102 GCCCGCTTTGTTAAGGGTCAGACACATCCCCACGAGATCGATTGGACGCTGGTCATTGCCGATAAAATG 69 FBan0008102 FBgn0034007 CG8102 2 2R "mitochondrial electron transport, NADH to ubiquinone; GO:0006120" NADH dehydrogenase activity; GO:0003954 ; EC:1.6.99.3; NADH dehydrogenase (ubiquinone) activity; GO:0008137 ; EC:1.6.5.3; ; GO:0008137 ; EC:1.6.5.3; ; GO:0003954 ; EC:1.6.99.3; ; GO:0003954 ; EC:1.6.99.3 respiratory chain complex I (sensu Eukaryota); GO:0005747 CG8102 CG8102 CDMC21212 4 17 16 DAC26-H24 22-CG8116-RA_2 CG8116 TGTGCATGTGCGTTTGAGGTTCCTTTCCTTTTTATATAAGCCCCTCGTCTCTTGCCAACAAACCAACAA 69 FBan0008116 FBgn0037614 CG8116 3 3R CG8116 CG8116 "EP(3)3246, GH04517" CDMC21212 4 18 16 DAC26-H24 22-CG8116-RA_2 CG8116 TGTGCATGTGCGTTTGAGGTTCCTTTCCTTTTTATATAAGCCCCTCGTCTCTTGCCAACAAACCAACAA 69 FBan0008116 FBgn0037614 CG8116 3 3R CG8116 CG8116 "EP(3)3246, GH04517" CDMC21213 4 19 16 DAC26-L12 23-CG8147-RA_2 CG8147 CTAAGCGACAAACGTATTATTCTCGTTTAAGAGAGAAGCCACTAGAAGATAAGCAATCGTTTAAGGGGG 69 FBgn0037699 CDMC21213 4 20 16 DAC26-L12 23-CG8147-RA_2 CG8147 CTAAGCGACAAACGTATTATTCTCGTTTAAGAGAGAAGCCACTAGAAGATAAGCAATCGTTTAAGGGGG 69 FBgn0037699 CDMC21214 4 21 16 DAC26-L24 1-CG8167-RA_1 CG8167 GCTCCGTGGTCAGAAATTAGGCCTCCTAATGCGAAAATCATTGACCCCAACTGACCTGGTCGACGCGAT 69 FBan0008167 FBgn0036046 Ilp2 3 3L growth; GO:0040007; insulin receptor signaling pathway; GO:0008286; positive regulation of body size; GO:0040018; regulation of body size; GO:0040014; regulation of cell size; GO:0008361 insulin receptor binding; GO:0005158; hormone activity; GO:0005179; ; GO:0005179; ; GO:0005158 extracellular region; GO:0005576 Ilp2 Insulin-related peptide "CG8167, CG8167, CG8167, dilp2, insulin-like peptide 2, DILP2, DILP, Drosophila insulin-like peptide 2, Dilp 2, dILP2, ILP2, Dilp, Dilp2, dilp-2, dilp, IRP, Insulin-related peptide" CDMC21214 4 22 16 DAC26-L24 1-CG8167-RA_1 CG8167 GCTCCGTGGTCAGAAATTAGGCCTCCTAATGCGAAAATCATTGACCCCAACTGACCTGGTCGACGCGAT 69 FBan0008167 FBgn0036046 Ilp2 3 3L growth; GO:0040007; insulin receptor signaling pathway; GO:0008286; positive regulation of body size; GO:0040018; regulation of body size; GO:0040014; regulation of cell size; GO:0008361 insulin receptor binding; GO:0005158; hormone activity; GO:0005179; ; GO:0005179; ; GO:0005158 extracellular region; GO:0005576 Ilp2 Insulin-related peptide "CG8167, CG8167, CG8167, dilp2, insulin-like peptide 2, DILP2, DILP, Drosophila insulin-like peptide 2, Dilp 2, dILP2, ILP2, Dilp, Dilp2, dilp-2, dilp, IRP, Insulin-related peptide" CDMC21215 4 23 16 DAC26-P12 24-CG8198-RA_4 CG8198 TAAGCACTCATATTTTCGAATTTTTTTTGTGGAAATTCTCGAGTCAAACAAATTATATAAAGGGCACGA 69 FBgn0030677 CDMC21215 4 24 16 DAC26-P12 24-CG8198-RA_4 CG8198 TAAGCACTCATATTTTCGAATTTTTTTTGTGGAAATTCTCGAGTCAAACAAATTATATAAAGGGCACGA 69 FBgn0030677 CDMC21216 4 25 16 DAC26-P24 6-CG8208-RA_2 CG8208 CGGCGTACACGGCCAGAGTTCTACGAAGGCTGATTTGACCAAGAATGCCATGGCGTTTATGAATCCTGA 69 FBan0008208 FBgn0027950 MBD-like 3 3R "development; GO:0007275; negative regulation of transcription, DNA-dependent; GO:0045892; regulation of transcription from RNA polymerase II promoter; GO:0006357" methyl-CpG binding; GO:0008327; NOT methyl-CpG binding; GO:0008327; ; GO:0008327; histone deacetylase binding; GO:0042826; ; GO:0008327; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0008327; ; GO:0042826 NuRD complex; GO:0016581; nucleus; GO:0005634; polytene chromosome; GO:0005700 MBD-like MBD-like "CG8208, CG8208, CG8208, dMBD2/3, dMBD-like, MBD2/3, DmMbd2/3, Dm Mbd2/3, dMbD2/3, MBD2-3, methyl-CpG-binding-domain-like-protein" CDMC21216 4 26 16 DAC26-P24 6-CG8208-RA_2 CG8208 CGGCGTACACGGCCAGAGTTCTACGAAGGCTGATTTGACCAAGAATGCCATGGCGTTTATGAATCCTGA 69 FBan0008208 FBgn0027950 MBD-like 3 3R "development; GO:0007275; negative regulation of transcription, DNA-dependent; GO:0045892; regulation of transcription from RNA polymerase II promoter; GO:0006357" methyl-CpG binding; GO:0008327; NOT methyl-CpG binding; GO:0008327; ; GO:0008327; histone deacetylase binding; GO:0042826; ; GO:0008327; transcription regulator activity; GO:0030528; ; GO:0030528; ; GO:0008327; ; GO:0042826 NuRD complex; GO:0016581; nucleus; GO:0005634; polytene chromosome; GO:0005700 MBD-like MBD-like "CG8208, CG8208, CG8208, dMBD2/3, dMBD-like, MBD2/3, DmMbd2/3, Dm Mbd2/3, dMbD2/3, MBD2-3, methyl-CpG-binding-domain-like-protein" CDMC21217 4 1 17 DAC27-D12 9-CG8445-RA_4 CG8445 CGGGTGAGGCGTTTCACTTCGTTAGCTTTGTGCCTATCAATGGACAACTGTTTGAGCTGGATGGCTTGA 69 FBan0008445 FBgn0034088 CG8445 2 2R ubiquitin-dependent protein catabolism; GO:0006511 NOT ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; ; GO:0004221 ; EC:3.1.2.15 intracellular; GO:0005622 CG8445 CG8445 CDMC21217 4 2 17 DAC27-D12 9-CG8445-RA_4 CG8445 CGGGTGAGGCGTTTCACTTCGTTAGCTTTGTGCCTATCAATGGACAACTGTTTGAGCTGGATGGCTTGA 69 FBan0008445 FBgn0034088 CG8445 2 2R ubiquitin-dependent protein catabolism; GO:0006511 NOT ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; ; GO:0004221 ; EC:3.1.2.15 intracellular; GO:0005622 CG8445 CG8445 CDMC21218 4 3 17 DAC27-D24 7-CG8457-RA_1 CG8457 CAAGGCTCCGGATATTCAAGAACGACTGAGGAGTGAGCTACGAGAAGCCTTCATCTCCACTGCTACCCT 69 FBan0008457 FBgn0033697 Cyp6t3 2 2R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6t3 Cyp6t3 "CG8457, 6t3" CDMC21218 4 4 17 DAC27-D24 7-CG8457-RA_1 CG8457 CAAGGCTCCGGATATTCAAGAACGACTGAGGAGTGAGCTACGAGAAGCCTTCATCTCCACTGCTACCCT 69 FBan0008457 FBgn0033697 Cyp6t3 2 2R electron transport; GO:0006118 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6t3 Cyp6t3 "CG8457, 6t3" CDMC21219 4 5 17 DAC27-H12 4-CG8501-RA_1 CG8501 GCACTGCGAGAAAACGCCCTCCAAAAGCAAGAGACTACACTGTCGTTTGGGATAAACTCGCATCTCGCT 69 FBan0008501 FBgn0033724 CG8501 2 2R CG8501 CG8501 CDMC21219 4 6 17 DAC27-H12 4-CG8501-RA_1 CG8501 GCACTGCGAGAAAACGCCCTCCAAAAGCAAGAGACTACACTGTCGTTTGGGATAAACTCGCATCTCGCT 69 FBan0008501 FBgn0033724 CG8501 2 2R CG8501 CG8501 CDMC21220 4 7 17 DAC27-H24 2-CG8515-RA_1 CG8515 GCCGGCTATTCCCGAGGAGATACAGAAGGGTTTGGATCAGATCTACGCTGGCATTAAACTGCAGCAGGA 69 FBan0008515 FBgn0033731 CG8515 2 2R structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG8515 CG8515 CDMC21220 4 8 17 DAC27-H24 2-CG8515-RA_1 CG8515 GCCGGCTATTCCCGAGGAGATACAGAAGGGTTTGGATCAGATCTACGCTGGCATTAAACTGCAGCAGGA 69 FBan0008515 FBgn0033731 CG8515 2 2R structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG8515 CG8515 CDMC21221 4 9 17 DAC27-L12 10-CG8548-RA_1 CG8548 TTGCTGGGCCATAGGCTACCTGTCAGATGGTCCCAATGATAAAATCCAGGCTGTAATTGATGCGGGTGT 69 FBan0008548 FBgn0024889 Kap-alpha1 3 3L protein import into nucleus; GO:0006606 protein carrier activity; GO:0008320; ; GO:0008320; ; GO:0008320 nuclear pore; GO:0005643 Kap-alpha1 karyopherin alpha1 "CG8548, Kap alpha1, karyopherin-alpha1, importin alpha1, Kap-alpha1, imp alpha1, anon-WO0118547.276" CDMC21221 4 10 17 DAC27-L12 10-CG8548-RA_1 CG8548 TTGCTGGGCCATAGGCTACCTGTCAGATGGTCCCAATGATAAAATCCAGGCTGTAATTGATGCGGGTGT 69 FBan0008548 FBgn0024889 Kap-alpha1 3 3L protein import into nucleus; GO:0006606 protein carrier activity; GO:0008320; ; GO:0008320; ; GO:0008320 nuclear pore; GO:0005643 Kap-alpha1 karyopherin alpha1 "CG8548, Kap alpha1, karyopherin-alpha1, importin alpha1, Kap-alpha1, imp alpha1, anon-WO0118547.276" CDMC21222 4 11 17 DAC27-L24 9-CG8557-RA_1 CG8557 GGAAACTGTCGAAGGAGCAGGACTTGTGGATGGAGTGCGACATGGTAATGCAAATGGTTATTTGGCCCA 69 FBan0008557 FBgn0030842 CG8557 X X CG8557 CG8557 CDMC21222 4 12 17 DAC27-L24 9-CG8557-RA_1 CG8557 GGAAACTGTCGAAGGAGCAGGACTTGTGGATGGAGTGCGACATGGTAATGCAAATGGTTATTTGGCCCA 69 FBan0008557 FBgn0030842 CG8557 X X CG8557 CG8557 CDMC21223 4 13 17 DAC27-P12 1-CG8595-RA_1 CG8595 GCACTGGAAGATAGCAGCTCGAATTCGGGATCCCTTGAGAAGAGAGAGCTGGACTTTAACGCCACAGGT 69 FBan0008595 FBgn0034476 Toll-7 2 2R cell adhesion; GO:0007155; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; defense response to bacteria; GO:0042742; macrophage activation; GO:0042116; signal transduction; GO:0007165 transmembrane receptor activity; GO:0004888; ; GO:0004888; ; GO:0004888 integral to membrane; GO:0016021; plasma membrane; GO:0005886 Toll-7 Toll-7 "CG8595, CG8595, Tl-7, CT24947, Toll-like, dTLR7, toll, dToll7, Toll-7" CDMC21223 4 14 17 DAC27-P12 1-CG8595-RA_1 CG8595 GCACTGGAAGATAGCAGCTCGAATTCGGGATCCCTTGAGAAGAGAGAGCTGGACTTTAACGCCACAGGT 69 FBan0008595 FBgn0034476 Toll-7 2 2R cell adhesion; GO:0007155; cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952; defense response to bacteria; GO:0042742; macrophage activation; GO:0042116; signal transduction; GO:0007165 transmembrane receptor activity; GO:0004888; ; GO:0004888; ; GO:0004888 integral to membrane; GO:0016021; plasma membrane; GO:0005886 Toll-7 Toll-7 "CG8595, CG8595, Tl-7, CT24947, Toll-like, dTLR7, toll, dToll7, Toll-7" CDMC21224 4 15 17 DAC27-P24 9-CG8605-RA_2 CG8605 GCGGTGGACATAGAACAGATTGCCCAGGACCAGATACTATTTGCCCATCTACTTGATGAGACGCTGGCC 69 FBan0008605 FBgn0035762 CG8605 3 3L CG8605 CG8605 CDMC21224 4 16 17 DAC27-P24 9-CG8605-RA_2 CG8605 GCGGTGGACATAGAACAGATTGCCCAGGACCAGATACTATTTGCCCATCTACTTGATGAGACGCTGGCC 69 FBan0008605 FBgn0035762 CG8605 3 3L CG8605 CG8605 CDMC21225 4 17 17 DAC28-D12 16-CG30362-RA_1 CG30362 GCAGCCACCCGAGTAACTTGCTTCAAATGACAACATTTGTGGAACGATCACATTCCGTTACAACGCTCA 69 FBan0030362 FBgn0050362 CG30362 2 2R CG30362 CG30362 "CG2149, CG2149, CG2149, NEST:bs34d07" CDMC21225 4 18 17 DAC28-D12 16-CG30362-RA_1 CG30362 GCAGCCACCCGAGTAACTTGCTTCAAATGACAACATTTGTGGAACGATCACATTCCGTTACAACGCTCA 69 FBan0030362 FBgn0050362 CG30362 2 2R CG30362 CG30362 "CG2149, CG2149, CG2149, NEST:bs34d07" CDMC21226 4 19 17 DAC28-D24 13-CG30375-RA_1 CG30375 ACCCCGGCGCTATACCAAGTGGTTCTAACTGTCGATTTCGCTTGAAGGCACCCAGTAATCATGTTATCT 69 FBan0030375 FBgn0050375 CG30375 2 2R amino acid biosynthesis; GO:0008652; amino acid metabolism; GO:0006520; protein metabolism; GO:0019538; proteolysis; GO:0006508; regulation of amino acid metabolism; GO:0006521 serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG30375 CG30375 "CG2280, SP80" CDMC21226 4 20 17 DAC28-D24 13-CG30375-RA_1 CG30375 ACCCCGGCGCTATACCAAGTGGTTCTAACTGTCGATTTCGCTTGAAGGCACCCAGTAATCATGTTATCT 69 FBan0030375 FBgn0050375 CG30375 2 2R amino acid biosynthesis; GO:0008652; amino acid metabolism; GO:0006520; protein metabolism; GO:0019538; proteolysis; GO:0006508; regulation of amino acid metabolism; GO:0006521 serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; trypsin activity; GO:0004295 ; EC:3.4.21.4; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG30375 CG30375 "CG2280, SP80" CDMC21227 4 21 17 DAC28-H12 23-CG30418-RA_16 CG30418 CAAAGCTTCGCTGCATTTTCGAATACAAACACTGAACTATCCGTCGTTGTAAAGCTACCTTATCCACTA 69 FBan0030418 FBgn0050418 nord 2 2R learning and/or memory; GO:0007611; olfactory learning; GO:0008355 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 nord nord "CG3372, CG30418, CG13574, CG3372, nord" CDMC21227 4 22 17 DAC28-H12 23-CG30418-RA_16 CG30418 CAAAGCTTCGCTGCATTTTCGAATACAAACACTGAACTATCCGTCGTTGTAAAGCTACCTTATCCACTA 69 FBan0030418 FBgn0050418 nord 2 2R learning and/or memory; GO:0007611; olfactory learning; GO:0008355 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 nord nord "CG3372, CG30418, CG13574, CG3372, nord" CDMC21228 4 23 17 DAC28-H24 3-CG30429-RA_1 CG30429 GGCAGGGAGTCGGATCAATGCTACGCAAACGCGGAACTGAGGTACAGCTGATATATTCGGGAAGATGGT 69 FBan0030429 FBgn0050429 CG30429 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30429 CG30429 CDMC21228 4 24 17 DAC28-H24 3-CG30429-RA_1 CG30429 GGCAGGGAGTCGGATCAATGCTACGCAAACGCGGAACTGAGGTACAGCTGATATATTCGGGAAGATGGT 69 FBan0030429 FBgn0050429 CG30429 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30429 CG30429 CDMC21229 4 25 17 DAC28-L12 16-CG30464-RA_1 CG30464 CGATCGGAGCTTTTCGGATATGGTGAGACTAAAACTGGCAACCATGAACGATTTTAGTCCACCACGGTT 69 FBan0030464 FBgn0050464 CG30464 2 2R CG30464 CG30464 CG12961 CDMC21229 4 26 17 DAC28-L12 16-CG30464-RA_1 CG30464 CGATCGGAGCTTTTCGGATATGGTGAGACTAAAACTGGCAACCATGAACGATTTTAGTCCACCACGGTT 69 FBan0030464 FBgn0050464 CG30464 2 2R CG30464 CG30464 CG12961 CDMC21230 4 1 18 DAC28-L24 17-CG30477-RA_2 CG30477 TGTGAATAGTGTGGATGGGGCTAATTTCCGATTTGCACTCACTTCCTCTCGCGGGAAATGCAATCATAA 69 FBan0030477 FBgn0050477 CG30477 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30477 CG30477 CDMC21230 4 2 18 DAC28-L24 17-CG30477-RA_2 CG30477 TGTGAATAGTGTGGATGGGGCTAATTTCCGATTTGCACTCACTTCCTCTCGCGGGAAATGCAATCATAA 69 FBan0030477 FBgn0050477 CG30477 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30477 CG30477 CDMC21231 4 3 18 DAC28-P12 15-CG30501-RA_5 CG30501 ACTGGTTGAGCCGGGATGGGAAGGCAAAAAGCAAAAGATGGCAAGGAAAACTTAAGAAATTGACACCGT 69 FBan0030501 FBgn0050501 CG30501 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30501 CG30501 CDMC21231 4 4 18 DAC28-P12 15-CG30501-RA_5 CG30501 ACTGGTTGAGCCGGGATGGGAAGGCAAAAAGCAAAAGATGGCAAGGAAAACTTAAGAAATTGACACCGT 69 FBan0030501 FBgn0050501 CG30501 2 2R biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG30501 CG30501 CDMC21232 4 5 18 DAC28-P24 2-CG3064-RB_1 CG3064 ACAGGAGAAAGGAGGGGAAGTAGAACAAGCCGTCCCTACCACAACTGCAGTTACAGCAAGCACTACAGC 69 FBan0003064 FBgn0015390 futsch X X axonogenesis; GO:0007409; dendrite morphogenesis; GO:0016358; eye development (sensu Endopterygota); GO:0007456; microtubule cytoskeleton organization and biogenesis; GO:0000226; microtubule-based process; GO:0007017; nervous system development; GO:0007399; neuromuscular junction development; GO:0007528; regulation of synaptic growth at neuromuscular junction; GO:0008582 microtubule binding; GO:0008017; ; GO:0008017; ; GO:0008017; protein binding; GO:0005515; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005515; ; GO:0008017 microtubule associated complex; GO:0005875; microtubule cytoskeleton; GO:0015630 futsch futsch "CG3064, CG3064, CG3064, mAb22C10, MAb22C10, Mab22C10, mAb 22C10, 22C10, 22c10, EG:49E4.1, Mab 22C10, mAb-22C10, map1b, MAP1B, 22C10/FUTSCH, ssC10, Futsch, futsch" CDMC21232 4 6 18 DAC28-P24 2-CG3064-RB_1 CG3064 ACAGGAGAAAGGAGGGGAAGTAGAACAAGCCGTCCCTACCACAACTGCAGTTACAGCAAGCACTACAGC 69 FBan0003064 FBgn0015390 futsch X X axonogenesis; GO:0007409; dendrite morphogenesis; GO:0016358; eye development (sensu Endopterygota); GO:0007456; microtubule cytoskeleton organization and biogenesis; GO:0000226; microtubule-based process; GO:0007017; nervous system development; GO:0007399; neuromuscular junction development; GO:0007528; regulation of synaptic growth at neuromuscular junction; GO:0008582 microtubule binding; GO:0008017; ; GO:0008017; ; GO:0008017; protein binding; GO:0005515; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0005515; ; GO:0008017 microtubule associated complex; GO:0005875; microtubule cytoskeleton; GO:0015630 futsch futsch "CG3064, CG3064, CG3064, mAb22C10, MAb22C10, Mab22C10, mAb 22C10, 22C10, 22c10, EG:49E4.1, Mab 22C10, mAb-22C10, map1b, MAP1B, 22C10/FUTSCH, ssC10, Futsch, futsch" CDMC21233 4 7 18 DAC29-D12 18-CG9995-RA_1 CG9995 CGAAGGACGCTAGTGGGCATTAGTATGCGCCTTAGCCAATTGCCGGCTAATTCCCAATCAAAATTACTT 69 FBan0009995 FBgn0027655 huntingtin 3 3R axon cargo transport; GO:0008088; proteolysis; GO:0006508 microtubule binding; GO:0008017; ; GO:0008017; protein binding; GO:0005515; ; GO:0005515; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 cytoplasm; GO:0005737 huntingtin huntingtin "CG9995, HD, Hsap\HD, Htt, dhtt, htt" CDMC21233 4 8 18 DAC29-D12 18-CG9995-RA_1 CG9995 CGAAGGACGCTAGTGGGCATTAGTATGCGCCTTAGCCAATTGCCGGCTAATTCCCAATCAAAATTACTT 69 FBan0009995 FBgn0027655 huntingtin 3 3R axon cargo transport; GO:0008088; proteolysis; GO:0006508 microtubule binding; GO:0008017; ; GO:0008017; protein binding; GO:0005515; ; GO:0005515; carboxypeptidase A activity; GO:0004182 ; EC:3.4.17.1; ; GO:0004182 ; EC:3.4.17.1 cytoplasm; GO:0005737 huntingtin huntingtin "CG9995, HD, Hsap\HD, Htt, dhtt, htt" CDMC21234 4 9 18 DAC29-D24 9-CR14753-RA_1 CR14753 ACCTGTGCACAGTGTTCACTACGATCCGCACTTATATCCACATCCAAAACTCTTCGATTCCAGCCGCCT 69 FBan0014753 FBgn0033303 Cyp6a15Psi 2 2R Cyp6a15Psi Cyp6a15Psi "CG14753, CG14753, Cyp6a15p, 6a15p, CR14753" CDMC21234 4 10 18 DAC29-D24 9-CR14753-RA_1 CR14753 ACCTGTGCACAGTGTTCACTACGATCCGCACTTATATCCACATCCAAAACTCTTCGATTCCAGCCGCCT 69 FBan0014753 FBgn0033303 Cyp6a15Psi 2 2R Cyp6a15Psi Cyp6a15Psi "CG14753, CG14753, Cyp6a15p, 6a15p, CR14753" CDMC21235 4 11 18 DAC29-H12 2-CR31511-RA_3 CR31511 GGAGCCACAAGATATTCAACCATGGAAAGGGACCCGAGATTGCTCACAGCCAGCTAGCAAGTGCGTAAA 69 FBgn0020769 CDMC21235 4 12 18 DAC29-H12 2-CR31511-RA_3 CR31511 GGAGCCACAAGATATTCAACCATGGAAAGGGACCCGAGATTGCTCACAGCCAGCTAGCAAGTGCGTAAA 69 FBgn0020769 CDMC21236 4 13 18 DAC29-H24 9-CR31863-RA_1 CR31863 CCAGCTACTGCCTCTCTCCGTTTTGGCCAAATTTGCATATTGAACGGCAGTTTGTCTTGAGCCTGAGCT 69 FBan0031863 FBgn0041606 bft 2 2L bristle morphogenesis; GO:0008407 bft bereft "CR31863, bereft" CDMC21236 4 14 18 DAC29-H24 9-CR31863-RA_1 CR31863 CCAGCTACTGCCTCTCTCCGTTTTGGCCAAATTTGCATATTGAACGGCAGTTTGTCTTGAGCCTGAGCT 69 FBan0031863 FBgn0041606 bft 2 2L bristle morphogenesis; GO:0008407 bft bereft "CR31863, bereft" CDMC21237 4 15 18 DAC29-L12 14-CR32665-RB_2 CR32665 CGACACGTTGCGCCTATGACAATCCTAATTCCATCCTCTTCTCTTTCGTTTAGGTAGCTCGGATGGCCA 69 FBan0032665 FBgn0019660 roX2 X X "dosage compensation; GO:0007549; dosage compensation complex assembly (sensu Insecta); GO:0016457; dosage compensation, by hyperactivation of X chromosome; GO:0009047" X chromosome; GO:0000805; dosage compensation complex (sensu Insecta); GO:0016456 roX2 RNA on the X 2 "roX, rox2, CR32665, RNA on the X 2" CDMC21237 4 16 18 DAC29-L12 14-CR32665-RB_2 CR32665 CGACACGTTGCGCCTATGACAATCCTAATTCCATCCTCTTCTCTTTCGTTTAGGTAGCTCGGATGGCCA 69 FBan0032665 FBgn0019660 roX2 X X "dosage compensation; GO:0007549; dosage compensation complex assembly (sensu Insecta); GO:0016457; dosage compensation, by hyperactivation of X chromosome; GO:0009047" X chromosome; GO:0000805; dosage compensation complex (sensu Insecta); GO:0016456 roX2 RNA on the X 2 "roX, rox2, CR32665, RNA on the X 2" CDMC21238 4 17 18 DAC29-L24 23-CR32881-RA_1 CR32881 TCTGGTTTCTCTTCAATTGTCGAATAAATCTTTCGCCTTTTACTAAAGATTTCCGTGGAGAGGAACACT 69 FBan0032881 FBgn0043022 snRNA:U5:38ABa 2 2L nuclear mRNA splicing via U2-type spliceosome; GO:0006374 snRNP U5; GO:0005682 snRNA:U5:38ABa snRNA:U5:38ABa "dU5, K2, U5, U5 small nuclear RNA, U5-38ABa, snRNA:U5, U5snRNA, CR32881, small nuclear RNA U5" CDMC21238 4 18 18 DAC29-L24 23-CR32881-RA_1 CR32881 TCTGGTTTCTCTTCAATTGTCGAATAAATCTTTCGCCTTTTACTAAAGATTTCCGTGGAGAGGAACACT 69 FBan0032881 FBgn0043022 snRNA:U5:38ABa 2 2L nuclear mRNA splicing via U2-type spliceosome; GO:0006374 snRNP U5; GO:0005682 snRNA:U5:38ABa snRNA:U5:38ABa "dU5, K2, U5, U5 small nuclear RNA, U5-38ABa, snRNA:U5, U5snRNA, CR32881, small nuclear RNA U5" CDMC21239 4 19 18 DAC29-P12 10-CR40454-RA_1 CR40454 TGTGCGTCATCGTGTGAACTGCAGGACACATGAACATCGACATTTTGAACGCATATCGCAGTCCATGCT 69 FBgn0058454 CDMC21239 4 20 18 DAC29-P12 10-CR40454-RA_1 CR40454 TGTGCGTCATCGTGTGAACTGCAGGACACATGAACATCGACATTTTGAACGCATATCGCAGTCCATGCT 69 FBgn0058454 CDMC21240 4 21 18 DAC29-P24 3-CR9700-RA_1 CR9700 AGTCCATATTGTCTGGTCAAGTCACTGCAGATCACCTTTCAGCTTTGCCTGCTGGTCTTTGTGGGCGTT 69 FBan0009700 FBgn0026399 Or85e 3 3R Or85e Odorant receptor 85e "CG9700, CG9700, CG9700, dor104, Odorant receptor 104, Dor104, 85B.1, DOR104, DOR85e, 85e, CR9700, Or104: Odorant receptor 104" CDMC21240 4 22 18 DAC29-P24 3-CR9700-RA_1 CR9700 AGTCCATATTGTCTGGTCAAGTCACTGCAGATCACCTTTCAGCTTTGCCTGCTGGTCTTTGTGGGCGTT 69 FBan0009700 FBgn0026399 Or85e 3 3R Or85e Odorant receptor 85e "CG9700, CG9700, CG9700, dor104, Odorant receptor 104, Dor104, 85B.1, DOR104, DOR85e, 85e, CR9700, Or104: Odorant receptor 104" CDMC21241 4 23 18 DAC30-D12 6-CG12006-RA_1 CG12006 GCCCGCCTGGTATCTGAGCACAGTGCATCAGAAGGGACCCATTGAACTGATGCCCAAGTTGAGAGAAAT 69 FBan0012006 FBgn0035464 CG12006 3 3L lipid metabolism; GO:0006629; phospholipid metabolism; GO:0006644; protein lipidation; GO:0006497; protein metabolism; GO:0019538; protein modification; GO:0006464 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-" CG12006 CG12006 CDMC21241 4 24 18 DAC30-D12 6-CG12006-RA_1 CG12006 GCCCGCCTGGTATCTGAGCACAGTGCATCAGAAGGGACCCATTGAACTGATGCCCAAGTTGAGAGAAAT 69 FBan0012006 FBgn0035464 CG12006 3 3L lipid metabolism; GO:0006629; phospholipid metabolism; GO:0006644; protein lipidation; GO:0006497; protein metabolism; GO:0019538; protein modification; GO:0006464 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-" CG12006 CG12006 CDMC21242 4 25 18 DAC30-D24 39-CG12017-RA_1 CG12017 CGGTCGGATACTTGATGCTTGGGATGGAGAGCTGAATATCCAATGGCAGAAACTAAAAGTCGAGGCCGA 69 FBan0012017 FBgn0035429 CG12017 3 3L CG12017 CG12017 CDMC21242 4 26 18 DAC30-D24 39-CG12017-RA_1 CG12017 CGGTCGGATACTTGATGCTTGGGATGGAGAGCTGAATATCCAATGGCAGAAACTAAAAGTCGAGGCCGA 69 FBan0012017 FBgn0035429 CG12017 3 3L CG12017 CG12017 CDMC21243 4 1 19 DAC30-H12 17-CG12052-RE_1 CG12052 TGATGAACGAGGAGTGGAACATGAAGCTGGGCCTACAGATCATATCGAATTCATTGCTCAAGGAGCGAT 69 FBan0012052 FBgn0005630 lola 2 2R "axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; chromatin assembly or disassembly; GO:0006333; ciliary or flagellar motility; GO:0001539; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003704; ; GO:0003676; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; motor activity; GO:0003774; ; GO:0003702; ; GO:0003704; ; GO:0005198; protein binding; GO:0005515; zinc ion binding; GO:0008270; transcriptional activator activity; GO:0016563; ; GO:0005509; ; GO:0008270; ; GO:0005515; ; GO:0003774; ; GO:0016563; ; GO:0005515 flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 lola longitudinals lacking "CG12052, CG18378, CG30012, CG18379, CG18381, CG18376, CG18380, CG30013, CG30014, CG12052, CG18378, CG18378, CG12052, CG30012, CG18378, CG18379, CG18381, CG12052, CG18381, l(2)s3697, BTB-IV, misguided, l(2)00642, LD03274, longitudinals absent, bs06a08.y1, BcDNA:LD17006, BEST:LD03274, BtbIV, sw59, BcDNA:RH31485, NEST:bs06a08, BTB-protein-IV" CDMC21243 4 2 19 DAC30-H12 17-CG12052-RE_1 CG12052 TGATGAACGAGGAGTGGAACATGAAGCTGGGCCTACAGATCATATCGAATTCATTGCTCAAGGAGCGAT 69 FBan0012052 FBgn0005630 lola 2 2R "axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; chromatin assembly or disassembly; GO:0006333; ciliary or flagellar motility; GO:0001539; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003704; ; GO:0003676; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; motor activity; GO:0003774; ; GO:0003702; ; GO:0003704; ; GO:0005198; protein binding; GO:0005515; zinc ion binding; GO:0008270; transcriptional activator activity; GO:0016563; ; GO:0005509; ; GO:0008270; ; GO:0005515; ; GO:0003774; ; GO:0016563; ; GO:0005515 flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 lola longitudinals lacking "CG12052, CG18378, CG30012, CG18379, CG18381, CG18376, CG18380, CG30013, CG30014, CG12052, CG18378, CG18378, CG12052, CG30012, CG18378, CG18379, CG18381, CG12052, CG18381, l(2)s3697, BTB-IV, misguided, l(2)00642, LD03274, longitudinals absent, bs06a08.y1, BcDNA:LD17006, BEST:LD03274, BtbIV, sw59, BcDNA:RH31485, NEST:bs06a08, BTB-protein-IV" CDMC21244 4 3 19 DAC30-H24 15-CG12052-RO_2 CG12052 ACCTCCAAAACCATAACCAACCCAAATGAACCCAATTGTTGTGGAAAAGCTGGTCCACATTCCTGCACA 69 FBan0012052 FBgn0005630 lola 2 2R "axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; chromatin assembly or disassembly; GO:0006333; ciliary or flagellar motility; GO:0001539; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003704; ; GO:0003676; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; motor activity; GO:0003774; ; GO:0003702; ; GO:0003704; ; GO:0005198; protein binding; GO:0005515; zinc ion binding; GO:0008270; transcriptional activator activity; GO:0016563; ; GO:0005509; ; GO:0008270; ; GO:0005515; ; GO:0003774; ; GO:0016563; ; GO:0005515 flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 lola longitudinals lacking "CG12052, CG18378, CG30012, CG18379, CG18381, CG18376, CG18380, CG30013, CG30014, CG12052, CG18378, CG18378, CG12052, CG30012, CG18378, CG18379, CG18381, CG12052, CG18381, l(2)s3697, BTB-IV, misguided, l(2)00642, LD03274, longitudinals absent, bs06a08.y1, BcDNA:LD17006, BEST:LD03274, BtbIV, sw59, BcDNA:RH31485, NEST:bs06a08, BTB-protein-IV" CDMC21244 4 4 19 DAC30-H24 15-CG12052-RO_2 CG12052 ACCTCCAAAACCATAACCAACCCAAATGAACCCAATTGTTGTGGAAAAGCTGGTCCACATTCCTGCACA 69 FBan0012052 FBgn0005630 lola 2 2R "axon guidance; GO:0007411; axon midline choice point recognition; GO:0016199; axonogenesis; GO:0007409; chromatin assembly or disassembly; GO:0006333; ciliary or flagellar motility; GO:0001539; positive regulation of transcription, DNA-dependent; GO:0045893; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226" nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; specific RNA polymerase II transcription factor activity; GO:0003704; ; GO:0003704; ; GO:0003704; ; GO:0003676; structural molecule activity; GO:0005198; calcium ion binding; GO:0005509; motor activity; GO:0003774; ; GO:0003702; ; GO:0003704; ; GO:0005198; protein binding; GO:0005515; zinc ion binding; GO:0008270; transcriptional activator activity; GO:0016563; ; GO:0005509; ; GO:0008270; ; GO:0005515; ; GO:0003774; ; GO:0016563; ; GO:0005515 flagellum (sensu Bacteria); GO:0009288; nucleus; GO:0005634 lola longitudinals lacking "CG12052, CG18378, CG30012, CG18379, CG18381, CG18376, CG18380, CG30013, CG30014, CG12052, CG18378, CG18378, CG12052, CG30012, CG18378, CG18379, CG18381, CG12052, CG18381, l(2)s3697, BTB-IV, misguided, l(2)00642, LD03274, longitudinals absent, bs06a08.y1, BcDNA:LD17006, BEST:LD03274, BtbIV, sw59, BcDNA:RH31485, NEST:bs06a08, BTB-protein-IV" CDMC21245 4 5 19 DAC30-L12 11-CG1208-RA_1 CG1208 TGCCGTAATCTTCTTCATGAACGAGATCTTCGAGTCTAGCAGCACGCTGAATCCCAACGTCTGCACCAT 69 FBan0001208 FBgn0037386 CG1208 3 3R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 glucose transporter activity; GO:0005355; ; GO:0005355; sugar porter activity; GO:0005351; ; GO:0005351 integral to membrane; GO:0016021; membrane; GO:0016020 CG1208 CG1208 CDMC21245 4 6 19 DAC30-L12 11-CG1208-RA_1 CG1208 TGCCGTAATCTTCTTCATGAACGAGATCTTCGAGTCTAGCAGCACGCTGAATCCCAACGTCTGCACCAT 69 FBan0001208 FBgn0037386 CG1208 3 3R carbohydrate metabolism; GO:0005975; carbohydrate transport; GO:0008643 glucose transporter activity; GO:0005355; ; GO:0005355; sugar porter activity; GO:0005351; ; GO:0005351 integral to membrane; GO:0016021; membrane; GO:0016020 CG1208 CG1208 CDMC21246 4 7 19 DAC30-L24 23-CG12106-RA_1 CG12106 TGCCAGGACAAACTGCAAAGGTAGTTGGCATTAGTTATGTATGTAGATATACTCGTTTAGATAATAGGT 69 FBan0012106 FBgn0030100 CG12106 X X CG12106 CG12106 BcDNA:GH03263 CDMC21246 4 8 19 DAC30-L24 23-CG12106-RA_1 CG12106 TGCCAGGACAAACTGCAAAGGTAGTTGGCATTAGTTATGTATGTAGATATACTCGTTTAGATAATAGGT 69 FBan0012106 FBgn0030100 CG12106 X X CG12106 CG12106 BcDNA:GH03263 CDMC21247 4 9 19 DAC30-P12 8-CG12133-RA_1 CG12133 GCCAAGGCACCATCAGTGGAATGAGTCCGGATGAATGCTTGAATCGGTATCCAACACTGCTCGTCGATA 69 FBan0012133 FBgn0033469 CG12133 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG12133 CG12133 SP15 CDMC21247 4 10 19 DAC30-P12 8-CG12133-RA_1 CG12133 GCCAAGGCACCATCAGTGGAATGAGTCCGGATGAATGCTTGAATCGGTATCCAACACTGCTCGTCGATA 69 FBan0012133 FBgn0033469 CG12133 2 2R proteolysis; GO:0006508 trypsin activity; GO:0004295 ; EC:3.4.21.4; serine-type endopeptidase activity; GO:0004252 ; EC:3.4.21.-; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004252 ; EC:3.4.21.-; ; GO:0004295 ; EC:3.4.21.4; ; GO:0004263 ; EC:3.4.21.1 CG12133 CG12133 SP15 CDMC21248 4 11 19 DAC30-P24 AutoBlank AutoBlank CDMC21248 4 12 19 DAC30-P24 AutoBlank AutoBlank CDMC21249 4 13 19 DAC31-D12 2-CG3999-RA_1 CG3999 GGTCGCATGGACAAGGCAGTCAATCCACTGAAGATGTCTCCTCACACCCAAGCTCAGGTGATCTCG 66 FBan0003999 FBgn0037801 CG3999 3 3R amino acid catabolism; GO:0009063; glycine metabolism; GO:0006544 glycine dehydrogenase (decarboxylating) activity; GO:0004375 ; EC:1.4.4.2; ; GO:0004375 ; EC:1.4.4.2 glycine dehydrogenase complex (decarboxylating); GO:0005961 CG3999 CG3999 CDMC21249 4 14 19 DAC31-D12 2-CG3999-RA_1 CG3999 GGTCGCATGGACAAGGCAGTCAATCCACTGAAGATGTCTCCTCACACCCAAGCTCAGGTGATCTCG 66 FBan0003999 FBgn0037801 CG3999 3 3R amino acid catabolism; GO:0009063; glycine metabolism; GO:0006544 glycine dehydrogenase (decarboxylating) activity; GO:0004375 ; EC:1.4.4.2; ; GO:0004375 ; EC:1.4.4.2 glycine dehydrogenase complex (decarboxylating); GO:0005961 CG3999 CG3999 CDMC21250 4 15 19 DAC31-D24 18-CG40384-RA_8 CG40384 AGTTTCAAAGGGTATTATTGGCTACTACAACCCCCGTTCCTTAGTGGGTAGCGAACGAGAGTTGGT 66 FBgn0058384 CG40384 CG40384 CG40384 CDMC21250 4 16 19 DAC31-D24 18-CG40384-RA_8 CG40384 AGTTTCAAAGGGTATTATTGGCTACTACAACCCCCGTTCCTTAGTGGGTAGCGAACGAGAGTTGGT 66 FBgn0058384 CG40384 CG40384 CG40384 CDMC21251 4 17 19 DAC31-H12 3-CG4501-RA_3 CG4501 GGAGAGCTGTGCATCCGAGGACGTCACGTTTTCATGGGCTACATCGACAACAAGGAGAAGACCGAG 66 FBan0004501 FBgn0027348 bgm 2 2L fatty acid metabolism; GO:0006631 long-chain-fatty-acid-CoA ligase activity; GO:0004467 ; EC:6.2.1.3; ; GO:0004467 ; EC:6.2.1.3; ; GO:0004467 ; EC:6.2.1.3 bgm bubblegum "CG4501, CG4501, BG:DS01514.2, BG:DS0514.2, 2a9hom, bubblegum" CDMC21251 4 18 19 DAC31-H12 3-CG4501-RA_3 CG4501 GGAGAGCTGTGCATCCGAGGACGTCACGTTTTCATGGGCTACATCGACAACAAGGAGAAGACCGAG 66 FBan0004501 FBgn0027348 bgm 2 2L fatty acid metabolism; GO:0006631 long-chain-fatty-acid-CoA ligase activity; GO:0004467 ; EC:6.2.1.3; ; GO:0004467 ; EC:6.2.1.3; ; GO:0004467 ; EC:6.2.1.3 bgm bubblegum "CG4501, CG4501, BG:DS01514.2, BG:DS0514.2, 2a9hom, bubblegum" CDMC21252 4 19 19 DAC31-H24 6-CG4636-RA_4 CG4636 TGAGCAATACTTTCCACAGCATCGGTATGACGGGCAATCAACTGAACTCCCTTAGCGACTTGCCGC 66 FBan0004636 FBgn0041781 SCAR 2 2L actin filament organization; GO:0007015; actin filament reorganization during cell cycle; GO:0030037; actin filament-based process; GO:0030029; axonal fasciculation; GO:0007413; axonogenesis; GO:0007409; cell projection biogenesis; GO:0030031; compound eye morphogenesis (sensu Endopterygota); GO:0001745; cortical actin cytoskeleton organization and biogenesis; GO:0030866; cytoskeleton organization and biogenesis; GO:0007010; ovarian ring canal stabilization; GO:0008335; regulation of cell shape; GO:0008360 actin binding; GO:0003779; ; GO:0003779 SCAR SCAR "CG4636, CG4636, l(2)k13811, l(2)k03107, D-SCAR, Scar, WAVE, scar, wave, Wave, BEST:SD02991" CDMC21252 4 20 19 DAC31-H24 6-CG4636-RA_4 CG4636 TGAGCAATACTTTCCACAGCATCGGTATGACGGGCAATCAACTGAACTCCCTTAGCGACTTGCCGC 66 FBan0004636 FBgn0041781 SCAR 2 2L actin filament organization; GO:0007015; actin filament reorganization during cell cycle; GO:0030037; actin filament-based process; GO:0030029; axonal fasciculation; GO:0007413; axonogenesis; GO:0007409; cell projection biogenesis; GO:0030031; compound eye morphogenesis (sensu Endopterygota); GO:0001745; cortical actin cytoskeleton organization and biogenesis; GO:0030866; cytoskeleton organization and biogenesis; GO:0007010; ovarian ring canal stabilization; GO:0008335; regulation of cell shape; GO:0008360 actin binding; GO:0003779; ; GO:0003779 SCAR SCAR "CG4636, CG4636, l(2)k13811, l(2)k03107, D-SCAR, Scar, WAVE, scar, wave, Wave, BEST:SD02991" CDMC21253 4 21 19 DAC31-L12 6-CG4988-RA_4 CG4988 GGGAGTTAACCCTTGTTGACAACACGGCTTATGATCTCAGGTCACCTGTGGTCCTGGGAGATCGCC 66 FBan0004988 FBgn0032372 CG4988 2 2L galactose metabolism; GO:0006012; monosaccharide metabolism; GO:0005996 UDP-glucose 4-epimerase activity; GO:0003978 ; EC:5.1.3.2; ; GO:0003978 ; EC:5.1.3.2; aldose 1-epimerase activity; GO:0004034 ; EC:5.1.3.3; ; GO:0004034 ; EC:5.1.3.3 CG4988 CG4988 CDMC21253 4 22 19 DAC31-L12 6-CG4988-RA_4 CG4988 GGGAGTTAACCCTTGTTGACAACACGGCTTATGATCTCAGGTCACCTGTGGTCCTGGGAGATCGCC 66 FBan0004988 FBgn0032372 CG4988 2 2L galactose metabolism; GO:0006012; monosaccharide metabolism; GO:0005996 UDP-glucose 4-epimerase activity; GO:0003978 ; EC:5.1.3.2; ; GO:0003978 ; EC:5.1.3.2; aldose 1-epimerase activity; GO:0004034 ; EC:5.1.3.3; ; GO:0004034 ; EC:5.1.3.3 CG4988 CG4988 CDMC21254 4 23 19 DAC31-L24 2-CG5068-RA_1 CG5068 GACCCCACAGCGAAGACAATCGGATCAATGTCGAGTTTACAGCGCACGATGTTGAAGGGCAAGCTG 66 FBan0005068 FBgn0035951 CG5068 3 3L protein metabolism; GO:0019538; protein modification; GO:0006464 "hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016788 ; EC:3.1.-.-" CG5068 CG5068 CDMC21254 4 24 19 DAC31-L24 2-CG5068-RA_1 CG5068 GACCCCACAGCGAAGACAATCGGATCAATGTCGAGTTTACAGCGCACGATGTTGAAGGGCAAGCTG 66 FBan0005068 FBgn0035951 CG5068 3 3L protein metabolism; GO:0019538; protein modification; GO:0006464 "hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0016788 ; EC:3.1.-.-" CG5068 CG5068 CDMC21255 4 25 19 DAC31-P12 AutoBlank AutoBlank CDMC21255 4 26 19 DAC31-P12 AutoBlank AutoBlank CDMC21256 4 1 20 DAC31-P24 AutoBlank AutoBlank CDMC21256 4 2 20 DAC31-P24 AutoBlank AutoBlank CDMC21257 4 3 20 DAC32-D12 12-CG11158-RA_2 CG11158 GGCCGGAAAGTGGACGACATTCATGGCAAGAAGATAAATGTGCACATCATTAGGCGCCTCACTAGTGGA 69 FBan0011158 FBgn0030511 CG11158 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; purine base metabolism; GO:0006144; pyrimidine base metabolism; GO:0006206" hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.- CG11158 CG11158 CDMC21257 4 4 20 DAC32-D12 12-CG11158-RA_2 CG11158 GGCCGGAAAGTGGACGACATTCATGGCAAGAAGATAAATGTGCACATCATTAGGCGCCTCACTAGTGGA 69 FBan0011158 FBgn0030511 CG11158 X X "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; purine base metabolism; GO:0006144; pyrimidine base metabolism; GO:0006206" hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.- CG11158 CG11158 CDMC21258 4 5 20 DAC32-D24 9-CG11169-RA_1 CG11169 CCACGGCCTTGACCTCCAGGAGATTGTCCACGAGCAGGTGAGTCGTGTCTATTCTATGTCTATTCAGCT 69 FBgn0034905 CDMC21258 4 6 20 DAC32-D24 9-CG11169-RA_1 CG11169 CCACGGCCTTGACCTCCAGGAGATTGTCCACGAGCAGGTGAGTCGTGTCTATTCTATGTCTATTCAGCT 69 FBgn0034905 CDMC21259 4 7 20 DAC32-H12 8-CG11226-RA_3 CG11226 CAGAGCGTTGGACTTGCCCGGGATAATACGATCATGACCTCTGCCAAAAATACGAACCCTTCCTGTCGT 69 FBan0011226 FBgn0037195 CG11226 3 3L CG11226 CG11226 BcDNA:AT16729 CDMC21259 4 8 20 DAC32-H12 8-CG11226-RA_3 CG11226 CAGAGCGTTGGACTTGCCCGGGATAATACGATCATGACCTCTGCCAAAAATACGAACCCTTCCTGTCGT 69 FBan0011226 FBgn0037195 CG11226 3 3L CG11226 CG11226 BcDNA:AT16729 CDMC21260 4 9 20 DAC32-H24 9-CG11245-RA_1 CG11245 ACGGTTGTGCGAACTTAAGCGCCAGCATGAAAAAGAAACTGCGCAAGGAGAAAAAGAAGCAAAAGGCGA 69 FBan0011245 FBgn0030388 CG11245 X X CG11245 CG11245 CDMC21260 4 10 20 DAC32-H24 9-CG11245-RA_1 CG11245 ACGGTTGTGCGAACTTAAGCGCCAGCATGAAAAAGAAACTGCGCAAGGAGAAAAAGAAGCAAAAGGCGA 69 FBan0011245 FBgn0030388 CG11245 X X CG11245 CG11245 CDMC21261 4 11 20 DAC32-L12 16-CG11271-RE_1 CG11271 TGGACGCGCGTTACCTCTACAAAGTGTTTCTGAAAATCCAGGCATCCAGTGAAATCAGCGTGTGATATT 69 FBan0011271 FBgn0014027 RpS12 3 3L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS12 Ribosomal protein S12 "CG11271, CG17672, l(3)s2783, RS12, 40S ribosomal protein S12., S12, BcDNA:RH29995, RpS12E" CDMC21261 4 12 20 DAC32-L12 16-CG11271-RE_1 CG11271 TGGACGCGCGTTACCTCTACAAAGTGTTTCTGAAAATCCAGGCATCCAGTGAAATCAGCGTGTGATATT 69 FBan0011271 FBgn0014027 RpS12 3 3L protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS12 Ribosomal protein S12 "CG11271, CG17672, l(3)s2783, RS12, 40S ribosomal protein S12., S12, BcDNA:RH29995, RpS12E" CDMC21262 4 13 20 DAC32-L24 9-CG11289-RA_1 CG11289 TGCAGTCGAAAAACTGGGGTTTGACCTTATCCACCAACAATCTGACGCATTGGAAACTAGCGAAGGCCA 69 FBan0011289 FBgn0031887 CG11289 2 2L defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 ATP binding; GO:0005524; ; GO:0005524; glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ATPase activity; GO:0016887; ; GO:0016887 membrane; GO:0016020 CG11289 CG11289 CDMC21262 4 14 20 DAC32-L24 9-CG11289-RA_1 CG11289 TGCAGTCGAAAAACTGGGGTTTGACCTTATCCACCAACAATCTGACGCATTGGAAACTAGCGAAGGCCA 69 FBan0011289 FBgn0031887 CG11289 2 2L defense response; GO:0006952; polysaccharide metabolism; GO:0005976; response to toxin; GO:0009636; steroid metabolism; GO:0008202 ATP binding; GO:0005524; ; GO:0005524; glucuronosyltransferase activity; GO:0015020 ; EC:2.4.1.17; ; GO:0015020 ; EC:2.4.1.17; ATPase activity; GO:0016887; ; GO:0016887 membrane; GO:0016020 CG11289 CG11289 CDMC21263 4 15 20 DAC32-P12 8-CG11321-RB_1 CG11321 AGGACCCTGGGACACCGATGAGATCTACAAGAACATGTGCTCCGAGGTAGGTGTTGGCTATCATCAGTT 69 FBan0011321 FBgn0031857 CG11321 2 2L protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG11321 CG11321 CDMC21263 4 16 20 DAC32-P12 8-CG11321-RB_1 CG11321 AGGACCCTGGGACACCGATGAGATCTACAAGAACATGTGCTCCGAGGTAGGTGTTGGCTATCATCAGTT 69 FBan0011321 FBgn0031857 CG11321 2 2L protein ubiquitination; GO:0016567 ubiquitin-protein ligase activity; GO:0004842 ; EC:6.3.2.19; zinc ion binding; GO:0008270; ; GO:0004842 ; EC:6.3.2.19; ; GO:0008270 ubiquitin ligase complex; GO:0000151 CG11321 CG11321 CDMC21264 4 17 20 DAC32-P24 AutoBlank AutoBlank CDMC21264 4 18 20 DAC32-P24 AutoBlank AutoBlank CDMC21265 4 19 20 DAC33-D12 22-CG12610-RA_1 CG12610 TGGTGCTCAATGTGATCATCGTGGTGTACATAATGTACCATCGACTTTACAAGGATGTGACCCATGCGT 69 FBan0032547 FBgn0052547 CG32547 X X G-protein coupled receptor protein signaling pathway; GO:0007186 neuropeptide receptor activity; GO:0008188; ; GO:0008188 integral to membrane; GO:0016021 CG32547 CG32547 "CG12610, CG15049, CG15050, CG12610, CG12610" CDMC21265 4 20 20 DAC33-D12 22-CG12610-RA_1 CG12610 TGGTGCTCAATGTGATCATCGTGGTGTACATAATGTACCATCGACTTTACAAGGATGTGACCCATGCGT 69 FBan0032547 FBgn0052547 CG32547 X X G-protein coupled receptor protein signaling pathway; GO:0007186 neuropeptide receptor activity; GO:0008188; ; GO:0008188 integral to membrane; GO:0016021 CG32547 CG32547 "CG12610, CG15049, CG15050, CG12610, CG12610" CDMC21266 4 21 20 DAC33-D24 22-CG1262-RA_1 CG1262 CCTGTGTTCTGCGATCCGATTGCCCAAAAGATGTTGTTCGAAAGGAAGATATGCTACTGGGTGTATCGA 69 FBan0001262 FBgn0020509 Acp62F 3 3L determination of adult life span; GO:0008340; negative regulation of proteolysis; GO:0045861; physiological process; GO:0007582; post-mating behavior; GO:0045297; regulation of proteolysis; GO:0030162 protease inhibitor activity; GO:0030414; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867; ; GO:0030414 Acp62F Accessory gland peptide 62F "CG1262, CG1262, Accessory gland protein 62F, CT2528, Acp62" CDMC21266 4 22 20 DAC33-D24 22-CG1262-RA_1 CG1262 CCTGTGTTCTGCGATCCGATTGCCCAAAAGATGTTGTTCGAAAGGAAGATATGCTACTGGGTGTATCGA 69 FBan0001262 FBgn0020509 Acp62F 3 3L determination of adult life span; GO:0008340; negative regulation of proteolysis; GO:0045861; physiological process; GO:0007582; post-mating behavior; GO:0045297; regulation of proteolysis; GO:0030162 protease inhibitor activity; GO:0030414; serine-type endopeptidase inhibitor activity; GO:0004867; ; GO:0004867; ; GO:0004867; ; GO:0030414 Acp62F Accessory gland peptide 62F "CG1262, CG1262, Accessory gland protein 62F, CT2528, Acp62" CDMC21267 4 23 20 DAC33-H12 2-CG12674-RA_3 CG12674 AGCAACAAAAGGCGATGATTGATGCGAGCTTCAAGGATATTGGCAAACCCCTCTACCGACATCCCACCA 69 FBan0012674 FBgn0031388 CG12674 2 2L CG12674 CG12674 CDMC21267 4 24 20 DAC33-H12 2-CG12674-RA_3 CG12674 AGCAACAAAAGGCGATGATTGATGCGAGCTTCAAGGATATTGGCAAACCCCTCTACCGACATCCCACCA 69 FBan0012674 FBgn0031388 CG12674 2 2L CG12674 CG12674 CDMC21268 4 25 20 DAC33-H24 11-CG12684-RA_1 CG12684 GCTGCTGCCAACTATTCATGTCCGCACTCAAAAGCCAAGAACAGTACATGTCCAAAAGCCAGGACCAAT 69 FBan0012684 FBgn0029717 CG12684 X X CG12684 CG12684 CDMC21268 4 26 20 DAC33-H24 11-CG12684-RA_1 CG12684 GCTGCTGCCAACTATTCATGTCCGCACTCAAAAGCCAAGAACAGTACATGTCCAAAAGCCAGGACCAAT 69 FBan0012684 FBgn0029717 CG12684 X X CG12684 CG12684 CDMC21269 4 1 21 DAC33-L12 24-CG12740-RA_1 CG12740 CGACAAACTATATTATTGTTGATACAAAAGGTATCTTTAGATCAATCAATCTTTGTTTGCCTAAATGAT 69 FBan0012740 FBgn0035422 RpL28 3 3L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL28 Ribosomal protein L28 "CG12740, L28, anon-WO0118547.321, BcDNA:GH04183, Ribosomal protein L28" CDMC21269 4 2 21 DAC33-L12 24-CG12740-RA_1 CG12740 CGACAAACTATATTATTGTTGATACAAAAGGTATCTTTAGATCAATCAATCTTTGTTTGCCTAAATGAT 69 FBan0012740 FBgn0035422 RpL28 3 3L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; ; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL28 Ribosomal protein L28 "CG12740, L28, anon-WO0118547.321, BcDNA:GH04183, Ribosomal protein L28" CDMC21270 4 3 21 DAC33-L24 9-CG12750-RA_6 CG12750 CGGATGGAGAGTAGTCGCAGTGAAAAAGACAGTCGTCGTGGTGACCGTTCCTCCAGAAACGAGAGATCA 69 FBan0012750 FBgn0032678 CG12750 2 2L protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; ; GO:0003729 CG12750 CG12750 CDMC21270 4 4 21 DAC33-L24 9-CG12750-RA_6 CG12750 CGGATGGAGAGTAGTCGCAGTGAAAAAGACAGTCGTCGTGGTGACCGTTCCTCCAGAAACGAGAGATCA 69 FBan0012750 FBgn0032678 CG12750 2 2L protein biosynthesis; GO:0006412 mRNA binding; GO:0003729; ; GO:0003729 CG12750 CG12750 CDMC21271 4 5 21 DAC33-P12 2-CG12787-RA_3 CG12787 TCTTCTTCGCAGCTCTGTTTATTCTCATGGAAGCCCTGACGGAACTGGGACTGATTGAGTGGATCGGCA 69 FBan0012787 FBgn0041150 hoe1 2 2L anion transport; GO:0006820; cation transport; GO:0006812; citrate transport; GO:0015746; transport; GO:0006810 transporter activity; GO:0005215; L-tyrosine transporter activity; GO:0005302; cation transporter activity; GO:0008324; ; GO:0005215; ; GO:0005302; ; GO:0008324; citrate transporter activity; GO:0015137; ; GO:0015137; arsenite transporter activity; GO:0015105; ; GO:0015105 integral to membrane; GO:0016021; membrane; GO:0016020 hoe1 hoepel1 "CG2831, CG12787, CG11918, CG2831, hoe, hoepel, BcDNA:GH02636" CDMC21271 4 6 21 DAC33-P12 2-CG12787-RA_3 CG12787 TCTTCTTCGCAGCTCTGTTTATTCTCATGGAAGCCCTGACGGAACTGGGACTGATTGAGTGGATCGGCA 69 FBan0012787 FBgn0041150 hoe1 2 2L anion transport; GO:0006820; cation transport; GO:0006812; citrate transport; GO:0015746; transport; GO:0006810 transporter activity; GO:0005215; L-tyrosine transporter activity; GO:0005302; cation transporter activity; GO:0008324; ; GO:0005215; ; GO:0005302; ; GO:0008324; citrate transporter activity; GO:0015137; ; GO:0015137; arsenite transporter activity; GO:0015105; ; GO:0015105 integral to membrane; GO:0016021; membrane; GO:0016020 hoe1 hoepel1 "CG2831, CG12787, CG11918, CG2831, hoe, hoepel, BcDNA:GH02636" CDMC21272 4 7 21 DAC33-P24 AutoBlank AutoBlank CDMC21272 4 8 21 DAC33-P24 AutoBlank AutoBlank CDMC21273 4 9 21 DAC34-D12 15-CG4371-RA_2 CG4371 CGTGGAGAGGTGGCTTAAGAATGCCCCAAAAGTAACTCCTGGATGGGAGCAAAATCTTGAGAGTCTGCA 69 FBan0004371 FBgn0010043 GstD7 3 3R defense response; GO:0006952; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 GstD7 Glutathione S transferase D7 "CG4371, CG4371, DmGST26, gstD26, Gst, DmGSTD7, GstD26: Glutathione S transferase D26, Glutathione S transferase D26, Glutathione S transferase D7" CDMC21273 4 10 21 DAC34-D12 15-CG4371-RA_2 CG4371 CGTGGAGAGGTGGCTTAAGAATGCCCCAAAAGTAACTCCTGGATGGGAGCAAAATCTTGAGAGTCTGCA 69 FBan0004371 FBgn0010043 GstD7 3 3R defense response; GO:0006952; response to toxin; GO:0009636 glutathione transferase activity; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18; ; GO:0004364 ; EC:2.5.1.18 GstD7 Glutathione S transferase D7 "CG4371, CG4371, DmGST26, gstD26, Gst, DmGSTD7, GstD26: Glutathione S transferase D26, Glutathione S transferase D26, Glutathione S transferase D7" CDMC21274 4 11 21 DAC34-D24 2-CG4380-RA_2 CG4380 AAAGCCGGTGTGTCAGCCATCTTCGACCGCATATTGTCGGAGCTGAGTGTAAAGATGAAGCGGCTGAAT 69 FBan0004380 FBgn0003964 usp X X "border follicle cell migration (sensu Insecta); GO:0007298; dendrite morphogenesis; GO:0016358; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; lipid metabolism; GO:0006629; metamorphosis; GO:0007552; negative regulation of cell differentiation; GO:0045596; negative regulation of transcription, DNA-dependent; GO:0045892; neuron remodeling; GO:0016322; positive regulation of transcription; GO:0045941; regulation of development, heterochronic; GO:0040034; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165" DNA binding; GO:0003677; juvenile hormone binding; GO:0005500; ; GO:0003677; ecdysteroid hormone receptor activity; GO:0004884; ; GO:0004884; ligand-dependent nuclear receptor activity; GO:0004879; ; GO:0005500; transcription factor activity; GO:0003700; protein binding; GO:0005515; ; GO:0004884; ; GO:0004879; ; GO:0004879; ; GO:0003700; ; GO:0005515 ecdysone receptor holocomplex; GO:0008230; nucleus; GO:0005634; polytene chromosome; GO:0005700 usp ultraspiracle "CG4380, CG4380, CG4380, l(1)usp, Cf1, XR2C, X receptor at 2C, 2C, CF1, Usp, CF1/USP, CF1/Usp, DmUsp, USP, DmUSP, NR2B4, chorion factor CF1, dmUSP, EG:22E5.1, Ultraspiracle, dUSP, cf1: Chorion factor 1, l(1)2Cf, Chorion factor 1" CDMC21274 4 12 21 DAC34-D24 2-CG4380-RA_2 CG4380 AAAGCCGGTGTGTCAGCCATCTTCGACCGCATATTGTCGGAGCTGAGTGTAAAGATGAAGCGGCTGAAT 69 FBan0004380 FBgn0003964 usp X X "border follicle cell migration (sensu Insecta); GO:0007298; dendrite morphogenesis; GO:0016358; ecdysone-mediated induction of salivary gland cell autophagic cell death; GO:0035072; lipid metabolism; GO:0006629; metamorphosis; GO:0007552; negative regulation of cell differentiation; GO:0045596; negative regulation of transcription, DNA-dependent; GO:0045892; neuron remodeling; GO:0016322; positive regulation of transcription; GO:0045941; regulation of development, heterochronic; GO:0040034; regulation of transcription from RNA polymerase II promoter; GO:0006357; signal transduction; GO:0007165" DNA binding; GO:0003677; juvenile hormone binding; GO:0005500; ; GO:0003677; ecdysteroid hormone receptor activity; GO:0004884; ; GO:0004884; ligand-dependent nuclear receptor activity; GO:0004879; ; GO:0005500; transcription factor activity; GO:0003700; protein binding; GO:0005515; ; GO:0004884; ; GO:0004879; ; GO:0004879; ; GO:0003700; ; GO:0005515 ecdysone receptor holocomplex; GO:0008230; nucleus; GO:0005634; polytene chromosome; GO:0005700 usp ultraspiracle "CG4380, CG4380, CG4380, l(1)usp, Cf1, XR2C, X receptor at 2C, 2C, CF1, Usp, CF1/USP, CF1/Usp, DmUsp, USP, DmUSP, NR2B4, chorion factor CF1, dmUSP, EG:22E5.1, Ultraspiracle, dUSP, cf1: Chorion factor 1, l(1)2Cf, Chorion factor 1" CDMC21275 4 13 21 DAC34-H12 6-CG4424-RA_2 CG4424 ACCCATCGAAATGAGCGTCCTTATGCCTGCAAGACCTGCGGAAAGAAGTTCACATATGCCAGTGTCCTT 69 FBan0004424 FBgn0038765 CG4424 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG4424 CG4424 CDMC21275 4 14 21 DAC34-H12 6-CG4424-RA_2 CG4424 ACCCATCGAAATGAGCGTCCTTATGCCTGCAAGACCTGCGGAAAGAAGTTCACATATGCCAGTGTCCTT 69 FBan0004424 FBgn0038765 CG4424 3 3R "nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG4424 CG4424 CDMC21276 4 15 21 DAC34-H24 23-CG4433-RA_8 CG4433 CTCGCGCTACATGTTTATCAATTCGATGCGTCAGATAAATCTCTCGGATGTGGAGTTGGAAATGCAGAT 69 FBan0004433 FBgn0038763 CG4433 3 3R protein metabolism; GO:0019538; protein modification; GO:0006464 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-" CG4433 CG4433 CDMC21276 4 16 21 DAC34-H24 23-CG4433-RA_8 CG4433 CTCGCGCTACATGTTTATCAATTCGATGCGTCAGATAAATCTCTCGGATGTGGAGTTGGAAATGCAGAT 69 FBan0004433 FBgn0038763 CG4433 3 3R protein metabolism; GO:0019538; protein modification; GO:0006464 "transferase activity, transferring glycosyl groups; GO:0016757 ; EC:2.4.-.-; transferase activity; GO:0016740 ; EC:2.-.-.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0016757 ; EC:2.4.-.-" CG4433 CG4433 CDMC21277 4 17 21 DAC34-L12 23-CG4467-RA_10 CG4467 GGTCCTGTCACAGTTCTCTCTTCACACACTCATTTGTAATTATGTTCCTCTCTCAGACACACGAATCTT 69 FBan0004467 FBgn0039064 CG4467 3 3R proteolysis; GO:0006508 membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; glutamyl aminopeptidase activity; GO:0004230 ; EC:3.4.11.7; ; GO:0004230 ; EC:3.4.11.7; ; GO:0004179 ; EC:3.4.11.2 CG4467 CG4467 CDMC21277 4 18 21 DAC34-L12 23-CG4467-RA_10 CG4467 GGTCCTGTCACAGTTCTCTCTTCACACACTCATTTGTAATTATGTTCCTCTCTCAGACACACGAATCTT 69 FBan0004467 FBgn0039064 CG4467 3 3R proteolysis; GO:0006508 membrane alanyl aminopeptidase activity; GO:0004179 ; EC:3.4.11.2; glutamyl aminopeptidase activity; GO:0004230 ; EC:3.4.11.7; ; GO:0004230 ; EC:3.4.11.7; ; GO:0004179 ; EC:3.4.11.2 CG4467 CG4467 CDMC21278 4 19 21 DAC34-L24 23-CG4479-RA_7 CG4479 GAGCCTGTGGAATGGCATAATTTCCATTTCTGCAAAAGATGAAAGTCCTAAAGGTCTCACTGAAATGTG 69 FBan0004479 FBgn0013300 Mst35Ba 2 2L DNA binding; GO:0003677; ; GO:0003677 Mst35Ba Male-specific-transcript-35Ba "CG4479 (mst35Ba), BG:DS03431.2, protamine (mst35Ba), mst35Bb (mst35Ba), BcDNA:AT31403 (mst35Ba), mst35b (mst35Ba), protamine, mst35Bb" CDMC21278 4 20 21 DAC34-L24 23-CG4479-RA_7 CG4479 GAGCCTGTGGAATGGCATAATTTCCATTTCTGCAAAAGATGAAAGTCCTAAAGGTCTCACTGAAATGTG 69 FBan0004479 FBgn0013300 Mst35Ba 2 2L DNA binding; GO:0003677; ; GO:0003677 Mst35Ba Male-specific-transcript-35Ba "CG4479 (mst35Ba), BG:DS03431.2, protamine (mst35Ba), mst35Bb (mst35Ba), BcDNA:AT31403 (mst35Ba), mst35b (mst35Ba), protamine, mst35Bb" CDMC21279 4 21 21 DAC34-P12 23-CG4531-RA_11 CG4531 AGTCTCGCCAAGTTACCAACTAATGAACTAATGAGAAGGGAAAAACGAACAGATACCAGCTAGGAACTT 69 FBan0004531 FBgn0004569 argos 3 3L axon guidance; GO:0007411; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; negative regulation of cell differentiation; GO:0045596; negative regulation of cell fate specification; GO:0009996; negative regulation of epidermal growth factor receptor signaling pathway; GO:0042059; ommatidial rotation; GO:0016318; ovarian follicle cell development (sensu Insecta); GO:0030707; wing disc morphogenesis; GO:0007472; wing morphogenesis; GO:0007476 receptor antagonist activity; GO:0048019; ; GO:0048019; epidermal growth factor receptor binding; GO:0005154; ; GO:0005154; ; GO:0005154; ; GO:0048019 extracellular region; GO:0005576 argos argos "CG4531, CG4531, aos: argos, sty, gil, strawberry, rlt, roulette, arg, Argos, Aos, l(3)05845, l(3)05959, l(3)j5E11, l(3)rJ472, l(3)rJ812, l(3)rQ526, giant lens, aos" CDMC21279 4 22 21 DAC34-P12 23-CG4531-RA_11 CG4531 AGTCTCGCCAAGTTACCAACTAATGAACTAATGAGAAGGGAAAAACGAACAGATACCAGCTAGGAACTT 69 FBan0004531 FBgn0004569 argos 3 3L axon guidance; GO:0007411; establishment of ommatidial polarity (sensu Endopterygota); GO:0042067; negative regulation of cell differentiation; GO:0045596; negative regulation of cell fate specification; GO:0009996; negative regulation of epidermal growth factor receptor signaling pathway; GO:0042059; ommatidial rotation; GO:0016318; ovarian follicle cell development (sensu Insecta); GO:0030707; wing disc morphogenesis; GO:0007472; wing morphogenesis; GO:0007476 receptor antagonist activity; GO:0048019; ; GO:0048019; epidermal growth factor receptor binding; GO:0005154; ; GO:0005154; ; GO:0005154; ; GO:0048019 extracellular region; GO:0005576 argos argos "CG4531, CG4531, aos: argos, sty, gil, strawberry, rlt, roulette, arg, Argos, Aos, l(3)05845, l(3)05959, l(3)j5E11, l(3)rJ472, l(3)rJ812, l(3)rQ526, giant lens, aos" CDMC21280 4 23 21 DAC34-P24 2-CG4538-RB_1 CG4538 GCTGCTGGATCCCATGTTCATAGTGCCTGGTTCAGACATTCGGGGTGTTCACATAACCGCCGACTATGT 69 FBan0004538 FBgn0038745 CG4538 3 3R ATP-dependent proteolysis; GO:0006510; protein folding; GO:0006457; protein transport; GO:0015031 ATP binding; GO:0005524; ; GO:0005524; endopeptidase Clp activity; GO:0008462 ; EC:3.4.21.92; protein binding; GO:0005515; ATPase activity; GO:0016887; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0008462 ; EC:3.4.21.92; ; GO:0008462 ; EC:3.4.21.92; ; GO:0000166; ; GO:0005515; ; GO:0017111 ; EC:3.6.1.15; ; GO:0016887 endopeptidase Clp complex; GO:0009368; mitochondrion; GO:0005739 CG4538 CG4538 CDMC21280 4 24 21 DAC34-P24 2-CG4538-RB_1 CG4538 GCTGCTGGATCCCATGTTCATAGTGCCTGGTTCAGACATTCGGGGTGTTCACATAACCGCCGACTATGT 69 FBan0004538 FBgn0038745 CG4538 3 3R ATP-dependent proteolysis; GO:0006510; protein folding; GO:0006457; protein transport; GO:0015031 ATP binding; GO:0005524; ; GO:0005524; endopeptidase Clp activity; GO:0008462 ; EC:3.4.21.92; protein binding; GO:0005515; ATPase activity; GO:0016887; nucleotide binding; GO:0000166; nucleoside-triphosphatase activity; GO:0017111 ; EC:3.6.1.15; ; GO:0008462 ; EC:3.4.21.92; ; GO:0008462 ; EC:3.4.21.92; ; GO:0000166; ; GO:0005515; ; GO:0017111 ; EC:3.6.1.15; ; GO:0016887 endopeptidase Clp complex; GO:0009368; mitochondrion; GO:0005739 CG4538 CG4538 CDMC21281 4 25 21 DAC35-D12 3-CG8822-RA_1 CG8822 CCGGCACCCATTCGAGTTGTGGGCGACATACACGGGCAGTTTTATGATCTGCTGAAGATCCTCGATCAA 69 FBan0008822 FBgn0005779 PpD6 2 2L protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722; protein phosphatase type 1 activity; GO:0000163; ; GO:0000163 PpD6 Protein phosphatase D6 "CG8822, CG8822, CG8822, D6, protein phosphatase from PCR fragment D6, PP1-like" CDMC21281 4 26 21 DAC35-D12 3-CG8822-RA_1 CG8822 CCGGCACCCATTCGAGTTGTGGGCGACATACACGGGCAGTTTTATGATCTGCTGAAGATCCTCGATCAA 69 FBan0008822 FBgn0005779 PpD6 2 2L protein amino acid dephosphorylation; GO:0006470 protein serine/threonine phosphatase activity; GO:0004722; ; GO:0004722; ; GO:0004722; protein phosphatase type 1 activity; GO:0000163; ; GO:0000163 PpD6 Protein phosphatase D6 "CG8822, CG8822, CG8822, D6, protein phosphatase from PCR fragment D6, PP1-like" CDMC21282 4 1 22 DAC35-D24 9-CG8831-RA_4 CG8831 TGCTCCCAACGAAAGCAAGCGTATACTTGCCACCGAACTCTCAAACTACCTTAATCAGGCGACGCTGAA 69 FBan0008831 FBgn0033737 CG8831 2 2R nucleocytoplasmic transport; GO:0006913; protein targeting; GO:0006605 transporter activity; GO:0005215; ; GO:0005215; nucleocytoplasmic transporter activity; GO:0005487; ; GO:0005487 nuclear pore; GO:0005643 CG8831 CG8831 CDMC21282 4 2 22 DAC35-D24 9-CG8831-RA_4 CG8831 TGCTCCCAACGAAAGCAAGCGTATACTTGCCACCGAACTCTCAAACTACCTTAATCAGGCGACGCTGAA 69 FBan0008831 FBgn0033737 CG8831 2 2R nucleocytoplasmic transport; GO:0006913; protein targeting; GO:0006605 transporter activity; GO:0005215; ; GO:0005215; nucleocytoplasmic transporter activity; GO:0005487; ; GO:0005487 nuclear pore; GO:0005643 CG8831 CG8831 CDMC21283 4 3 22 DAC35-H12 3-CG8870-RA_4 CG8870 TGCCCTCAAAACAGTGAGACTGGGCGAACATAACACGTCCACAAATCCCGATCGGGCTATTGTGAATGG 69 FBan0008870 FBgn0038144 CG8870 3 3R "proteolysis; GO:0006508; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; trypsin activity; GO:0004295 ; EC:3.4.21.4; monophenol monooxygenase activator activity; GO:0008439; transcription factor activity; GO:0003700; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0008439; ; GO:0003700; ; GO:0003677; ; GO:0004263 ; EC:3.4.21.1 nucleus; GO:0005634 CG8870 CG8870 SP38 CDMC21283 4 4 22 DAC35-H12 3-CG8870-RA_4 CG8870 TGCCCTCAAAACAGTGAGACTGGGCGAACATAACACGTCCACAAATCCCGATCGGGCTATTGTGAATGG 69 FBan0008870 FBgn0038144 CG8870 3 3R "proteolysis; GO:0006508; regulation of transcription, DNA-dependent; GO:0006355" DNA binding; GO:0003677; trypsin activity; GO:0004295 ; EC:3.4.21.4; monophenol monooxygenase activator activity; GO:0008439; transcription factor activity; GO:0003700; chymotrypsin activity; GO:0004263 ; EC:3.4.21.1; ; GO:0004295 ; EC:3.4.21.4; ; GO:0008439; ; GO:0003700; ; GO:0003677; ; GO:0004263 ; EC:3.4.21.1 nucleus; GO:0005634 CG8870 CG8870 SP38 CDMC21284 4 5 22 DAC35-H24 2-CG8889-RB_1 CG8889 CGGAGGACCCCTGTTGAGAGCCATCATCAGCGACTTGGATCCACATATCATTTTCTCAGGACACTGGCA 69 FBan0008889 FBgn0033675 CG8889 2 2R hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.- CG8889 CG8889 CDMC21284 4 6 22 DAC35-H24 2-CG8889-RB_1 CG8889 CGGAGGACCCCTGTTGAGAGCCATCATCAGCGACTTGGATCCACATATCATTTTCTCAGGACACTGGCA 69 FBan0008889 FBgn0033675 CG8889 2 2R hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.- CG8889 CG8889 CDMC21285 4 7 22 DAC35-L12 23-CG8929-RA_15 CG8929 GGAGGAGTGGTGGTATAAATATCAGGAATGGTTGAAACAGGAACGCTACTATGAGTACTGGGATCGCAG 69 FBan0008929 FBgn0034504 CG8929 2 2R CG8929 CG8929 anon-WO0118547.91 CDMC21285 4 8 22 DAC35-L12 23-CG8929-RA_15 CG8929 GGAGGAGTGGTGGTATAAATATCAGGAATGGTTGAAACAGGAACGCTACTATGAGTACTGGGATCGCAG 69 FBan0008929 FBgn0034504 CG8929 2 2R CG8929 CG8929 anon-WO0118547.91 CDMC21286 4 9 22 DAC35-L24 16-CG8944-RA_1 CG8944 CCGCGAACGACTGAATCTGTAATACTACACTTCGAGGCGAGTTAGGTTCTCGAAAATATCGCGCCACTT 69 FBan0008944 FBgn0030680 CG8944 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG8944 CG8944 CDMC21286 4 10 22 DAC35-L24 16-CG8944-RA_1 CG8944 CCGCGAACGACTGAATCTGTAATACTACACTTCGAGGCGAGTTAGGTTCTCGAAAATATCGCGCCACTT 69 FBan0008944 FBgn0030680 CG8944 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG8944 CG8944 CDMC21287 4 11 22 DAC35-P12 2-CG8975-RA_1 CG8975 TGCCCGTCAATTTGATTGGCATGAATTGCGACCTGATGTCCCAGTACATTGAGTTCGTAGCGGACCGTT 69 FBan0008975 FBgn0011704 RnrS 2 2R DNA replication; GO:0006260; deoxyribonucleoside diphosphate metabolism; GO:0009186; purine base metabolism; GO:0006144; pyrimidine base metabolism; GO:0006206 ribonucleoside-diphosphate reductase activity; GO:0004748 ; EC:1.17.4.1; ; GO:0004748 ; EC:1.17.4.1 ribonucleoside-diphosphate reductase complex; GO:0005971 RnrS Ribonucleoside diphosphate reductase small subunit "CG8975, RNR2, Ribonucleotide reductase small subunit, DmRNR2, Rnr2, ribonucleoside-diphosphate reductase small subunit, RNrS, dRNR2, rnr2, anon-WO0118547.148" CDMC21287 4 12 22 DAC35-P12 2-CG8975-RA_1 CG8975 TGCCCGTCAATTTGATTGGCATGAATTGCGACCTGATGTCCCAGTACATTGAGTTCGTAGCGGACCGTT 69 FBan0008975 FBgn0011704 RnrS 2 2R DNA replication; GO:0006260; deoxyribonucleoside diphosphate metabolism; GO:0009186; purine base metabolism; GO:0006144; pyrimidine base metabolism; GO:0006206 ribonucleoside-diphosphate reductase activity; GO:0004748 ; EC:1.17.4.1; ; GO:0004748 ; EC:1.17.4.1 ribonucleoside-diphosphate reductase complex; GO:0005971 RnrS Ribonucleoside diphosphate reductase small subunit "CG8975, RNR2, Ribonucleotide reductase small subunit, DmRNR2, Rnr2, ribonucleoside-diphosphate reductase small subunit, RNrS, dRNR2, rnr2, anon-WO0118547.148" CDMC21288 4 13 22 DAC35-P24 24-CG8989-RC_2 CG8989 AATCTATCATTCATATTTACATGTATACATTTATCATCCTTTTGTTGTTCAATCGAATCGTCAGCATGA 69 FBan0008989 FBgn0004828 His3.3B X X chromatin assembly or disassembly; GO:0006333 DNA binding; GO:0003677; ; GO:0003677 nucleosome; GO:0000786 His3.3B Histone H3.3B "CG8989, H3.3, H3.3B, PH3, His3.3, HisH3-3Q: Histone H3-3Q, anon-EST:fe1B6, Histone H3-3Q, anon-fast-evolving-1B6" CDMC21288 4 14 22 DAC35-P24 24-CG8989-RC_2 CG8989 AATCTATCATTCATATTTACATGTATACATTTATCATCCTTTTGTTGTTCAATCGAATCGTCAGCATGA 69 FBan0008989 FBgn0004828 His3.3B X X chromatin assembly or disassembly; GO:0006333 DNA binding; GO:0003677; ; GO:0003677 nucleosome; GO:0000786 His3.3B Histone H3.3B "CG8989, H3.3, H3.3B, PH3, His3.3, HisH3-3Q: Histone H3-3Q, anon-EST:fe1B6, Histone H3-3Q, anon-fast-evolving-1B6" CDMC21289 4 15 22 DAC36-D12 3-CG7111-RA_2 CG7111 CTGCTGTGGGACCTCAATGACGGCAAGAACCTGTACACTCTGGAGCACAACGACATCATCAACGC 65 FBan0007111 FBgn0020618 Rack1 2 2L protein targeting; GO:0006605; signal transduction; GO:0007165 protein kinase C binding; GO:0005080; ; GO:0005080 Rack1 Receptor of activated protein kinase C 1 "CG7111, CG7111, rack1, RACK1, i173, Guanine nucleotide-binding protein beta-subunit like protein" CDMC21289 4 16 22 DAC36-D12 3-CG7111-RA_2 CG7111 CTGCTGTGGGACCTCAATGACGGCAAGAACCTGTACACTCTGGAGCACAACGACATCATCAACGC 65 FBan0007111 FBgn0020618 Rack1 2 2L protein targeting; GO:0006605; signal transduction; GO:0007165 protein kinase C binding; GO:0005080; ; GO:0005080 Rack1 Receptor of activated protein kinase C 1 "CG7111, CG7111, rack1, RACK1, i173, Guanine nucleotide-binding protein beta-subunit like protein" CDMC21290 4 17 22 DAC36-D24 6-CG7191-RA_1 CG7191 CTGCACGAGAATCGCAAGGGCAATCACAGCAAGACGGTTAACTTCTGCAATCGAAAGCGTCCGGC 65 FBan0007191 FBgn0031945 CG7191 2 2L CG7191 CG7191 CDMC21290 4 18 22 DAC36-D24 6-CG7191-RA_1 CG7191 CTGCACGAGAATCGCAAGGGCAATCACAGCAAGACGGTTAACTTCTGCAATCGAAAGCGTCCGGC 65 FBan0007191 FBgn0031945 CG7191 2 2L CG7191 CG7191 CDMC21291 4 19 22 DAC36-H12 3-CG7262-RA_2 CG7262 AAAATCGGGCACATGCAGTTCACATGGCCATAGCGCTGTTTGAGCTAGGACTTCTAGGCAGTGCG 65 FBan0007262 FBgn0038274 CG7262 3 3R protein targeting; GO:0006605 transporter activity; GO:0005215; ; GO:0005215 nuclear pore; GO:0005643 CG7262 CG7262 CDMC21291 4 20 22 DAC36-H12 3-CG7262-RA_2 CG7262 AAAATCGGGCACATGCAGTTCACATGGCCATAGCGCTGTTTGAGCTAGGACTTCTAGGCAGTGCG 65 FBan0007262 FBgn0038274 CG7262 3 3R protein targeting; GO:0006605 transporter activity; GO:0005215; ; GO:0005215 nuclear pore; GO:0005643 CG7262 CG7262 CDMC21292 4 21 22 DAC36-H24 1-CG7299-RA_1 CG7299 ATTCGGTGGTAACTCCGAAGCTAACGCCAATGCCAATGCTGTCGCCAACTCTGACGGAGGATTTG 65 FBan0007299 FBgn0032282 CG7299 2 2L CG7299 CG7299 "CT22515, BcDNA:RE24635" CDMC21292 4 22 22 DAC36-H24 1-CG7299-RA_1 CG7299 ATTCGGTGGTAACTCCGAAGCTAACGCCAATGCCAATGCTGTCGCCAACTCTGACGGAGGATTTG 65 FBan0007299 FBgn0032282 CG7299 2 2L CG7299 CG7299 "CT22515, BcDNA:RE24635" CDMC21293 4 23 22 DAC36-L12 2-CG7407-RA_1 CG7407 ATGACGAGGCCTACGAAGAGAACTCCACCGAAAGCGAAGTTGAGCTAATCGAGGAACAGCTGCCC 65 FBan0007407 FBgn0037134 CG7407 3 3L CG7407 CG7407 BcDNA:LD29166 CDMC21293 4 24 22 DAC36-L12 2-CG7407-RA_1 CG7407 ATGACGAGGCCTACGAAGAGAACTCCACCGAAAGCGAAGTTGAGCTAATCGAGGAACAGCTGCCC 65 FBan0007407 FBgn0037134 CG7407 3 3L CG7407 CG7407 BcDNA:LD29166 CDMC21294 4 25 22 DAC36-L24 19-CG7423-RA_1 CG7423 GAGTTCTTTGTGCGGATCGGCGCGGAGGTGGACAGGAAGGACAAGTACGGCATCACACCGCTCCT 65 FBan0007423 FBgn0030982 CG7423 X X CG7423 CG7423 CDMC21294 4 26 22 DAC36-L24 19-CG7423-RA_1 CG7423 GAGTTCTTTGTGCGGATCGGCGCGGAGGTGGACAGGAAGGACAAGTACGGCATCACACCGCTCCT 65 FBan0007423 FBgn0030982 CG7423 X X CG7423 CG7423 CDMC21295 4 1 23 DAC36-P12 2-CG7528-RA_1 CG7528 AATCGGCTAAGAAGCGTTCTACCAACGGGGAAGGAGACTCAAAGGACGATGGACCCTCCACTTCG 65 FBan0007528 FBgn0029113 Uba2 3 3L SMT3-dependent protein catabolism; GO:0019950; activation of NF-kappaB transcription factor; GO:0051092; protein sumoylation; GO:0016925; ubiquitin cycle; GO:0006512 ubiquitin activating enzyme activity; GO:0004839; SUMO activating enzyme activity; GO:0019948; ubiquitin-like activating enzyme activity; GO:0008642; ; GO:0008642; ; GO:0008642; ; GO:0008642; ; GO:0019948; ligase activity; GO:0016874 ; EC:6.-.-.-; protein binding; GO:0005515; ; GO:0016874 ; EC:6.-.-.-; ; GO:0019948; ; GO:0004839; ; GO:0008642; ; GO:0005515; ; GO:0019948; ; GO:0005515 SUMO activating enzyme complex; GO:0031510; cytoplasm; GO:0005737; nucleus; GO:0005634 Uba2 Smt3 activating enzyme 2 "CG7528, CG7528 (E1), CG7528, CG7528, sip2, DmSAE2, SAE2, Dmuba2, DmUba2, DmSae2, dUba2, L36, Sae2, Ubc2, ubiquitin-activating enzyme (E1), SAE2 (E1), sip2 (E1), ubiquitin-activating enzyme, Smt3 activating enzyme 2" CDMC21295 4 2 23 DAC36-P12 2-CG7528-RA_1 CG7528 AATCGGCTAAGAAGCGTTCTACCAACGGGGAAGGAGACTCAAAGGACGATGGACCCTCCACTTCG 65 FBan0007528 FBgn0029113 Uba2 3 3L SMT3-dependent protein catabolism; GO:0019950; activation of NF-kappaB transcription factor; GO:0051092; protein sumoylation; GO:0016925; ubiquitin cycle; GO:0006512 ubiquitin activating enzyme activity; GO:0004839; SUMO activating enzyme activity; GO:0019948; ubiquitin-like activating enzyme activity; GO:0008642; ; GO:0008642; ; GO:0008642; ; GO:0008642; ; GO:0019948; ligase activity; GO:0016874 ; EC:6.-.-.-; protein binding; GO:0005515; ; GO:0016874 ; EC:6.-.-.-; ; GO:0019948; ; GO:0004839; ; GO:0008642; ; GO:0005515; ; GO:0019948; ; GO:0005515 SUMO activating enzyme complex; GO:0031510; cytoplasm; GO:0005737; nucleus; GO:0005634 Uba2 Smt3 activating enzyme 2 "CG7528, CG7528 (E1), CG7528, CG7528, sip2, DmSAE2, SAE2, Dmuba2, DmUba2, DmSae2, dUba2, L36, Sae2, Ubc2, ubiquitin-activating enzyme (E1), SAE2 (E1), sip2 (E1), ubiquitin-activating enzyme, Smt3 activating enzyme 2" CDMC21296 4 3 23 DAC36-P24 AutoBlank AutoBlank CDMC21296 4 4 23 DAC36-P24 AutoBlank AutoBlank CDMC21297 4 5 23 DAC37-D12 3-CG12936-RA_9 CG12936 AGATGAAGCCTGGAAATCGGAAAACCAAGTGGTCCAGTGGCTATCCGAAAGCAGCTTCCAACGGG 65 FBan0012936 FBgn0033549 CG12936 2 2R CG12936 CG12936 CDMC21297 4 6 23 DAC37-D12 3-CG12936-RA_9 CG12936 AGATGAAGCCTGGAAATCGGAAAACCAAGTGGTCCAGTGGCTATCCGAAAGCAGCTTCCAACGGG 65 FBan0012936 FBgn0033549 CG12936 2 2R CG12936 CG12936 CDMC21298 4 7 23 DAC37-D24 23-CG12971-RA_1 CG12971 TCTCCATTGAAGCTGTACTCGTATAAATATCATATCTTCGATCTGTTCCAACATCAGACGCTTCA 65 FBan0012971 FBgn0037078 CG12971 3 3L CG12971 CG12971 CDMC21298 4 8 23 DAC37-D24 23-CG12971-RA_1 CG12971 TCTCCATTGAAGCTGTACTCGTATAAATATCATATCTTCGATCTGTTCCAACATCAGACGCTTCA 65 FBan0012971 FBgn0037078 CG12971 3 3L CG12971 CG12971 CDMC21299 4 9 23 DAC37-H12 19-CG13044-RA_1 CG13044 CCGCCCCGGTGGCCTACTCCTCGTATGCCGCTCCTCTGACCTATTCCGCACCGGTGGCCTACTCG 65 FBan0013044 FBgn0036599 CG13044 3 3L CG13044 CG13044 CDMC21299 4 10 23 DAC37-H12 19-CG13044-RA_1 CG13044 CCGCCCCGGTGGCCTACTCCTCGTATGCCGCTCCTCTGACCTATTCCGCACCGGTGGCCTACTCG 65 FBan0013044 FBgn0036599 CG13044 3 3L CG13044 CG13044 CDMC21300 4 11 23 DAC37-H24 12-CG13055-RA_1 CG13055 CAATCGAAACGGAAGCCGATTAGCCGAGCCAGTTTCTCGCGTCTCCATCGTCGCTCCACATCCTC 65 FBan0013055 FBgn0036583 CG13055 3 3L CG13055 CG13055 CDMC21300 4 12 23 DAC37-H24 12-CG13055-RA_1 CG13055 CAATCGAAACGGAAGCCGATTAGCCGAGCCAGTTTCTCGCGTCTCCATCGTCGCTCCACATCCTC 65 FBan0013055 FBgn0036583 CG13055 3 3L CG13055 CG13055 CDMC21301 4 13 23 DAC37-L12 2-CG13114-RA_2 CG13114 CGGAGATCAAGCCATATGGTGGTCCCGATTCTGGACCCGATAAGCCATCGTCCACGTTCGATCTG 65 FBan0013114 FBgn0032127 CG13114 2 2L CG13114 CG13114 CDMC21301 4 14 23 DAC37-L12 2-CG13114-RA_2 CG13114 CGGAGATCAAGCCATATGGTGGTCCCGATTCTGGACCCGATAAGCCATCGTCCACGTTCGATCTG 65 FBan0013114 FBgn0032127 CG13114 2 2L CG13114 CG13114 CDMC21302 4 15 23 DAC37-L24 12-CG13135-RA_1 CG13135 GTGTGCCGATGATCCCACCGATACGGCTTGCATCGATTGCACAGATACCGCGAATGCAGCTGAAG 65 FBan0013135 FBgn0032184 CG13135 2 2L CG13135 CG13135 CDMC21302 4 16 23 DAC37-L24 12-CG13135-RA_1 CG13135 GTGTGCCGATGATCCCACCGATACGGCTTGCATCGATTGCACAGATACCGCGAATGCAGCTGAAG 65 FBan0013135 FBgn0032184 CG13135 2 2L CG13135 CG13135 CDMC21303 4 17 23 DAC37-P12 15-CG13203-RA_3 CG13203 CAAATCGGACAGCTATCCGCCCACCTTCCAACTGGCCTCCAAGGAGTACTCGCACATGATACGCC 65 FBan0013203 FBgn0033628 CG13203 2 2R CG13203 CG13203 anon-EST:Posey175 CDMC21303 4 18 23 DAC37-P12 15-CG13203-RA_3 CG13203 CAAATCGGACAGCTATCCGCCCACCTTCCAACTGGCCTCCAAGGAGTACTCGCACATGATACGCC 65 FBan0013203 FBgn0033628 CG13203 2 2R CG13203 CG13203 anon-EST:Posey175 CDMC21304 4 19 23 DAC37-P24 AutoBlank AutoBlank CDMC21304 4 20 23 DAC37-P24 AutoBlank AutoBlank CDMC21305 4 21 23 DAC38-D12 15-CG32590-RA_1 CG32590 CGCAAGGTTACCCCAGCGATTTTCGAGAAACGCGATGAAGTCTTTCAGCTGCAAAATAATCTCCAGGGA 69 FBan0032590 FBgn0052590 CG32590 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32590 CG32590 CDMC21305 4 22 23 DAC38-D12 15-CG32590-RA_1 CG32590 CGCAAGGTTACCCCAGCGATTTTCGAGAAACGCGATGAAGTCTTTCAGCTGCAAAATAATCTCCAGGGA 69 FBan0032590 FBgn0052590 CG32590 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32590 CG32590 CDMC21306 4 23 23 DAC38-D24 18-CG32598-RA_1 CG32598 CGGATGAGCAGCTCAATCCGAAGACTTATCGCGCTCAGGTCTCCGAGGACGAAGATTAGACATATTCAT 69 FBan0032598 FBgn0052598 CG32598 X X CG32598 CG32598 CDMC21306 4 24 23 DAC38-D24 18-CG32598-RA_1 CG32598 CGGATGAGCAGCTCAATCCGAAGACTTATCGCGCTCAGGTCTCCGAGGACGAAGATTAGACATATTCAT 69 FBan0032598 FBgn0052598 CG32598 X X CG32598 CG32598 CDMC21307 4 25 23 DAC38-H12 13-CG32640-RA_1 CG32640 ACATCCACGAACGACGGCTCAATTCCGGAAGATCAACGAAGCATTTAATGTCCTGTCAGATGCGTCGGC 69 FBan0032640 FBgn0052640 CG32640 X X protein folding; GO:0006457; response to heat; GO:0009408 unfolded protein binding; GO:0051082; ; GO:0051082 CG32640 CG32640 CDMC21307 4 26 23 DAC38-H12 13-CG32640-RA_1 CG32640 ACATCCACGAACGACGGCTCAATTCCGGAAGATCAACGAAGCATTTAATGTCCTGTCAGATGCGTCGGC 69 FBan0032640 FBgn0052640 CG32640 X X protein folding; GO:0006457; response to heat; GO:0009408 unfolded protein binding; GO:0051082; ; GO:0051082 CG32640 CG32640 CDMC21308 4 1 24 DAC38-H24 8-CG32649-RA_1 CG32649 GCATGAATTGCGTGCCCTTCTACAAGGACATCGTTCTGGGGAAGTTCAAGGACTAGTGAGCACAGCTCA 69 FBan0032649 FBgn0052649 CG32649 X X "coenzyme metabolism; GO:0006732; mitochondrial electron transport, ubiquinol to cytochrome c; GO:0006122; prosthetic group metabolism; GO:0051189" protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 mitochondrion; GO:0005739 CG32649 CG32649 "CG4410, CG4410" CDMC21308 4 2 24 DAC38-H24 8-CG32649-RA_1 CG32649 GCATGAATTGCGTGCCCTTCTACAAGGACATCGTTCTGGGGAAGTTCAAGGACTAGTGAGCACAGCTCA 69 FBan0032649 FBgn0052649 CG32649 X X "coenzyme metabolism; GO:0006732; mitochondrial electron transport, ubiquinol to cytochrome c; GO:0006122; prosthetic group metabolism; GO:0051189" protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0004672 ; EC:2.7.1.37 mitochondrion; GO:0005739 CG32649 CG32649 "CG4410, CG4410" CDMC21309 4 3 24 DAC38-L12 1-CG32683-RA_1 CG32683 AGGATTGCGCAAACATTTTGGTTCCCCTCCTATCCCATTCGATTCCGTTGTCCTTTCTGTCTCCGGAGC 69 FBan0032683 FBgn0052683 CG32683 X X G-protein coupled receptor protein signaling pathway; GO:0007186; cell surface receptor linked signal transduction; GO:0007166; endocytosis; GO:0006897; intracellular protein transport; GO:0006886; sensory perception; GO:0007600; signal transduction; GO:0007165; visual perception; GO:0007601 CG32683 CG32683 "CG15303, CG2881, CG2883" CDMC21309 4 4 24 DAC38-L12 1-CG32683-RA_1 CG32683 AGGATTGCGCAAACATTTTGGTTCCCCTCCTATCCCATTCGATTCCGTTGTCCTTTCTGTCTCCGGAGC 69 FBan0032683 FBgn0052683 CG32683 X X G-protein coupled receptor protein signaling pathway; GO:0007186; cell surface receptor linked signal transduction; GO:0007166; endocytosis; GO:0006897; intracellular protein transport; GO:0006886; sensory perception; GO:0007600; signal transduction; GO:0007165; visual perception; GO:0007601 CG32683 CG32683 "CG15303, CG2881, CG2883" CDMC21310 4 5 24 DAC38-L24 23-CG32695-RA_1 CG32695 AAACTGGACTCTCCCACTGAGCAAAGTTAAATTTAAATGCGTGTTTATTTTTAAGTCTGTTTGCCTTGC 69 FBan0032695 FBgn0052695 CG32695 X X CG32695 CG32695 "CG15246, BcDNA:RH68724" CDMC21310 4 6 24 DAC38-L24 23-CG32695-RA_1 CG32695 AAACTGGACTCTCCCACTGAGCAAAGTTAAATTTAAATGCGTGTTTATTTTTAAGTCTGTTTGCCTTGC 69 FBan0032695 FBgn0052695 CG32695 X X CG32695 CG32695 "CG15246, BcDNA:RH68724" CDMC21311 4 7 24 DAC38-P12 17-CG32718-RA_3 CG32718 TGAGGAAAATGCCTCTTGGACTACCCATTTGGACACCATTGTTCATCCTTTTCTTGCTTTTCCTGGCCG 69 FBan0032718 FBgn0052718 CG32718 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32718 CG32718 CDMC21311 4 8 24 DAC38-P12 17-CG32718-RA_3 CG32718 TGAGGAAAATGCCTCTTGGACTACCCATTTGGACACCATTGTTCATCCTTTTCTTGCTTTTCCTGGCCG 69 FBan0032718 FBgn0052718 CG32718 X X biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32718 CG32718 CDMC21312 4 9 24 DAC38-P24 2-CG32732-RA_1 CG32732 TCTCGCCGGAGCTTTACAATACGCCCAAGAGCATCGCAAGGTCTAGGGATTTAAGCAGACAACCCACAA 69 FBan0032732 FBgn0052732 CG32732 X X CG32732 CG32732 "CG12542, CG3042" CDMC21312 4 10 24 DAC38-P24 2-CG32732-RA_1 CG32732 TCTCGCCGGAGCTTTACAATACGCCCAAGAGCATCGCAAGGTCTAGGGATTTAAGCAGACAACCCACAA 69 FBan0032732 FBgn0052732 CG32732 X X CG32732 CG32732 "CG12542, CG3042" CDMC21313 4 11 24 DAC39-D12 3-CG13692-RA_1 CG13692 AGTATGGCCCCCTTGTGGAGGCAGTATTTCGAGGATGTCAAGAAGCTGATCTACGTCGTGGACACCTCT 69 FBan0013692 FBgn0031254 CG13692 2 2L protein amino acid ADP-ribosylation; GO:0006471 GTP binding; GO:0005525; ARF GTPase activator activity; GO:0008060; ; GO:0008060; ; GO:0005525 CG13692 CG13692 CDMC21313 4 12 24 DAC39-D12 3-CG13692-RA_1 CG13692 AGTATGGCCCCCTTGTGGAGGCAGTATTTCGAGGATGTCAAGAAGCTGATCTACGTCGTGGACACCTCT 69 FBan0013692 FBgn0031254 CG13692 2 2L protein amino acid ADP-ribosylation; GO:0006471 GTP binding; GO:0005525; ARF GTPase activator activity; GO:0008060; ; GO:0008060; ; GO:0005525 CG13692 CG13692 CDMC21314 4 13 24 DAC39-D24 23-CG13704-RA_4 CG13704 CGTGCGCGTTACAAACTTGGCTAACAGCTAAAAGCGAACATAAGTTTTTCGAAAGAACCGACGAAAACG 69 FBan0013704 FBgn0035583 CG13704 3 3L CG13704 CG13704 BcDNA:RE40159 CDMC21314 4 14 24 DAC39-D24 23-CG13704-RA_4 CG13704 CGTGCGCGTTACAAACTTGGCTAACAGCTAAAAGCGAACATAAGTTTTTCGAAAGAACCGACGAAAACG 69 FBan0013704 FBgn0035583 CG13704 3 3L CG13704 CG13704 BcDNA:RE40159 CDMC21315 4 15 24 DAC39-H12 3-CG13746-RA_1 CG13746 AGCGCCGTCGCATATAGGTGACCCCCGCCCGAAACTGACGATTGTTGATCCGTTTTAGCTCATTAGTTT 69 FBan0013746 FBgn0033341 MrgBP 2 2R MrgBP MrgBP "CG13746, CG13746, dMrgBP" CDMC21315 4 16 24 DAC39-H12 3-CG13746-RA_1 CG13746 AGCGCCGTCGCATATAGGTGACCCCCGCCCGAAACTGACGATTGTTGATCCGTTTTAGCTCATTAGTTT 69 FBan0013746 FBgn0033341 MrgBP 2 2R MrgBP MrgBP "CG13746, CG13746, dMrgBP" CDMC21316 4 17 24 DAC39-H24 2-CG13771-RA_2 CG13771 GCGGATGCAGATGTGTCCCTCTCCGGTCACGTTTCATATACGGACAATAACTTCATGGAGGTCACGGCA 69 FBan0013771 FBgn0031844 CG13771 2 2L lipid metabolism; GO:0006629 "acyl-CoA thioesterase activity; GO:0016291 ; EC:3.1.2.-; hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; ; GO:0016788 ; EC:3.1.-.-; ; GO:0016291 ; EC:3.1.2.-" CG13771 CG13771 CDMC21316 4 18 24 DAC39-H24 2-CG13771-RA_2 CG13771 GCGGATGCAGATGTGTCCCTCTCCGGTCACGTTTCATATACGGACAATAACTTCATGGAGGTCACGGCA 69 FBan0013771 FBgn0031844 CG13771 2 2L lipid metabolism; GO:0006629 "acyl-CoA thioesterase activity; GO:0016291 ; EC:3.1.2.-; hydrolase activity, acting on ester bonds; GO:0016788 ; EC:3.1.-.-; ; GO:0016788 ; EC:3.1.-.-; ; GO:0016291 ; EC:3.1.2.-" CG13771 CG13771 CDMC21317 4 19 24 DAC39-L12 18-CG13794-RA_2 CG13794 ACAAACAAGTATTGACTCATTGGGCTCTGTATTTGTCCAGTGCTACCGCATTGTCTTCTCTGGGTTGGC 69 FBan0013794 FBgn0031936 CG13794 2 2L CG13794 CG13794 CDMC21317 4 20 24 DAC39-L12 18-CG13794-RA_2 CG13794 ACAAACAAGTATTGACTCATTGGGCTCTGTATTTGTCCAGTGCTACCGCATTGTCTTCTCTGGGTTGGC 69 FBan0013794 FBgn0031936 CG13794 2 2L CG13794 CG13794 CDMC21318 4 21 24 DAC39-L24 15-CG13809-RA_3 CG13809 GCGCCACCGATCGAAGCTCACTTTAATATATACACCAGGATAGCACTGGACTGTTTGGCTCTGAGGGAG 69 FBan0013809 FBgn0035317 osm-1 3 3L microtubule-based movement; GO:0007018; sensory cilium biogenesis; GO:0035058 microtubule motor activity; GO:0003777; ; GO:0003777 kinesin complex; GO:0005871 osm-1 osm-1 "CG13809, CG13809, CG13809, OSEG2" CDMC21318 4 22 24 DAC39-L24 15-CG13809-RA_3 CG13809 GCGCCACCGATCGAAGCTCACTTTAATATATACACCAGGATAGCACTGGACTGTTTGGCTCTGAGGGAG 69 FBan0013809 FBgn0035317 osm-1 3 3L microtubule-based movement; GO:0007018; sensory cilium biogenesis; GO:0035058 microtubule motor activity; GO:0003777; ; GO:0003777 kinesin complex; GO:0005871 osm-1 osm-1 "CG13809, CG13809, CG13809, OSEG2" CDMC21319 4 23 24 DAC39-P12 1-CG13869-RA_2 CG13869 CCAGTTGGGTCAAAATGGTAGTGCCTGTCTGGATCGTCTGATCTGCGAGAATGGTCAGGTGGATGAGCA 69 FBan0013869 FBgn0034486 CG13869 2 2R CG13869 CG13869 CDMC21319 4 24 24 DAC39-P12 1-CG13869-RA_2 CG13869 CCAGTTGGGTCAAAATGGTAGTGCCTGTCTGGATCGTCTGATCTGCGAGAATGGTCAGGTGGATGAGCA 69 FBan0013869 FBgn0034486 CG13869 2 2R CG13869 CG13869 CDMC21320 4 25 24 DAC39-P24 AutoBlank AutoBlank CDMC21320 4 26 24 DAC39-P24 AutoBlank AutoBlank CDMC21321 4 1 25 DAC40-D12 21-CG14177-RA_1 CG14177 ACGACCCAAGCCAGGTATCCTGCGACTGGACATCGGCAAACCGCGACGCTCATCAGGTGGTTCCG 65 FBan0014177 FBgn0036013 CG14177 3 3L CG14177 CG14177 CDMC21321 4 2 25 DAC40-D12 21-CG14177-RA_1 CG14177 ACGACCCAAGCCAGGTATCCTGCGACTGGACATCGGCAAACCGCGACGCTCATCAGGTGGTTCCG 65 FBan0014177 FBgn0036013 CG14177 3 3L CG14177 CG14177 CDMC21322 4 3 25 DAC40-D24 10-CG14199-RA_1 CG14199 CTCTTCCCCAGCTTGATAGACCGCAACAAGACCGGATTCATGGGCACCTTCTGGAAGCTGGCAAG 65 FBan0014199 FBgn0040890 CG14199 X X CG14199 CG14199 CDMC21322 4 4 25 DAC40-D24 10-CG14199-RA_1 CG14199 CTCTTCCCCAGCTTGATAGACCGCAACAAGACCGGATTCATGGGCACCTTCTGGAAGCTGGCAAG 65 FBan0014199 FBgn0040890 CG14199 X X CG14199 CG14199 CDMC21323 4 5 25 DAC40-H12 1-CG14266-RA_4 CG14266 GAAGGTCAGGAAAATCACAAGGAGAAGGGGTCTCAGGAGCCGCAATGGTCGCAGCAGTAGAAACC 65 FBan0014266 FBgn0010294 ng2 X X puparial adhesion; GO:0007594 structural molecule activity; GO:0005198; ; GO:0005198 extracellular region; GO:0005576 ng2 new glue 2 "CG14266, ng-2, ng, BcDNA:RE05239, EG:96G10.4" CDMC21323 4 6 25 DAC40-H12 1-CG14266-RA_4 CG14266 GAAGGTCAGGAAAATCACAAGGAGAAGGGGTCTCAGGAGCCGCAATGGTCGCAGCAGTAGAAACC 65 FBan0014266 FBgn0010294 ng2 X X puparial adhesion; GO:0007594 structural molecule activity; GO:0005198; ; GO:0005198 extracellular region; GO:0005576 ng2 new glue 2 "CG14266, ng-2, ng, BcDNA:RE05239, EG:96G10.4" CDMC21324 4 7 25 DAC40-H24 3-CG14291-RA_5 CG14291 CAACCAGATTGGCAGAAACATCACCCGGATGAAGGAGTATGCCAGGCAGTTTCTCAAGCAGGCCA 65 FBan0014291 FBgn0038660 CG14291 3 3R sulfur metabolism; GO:0006790 N-sulfoglucosamine sulfohydrolase activity; GO:0016250 ; EC:3.10.1.1; ; GO:0016250 ; EC:3.10.1.1; sulfuric ester hydrolase activity; GO:0008484 ; EC:3.1.6.-; ; GO:0008484 ; EC:3.1.6.- CG14291 CG14291 CDMC21324 4 8 25 DAC40-H24 3-CG14291-RA_5 CG14291 CAACCAGATTGGCAGAAACATCACCCGGATGAAGGAGTATGCCAGGCAGTTTCTCAAGCAGGCCA 65 FBan0014291 FBgn0038660 CG14291 3 3R sulfur metabolism; GO:0006790 N-sulfoglucosamine sulfohydrolase activity; GO:0016250 ; EC:3.10.1.1; ; GO:0016250 ; EC:3.10.1.1; sulfuric ester hydrolase activity; GO:0008484 ; EC:3.1.6.-; ; GO:0008484 ; EC:3.1.6.- CG14291 CG14291 CDMC21325 4 9 25 DAC40-L12 23-CG14394-RA_1 CG14394 GCTTCGCCATCAACCACTTCATAGATGCCTTCATATTCCTGTCCGTGTTTTGTGACATCATGAAG 65 FBan0014394 FBgn0038079 CG14394 3 3R CG14394 CG14394 CDMC21325 4 10 25 DAC40-L12 23-CG14394-RA_1 CG14394 GCTTCGCCATCAACCACTTCATAGATGCCTTCATATTCCTGTCCGTGTTTTGTGACATCATGAAG 65 FBan0014394 FBgn0038079 CG14394 3 3R CG14394 CG14394 CDMC21326 4 11 25 DAC40-L24 23-CG14414-RC_1 CG14414 TTTTAATTTTCATTTATTTTCGCACACAAAATGGCTAGCACTGTCCGTAAATCCGCGTAGAAACG 65 FBan0014414 FBgn0030571 CG14414 X X mRNA binding; GO:0003729; ; GO:0003729 CG14414 CG14414 "cg14414, BcDNA:AT01764" CDMC21326 4 12 25 DAC40-L24 23-CG14414-RC_1 CG14414 TTTTAATTTTCATTTATTTTCGCACACAAAATGGCTAGCACTGTCCGTAAATCCGCGTAGAAACG 65 FBan0014414 FBgn0030571 CG14414 X X mRNA binding; GO:0003729; ; GO:0003729 CG14414 CG14414 "cg14414, BcDNA:AT01764" CDMC21327 4 13 25 DAC40-P12 23-CG14482-RA_2 CG14482 TTTGGTGCGTGTGAAAAGTTATTAAATCAACAAAAATGGCTTTCCGCATACCTTTTGGCAAGAAG 65 FBan0014482 FBgn0034245 CG14482 2 2R "mitochondrial electron transport, ubiquinol to cytochrome c; GO:0006122" ubiquinol-cytochrome-c reductase activity; GO:0008121 ; EC:1.10.2.2; ; GO:0008121 ; EC:1.10.2.2 respiratory chain complex III (sensu Eukaryota); GO:0005750 CG14482 CG14482 CDMC21327 4 14 25 DAC40-P12 23-CG14482-RA_2 CG14482 TTTGGTGCGTGTGAAAAGTTATTAAATCAACAAAAATGGCTTTCCGCATACCTTTTGGCAAGAAG 65 FBan0014482 FBgn0034245 CG14482 2 2R "mitochondrial electron transport, ubiquinol to cytochrome c; GO:0006122" ubiquinol-cytochrome-c reductase activity; GO:0008121 ; EC:1.10.2.2; ; GO:0008121 ; EC:1.10.2.2 respiratory chain complex III (sensu Eukaryota); GO:0005750 CG14482 CG14482 CDMC21328 4 15 25 DAC40-P24 AutoBlank AutoBlank CDMC21328 4 16 25 DAC40-P24 AutoBlank AutoBlank CDMC21329 4 17 25 DAC41-D12 AutoBlank AutoBlank CDMC21329 4 18 25 DAC41-D12 AutoBlank AutoBlank CDMC21330 4 19 25 DAC41-D24 AutoBlank AutoBlank CDMC21330 4 20 25 DAC41-D24 AutoBlank AutoBlank CDMC21331 4 21 25 DAC41-H12 AutoBlank AutoBlank CDMC21331 4 22 25 DAC41-H12 AutoBlank AutoBlank CDMC21332 4 23 25 DAC41-H24 AutoBlank AutoBlank CDMC21332 4 24 25 DAC41-H24 AutoBlank AutoBlank CDMC21333 4 25 25 DAC41-L12 AutoBlank AutoBlank CDMC21333 4 26 25 DAC41-L12 AutoBlank AutoBlank CDMC21334 4 1 26 DAC41-L24 AutoBlank AutoBlank CDMC21334 4 2 26 DAC41-L24 AutoBlank AutoBlank CDMC21335 4 3 26 DAC41-P12 AutoBlank AutoBlank CDMC21335 4 4 26 DAC41-P12 AutoBlank AutoBlank CDMC21336 4 5 26 DAC41-P24 AutoBlank AutoBlank CDMC21336 4 6 26 DAC41-P24 AutoBlank AutoBlank CDMC21337 4 7 26 DAC42-D12 Oligo GFP control GFP CDMC21337 4 8 26 DAC42-D12 Oligo GFP control GFP CDMC21338 4 9 26 DAC42-D24 Oligo lacZ control lacZ CDMC21338 4 10 26 DAC42-D24 Oligo lacZ control lacZ CDMC21339 4 11 26 DAC42-H12 pBS vector pBS vector CDMC21339 4 12 26 DAC42-H12 pBS vector pBS vector CDMC21340 4 13 26 DAC42H24 pOT2A vector pOT2A vector CDMC21340 4 14 26 DAC42H24 pOT2A vector pOT2A vector CDMC21341 4 15 26 DAC42-L12 Oligo Tet control Tet CDMC21341 4 16 26 DAC42-L12 Oligo Tet control Tet CDMC21342 4 17 26 DAC42-L24 5uM MSP 5uM MSP CDMC21342 4 18 26 DAC42-L24 5uM MSP 5uM MSP CDMC21343 4 19 26 DAC42-P12 10uM MSP 10uM MSP CDMC21343 4 20 26 DAC42-P12 10uM MSP 10uM MSP CDMC21344 4 21 26 DAC42-P24 20uM MSP 20uM MSP CDMC21344 4 22 26 DAC42-P24 20uM MSP 20uM MSP 4 23 26 EMPTY EMPTY 4 24 26 EMPTY EMPTY 4 25 26 EMPTY EMPTY 4 26 26 EMPTY EMPTY CDMC21345 1 1 1 DAC01-A11 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC21345 1 2 1 DAC01-A11 1-Z49777_1 Z49777 ACCGGTTGCTTTGGTGGTTACTACTTGCCAACATTGGTTCAGTTCGAGCCTGGTCTCACTTCTCCTCCT 69 CDMC21346 1 3 1 DAC01-A23 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC21346 1 4 1 DAC01-A23 7-Q9LU32_1 Q9LU32 GCCGTAGAAATGACGCGATGATGGGAATTGAGAAAGGGAAGTGGAGTGTTAGTCCCACGTGTTGGAGGA 69 CDMC21347 1 5 1 DAC01-E11 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC21347 1 6 1 DAC01-E11 11-X64464_1 X64464 TGCCCCGGATTCATTGCATCTGACATGACTGCAGAGCTTGGAGAAGACATGGAAAAGAAAATCCTGGGA 69 CDMC21348 1 7 1 DAC01-E23 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC21348 1 8 1 DAC01-E23 18-O04513_1 O04513 CCGCAGGCAATGGAAACTCACAGAACTCGCATGTTACAATCCTCTTGGGGCAAATTTCTCCTTTATGAC 69 CDMC21349 1 9 1 DAC01-I11 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC21349 1 10 1 DAC01-I11 20-O49366_1 O49366 AAAGAGGCCCCATGCTCTGTCTGGTGTCAGCGCTACATGGTCCAGGACAAGTATGGACTTCCCCACCCC 69 CDMC21350 1 11 1 DAC01-I23 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC21350 1 12 1 DAC01-I23 13-U74610_1 U74610 TCCAGCTCACGACTACAAAGGTTTCGAGGTAAGTACAGTTGGAGAAGAGATGCAACACAACCCGCGTCT 69 CDMC21351 1 13 1 DAC01-M11 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC21351 1 14 1 DAC01-M11 11-O81842_1 O81842 CGCTGTCTCTGTCTATGCTCAATCAAGCAAGCTCTCAACCCCAACTTGGTTTGGAGCATAGAAGGAGCC 69 CDMC21352 1 15 1 DAC01-M23 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC21352 1 16 1 DAC01-M23 14-ATU18126_1 ATU18126 CTTGGGGTAATCGGATTGGTATCATTGGATTGGTTTACGCAGGGATCGAGAGTGGTATTGTGGCTGCCA 69 CDMC21353 1 17 1 DAC02-A11 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC21353 1 18 1 DAC02-A11 22-Q9LJQ4_1 Q9LJQ4 GCGGGAAGCTAGTGAGTTTCTGAGAGAGTTACCGGAGATGAAACTCGGTAATGTTCTTCAGGAGATCGG 69 CDMC21354 1 19 1 DAC02-A23 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC21354 1 20 1 DAC02-A23 15-O04600_1 O04600 GCATTGACCAGTACTCTAAGAGACGGACCAGATCAAGAACCTTGTCCTCTTTGGGAACAGACAACCGCA 69 CDMC21355 1 21 1 DAC02-E11 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC21355 1 22 1 DAC02-E11 12-Q9XIB8_1 Q9XIB8 AGACGAGGCGAGATCTTCAAAGCGGTTTCTTGTAGAACGCCAGCGACAACCATACCGATGACTAATGGA 69 CDMC21356 1 23 1 DAC02-E23 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC21356 1 24 1 DAC02-E23 14-Q9LZJ2_2 Q9LZJ2 CACGCACAAGCCTTCGTCCTTGATCCCGCACATACCGAGTTCATTACGGAGGTTAGATATCTCATTGGT 69 CDMC21357 1 25 1 DAC02-I11 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC21357 1 26 1 DAC02-I11 16-L22585_1 L22585 GAGTCCGAGAAGCTGACATAGACTAGCCTGAATGAGAAAATCAGCTGTGTTCGAATAGTGCCTCCCTGT 69 CDMC21358 1 1 2 DAC02-I23 N/A CG9075 (01196-01434) CDMC21358 1 2 2 DAC02-I23 N/A CG9075 (01196-01434) CDMC21359 1 3 2 DAC02-M11 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC21359 1 4 2 DAC02-M11 3-AB007987_1 AB007987 TGGCATGGAAATGGGATTCAGATACGTAGCATCAGGACCAATGGTGAGGTCGTCGTACAAAGCGGGAGA 69 CDMC21360 1 5 2 DAC02-M23 AutoBlank AutoBlank CDMC21360 1 6 2 DAC02-M23 AutoBlank AutoBlank CDMC21361 1 7 2 DAC03-A11 9-CG17083-RA_3 CG17083 GCAACATCAGGCCTATGTAATGCGAGCACGGAAAAGGATGACCATTTTGGAGAATTCCCTGGAGGTGGG 69 FBan0017083 FBgn0039070 CG17083 3 3R CG17083 CG17083 CDMC21361 1 8 2 DAC03-A11 9-CG17083-RA_3 CG17083 GCAACATCAGGCCTATGTAATGCGAGCACGGAAAAGGATGACCATTTTGGAGAATTCCCTGGAGGTGGG 69 FBan0017083 FBgn0039070 CG17083 3 3R CG17083 CG17083 CDMC21362 1 9 2 DAC03-A23 15-CG1709-RC_5 CG1709 TCTTCGGTGTGGTGATGAGCTGGCACAATCATACGTATTTCAGGAACAGGATCTCCCTGCTCTACGAGT 69 FBan0001709 FBgn0028671 Vha100-1 3 3R cation transport; GO:0006812; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6" hydrogen-transporting ATPase V0 domain; GO:0000220 Vha100-1 Vha100-1 "CG1709, vha100-1, V-ATPase, BcDNA:LD21248" CDMC21362 1 10 2 DAC03-A23 15-CG1709-RC_5 CG1709 TCTTCGGTGTGGTGATGAGCTGGCACAATCATACGTATTTCAGGAACAGGATCTCCCTGCTCTACGAGT 69 FBan0001709 FBgn0028671 Vha100-1 3 3R cation transport; GO:0006812; proton transport; GO:0015992 "hydrogen-exporting ATPase activity, phosphorylative mechanism; GO:0008553 ; EC:3.6.3.6; ; GO:0008553 ; EC:3.6.3.6" hydrogen-transporting ATPase V0 domain; GO:0000220 Vha100-1 Vha100-1 "CG1709, vha100-1, V-ATPase, BcDNA:LD21248" CDMC21363 1 11 2 DAC03-E11 2-CG17148-RA_2 CG17148 GCTGTCCGAAGCTTCCTTGTGTTTTCCTATGTACCCTTCAGTGCTTTTGGACCTGTTGTGGAGCCGTCA 69 FBan0017148 FBgn0000594 Est-P 3 3L neuromuscular synaptic transmission; GO:0007274; signal transduction; GO:0007165 carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; receptor binding; GO:0005102; ; GO:0005102; ; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 Est-P Esterase P "CG17148, est-P, EstP, ESTP, Est-5, PsiEst-6, yEst-6, EST-5, Est-7" CDMC21363 1 12 2 DAC03-E11 2-CG17148-RA_2 CG17148 GCTGTCCGAAGCTTCCTTGTGTTTTCCTATGTACCCTTCAGTGCTTTTGGACCTGTTGTGGAGCCGTCA 69 FBan0017148 FBgn0000594 Est-P 3 3L neuromuscular synaptic transmission; GO:0007274; signal transduction; GO:0007165 carboxylesterase activity; GO:0004091 ; EC:3.1.1.1; receptor binding; GO:0005102; ; GO:0005102; ; GO:0004091 ; EC:3.1.1.1; ; GO:0004091 ; EC:3.1.1.1 Est-P Esterase P "CG17148, est-P, EstP, ESTP, Est-5, PsiEst-6, yEst-6, EST-5, Est-7" CDMC21364 1 13 2 DAC03-E23 23-CG17158-RA_4 CG17158 GGCAGTAAATTTGTTACATGAGAAAATTGTTACACCACGAGAAGCACATTAATGTAAATTTTGCCCGCC 69 FBan0017158 FBgn0011570 cpb 2 2L actin filament organization; GO:0007015; barbed-end actin filament capping; GO:0051016; cytoskeleton organization and biogenesis; GO:0007010; regulation of actin filament length; GO:0030832 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0003779 F-actin capping protein complex; GO:0008290 cpb capping protein beta "CG17158, CG17158, CP beta subunit, J, capping protein, CP-beta, capping protein beta, CapZ, CP, Ancpbeta, Capping-protein-beta, capping protein beta" CDMC21364 1 14 2 DAC03-E23 23-CG17158-RA_4 CG17158 GGCAGTAAATTTGTTACATGAGAAAATTGTTACACCACGAGAAGCACATTAATGTAAATTTTGCCCGCC 69 FBan0017158 FBgn0011570 cpb 2 2L actin filament organization; GO:0007015; barbed-end actin filament capping; GO:0051016; cytoskeleton organization and biogenesis; GO:0007010; regulation of actin filament length; GO:0030832 actin binding; GO:0003779; ; GO:0003779; structural constituent of cytoskeleton; GO:0005200; ; GO:0005200; ; GO:0003779 F-actin capping protein complex; GO:0008290 cpb capping protein beta "CG17158, CG17158, CP beta subunit, J, capping protein, CP-beta, capping protein beta, CapZ, CP, Ancpbeta, Capping-protein-beta, capping protein beta" CDMC21365 1 15 2 DAC03-I11 14-CG17196-RA_1 CG17196 TGGTGCCGCGAATATGCCAATCTCTATCCTAAGAAGGCCGTGAGCATAGGACATCCTTTGTCAGTGATT 69 FBan0017196 FBgn0039368 CG17196 3 3R metal ion binding; GO:0046872; ; GO:0046872 CG17196 CG17196 CDMC21365 1 16 2 DAC03-I11 14-CG17196-RA_1 CG17196 TGGTGCCGCGAATATGCCAATCTCTATCCTAAGAAGGCCGTGAGCATAGGACATCCTTTGTCAGTGATT 69 FBan0017196 FBgn0039368 CG17196 3 3R metal ion binding; GO:0046872; ; GO:0046872 CG17196 CG17196 CDMC21366 1 17 2 DAC03-I23 23-CG17205-RA_4 CG17205 GCCCGAACAACCATATGAAAAAGCGCTGTGATCGTATCTTTAATATTGTTAATCACAATCCTTGCGTGG 69 FBan0017205 FBgn0038794 CG17205 3 3R CG17205 CG17205 BcDNA:GH26447 CDMC21366 1 18 2 DAC03-I23 23-CG17205-RA_4 CG17205 GCCCGAACAACCATATGAAAAAGCGCTGTGATCGTATCTTTAATATTGTTAATCACAATCCTTGCGTGG 69 FBan0017205 FBgn0038794 CG17205 3 3R CG17205 CG17205 BcDNA:GH26447 CDMC21367 1 19 2 DAC03-M11 23-CG17244-RA_1 CG17244 CTTCGTGACACGTGTTTACTGCATAATTATACCTGTGGAATTTTCGTTTTTATATACATGCCTGCTCCC 69 FBan0017244 FBgn0039031 CG17244 3 3R CG17244 CG17244 BcDNA:RH17470 CDMC21367 1 20 2 DAC03-M11 23-CG17244-RA_1 CG17244 CTTCGTGACACGTGTTTACTGCATAATTATACCTGTGGAATTTTCGTTTTTATATACATGCCTGCTCCC 69 FBan0017244 FBgn0039031 CG17244 3 3R CG17244 CG17244 BcDNA:RH17470 CDMC21368 1 21 2 DAC03-M23 2-CG17257-RA_1 CG17257 GGCTGAGGACAGTCGAGAGCGATCCCACATCCTAGGATGCTGTTGTAACTGCGTGGACTTCGACTTAGT 69 FBan0017257 FBgn0031495 CG17257 2 2L metal ion binding; GO:0046872; ; GO:0046872 CG17257 CG17257 CDMC21368 1 22 2 DAC03-M23 2-CG17257-RA_1 CG17257 GGCTGAGGACAGTCGAGAGCGATCCCACATCCTAGGATGCTGTTGTAACTGCGTGGACTTCGACTTAGT 69 FBan0017257 FBgn0031495 CG17257 2 2L metal ion binding; GO:0046872; ; GO:0046872 CG17257 CG17257 CDMC21369 1 23 2 DAC04-A11 9-CG15874-RA_1 CG15874 ACATTATCCTGGTGAGACATGGCGAGTACACGAGGACCCCGAATGGAAGCCACCTCACGGAACTG 65 FBan0015874 FBgn0035004 CG15874 2 2R CG15874 CG15874 CDMC21369 1 24 2 DAC04-A11 9-CG15874-RA_1 CG15874 ACATTATCCTGGTGAGACATGGCGAGTACACGAGGACCCCGAATGGAAGCCACCTCACGGAACTG 65 FBan0015874 FBgn0035004 CG15874 2 2R CG15874 CG15874 CDMC21370 1 25 2 DAC04-A23 2-CG15904-RA_2 CG15904 GGTGGACAAGCACATGCTGGACCTGCATCGTGATCCATTCAACACCTCCTTTGGCTACACGGTAA 65 FBan0015904 FBgn0034458 CG15904 2 2R CG15904 CG15904 CDMC21370 1 26 2 DAC04-A23 2-CG15904-RA_2 CG15904 GGTGGACAAGCACATGCTGGACCTGCATCGTGATCCATTCAACACCTCCTTTGGCTACACGGTAA 65 FBan0015904 FBgn0034458 CG15904 2 2R CG15904 CG15904 CDMC21371 1 1 3 DAC04-E11 1-CG1675-RA_1 CG1675 AGGGGTCGTCGAAGCAGAAGGATGATAGCAGTATAGCCGCAAGTTCAGATGCCAAGACAGCGTCC 65 FBan0001675 FBgn0033457 CG1675 2 2R transferase activity; GO:0016740 ; EC:2.-.-.-; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008168 ; EC:2.1.1.- CG1675 CG1675 CDMC21371 1 2 3 DAC04-E11 1-CG1675-RA_1 CG1675 AGGGGTCGTCGAAGCAGAAGGATGATAGCAGTATAGCCGCAAGTTCAGATGCCAAGACAGCGTCC 65 FBan0001675 FBgn0033457 CG1675 2 2R transferase activity; GO:0016740 ; EC:2.-.-.-; methyltransferase activity; GO:0008168 ; EC:2.1.1.-; ; GO:0016740 ; EC:2.-.-.-; ; GO:0008168 ; EC:2.1.1.- CG1675 CG1675 CDMC21372 1 3 3 DAC04-E23 3-CG1677-RA_1 CG1677 TATAAGAGACCAGCTGTGGACAAGCGTGGCGTTGGACACAGTCCGTCTTCCAAGCGTAAGAAGCT 65 FBan0001677 FBgn0029941 CG1677 X X nucleic acid binding; GO:0003676; ; GO:0003676 nucleus; GO:0005634 CG1677 CG1677 CDMC21372 1 4 3 DAC04-E23 3-CG1677-RA_1 CG1677 TATAAGAGACCAGCTGTGGACAAGCGTGGCGTTGGACACAGTCCGTCTTCCAAGCGTAAGAAGCT 65 FBan0001677 FBgn0029941 CG1677 X X nucleic acid binding; GO:0003676; ; GO:0003676 nucleus; GO:0005634 CG1677 CG1677 CDMC21373 1 5 3 DAC04-I11 2-CG16908-RA_2 CG16908 ATTGGTTTGAGGACCGTACTCCTGGCATCTATTCATCGGCGATTGAGGTACGCACCCAGGACTGC 65 FBan0016908 FBgn0037741 CG16908 3 3R CG16908 CG16908 CDMC21373 1 6 3 DAC04-I11 2-CG16908-RA_2 CG16908 ATTGGTTTGAGGACCGTACTCCTGGCATCTATTCATCGGCGATTGAGGTACGCACCCAGGACTGC 65 FBan0016908 FBgn0037741 CG16908 3 3R CG16908 CG16908 CDMC21374 1 7 3 DAC04-I23 23-CG16958-RA_2 CG16958 CTACATTTACATGCGGGAAAATATTCCACACATCAACATCGAATGTAGACACACTCGTACGTCTT 65 FBgn0030902 CDMC21374 1 8 3 DAC04-I23 23-CG16958-RA_2 CG16958 CTACATTTACATGCGGGAAAATATTCCACACATCAACATCGAATGTAGACACACTCGTACGTCTT 65 FBgn0030902 CDMC21375 1 9 3 DAC04-M11 19-CG17127-RA_1 CG17127 TGGGCGCGTACGAGCAGATACCCGGCAACCAGCGCATCAATCTCTTCGAGATCCTCGGCGACCAG 65 FBan0017127 FBgn0032299 CG17127 2 2L CG17127 CG17127 CDMC21375 1 10 3 DAC04-M11 19-CG17127-RA_1 CG17127 TGGGCGCGTACGAGCAGATACCCGGCAACCAGCGCATCAATCTCTTCGAGATCCTCGGCGACCAG 65 FBan0017127 FBgn0032299 CG17127 2 2L CG17127 CG17127 CDMC21376 1 11 3 DAC04-M23 3-CG17150-RC_3 CG17150 GCCCAAGCTGAAAGTCCTGTCCGAGGAAACGGATCGCATAATGGTGAACATCGAACGTGAGACGG 65 FBan0017150 FBgn0035581 CG17150 3 3L cell motility; GO:0006928; microtubule-based movement; GO:0007018; proteolysis; GO:0006508 "motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0042623; ; GO:0003774; ; GO:0003777; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; nucleotide binding; GO:0000166; ; GO:0000166; ; GO:0004197 ; EC:3.4.22.-" dynein complex; GO:0030286; microtubule associated complex; GO:0005875 CG17150 CG17150 CDMC21376 1 12 3 DAC04-M23 3-CG17150-RC_3 CG17150 GCCCAAGCTGAAAGTCCTGTCCGAGGAAACGGATCGCATAATGGTGAACATCGAACGTGAGACGG 65 FBan0017150 FBgn0035581 CG17150 3 3L cell motility; GO:0006928; microtubule-based movement; GO:0007018; proteolysis; GO:0006508 "motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; microtubule motor activity; GO:0003777; ; GO:0005200; ; GO:0042623; ; GO:0003774; ; GO:0003777; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; nucleotide binding; GO:0000166; ; GO:0000166; ; GO:0004197 ; EC:3.4.22.-" dynein complex; GO:0030286; microtubule associated complex; GO:0005875 CG17150 CG17150 CDMC21377 1 13 3 DAC05-A11 5-CG10240-RA_1 CG10240 GGATCGGGGAATGTATCACAATGAGCGGGATGATCCTCTAACTGGGCATCTATTCCGCATTGACGGGC 68 FBan0010240 FBgn0013773 Cyp6a22 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6a22 Cyp6a22 "CG10240, P-450, BF6-2, P450, 6a22, Cyt-P450-rBF6-2: Cytochrome P450 related BF6-2, Cytochrome P450 related BF6-2" CDMC21377 1 14 3 DAC05-A11 5-CG10240-RA_1 CG10240 GGATCGGGGAATGTATCACAATGAGCGGGATGATCCTCTAACTGGGCATCTATTCCGCATTGACGGGC 68 FBan0010240 FBgn0013773 Cyp6a22 2 2R electron transport; GO:0006118; steroid metabolism; GO:0008202 electron transporter activity; GO:0005489; ; GO:0005489; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0005489; monooxygenase activity; GO:0004497; ; GO:0004497 membrane; GO:0016020; microsome; GO:0005792 Cyp6a22 Cyp6a22 "CG10240, P-450, BF6-2, P450, 6a22, Cyt-P450-rBF6-2: Cytochrome P450 related BF6-2, Cytochrome P450 related BF6-2" CDMC21378 1 15 3 DAC05-A23 3-CG10361-RA_6 CG10361 CCCGAATCGTTGAACTGGCTAGGAAATACAATGCCCTGGTGTTTGTGGACGAGTGTCATGCTACGGGC 68 FBan0010361 FBgn0036208 CG10361 3 3L amino acid metabolism; GO:0006520; biosynthesis; GO:0009058 transaminase activity; GO:0008483 ; EC:2.6.1.-; ; GO:0008483 ; EC:2.6.1.-; glycine C-acetyltransferase activity; GO:0008890 ; EC:2.3.1.29; ; GO:0008890 ; EC:2.3.1.29; ; GO:0008890 ; EC:2.3.1.29 mitochondrion; GO:0005739 CG10361 CG10361 CDMC21378 1 16 3 DAC05-A23 3-CG10361-RA_6 CG10361 CCCGAATCGTTGAACTGGCTAGGAAATACAATGCCCTGGTGTTTGTGGACGAGTGTCATGCTACGGGC 68 FBan0010361 FBgn0036208 CG10361 3 3L amino acid metabolism; GO:0006520; biosynthesis; GO:0009058 transaminase activity; GO:0008483 ; EC:2.6.1.-; ; GO:0008483 ; EC:2.6.1.-; glycine C-acetyltransferase activity; GO:0008890 ; EC:2.3.1.29; ; GO:0008890 ; EC:2.3.1.29; ; GO:0008890 ; EC:2.3.1.29 mitochondrion; GO:0005739 CG10361 CG10361 CDMC21379 1 17 3 DAC05-E11 1-CG10887-RA_2 CG10887 GCGCGCTTATGAAGAATCATCCTCCGAAACGTGACAGGCACTATCAAGGCTCCGATCACAATGTGGCC 68 FBan0010887 FBgn0038773 CG10887 3 3R CG10887 CG10887 CDMC21379 1 18 3 DAC05-E11 1-CG10887-RA_2 CG10887 GCGCGCTTATGAAGAATCATCCTCCGAAACGTGACAGGCACTATCAAGGCTCCGATCACAATGTGGCC 68 FBan0010887 FBgn0038773 CG10887 3 3R CG10887 CG10887 CDMC21380 1 19 3 DAC05-E23 2-CG11015-RA_1 CG11015 TCACCACTTAAGACCGACCGAAATTTTCGCAAAACGAACAATGGCATCGATCTGTGGACGCATGGCGC 68 FBan0011015 FBgn0031830 CG11015 2 2L "mitochondrial electron transport, cytochrome c to oxygen; GO:0006123" cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 mitochondrion; GO:0005739; respiratory chain complex IV (sensu Eukaryota); GO:0005751 CG11015 CG11015 "Vb, anon-WO0118547.187, BcDNA:RH49324, anon-EST:Posey143" CDMC21380 1 20 3 DAC05-E23 2-CG11015-RA_1 CG11015 TCACCACTTAAGACCGACCGAAATTTTCGCAAAACGAACAATGGCATCGATCTGTGGACGCATGGCGC 68 FBan0011015 FBgn0031830 CG11015 2 2L "mitochondrial electron transport, cytochrome c to oxygen; GO:0006123" cytochrome-c oxidase activity; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1; ; GO:0004129 ; EC:1.9.3.1 mitochondrion; GO:0005739; respiratory chain complex IV (sensu Eukaryota); GO:0005751 CG11015 CG11015 "Vb, anon-WO0118547.187, BcDNA:RH49324, anon-EST:Posey143" CDMC21381 1 21 3 DAC05-I11 3-CG11309-RB_5 CG11309 CGGGTCCCAGGAGCTGTGTGTGGAAATGGCCAATCGGATTACATGTCCTTACTTGTTCATCAAGGCCG 68 FBan0011309 FBgn0037070 CG11309 3 3L calcium ion binding; GO:0005509; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0005509 CG11309 CG11309 CDMC21381 1 22 3 DAC05-I11 3-CG11309-RB_5 CG11309 CGGGTCCCAGGAGCTGTGTGTGGAAATGGCCAATCGGATTACATGTCCTTACTTGTTCATCAAGGCCG 68 FBan0011309 FBgn0037070 CG11309 3 3L calcium ion binding; GO:0005509; hydrolase activity; GO:0016787 ; EC:3.-.-.-; ; GO:0016787 ; EC:3.-.-.-; ; GO:0005509 CG11309 CG11309 CDMC21382 1 23 3 DAC05-I23 3-CG11396-RA_1 CG11396 ACCGGCAACACAATGATCCTGAACAACATGGGAGTGTGCCTTCTCTACGCCGGAAAGCTAAAGGATGC 68 FBan0011396 FBgn0037022 CG11396 3 3L CG11396 CG11396 CDMC21382 1 24 3 DAC05-I23 3-CG11396-RA_1 CG11396 ACCGGCAACACAATGATCCTGAACAACATGGGAGTGTGCCTTCTCTACGCCGGAAAGCTAAAGGATGC 68 FBan0011396 FBgn0037022 CG11396 3 3L CG11396 CG11396 CDMC21383 1 25 3 DAC05-M11 5-CG11981-RA_1 CG11981 CGATCGCCTGATGTTCCGCAAGAATCTGTACGAGACACGCGAAAACCGTGAAATGTGTCCCAAGCCCT 68 FBan0011981 FBgn0026380 Prosbeta3 3 3R ATP-dependent proteolysis; GO:0006510; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 proteasome complex (sensu Eukaryota); GO:0000502; proteasome core complex (sensu Eukaryota); GO:0005839 Prosbeta3 Prosbeta3 "CG11981, 20S proteasome beta3 subunit, 20S proteasome, 20s proteasome, Prosbeta3" CDMC21383 1 26 3 DAC05-M11 5-CG11981-RA_1 CG11981 CGATCGCCTGATGTTCCGCAAGAATCTGTACGAGACACGCGAAAACCGTGAAATGTGTCCCAAGCCCT 68 FBan0011981 FBgn0026380 Prosbeta3 3 3R ATP-dependent proteolysis; GO:0006510; ubiquitin-dependent protein catabolism; GO:0006511 endopeptidase activity; GO:0004175; ; GO:0004175; ; GO:0004175 proteasome complex (sensu Eukaryota); GO:0000502; proteasome core complex (sensu Eukaryota); GO:0005839 Prosbeta3 Prosbeta3 "CG11981, 20S proteasome beta3 subunit, 20S proteasome, 20s proteasome, Prosbeta3" CDMC21384 1 1 4 DAC05-M23 2-CG12110-RB_2 CG12110 AGCGAAGGTTCCAGTCGGTCTGACCTGGACATTAACGATCCTGTTTGTGAGAAGTTTTGGCACGGCAC 68 FBan0012110 FBgn0033075 Pld 2 2R intracellular signaling cascade; GO:0007242; phospholipid metabolism; GO:0006644; signal transduction; GO:0007165 phospholipase D activity; GO:0004630 ; EC:3.1.4.4; ; GO:0004630 ; EC:3.1.4.4 Pld Phospholipase D "CG12110, CG12110, dPLD, Phospholipase D" CDMC21384 1 2 4 DAC05-M23 2-CG12110-RB_2 CG12110 AGCGAAGGTTCCAGTCGGTCTGACCTGGACATTAACGATCCTGTTTGTGAGAAGTTTTGGCACGGCAC 68 FBan0012110 FBgn0033075 Pld 2 2R intracellular signaling cascade; GO:0007242; phospholipid metabolism; GO:0006644; signal transduction; GO:0007165 phospholipase D activity; GO:0004630 ; EC:3.1.4.4; ; GO:0004630 ; EC:3.1.4.4 Pld Phospholipase D "CG12110, CG12110, dPLD, Phospholipase D" CDMC21385 1 3 4 DAC06-A11 15-CG32985-RA_1 CG32985 TGGTGGAGTGCAGGACAGCTGACGAAATGAGAGTCCTTCAAAGAGATGCCTTCGTGTTTGTGCAATACA 69 FBan0032985 FBgn0052985 CG32985 2 2L CG32985 CG32985 CG17789 CDMC21385 1 4 4 DAC06-A11 15-CG32985-RA_1 CG32985 TGGTGGAGTGCAGGACAGCTGACGAAATGAGAGTCCTTCAAAGAGATGCCTTCGTGTTTGTGCAATACA 69 FBan0032985 FBgn0052985 CG32985 2 2L CG32985 CG32985 CG17789 CDMC21386 1 5 4 DAC06-A23 2-CG33003-RA_1 CG33003 CCGCAAGCTCTGGTACATCCCGCTCTACTTTACGGTGTGGTTCAGCTTCTACATCCTGTGGCTGATCAT 69 FBan0033003 FBgn0053003 CG33003 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33003 CG33003 CDMC21386 1 6 4 DAC06-A23 2-CG33003-RA_1 CG33003 CCGCAAGCTCTGGTACATCCCGCTCTACTTTACGGTGTGGTTCAGCTTCTACATCCTGTGGCTGATCAT 69 FBan0033003 FBgn0053003 CG33003 2 2L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG33003 CG33003 CDMC21387 1 7 4 DAC06-E11 22-CG33056-RA_1 CG33056 GCCGAGGATAGCGTGGACATAATTGCATTCTTCTACACACCGCCACAAATGGTTAAGGACACGTTGAAC 69 FBan0033056 FBgn0053056 CG33056 3 3L CG33056 CG33056 "CG10517, CG10517, CG10517" CDMC21387 1 8 4 DAC06-E11 22-CG33056-RA_1 CG33056 GCCGAGGATAGCGTGGACATAATTGCATTCTTCTACACACCGCCACAAATGGTTAAGGACACGTTGAAC 69 FBan0033056 FBgn0053056 CG33056 3 3L CG33056 CG33056 "CG10517, CG10517, CG10517" CDMC21388 1 9 4 DAC06-E23 8-CG3306-RA_1 CG3306 GCCCGTCGACTTTGAGATGAAGGATCATTACACGATGAGTTTCAAACCCTGGACGTATTGCACGCCGGA 69 FBan0003306 FBgn0036016 CG3306 3 3L CG3306 CG3306 CDMC21388 1 10 4 DAC06-E23 8-CG3306-RA_1 CG3306 GCCCGTCGACTTTGAGATGAAGGATCATTACACGATGAGTTTCAAACCCTGGACGTATTGCACGCCGGA 69 FBan0003306 FBgn0036016 CG3306 3 3L CG3306 CG3306 CDMC21389 1 11 4 DAC06-I11 3-CG3309-RA_1 CG3309 TGGCCTCCGTTAATGAAATCGAACTCTTCCGCTCCCTGGACTTTGTCATGGAGCAACTGTACACGCTGT 69 FBan0003309 FBgn0029756 CG3309 X X CG3309 CG3309 BEST:LD39762 CDMC21389 1 12 4 DAC06-I11 3-CG3309-RA_1 CG3309 TGGCCTCCGTTAATGAAATCGAACTCTTCCGCTCCCTGGACTTTGTCATGGAGCAACTGTACACGCTGT 69 FBan0003309 FBgn0029756 CG3309 X X CG3309 CG3309 BEST:LD39762 CDMC21390 1 13 4 DAC06-I23 2-CG33107-RA_1 CG33107 TGGAAGTGGATGAAATGCGCCTAGGCTATGACCACGAATCCATCATGTCCTTTCTCCGGAAGTCGTCCA 69 FBan0033107 FBgn0053107 CG33107 3 3R CG33107 CG33107 CG5275 CDMC21390 1 14 4 DAC06-I23 2-CG33107-RA_1 CG33107 TGGAAGTGGATGAAATGCGCCTAGGCTATGACCACGAATCCATCATGTCCTTTCTCCGGAAGTCGTCCA 69 FBan0033107 FBgn0053107 CG33107 3 3R CG33107 CG33107 CG5275 CDMC21391 1 15 4 DAC06-M11 12-CG33129-RE_1 CG33129 TGGACCACGTCTACCCATGAGTTGGCTACGTCGACTGTGTATCACTCTTTTCTGCAAGATGTGGCGAAT 69 FBan0033129 FBgn0053129 CG33129 2 2L CG33129 CG33129 "CG6087, CG6089" CDMC21391 1 16 4 DAC06-M11 12-CG33129-RE_1 CG33129 TGGACCACGTCTACCCATGAGTTGGCTACGTCGACTGTGTATCACTCTTTTCTGCAAGATGTGGCGAAT 69 FBan0033129 FBgn0053129 CG33129 2 2L CG33129 CG33129 "CG6087, CG6089" CDMC21392 1 17 4 DAC06-M23 15-CG33137-RA_3 CG33137 GCAACAAGTTTCAGCCGTTCCTCGTAGACGTCGTGATAAACATGTGCGATGCATTATCCAGGCGTAGCT 69 FBan0033137 FBgn0053137 CG33137 2 2R CG33137 CG33137 "CG4023, CG4023" CDMC21392 1 18 4 DAC06-M23 15-CG33137-RA_3 CG33137 GCAACAAGTTTCAGCCGTTCCTCGTAGACGTCGTGATAAACATGTGCGATGCATTATCCAGGCGTAGCT 69 FBan0033137 FBgn0053137 CG33137 2 2R CG33137 CG33137 "CG4023, CG4023" CDMC21393 1 19 4 DAC07-A11 14-CG5786-RA_12 CG5786 AGCAGCCACACTGATCCATACACGTGCGGGAGAAAAGTGAACAAAAACATTGAAACATGGGCGGTAAGA 69 FBan0005786 FBgn0010770 ppan 3 3R imaginal disc development; GO:0007444; larval development; GO:0002164; mitosis; GO:0007067; oogenesis (sensu Insecta); GO:0009993 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 ppan peter pan "CG5786, l(3)02231, Peter Pan, l(3)j6B6, peter pan" CDMC21393 1 20 4 DAC07-A11 14-CG5786-RA_12 CG5786 AGCAGCCACACTGATCCATACACGTGCGGGAGAAAAGTGAACAAAAACATTGAAACATGGGCGGTAAGA 69 FBan0005786 FBgn0010770 ppan 3 3R imaginal disc development; GO:0007444; larval development; GO:0002164; mitosis; GO:0007067; oogenesis (sensu Insecta); GO:0009993 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 ppan peter pan "CG5786, l(3)02231, Peter Pan, l(3)j6B6, peter pan" CDMC21394 1 21 4 DAC07-A23 12-CG5794-RD_1 CG5794 CGGAGAGCGAGAAAGAGACCTCAACGGAGAACGACAAACCATCAGATGTTTCCATGGAATCCAGCGGTA 69 FBan0005794 FBgn0039214 CG5794 3 3R protein metabolism; GO:0019538; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 peptidase activity; GO:0008233 ; EC:3.4.-.-; cysteine-type peptidase activity; GO:0008234 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0008234 ; EC:3.4.-.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 CG5794 CG5794 "BcDNA:AT28817, NEST:bs19d10" CDMC21394 1 22 4 DAC07-A23 12-CG5794-RD_1 CG5794 CGGAGAGCGAGAAAGAGACCTCAACGGAGAACGACAAACCATCAGATGTTTCCATGGAATCCAGCGGTA 69 FBan0005794 FBgn0039214 CG5794 3 3R protein metabolism; GO:0019538; proteolysis; GO:0006508; ubiquitin-dependent protein catabolism; GO:0006511 peptidase activity; GO:0008233 ; EC:3.4.-.-; cysteine-type peptidase activity; GO:0008234 ; EC:3.4.-.-; ; GO:0008233 ; EC:3.4.-.-; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0008234 ; EC:3.4.-.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 CG5794 CG5794 "BcDNA:AT28817, NEST:bs19d10" CDMC21395 1 23 4 DAC07-E11 15-CG5827-RB_3 CG5827 TTGAATGCTCCGCTATGCTAGCTCCCGTAGTTTTAATCTGACAACGCGATTTTCCTGTGGTTTGCGCCG 69 FBan0005827 FBgn0028696 RpL37A 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL37A Ribosomal protein L37A "CG5827, DmL37a, Ribosomal protein L37a, RpL37a, L37A, BcDNA:RE23595, BcDNA:RH41593, Ribosomal protein L37A" CDMC21395 1 24 4 DAC07-E11 15-CG5827-RB_3 CG5827 TTGAATGCTCCGCTATGCTAGCTCCCGTAGTTTTAATCTGACAACGCGATTTTCCTGTGGTTTGCGCCG 69 FBan0005827 FBgn0028696 RpL37A 2 2L protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003676; ; GO:0003735 cytosolic large ribosomal subunit (sensu Eukaryota); GO:0005842 RpL37A Ribosomal protein L37A "CG5827, DmL37a, Ribosomal protein L37a, RpL37a, L37A, BcDNA:RE23595, BcDNA:RH41593, Ribosomal protein L37A" CDMC21396 1 25 4 DAC07-E23 9-CG5842-RA_2 CG5842 TGGAGCGATGGTGTCTACGCAGCACGAATACGAGGCGAAGATCCTCTTCTTTCTGTTCATGGTGATCGT 69 FBan0005842 FBgn0036414 nan 3 3L calcium ion transport; GO:0006816; sensory perception of pain; GO:0019233; sensory perception of sound; GO:0007605 calcium channel activity; GO:0005262; ion channel activity; GO:0005216; ; GO:0005262; ; GO:0005216 membrane; GO:0016020 nan nanchung "CG5842, CT18317, OCR, TRPV, nanchung" CDMC21396 1 26 4 DAC07-E23 9-CG5842-RA_2 CG5842 TGGAGCGATGGTGTCTACGCAGCACGAATACGAGGCGAAGATCCTCTTCTTTCTGTTCATGGTGATCGT 69 FBan0005842 FBgn0036414 nan 3 3L calcium ion transport; GO:0006816; sensory perception of pain; GO:0019233; sensory perception of sound; GO:0007605 calcium channel activity; GO:0005262; ion channel activity; GO:0005216; ; GO:0005262; ; GO:0005216 membrane; GO:0016020 nan nanchung "CG5842, CT18317, OCR, TRPV, nanchung" CDMC21397 1 1 5 DAC07-I11 8-CG5872-RA_1 CG5872 GCGGTGGGAAATAGTTGGACCCGCAAGACACCCAAGAATCAGGGAGTCCTTACAAAGCTATCACTCACA 69 FBan0005872 FBgn0036991 CG5872 3 3L CG5872 CG5872 CDMC21397 1 2 5 DAC07-I11 8-CG5872-RA_1 CG5872 GCGGTGGGAAATAGTTGGACCCGCAAGACACCCAAGAATCAGGGAGTCCTTACAAAGCTATCACTCACA 69 FBan0005872 FBgn0036991 CG5872 3 3L CG5872 CG5872 CDMC21398 1 3 5 DAC07-I23 22-CG5880-RA_1 CG5880 TCCTCTACATGACGTACACCACTCTGGGTTGTCTGTTTCTTATTTTGTTTGGCTTGGAGATTGGCCACA 69 FBan0005880 FBgn0039489 CG5880 3 3R metal ion binding; GO:0046872; ; GO:0046872 CG5880 CG5880 CDMC21398 1 4 5 DAC07-I23 22-CG5880-RA_1 CG5880 TCCTCTACATGACGTACACCACTCTGGGTTGTCTGTTTCTTATTTTGTTTGGCTTGGAGATTGGCCACA 69 FBan0005880 FBgn0039489 CG5880 3 3R metal ion binding; GO:0046872; ; GO:0046872 CG5880 CG5880 CDMC21399 1 5 5 DAC07-M11 6-CG5922-RA_3 CG5922 GGCTAGACCCTGTAGCGACAGTCAGCTACAGTTGGTTAATTGGTACGACGGCGATAACCTTGGTCTGCA 69 FBan0005922 FBgn0032983 CG5922 2 2L CG5922 CG5922 CDMC21399 1 6 5 DAC07-M11 6-CG5922-RA_3 CG5922 GGCTAGACCCTGTAGCGACAGTCAGCTACAGTTGGTTAATTGGTACGACGGCGATAACCTTGGTCTGCA 69 FBan0005922 FBgn0032983 CG5922 2 2L CG5922 CG5922 CDMC21400 1 7 5 DAC07-M23 1-CG5933-RA_1 CG5933 GCCGGATGAGATTTATGGTATTATCGAGCGTCTAAGCCCGGGTACTCGCAAGATCGAGCTCTTTGGGCG 69 FBan0005933 FBgn0039139 CG5933 3 3R RNA methylation; GO:0001510 mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity; GO:0016422 ; EC:2.1.1.62; ; GO:0016422 ; EC:2.1.1.62; ; GO:0016422 ; EC:2.1.1.62 nucleus; GO:0005634 CG5933 CG5933 CDMC21400 1 8 5 DAC07-M23 1-CG5933-RA_1 CG5933 GCCGGATGAGATTTATGGTATTATCGAGCGTCTAAGCCCGGGTACTCGCAAGATCGAGCTCTTTGGGCG 69 FBan0005933 FBgn0039139 CG5933 3 3R RNA methylation; GO:0001510 mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity; GO:0016422 ; EC:2.1.1.62; ; GO:0016422 ; EC:2.1.1.62; ; GO:0016422 ; EC:2.1.1.62 nucleus; GO:0005634 CG5933 CG5933 CDMC21401 1 9 5 DAC08-A11 2-CG8223-RA_2 CG8223 GCCGAGTTGCATTACAAGATCGGGCTGACCTATTTGATGCAGCAACTCAACAAGGAAGGAGCGACAGCA 69 FBan0008223 FBgn0037624 CG8223 3 3R CG8223 CG8223 CDMC21401 1 10 5 DAC08-A11 2-CG8223-RA_2 CG8223 GCCGAGTTGCATTACAAGATCGGGCTGACCTATTTGATGCAGCAACTCAACAAGGAAGGAGCGACAGCA 69 FBan0008223 FBgn0037624 CG8223 3 3R CG8223 CG8223 CDMC21402 1 11 5 DAC08-A23 2-CG8232-RA_1 CG8232 GCACACAAGCCAACCGAATGCTGTCAACAATTCTCCCAATGGACGCCAAAAGTCCTGGTTTCCCCTTAC 69 FBan0008232 FBgn0033352 CG8232 2 2R ubiquitin-dependent protein catabolism; GO:0006511 poly(A)-specific ribonuclease activity; GO:0004535 ; EC:3.1.13.4; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004535 ; EC:3.1.13.4; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 intracellular; GO:0005622 CG8232 CG8232 CDMC21402 1 12 5 DAC08-A23 2-CG8232-RA_1 CG8232 GCACACAAGCCAACCGAATGCTGTCAACAATTCTCCCAATGGACGCCAAAAGTCCTGGTTTCCCCTTAC 69 FBan0008232 FBgn0033352 CG8232 2 2R ubiquitin-dependent protein catabolism; GO:0006511 poly(A)-specific ribonuclease activity; GO:0004535 ; EC:3.1.13.4; ubiquitin thiolesterase activity; GO:0004221 ; EC:3.1.2.15; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004535 ; EC:3.1.13.4; ; GO:0004197 ; EC:3.4.22.-; ; GO:0004221 ; EC:3.1.2.15 intracellular; GO:0005622 CG8232 CG8232 CDMC21403 1 13 5 DAC08-E11 12-CG8277-RA_2 CG8277 CGAGATTACCGAGATTGACAGTGTGGAGACCTTCTGGAGCTTGTACCATACCATCAAGACCCCAGCGGA 69 FBan0008277 FBgn0035823 CG8277 3 3L autophagic cell death; GO:0048102; protein biosynthesis; GO:0006412; salivary gland cell autophagic cell death; GO:0035071; translational initiation; GO:0006413 RNA cap binding; GO:0000339; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0000339 eukaryotic translation initiation factor 4F complex; GO:0016281 CG8277 CG8277 "eIF4E, CT24507" CDMC21403 1 14 5 DAC08-E11 12-CG8277-RA_2 CG8277 CGAGATTACCGAGATTGACAGTGTGGAGACCTTCTGGAGCTTGTACCATACCATCAAGACCCCAGCGGA 69 FBan0008277 FBgn0035823 CG8277 3 3L autophagic cell death; GO:0048102; protein biosynthesis; GO:0006412; salivary gland cell autophagic cell death; GO:0035071; translational initiation; GO:0006413 RNA cap binding; GO:0000339; translation initiation factor activity; GO:0003743; ; GO:0003743; ; GO:0000339 eukaryotic translation initiation factor 4F complex; GO:0016281 CG8277 CG8277 "eIF4E, CT24507" CDMC21404 1 15 5 DAC08-E23 16-CG8286-RA_1 CG8286 AAACCCATGGTCCGTTGTCAGAGAGTACCACAAACAAACACAAATCGCAACAAAACACACTGAGCACTT 69 FBan0008286 FBgn0037718 CG8286 3 3R cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952 protein kinase inhibitor activity; GO:0004860; ; GO:0004860 CG8286 CG8286 "SD05682.5prime, BEST:SD05682" CDMC21404 1 16 5 DAC08-E23 16-CG8286-RA_1 CG8286 AAACCCATGGTCCGTTGTCAGAGAGTACCACAAACAAACACAAATCGCAACAAAACACACTGAGCACTT 69 FBan0008286 FBgn0037718 CG8286 3 3R cytokine and chemokine mediated signaling pathway; GO:0019221; defense response; GO:0006952 protein kinase inhibitor activity; GO:0004860; ; GO:0004860 CG8286 CG8286 "SD05682.5prime, BEST:SD05682" CDMC21405 1 17 5 DAC08-I11 15-CG8319-RA_8 CG8319 AGCAATTCACACGTATGCCAAAACTGCGAAGAGCGTTTTCTGTTCAAGGCCGATCTGGATAACCACCAA 69 FBan0008319 FBgn0037722 CG8319 3 3R cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription regulator activity; GO:0030528; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG8319 CG8319 CDMC21405 1 18 5 DAC08-I11 15-CG8319-RA_8 CG8319 AGCAATTCACACGTATGCCAAAACTGCGAAGAGCGTTTTCTGTTCAAGGCCGATCTGGATAACCACCAA 69 FBan0008319 FBgn0037722 CG8319 3 3R cell proliferation; GO:0008283; regulation of transcription from RNA polymerase II promoter; GO:0006357 transcription regulator activity; GO:0030528; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG8319 CG8319 CDMC21406 1 19 5 DAC08-I23 3-CG8327-RB_1 CG8327 GCTTCGTCATGGGCTCCCTGAACAAAAACCAGGACTTCGCTACTCCCAAGCTTGGAAAGTCCGAAATCG 69 FBan0008327 FBgn0037723 SpdS 3 3R spermidine biosynthesis; GO:0008295 spermidine synthase activity; GO:0004766 ; EC:2.5.1.16; S-adenosylmethionine-dependent methyltransferase activity; GO:0008757; ; GO:0008757; ; GO:0004766 ; EC:2.5.1.16 cellular component unknown; GO:0008372 SpdS Spermidine Synthase "CG8327, CG8327, CG8327, Spermidine Synthase" CDMC21406 1 20 5 DAC08-I23 3-CG8327-RB_1 CG8327 GCTTCGTCATGGGCTCCCTGAACAAAAACCAGGACTTCGCTACTCCCAAGCTTGGAAAGTCCGAAATCG 69 FBan0008327 FBgn0037723 SpdS 3 3R spermidine biosynthesis; GO:0008295 spermidine synthase activity; GO:0004766 ; EC:2.5.1.16; S-adenosylmethionine-dependent methyltransferase activity; GO:0008757; ; GO:0008757; ; GO:0004766 ; EC:2.5.1.16 cellular component unknown; GO:0008372 SpdS Spermidine Synthase "CG8327, CG8327, CG8327, Spermidine Synthase" CDMC21407 1 21 5 DAC08-M11 23-CG8369-RA_1 CG8369 GCCTGTCCTAGAAGTCCAATTTCAACACTTTTGACGATTAAACATCTTTCACTGATTGTGCAATAATAT 69 FBan0008369 FBgn0040532 CG8369 3 3R CG8369 CG8369 "BcDNA:GH11984, anon-EST:Posey161" CDMC21407 1 22 5 DAC08-M11 23-CG8369-RA_1 CG8369 GCCTGTCCTAGAAGTCCAATTTCAACACTTTTGACGATTAAACATCTTTCACTGATTGTGCAATAATAT 69 FBan0008369 FBgn0040532 CG8369 3 3R CG8369 CG8369 "BcDNA:GH11984, anon-EST:Posey161" CDMC21408 1 23 5 DAC08-M23 23-CG8384-RE_5 CG8384 ACGATGCGAGTGCTTTTAGTTTGTTTTATGTGAGCGGTTTTTGTAATTTAGCTGAAAAGTCAGACAGCG 69 FBan0008384 FBgn0001139 gro 3 3R "actin filament organization; GO:0007015; ectoderm development; GO:0007398; negative regulation of frizzled signaling pathway; GO:0045810; negative regulation of transcription; GO:0016481; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; nervous system development; GO:0007399; sex determination, primary response to X:A ratio; GO:0007541" "NOT DNA binding; GO:0003677; ; GO:0003677; transcription corepressor activity; GO:0003714; ; GO:0003714; ; GO:0003714; protein binding; GO:0005515; ; GO:0003714; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides; GO:0016812 ; EC:3.5.2.-; ; GO:0005515; ; GO:0016812 ; EC:3.5.2.-" nucleus; GO:0005634 gro groucho "CG8384, m9/m10, m9,m10, m10, m9, E(spl)m9/m10, m9/10, E(spl)-WD, m9-m10, l(3)gro, E(spl)[2], BcDNA.LD33829, dAES2, dAES1, dGro, E(spl)gro, Groucho, Gro, Dgroucho, anon-WO0118547.385, BcDNA:LD33829, En-spl, BEST:GM01575, BEST:LD15161, groucho" CDMC21408 1 24 5 DAC08-M23 23-CG8384-RE_5 CG8384 ACGATGCGAGTGCTTTTAGTTTGTTTTATGTGAGCGGTTTTTGTAATTTAGCTGAAAAGTCAGACAGCG 69 FBan0008384 FBgn0001139 gro 3 3R "actin filament organization; GO:0007015; ectoderm development; GO:0007398; negative regulation of frizzled signaling pathway; GO:0045810; negative regulation of transcription; GO:0016481; negative regulation of transcription from RNA polymerase II promoter; GO:0000122; nervous system development; GO:0007399; sex determination, primary response to X:A ratio; GO:0007541" "NOT DNA binding; GO:0003677; ; GO:0003677; transcription corepressor activity; GO:0003714; ; GO:0003714; ; GO:0003714; protein binding; GO:0005515; ; GO:0003714; hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides; GO:0016812 ; EC:3.5.2.-; ; GO:0005515; ; GO:0016812 ; EC:3.5.2.-" nucleus; GO:0005634 gro groucho "CG8384, m9/m10, m9,m10, m10, m9, E(spl)m9/m10, m9/10, E(spl)-WD, m9-m10, l(3)gro, E(spl)[2], BcDNA.LD33829, dAES2, dAES1, dGro, E(spl)gro, Groucho, Gro, Dgroucho, anon-WO0118547.385, BcDNA:LD33829, En-spl, BEST:GM01575, BEST:LD15161, groucho" CDMC21409 1 25 5 DAC09-A12 3-CG12812-RA_6 CG12812 AGAGGAGGCCCTAAACCTCTTTCGCAAGCTTCTCGAGGATCTGCGTCCCTTCTACGACAACTTCATGGA 69 FBan0012812 FBgn0037781 CG12812 3 3R CG12812 CG12812 CDMC21409 1 26 5 DAC09-A12 3-CG12812-RA_6 CG12812 AGAGGAGGCCCTAAACCTCTTTCGCAAGCTTCTCGAGGATCTGCGTCCCTTCTACGACAACTTCATGGA 69 FBan0012812 FBgn0037781 CG12812 3 3R CG12812 CG12812 CDMC21410 1 1 6 DAC09-A24 24-CG12821-RA_1 CG12821 ACACAGATCAGGTATTTACATATTTTACAAAATCTCACTAGATGTGAAAATAAATCCACTTATCGTAGA 69 FBan0012821 FBgn0040780 CG12821 2 2R CG12821 CG12821 CDMC21410 1 2 6 DAC09-A24 24-CG12821-RA_1 CG12821 ACACAGATCAGGTATTTACATATTTTACAAAATCTCACTAGATGTGAAAATAAATCCACTTATCGTAGA 69 FBan0012821 FBgn0040780 CG12821 2 2R CG12821 CG12821 CDMC21411 1 3 6 DAC09-E12 9-CG12857-RA_5 CG12857 AGGACAATCCCGCCATGGATGTAGTTCGCAATTTGATGCTGACTAGGATCCGCAAGTTTCTGCTCACCT 69 FBan0012857 FBgn0033963 CG12857 2 2R CG12857 CG12857 CDMC21411 1 4 6 DAC09-E12 9-CG12857-RA_5 CG12857 AGGACAATCCCGCCATGGATGTAGTTCGCAATTTGATGCTGACTAGGATCCGCAAGTTTCTGCTCACCT 69 FBan0012857 FBgn0033963 CG12857 2 2R CG12857 CG12857 CDMC21412 1 5 6 DAC09-E24 1-CG12865-RA_1 CG12865 GGGTGGTGCATTAGGAGGTCTAACAAATCGCGGTGATGTTGGTCTGAATGCCGTATCGTTAGCCTTGGC 69 FBan0012865 FBgn0033957 CG12865 2 2R CG12865 CG12865 CDMC21412 1 6 6 DAC09-E24 1-CG12865-RA_1 CG12865 GGGTGGTGCATTAGGAGGTCTAACAAATCGCGGTGATGTTGGTCTGAATGCCGTATCGTTAGCCTTGGC 69 FBan0012865 FBgn0033957 CG12865 2 2R CG12865 CG12865 CDMC21413 1 7 6 DAC09-I12 13-CG12909-RA_1 CG12909 AGCTCGCCGATTCCTTGGAAGTCGAGGGTGAAATAGTTAAGATCGCTAGCTAGCCGAATATCCCACCTT 69 FBan0012909 FBgn0033507 CG12909 2 2R nucleolus; GO:0005730 CG12909 CG12909 CDMC21413 1 8 6 DAC09-I12 13-CG12909-RA_1 CG12909 AGCTCGCCGATTCCTTGGAAGTCGAGGGTGAAATAGTTAAGATCGCTAGCTAGCCGAATATCCCACCTT 69 FBan0012909 FBgn0033507 CG12909 2 2R nucleolus; GO:0005730 CG12909 CG12909 CDMC21414 1 9 6 DAC09-I24 15-CG12919-RA_4 CG12919 CGGACAGTGCATCCTCAGCCTCAAATGATGACAATGTGTTCGATGACTTTACCAGCTACAATGCCCACA 69 FBan0012919 FBgn0033483 egr 2 2R JNK cascade; GO:0007254; apoptosis; GO:0006915; immune response; GO:0006955; induction of apoptosis; GO:0006917; response to pathogenic bacteria; GO:0009618 tumor necrosis factor receptor binding; GO:0005164; protein binding; GO:0005515; ; GO:0005164; ; GO:0005164; ; GO:0005515; ; GO:0005164 membrane; GO:0016020 egr eiger "CG12919, CG12919, CG12919, regg1, Eiger, Ect1, dt1, tumor necrosis factor family member DT1, darth, Drosophila aspartate rich TNF homolog, BcDNA:RH51659, eiger" CDMC21414 1 10 6 DAC09-I24 15-CG12919-RA_4 CG12919 CGGACAGTGCATCCTCAGCCTCAAATGATGACAATGTGTTCGATGACTTTACCAGCTACAATGCCCACA 69 FBan0012919 FBgn0033483 egr 2 2R JNK cascade; GO:0007254; apoptosis; GO:0006915; immune response; GO:0006955; induction of apoptosis; GO:0006917; response to pathogenic bacteria; GO:0009618 tumor necrosis factor receptor binding; GO:0005164; protein binding; GO:0005515; ; GO:0005164; ; GO:0005164; ; GO:0005515; ; GO:0005164 membrane; GO:0016020 egr eiger "CG12919, CG12919, CG12919, regg1, Eiger, Ect1, dt1, tumor necrosis factor family member DT1, darth, Drosophila aspartate rich TNF homolog, BcDNA:RH51659, eiger" CDMC21415 1 11 6 DAC09-M12 23-CG12963-RB_2 CG12963 AGCAGTGTTTCCAATTTTAATTAATTAACGAATAACAAGGTTGTTGTGTGGGTTAATCAAACTGCACAT 69 FBan0012963 FBgn0034031 CG12963 2 2R CG12963 CG12963 BcDNA:AT28470 CDMC21415 1 12 6 DAC09-M12 23-CG12963-RB_2 CG12963 AGCAGTGTTTCCAATTTTAATTAATTAACGAATAACAAGGTTGTTGTGTGGGTTAATCAAACTGCACAT 69 FBan0012963 FBgn0034031 CG12963 2 2R CG12963 CG12963 BcDNA:AT28470 CDMC21416 1 13 6 DAC09-M24 23-CG12990-RA_11 CG12990 CGACTCAATGCCGTACGCAACGTTTTCTTCATCCAGAATTTGTTTCCCATTCAGTTTATGTGCGGATCG 69 FBan0012990 FBgn0030859 CG12990 X X CG12990 CG12990 CDMC21416 1 14 6 DAC09-M24 23-CG12990-RA_11 CG12990 CGACTCAATGCCGTACGCAACGTTTTCTTCATCCAGAATTTGTTTCCCATTCAGTTTATGTGCGGATCG 69 FBan0012990 FBgn0030859 CG12990 X X CG12990 CG12990 CDMC21417 1 15 6 DAC10-A11 17-CG10939-RA_1 CG10939 GCTCTGAGACGAAAAGGGTAGCCCAACCAACTACTTGTTATAATGTCAGGATGAGGAGCTAGAGCTGGT 69 FBan0010939 FBgn0010620 Sip1 2 2R cell homeostasis; GO:0019725; ion transport; GO:0006811 sodium:hydrogen antiporter regulator activity; GO:0017155; protein binding; GO:0005515; ; GO:0017155; ; GO:0005515 Sip1 SRY interacting protein 1 "CG10939, CG10939, l(2)06373, SRY interacting protein 1" CDMC21417 1 16 6 DAC10-A11 17-CG10939-RA_1 CG10939 GCTCTGAGACGAAAAGGGTAGCCCAACCAACTACTTGTTATAATGTCAGGATGAGGAGCTAGAGCTGGT 69 FBan0010939 FBgn0010620 Sip1 2 2R cell homeostasis; GO:0019725; ion transport; GO:0006811 sodium:hydrogen antiporter regulator activity; GO:0017155; protein binding; GO:0005515; ; GO:0017155; ; GO:0005515 Sip1 SRY interacting protein 1 "CG10939, CG10939, l(2)06373, SRY interacting protein 1" CDMC21418 1 17 6 DAC10-A23 6-CG10950-RA_3 CG10950 TGGCTGTTTGCGCGTCATGGACCAAATTTAGTATGCTTTCACCCGACCAAGTTCTGCAACGCAAACTGT 69 FBan0010950 FBgn0034205 CG10950 2 2R protein import into nucleus; GO:0006606 protein carrier activity; GO:0008320; ; GO:0008320 CG10950 CG10950 CDMC21418 1 18 6 DAC10-A23 6-CG10950-RA_3 CG10950 TGGCTGTTTGCGCGTCATGGACCAAATTTAGTATGCTTTCACCCGACCAAGTTCTGCAACGCAAACTGT 69 FBan0010950 FBgn0034205 CG10950 2 2R protein import into nucleus; GO:0006606 protein carrier activity; GO:0008320; ; GO:0008320 CG10950 CG10950 CDMC21419 1 19 6 DAC10-E11 14-CG10987-RA_2 CG10987 ATGTGAGCATTGACCCGATCTTGATGGCGTCTTGATGATGTCTTGACCTGATCACGATGGCGATACGAT 69 FBan0010987 FBgn0040647 CG10987 X X CG10987 CG10987 CDMC21419 1 20 6 DAC10-E11 14-CG10987-RA_2 CG10987 ATGTGAGCATTGACCCGATCTTGATGGCGTCTTGATGATGTCTTGACCTGATCACGATGGCGATACGAT 69 FBan0010987 FBgn0040647 CG10987 X X CG10987 CG10987 CDMC21420 1 21 6 DAC10-E23 2-CG10993-RA_1 CG10993 GGGCCCGTCTAAACGAACTCATGAACATCGTGCCGGTCACCAACTCTCAGAACCATCTCAAGTTCCTCA 69 FBan0010993 FBgn0030524 CG10993 X X mRNA binding; GO:0003729; ; GO:0003729 CG10993 CG10993 BcDNA:GH23064 CDMC21420 1 22 6 DAC10-E23 2-CG10993-RA_1 CG10993 GGGCCCGTCTAAACGAACTCATGAACATCGTGCCGGTCACCAACTCTCAGAACCATCTCAAGTTCCTCA 69 FBan0010993 FBgn0030524 CG10993 X X mRNA binding; GO:0003729; ; GO:0003729 CG10993 CG10993 BcDNA:GH23064 CDMC21421 1 23 6 DAC10-I11 2-CG11044-RA_1 CG11044 GGCGCCTTCTTAGCGATCGAGACTTCAAGCAGCTGACTGTGAATGTCAAGTCAGGAGCCTAGATGCCAA 69 FBan0011044 FBgn0034484 CG11044 2 2R CG11044 CG11044 CDMC21421 1 24 6 DAC10-I11 2-CG11044-RA_1 CG11044 GGCGCCTTCTTAGCGATCGAGACTTCAAGCAGCTGACTGTGAATGTCAAGTCAGGAGCCTAGATGCCAA 69 FBan0011044 FBgn0034484 CG11044 2 2R CG11044 CG11044 CDMC21422 1 25 6 DAC10-I23 18-CG11053-RA_1 CG11053 GACGTGATCTATGACAGTGAGATAGCTCAGTTGACGAATGTGACCCGAGAGGAGATGATTCTGGGCACC 69 FBan0011053 FBgn0031838 CG11053 2 2L peptidyl-proline hydroxylation to 4-hydroxy-L-proline; GO:0018401 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" CG11053 CG11053 CDMC21422 1 26 6 DAC10-I23 18-CG11053-RA_1 CG11053 GACGTGATCTATGACAGTGAGATAGCTCAGTTGACGAATGTGACCCGAGAGGAGATGATTCTGGGCACC 69 FBan0011053 FBgn0031838 CG11053 2 2L peptidyl-proline hydroxylation to 4-hydroxy-L-proline; GO:0018401 procollagen-proline 4-dioxygenase activity; GO:0004656 ; EC:1.14.11.2; ; GO:0004656 ; EC:1.14.11.2 "procollagen-proline, 2-oxoglutarate-4-dioxygenase complex; GO:0016222" CG11053 CG11053 CDMC21423 1 1 7 DAC10-M11 1-CG11092-RA_1 CG11092 CCCTTCTGAGCTCCGACCCTGACGACCCAAAACCAATGAAACGACTCAATCTTGTGCGTCTGATCGTCA 69 FBan0011092 FBgn0027537 CG11092 X X protein targeting; GO:0006605 transporter activity; GO:0005215; ; GO:0005215 nuclear pore; GO:0005643 CG11092 CG11092 BcDNA:LD21129 CDMC21423 1 2 7 DAC10-M11 1-CG11092-RA_1 CG11092 CCCTTCTGAGCTCCGACCCTGACGACCCAAAACCAATGAAACGACTCAATCTTGTGCGTCTGATCGTCA 69 FBan0011092 FBgn0027537 CG11092 X X protein targeting; GO:0006605 transporter activity; GO:0005215; ; GO:0005215 nuclear pore; GO:0005643 CG11092 CG11092 BcDNA:LD21129 CDMC21424 1 3 7 DAC10-M23 9-CG11099-RA_1 CG11099 CGGCAGCTCTCTCCAAGTTCATGAACCATGTGCGCATCTTCCACAACACCGCTATCAACTACATACCCA 69 FBan0011099 FBgn0034485 CG11099 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186 rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 integral to membrane; GO:0016021 CG11099 CG11099 CT31033 CDMC21424 1 4 7 DAC10-M23 9-CG11099-RA_1 CG11099 CGGCAGCTCTCTCCAAGTTCATGAACCATGTGCGCATCTTCCACAACACCGCTATCAACTACATACCCA 69 FBan0011099 FBgn0034485 CG11099 2 2R G-protein coupled receptor protein signaling pathway; GO:0007186 rhodopsin-like receptor activity; GO:0001584; ; GO:0001584 integral to membrane; GO:0016021 CG11099 CG11099 CT31033 CDMC21425 1 5 7 DAC11-A11 24-CG12171-RA_1 CG12171 ATACTTTTCAAGGATGTGATTCTATGTAAATGTAATAGTTTGCTAGAAATAAATAAAATGAAAACCGCC 69 FBan0012171 FBgn0037354 CG12171 3 3R lipid metabolism; GO:0006629 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0016614 ; EC:1.1.-.-" CG12171 CG12171 anon-WO0118547.83 CDMC21425 1 6 7 DAC11-A11 24-CG12171-RA_1 CG12171 ATACTTTTCAAGGATGTGATTCTATGTAAATGTAATAGTTTGCTAGAAATAAATAAAATGAAAACCGCC 69 FBan0012171 FBgn0037354 CG12171 3 3R lipid metabolism; GO:0006629 "oxidoreductase activity, acting on CH-OH group of donors; GO:0016614 ; EC:1.1.-.-; ; GO:0016614 ; EC:1.1.-.-" CG12171 CG12171 anon-WO0118547.83 CDMC21426 1 7 7 DAC11-A23 13-CG12187-RA_1 CG12187 ACCCGAGACACCTATATCTGTATGGTACACGACTAAAGTCCGAGAGTTGTGCGCATTTGTAGACCCCGT 69 FBan0012187 FBgn0035367 CG12187 3 3L protein binding; GO:0005515; ; GO:0005515 CG12187 CG12187 anon-EST:Posey171 CDMC21426 1 8 7 DAC11-A23 13-CG12187-RA_1 CG12187 ACCCGAGACACCTATATCTGTATGGTACACGACTAAAGTCCGAGAGTTGTGCGCATTTGTAGACCCCGT 69 FBan0012187 FBgn0035367 CG12187 3 3L protein binding; GO:0005515; ; GO:0005515 CG12187 CG12187 anon-EST:Posey171 CDMC21427 1 9 7 DAC11-E11 3-CG12220-RA_2 CG12220 GCCGAACAGTCCACAGATGATCTGAAAAACAAGCGCATCGTGGAGATGAAGAAGCCTCGTCCCATGTGG 69 FBan0012220 FBgn0039835 mRpL32 3 3R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL32 mitochondrial ribosomal protein L32 "CG12220, CG12220, L32, BcDNA:LD41522, mitochondrial ribosomal protein L32" CDMC21427 1 10 7 DAC11-E11 3-CG12220-RA_2 CG12220 GCCGAACAGTCCACAGATGATCTGAAAAACAAGCGCATCGTGGAGATGAAGAAGCCTCGTCCCATGTGG 69 FBan0012220 FBgn0039835 mRpL32 3 3R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL32 mitochondrial ribosomal protein L32 "CG12220, CG12220, L32, BcDNA:LD41522, mitochondrial ribosomal protein L32" CDMC21428 1 11 7 DAC11-E23 2-CG12231-RA_2 CG12231 CGGCGACAGGGAGATCAGTACCGAAGACATTGAACAGAGGGAGCCGGTAATGCTGAACATCTACGACCT 69 FBan0012231 FBgn0031026 CG12231 X X CG12231 CG12231 CDMC21428 1 12 7 DAC11-E23 2-CG12231-RA_2 CG12231 CGGCGACAGGGAGATCAGTACCGAAGACATTGAACAGAGGGAGCCGGTAATGCTGAACATCTACGACCT 69 FBan0012231 FBgn0031026 CG12231 X X CG12231 CG12231 CDMC21429 1 13 7 DAC11-I11 18-CG12268-RA_2 CG12268 AGGCGCTGTCGGAAGATTTAATTTGCAGATACAACAATAAGCTGCCCATAATCATCACAAGGCCCTCGA 69 FBan0012268 FBgn0039131 CG12268 3 3R oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG12268 CG12268 CDMC21429 1 14 7 DAC11-I11 18-CG12268-RA_2 CG12268 AGGCGCTGTCGGAAGATTTAATTTGCAGATACAACAATAAGCTGCCCATAATCATCACAAGGCCCTCGA 69 FBan0012268 FBgn0039131 CG12268 3 3R oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.- CG12268 CG12268 CDMC21430 1 15 7 DAC11-I23 2-CG12292-RA_2 CG12292 TGGGGAAGATCGGCTGCTTTCTGTGCATACTGGGATCCACCATCATTGTGATTCACTCGCCCAAAGAGA 69 FBan0012292 FBgn0032451 CG12292 2 2L CG12292 CG12292 CDMC21430 1 16 7 DAC11-I23 2-CG12292-RA_2 CG12292 TGGGGAAGATCGGCTGCTTTCTGTGCATACTGGGATCCACCATCATTGTGATTCACTCGCCCAAAGAGA 69 FBan0012292 FBgn0032451 CG12292 2 2L CG12292 CG12292 CDMC21431 1 17 7 DAC11-M11 23-CG1232-RA_1 CG1232 AGAAATCGTTTGTTTTTAACGACAGTTGGAAATAGTTAACGAGGGTCAAGCAATGGCAACAGAAGCGCA 69 FBan0001232 FBgn0003710 tipE 3 3L sodium ion transport; GO:0006814 voltage-gated sodium channel activity; GO:0005248; ; GO:0005248; ; GO:0005248 integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 tipE temperature-induced paralytic E "CG1232, tip-E, temperature-induced paralysis locus E, TipE" CDMC21431 1 18 7 DAC11-M11 23-CG1232-RA_1 CG1232 AGAAATCGTTTGTTTTTAACGACAGTTGGAAATAGTTAACGAGGGTCAAGCAATGGCAACAGAAGCGCA 69 FBan0001232 FBgn0003710 tipE 3 3L sodium ion transport; GO:0006814 voltage-gated sodium channel activity; GO:0005248; ; GO:0005248; ; GO:0005248 integral to plasma membrane; GO:0005887; plasma membrane; GO:0005886 tipE temperature-induced paralytic E "CG1232, tip-E, temperature-induced paralysis locus E, TipE" CDMC21432 1 19 7 DAC11-M23 3-CG12343-RA_1 CG12343 CGCCTTCTACGGTGGAGCACACACCACTTTGCATTCGAGGACGAAGGACACTCCAGGTGCTATTAACAA 69 FBan0012343 FBgn0033556 CG12343 2 2R CG12343 CG12343 CDMC21432 1 20 7 DAC11-M23 3-CG12343-RA_1 CG12343 CGCCTTCTACGGTGGAGCACACACCACTTTGCATTCGAGGACGAAGGACACTCCAGGTGCTATTAACAA 69 FBan0012343 FBgn0033556 CG12343 2 2R CG12343 CG12343 CDMC21433 1 21 7 DAC12-A11 23-CG7847-RA_5 CG7847 ACAATATGCTACAGTTAGCCTAGATAATATTTCACACATCCAAGAATGGTCAGGATAGGAAATCGAGAT 69 FBan0007847 FBgn0003499 sr 3 3R central nervous system development; GO:0007417; determination of muscle attachment site; GO:0016204; muscle development; GO:0007517; pigment metabolism; GO:0042440; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; tracheal epithelial cell migration (sensu Insecta); GO:0007427 nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003676; ; GO:0003702; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 sr stripe "CG7847, Stripe, l(3)06948, Sr, Striped, l(3)03999, l(3)06948b, stripe" CDMC21433 1 22 7 DAC12-A11 23-CG7847-RA_5 CG7847 ACAATATGCTACAGTTAGCCTAGATAATATTTCACACATCCAAGAATGGTCAGGATAGGAAATCGAGAT 69 FBan0007847 FBgn0003499 sr 3 3R central nervous system development; GO:0007417; determination of muscle attachment site; GO:0016204; muscle development; GO:0007517; pigment metabolism; GO:0042440; regulation of transcription; GO:0045449; regulation of transcription from RNA polymerase II promoter; GO:0006357; tracheal epithelial cell migration (sensu Insecta); GO:0007427 nucleic acid binding; GO:0003676; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003676; ; GO:0003702; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 sr stripe "CG7847, Stripe, l(3)06948, Sr, Striped, l(3)03999, l(3)06948b, stripe" CDMC21434 1 23 7 DAC12-A23 1-CG7856-RA_1 CG7856 GCTGTCGTTGCATTGGATCACCCATGACCTTGACAGCGTAGACCACTTCGACGTTTTTGTGGACAACGT 69 FBan0007856 FBgn0033056 CG7856 2 2R CG7856 CG7856 CDMC21434 1 24 7 DAC12-A23 1-CG7856-RA_1 CG7856 GCTGTCGTTGCATTGGATCACCCATGACCTTGACAGCGTAGACCACTTCGACGTTTTTGTGGACAACGT 69 FBan0007856 FBgn0033056 CG7856 2 2R CG7856 CG7856 CDMC21435 1 25 7 DAC12-E11 22-CG7890-RA_1 CG7890 AGGCTAGGCACCTTCACTGATCTGCTCAATTTACATATCACATCCATCCCCATTGGAGTATGCTTGACT 69 FBan0007890 FBgn0031005 CG7890 X X defense response; GO:0006952; polysaccharide metabolism; GO:0005976 heparin-glucosamine 3-O-sulfotransferase activity; GO:0008467 ; EC:2.8.2.23; ; GO:0008467 ; EC:2.8.2.23 CG7890 CG7890 CDMC21435 1 26 7 DAC12-E11 22-CG7890-RA_1 CG7890 AGGCTAGGCACCTTCACTGATCTGCTCAATTTACATATCACATCCATCCCCATTGGAGTATGCTTGACT 69 FBan0007890 FBgn0031005 CG7890 X X defense response; GO:0006952; polysaccharide metabolism; GO:0005976 heparin-glucosamine 3-O-sulfotransferase activity; GO:0008467 ; EC:2.8.2.23; ; GO:0008467 ; EC:2.8.2.23 CG7890 CG7890 CDMC21436 1 1 8 DAC12-E23 3-CG7903-RA_1 CG7903 ACCCGGGCCAAATATGGGCGGCAATAGAAGATTTTAAGCAAGTGCAATGCAGCAACGATGTTTGCCAGT 69 FBan0007903 FBgn0039730 CG7903 3 3R mRNA binding; GO:0003729; ; GO:0003729 CG7903 CG7903 cg7903 CDMC21436 1 2 8 DAC12-E23 3-CG7903-RA_1 CG7903 ACCCGGGCCAAATATGGGCGGCAATAGAAGATTTTAAGCAAGTGCAATGCAGCAACGATGTTTGCCAGT 69 FBan0007903 FBgn0039730 CG7903 3 3R mRNA binding; GO:0003729; ; GO:0003729 CG7903 CG7903 cg7903 CDMC21437 1 3 8 DAC12-I11 16-CG7930-RB_1 CG7930 TGGACACACGTTTGTTTGCTCCTGTTTGCACACTTGTTTCGCTTTTTATTTGCATTTTGCCCCAACCAT 69 FBan0007930 FBgn0010424 TpnC73F 3 3L calcium-mediated signaling; GO:0019722; ciliary or flagellar motility; GO:0001539; muscle contraction; GO:0006936 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005516; ; GO:0005509 flagellum (sensu Bacteria); GO:0009288 TpnC73F Troponin C at 73F "CG7930, CG7930, troponin C, TnC73F, TnC, DmTnC3, TNC, TpnC Ia, DmTpnC73F, DmTpnCIa" CDMC21437 1 4 8 DAC12-I11 16-CG7930-RB_1 CG7930 TGGACACACGTTTGTTTGCTCCTGTTTGCACACTTGTTTCGCTTTTTATTTGCATTTTGCCCCAACCAT 69 FBan0007930 FBgn0010424 TpnC73F 3 3L calcium-mediated signaling; GO:0019722; ciliary or flagellar motility; GO:0001539; muscle contraction; GO:0006936 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005516; ; GO:0005509 flagellum (sensu Bacteria); GO:0009288 TpnC73F Troponin C at 73F "CG7930, CG7930, troponin C, TnC73F, TnC, DmTnC3, TNC, TpnC Ia, DmTpnC73F, DmTpnCIa" CDMC21438 1 5 8 DAC12-I23 8-CG7941-RA_1 CG7941 ACCATTCAGAGTCGTCTCTCAGTTTAGACAAACGCACTCCAAGCCAGCAAAGATGTTCCGCTACCTGCT 69 FBan0007941 FBgn0036108 CG7941 3 3L structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG7941 CG7941 BcDNA:RE57116 CDMC21438 1 6 8 DAC12-I23 8-CG7941-RA_1 CG7941 ACCATTCAGAGTCGTCTCTCAGTTTAGACAAACGCACTCCAAGCCAGCAAAGATGTTCCGCTACCTGCT 69 FBan0007941 FBgn0036108 CG7941 3 3L structural constituent of larval cuticle (sensu Insecta); GO:0008010; ; GO:0008010 CG7941 CG7941 BcDNA:RE57116 CDMC21439 1 7 8 DAC12-M11 8-CG7973-RB_1 CG7973 CGCTCTGGCTATTTGATGGTCCAGCAGTGTCCTTTCTTCTACGGATGGGACTACGAGAAGCGATCCTGT 69 FBgn0036507 CDMC21439 1 8 8 DAC12-M11 8-CG7973-RB_1 CG7973 CGCTCTGGCTATTTGATGGTCCAGCAGTGTCCTTTCTTCTACGGATGGGACTACGAGAAGCGATCCTGT 69 FBgn0036507 CDMC21440 1 9 8 DAC12-M23 3-CG7987-RB_3 CG7987 TCGCGACCTCGAATGATTCACACAGAGAAAGCCAAGGTGACAAAAGGAGTTGGCGGAGACTCCACTAGT 69 FBan0007987 FBgn0038244 CG7987 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG7987 CG7987 anon-WO0118547.245 CDMC21440 1 10 8 DAC12-M23 3-CG7987-RB_3 CG7987 TCGCGACCTCGAATGATTCACACAGAGAAAGCCAAGGTGACAAAAGGAGTTGGCGGAGACTCCACTAGT 69 FBan0007987 FBgn0038244 CG7987 3 3R "cell proliferation; GO:0008283; nucleobase, nucleoside, nucleotide and nucleic acid metabolism; GO:0006139; regulation of transcription from RNA polymerase II promoter; GO:0006357; transcription from RNA polymerase II promoter; GO:0006366" nucleic acid binding; GO:0003676; transcription regulator activity; GO:0030528; ; GO:0003676; ; GO:0030528; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG7987 CG7987 anon-WO0118547.245 CDMC21441 1 11 8 DAC13-A11 9-CG13248-RA_1 CG13248 CCTCCTCACCGACCAGTGAGATGATAGAGGAAGTCTTAGCTGGAAGACTAAAGGCCCAGTTCAGGTGCT 69 FBan0013248 FBgn0036984 CG13248 3 3L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865 cationic amino acid transporter activity; GO:0015326; ; GO:0015326 membrane; GO:0016020 CG13248 CG13248 CDMC21441 1 12 8 DAC13-A11 9-CG13248-RA_1 CG13248 CCTCCTCACCGACCAGTGAGATGATAGAGGAAGTCTTAGCTGGAAGACTAAAGGCCCAGTTCAGGTGCT 69 FBan0013248 FBgn0036984 CG13248 3 3L amino acid metabolism; GO:0006520; amino acid transport; GO:0006865 cationic amino acid transporter activity; GO:0015326; ; GO:0015326 membrane; GO:0016020 CG13248 CG13248 CDMC21442 1 13 8 DAC13-A23 3-CG13260-RA_1 CG13260 ACGACGACAACAACCACAGCTTTGGGCTATACCGCCTATGAGCAGACAACGGTCTACTATCAGCAGCAA 69 FBan0013260 FBgn0032589 CG13260 2 2L CG13260 CG13260 CDMC21442 1 14 8 DAC13-A23 3-CG13260-RA_1 CG13260 ACGACGACAACAACCACAGCTTTGGGCTATACCGCCTATGAGCAGACAACGGTCTACTATCAGCAGCAA 69 FBan0013260 FBgn0032589 CG13260 2 2L CG13260 CG13260 CDMC21443 1 15 8 DAC13-E11 1-CG13299-RA_2 CG13299 GGTTCAAGAAACCCATCCTCAGGTTCGATCGTCTTTTTGCCACCGAAGAATCACCGTCGGGAAGTCGGA 69 FBan0013299 FBgn0035694 CG13299 3 3L CG13299 CG13299 CDMC21443 1 16 8 DAC13-E11 1-CG13299-RA_2 CG13299 GGTTCAAGAAACCCATCCTCAGGTTCGATCGTCTTTTTGCCACCGAAGAATCACCGTCGGGAAGTCGGA 69 FBan0013299 FBgn0035694 CG13299 3 3L CG13299 CG13299 CDMC21444 1 17 8 DAC13-E23 15-CG13310-RA_11 CG13310 CCAATCACCCGGATGTCTACGATGGCACTGGTAGTTGTCAGGTAACCGTTCAAAAACTGCATCCGGACA 69 FBan0013310 FBgn0035928 CG13310 3 3L CG13310 CG13310 CDMC21444 1 18 8 DAC13-E23 15-CG13310-RA_11 CG13310 CCAATCACCCGGATGTCTACGATGGCACTGGTAGTTGTCAGGTAACCGTTCAAAAACTGCATCCGGACA 69 FBan0013310 FBgn0035928 CG13310 3 3L CG13310 CG13310 CDMC21445 1 19 8 DAC13-I11 9-CG13335-RA_1 CG13335 CGGCAAGTTCGTGTATCCGGATGGAGCTGTCAATAATGTGTCCAAGATACGTCGCCAGAACCAGAACGT 69 FBan0013335 FBgn0033857 CG13335 2 2R CG13335 CG13335 "CG6183, CG6183, BcDNA:GM30351" CDMC21445 1 20 8 DAC13-I11 9-CG13335-RA_1 CG13335 CGGCAAGTTCGTGTATCCGGATGGAGCTGTCAATAATGTGTCCAAGATACGTCGCCAGAACCAGAACGT 69 FBan0013335 FBgn0033857 CG13335 2 2R CG13335 CG13335 "CG6183, CG6183, BcDNA:GM30351" CDMC21446 1 21 8 DAC13-I23 23-CG13340-RA_3 CG13340 ATCAGTGCAGTGATCAGTGGCCGATTCACATTCGACCAAGTGTTATATTTCGTTTGATATTTTCAAGTA 69 FBan0013340 FBgn0033868 CG13340 2 2R proteolysis; GO:0006508 leucyl aminopeptidase activity; GO:0004178 ; EC:3.4.11.1; ; GO:0004178 ; EC:3.4.11.1; manganese ion binding; GO:0030145; ; GO:0030145 cytoplasm; GO:0005737; intracellular; GO:0005622 CG13340 CG13340 CDMC21446 1 22 8 DAC13-I23 23-CG13340-RA_3 CG13340 ATCAGTGCAGTGATCAGTGGCCGATTCACATTCGACCAAGTGTTATATTTCGTTTGATATTTTCAAGTA 69 FBan0013340 FBgn0033868 CG13340 2 2R proteolysis; GO:0006508 leucyl aminopeptidase activity; GO:0004178 ; EC:3.4.11.1; ; GO:0004178 ; EC:3.4.11.1; manganese ion binding; GO:0030145; ; GO:0030145 cytoplasm; GO:0005737; intracellular; GO:0005622 CG13340 CG13340 CDMC21447 1 23 8 DAC13-M11 3-CG13392-RA_1 CG13392 CCCGCTGCTACACGTACCGTATTCCCTCGATTACGGAAAATCCCAGAGAAGTGTTTCTGTTGTGGCGGA 69 FBan0013392 FBgn0032033 CG13392 2 2L CG13392 CG13392 CDMC21447 1 24 8 DAC13-M11 3-CG13392-RA_1 CG13392 CCCGCTGCTACACGTACCGTATTCCCTCGATTACGGAAAATCCCAGAGAAGTGTTTCTGTTGTGGCGGA 69 FBan0013392 FBgn0032033 CG13392 2 2L CG13392 CG13392 CDMC21448 1 25 8 DAC13-M23 2-CG13398-RA_2 CG13398 CCCATGCAGACCCAAAGCCTGAATAGCATCTCTGCTGATACGGGAGATACGCAGGCGAAGAAGGTAACA 69 FBan0013398 FBgn0032042 CG13398 2 2L CG13398 CG13398 CDMC21448 1 26 8 DAC13-M23 2-CG13398-RA_2 CG13398 CCCATGCAGACCCAAAGCCTGAATAGCATCTCTGCTGATACGGGAGATACGCAGGCGAAGAAGGTAACA 69 FBan0013398 FBgn0032042 CG13398 2 2L CG13398 CG13398 CDMC21449 1 1 9 DAC14-A11 5-CG8612-RA_1 CG8612 CAAGAGCTCCACCCTAGTCACCGGTCTCAAGTACCGTGGAAAGTACGAGGGACACGAAGCCAAGC 65 FBan0008612 FBgn0028648 mRpL50 3 3L structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL50 mitochondrial ribosomal protein L50 "CG8612, ANON-65Eb, MRP-L50, BcDNA:RE06140, BcDNA:GM06185, anon-65Eb, mitochondrial ribosomal protein L50" CDMC21449 1 2 9 DAC14-A11 5-CG8612-RA_1 CG8612 CAAGAGCTCCACCCTAGTCACCGGTCTCAAGTACCGTGGAAAGTACGAGGGACACGAAGCCAAGC 65 FBan0008612 FBgn0028648 mRpL50 3 3L structural constituent of ribosome; GO:0003735; ; GO:0003735 mitochondrial large ribosomal subunit; GO:0005762 mRpL50 mitochondrial ribosomal protein L50 "CG8612, ANON-65Eb, MRP-L50, BcDNA:RE06140, BcDNA:GM06185, anon-65Eb, mitochondrial ribosomal protein L50" CDMC21450 1 3 9 DAC14-A23 3-CG8647-RA_1 CG8647 CGCTCCTGGTTCCAGTGCTAGGATCTTTTGAGCTGGTTGGACAGTCCATTAAAGATGCCCTGGCC 65 FBan0008647 FBgn0035729 CG8647 3 3L cell adhesion; GO:0007155 structural molecule activity; GO:0005198; ; GO:0005198 CG8647 CG8647 CDMC21450 1 4 9 DAC14-A23 3-CG8647-RA_1 CG8647 CGCTCCTGGTTCCAGTGCTAGGATCTTTTGAGCTGGTTGGACAGTCCATTAAAGATGCCCTGGCC 65 FBan0008647 FBgn0035729 CG8647 3 3L cell adhesion; GO:0007155 structural molecule activity; GO:0005198; ; GO:0005198 CG8647 CG8647 CDMC21451 1 5 9 DAC14-E11 3-CG8778-RA_1 CG8778 CATCCGGACTGCTGCTAGCGACACGAAGATGGGTCTGGTGGAGACAAGGTTAGCCATCATACCAG 65 FBan0008778 FBgn0033761 CG8778 2 2R fatty acid beta-oxidation; GO:0006635 AU-specific RNA binding; GO:0017091; enoyl-CoA hydratase activity; GO:0004300 ; EC:4.2.1.17; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0017091; ; GO:0004300 ; EC:4.2.1.17 CG8778 CG8778 CDMC21451 1 6 9 DAC14-E11 3-CG8778-RA_1 CG8778 CATCCGGACTGCTGCTAGCGACACGAAGATGGGTCTGGTGGAGACAAGGTTAGCCATCATACCAG 65 FBan0008778 FBgn0033761 CG8778 2 2R fatty acid beta-oxidation; GO:0006635 AU-specific RNA binding; GO:0017091; enoyl-CoA hydratase activity; GO:0004300 ; EC:4.2.1.17; oxidoreductase activity; GO:0016491 ; EC:1.-.-.-; ; GO:0016491 ; EC:1.-.-.-; ; GO:0017091; ; GO:0004300 ; EC:4.2.1.17 CG8778 CG8778 CDMC21452 1 7 9 DAC14-E23 3-CG8801-RA_1 CG8801 GTAATGCTCATGTCCACCGTACAGGAAACCGGTGTCATGGAGGTGAAAACCGAGGCATGTGAGCG 65 FBan0008801 FBgn0028473 CG8801 2 2R cell proliferation; GO:0008283 GTP binding; GO:0005525; ; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924 nucleus; GO:0005634 CG8801 CG8801 "CG30341, BcDNA:LD23830" CDMC21452 1 8 9 DAC14-E23 3-CG8801-RA_1 CG8801 GTAATGCTCATGTCCACCGTACAGGAAACCGGTGTCATGGAGGTGAAAACCGAGGCATGTGAGCG 65 FBan0008801 FBgn0028473 CG8801 2 2R cell proliferation; GO:0008283 GTP binding; GO:0005525; ; GO:0005525; ; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924 nucleus; GO:0005634 CG8801 CG8801 "CG30341, BcDNA:LD23830" CDMC21453 1 9 9 DAC14-I11 1-CG8922-RA_6 CG8922 TTTCTTCTGTGACAAACATGGCCGAAGTTGCTGAAAACGTGGTGGAGACCTTCGAGGAGCCAGCG 65 FBan0008922 FBgn0002590 RpS5a X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS5a Ribosomal protein S5a "CG8922 1(o), CG8922, CG8922, M[[o]], M(1)o, Minute 1(o), M(1)o 1(o), RpS5 1(o), transcript e 1(o), RS5 1(o), M(1)15D: Minute(1)15D 1(o), rpS5 1(o), RpS5: Ribosomal protein S5, M(1)15D: Minute(1)15D, M(1)34i28, Ribosomal protein S5, Minute(1)15D, RpS5, M(1)15D, Ribosomal protein S5a" CDMC21453 1 10 9 DAC14-I11 1-CG8922-RA_6 CG8922 TTTCTTCTGTGACAAACATGGCCGAAGTTGCTGAAAACGTGGTGGAGACCTTCGAGGAGCCAGCG 65 FBan0008922 FBgn0002590 RpS5a X X protein biosynthesis; GO:0006412 nucleic acid binding; GO:0003676; structural constituent of ribosome; GO:0003735; ; GO:0003676; ; GO:0003735; ; GO:0003735 cytosolic small ribosomal subunit (sensu Eukaryota); GO:0005843; ribosome; GO:0005840 RpS5a Ribosomal protein S5a "CG8922 1(o), CG8922, CG8922, M[[o]], M(1)o, Minute 1(o), M(1)o 1(o), RpS5 1(o), transcript e 1(o), RS5 1(o), M(1)15D: Minute(1)15D 1(o), rpS5 1(o), RpS5: Ribosomal protein S5, M(1)15D: Minute(1)15D, M(1)34i28, Ribosomal protein S5, Minute(1)15D, RpS5, M(1)15D, Ribosomal protein S5a" CDMC21454 1 11 9 DAC14-I23 3-CG8967-RA_3 CG8967 CAAGGGAGTAGTACGTCTGTTTGGCCTGTGTCGCGAAAAGGATCCGCACTACATGGTGCTGGAGT 65 FBan0008967 FBgn0004839 otk 2 2R axon guidance; GO:0007411; cell adhesion; GO:0007155; cell-cell adhesion; GO:0016337; cell-cell signaling; GO:0007267; defense response; GO:0006952; protein amino acid phosphorylation; GO:0006468; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 ATP binding; GO:0005524; ; GO:0005524; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; receptor activity; GO:0004872; ; GO:0004872; semaphorin receptor binding; GO:0030215; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; cell adhesion molecule binding; GO:0050839; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0050839; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004872; ; GO:0004714 ; EC:2.7.1.-; ; GO:0050839; ; GO:0030215 plasma membrane; GO:0005886 otk off-track "CG8967, CG8967, Dtrk, DTrk, OFT/TRK, CT25769, dTrk, Otk, OTK, Off-track, anon-WO2004063362.81, Dtkr, IGGtyk, Tk48D: Tyrosine kinase at 48D, Trk48D, Tyrosine kinase at 48D" CDMC21454 1 12 9 DAC14-I23 3-CG8967-RA_3 CG8967 CAAGGGAGTAGTACGTCTGTTTGGCCTGTGTCGCGAAAAGGATCCGCACTACATGGTGCTGGAGT 65 FBan0008967 FBgn0004839 otk 2 2R axon guidance; GO:0007411; cell adhesion; GO:0007155; cell-cell adhesion; GO:0016337; cell-cell signaling; GO:0007267; defense response; GO:0006952; protein amino acid phosphorylation; GO:0006468; transmembrane receptor protein tyrosine kinase signaling pathway; GO:0007169 ATP binding; GO:0005524; ; GO:0005524; transmembrane receptor protein tyrosine kinase activity; GO:0004714 ; EC:2.7.1.-; receptor activity; GO:0004872; ; GO:0004872; semaphorin receptor binding; GO:0030215; protein-tyrosine kinase activity; GO:0004713 ; EC:2.7.1.112; ; GO:0004713 ; EC:2.7.1.112; cell adhesion molecule binding; GO:0050839; protein kinase activity; GO:0004672 ; EC:2.7.1.37; ; GO:0050839; ; GO:0004713 ; EC:2.7.1.112; ; GO:0004672 ; EC:2.7.1.37; ; GO:0004872; ; GO:0004714 ; EC:2.7.1.-; ; GO:0050839; ; GO:0030215 plasma membrane; GO:0005886 otk off-track "CG8967, CG8967, Dtrk, DTrk, OFT/TRK, CT25769, dTrk, Otk, OTK, Off-track, anon-WO2004063362.81, Dtkr, IGGtyk, Tk48D: Tyrosine kinase at 48D, Trk48D, Tyrosine kinase at 48D" CDMC21455 1 13 9 DAC14-M11 2-CG9040-RA_1 CG9040 CTCCGCCGAAACGACCTCCAGTTCAACTCCAACCAAGGCAGAAAAAGCCAAGAAAACTGCTGCAC 65 FBan0009040 FBgn0036394 CG9040 3 3L CG9040 CG9040 BcDNA:LP10528 CDMC21455 1 14 9 DAC14-M11 2-CG9040-RA_1 CG9040 CTCCGCCGAAACGACCTCCAGTTCAACTCCAACCAAGGCAGAAAAAGCCAAGAAAACTGCTGCAC 65 FBan0009040 FBgn0036394 CG9040 3 3L CG9040 CG9040 BcDNA:LP10528 CDMC21456 1 15 9 DAC14-M23 23-CG9073-RA_3 CG9073 TGATTCAGTCGTTAGCGGTGATCGATCTGGTGAACAACTAGCACAGGATTTAAAATGGATAACAT 65 FBan0009073 FBgn0010423 TpnC47D 2 2R calcium-mediated signaling; GO:0019722; ciliary or flagellar motility; GO:0001539; muscle contraction; GO:0006936 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005516; ; GO:0005509 flagellum (sensu Bacteria); GO:0009288 TpnC47D Troponin C at 47D "CG9073, CG9073, troponin C, TnC47D, TnC, DmTnC2, TNC, TpnC Ib, DmTpnC47D, DmTpnCIb, BcDNA:RE34610" CDMC21456 1 16 9 DAC14-M23 23-CG9073-RA_3 CG9073 TGATTCAGTCGTTAGCGGTGATCGATCTGGTGAACAACTAGCACAGGATTTAAAATGGATAACAT 65 FBan0009073 FBgn0010423 TpnC47D 2 2R calcium-mediated signaling; GO:0019722; ciliary or flagellar motility; GO:0001539; muscle contraction; GO:0006936 calmodulin binding; GO:0005516; calcium ion binding; GO:0005509; ; GO:0005516; ; GO:0005509 flagellum (sensu Bacteria); GO:0009288 TpnC47D Troponin C at 47D "CG9073, CG9073, troponin C, TnC47D, TnC, DmTnC2, TNC, TpnC Ib, DmTpnC47D, DmTpnCIb, BcDNA:RE34610" CDMC21457 1 17 9 DAC15-A11 11-CG8204-RA_1 CG8204 TGCGACAAGGGAGTCCGACTTGAAAAAGACTGAAGTTGGCTACCAGGAGGAACCTACGCTTCATGTG 67 FBan0008204 FBgn0034033 CG8204 2 2R CG8204 CG8204 BcDNA:AT23078 CDMC21457 1 18 9 DAC15-A11 11-CG8204-RA_1 CG8204 TGCGACAAGGGAGTCCGACTTGAAAAAGACTGAAGTTGGCTACCAGGAGGAACCTACGCTTCATGTG 67 FBan0008204 FBgn0034033 CG8204 2 2R CG8204 CG8204 BcDNA:AT23078 CDMC21458 1 19 9 DAC15-A23 3-CG8338-RA_1 CG8338 CCAGTGGCATTGGTCGTTTCTACGCCAAGTCGGCAAAAATCATACGTTTCGTACGCCTGGGATGCAC 67 FBan0008338 FBgn0033907 mRpS16 2 2R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS16 mitochondrial ribosomal protein S16 "CG8338, MRP-S16, BcDNA:SD15809, mitochondrial ribosomal protein S16" CDMC21458 1 20 9 DAC15-A23 3-CG8338-RA_1 CG8338 CCAGTGGCATTGGTCGTTTCTACGCCAAGTCGGCAAAAATCATACGTTTCGTACGCCTGGGATGCAC 67 FBan0008338 FBgn0033907 mRpS16 2 2R protein biosynthesis; GO:0006412 structural constituent of ribosome; GO:0003735; ; GO:0003735; ; GO:0003735 mitochondrial small ribosomal subunit; GO:0005763 mRpS16 mitochondrial ribosomal protein S16 "CG8338, MRP-S16, BcDNA:SD15809, mitochondrial ribosomal protein S16" CDMC21459 1 21 9 DAC15-E11 3-CG8663-RC_2 CG8663 GGGTCTCGTGCGAGGGAGAAAATCCCGCTGATGTCGAGAACATAAAAGCACGCGACTACTATCCCCG 67 FBan0008663 FBgn0032946 nrv3 2 2L cation transport; GO:0006812; potassium ion transport; GO:0006813; sodium ion transport; GO:0006814 sodium:potassium-exchanging ATPase activity; GO:0005391 ; EC:3.6.3.9; ; GO:0005391 ; EC:3.6.3.9 plasma membrane; GO:0005886; sodium:potassium-exchanging ATPase complex; GO:0005890 nrv3 nervana 3 "CG8663, CG8663, CG8663, CG8663, JYbeta1, Nrv3: Nervana 3, Nervana 3" CDMC21459 1 22 9 DAC15-E11 3-CG8663-RC_2 CG8663 GGGTCTCGTGCGAGGGAGAAAATCCCGCTGATGTCGAGAACATAAAAGCACGCGACTACTATCCCCG 67 FBan0008663 FBgn0032946 nrv3 2 2L cation transport; GO:0006812; potassium ion transport; GO:0006813; sodium ion transport; GO:0006814 sodium:potassium-exchanging ATPase activity; GO:0005391 ; EC:3.6.3.9; ; GO:0005391 ; EC:3.6.3.9 plasma membrane; GO:0005886; sodium:potassium-exchanging ATPase complex; GO:0005890 nrv3 nervana 3 "CG8663, CG8663, CG8663, CG8663, JYbeta1, Nrv3: Nervana 3, Nervana 3" CDMC21460 1 23 9 DAC15-E23 6-CG8873-RA_2 CG8873 CGACTTCTATCCCAGCGATTTCCTTGTTTACTAGCCCACACTTCGTTCTCCCTCTTCCGCAGTGCCC 67 FBan0008873 FBgn0031652 CG8873 2 2L CG8873 CG8873 CDMC21460 1 24 9 DAC15-E23 6-CG8873-RA_2 CG8873 CGACTTCTATCCCAGCGATTTCCTTGTTTACTAGCCCACACTTCGTTCTCCCTCTTCCGCAGTGCCC 67 FBan0008873 FBgn0031652 CG8873 2 2L CG8873 CG8873 CDMC21461 1 25 9 DAC15-I11 2-CG9238-RB_1 CG9238 CCTATGATAAGGGTCAGAATCGCAACTCGAGCCAGCAAATAAGGTCCACCCTGACCGATGCCTTGGC 67 FBan0009238 FBgn0036428 CG9238 3 3L glycogen metabolism; GO:0005977 protein phosphatase 1 binding; GO:0008157; ; GO:0008157; protein phosphatase type 1 regulator activity; GO:0008599; ; GO:0008599 CG9238 CG9238 anon-WO0118547.400 CDMC21461 1 26 9 DAC15-I11 2-CG9238-RB_1 CG9238 CCTATGATAAGGGTCAGAATCGCAACTCGAGCCAGCAAATAAGGTCCACCCTGACCGATGCCTTGGC 67 FBan0009238 FBgn0036428 CG9238 3 3L glycogen metabolism; GO:0005977 protein phosphatase 1 binding; GO:0008157; ; GO:0008157; protein phosphatase type 1 regulator activity; GO:0008599; ; GO:0008599 CG9238 CG9238 anon-WO0118547.400 CDMC21462 1 1 10 DAC15-I23 2-CG9347-RA_1 CG9347 TGCAAACGAATCCCAATTATGCTACCCTCTTTCGTGGACGTCCCTTGAGATTCGTCCTGCCCTTGGG 67 FBgn0038171 CDMC21462 1 2 10 DAC15-I23 2-CG9347-RA_1 CG9347 TGCAAACGAATCCCAATTATGCTACCCTCTTTCGTGGACGTCCCTTGAGATTCGTCCTGCCCTTGGG 67 FBgn0038171 CDMC21463 1 3 10 DAC15-M11 2-CG9775-RA_1 CG9775 CGGAGCCGGAAATCAAGGAATGTCCGCGGTCAACTCTAGGCTGCTGAATGAATTCAAGAGGCTCCAC 67 FBan0009775 FBgn0037261 CG9775 3 3R CG9775 CG9775 CDMC21463 1 4 10 DAC15-M11 2-CG9775-RA_1 CG9775 CGGAGCCGGAAATCAAGGAATGTCCGCGGTCAACTCTAGGCTGCTGAATGAATTCAAGAGGCTCCAC 67 FBan0009775 FBgn0037261 CG9775 3 3R CG9775 CG9775 CDMC21464 1 5 10 DAC15-M23 16-CG9894-RA_1 CG9894 TCCGGAAAACCTCAAAGAAACCAATTCAAATATGTCGGCTGCTACGGAACAACAGAACAACGGCGAT 67 FBan0009894 FBgn0031453 CG9894 2 2L nucleus; GO:0005634 CG9894 CG9894 "clone 2.54, anon-EST:Liang-2.54" CDMC21464 1 6 10 DAC15-M23 16-CG9894-RA_1 CG9894 TCCGGAAAACCTCAAAGAAACCAATTCAAATATGTCGGCTGCTACGGAACAACAGAACAACGGCGAT 67 FBan0009894 FBgn0031453 CG9894 2 2L nucleus; GO:0005634 CG9894 CG9894 "clone 2.54, anon-EST:Liang-2.54" CDMC21465 1 7 10 DAC16-A11 18-CG4879-RA_4 CG4879 AGCATCCCACAGGAAAACGTCAAAGGAATCGTTATCGAACTTGAAGAAGGAAGGATCCGACTCCAGAGT 69 FBan0004879 FBgn0027375 RecQ5 3 3L DNA recombination; GO:0006310; DNA replication; GO:0006260 GTP binding; GO:0005525; ; GO:0005525; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; DNA helicase activity; GO:0003678; ; GO:0003678; ; GO:0003676; GTPase activity; GO:0003924; ; GO:0004386; ; GO:0003678; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003; single-stranded DNA-dependent ATP-dependent DNA helicase activity; GO:0017116; ; GO:0003924; ; GO:0004003; ; GO:0017116 RecQ5 homolog of RecQ "CG4879, DQ1, Drosophila homolog of RecQ, Q1, Dq1, RECQE, RECQ5, RECQ5/QE, Dm RECQ5/QE, DmRECQ5, anon-EST:Posey293, homolog of RecQ" CDMC21465 1 8 10 DAC16-A11 18-CG4879-RA_4 CG4879 AGCATCCCACAGGAAAACGTCAAAGGAATCGTTATCGAACTTGAAGAAGGAAGGATCCGACTCCAGAGT 69 FBan0004879 FBgn0027375 RecQ5 3 3L DNA recombination; GO:0006310; DNA replication; GO:0006260 GTP binding; GO:0005525; ; GO:0005525; nucleic acid binding; GO:0003676; ATP binding; GO:0005524; ; GO:0005524; helicase activity; GO:0004386; DNA helicase activity; GO:0003678; ; GO:0003678; ; GO:0003676; GTPase activity; GO:0003924; ; GO:0004386; ; GO:0003678; ATP-dependent DNA helicase activity; GO:0004003; ; GO:0004003; single-stranded DNA-dependent ATP-dependent DNA helicase activity; GO:0017116; ; GO:0003924; ; GO:0004003; ; GO:0017116 RecQ5 homolog of RecQ "CG4879, DQ1, Drosophila homolog of RecQ, Q1, Dq1, RECQE, RECQ5, RECQ5/QE, Dm RECQ5/QE, DmRECQ5, anon-EST:Posey293, homolog of RecQ" CDMC21466 1 9 10 DAC16-A23 17-CG4894-RC_1 CG4894 ACAATCGCCGCTAAGAGGACAGGGCAATCAGACTTACTCCTCATAGCACCCACATTGTAAGCTATACAT 69 FBan0004894 FBgn0001991 Ca-alpha1D 2 2L calcium ion transport; GO:0006816; embryonic development; GO:0009790; epithelial fluid transport; GO:0042045; muscle contraction; GO:0006936; neurotransmitter secretion; GO:0007269; proteolysis; GO:0006508; sodium ion transport; GO:0006814 voltage-gated calcium channel activity; GO:0005245; ; GO:0005245; voltage-gated sodium channel activity; GO:0005248; ; GO:0005245; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0005248 apical plasma membrane; GO:0016324; basolateral plasma membrane; GO:0016323; voltage-gated calcium channel complex; GO:0005891; voltage-gated sodium channel complex; GO:0001518 Ca-alpha1D Ca[2+]-channel protein alpha[[1]] subunit D "CG4894, CG4894, l(2)35Fa, l35Fa, DroCa1, alpha1, Dmca1D, DmCa1alpha1, Ca-alpha1, Ca[2+]-channel alpha1 subunit, Drosophila melanogaster calcium channel alpha[[1]] subunit DHP-sensitive, BG:DS02795.1, Ca-alpha1, Ca-_1D, Ca-a1D, calcium channel alpha-1 subunit, alpha1D, DmCa1D" CDMC21466 1 10 10 DAC16-A23 17-CG4894-RC_1 CG4894 ACAATCGCCGCTAAGAGGACAGGGCAATCAGACTTACTCCTCATAGCACCCACATTGTAAGCTATACAT 69 FBan0004894 FBgn0001991 Ca-alpha1D 2 2L calcium ion transport; GO:0006816; embryonic development; GO:0009790; epithelial fluid transport; GO:0042045; muscle contraction; GO:0006936; neurotransmitter secretion; GO:0007269; proteolysis; GO:0006508; sodium ion transport; GO:0006814 voltage-gated calcium channel activity; GO:0005245; ; GO:0005245; voltage-gated sodium channel activity; GO:0005248; ; GO:0005245; cysteine-type endopeptidase activity; GO:0004197 ; EC:3.4.22.-; ; GO:0004197 ; EC:3.4.22.-; ; GO:0005248 apical plasma membrane; GO:0016324; basolateral plasma membrane; GO:0016323; voltage-gated calcium channel complex; GO:0005891; voltage-gated sodium channel complex; GO:0001518 Ca-alpha1D Ca[2+]-channel protein alpha[[1]] subunit D "CG4894, CG4894, l(2)35Fa, l35Fa, DroCa1, alpha1, Dmca1D, DmCa1alpha1, Ca-alpha1, Ca[2+]-channel alpha1 subunit, Drosophila melanogaster calcium channel alpha[[1]] subunit DHP-sensitive, BG:DS02795.1, Ca-alpha1, Ca-_1D, Ca-a1D, calcium channel alpha-1 subunit, alpha1D, DmCa1D" CDMC21467 1 11 10 DAC16-E11 2-CG4921-RA_1 CG4921 AGCGCCAAGACGGGGGAGAATGTTGAAGAGGCCTTTCTCAAGTGCTCAAAGACCATACTGGCCAAAATT 69 FBan0004921 FBgn0016701 Rab4 2 2R endocytosis; GO:0006897; intracellular protein transport; GO:0006886; lysosomal transport; GO:0007041; phagocytosis; GO:0006909; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525 Rab4 Rab-protein 4 "CG4921, CG4921, CG4921, DRAB4, DmRab4" CDMC21467 1 12 10 DAC16-E11 2-CG4921-RA_1 CG4921 AGCGCCAAGACGGGGGAGAATGTTGAAGAGGCCTTTCTCAAGTGCTCAAAGACCATACTGGCCAAAATT 69 FBan0004921 FBgn0016701 Rab4 2 2R endocytosis; GO:0006897; intracellular protein transport; GO:0006886; lysosomal transport; GO:0007041; phagocytosis; GO:0006909; small GTPase mediated signal transduction; GO:0007264 GTP binding; GO:0005525; GTPase activity; GO:0003924; ; GO:0003924; ; GO:0003924; ; GO:0005525 Rab4 Rab-protein 4 "CG4921, CG4921, CG4921, DRAB4, DmRab4" CDMC21468 1 13 10 DAC16-E23 10-CG4930-RA_2 CG4930 TCCGCTCGAGGAATACCGAACTCTAATGAAGCGCTTTGTTCTGACCAAAATCATCGTTCCGGACAGCGT 69 FBan0004930 FBgn0028515 CG4930 2 2L CG4930 CG4930 BG:DS07473.2 CDMC21468 1 14 10 DAC16-E23 10-CG4930-RA_2 CG4930 TCCGCTCGAGGAATACCGAACTCTAATGAAGCGCTTTGTTCTGACCAAAATCATCGTTCCGGACAGCGT 69 FBan0004930 FBgn0028515 CG4930 2 2L CG4930 CG4930 BG:DS07473.2 CDMC21469 1 15 10 DAC16-I11 17-CG4956-RA_4 CG4956 GGCTCGGCTGTATGACCAATACCTCAGTCGATAGCTTAGTTCTGGAAAGACAGTATCCTGTGGCAGGTG 69 FBan0004956 FBgn0039370 CG4956 3 3R metal ion binding; GO:0046872; ; GO:0046872 CG4956 CG4956 CDMC21469 1 16 10 DAC16-I11 17-CG4956-RA_4 CG4956 GGCTCGGCTGTATGACCAATACCTCAGTCGATAGCTTAGTTCTGGAAAGACAGTATCCTGTGGCAGGTG 69 FBan0004956 FBgn0039370 CG4956 3 3R metal ion binding; GO:0046872; ; GO:0046872 CG4956 CG4956 CDMC21470 1 17 10 DAC16-I23 2-CG4972-RA_1 CG4972 GGCCATACAATACTTCCCCCGGTTTTACGATGAAGTTTCCAAGCTAACGAAGGAGGATCCCGCGGGTCA 69 FBan0004972 FBgn0032217 CG4972 2 2L CG4972 CG4972 CDMC21470 1 18 10 DAC16-I23 2-CG4972-RA_1 CG4972 GGCCATACAATACTTCCCCCGGTTTTACGATGAAGTTTCCAAGCTAACGAAGGAGGATCCCGCGGGTCA 69 FBan0004972 FBgn0032217 CG4972 2 2L CG4972 CG4972 CDMC21471 1 19 10 DAC16-M11 23-CG5001-RA_4 CG5001 AAACCGATCCCATTCATTTTGTAACAACCCATCGAGATCTTGCTCCCATTTTGCTTGTTTTTGTGTTCA 69 FBan0005001 FBgn0031322 CG5001 2 2L defense response; GO:0006952; protein folding; GO:0006457; response to heat; GO:0009408; response to stress; GO:0006950 unfolded protein binding; GO:0051082; ; GO:0051082 CG5001 CG5001 CDMC21471 1 20 10 DAC16-M11 23-CG5001-RA_4 CG5001 AAACCGATCCCATTCATTTTGTAACAACCCATCGAGATCTTGCTCCCATTTTGCTTGTTTTTGTGTTCA 69 FBan0005001 FBgn0031322 CG5001 2 2L defense response; GO:0006952; protein folding; GO:0006457; response to heat; GO:0009408; response to stress; GO:0006950 unfolded protein binding; GO:0051082; ; GO:0051082 CG5001 CG5001 CDMC21472 1 21 10 DAC16-M23 23-CG5011-RA_2 CG5011 TAGAATGCAGATAAGATTACAGCCTACTGAAACTATGTTACTTTTGTATAAAAGGTCTGGCAGGAGTGA 69 FBan0005011 FBgn0040723 CG5011 2 2L CG5011 CG5011 CDMC21472 1 22 10 DAC16-M23 23-CG5011-RA_2 CG5011 TAGAATGCAGATAAGATTACAGCCTACTGAAACTATGTTACTTTTGTATAAAAGGTCTGGCAGGAGTGA 69 FBan0005011 FBgn0040723 CG5011 2 2L CG5011 CG5011 CDMC21473 1 23 10 DAC17-A11 3-CG7092-RA_2 CG7092 GCGCACCATTCTGACCATCTTTTCCTCGAAGCGAATCATCCAGCCCGACTACAAGTACTGTCGTGGTGA 69 FBan0007092 FBgn0013809 Dhc16F X X "cell motility; GO:0006928; microtubule-based movement; GO:0007018; regulation of transcription, DNA-dependent; GO:0006355; two-component signal transduction system (phosphorelay); GO:0000160" "DNA binding; GO:0003677; motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; microtubule motor activity; GO:0003777; calcium ion binding; GO:0005509; ; GO:0005200; ; GO:0042623; ; GO:0003774; ; GO:0003777; ; GO:0005509; nucleotide binding; GO:0000166; ; GO:0003677; ; GO:0000166" axonemal dynein complex; GO:0005858; microtubule associated complex; GO:0005875 Dhc16F Dynein heavy chain at 16F "CG7092, CG7092, Dhc, dynein-related heavy chain polypeptide, DHC, dhc" CDMC21473 1 24 10 DAC17-A11 3-CG7092-RA_2 CG7092 GCGCACCATTCTGACCATCTTTTCCTCGAAGCGAATCATCCAGCCCGACTACAAGTACTGTCGTGGTGA 69 FBan0007092 FBgn0013809 Dhc16F X X "cell motility; GO:0006928; microtubule-based movement; GO:0007018; regulation of transcription, DNA-dependent; GO:0006355; two-component signal transduction system (phosphorelay); GO:0000160" "DNA binding; GO:0003677; motor activity; GO:0003774; structural constituent of cytoskeleton; GO:0005200; ATPase activity, coupled; GO:0042623; microtubule motor activity; GO:0003777; calcium ion binding; GO:0005509; ; GO:0005200; ; GO:0042623; ; GO:0003774; ; GO:0003777; ; GO:0005509; nucleotide binding; GO:0000166; ; GO:0003677; ; GO:0000166" axonemal dynein complex; GO:0005858; microtubule associated complex; GO:0005875 Dhc16F Dynein heavy chain at 16F "CG7092, CG7092, Dhc, dynein-related heavy chain polypeptide, DHC, dhc" CDMC21474 1 25 10 DAC17-A23 23-CG7101-RA_1 CG7101 CCTGAGCGACATCTCACGTCCAGAACTACGATTAATATATACTTAAGCAATGGATAAATGTAACGTTTT 69 FBan0007101 FBgn0030963 CG7101 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG7101 CG7101 CDMC21474 1 26 10 DAC17-A23 23-CG7101-RA_1 CG7101 CCTGAGCGACATCTCACGTCCAGAACTACGATTAATATATACTTAAGCAATGGATAAATGTAACGTTTT 69 FBan0007101 FBgn0030963 CG7101 X X nucleic acid binding; GO:0003676; ; GO:0003676; zinc ion binding; GO:0008270; ; GO:0008270 nucleus; GO:0005634 CG7101 CG7101 CDMC21475 1 1 11 DAC17-E11 3-CG7138-RA_3 CG7138 CGGCTTGATGAAGGATTCGACTGTGGGTGATCTGGATGAGGAACTGACTAACCTCAACCGGGACATGGT 69 FBan0007138 FBgn0031951 r2d2 2 2L "RNA interference, siRNA loading onto RISC; GO:0035087" double-stranded RNA binding; GO:0003725; ; GO:0003725 intracellular; GO:0005622 r2d2 r2d2 "CG7138, cg7138, R2D2" CDMC21475 1 2 11 DAC17-E11 3-CG7138-RA_3 CG7138 CGGCTTGATGAAGGATTCGACTGTGGGTGATCTGGATGAGGAACTGACTAACCTCAACCGGGACATGGT 69 FBan0007138 FBgn0031951 r2d2 2 2L "RNA interference, siRNA loading onto RISC; GO:0035087" double-stranded RNA binding; GO:0003725; ; GO:0003725 intracellular; GO:0005622 r2d2 r2d2 "CG7138, cg7138, R2D2" CDMC21476 1 3 11 DAC17-E23 2-CG7148-RA_1 CG7148 GGCCATTTGCAGCTGGACTCATTCGGCAGACTACCTAAAGCGCTATACCTGTATGACAGAGCTGCAGCT 69 FBan0007148 FBgn0046301 CG7148 3 3L CG7148 CG7148 BEST:GH10766 CDMC21476 1 4 11 DAC17-E23 2-CG7148-RA_1 CG7148 GGCCATTTGCAGCTGGACTCATTCGGCAGACTACCTAAAGCGCTATACCTGTATGACAGAGCTGCAGCT 69 FBan0007148 FBgn0046301 CG7148 3 3L CG7148 CG7148 BEST:GH10766 CDMC21477 1 5 11 DAC17-I11 23-CG7184-RA_17 CG7184 AGATTACTCGGATGAAGACTAAGCTTCTGAAGCAGAAGGAAACAAAAAAAAGAAACATCAGCCCAAAAG 69 FBan0007184 FBgn0029152 Mkrn1 3 3L Mkrn1 Makorin 1 "CG7184, MKRN1" CDMC21477 1 6 11 DAC17-I11 23-CG7184-RA_17 CG7184 AGATTACTCGGATGAAGACTAAGCTTCTGAAGCAGAAGGAAACAAAAAAAAGAAACATCAGCCCAAAAG 69 FBan0007184 FBgn0029152 Mkrn1 3 3L Mkrn1 Makorin 1 "CG7184, MKRN1" CDMC21478 1 7 11 DAC17-I23 8-CG7192-RA_1 CG7192 GCTCGCCCGAGCAATCAAACACCTCAGTTTCGTAGAACCCCTCATTGGAAAGCAACCGAATCAGAATCC 69 FBan0007192 FBgn0030894 CG7192 X X CG7192 CG7192 CDMC21478 1 8 11 DAC17-I23 8-CG7192-RA_1 CG7192 GCTCGCCCGAGCAATCAAACACCTCAGTTTCGTAGAACCCCTCATTGGAAAGCAACCGAATCAGAATCC 69 FBan0007192 FBgn0030894 CG7192 X X CG7192 CG7192 CDMC21479 1 9 11 DAC17-M11 23-CG7234-RI_4 CG7234 TGCGAAAAAGAAAAAAAAGACCAGGCGAATTGAAAAGTAGGGGAGTAAAAAGGCTTGCGAACATTCAGT 69 FBan0007234 FBgn0020429 GluRIIB 2 2L cation transport; GO:0006812; muscle contraction; GO:0006936; nerve-nerve synaptic transmission; GO:0007270; neuromuscular synaptic transmission; GO:0007274 kainate selective glutamate receptor activity; GO:0015277; alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity; GO:0004971; glutamate receptor activity; GO:0008066; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; ; GO:0015277; ; GO:0008066; ; GO:0004971 plasma membrane; GO:0005886 GluRIIB Glutamate receptor IIB "CG7234, DGluIIB, DGluRIIB, dGluRIIB, GluRIIb, DGluR-IIB, glurIIB, dglurIIB, glutamate receptor, Glu-RIIB" CDMC21479 1 10 11 DAC17-M11 23-CG7234-RI_4 CG7234 TGCGAAAAAGAAAAAAAAGACCAGGCGAATTGAAAAGTAGGGGAGTAAAAAGGCTTGCGAACATTCAGT 69 FBan0007234 FBgn0020429 GluRIIB 2 2L cation transport; GO:0006812; muscle contraction; GO:0006936; nerve-nerve synaptic transmission; GO:0007270; neuromuscular synaptic transmission; GO:0007274 kainate selective glutamate receptor activity; GO:0015277; alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity; GO:0004971; glutamate receptor activity; GO:0008066; ligand-gated ion channel activity; GO:0015276; ; GO:0015276; ; GO:0015277; ; GO:0008066; ; GO:0004971 plasma membrane; GO:0005886 GluRIIB Glutamate receptor IIB "CG7234, DGluIIB, DGluRIIB, dGluRIIB, GluRIIb, DGluR-IIB, glurIIB, dglurIIB, glutamate receptor, Glu-RIIB" CDMC21480 1 11 11 DAC17-M23 2-CG7251-RA_1 CG7251 GGCATGGACTCACTGCGAGGCACCATATCTCAACTCTATGTGAATCCCACTCCATGGATGGGTCCAGTT 69 FBan0007251 FBgn0031723 CG7251 2 2L CG7251 CG7251 "bs11h10.y1, anon-WO0140519.103" CDMC21480 1 12 11 DAC17-M23 2-CG7251-RA_1 CG7251 GGCATGGACTCACTGCGAGGCACCATATCTCAACTCTATGTGAATCCCACTCCATGGATGGGTCCAGTT 69 FBan0007251 FBgn0031723 CG7251 2 2L CG7251 CG7251 "bs11h10.y1, anon-WO0140519.103" CDMC21481 1 13 11 DAC18-A11 3-CG32398-RA_1 CG32398 CGCAGTCTCAGCTCAACACAGGCAGCTCAAATATGCCAAAAGCTGTGGTTCTGCTCGCTGTAGTTGACA 69 FBan0032398 FBgn0052398 CG32398 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32398 CG32398 CDMC21481 1 14 11 DAC18-A11 3-CG32398-RA_1 CG32398 CGCAGTCTCAGCTCAACACAGGCAGCTCAAATATGCCAAAAGCTGTGGTTCTGCTCGCTGTAGTTGACA 69 FBan0032398 FBgn0052398 CG32398 3 3L biological process unknown; GO:0000004 molecular function unknown; GO:0005554; ; GO:0005554 cellular component unknown; GO:0008372 CG32398 CG32398 CDMC21482 1 15 11 DAC18-A23 22-CG32405-RA_1 CG32405 AGCCAGGACCTTTTGAAAAGTCTCTACCAGAATCCAATCCAACTAAACATGCAGTCCTCCAGCATCTGT 69 FBan0032405 FBgn0052405 CG32405 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG32405 CG32405 "CG10461, CG10461, BcDNA:RE31218" CDMC21482 1 16 11 DAC18-A23 22-CG32405-RA_1 CG32405 AGCCAGGACCTTTTGAAAAGTCTCTACCAGAATCCAATCCAACTAAACATGCAGTCCTCCAGCATCTGT 69 FBan0032405 FBgn0052405 CG32405 3 3L structural constituent of cuticle (sensu Insecta); GO:0005214; ; GO:0005214 CG32405 CG32405 "CG10461, CG10461, BcDNA:RE31218" CDMC21483 1 17 11 DAC18-E11 17-CG32440-RA_2 CG32440 TCTCGGCCCTAAATTGTCCGTTCGACGAGGAATTTGCCTTTTTTTCGTTTCAATCCCAAGATCAGTGGG 69 FBan0032440 FBgn0052440 CG32440 3 3L CG32440 CG32440 "CG5051, CG5051, CG5051, bs36c07.y1" CDMC21483 1 18 11 DAC18-E11 17-CG32440-RA_2 CG32440 TCTCGGCCCTAAATTGTCCGTTCGACGAGGAATTTGCCTTTTTTTCGTTTCAATCCCAAGATCAGTGGG 69 FBan0032440 FBgn0052440 CG32440 3 3L CG32440 CG32440 "CG5051, CG5051, CG5051, bs36c07.y1" CDMC21484 1 19 11 DAC18-E23 2-CG3244-RA_1 CG3244 CGTCTGGTCTCGTCTGGTTGTCTGCTTGGACAATTCGGCGACTACAGTATAGAAACCGTGCTGTGCAGT 69 FBan0003244 FBgn0031629 CG3244 2 2L sugar binding; GO:0005529; ; GO:0005529 CG3244 CG3244 CDMC21484 1 20 11 DAC18-E23 2-CG3244-RA_1 CG3244 CGTCTGGTCTCGTCTGGTTGTCTGCTTGGACAATTCGGCGACTACAGTATAGAAACCGTGCTGTGCAGT 69 FBan0003244 FBgn0031629 CG3244 2 2L sugar binding; GO:0005529; ; GO:0005529 CG3244 CG3244 CDMC21485 1 21 11 DAC18-I11 3-CG32483-RA_2 CG32483 TCGAATGTCATCTGGGGATCGCAGAGTGGGACCACTTTTGACATCCACAGAACGGACTTCATGAAGCCA 69 FBan0032483 FBgn0052483 CG32483 3 3L protein metabolism; GO:0019538; proteolysis; GO:0006508 serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; serine carboxypeptidase activity; GO:0004185 ; EC:3.4.16.-; ; GO:0004185 ; EC:3.4.16.- CG32483 CG32483 CDMC21485 1 22 11 DAC18-I11 3-CG32483-RA_2 CG32483 TCGAATGTCATCTGGGGATCGCAGAGTGGGACCACTTTTGACATCCACAGAACGGACTTCATGAAGCCA 69 FBan0032483 FBgn0052483 CG32483 3 3L protein metabolism; GO:0019538; proteolysis; GO:0006508 serine-type peptidase activity; GO:0008236; peptidase activity; GO:0008233 ; EC:3.4.-.-; ; GO:0008236; ; GO:0008233 ; EC:3.4.-.-; serine carboxypeptidase activity; GO:0004185 ; EC:3.4.16.-; ; GO:0004185 ; EC:3.4.16.- CG32483 CG32483 CDMC21486 1 23 11 DAC18-I23 3-CG32491-RB_1 CG32491 CCTAGCAACCTGGCTGACTTTGGTAACGAGAGCTTCTTGCCCAAAACCAAGGGTAAACGGCCACAGAAT 69 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC21486 1 24 11 DAC18-I23 3-CG32491-RB_1 CG32491 CCTAGCAACCTGGCTGACTTTGGTAACGAGAGCTTCTTGCCCAAAACCAAGGGTAAACGGCCACAGAAT 69 FBan0032491 FBgn0002781 mod(mdg4) 3 3R chromatin assembly or disassembly; GO:0006333; establishment and/or maintenance of chromatin architecture; GO:0006325; germ cell migration; GO:0008354; induction of apoptosis; GO:0006917; nuclear organization and biogenesis; GO:0006997; oogenesis (sensu Insecta); GO:0009993; regulation of apoptosis; GO:0042981; regulation of chromatin assembly or disassembly; GO:0001672; regulation of transcription from RNA polymerase II promoter; GO:0006357; sex determination; GO:0007530; transmission of nerve impulse; GO:0019226 chromatin binding; GO:0003682; phosphatidate phosphatase activity; GO:0008195 ; EC:3.1.3.4; RNA polymerase II transcription factor activity; GO:0003702; ; GO:0003702; ; GO:0008195 ; EC:3.1.3.4; protein binding; GO:0005515; ; GO:0005515; ; GO:0003682 chromatin; GO:0000785; nucleus; GO:0005634; plasma membrane; GO:0005886; polytene chromosome; GO:0005700 mod(mdg4) modifier of mdg4 "CG7836, CG15500, CG32491, CG15501, CG15802, CG18151, CG8076, CG7859, CG7836, CG15500, E-var(3)1, E(var)3-93D, l(3)L3101, doom, mod(mdg-4), Mod[mdg4], Doom, bpd, branch point disrupted, E-(var)3-93D, Mod(mdg)4, modifier of midget4, Mod(mdg4), modifier mdg4, pf-2, mod(mdg4)67.2, MOD(MDG4)56.3, Modifier of mdg4 67.2, Modifier67.2, BcDNA:SD03001, E(var)129, E(var)93D: Enhancer of variegation 93D, E-var(3)3, l(3)03852, l(3)j2B7, mod(gypsy), mod2.2, BcDNA:GH07769, Enhancer of variegation 93D" CDMC21487 1 25 11 DAC18-M11 16-CG3250-RA_1 CG3250 GCCGTCGAGAAGAACGAATAGCCGAGCCAAATTTAATGTGACTACCATTGAAGGAACTGGACCGGAATT 69 FBan0003250 FBgn0010401 Os-C 3 3R biological process unknown; GO:0000004 pheromone binding; GO:0005550; ; GO:0005550 cellular component unknown; GO:0008372 Os-C Os-C "CG3250, OS-C, Os-c" CDMC21487 1 26 11 DAC18-M11 16-CG3250-RA_1 CG3250 GCCGTCGAGAAGAACGAATAGCCGAGCCAAATTTAATGTGACTACCATTGAAGGAACTGGACCGGAATT 69 FBan0003250 FBgn0010401 Os-C 3 3R biological process unknown; GO:0000004 pheromone binding; GO:0005550; ; GO:0005550 cellular component unknown; GO:0008372 Os-C Os-C "CG3250, OS-C, Os-c" CDMC21488 1 1 12 DAC18-M23 23-CG32527-RA_8 CG32527 AGGTTTTACATGTTTTTCGGGCTATGTTGCACACATATCCAAAATATTCAGTTCATATCCGCACAACTG 69 FBgn0052527 CDMC21488 1 2 12 DAC18-M23 23-CG32527-RA_8 CG32527 AGGTTTTACATGTTTTTCGGGCTATGTTGCACACATATCCAAAATATTCAGTTCATATCCGCACAACTG 69 FBgn0052527 CDMC21489 1 3 12 DAC19-A11 5-CG8132-RA_3 CG8132 CAGCGATCCCGTGCCAATGACAACCAACTCTTTGTGGTCACAACATCACCAGCCCGTGACACAAG 65 FBan0008132 FBgn0037687 CG8132 3 3R nitrogen compound metabolism; GO:0006807 nitrilase activity; GO:0000257 ; EC:3.5.5.1; ; GO:0000257 ; EC:3.5.5.1 CG8132 CG8132 CDMC21489 1 4 12 DAC19-A11 5-CG8132-RA_3 CG8132 CAGCGATCCCGTGCCAATGACAACCAACTCTTTGTGGTCACAACATCACCAGCCCGTGACACAAG 65 FBan0008132 FBgn0037687 CG8132 3 3R nitrogen compound metabolism; GO:0006807 nitrilase activity; GO:0000257 ; EC:3.5.5.1; ; GO:0000257 ; EC:3.5.5.1 CG8132 CG8132 CDMC21490 1 5 12 DAC19-A23 3-CG8171-RA_3 CG8171 CAATCGGAGAAGCCACAACATTTCACCAAGATCAACGAAGACGATGTGCTCGCGTCGGCCCAGTC 65 FBan0008171 FBgn0000996 dup 2 2R DNA replication; GO:0006260; DNA replication checkpoint; GO:0000076; DNA-dependent DNA replication; GO:0006261; chorion gene amplification; GO:0007307; eggshell formation (sensu Insecta); GO:0007304 DNA binding; GO:0003677; ; GO:0003677 cytoplasm; GO:0005737; nuclear origin of replication recognition complex; GO:0005664; nucleus; GO:0005634; replication fork; GO:0005657 dup double parked "CG8171, CG8171, CG8171, fs(2)51Fa: female sterile(2)51Fa, l(2)51Ec, fs(2)PA77, fs(2)ltoPA77, speckled, l(2)k03308, 19k, double parked, DUP/CDT1, Cdt1, Dup, cdt1/dup, DUP, Double-parked, CDT1/DUP, CDT1, anon-WO0257455.31, female sterile(2)51Fa, lethal(2)51Ec, fs(2)51Fa" CDMC21490 1 6 12 DAC19-A23 3-CG8171-RA_3 CG8171 CAATCGGAGAAGCCACAACATTTCACCAAGATCAACGAAGACGATGTGCTCGCGTCGGCCCAGTC 65 FBan0008171 FBgn0000996 dup 2 2R DNA replication; GO:0006260; DNA replication checkpoint; GO:0000076; DNA-dependent DNA replication; GO:0006261; chorion gene amplification; GO:0007307; eggshell formation (sensu Insecta); GO:0007304 DNA binding; GO:0003677; ; GO:0003677 cytoplasm; GO:0005737; nuclear origin of replication recognition complex; GO:0005664; nucleus; GO:0005634; replication fork; GO:0005657 dup double parked "CG8171, CG8171, CG8171, fs(2)51Fa: female sterile(2)51Fa, l(2)51Ec, fs(2)PA77, fs(2)ltoPA77, speckled, l(2)k03308, 19k, double parked, DUP/CDT1, Cdt1, Dup, cdt1/dup, DUP, Double-parked, CDT1/DUP, CDT1, anon-WO0257455.31, female sterile(2)51Fa, lethal(2)51Ec, fs(2)51Fa" CDMC21491 1 7 12 DAC19-E11 8-CG8251-RA_4 CG8251 CCTGTTATCCTGGCGTTGCTAGGCGTTTGGTACTCCAACTTCTTCAAGGCGGAAACACATGCCCT 65 FBan0008251 FBgn0003074 Pgi 2 2R gluconeogenesis; GO:0006094; glycolysis; GO:0006096 phosphogluconate dehydrogenase (decarboxylating) activity; GO:0004616 ; EC:1.1.1.44; glucose-6-phosphate isomerase activity; GO:0004347 ; EC:5.3.1.9; ; GO:0004616 ; EC:1.1.1.44; ; GO:0004347 ; EC:5.3.1.9; ; GO:0004616 ; EC:1.1.1.44